data_2l7u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l7u _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.784 0.326 . . . . 74.41 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.05 132.63 36.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.53 110.842 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -90.05 121.22 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.23 110.849 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.65 122.42 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.21 111.178 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -95.07 141.62 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.12 111.134 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.02 167.19 25.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.21 111.015 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.64 148.45 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.24 110.843 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.0 mt -52.45 120.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 75.3 111.132 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.28 8.92 67.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 73.23 112.526 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -101.71 138.32 19.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.652 0.739 . . . . 73.43 110.889 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 143.14 49.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.677 2.251 . . . . 72.55 112.258 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.4 tp -145.92 141.36 27.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 71.42 110.877 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.9 139.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.32 111.197 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.2 mt -132.19 149.02 52.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.445 . . . . 73.45 110.878 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -112.72 153.24 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 75.24 110.918 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 t -105.83 100.71 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 62.4 110.895 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -54.19 128.91 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.855 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -40.84 1.8 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.756 . . . . 64.43 112.499 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.25 129.74 42.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.539 0.685 . . . . 72.05 111.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -164.22 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.555 2.17 . . . . 74.54 112.354 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -48.46 -49.12 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 74.51 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.897 0.379 . . . . 73.54 110.835 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 pp -136.2 149.4 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 61.44 110.877 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -121.28 127.03 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 75.43 110.862 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -118.08 144.72 45.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 72.35 110.944 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -136.77 139.27 41.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 73.53 110.902 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.42 138.9 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 75.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -115.21 119.31 35.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.846 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.7 p -136.28 179.49 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 73.54 111.183 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.4 -132.11 14.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.799 -0.715 . . . . 72.13 112.499 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -112.68 -37.76 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 74.54 110.828 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 t -179.47 -29.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 74.21 111.141 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -102.12 34.26 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.84 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.53 -6.24 8.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 73.41 111.126 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -59.31 128.98 39.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.5 110.861 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.24 158.88 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 72.11 110.908 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -101.65 123.76 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.43 111.129 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.1 mt -87.25 144.02 27.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.2 -0.454 . . . . 75.42 110.941 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 75.52 110.854 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.741 0.305 . . . . 75.22 111.207 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -119.11 160.44 22.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.826 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.01 128.73 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.34 111.108 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.51 156.46 90.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.686 0.755 . . . . 74.41 110.893 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -22.97 31.41 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.74 2.293 . . . . 75.1 112.301 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -82.98 0.05 46.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 73.22 110.903 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.61 13.35 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 73.41 112.431 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.4 m -109.68 179.0 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 61.24 110.868 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 tp -128.36 128.33 44.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 73.31 110.961 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -125.95 129.73 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.843 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -117.19 130.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 75.13 110.84 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -34.8 13.91 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 72.42 112.339 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.21 100.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.41 111.111 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -73.45 114.68 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 71.55 111.143 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.29 166.94 42.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.824 -0.703 . . . . 61.23 112.433 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -31.05 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.308 . . . . 73.05 111.116 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -76.25 -21.96 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.41 110.93 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -5.44 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 74.44 110.909 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.23 140.47 55.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 74.3 110.877 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.7 -147.46 12.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.654 -0.784 . . . . 71.55 112.449 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.57 135.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.952 0.406 . . . . 70.05 111.041 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -100.05 124.92 45.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 71.25 110.852 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 127.25 40.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 75.31 110.884 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 149.45 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 61.1 110.945 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -142.62 126.24 16.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 73.41 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.48 31.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.43 111.093 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.9 tpp -130.27 125.86 35.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -86.49 170.79 11.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 74.31 110.859 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -72.7 -17.58 61.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 71.25 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -72.1 -21.04 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.928 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.05 -21.46 17.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.708 . . . . 74.54 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 145.88 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.279 . . . . 72.02 110.903 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.25 145.11 32.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 74.41 110.903 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.07 127.86 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.05 111.102 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 145.5 30.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.936 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.7 m -144.33 121.23 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 75.51 110.916 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -126.63 119.3 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 71.42 110.913 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -132.03 118.11 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.05 110.874 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.49 133.56 33.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 64.12 110.851 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.28 138.36 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.22 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 127.96 39.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 74.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.6 m -87.42 -177.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 75.52 111.102 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -60.64 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.953 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -72.1 143.53 49.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 63.03 110.947 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.28 159.52 49.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.7 0.762 . . . . 73.13 111.084 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.681 2.254 . . . . 64.41 112.415 179.818 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.751 0.31 . . . . 72.03 111.117 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.91 138.19 31.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.915 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.98 120.88 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.31 110.887 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.13 127.47 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 74.51 111.144 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -95.31 141.78 28.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 74.24 111.215 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -145.01 165.41 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 54.11 111.069 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.19 149.5 42.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.02 110.916 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.3 mt -57.41 121.04 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 65.34 111.069 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 8.13 73.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.777 -0.725 . . . . 70.45 112.586 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -102.7 138.69 19.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.702 . . . . 72.24 110.911 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 143.95 51.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 72.12 112.269 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.0 tp -144.96 141.08 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 74.23 110.911 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.44 145.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 73.34 111.146 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.2 mt -131.25 148.09 52.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 63.14 110.941 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 152.75 29.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 70.12 110.961 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.0 t -106.18 100.6 10.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 64.13 110.897 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 124.35 14.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.841 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.93 -42.65 1.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.774 -0.726 . . . . 65.51 112.491 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 128.19 51.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.538 0.685 . . . . 54.32 111.153 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -164.46 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.62 2.213 . . . . 71.43 112.316 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -47.89 46.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 75.31 110.841 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.554 0.693 . . . . 71.11 110.865 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.889 0.376 . . . . 74.13 110.829 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.64 161.75 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.957 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -121.26 147.63 45.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 74.23 110.895 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -124.23 137.96 54.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 74.31 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -141.23 140.13 33.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 74.52 110.859 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 tp -138.1 134.26 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 74.42 110.988 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -116.01 121.17 41.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 64.53 110.879 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -138.99 179.37 6.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 74.34 111.195 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.4 10.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 64.45 112.412 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -112.42 -36.63 5.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.888 0.375 . . . . 75.45 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.74 -29.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 74.33 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -102.57 33.78 3.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 62.22 110.861 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.68 -6.42 8.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 73.41 111.237 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.65 132.6 54.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 70.01 110.939 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 158.61 39.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 73.13 110.931 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.72 120.24 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.053 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 147.95 23.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 71.52 110.938 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.699 0.761 . . . . 63.2 110.846 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.746 0.308 . . . . 74.25 111.136 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.0 164.22 20.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 75.34 110.963 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.57 129.95 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 75.11 111.108 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.8 mt -69.99 159.05 85.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 75.33 110.882 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -21.75 32.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 55.42 112.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.33 1.37 41.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.416 . . . . 54.22 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.08 27.44 21.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 73.34 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.7 m -111.58 -179.0 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 73.42 110.918 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.5 tp -128.82 129.99 46.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.84 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -123.64 133.8 53.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 73.21 110.876 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.24 123.88 31.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 73.33 110.913 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.2 19.44 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.727 2.284 . . . . 74.52 112.406 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.61 103.15 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.01 111.116 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.6 m -71.7 113.0 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 72.13 111.188 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.92 156.94 24.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.818 -0.706 . . . . 72.12 112.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.28 -31.67 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 75.43 111.11 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -77.34 -24.12 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 61.04 110.868 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -4.04 54.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.895 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -58.05 141.84 48.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 73.04 110.889 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.73 -145.77 11.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 61.1 112.548 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.41 135.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.841 0.353 . . . . 70.15 111.165 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -98.88 134.78 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.54 110.947 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.91 126.35 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 73.2 110.861 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 45.9 t -122.62 150.22 42.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -146.71 129.76 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.911 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.05 31.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.12 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.6 ttm -130.64 126.75 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.428 . . . . 75.44 110.86 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -85.81 170.42 12.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 60.22 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -73.26 -17.62 61.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.874 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -71.63 -19.66 62.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 74.22 110.928 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.18 -21.95 19.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 73.53 112.45 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 144.35 28.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 73.44 110.87 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.64 144.39 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 75.14 110.918 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.54 132.3 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.497 . . . . 75.15 111.167 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -105.21 143.19 33.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.218 -0.446 . . . . 73.4 110.88 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -147.37 120.43 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.877 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.66 124.4 41.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 75.13 110.901 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 118.86 24.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.932 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.78 136.25 33.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.907 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.1 t -124.66 137.27 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 75.23 111.099 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -130.62 128.26 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.86 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -85.65 -176.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 72.0 111.094 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -70.79 -81.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 74.34 110.848 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -59.65 145.48 44.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 74.04 110.916 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.29 159.6 49.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.544 0.688 . . . . 74.34 111.202 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.594 2.196 . . . . 73.42 112.287 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.726 0.298 . . . . 73.32 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -93.21 133.2 36.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 74.12 110.941 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -89.99 122.01 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.4 110.884 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.1 mm -125.17 122.68 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.32 111.223 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -94.06 141.2 28.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 61.43 111.127 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.57 167.33 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 62.1 111.148 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 149.22 41.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 75.32 110.885 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mt -52.43 120.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.101 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 10.17 70.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 71.53 112.5 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -102.77 139.02 19.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.64 0.733 . . . . 72.44 110.813 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 143.55 50.89 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.692 2.261 . . . . 63.14 112.335 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.5 tp -145.76 143.81 29.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.1 110.89 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.11 145.37 28.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.21 111.136 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.91 147.51 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.927 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 151.96 31.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 64.54 110.908 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.74 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 124.35 17.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.917 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.86 -40.63 1.86 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 52.54 112.462 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.02 128.69 46.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.497 0.665 . . . . 75.34 111.085 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -164.79 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.65 2.233 . . . . 75.31 112.271 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.38 -48.31 47.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.873 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 74.44 110.851 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.35 . . . . 70.32 110.877 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.88 157.71 46.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 72.33 110.979 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.06 146.93 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.9 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -121.47 141.92 50.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.898 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.6 139.28 38.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 75.4 110.824 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.71 131.41 29.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.864 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -116.44 121.02 40.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 75.21 110.949 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.7 p -139.84 179.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 72.21 111.119 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.12 -131.42 10.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.703 -0.76 . . . . 55.14 112.492 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mmm-85 -112.63 -38.43 4.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 63.21 110.866 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 t 179.83 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 74.5 111.107 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -103.11 33.99 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 70.24 110.844 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.23 -6.33 8.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 63.25 111.153 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -63.63 130.95 46.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 73.45 110.865 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 158.27 41.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 73.3 110.905 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.0 t -92.68 122.62 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 73.3 111.061 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.61 147.66 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 75.21 110.9 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.642 0.734 . . . . 71.23 110.831 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.688 0.28 . . . . 72.5 111.215 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.54 166.43 15.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 74.14 110.895 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.16 128.98 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 73.41 111.11 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -69.06 157.15 90.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.669 0.747 . . . . 75.41 110.883 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 -22.47 32.53 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.716 2.278 . . . . 74.2 112.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -82.98 0.92 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.933 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 29.2 12.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 52.35 112.415 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 m -113.1 179.19 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 65.2 110.878 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 tp -130.15 129.0 42.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.941 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -125.44 130.61 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 74.05 110.857 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.08 129.13 25.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.601 0.715 . . . . 73.21 110.908 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -34.84 13.61 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.645 2.23 . . . . 72.44 112.368 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.75 100.26 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 72.21 111.141 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 m -73.89 112.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.42 111.144 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.34 167.97 41.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 62.51 112.497 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -30.37 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.739 0.304 . . . . 73.05 111.108 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -75.9 -22.17 56.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.04 110.845 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -2.86 35.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 73.05 110.844 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 142.01 53.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 72.01 110.895 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.39 -154.06 25.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 72.01 112.461 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.08 134.97 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 74.43 111.135 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -102.87 133.89 47.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 73.1 110.838 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.62 131.82 49.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 75.2 110.842 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 35.6 t -120.67 150.49 40.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.35 110.82 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -143.29 127.94 18.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.3 110.917 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.46 162.94 29.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.13 111.038 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.5 mtp -130.9 125.51 33.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 71.54 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -86.66 171.18 11.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.4 110.878 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -72.03 -18.21 61.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 64.33 110.906 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -72.46 -19.62 61.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 53.11 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.46 -18.32 27.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.822 -0.704 . . . . 74.31 112.513 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.06 146.17 27.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 73.45 110.953 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.76 145.02 31.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.834 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.87 127.19 47.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 73.31 111.152 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 143.59 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.908 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.26 124.62 13.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 72.53 110.857 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.49 120.52 26.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 74.12 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -130.23 117.18 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.885 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.98 134.08 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 75.32 110.872 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.2 t -120.13 139.53 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 71.3 111.148 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.09 127.92 42.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 74.54 110.873 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.9 m -88.62 -176.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.33 111.151 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.59 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.864 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -69.14 144.96 53.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.975 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.45 159.43 50.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 75.5 111.067 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.597 2.198 . . . . 74.32 112.393 179.903 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.744 0.307 . . . . 75.03 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.59 133.09 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.923 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -87.76 121.98 30.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.916 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mm -125.35 127.69 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 75.34 111.081 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 138.8 32.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.4 111.171 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.33 27.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.12 111.096 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.65 148.25 48.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.281 -0.418 . . . . 64.15 110.839 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 mt -53.32 122.08 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 71.22 111.152 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.09 4.44 78.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 73.13 112.448 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -101.22 139.64 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.561 0.696 . . . . 70.02 110.967 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.67 45.84 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.765 2.31 . . . . 73.15 112.308 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.4 tp -144.7 141.31 29.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 75.21 110.902 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.9 147.15 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 63.13 111.201 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 mt -131.58 148.23 52.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.857 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -111.41 149.81 30.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 65.53 110.85 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.3 t -108.16 101.09 10.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.447 . . . . 73.12 110.882 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.82 101.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 74.1 110.915 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 144.5 -47.9 0.75 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.703 -0.76 . . . . 74.34 112.498 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.15 103.04 10.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.558 0.694 . . . . 75.14 111.189 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.8 Cg_endo -69.69 -161.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.688 2.259 . . . . 75.13 112.311 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -60.52 -10.51 5.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-O 121.572 0.701 . . . . 75.43 110.916 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.86 0.362 . . . . 74.23 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 pp -178.85 161.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 74.43 110.837 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -121.43 135.75 55.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 75.54 110.852 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -120.72 137.95 54.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.0 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -138.31 139.99 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 63.2 110.866 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 tp -137.67 134.59 35.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 64.33 110.935 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -116.21 121.66 42.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 61.1 110.923 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.9 p -137.72 179.6 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.33 111.098 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -132.06 15.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.463 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -37.63 4.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 74.43 110.874 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 t -179.24 -29.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 73.14 111.12 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.32 33.55 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 75.33 110.935 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.41 -5.33 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 72.23 111.133 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -65.87 130.11 42.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 71.5 110.928 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.66 43.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 74.53 110.95 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -95.67 119.85 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 73.42 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.52 145.29 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 75.42 110.884 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 72.13 110.886 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.789 0.328 . . . . 74.24 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.96 160.16 28.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 75.31 110.83 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.47 127.08 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 72.1 111.078 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.6 mt -69.4 157.46 89.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 74.25 110.938 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -22.74 31.33 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.655 2.236 . . . . 73.24 112.403 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -82.67 0.68 42.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.876 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.93 26.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.63 -0.795 . . . . 73.55 112.451 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.1 m -105.51 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.408 . . . . 70.4 110.862 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tp -131.15 129.5 41.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.897 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -125.52 129.0 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.54 111.0 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.36 131.17 24.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 71.42 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -32.98 17.76 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.664 2.242 . . . . 71.31 112.403 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.79 100.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 72.11 111.087 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -76.76 118.58 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 65.43 111.134 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.29 165.42 37.45 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.672 -0.775 . . . . 71.22 112.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -31.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 75.13 111.15 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.2 -22.22 58.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.451 . . . . 75.41 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.08 -5.02 41.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 70.2 110.819 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.59 141.58 51.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.03 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.65 -147.69 16.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.758 . . . . 74.31 112.445 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.62 134.96 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 75.43 111.224 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -104.43 126.57 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 71.14 110.877 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.441 ' HG3' ' ND2' ' A' ' 92' ' ' ASN . 5.7 ttp85 -124.45 136.54 54.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.42 110.852 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.45 156.26 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 63.42 110.925 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -141.02 126.25 18.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.982 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.46 162.05 33.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 73.11 111.115 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.1 mtp -130.32 125.84 35.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.858 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -86.19 171.6 11.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 75.34 110.866 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -71.66 -17.46 62.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.05 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.93 -26.0 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 62.02 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.61 -19.53 11.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 73.53 112.452 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.97 147.56 26.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.649 0.262 . . . . 65.04 111.01 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.39 144.27 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 74.23 110.906 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.14 126.64 50.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.44 111.133 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.41 142.58 35.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 73.3 110.891 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -146.8 119.01 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.785 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.441 ' ND2' ' HG3' ' A' ' 78' ' ' ARG . 6.4 t-20 -125.76 128.66 48.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 74.55 110.901 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -128.7 118.9 23.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.53 110.883 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.74 128.08 34.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 74.24 110.751 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -119.28 139.59 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.183 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 127.79 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.833 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.94 -176.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 73.33 111.104 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.5 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 75.42 110.932 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.49 145.83 55.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.99 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.33 159.4 50.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 73.41 111.072 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.151 0 C-N-CA 122.718 2.279 . . . . 75.32 112.277 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.678 0.275 . . . . 74.04 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.39 133.68 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 72.11 110.874 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.02 122.04 31.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 74.44 110.853 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.72 121.29 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.42 111.071 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -95.16 142.65 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.35 111.06 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -142.55 166.31 25.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 71.3 111.063 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.53 147.62 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.883 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.1 mt -59.05 121.16 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.21 111.159 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.16 0.08 88.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 62.41 112.435 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.62 142.04 23.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.663 0.745 . . . . 73.4 110.927 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 143.85 52.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.651 2.234 . . . . 74.24 112.275 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.8 tp -144.65 143.21 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.14 110.942 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.55 148.66 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 72.2 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mt -130.9 147.96 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.03 110.951 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -112.35 151.98 29.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.946 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 101.97 11.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 54.43 110.88 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.18 120.9 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 72.45 110.81 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.14 -38.5 2.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.811 -0.709 . . . . 42.33 112.532 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.23 128.26 47.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.32 111.119 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.666 2.244 . . . . 74.51 112.374 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.34 -49.39 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.896 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 75.11 110.912 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.812 0.339 . . . . 75.33 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.62 156.31 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.925 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.1 148.35 44.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 70.43 110.896 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -129.63 142.02 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.872 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -146.77 137.01 23.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 75.13 110.876 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.59 139.52 38.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 62.03 110.936 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -112.42 124.44 52.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 64.52 110.889 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.3 p -138.45 -179.24 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 74.33 111.111 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.01 -130.55 14.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 72.31 112.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.41 -37.84 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 71.42 110.855 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.6 t -179.5 -30.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.22 111.145 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -102.21 33.71 2.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.877 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.33 -7.26 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 73.13 111.127 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.19 129.44 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.52 110.874 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.89 153.41 50.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 74.32 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.73 121.55 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.43 111.111 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.55 146.73 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 74.12 110.974 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.722 0.773 . . . . 75.43 110.848 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.818 0.342 . . . . 65.22 111.1 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 159.64 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 72.41 110.828 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -109.05 129.94 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.13 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.3 mt -68.56 157.77 87.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.665 0.745 . . . . 72.34 110.877 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -21.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 72.13 112.36 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -83.27 0.25 46.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 73.11 110.89 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.05 9.57 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.795 -0.716 . . . . 45.13 112.397 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 m -112.4 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.959 0.409 . . . . 73.31 110.849 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.2 tp -128.48 127.69 42.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 74.23 110.833 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -125.71 133.54 52.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 72.12 110.863 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 mp -119.88 131.27 24.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.522 0.677 . . . . 62.45 110.955 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -36.29 11.13 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.766 2.311 . . . . 73.1 112.35 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.99 101.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 60.44 111.122 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.48 117.78 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 75.13 111.173 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.24 163.09 39.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 75.12 112.476 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -30.93 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 71.22 111.106 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.909 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -5.44 37.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.274 -0.421 . . . . 75.33 110.832 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -58.56 142.06 50.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.886 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.6 -151.83 23.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 44.14 112.478 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.29 134.21 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 74.12 111.182 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -102.58 132.73 48.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.938 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.87 134.64 49.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.938 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 146.19 46.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 64.13 110.876 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -141.17 126.12 18.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.924 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.05 164.0 27.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.2 111.055 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 124.82 34.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 72.2 110.881 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -86.81 172.29 10.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 74.23 110.906 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -71.32 -18.1 62.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.214 -0.448 . . . . 74.23 110.878 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.0 -20.12 61.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.87 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.99 -18.24 28.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.2 112.415 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -84.97 146.75 27.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.708 0.289 . . . . 75.4 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -105.17 145.0 31.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 63.12 110.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 m -102.24 129.41 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.53 111.225 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 90' ' ' LYS . 23.9 mtpp -105.3 146.06 29.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 72.52 110.884 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.95 126.78 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.31 110.826 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -121.31 120.4 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.23 110.9 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.98 127.56 40.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 73.51 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -89.55 131.07 35.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 72.02 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.0 t -120.92 130.58 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 75.53 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -131.72 153.32 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.54 110.83 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.06 -177.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.22 111.179 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.19 -82.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 75.21 110.978 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -59.1 146.69 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.972 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.37 159.66 49.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 61.11 111.076 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.343 0.238 0 C-N-CA 122.65 2.233 . . . . 72.43 112.279 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.778 0.323 . . . . 74.54 111.139 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.51 132.63 37.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.34 110.915 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.66 121.29 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 75.43 110.944 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.22 120.81 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.089 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.8 p -96.95 142.58 28.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 74.1 111.159 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.0 168.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 65.22 111.129 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.32 145.66 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 74.13 110.906 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.3 mt -52.21 120.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.077 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.83 5.8 70.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 70.44 112.492 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -101.67 140.8 21.53 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 121.539 0.685 . . . . 64.55 110.98 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 143.89 52.88 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.752 2.302 . . . . 70.23 112.315 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 tp -142.89 142.13 31.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 75.51 110.841 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -122.41 149.32 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.54 111.115 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.3 mt -130.73 146.91 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 72.54 110.954 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -112.91 152.86 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.897 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.89 100.6 10.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 61.42 110.862 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.32 120.65 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 72.41 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.28 -36.7 2.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 74.12 112.424 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.7 130.37 39.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.624 0.726 . . . . 71.54 111.062 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.66 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 72.05 112.374 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -49.32 -49.36 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 72.34 110.88 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 75.23 110.812 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.79 0.329 . . . . 74.51 110.889 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.31 146.94 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.874 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -129.07 137.07 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.859 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -124.68 144.95 49.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 74.34 110.85 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -136.33 142.28 43.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.897 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.82 140.06 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.32 110.946 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 70.33 110.835 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.5 p -136.82 179.91 6.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.11 111.193 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.78 -130.01 19.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.797 -0.716 . . . . 62.32 112.485 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -112.68 -37.38 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 71.12 110.901 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -178.9 -29.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 73.32 111.153 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -102.14 33.6 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 72.25 110.951 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.33 -5.81 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 62.13 111.102 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -59.14 132.22 53.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 65.44 110.956 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 157.17 41.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 71.34 110.857 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.11 123.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.215 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.38 136.68 32.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.941 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.759 0.79 . . . . 74.13 110.827 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.754 0.311 . . . . 74.33 111.136 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.85 158.01 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 73.12 110.908 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.8 t -116.35 126.87 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.14 111.139 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.7 mt -69.02 156.4 91.6 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 75.23 110.956 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -21.84 32.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.668 2.246 . . . . 72.32 112.431 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -82.89 -0.19 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.889 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.94 29.64 10.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.723 -0.751 . . . . 60.44 112.438 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -111.4 177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 71.22 110.863 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 tp -128.63 130.02 46.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.02 110.89 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -125.13 131.9 53.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 64.02 110.958 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mp -115.07 130.8 23.92 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.653 0.74 . . . . 70.23 110.855 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -37.84 8.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.785 2.323 . . . . 72.34 112.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.36 102.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.43 111.083 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.2 m -73.7 116.44 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.3 111.077 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 163.12 38.3 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.674 -0.774 . . . . 70.31 112.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.422 ' HA ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.16 -34.04 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.723 0.297 . . . . 71.2 111.115 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.95 -15.92 60.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 75.1 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -4.51 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 62.03 110.921 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.5 141.49 42.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 75.53 110.973 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.08 -156.41 27.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.749 -0.739 . . . . 71.21 112.519 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.3 mm -125.38 134.09 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 75.15 111.137 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -102.84 126.44 49.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 73.25 110.876 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 127.86 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.55 110.779 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.84 146.58 46.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.891 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -139.47 132.91 30.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 163.89 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 70.41 111.039 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.6 mtp -129.1 125.01 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 72.52 110.938 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.88 172.81 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 74.11 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -70.71 -18.42 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.828 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -73.21 -19.86 61.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 63.53 110.92 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.92 -15.09 37.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 61.22 112.505 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 146.61 27.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.657 0.265 . . . . 72.31 110.936 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.37 144.81 31.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 75.32 110.89 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 132.59 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 72.35 111.128 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.45 145.47 27.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 73.31 110.934 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.2 m -144.72 123.88 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 63.14 110.818 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -127.48 121.24 30.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 74.45 110.884 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.58 123.05 32.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 73.41 111.0 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -84.4 134.17 34.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.861 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -120.27 129.29 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 64.04 111.108 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.47 46.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -109.68 -175.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 73.4 111.099 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -65.79 -71.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 75.4 110.952 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -71.05 140.52 50.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.51 110.952 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.27 159.81 48.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.665 0.745 . . . . 65.32 111.138 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 75.13 112.394 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.703 0.287 . . . . 72.42 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.62 137.25 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 74.34 110.826 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -89.09 121.13 31.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.86 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.65 121.94 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 75.41 111.15 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -95.31 142.68 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 72.5 111.202 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.61 167.29 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 52.53 111.13 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -119.99 148.68 43.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.408 . . . . 75.13 110.898 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mt -56.81 120.75 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 75.41 111.219 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 5.72 79.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.76 . . . . 72.31 112.46 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -102.05 139.42 20.28 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.657 0.742 . . . . 75.34 110.918 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 143.27 50.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 75.31 112.356 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 tp -145.27 142.43 29.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 70.42 110.891 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.96 145.27 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 74.44 111.134 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.1 mt -130.74 147.27 52.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 62.53 111.0 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -113.46 150.73 32.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.41 110.882 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -108.07 99.73 9.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 53.21 110.846 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -54.26 128.45 31.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.847 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.38 -40.45 1.92 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 65.23 112.468 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.92 128.89 43.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 71.54 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.19 0.15 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.665 2.244 . . . . 64.21 112.376 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -48.95 45.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 74.4 110.945 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.565 0.697 . . . . 63.14 110.942 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.883 0.373 . . . . 75.5 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 159.13 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 73.22 110.918 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -132.53 146.14 51.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.851 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -123.6 134.25 53.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.922 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -136.36 138.33 41.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 73.53 110.91 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 138.24 38.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 75.51 110.903 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.33 127.8 56.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.89 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.2 p -138.52 -179.87 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 71.15 111.139 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.17 21.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.815 -0.707 . . . . 64.14 112.463 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.89 -37.26 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 75.04 110.869 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.2 t -178.72 -29.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.42 111.015 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -102.06 34.06 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 75.22 110.821 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.71 -5.59 8.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.41 111.114 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -59.57 132.16 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 71.11 110.958 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 152.46 48.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.316 -0.402 . . . . 73.41 110.92 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.1 t -105.26 116.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 72.42 111.131 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.0 mt -96.28 146.03 25.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 74.44 110.823 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 121.586 0.708 . . . . 74.13 110.865 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.708 0.29 . . . . 62.23 111.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.37 162.41 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 73.42 110.903 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.69 130.72 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.119 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.99 156.46 91.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.596 0.712 . . . . 71.21 110.965 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -22.43 32.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 74.44 112.265 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -81.91 0.15 41.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.3 110.921 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.8 22.92 24.63 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 65.32 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -106.24 178.91 4.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 74.23 110.88 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.5 tp -129.68 129.95 44.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 74.52 110.952 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -124.34 129.96 51.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 75.04 110.86 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.57 127.23 27.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.678 0.752 . . . . 75.42 110.844 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -32.62 18.11 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.24 112.386 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.5 101.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 63.31 111.145 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 m -73.09 115.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 74.22 111.185 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.63 161.81 31.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 72.11 112.457 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -31.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 73.13 111.168 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -77.46 -22.47 51.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.924 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.15 -5.34 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 75.01 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.33 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 74.54 110.822 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.39 -148.91 17.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.793 -0.718 . . . . 64.23 112.516 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -126.18 133.66 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.89 0.376 . . . . 73.13 111.178 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -103.32 135.2 45.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 63.23 110.908 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -125.99 134.61 51.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 75.24 110.813 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.49 147.95 44.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -141.37 129.21 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 63.03 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.73 163.13 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.31 111.12 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 125.09 33.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 63.32 110.937 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -86.84 172.1 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 74.14 110.823 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.47 -18.3 62.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 74.51 110.934 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.07 -19.87 61.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 65.01 110.848 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.03 32.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.545 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -85.02 147.07 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.795 0.331 . . . . 75.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.79 145.14 30.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 72.22 110.955 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.69 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.3 111.107 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -98.65 145.31 27.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.943 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 m -144.73 127.76 16.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 70.53 110.748 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -128.14 121.52 29.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 74.23 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.22 126.1 40.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.53 110.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.6 mmm-85 -89.85 132.1 35.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 74.5 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.82 130.02 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 64.24 111.129 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -131.55 146.17 52.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.886 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.0 m -109.58 -176.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 73.11 111.12 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.86 -79.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.992 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.45 146.21 54.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 73.22 111.032 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.38 159.42 50.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.719 0.771 . . . . 73.04 111.145 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.649 2.233 . . . . 73.11 112.321 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.691 0.281 . . . . 74.41 111.156 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.12 133.6 36.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.893 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.6 121.27 28.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.884 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.1 mm -125.16 127.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 75.23 111.111 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -91.56 142.52 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 64.15 111.17 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.0 165.85 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 73.24 111.133 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -119.1 149.71 41.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 62.23 110.906 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 10.6 mt -68.43 120.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 71.53 111.108 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.5 -6.99 57.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.815 -0.707 . . . . 64.44 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -102.72 140.76 21.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.71 0.767 . . . . 74.3 110.923 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 146.11 59.7 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.84 2.36 . . . . 74.2 112.323 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.3 tp -138.33 142.8 39.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 75.24 110.966 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.59 148.22 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.54 111.141 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 mt -130.99 147.48 52.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.933 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -112.78 152.04 29.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 73.14 111.002 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -107.33 100.53 9.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.413 . . . . 61.41 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.88 122.41 12.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.839 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.15 -39.8 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 72.13 112.484 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.29 129.32 43.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.522 0.677 . . . . 73.33 111.171 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.91 -165.08 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.64 2.226 . . . . 75.23 112.383 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -49.02 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.981 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.603 0.716 . . . . 71.51 110.936 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.769 0.319 . . . . 75.12 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.09 151.31 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 73.31 110.912 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.82 148.18 45.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.41 110.834 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -121.81 139.97 52.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 73.4 110.922 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -146.65 135.35 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.23 110.928 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.58 137.84 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.891 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -112.28 125.2 53.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 65.11 110.893 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -139.22 -178.96 5.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 73.53 111.137 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.98 -127.04 9.95 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.703 -0.76 . . . . 55.12 112.53 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' O ' ' HB ' ' A' ' 38' ' ' THR . 1.2 mpp_? -112.9 -38.88 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 75.32 110.863 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 37' ' ' ARG . 3.8 t 179.0 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 73.45 111.171 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -102.03 34.18 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.823 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.12 -6.92 8.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 74.01 111.105 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -71.47 128.71 36.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.57 159.65 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.929 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 t -93.59 121.01 43.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 72.2 111.135 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.05 145.74 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 72.21 110.879 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 63.25 110.91 -179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.419 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.894 0.378 . . . . 74.44 111.011 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.18 161.14 25.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.944 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.44 130.28 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.45 111.084 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.5 mt -68.81 157.88 87.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 73.31 110.923 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -21.86 33.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.772 2.315 . . . . 72.44 112.353 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -82.37 0.95 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 75.41 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 26.46 20.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 73.31 112.514 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.8 m -111.97 -179.53 3.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 74.24 110.874 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 tp -129.84 130.54 45.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.12 110.909 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -123.81 133.04 53.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HG ' ' CB ' ' A' ' 56' ' ' ALA . 7.3 mp -114.83 127.08 27.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.651 0.738 . . . . 75.44 110.939 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -32.28 19.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 74.22 112.374 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.64 102.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 74.43 111.084 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 27.5 m -73.07 118.71 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 75.41 111.136 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.01 161.61 21.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 41.31 112.524 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.76 -34.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 73.11 111.212 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.08 -20.2 56.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.45 110.903 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -2.9 28.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.42 110.965 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.22 141.91 49.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 60.51 110.883 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.4 -155.09 26.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 73.04 112.428 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.74 135.34 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 71.54 111.142 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -103.71 126.75 51.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 71.34 110.874 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.93 127.55 47.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 74.14 110.868 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.01 150.9 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.54 110.857 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -139.65 132.6 29.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.936 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.16 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 73.44 111.176 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.4 ttm -129.48 126.09 37.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 71.34 110.884 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -86.22 172.62 10.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.05 110.915 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -71.26 -18.48 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 74.31 110.814 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -73.13 -19.85 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 73.4 110.874 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.69 -17.36 30.54 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 74.13 112.454 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -85.15 146.58 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 75.41 110.832 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.39 144.86 31.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.866 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 132.8 48.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.12 111.218 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 144.08 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.14 111.033 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -145.52 121.66 10.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 64.22 110.9 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 122.08 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.836 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -128.0 118.97 24.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 75.32 110.965 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.13 135.79 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.1 110.864 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 68.9 t -120.68 134.2 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 75.12 111.115 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 127.25 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.53 110.88 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.428 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 13.1 m -88.32 -177.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.13 111.065 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -68.84 -80.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 72.21 110.942 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.25 144.23 46.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 73.21 110.849 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.13 159.62 48.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.581 0.705 . . . . 74.52 111.131 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 74.43 112.329 179.857 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.696 0.284 . . . . 63.21 111.093 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -93.3 133.51 36.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.881 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.0 121.34 27.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 70.54 110.79 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.56 121.88 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.142 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -95.93 142.06 28.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 73.22 111.152 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.72 165.26 30.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 73.5 111.109 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 148.64 45.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 72.13 110.909 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -57.13 122.13 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.094 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.28 4.45 80.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.685 -0.769 . . . . 75.32 112.506 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -101.19 139.4 20.43 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.641 0.734 . . . . 71.15 110.935 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 138.62 38.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.609 2.206 . . . . 44.22 112.359 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 18.4 tp -145.0 141.26 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 74.55 110.861 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.64 147.81 31.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 73.2 111.178 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.88 147.29 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 75.01 110.96 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -111.7 149.11 32.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.13 110.869 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -112.32 101.56 9.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.86 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.53 110.906 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 150.31 -49.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 72.15 112.476 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.52 102.95 11.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 73.3 111.044 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.4 Cg_endo -69.71 -161.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.626 2.217 . . . . 64.33 112.402 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -12.68 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 75.33 110.942 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 72.13 110.9 179.836 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.86 0.362 . . . . 75.41 110.946 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -168.63 174.26 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 75.25 110.927 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 124.1 40.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.931 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.35 143.4 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 73.02 110.866 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -143.96 144.1 31.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 72.12 110.941 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.57 132.83 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 72.33 110.882 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 120.43 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 75.44 110.878 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.4 p -140.02 179.6 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 71.52 111.099 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.1 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 74.13 112.434 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.39 -38.46 4.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 74.31 110.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t 179.24 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 71.22 111.152 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -102.03 33.93 2.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 72.54 110.825 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.93 -6.67 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 72.45 111.101 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -68.37 130.2 42.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 65.41 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 159.08 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.42 110.883 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.59 122.1 38.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 72.53 111.181 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.2 mt -92.31 148.84 21.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 72.14 110.862 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.712 0.768 . . . . 61.22 110.825 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.795 0.331 . . . . 73.13 111.081 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.25 165.39 23.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 74.24 110.899 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.2 t -106.51 130.13 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 74.04 111.156 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.76 157.84 88.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.577 0.703 . . . . 73.22 110.907 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -22.9 31.79 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.717 2.278 . . . . 65.12 112.37 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.37 2.06 38.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.93 30.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 73.44 112.494 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.7 m -105.67 179.42 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.953 0.406 . . . . 73.15 110.805 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.9 tp -132.3 128.35 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 74.43 110.959 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -129.65 128.16 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 73.22 110.858 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.27 132.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.698 0.761 . . . . 72.15 110.927 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.27 19.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.743 2.295 . . . . 64.12 112.414 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.81 103.5 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 74.3 111.055 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.2 119.36 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.19 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.82 156.17 26.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.741 . . . . 64.4 112.526 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -29.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 74.11 111.087 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -73.32 -23.5 60.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 74.11 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.26 -5.26 57.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 75.03 110.831 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.55 140.61 57.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 75.41 110.869 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.23 -137.93 5.63 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.778 -0.725 . . . . 64.21 112.485 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.46 135.26 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 74.02 111.197 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -100.85 128.39 46.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.874 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -127.92 127.72 43.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.902 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -121.24 149.73 42.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.12 110.854 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -146.98 126.68 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.874 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.13 163.74 27.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 72.22 111.101 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.4 mtp -129.96 125.83 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.879 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -86.2 172.03 10.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.52 110.83 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -71.78 -17.95 62.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 62.33 110.843 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.1 -19.61 61.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.13 110.895 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.7 -18.58 29.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 64.43 112.53 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 145.19 27.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 63.34 110.83 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.91 145.0 32.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.893 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.01 131.32 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.3 111.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.35 145.6 30.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.936 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -146.04 123.95 12.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.81 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.49 120.39 26.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 74.21 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.64 127.85 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 75.25 110.989 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.1 mmm-85 -87.62 136.18 33.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 75.51 110.831 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.45 132.29 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.14 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 128.83 41.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.11 110.9 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.92 -176.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 73.22 111.083 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -66.49 -81.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 72.11 110.941 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -60.97 142.59 56.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 74.43 110.811 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.67 159.88 48.9 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.548 0.69 . . . . 72.51 111.151 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--N 1.34 0.086 0 C-N-CA 122.746 2.297 . . . . 72.01 112.339 179.8 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.773 0.32 . . . . 74.32 111.075 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -93.47 133.73 36.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 64.32 110.924 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.7 120.48 26.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.9 121.51 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 75.33 111.144 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.89 140.95 29.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 74.01 111.085 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.62 166.62 27.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 73.45 111.088 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.79 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 71.31 110.904 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.59 120.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.22 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.89 9.3 74.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.685 -0.769 . . . . 71.43 112.463 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -102.66 139.14 19.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 74.45 110.883 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 143.7 51.55 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.686 2.257 . . . . 73.25 112.355 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.2 tp -145.88 143.42 29.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.288 -0.414 . . . . 75.33 110.901 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 142.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.34 111.153 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.5 147.99 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 74.32 110.895 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -113.75 151.19 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 72.34 110.85 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -107.53 101.63 10.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 64.34 110.813 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -50.16 125.66 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 74.2 111.012 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.38 -45.12 1.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.8 -0.714 . . . . 65.11 112.464 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.16 123.84 63.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.595 0.712 . . . . 72.03 111.076 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.667 2.245 . . . . 71.1 112.385 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -47.5 39.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.869 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 71.31 110.872 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.928 0.394 . . . . 72.42 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 pp -135.69 163.38 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.34 110.913 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -120.56 149.02 43.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.04 110.913 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.43 143.16 51.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 74.01 110.96 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -143.03 140.79 31.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 75.1 110.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -137.65 132.82 33.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 65.04 110.916 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -114.9 120.94 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.25 110.915 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.2 p -139.03 179.52 6.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 63.21 111.172 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.09 -130.03 10.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.644 -0.788 . . . . 60.55 112.537 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.67 -38.34 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 71.34 110.863 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 t 179.91 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 53.05 111.151 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -102.7 33.8 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 71.12 110.994 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.97 -7.04 8.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 74.45 111.1 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -64.52 130.93 45.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.31 110.888 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 153.49 47.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.938 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.54 120.84 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 65.24 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.26 149.68 21.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.18 -0.463 . . . . 70.41 110.873 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.728 0.775 . . . . 71.41 110.831 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.799 0.333 . . . . 74.23 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 168.66 16.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.843 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.9 t -106.45 130.11 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 73.33 111.154 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mp -69.31 156.62 91.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 71.42 110.945 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -20.46 34.72 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.0 112.422 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 1.91 32.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 41.55 110.861 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.3 25.12 27.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.668 -0.777 . . . . 72.43 112.445 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.9 m -113.5 -179.29 3.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 63.22 110.86 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tp -129.59 128.53 42.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 72.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -126.11 132.81 51.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 71.14 110.958 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mp -114.7 128.28 26.03 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 71.13 110.94 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.63 -34.24 15.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.685 2.257 . . . . 74.41 112.395 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.69 99.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 73.3 111.079 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.4 m -74.97 112.22 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.35 111.215 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.18 171.01 43.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 74.23 112.492 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -30.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.729 0.3 . . . . 72.34 111.095 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.49 -23.12 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 73.54 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -3.59 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.05 110.847 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 140.66 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 72.24 110.867 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.18 -149.04 18.76 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 54.43 112.502 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.69 135.26 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 71.24 111.141 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -101.17 130.96 47.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 62.22 110.897 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.51 131.02 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 70.41 110.85 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 151.07 40.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.42 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -144.98 126.11 14.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.799 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.7 162.8 29.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 75.34 111.056 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.3 ttm -130.18 125.48 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 73.23 110.866 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.08 172.22 10.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -71.33 -19.07 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 75.44 110.886 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -74.21 -20.14 60.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.847 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.96 -9.1 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 75.04 112.531 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -85.11 146.28 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 74.31 110.893 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.73 142.12 36.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.945 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 125.9 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.12 111.043 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -106.87 143.1 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 74.33 110.9 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -146.74 120.61 9.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 63.32 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.63 122.6 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 74.02 110.919 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.19 125.88 43.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.902 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.9 mmm-85 -86.34 132.68 33.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 74.53 110.902 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.81 133.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.15 111.123 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 128.93 41.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 71.54 110.812 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.0 m -92.58 -176.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 71.35 111.136 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -66.83 -82.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 75.44 110.963 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -62.97 146.34 53.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.886 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.33 159.55 49.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 73.35 111.204 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.244 . . . . 70.32 112.243 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.722 0.296 . . . . 73.35 111.082 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -93.33 133.24 36.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.937 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -84.96 122.17 28.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 73.01 110.891 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.6 mm -124.03 120.89 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 75.01 111.153 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -96.05 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 71.13 111.215 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.68 164.86 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.12 111.137 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -124.67 151.31 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.908 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.57 118.6 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 65.31 111.111 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.21 8.84 87.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 63.5 112.465 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -102.19 140.44 21.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 73.2 110.935 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 143.83 51.9 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.638 2.225 . . . . 73.44 112.366 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 tp -145.27 142.22 29.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.11 110.963 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.63 145.12 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 74.42 111.168 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.1 mt -131.66 147.78 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 73.24 110.916 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -113.39 150.32 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 72.41 110.809 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -110.67 100.96 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.852 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.53 128.04 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 72.33 110.956 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -45.02 1.2 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.768 -0.729 . . . . 52.21 112.439 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.85 59.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.602 0.715 . . . . 70.44 111.069 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -163.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 71.32 112.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.31 -47.57 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 75.14 110.939 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.627 0.727 . . . . 72.33 110.878 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.829 0.347 . . . . 75.24 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.22 150.63 37.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 72.22 110.909 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -121.03 149.77 42.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 75.44 110.913 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -107.28 136.64 46.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.903 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.42 145.08 38.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 73.44 110.911 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.79 137.96 13.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.952 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.57 128.89 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 75.35 110.925 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -136.59 179.2 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.11 111.111 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.84 14.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 70.24 112.498 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 74.44 110.865 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.3 t -179.69 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 62.22 111.184 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -102.94 33.46 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.883 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.19 -6.71 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 75.4 111.097 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -59.78 132.23 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 75.01 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.61 151.89 49.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.821 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.7 121.91 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.22 111.166 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.13 146.36 24.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 75.3 110.831 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.685 0.755 . . . . 74.24 110.877 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.716 0.293 . . . . 74.3 111.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.72 164.76 19.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.13 110.913 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -106.52 130.28 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 73.31 111.144 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 mt -70.39 158.64 87.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 74.42 110.921 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.59 31.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.759 2.306 . . . . 73.31 112.313 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.05 1.65 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.54 17.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 71.23 112.513 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.6 m -112.48 -178.3 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.396 . . . . 73.25 110.829 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.8 tp -127.73 128.66 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.924 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -125.33 137.24 54.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 72.51 110.83 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.48 125.03 28.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.601 0.715 . . . . 75.51 110.969 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -31.92 19.4 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.5 112.343 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.51 100.61 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 74.3 111.091 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.4 118.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 63.44 111.137 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.45 162.77 17.79 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.807 -0.711 . . . . 75.24 112.447 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -29.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 74.52 111.175 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.7 -24.01 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 64.34 110.846 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.8 -4.64 56.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.288 -0.415 . . . . 75.24 110.809 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.3 140.77 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 62.12 110.802 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.03 -138.23 5.56 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.734 . . . . 64.13 112.554 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.63 134.66 61.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.888 0.375 . . . . 73.1 111.142 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -103.5 132.86 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.34 110.894 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.22 126.64 43.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 71.34 110.839 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 150.38 34.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.12 110.833 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.73 127.64 22.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 64.22 110.879 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.42 164.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.11 111.129 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.1 ttm -129.52 125.66 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.34 110.878 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.41 171.58 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 72.23 110.876 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -71.52 -17.72 62.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.827 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -72.36 -20.02 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 62.13 110.863 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.8 -21.0 23.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 41.51 112.483 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.69 148.13 26.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 75.31 110.79 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.45 145.16 30.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 73.41 110.953 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.3 132.61 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.149 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -98.51 146.71 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 73.11 110.952 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.66 126.62 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 70.15 110.817 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -129.08 120.83 26.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 62.43 110.852 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.56 127.26 41.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.995 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -83.75 135.46 34.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.25 110.925 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.5 t -120.19 133.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 72.3 111.142 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 141.82 49.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.35 110.803 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.65 -176.21 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 73.22 111.162 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -75.93 -73.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 65.11 110.89 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 147.77 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 73.5 110.956 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.41 159.61 49.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.657 0.742 . . . . 72.34 111.161 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.182 0 C-N-CA 122.771 2.314 . . . . 62.02 112.313 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.79 0.328 . . . . 62.4 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.94 133.65 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 74.14 110.918 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.24 121.43 28.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 74.13 110.946 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.0 122.35 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 74.44 111.177 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -95.53 139.93 31.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 73.23 111.224 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.69 167.49 25.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.1 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.8 149.0 43.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 75.53 110.839 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.3 mt -52.73 120.54 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.166 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.7 68.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 74.3 112.516 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -102.81 138.18 19.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 75.41 110.902 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 143.12 49.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.708 2.272 . . . . 74.23 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.9 tp -145.82 142.91 29.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 74.04 110.862 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.86 146.87 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 63.51 111.179 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 mt -133.2 146.96 51.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.51 110.861 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -113.83 153.09 29.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.25 110.876 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.6 101.45 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.897 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.77 123.77 13.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 74.43 110.844 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.56 -40.92 1.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.711 . . . . 71.14 112.544 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.11 129.16 44.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 74.2 111.118 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -164.21 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 73.2 112.325 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -47.46 47.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.825 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 72.01 110.939 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.835 0.35 . . . . 75.22 110.819 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.54 164.75 27.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 75.33 110.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -133.73 146.78 51.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 70.45 110.897 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -121.81 137.43 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 139.2 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 72.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 77' ' ' PHE . 1.3 tm? -138.12 131.89 31.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.404 . . . . 75.22 110.917 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -115.78 120.55 39.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 71.4 110.901 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.7 p -139.73 179.47 6.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 72.14 111.145 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.11 -133.44 18.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 64.34 112.444 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -112.39 -37.28 5.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 73.31 110.869 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 t -179.28 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 72.32 111.205 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -101.29 33.69 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 72.42 110.947 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.39 -6.08 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 71.55 111.094 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -68.87 130.1 41.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 74.5 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 158.97 43.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 75.41 110.889 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.86 120.56 52.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.064 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 147.79 23.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 74.45 110.836 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 63.21 110.86 -179.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.822 0.344 . . . . 75.24 111.067 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.23 161.38 23.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 75.12 111.004 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -107.9 129.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 70.12 111.119 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.97 157.19 90.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.739 0.78 . . . . 71.23 110.863 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -20.63 35.16 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.63 2.22 . . . . 64.34 112.411 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -82.18 1.39 36.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.917 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.98 20.61 35.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.684 -0.769 . . . . 65.41 112.521 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.9 m -107.52 -179.22 3.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 72.32 110.829 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.4 129.22 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 72.12 110.956 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -126.21 131.64 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 75.01 110.876 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mp -115.17 129.9 24.69 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.586 0.708 . . . . 63.23 110.944 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.84 17.71 Favored 'Trans proline' 0 N--CA 1.466 -0.12 0 C-N-CA 122.74 2.293 . . . . 74.54 112.323 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.21 99.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.42 111.127 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 m -77.46 112.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 71.12 111.053 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.33 175.63 46.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 62.04 112.532 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.41 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.18 -31.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 74.34 111.081 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -76.59 -21.96 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 73.23 110.937 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.55 -3.6 35.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.87 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 141.1 56.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 63.1 110.932 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.56 -150.47 21.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 71.42 112.422 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.4 mm -130.63 137.25 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 74.22 111.115 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HA ' HD21 ' A' ' 33' ' ' LEU . 41.3 m-85 -103.11 127.43 50.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 63.51 110.869 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -124.92 128.37 48.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.932 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.83 151.25 39.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.11 110.871 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 71.11 110.996 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.7 163.07 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 64.34 111.125 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 72.3 mmm -129.8 124.84 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.44 110.905 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -89.71 170.61 10.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.15 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -21.81 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.805 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -73.39 -19.97 60.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 71.11 110.902 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 -7.48 32.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 73.2 112.455 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 146.59 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 72.14 110.959 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.0 144.02 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 64.11 110.934 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.12 126.17 50.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 73.01 111.124 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -102.48 142.39 33.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 74.54 110.98 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -146.46 120.05 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 72.51 110.882 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 122.47 29.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 72.11 110.955 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.48 119.41 22.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.05 110.915 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.46 134.46 34.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 73.52 110.924 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.91 137.24 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 65.42 111.18 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -129.91 130.5 45.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 22.6 m -93.5 -176.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 75.33 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.34 -77.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.42 110.958 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.75 140.64 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 74.23 110.949 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.04 159.69 48.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 73.54 111.19 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 N--CA 1.465 -0.177 0 C-N-CA 122.786 2.324 . . . . 64.11 112.339 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.705 0.288 . . . . 75.14 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -93.14 133.05 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 73.22 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.06 119.84 25.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 73.54 110.896 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -125.83 122.0 61.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.122 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -95.84 142.27 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 63.5 111.148 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.14 166.55 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 72.34 111.141 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.29 148.94 44.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 72.34 110.847 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 mt -54.38 119.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 71.1 111.147 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.92 7.85 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 74.44 112.418 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -102.55 140.08 20.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 74.4 110.901 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 143.02 49.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.654 2.236 . . . . 64.44 112.298 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.5 tp -145.27 143.49 30.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 71.32 110.882 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -124.08 147.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 72.5 111.142 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.8 mt -131.39 148.26 52.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 65.12 110.996 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 151.88 28.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 73.21 110.912 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.7 101.5 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.12 110.897 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -58.93 120.98 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 75.31 110.838 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.99 -39.4 2.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.826 -0.702 . . . . 75.03 112.587 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.6 128.32 46.95 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 72.34 111.153 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -165.32 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 72.53 112.387 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.6 52.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.913 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.518 0.675 . . . . 71.33 110.864 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.87 0.367 . . . . 71.24 110.803 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.55 158.6 43.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.915 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.25 148.16 44.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 64.15 110.876 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -131.75 128.94 39.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 72.54 110.887 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -137.66 136.0 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.891 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.86 139.37 38.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 72.4 110.892 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -111.89 126.65 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 65.41 110.921 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 p -138.52 -179.67 5.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 73.13 111.137 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.3 -130.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 63.33 112.511 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.98 -37.14 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 73.3 110.835 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 t -179.3 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 72.14 111.092 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -102.12 34.3 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 72.33 110.875 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.07 -6.99 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 73.05 111.178 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.1 t90 -59.5 130.44 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 75.43 110.908 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.96 153.67 48.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 63.13 110.831 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 t -104.62 113.8 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.43 111.186 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.32 147.2 23.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.916 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.7 0.762 . . . . 74.4 110.9 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.817 0.341 . . . . 72.33 111.093 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 165.55 16.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 75.53 110.875 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -108.63 130.05 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 73.25 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.3 mt -69.28 156.96 90.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 73.02 110.892 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -21.6 33.72 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.769 2.313 . . . . 63.15 112.344 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -82.19 1.0 38.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.927 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.71 26.35 20.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 74.14 112.457 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -111.25 179.39 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 54.51 110.917 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.89 128.82 42.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.901 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -125.59 131.3 52.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 72.43 110.897 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.4 ' CD2' HG12 ' A' ' 69' ' ' VAL . 3.7 mp -114.34 126.9 27.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.649 0.738 . . . . 74.34 110.978 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -32.02 19.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.74 2.293 . . . . 73.24 112.289 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.34 99.17 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 72.02 111.128 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' A' ' 66' ' ' LEU . 15.9 m -73.94 115.7 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 74.25 111.093 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.53 167.46 28.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 63.41 112.426 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -29.98 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 74.31 111.142 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -75.57 -22.9 56.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.24 110.912 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -7.92 58.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 75.44 110.921 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.25 141.1 55.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 64.21 110.821 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.4 -142.73 8.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 71.23 112.533 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.88 129.29 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 73.2 111.154 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.79 131.07 51.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 72.31 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.09 140.86 51.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 71.24 110.915 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.4 153.09 38.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 65.45 110.887 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -139.76 126.5 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 75.3 110.825 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.53 161.78 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 72.11 111.054 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.4 ttm -131.04 125.25 32.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 73.54 110.859 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -86.82 172.21 10.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 74.44 110.863 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.19 -18.28 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.86 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.22 -19.84 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.463 . . . . 65.45 110.919 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.41 -16.54 31.88 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.612 -0.804 . . . . 72.34 112.436 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -85.26 145.93 27.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 74.34 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.49 144.77 31.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.871 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.21 130.84 48.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.35 111.186 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 90' ' ' LYS . 7.1 mmmt -105.08 142.37 34.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.847 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -144.76 125.07 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 65.23 110.99 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.48 127.07 45.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -128.3 124.21 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.03 110.968 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -84.27 132.37 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.23 110.848 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.9 t -120.82 134.46 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 72.14 111.114 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -131.95 128.17 37.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 75.34 110.882 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 m -92.93 -175.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 74.04 111.151 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -70.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 75.14 110.963 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -71.23 139.98 50.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 61.33 110.924 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.5 159.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.535 0.683 . . . . 74.13 111.161 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--N 1.34 0.11 0 C-N-CA 122.713 2.276 . . . . 71.4 112.23 179.89 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.741 0.305 . . . . 54.02 111.1 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -93.21 132.61 37.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.02 110.882 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 121.34 27.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 72.24 110.882 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -125.08 120.21 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.101 -0.5 . . . . 74.14 111.198 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -96.76 137.94 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.41 28.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.4 111.11 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.51 148.98 44.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.11 110.937 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.6 mt -51.91 121.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.265 -0.425 . . . . 75.01 111.125 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.58 5.95 74.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 72.42 112.481 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -101.29 139.49 20.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 71.23 110.89 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.13 49.85 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.655 2.237 . . . . 75.35 112.315 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.4 tp -145.18 141.76 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 70.31 110.875 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.81 148.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 73.23 111.081 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.8 mt -132.48 148.27 52.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 74.23 110.957 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.33 153.05 27.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 75.42 110.83 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 t -105.94 102.31 11.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.34 110.831 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.6 121.91 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.42 110.907 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.93 -36.05 2.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.781 -0.723 . . . . 71.31 112.519 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.25 39.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 72.54 111.105 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.5 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.696 2.264 . . . . 63.33 112.331 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -48.49 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 75.33 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.54 0.686 . . . . 74.45 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.909 0.385 . . . . 73.33 110.823 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.82 156.57 48.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 74.02 110.892 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.79 148.11 51.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.873 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -117.98 145.52 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 72.43 110.906 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -138.04 144.03 40.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 55.0 110.953 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 75.01 110.868 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -115.04 124.01 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.862 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 p -138.87 178.37 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 74.21 111.157 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.31 -130.17 11.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 70.41 112.498 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -112.64 -37.96 4.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.412 . . . . 75.43 110.93 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.1 t -179.71 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 72.04 111.115 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -102.38 33.26 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 71.44 110.918 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.22 -7.07 7.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 75.01 111.072 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -62.47 130.15 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 75.5 110.929 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.98 153.28 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.901 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.57 124.78 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 64.21 111.096 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.57 143.79 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.521 . . . . 72.33 110.969 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.607 0.718 . . . . 75.14 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.7 0.286 . . . . 72.34 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -128.18 159.85 33.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 74.32 110.811 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.33 131.85 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 73.31 111.092 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.07 157.71 86.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.649 0.737 . . . . 75.32 110.956 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -23.12 31.55 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.702 2.268 . . . . 71.15 112.339 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.07 1.31 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 25.56 18.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 65.24 112.47 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.65 -179.1 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 73.23 110.849 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 tp -129.09 128.56 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.492 . . . . 64.43 110.848 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -126.16 130.73 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.05 110.853 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.41 131.07 24.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 72.32 110.939 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -34.76 13.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 75.14 112.336 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.73 103.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 64.0 111.049 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 m -73.7 118.93 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.55 111.109 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.38 162.02 31.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 71.2 112.514 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -29.47 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 75.31 111.166 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.16 -22.54 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 74.21 110.835 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.08 -4.76 56.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.31 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.43 140.44 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.954 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.76 -139.83 6.99 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.701 -0.761 . . . . 52.13 112.455 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.81 130.59 71.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 74.52 111.18 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.85 129.02 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 74.24 110.909 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -126.55 126.15 43.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.907 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 154.5 24.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 73.52 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.73 135.11 31.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 75.34 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.08 163.26 29.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.082 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.14 123.98 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 71.42 110.858 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.28 171.72 9.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 73.31 110.877 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -18.71 62.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 62.45 110.851 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -73.38 -20.11 60.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.31 32.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 71.22 112.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -85.27 146.76 26.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 74.44 110.835 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.33 144.95 31.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.41 110.869 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 126.69 50.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 64.12 111.153 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -103.14 143.25 32.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 75.55 110.923 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.8 m -143.76 126.75 16.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.41 110.826 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.1 124.31 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 73.02 110.909 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -128.84 126.38 39.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 75.34 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -84.46 131.36 34.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 74.53 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.13 133.87 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 73.53 111.168 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -131.75 128.58 39.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 73.45 110.928 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.3 m -96.45 -176.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.22 111.098 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -61.7 -79.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.925 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -70.71 144.26 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.33 110.848 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.33 159.49 49.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.664 0.745 . . . . 74.14 111.102 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.694 2.263 . . . . 73.01 112.372 179.8 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.739 0.304 . . . . 72.41 111.13 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.42 132.57 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.838 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -90.45 120.47 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 73.4 110.855 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.44 122.53 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 74.53 111.146 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -95.45 142.3 27.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.3 111.1 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.49 167.42 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 65.02 111.112 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.26 149.18 42.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.21 110.87 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.4 mt -52.19 120.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 74.34 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 10.09 69.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 63.14 112.475 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -103.31 138.95 19.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.54 0.686 . . . . 74.22 110.88 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.66 51.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.673 2.248 . . . . 74.13 112.308 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.2 tp -144.92 142.02 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.983 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.93 148.29 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 75.11 111.081 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.8 mt -134.77 148.29 50.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.02 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -112.55 151.53 29.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 74.22 110.903 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.1 t -107.28 99.7 9.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 72.31 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -54.37 125.03 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.852 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.97 -41.74 1.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 53.23 112.51 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.12 43.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.581 0.705 . . . . 62.32 111.102 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -165.0 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.709 2.272 . . . . 74.21 112.381 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -49.41 -48.82 46.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.458 . . . . 74.51 110.794 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.545 0.688 . . . . 73.52 110.911 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 65.15 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 pp -135.82 160.33 38.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.981 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -121.26 145.01 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 70.01 110.864 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -128.38 137.33 51.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.891 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -140.81 139.07 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 75.11 110.94 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -137.29 136.0 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.88 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 121.54 43.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 72.11 110.914 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.3 p -137.59 179.36 6.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 63.12 111.146 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.89 -129.18 9.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.712 -0.756 . . . . 71.54 112.442 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -112.48 -38.43 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 74.22 110.827 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t 179.78 -31.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 74.24 111.231 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -103.44 33.96 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 64.42 110.894 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.43 -6.8 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 75.05 111.083 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.55 132.3 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 74.32 110.932 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 158.95 38.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 63.34 110.927 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.07 120.52 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 74.3 111.136 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.12 147.2 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.3 110.893 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.23 110.85 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.724 0.297 . . . . 64.51 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.6 164.13 18.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.876 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.51 130.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.3 111.055 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.63 158.85 85.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 75.15 110.947 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -22.19 32.46 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.721 2.28 . . . . 61.21 112.354 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.57 1.34 42.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.885 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.41 28.5 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 62.11 112.488 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 m -111.87 -178.88 3.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 72.21 110.843 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -128.89 128.93 44.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 74.23 110.92 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -125.57 134.82 51.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.844 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.8 124.45 30.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.657 0.741 . . . . 63.44 110.922 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -31.77 19.77 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 70.34 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.57 101.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 63.21 111.101 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 35.7 m -71.71 114.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 74.12 111.138 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.01 159.18 22.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 71.31 112.493 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -31.0 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 73.34 111.113 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -77.15 -22.82 51.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.929 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.84 -3.87 37.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 74.15 110.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 143.3 39.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 73.41 110.876 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.1 -148.37 17.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 74.12 112.546 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.2 mm -131.22 137.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 74.1 111.071 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -101.65 127.84 48.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 75.12 110.899 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.32 126.91 45.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.52 110.855 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.43 149.8 43.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.835 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -141.95 134.18 27.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 73.13 110.97 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.15 163.3 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 74.33 111.114 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ttm -130.55 124.94 32.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 73.34 110.894 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -86.9 172.28 10.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.4 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -70.96 -18.53 62.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 74.3 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.26 -19.9 60.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.31 110.849 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.17 -13.69 37.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 71.02 112.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -85.08 146.38 27.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.705 0.288 . . . . 72.54 110.963 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.43 144.95 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 61.51 110.857 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -102.01 132.63 47.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 74.32 111.13 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -98.96 143.48 29.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 75.52 110.9 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 m -144.66 121.14 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 75.52 110.878 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.18 120.13 25.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.873 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -129.67 119.71 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 75.42 110.869 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.79 135.44 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 72.21 110.859 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.94 136.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 75.33 111.093 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -131.06 142.88 50.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 75.21 110.868 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.0 m -106.3 -175.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 75.1 111.092 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -67.69 -81.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 74.3 110.989 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -62.85 145.45 55.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 64.02 110.855 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.43 159.67 49.24 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.723 0.773 . . . . 71.31 111.052 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.708 2.272 . . . . 63.13 112.318 179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.729 0.3 . . . . 71.31 111.1 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 133.75 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.53 110.849 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -90.3 121.29 32.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 72.22 110.864 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.76 122.15 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 71.33 111.141 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -94.62 140.14 30.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.144 -0.48 . . . . 45.12 111.117 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.66 167.65 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.51 111.076 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.13 43.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.819 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mt -52.12 120.44 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 73.42 111.119 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.61 10.35 70.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 73.31 112.457 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -102.7 139.46 20.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.69 0.757 . . . . 74.51 110.889 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.98 49.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.667 2.245 . . . . 54.3 112.342 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.9 tp -145.42 143.32 30.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 75.32 110.864 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.88 147.75 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 75.12 111.101 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -132.2 150.21 52.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 72.13 110.917 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -111.71 151.52 28.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 75.31 110.904 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -107.3 100.82 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.938 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -54.16 125.09 17.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 71.22 110.827 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.47 -43.21 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.729 . . . . 73.5 112.512 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.45 42.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 74.21 111.012 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -161.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.613 2.209 . . . . 73.45 112.408 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -48.26 -47.02 36.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.21 110.938 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 65.51 110.866 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.841 0.353 . . . . 71.43 110.87 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.54 157.28 46.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -121.77 145.86 47.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 72.14 110.848 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -120.24 143.64 48.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 74.5 111.03 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -148.88 135.44 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 74.32 110.896 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.23 138.31 33.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.921 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.49 126.11 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.53 110.807 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.5 p -138.72 -178.9 5.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 74.41 111.038 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -127.27 9.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.713 -0.756 . . . . 75.12 112.517 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -112.79 -38.64 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 73.41 110.875 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t 178.97 -29.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.124 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -102.43 34.08 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 65.12 110.913 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.99 -6.96 8.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 64.43 111.063 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -70.06 129.07 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 73.44 110.952 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.18 159.25 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.4 110.809 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.2 121.96 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.42 111.167 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.23 144.67 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 71.41 110.888 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 75.0 110.898 -179.891 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.826 0.346 . . . . 75.51 111.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.79 161.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 71.54 110.904 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.23 130.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 74.34 111.073 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.3 mt -69.01 156.98 90.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 75.23 110.927 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.95 32.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.254 . . . . 74.41 112.331 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -81.48 0.39 38.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 73.34 110.91 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.88 30.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 74.3 112.525 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -106.38 -179.55 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.951 0.405 . . . . 65.01 110.851 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -130.21 130.74 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.969 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -124.89 130.36 52.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.02 110.892 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mp -117.19 127.12 26.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 75.12 110.899 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -32.37 18.57 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.804 2.336 . . . . 64.12 112.382 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.45 100.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 62.34 111.101 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.01 113.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 73.12 111.156 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.82 173.85 43.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 73.2 112.44 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.413 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.7 -32.23 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 75.23 111.109 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -77.26 -21.61 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.15 110.928 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -5.61 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 62.21 110.833 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 142.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 65.14 110.958 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.71 -151.49 22.24 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.734 -0.746 . . . . 63.54 112.463 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mm -131.38 134.85 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 75.41 111.093 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -103.96 132.82 49.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 74.02 110.856 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.03 134.17 50.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.78 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.73 148.12 45.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 64.53 110.902 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -142.4 127.43 18.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.41 110.903 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.38 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 74.51 111.083 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ttm -130.64 125.66 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.55 110.926 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.58 171.92 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 74.35 110.95 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -19.15 61.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.802 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.9 -20.24 60.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 65.31 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.56 35.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 71.32 112.472 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 146.32 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.662 0.268 . . . . 74.14 110.886 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -105.63 142.62 35.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 73.23 110.863 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.96 131.09 50.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 75.01 111.085 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.42 142.85 34.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.15 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -146.1 123.61 11.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 62.0 110.816 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.13 122.28 31.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 71.14 110.819 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.02 118.81 24.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 72.44 110.94 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 134.16 34.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.886 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.5 135.73 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 74.23 111.142 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -130.65 131.61 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 75.35 110.854 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -96.51 -176.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.14 111.164 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -67.4 -78.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.939 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 73.42 110.953 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.07 159.45 49.31 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 75.43 111.084 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 C-N-CA 122.647 2.231 . . . . 70.34 112.415 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.67 0.272 . . . . 73.12 111.031 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -93.92 133.12 37.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.935 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -89.5 121.63 31.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.83 120.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 72.13 111.17 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 p -96.7 142.47 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 73.22 111.13 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.43 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 60.12 111.132 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.69 147.97 40.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 74.1 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 121.3 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 75.12 111.14 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.48 5.89 74.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 64.2 112.497 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -101.47 141.43 22.58 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.606 0.717 . . . . 75.24 110.831 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.78 52.21 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.606 2.204 . . . . 74.04 112.384 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.48 143.14 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.437 . . . . 73.11 110.902 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -121.84 146.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 74.1 111.153 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.5 mt -131.41 148.28 52.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 70.13 110.951 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 152.04 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 74.03 110.972 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.9 t -107.08 99.88 9.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 61.24 110.871 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.66 123.56 14.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 63.54 110.908 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.18 -39.4 2.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.53 112.483 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 131.28 37.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 73.41 111.101 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -163.96 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.675 2.25 . . . . 53.03 112.32 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -50.09 30.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 64.42 110.871 179.846 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.875 0.369 . . . . 74.44 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.6 159.11 42.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 75.13 110.93 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.09 139.59 53.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 71.4 110.885 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -121.34 139.09 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.886 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -139.05 137.07 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.23 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.82 134.09 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.918 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.417 ' O ' ' HA3' ' A' ' 75' ' ' GLY . 1.8 m-80 -115.77 125.18 52.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.852 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.8 p -138.43 -179.5 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 75.15 111.129 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.61 -130.83 13.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.481 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -112.84 -37.56 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 73.13 110.905 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 t -179.74 -29.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 64.32 111.187 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -101.97 33.6 2.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.896 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.75 -7.23 7.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 73.21 111.121 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -60.26 130.41 46.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 74.32 110.919 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 153.45 49.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 74.14 110.907 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.54 121.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 65.41 111.191 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.65 145.96 24.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.42 110.942 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.664 0.745 . . . . 74.34 110.88 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.819 0.342 . . . . 63.13 111.07 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -123.25 159.25 29.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.9 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.38 130.17 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 73.53 111.132 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.06 157.64 88.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.54 0.686 . . . . 74.23 110.947 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -21.8 32.77 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.622 2.215 . . . . 75.43 112.357 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -84.24 1.44 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.908 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.86 32.83 8.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.803 -0.713 . . . . 71.4 112.451 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -115.35 179.11 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 73.11 110.868 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -129.47 128.22 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.847 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -126.78 136.61 52.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.81 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mp -118.45 130.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 74.22 110.974 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -34.87 13.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 64.01 112.336 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.58 101.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 74.12 111.1 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 m -72.65 113.22 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 75.34 111.11 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.85 161.82 33.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 64.4 112.478 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.84 -30.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 74.1 111.152 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.1 -20.43 57.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.933 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -3.55 29.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 74.14 110.871 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HG3' HG22 ' A' ' 97' ' ' VAL . 27.5 mt-10 -57.13 142.52 42.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.866 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 34' ' ' ASN . . . 158.75 -153.99 25.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.674 -0.774 . . . . 72.13 112.41 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.81 134.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 75.53 111.156 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -104.0 127.54 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.852 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.2 128.86 47.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 73.11 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 7.0 t -120.54 150.2 41.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 51.03 110.891 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.85 133.7 29.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 64.1 110.927 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.81 162.99 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 75.31 111.129 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 25.0 mtp -129.69 124.77 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 71.41 110.967 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.21 172.82 9.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 64.41 110.87 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -70.71 -19.03 62.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 75.33 110.922 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.83 -20.05 60.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.43 40.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.82 -0.705 . . . . 62.11 112.547 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.08 146.87 26.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 72.3 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -105.05 142.5 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 75.45 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.72 131.84 50.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.52 111.122 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -102.53 143.56 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 t -144.39 125.72 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.24 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -126.83 122.07 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 74.31 110.896 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 121.77 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 74.13 110.883 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -83.79 134.01 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 64.54 110.905 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.35 128.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 74.15 111.079 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.09 142.93 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.91 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.8 m -108.86 -174.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 71.14 111.176 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -67.3 -79.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.85 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -63.09 145.99 54.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 70.31 110.932 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.2 159.59 49.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.536 0.684 . . . . 74.3 111.204 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.342 0.222 0 C-N-CA 122.756 2.304 . . . . 72.23 112.355 179.859 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.797 0.332 . . . . 75.01 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.57 132.38 37.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.906 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -83.84 122.49 28.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.53 110.99 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.8 mm -124.6 121.64 61.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 73.3 111.116 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -95.92 141.86 28.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.061 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.52 166.04 29.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 55.3 111.077 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -124.67 148.91 47.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.47 . . . . 75.35 110.92 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.9 mt -54.57 121.21 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 73.14 111.103 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.61 5.44 81.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 61.42 112.541 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -102.26 139.6 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.561 0.696 . . . . 73.14 110.938 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 144.76 55.33 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.69 2.26 . . . . 75.41 112.351 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 tp -143.43 141.35 30.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.86 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.04 145.12 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 65.44 111.061 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.8 mt -131.83 147.12 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 74.32 110.899 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -114.56 154.17 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 64.51 110.858 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.3 t -105.43 100.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.13 110.831 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -57.03 123.38 14.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.899 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.42 -43.52 1.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.782 -0.723 . . . . 63.44 112.496 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.67 131.26 36.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.523 0.678 . . . . 75.43 111.12 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.16 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.661 2.241 . . . . 74.11 112.351 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.1 -53.25 21.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.44 110.812 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptp . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 75.54 110.91 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.914 0.388 . . . . 74.22 110.841 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.07 155.04 50.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 75.54 110.891 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.89 140.86 51.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 74.25 110.885 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -123.72 141.35 52.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 75.25 110.914 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -144.4 140.38 28.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 73.2 110.844 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 tp -137.55 136.33 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.221 -0.445 . . . . 72.01 110.936 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -115.4 120.49 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 73.51 110.838 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.3 p -138.08 -179.82 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 73.14 111.131 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.32 -130.36 9.82 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 75.42 112.453 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.45 -38.77 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 72.02 110.912 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.5 t 179.42 -30.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.11 111.143 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -103.22 33.89 3.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 63.44 110.92 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.26 -7.47 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 54.31 111.128 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -61.92 129.8 42.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.927 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 158.42 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 75.32 110.88 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -94.84 122.21 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 74.35 111.152 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.99 144.69 25.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 72.33 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.718 0.771 . . . . 64.32 110.814 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.74 0.305 . . . . 75.13 111.065 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 mmm-85 -126.79 158.52 36.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 74.45 110.874 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 t -109.14 130.82 61.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.127 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.84 158.3 86.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 53.45 110.851 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -22.24 32.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 72.31 112.413 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.43 1.61 40.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 72.22 110.898 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.91 29.3 13.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 61.12 112.538 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.3 m -112.74 -178.64 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 71.15 110.852 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.1 tp -128.27 128.98 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 75.42 110.906 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -125.64 136.6 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 72.52 110.82 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -119.1 127.63 26.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.574 0.702 . . . . 71.13 110.898 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.93 -32.81 17.15 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.69 2.26 . . . . 75.55 112.336 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.14 102.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 73.35 111.167 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.7 m -71.98 117.19 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 74.41 111.11 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.81 160.11 28.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 73.41 112.525 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.425 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -33.86 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 65.52 111.129 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -77.69 -21.56 51.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.125 -0.489 . . . . 73.21 110.956 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.08 -4.73 40.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.53 110.834 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 142.7 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.875 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.63 -148.32 15.14 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.727 -0.749 . . . . 72.42 112.444 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.67 133.71 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 74.41 111.084 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 73.54 110.926 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.98 126.97 44.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.13 110.903 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.6 t -121.16 151.11 40.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.01 110.913 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -139.44 133.9 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.917 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.82 163.63 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 73.24 111.176 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.2 mmm -129.23 124.69 35.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.288 -0.415 . . . . 75.12 110.84 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.93 170.1 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 75.33 110.811 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -73.8 -18.32 60.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 75.2 110.825 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -72.89 -20.12 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 74.04 110.843 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.45 -20.04 21.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.7 -0.762 . . . . 73.22 112.508 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.7 147.86 26.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 74.24 110.916 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -103.67 145.27 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 71.15 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.04 132.51 43.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 74.0 111.073 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.02 139.97 37.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.872 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.1 m -146.7 120.74 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 73.34 110.891 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.42 123.29 31.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 64.51 110.909 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -130.14 120.6 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.818 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.87 136.13 33.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 74.05 110.905 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.1 t -120.54 137.51 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 70.14 111.132 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -128.42 146.61 50.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 75.31 110.937 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 12.4 m -107.11 -176.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 71.3 111.111 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -68.11 -77.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.912 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.31 144.55 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 72.45 110.962 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.15 160.44 45.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.6 0.714 . . . . 62.3 111.17 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.176 0 C-N-CA 122.731 2.287 . . . . 73.52 112.364 179.861 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.704 0.288 . . . . 72.1 111.128 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 132.46 38.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 74.11 110.89 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.7 121.2 32.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.33 110.876 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.87 122.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 64.43 111.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -96.0 142.13 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 73.41 111.036 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.61 168.23 20.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.44 111.071 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 149.34 46.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 75.14 110.859 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.8 mt -65.06 120.49 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.147 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.77 -12.24 57.82 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.654 -0.784 . . . . 72.31 112.421 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -101.45 140.88 21.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.623 0.725 . . . . 73.14 110.946 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 145.01 55.9 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 71.02 112.348 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.3 tp -137.77 142.46 40.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 74.2 110.921 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.6 t -123.1 146.72 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 74.35 111.128 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.84 151.92 51.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.917 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -111.63 149.71 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.23 110.856 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.81 101.64 9.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 64.34 110.935 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -54.09 99.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.52 110.916 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.61 -47.34 0.65 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.628 -0.796 . . . . 75.11 112.473 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.31 103.58 12.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 74.14 111.128 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.4 Cg_endo -69.79 -161.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.71 2.273 . . . . 63.25 112.325 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.59 -8.08 8.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.853 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 mptt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 72.45 110.942 179.871 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.748 0.309 . . . . 72.23 110.936 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -179.22 161.31 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 72.23 111.002 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.43 137.15 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 64.03 110.917 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -125.05 143.82 50.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.477 . . . . 74.05 110.972 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -148.66 136.26 20.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 75.14 110.86 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tp -138.62 138.07 37.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 75.31 110.922 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.62 126.83 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 70.22 110.865 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 p -137.57 179.81 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.2 111.15 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.12 -132.72 17.29 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.65 -37.26 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 75.24 110.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -179.38 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 64.3 111.085 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -101.5 33.67 2.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 74.33 110.885 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.62 -6.5 7.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 71.23 111.085 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -59.53 129.75 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.895 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.74 153.15 50.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 74.1 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.18 123.31 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 74.35 111.045 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.59 145.0 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.32 110.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.754 . . . . 72.23 110.822 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.812 0.339 . . . . 75.33 111.132 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.83 157.33 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 73.43 110.895 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.55 127.02 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 72.3 111.115 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.69 157.91 88.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.662 0.744 . . . . 73.55 110.841 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -22.8 31.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.245 . . . . 73.22 112.295 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -83.52 4.02 29.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 63.3 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.96 13.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.802 -0.713 . . . . 60.52 112.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -114.63 178.6 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.407 . . . . 73.24 110.839 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.09 127.88 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 73.25 110.986 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -126.26 130.27 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.857 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mp -120.93 130.31 24.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.649 0.737 . . . . 73.41 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.64 18.27 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 72.51 112.39 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.66 103.4 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 63.03 111.146 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 m -73.01 121.91 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.469 . . . . 73.12 111.1 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.08 156.42 22.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.683 -0.77 . . . . 75.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -30.18 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.305 . . . . 74.33 111.129 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -73.97 -23.74 59.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 62.45 110.849 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.43 -5.0 45.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.202 -0.454 . . . . 73.41 110.923 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 141.06 58.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.869 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.39 -138.91 6.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 63.4 112.413 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.13 127.64 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 70.43 111.152 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -104.5 131.1 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.42 110.859 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.08 137.36 53.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 74.3 110.944 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.8 t -119.95 149.07 42.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 71.33 110.939 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.99 127.07 19.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.897 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.59 163.87 27.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.11 111.094 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ttm -128.75 125.29 37.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.885 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -86.93 173.21 9.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 71.13 110.887 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -70.32 -18.13 63.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.35 110.848 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.14 -19.93 61.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.33 110.882 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.75 -16.37 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 71.41 112.478 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 146.76 27.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.727 0.299 . . . . 75.14 110.881 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.26 143.4 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 55.04 110.9 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.92 130.38 51.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 74.41 111.193 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -105.49 144.85 31.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.917 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -144.44 125.82 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 74.34 110.824 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.06 123.59 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 74.3 110.943 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.83 118.84 24.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.93 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -82.66 129.89 35.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 75.53 110.97 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.97 131.05 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 74.11 111.197 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -130.78 128.32 40.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 74.34 110.826 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 m -95.08 -177.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 72.41 111.095 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -66.95 -82.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.89 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -58.02 137.91 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.873 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 160.08 44.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 75.22 111.188 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 62.32 112.314 179.897 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.741 0.305 . . . . 61.53 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -93.69 134.94 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.875 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -85.81 121.78 28.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 75.25 110.852 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mm -125.19 121.57 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.085 -0.507 . . . . 74.34 111.211 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -96.55 142.01 29.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.35 111.188 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.27 166.04 29.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 74.51 111.173 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -124.31 148.18 47.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 73.54 110.887 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mt -54.21 121.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 70.24 111.174 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.57 4.34 80.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.776 -0.726 . . . . 72.22 112.465 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -102.08 140.15 20.92 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 71.2 110.931 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 144.07 52.85 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.709 2.272 . . . . 62.22 112.305 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.5 tp -144.41 141.71 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.45 110.871 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.28 147.38 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.33 111.161 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -132.02 148.72 52.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 70.53 110.934 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -111.82 151.3 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 75.42 110.946 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.4 t -107.38 99.9 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 73.14 110.918 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -57.62 121.24 9.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 74.05 110.898 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.01 -39.4 1.91 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.786 -0.721 . . . . 63.24 112.515 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.53 43.67 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.544 0.688 . . . . 72.42 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.676 2.251 . . . . 74.32 112.397 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -49.36 -48.45 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.5 110.918 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.504 0.669 . . . . 75.45 110.915 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.846 0.355 . . . . 72.25 110.832 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 pp -136.58 151.83 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 75.33 110.852 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.86 148.14 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.879 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.27 139.91 53.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 73.13 110.946 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -136.34 135.46 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 73.32 110.887 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.25 137.62 37.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.943 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -113.52 126.76 55.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 52.43 110.882 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.5 p -136.71 179.78 6.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 73.12 111.181 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.17 -119.69 6.83 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.648 -0.787 . . . . 73.42 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -114.57 -38.96 3.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.53 110.946 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 174.51 -27.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 64.14 111.103 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.64 33.2 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.865 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.27 -7.55 8.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.12 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -60.72 129.77 43.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.33 110.878 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 153.71 51.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 65.15 110.907 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 m -88.81 122.35 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 74.15 111.109 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.2 145.22 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 72.23 110.846 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.716 0.769 . . . . 71.13 110.798 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.783 0.325 . . . . 64.32 111.106 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 159.58 33.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 64.02 110.888 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 t -113.33 130.58 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.44 111.158 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.4 mt -68.55 157.55 87.83 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 72.41 110.889 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.632 2.221 . . . . 74.31 112.353 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -83.42 -0.15 48.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 75.12 110.812 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.4 9.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 61.32 112.461 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 m -111.65 179.6 3.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 72.31 110.898 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.34 128.08 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.482 . . . . 75.2 110.947 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -126.68 132.83 51.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 71.44 110.844 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.78 128.35 25.98 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.518 0.675 . . . . 73.12 110.985 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.29 19.12 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.651 2.234 . . . . 72.01 112.411 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.8 102.36 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 74.04 111.151 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.09 118.97 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 74.02 111.167 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.37 158.64 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 72.54 112.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -30.37 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 73.25 111.182 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.5 -23.11 56.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.92 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.38 -5.09 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 73.33 110.783 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.03 140.9 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 74.33 110.885 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.66 -139.57 6.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.82 -0.705 . . . . 55.23 112.476 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mp -131.78 135.34 58.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 73.32 111.11 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -104.67 126.75 52.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.838 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.1 mmm180 -126.39 130.65 51.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.915 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.17 151.22 39.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 73.25 110.86 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -140.54 129.44 23.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 163.35 28.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.3 111.05 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.3 ttm -129.54 125.41 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 65.04 110.876 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.48 171.77 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -17.41 62.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.868 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.58 -25.13 61.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 71.11 110.894 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.94 -20.23 13.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 73.14 112.538 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.09 146.87 26.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.733 0.301 . . . . 73.31 110.868 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.04 145.39 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.834 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.77 131.89 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 74.51 111.212 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -105.05 142.66 34.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.917 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -145.93 126.95 14.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 72.24 110.913 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.77 127.25 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 72.42 110.822 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -129.03 124.3 34.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 65.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -82.61 135.53 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 73.23 110.933 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.5 t -123.98 132.5 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.01 111.232 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.0 128.4 40.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.908 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.3 m -93.71 -176.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 73.53 111.149 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -66.35 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 72.1 110.874 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -63.93 145.87 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 70.15 110.945 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.53 159.48 50.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.509 0.671 . . . . 74.55 111.202 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.15 0 C-N-CA 122.759 2.306 . . . . 73.11 112.284 179.946 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.742 0.306 . . . . 71.54 111.118 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.0 132.9 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.53 110.9 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -86.98 120.97 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.86 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.64 122.74 63.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 73.44 111.076 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.08 142.17 28.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.15 111.075 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.66 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.45 111.11 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.45 148.23 44.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.84 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.77 122.16 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 73.41 111.141 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.13 4.22 78.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.673 -0.775 . . . . 51.54 112.519 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -101.18 140.4 21.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.712 0.768 . . . . 72.2 110.879 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.49 45.46 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.669 2.246 . . . . 73.11 112.375 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.8 tp -144.48 141.98 29.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 73.34 111.029 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.84 148.6 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 71.34 111.081 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 mt -130.56 147.94 52.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.896 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.95 31.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.868 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.4 100.79 8.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 72.4 110.875 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.64 122.05 7.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 74.41 110.916 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.426 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 125.55 -47.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.837 -0.697 . . . . 75.34 112.511 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.96 102.2 10.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 63.01 111.065 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.1 Cg_endo -69.75 -161.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.625 2.217 . . . . 52.33 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -11.15 5.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 74.31 110.916 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mptt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.662 0.744 . . . . 72.34 110.866 179.933 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.843 0.354 . . . . 74.33 110.92 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.3 pp -172.3 174.23 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.897 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.43 131.16 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.809 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -124.09 128.95 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 75.52 110.856 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -138.41 137.79 37.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.842 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 tp -137.75 136.94 37.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 64.22 110.899 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.92 126.39 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.32 110.85 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.5 p -138.58 -179.35 5.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 75.44 111.083 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.26 -126.64 10.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.817 -0.706 . . . . 71.2 112.489 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.1 mmm-85 -112.61 -38.62 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.04 110.808 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 t 178.93 -29.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 73.03 111.159 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -102.16 34.28 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.822 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.6 -7.01 8.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 70.23 111.14 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -63.07 131.23 47.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 75.14 110.927 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 154.27 47.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 75.13 110.904 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.29 117.01 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 75.53 111.073 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.29 149.71 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 64.4 110.927 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.751 0.786 . . . . 73.02 110.802 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.828 0.347 . . . . 74.22 111.111 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 161.42 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 73.14 110.876 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.9 t -107.65 128.26 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 70.14 111.121 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.4 mt -70.31 158.68 87.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 73.44 110.926 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -22.42 31.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.649 2.233 . . . . 73.54 112.301 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.93 1.6 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 74.43 110.897 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 30.86 11.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 72.3 112.519 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.3 m -112.65 178.26 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 72.33 110.833 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -131.62 130.62 42.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 75.41 110.89 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -124.57 128.2 48.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.32 110.913 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.69 131.65 24.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 74.25 110.918 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -32.7 18.39 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 42.22 112.396 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.62 101.75 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.086 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.3 m -72.98 118.83 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 72.43 111.118 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.51 163.78 35.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 71.54 112.451 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -29.97 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 73.42 111.049 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -74.41 -22.32 59.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 74.24 110.808 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -5.96 47.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 74.52 110.912 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.0 141.99 54.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.841 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.24 -142.28 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 44.1 112.537 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.94 135.48 59.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.887 0.375 . . . . 71.42 111.195 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.6 127.39 48.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.766 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 131.62 52.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 74.55 110.886 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.63 150.09 43.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 75.2 110.866 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -148.9 125.65 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 75.21 110.851 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.57 27.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 73.23 111.103 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.22 125.23 27.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.31 110.872 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.59 170.79 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 70.43 110.854 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -72.69 -18.74 61.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 72.25 110.889 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -73.01 -20.03 61.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.31 110.883 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.54 -11.25 33.02 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.772 -0.728 . . . . 73.3 112.527 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -84.77 145.39 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 75.55 110.898 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.42 145.49 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 72.03 110.876 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.28 126.55 48.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 75.33 111.152 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 134.54 48.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.97 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.9 m -144.68 120.08 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 73.02 110.788 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.11 121.02 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 73.51 110.876 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.57 127.16 36.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.96 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -83.88 136.8 33.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 74.55 110.934 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.17 130.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 75.34 111.091 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.84 128.82 39.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 71.23 110.871 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.3 m -93.5 -177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 74.13 111.131 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -63.02 -69.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 75.51 110.884 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.98 138.92 39.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 73.43 110.963 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.29 159.54 49.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.716 0.769 . . . . 63.14 111.114 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 74.42 112.317 179.916 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.684 0.278 . . . . 73.03 111.147 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -92.64 134.64 34.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.43 110.92 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -83.21 120.79 26.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.914 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -125.4 120.89 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.174 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -96.53 142.38 28.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 75.24 111.126 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.1 164.98 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 73.43 111.12 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.36 148.94 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.821 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mt -56.13 121.36 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 71.1 111.156 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.6 3.31 86.44 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.668 -0.777 . . . . 53.05 112.536 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -101.17 140.89 21.66 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.564 0.697 . . . . 63.52 110.972 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 143.83 51.94 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.599 2.199 . . . . 72.02 112.411 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.3 tp -144.35 142.88 30.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 74.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.53 146.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 73.05 111.178 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -131.42 147.24 52.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 65.44 110.924 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -113.17 151.08 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 72.31 110.829 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.8 t -108.25 100.48 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 64.21 110.844 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.73 126.97 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 74.11 110.887 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.48 -38.84 2.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 65.25 112.518 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.41 31.1 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.536 0.684 . . . . 72.51 111.15 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -164.23 0.12 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 64.23 112.339 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.1 -50.96 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 75.45 110.88 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 65.22 110.909 179.791 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.878 0.371 . . . . 74.34 110.895 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.94 144.54 45.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 72.53 110.95 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -122.07 133.01 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.14 110.887 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -121.18 144.76 48.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 74.11 110.887 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -136.49 138.26 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.885 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -134.57 141.44 46.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 73.13 110.886 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -111.95 125.33 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 70.14 110.886 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.8 p -138.58 -179.24 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 71.11 111.124 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.54 -129.57 9.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 65.4 112.497 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -112.48 -37.23 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.747 0.308 . . . . 65.21 110.83 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t 176.81 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 75.31 111.192 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.52 33.64 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 74.02 110.945 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.54 -6.75 9.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 73.22 111.146 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -59.84 129.16 40.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.32 110.91 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.4 161.11 37.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 61.3 110.85 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.8 t -99.5 122.87 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.175 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.45 143.33 27.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.902 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 52.11 110.815 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.748 0.309 . . . . 75.41 111.132 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.93 159.52 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 74.21 110.879 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.9 t -108.95 130.34 62.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 74.24 111.181 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.5 mt -69.23 157.15 90.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 75.44 110.933 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.04 32.77 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 74.32 112.273 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -82.88 0.39 44.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 64.02 110.9 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.54 28.2 13.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 72.02 112.418 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -112.0 -179.18 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 75.34 110.919 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -128.53 127.4 42.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 64.34 110.9 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -126.9 132.06 50.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.819 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mp -115.33 130.83 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 73.41 110.921 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.79 -32.83 17.68 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.679 2.253 . . . . 74.12 112.36 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.73 101.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 74.45 111.157 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.2 m -76.58 118.54 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 71.52 111.229 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.99 165.39 34.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.731 . . . . 51.22 112.414 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -31.12 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 71.5 111.136 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.19 -22.59 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 64.34 110.914 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -5.35 44.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.12 110.88 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.7 142.21 50.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.876 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.16 -152.34 23.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.801 -0.714 . . . . 61.44 112.521 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 mm -124.81 135.22 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.25 111.097 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 21.9 t80 -103.38 131.66 50.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 71.53 110.836 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 138.4 54.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.837 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.86 42.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.02 110.857 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.36 125.34 19.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.44 110.848 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.38 163.91 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 71.33 111.091 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttm -129.69 125.66 36.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.855 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.86 172.61 10.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 73.43 110.912 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -70.34 -18.04 63.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 72.32 110.914 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 75.03 110.881 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -18.78 32.93 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.733 . . . . 73.03 112.481 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 147.84 26.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.313 . . . . 74.24 110.906 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -103.74 144.8 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.43 110.878 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -101.84 131.86 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 74.53 111.159 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 145.43 27.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 75.34 110.918 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 t -143.79 127.96 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 55.5 110.826 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -128.31 129.26 46.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 61.54 110.853 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.82 126.03 33.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 64.14 110.919 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.51 131.42 34.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 74.35 110.858 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.4 t -120.7 130.07 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 73.24 111.115 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 128.64 38.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 75.53 110.863 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -94.26 -177.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 72.21 111.076 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -62.12 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 63.42 110.927 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.66 143.43 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 63.33 110.956 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.41 159.75 48.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 75.54 111.12 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 72.15 112.319 179.93 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.79 0.329 . . . . 70.43 111.089 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -93.16 132.72 37.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.44 110.928 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.36 122.78 32.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 74.32 110.849 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.3 mm -124.2 126.27 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.23 111.163 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -94.09 142.37 27.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 75.25 111.233 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.49 168.98 20.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 72.43 111.088 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.63 148.9 40.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 73.41 110.916 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.8 mt -54.17 121.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 73.52 111.111 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.06 12.37 65.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 63.23 112.502 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -102.7 138.31 19.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 74.02 110.908 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 143.14 50.55 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.697 2.265 . . . . 75.0 112.401 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.7 tp -145.68 143.05 29.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.891 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.1 144.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.41 111.106 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.39 147.55 52.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.854 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -113.77 153.33 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.855 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 t -104.28 100.88 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 62.14 110.832 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -56.01 123.52 14.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 73.33 110.852 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.73 -39.85 2.02 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.663 -0.78 . . . . 71.03 112.504 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.34 129.44 43.23 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.517 0.675 . . . . 73.32 111.152 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -163.91 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.787 2.325 . . . . 63.41 112.313 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -49.01 -48.2 43.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 65.43 110.909 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.586 0.708 . . . . 75.13 110.928 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.884 0.373 . . . . 74.53 110.878 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 pp -135.61 156.06 49.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 75.25 110.932 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -121.55 147.67 45.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 64.14 110.958 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -130.49 130.0 43.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 73.44 110.883 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -136.52 136.91 39.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 71.34 110.844 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.35 138.54 38.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.23 110.926 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -111.83 126.34 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 74.22 110.952 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.1 p -137.99 179.56 6.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 74.12 111.186 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.54 -129.93 14.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.791 -0.719 . . . . 71.41 112.449 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -112.65 -37.68 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 73.14 110.878 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 t -179.12 -31.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.51 111.129 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.57 33.94 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 74.34 110.945 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.93 -6.42 8.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 71.42 111.165 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -59.36 131.72 51.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 64.53 110.985 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.52 153.53 47.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 73.03 110.866 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.68 120.28 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 63.53 111.148 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 mt -95.83 146.75 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 75.02 110.899 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.678 0.751 . . . . 74.23 110.847 -179.93 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.841 0.353 . . . . 71.52 111.052 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -114.36 160.9 18.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 65.22 110.831 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.44 129.68 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 74.03 111.15 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.0 mt -69.47 157.87 88.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.582 0.706 . . . . 75.31 110.883 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -23.0 31.01 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.677 2.251 . . . . 62.0 112.284 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -82.96 1.14 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.899 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.24 29.84 11.86 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.772 -0.728 . . . . 72.31 112.484 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -112.62 -179.43 3.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.399 . . . . 74.31 110.846 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.1 tp -129.14 130.84 46.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 73.13 110.898 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -123.87 130.48 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.909 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.86 124.15 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 73.35 110.929 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -32.8 18.05 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 62.02 112.314 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.48 101.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.42 . . . . 62.54 111.151 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.9 m -72.84 112.2 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 74.43 111.064 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.53 164.69 36.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.745 -0.74 . . . . 73.32 112.475 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.436 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.81 -33.46 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 72.4 111.086 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -77.6 -22.04 51.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 63.34 110.84 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -5.07 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 74.52 110.916 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 142.16 52.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 70.51 110.827 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.48 -148.12 15.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 54.24 112.537 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mm -129.71 135.59 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 65.24 111.154 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -104.43 123.97 48.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.877 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 126.95 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 73.53 110.858 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.6 t -121.59 153.93 37.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 75.51 110.923 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -141.0 140.08 34.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 64.13 110.928 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 162.41 30.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 74.34 111.152 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 75.9 mmm -130.14 125.24 34.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 71.31 110.888 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -88.44 170.8 10.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 64.42 110.853 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -72.94 -22.48 60.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 74.42 110.888 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.54 -20.43 60.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.34 110.915 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.8 -2.86 31.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 75.11 112.515 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.56 146.46 27.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 74.44 110.938 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.32 142.42 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 75.21 110.955 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.2 129.67 51.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.165 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.82 141.46 34.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 74.05 110.922 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 58.7 m -145.92 120.13 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.34 110.844 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.72 121.92 25.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.907 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 91' ' ' SER . 6.9 m-85 -131.96 120.61 22.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 75.35 110.906 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.14 132.6 34.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 74.22 110.881 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.6 t -120.66 136.03 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 74.41 111.199 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.75 151.22 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 63.24 110.89 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 13.5 m -112.06 -175.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 73.21 111.158 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -67.29 -76.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.896 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.02 137.31 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.909 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.01 159.87 47.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.665 0.745 . . . . 72.5 111.135 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 73.31 112.325 179.895 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.718 0.294 . . . . 74.02 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -93.65 135.18 35.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 75.12 110.98 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -90.42 122.91 33.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.5 110.875 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -125.39 124.56 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 74.25 111.164 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -89.61 144.17 26.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 73.24 111.147 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -140.54 165.68 26.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 71.34 111.038 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.43 110.887 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.5 mm -61.74 120.47 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 75.12 111.173 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.34 10.84 85.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 75.24 112.472 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -101.44 140.69 21.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.609 0.718 . . . . 74.34 110.841 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 143.48 51.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.236 . . . . 71.34 112.37 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 tp -144.58 142.39 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.01 110.897 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.23 148.19 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.3 111.239 179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.6 mt -131.54 148.05 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 64.41 110.824 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -113.33 152.53 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 74.42 110.877 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.0 t -107.09 102.24 11.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.11 110.868 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -58.19 123.25 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.915 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.57 -37.97 2.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.49 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.66 128.63 45.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.553 0.692 . . . . 73.54 111.109 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -164.28 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.657 2.238 . . . . 72.31 112.345 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -49.31 -48.92 45.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 74.33 110.9 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 72.21 110.846 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.772 0.32 . . . . 74.3 110.922 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 pp -135.94 157.93 45.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 74.41 110.899 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -123.08 147.17 47.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 74.41 110.841 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.04 110.988 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -151.84 137.13 17.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 73.53 110.835 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.401 HD22 ' HE3' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -140.9 138.29 33.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 75.23 110.954 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.83 127.35 55.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.818 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.9 p -140.52 -179.34 5.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 71.12 111.123 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.9 -120.45 5.31 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 72.15 112.528 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -114.68 -39.72 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 74.31 110.863 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 173.66 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.33 111.139 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.37 33.46 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.875 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.42 -7.48 9.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.119 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -63.09 130.43 44.61 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.151 -0.477 . . . . 71.51 110.931 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -135.67 158.91 43.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 73.54 110.885 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.84 121.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 70.33 111.114 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.7 145.27 25.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.871 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 70.51 110.833 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.836 0.35 . . . . 71.13 111.071 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -127.14 159.84 33.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 74.01 110.842 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 t -108.71 130.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.171 -0.468 . . . . 75.15 111.149 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.8 mt -68.41 157.93 86.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 71.21 110.936 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -23.04 30.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.754 2.303 . . . . 75.4 112.337 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -83.24 0.68 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 70.14 110.898 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.4 29.38 11.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 73.34 112.484 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -111.43 -178.95 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 54.42 110.881 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -128.76 130.06 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 75.23 110.831 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -124.05 130.72 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 70.41 110.861 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.15 131.0 24.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.594 0.712 . . . . 72.22 110.9 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -38.29 8.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 73.1 112.377 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.19 103.8 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 74.54 111.084 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.97 115.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 70.12 111.135 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.58 165.76 29.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 75.12 112.479 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.408 HG13 ' HB3' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -54.02 -30.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 75.15 111.131 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.09 -22.57 55.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 64.11 110.88 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.65 -1.55 42.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 64.24 110.779 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.21 141.12 58.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.932 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.91 -145.17 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 74.33 112.456 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.58 134.72 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 74.22 111.045 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -103.44 135.29 45.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 75.23 110.832 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.01 130.71 48.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 71.33 110.874 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 147.93 43.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 64.3 110.875 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -146.09 126.96 14.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.917 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.26 162.67 30.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 72.31 111.084 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 33.8 tpp -130.15 125.76 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.22 110.938 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.52 171.63 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 71.02 110.879 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -18.56 62.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 73.1 110.901 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -73.35 -19.78 60.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 72.12 110.865 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.16 37.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.58 -0.819 . . . . 72.4 112.369 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -84.78 145.73 27.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.689 0.281 . . . . 73.42 110.916 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -105.58 142.22 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 70.23 110.877 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.05 129.7 51.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 70.54 111.054 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -105.72 144.13 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.983 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -145.65 120.63 10.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 75.23 110.877 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -121.28 120.76 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 75.53 110.888 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -127.72 126.6 42.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 71.55 110.94 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.5 mmm-85 -91.11 135.65 33.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.892 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.79 130.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.22 111.211 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.19 127.65 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 71.14 110.949 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.2 m -91.1 -176.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 73.41 111.148 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -75.84 -76.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 73.41 110.93 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' A' ' 71' ' ' ILE . 10.5 tp-100 -58.68 148.03 30.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 75.12 110.917 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.29 159.37 50.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.565 0.698 . . . . 74.25 111.093 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.231 0.167 0 C-N-CA 122.568 2.178 . . . . 70.32 112.343 179.878 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.751 0.31 . . . . 72.42 111.048 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.61 133.25 37.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.917 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -84.65 120.76 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 70.23 110.91 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mm -125.88 121.98 60.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.119 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -94.19 139.83 30.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 74.44 111.143 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.76 167.0 26.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 74.41 111.088 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.37 148.12 44.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 75.42 110.876 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mt -52.51 121.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 74.53 111.222 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.76 7.72 70.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 74.44 112.476 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -101.76 139.43 20.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 62.31 110.822 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 143.05 49.4 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.682 2.255 . . . . 70.32 112.286 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.7 tp -145.58 141.84 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 75.1 110.95 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.6 t -123.16 146.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.45 111.13 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.4 mt -130.87 146.62 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.921 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.47 152.13 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.31 110.87 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.1 t -107.34 100.73 10.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 65.54 110.869 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -58.96 122.04 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 73.12 110.89 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.53 -38.42 2.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 71.33 112.466 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.35 44.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.519 0.676 . . . . 53.22 111.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.64 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.752 2.301 . . . . 74.24 112.374 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -49.65 -49.89 45.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 74.33 110.913 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 74.53 110.91 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 72.33 110.877 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.19 155.27 50.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.929 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -120.87 148.52 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.03 110.952 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -127.73 145.05 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.948 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -145.08 144.25 30.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.1 110.889 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.92 134.98 41.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 74.34 110.908 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -117.92 120.83 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 71.24 110.867 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -141.44 179.52 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 54.55 111.096 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.81 -133.26 20.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 73.4 112.568 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.7 mmm-85 -112.77 -36.78 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 74.11 110.914 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 t -179.16 -27.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 75.12 111.114 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -100.72 32.59 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 75.14 110.859 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.17 -6.68 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.3 111.089 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 t90 -73.92 128.14 34.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.921 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.63 159.07 43.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 75.24 110.958 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.2 t -87.2 121.54 38.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 74.42 111.094 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.45 146.76 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.917 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 74.13 110.875 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.758 0.313 . . . . 73.31 111.107 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -122.79 159.74 27.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.815 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.92 129.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 72.23 111.114 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.1 156.13 92.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.521 0.676 . . . . 73.02 110.951 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -22.2 32.39 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.672 2.248 . . . . 71.44 112.309 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -83.32 0.6 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 73.42 110.892 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.51 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.773 -0.727 . . . . 75.14 112.575 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.1 m -113.7 178.88 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 73.55 110.863 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 tp -128.81 127.52 42.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.34 110.905 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -126.17 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 71.42 110.922 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mp -117.83 128.18 26.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.532 0.682 . . . . 70.15 110.942 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.15 17.19 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.661 2.241 . . . . 74.01 112.33 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.73 101.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 75.53 111.118 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 m -73.06 113.28 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.45 111.139 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.65 36.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.694 -0.765 . . . . 75.13 112.501 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -30.02 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.777 0.323 . . . . 74.53 111.086 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.14 -23.77 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.918 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.61 -5.18 57.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.9 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.76 141.4 58.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 73.42 110.791 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.66 -138.93 6.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 73.23 112.481 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.1 135.55 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 75.42 111.125 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -102.61 134.8 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.02 110.906 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -128.02 127.66 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 74.23 110.915 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.6 t -121.56 149.48 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 52.03 110.9 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.46 132.55 23.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 75.45 110.878 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 162.26 30.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 72.52 111.082 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.2 ttm -130.36 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 73.55 110.857 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.42 170.96 11.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 74.53 110.857 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -17.81 62.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.91 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -73.37 -25.59 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 74.35 110.841 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.01 19.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 51.43 112.496 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -84.59 146.78 27.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 74.03 110.94 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.24 142.34 35.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.041 0.448 . . . . 74.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.54 131.84 49.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 75.43 111.145 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -104.97 140.86 37.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 74.34 110.984 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.57 127.23 14.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.876 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.74 129.4 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 54.45 110.856 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -127.92 118.01 22.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 75.11 110.884 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.5 mmm-85 -85.57 130.33 34.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 54.14 110.891 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.4 t -122.54 132.25 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 74.32 111.105 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -131.17 128.26 39.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 74.43 110.976 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 m -93.86 -176.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 75.53 111.126 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.03 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.919 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.86 145.71 54.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.924 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.44 159.58 49.65 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.691 0.758 . . . . 75.41 111.105 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 70.34 112.358 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.528 -0.229 . . . . 65.21 112.528 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 61.76 102.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 75.13 110.798 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.46 69.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 74.41 111.136 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.05 132.63 36.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.53 110.842 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -90.05 121.22 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.23 110.849 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.65 122.42 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.21 111.178 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -95.07 141.62 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.12 111.134 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.02 167.19 25.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.21 111.015 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.64 148.45 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.24 110.843 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.0 mt -52.45 120.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 75.3 111.132 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.28 8.92 67.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 73.23 112.526 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -101.71 138.32 19.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.652 0.739 . . . . 73.43 110.889 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 143.14 49.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.677 2.251 . . . . 72.55 112.258 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.4 tp -145.92 141.36 27.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 71.42 110.877 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.9 139.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.32 111.197 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.2 mt -132.19 149.02 52.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.445 . . . . 73.45 110.878 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -112.72 153.24 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 75.24 110.918 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 t -105.83 100.71 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 62.4 110.895 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -54.19 128.91 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.855 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -40.84 1.8 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.756 . . . . 64.43 112.499 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.25 129.74 42.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.539 0.685 . . . . 72.05 111.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -164.22 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.555 2.17 . . . . 74.54 112.354 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -48.46 -49.12 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.11 150.4 41.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 74.51 110.934 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 109.83 2.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.756 2.304 . . . . 64.13 112.326 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -85.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.657 2.238 . . . . 53.43 112.339 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -103.44 -177.54 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.854 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 143.2 58.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.835 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 pp -136.2 149.4 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 61.44 110.877 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -121.28 127.03 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 75.43 110.862 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -118.08 144.72 45.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 72.35 110.944 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -136.77 139.27 41.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 73.53 110.902 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.42 138.9 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 75.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -115.21 119.31 35.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.846 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.7 p -136.28 179.49 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 73.54 111.183 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.4 -132.11 14.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.799 -0.715 . . . . 72.13 112.499 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -112.68 -37.76 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 74.54 110.828 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 t -179.47 -29.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 74.21 111.141 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -102.12 34.26 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.84 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.53 -6.24 8.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 73.41 111.126 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -59.31 128.98 39.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.5 110.861 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.24 158.88 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 72.11 110.908 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -101.65 123.76 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.43 111.129 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.1 mt -87.25 144.02 27.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.2 -0.454 . . . . 75.42 110.941 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.41 163.43 42.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 75.52 110.854 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 0.31 5.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.702 2.268 . . . . 64.2 112.311 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -149.61 89.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 70.23 110.953 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.08 -43.17 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 51.32 112.566 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 43.14 37.4 3.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.744 -0.741 . . . . 72.42 112.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.55 -175.24 13.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 72.14 112.47 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 130.21 18.96 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.697 2.265 . . . . 74.4 112.405 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -83.7 -34.12 25.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 72.11 110.841 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -25.83 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 75.41 110.927 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.03 -47.6 8.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.888 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -130.13 -99.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 72.24 111.035 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.437 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -165.26 173.74 10.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 75.22 111.207 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -119.11 160.44 22.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.826 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.01 128.73 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.34 111.108 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.51 156.46 90.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.686 0.755 . . . . 74.41 110.893 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -22.97 31.41 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.74 2.293 . . . . 75.1 112.301 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -82.98 0.05 46.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 73.22 110.903 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.61 13.35 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 73.41 112.431 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.4 m -109.68 179.0 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 61.24 110.868 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 tp -128.36 128.33 44.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 73.31 110.961 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -125.95 129.73 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.843 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -117.19 130.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 75.13 110.84 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -34.8 13.91 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 72.42 112.339 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.21 100.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.41 111.111 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -73.45 114.68 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 71.55 111.143 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.29 166.94 42.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.824 -0.703 . . . . 61.23 112.433 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -31.05 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.308 . . . . 73.05 111.116 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -76.25 -21.96 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.41 110.93 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -5.44 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 74.44 110.909 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.23 140.47 55.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 74.3 110.877 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.7 -147.46 12.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.654 -0.784 . . . . 71.55 112.449 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.57 135.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.952 0.406 . . . . 70.05 111.041 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -100.05 124.92 45.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 71.25 110.852 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 127.25 40.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 75.31 110.884 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 149.45 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 61.1 110.945 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -142.62 126.24 16.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 73.41 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.48 31.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.43 111.093 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.9 tpp -130.27 125.86 35.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -86.49 170.79 11.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 74.31 110.859 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -72.7 -17.58 61.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 71.25 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -72.1 -21.04 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.928 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.05 -21.46 17.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.708 . . . . 74.54 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 145.88 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.279 . . . . 72.02 110.903 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.25 145.11 32.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 74.41 110.903 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.07 127.86 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.05 111.102 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 145.5 30.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.936 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.7 m -144.33 121.23 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 75.51 110.916 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -126.63 119.3 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 71.42 110.913 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -132.03 118.11 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.05 110.874 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.49 133.56 33.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 64.12 110.851 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.28 138.36 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.22 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 127.96 39.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 74.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.6 m -87.42 -177.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 75.52 111.102 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -60.64 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.953 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -72.1 143.53 49.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 63.03 110.947 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.28 159.52 49.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.7 0.762 . . . . 73.13 111.084 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 178.5 4.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.681 2.254 . . . . 64.41 112.415 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.49 -36.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.707 -0.759 . . . . 73.05 112.533 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.34 68.5 7.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.703 . . . . 74.1 110.857 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 171.52 14.34 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.59 2.194 . . . . 64.02 112.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 65.32 110.85 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.818 0.342 . . . . 75.14 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.96 67.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 73.31 110.887 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER 60.04 -167.2 0.18 Allowed 'General case' 0 C--O 1.182 -2.497 0 CA-C-O 118.201 -0.904 . . . . 73.44 110.853 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.432 ' C ' ' O ' ' B' ' 3' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.01 152.06 4.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 54.34 111.145 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -172.64 115.97 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.03 110.885 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 70.42 110.904 -179.905 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 112.501 -0.239 . . . . 71.21 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 65.05 112.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 70.22 110.85 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.51 55.16 9.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 72.03 111.117 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.91 138.19 31.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.915 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.98 120.88 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.31 110.887 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.13 127.47 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 74.51 111.144 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -95.31 141.78 28.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 74.24 111.215 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -145.01 165.41 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 54.11 111.069 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.19 149.5 42.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.02 110.916 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.3 mt -57.41 121.04 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 65.34 111.069 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.8 8.13 73.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.777 -0.725 . . . . 70.45 112.586 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -102.7 138.69 19.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.702 . . . . 72.24 110.911 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 143.95 51.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 72.12 112.269 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.0 tp -144.96 141.08 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 74.23 110.911 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.44 145.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 73.34 111.146 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.2 mt -131.25 148.09 52.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 63.14 110.941 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 152.75 29.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 70.12 110.961 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.0 t -106.18 100.6 10.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 64.13 110.897 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 124.35 14.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.841 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.93 -42.65 1.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.774 -0.726 . . . . 65.51 112.491 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 128.19 51.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.538 0.685 . . . . 54.32 111.153 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -164.46 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.62 2.213 . . . . 71.43 112.316 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -47.89 46.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 75.31 110.841 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.71 154.95 38.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.554 0.693 . . . . 71.11 110.865 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 109.56 2.34 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.781 2.321 . . . . 61.53 112.359 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 52.9 Cg_endo -69.76 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.754 2.303 . . . . 73.23 112.291 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -104.04 -178.19 3.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 73.05 110.927 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -64.82 135.77 56.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.829 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.64 161.75 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.957 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -121.26 147.63 45.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 74.23 110.895 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -124.23 137.96 54.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 74.31 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -141.23 140.13 33.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 74.52 110.859 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.1 tp -138.1 134.26 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 74.42 110.988 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.889 ' HB3' ' CE2' ' B' ' 3' ' ' PHE . 12.8 t-20 -116.01 121.17 41.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 64.53 110.879 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -138.99 179.37 6.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 74.34 111.195 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.4 10.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 64.45 112.412 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -112.42 -36.63 5.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.888 0.375 . . . . 75.45 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.74 -29.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 74.33 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -102.57 33.78 3.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 62.22 110.861 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.68 -6.42 8.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 73.41 111.237 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.65 132.6 54.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 70.01 110.939 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 158.61 39.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 73.13 110.931 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.72 120.24 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.053 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 147.95 23.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 71.52 110.938 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -124.2 155.87 67.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.699 0.761 . . . . 63.2 110.846 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -0.58 7.12 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 2.238 . . . . 64.02 112.376 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.94 75.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 74.15 110.947 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.25 73.67 1.08 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 70.14 112.478 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.76 58.23 3.45 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.772 -0.728 . . . . 70.22 112.445 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -179.08 38.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 74.25 112.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 105.76 1.54 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.683 2.255 . . . . 74.4 112.374 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -55.05 -34.43 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 71.11 110.908 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -26.65 66.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 55.52 110.872 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.81 -43.36 9.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 75.31 110.841 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.27 -97.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 73.11 111.126 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.83 173.71 14.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.25 111.136 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.0 164.22 20.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 75.34 110.963 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.57 129.95 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 75.11 111.108 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.8 mt -69.99 159.05 85.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 75.33 110.882 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -21.75 32.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 55.42 112.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.33 1.37 41.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.416 . . . . 54.22 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.08 27.44 21.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 73.34 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.7 m -111.58 -179.0 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 73.42 110.918 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.5 tp -128.82 129.99 46.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.84 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -123.64 133.8 53.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 73.21 110.876 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.24 123.88 31.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 73.33 110.913 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.2 19.44 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.727 2.284 . . . . 74.52 112.406 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.61 103.15 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.01 111.116 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.6 m -71.7 113.0 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 72.13 111.188 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.92 156.94 24.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.818 -0.706 . . . . 72.12 112.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.28 -31.67 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 75.43 111.11 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -77.34 -24.12 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 61.04 110.868 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -4.04 54.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.895 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -58.05 141.84 48.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 73.04 110.889 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.73 -145.77 11.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 61.1 112.548 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.635 HD13 ' HG3' ' B' ' 2' ' ' GLU . 3.5 mp -131.41 135.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.841 0.353 . . . . 70.15 111.165 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -98.88 134.78 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.54 110.947 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.91 126.35 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 73.2 110.861 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 45.9 t -122.62 150.22 42.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -146.71 129.76 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.911 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.05 31.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.12 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.6 ttm -130.64 126.75 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.428 . . . . 75.44 110.86 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -85.81 170.42 12.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 60.22 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -73.26 -17.62 61.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.874 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -71.63 -19.66 62.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 74.22 110.928 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.18 -21.95 19.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 73.53 112.45 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 144.35 28.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 73.44 110.87 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.64 144.39 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 75.14 110.918 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.54 132.3 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.497 . . . . 75.15 111.167 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.349 ' NZ ' ' H13' ' B' ' 4' ' ' MCL . 9.3 ptmm? -105.21 143.19 33.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.218 -0.446 . . . . 73.4 110.88 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -147.37 120.43 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.877 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.655 ' OD1' ' HE2' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -125.66 124.4 41.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 75.13 110.901 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 118.86 24.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.932 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.317 ' NH2' ' CG ' ' B' ' 7' ' ' GLU . 0.8 OUTLIER -88.78 136.25 33.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.907 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.1 t -124.66 137.27 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 75.23 111.099 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -130.62 128.26 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.86 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -85.65 -176.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 72.0 111.094 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -70.79 -81.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 74.34 110.848 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -59.65 145.48 44.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 74.04 110.916 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.29 159.6 49.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.544 0.688 . . . . 74.34 111.202 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 133.85 26.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.594 2.196 . . . . 73.42 112.287 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.39 35.76 0.22 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.671 -0.776 . . . . 72.03 112.438 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -155.23 160.57 30.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.657 0.742 . . . . 75.13 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.752 2.301 . . . . 73.24 112.293 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 73.42 110.83 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.806 0.336 . . . . 73.52 110.829 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.635 ' HG3' HD13 ' A' ' 76' ' ' ILE . 4.3 pm0 -119.91 -37.41 3.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.86 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.889 ' CE2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -174.75 -165.31 0.19 Allowed 'General case' 0 C--O 1.181 -2.508 0 CA-C-O 118.116 -0.945 . . . . 74.42 110.878 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.349 ' H13' ' NZ ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.021 ' CB ' ' CD ' ' A' ' 94' ' ' ARG . . . -49.81 136.98 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 74.43 111.058 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -148.51 109.23 4.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 65.21 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 1.317 ' CG ' ' NH2' ' A' ' 94' ' ' ARG . 13.5 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 75.15 110.881 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.204 0 N-CA-C 112.486 -0.245 . . . . 74.31 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.29 122.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 62.5 110.902 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.28 65.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.32 111.105 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -93.21 133.2 36.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 74.12 110.941 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -89.99 122.01 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.4 110.884 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.1 mm -125.17 122.68 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.32 111.223 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -94.06 141.2 28.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 61.43 111.127 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.57 167.33 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 62.1 111.148 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 149.22 41.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 75.32 110.885 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mt -52.43 120.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.101 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 10.17 70.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 71.53 112.5 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -102.77 139.02 19.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.64 0.733 . . . . 72.44 110.813 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 143.55 50.89 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.692 2.261 . . . . 63.14 112.335 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.5 tp -145.76 143.81 29.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.1 110.89 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.11 145.37 28.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.21 111.136 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.91 147.51 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.927 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 151.96 31.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 64.54 110.908 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.74 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 124.35 17.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.917 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.86 -40.63 1.86 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 52.54 112.462 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.02 128.69 46.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.497 0.665 . . . . 75.34 111.085 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -164.79 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.65 2.233 . . . . 75.31 112.271 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.38 -48.31 47.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.873 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.45 151.86 41.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 74.44 110.851 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 64.12 112.354 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -84.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.759 2.306 . . . . 73.44 112.296 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.43 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 75.1 110.947 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -64.43 137.8 58.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 70.32 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.88 157.71 46.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 72.33 110.979 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.06 146.93 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.9 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -121.47 141.92 50.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.898 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.6 139.28 38.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 75.4 110.824 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.71 131.41 29.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.864 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -116.44 121.02 40.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 75.21 110.949 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.7 p -139.84 179.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 72.21 111.119 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.12 -131.42 10.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.703 -0.76 . . . . 55.14 112.492 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mmm-85 -112.63 -38.43 4.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 63.21 110.866 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 t 179.83 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 74.5 111.107 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -103.11 33.99 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 70.24 110.844 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.23 -6.33 8.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 63.25 111.153 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -63.63 130.95 46.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 73.45 110.865 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 158.27 41.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 73.3 110.905 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.0 t -92.68 122.62 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 73.3 111.061 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.61 147.66 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 75.21 110.9 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.65 149.42 65.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.642 0.734 . . . . 71.23 110.831 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 1.38 4.46 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.653 2.235 . . . . 63.22 112.356 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -118.99 69.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 61.44 110.941 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.97 5.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 62.22 112.556 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.47 40.94 32.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 31.03 112.49 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.98 -173.97 26.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 72.04 112.423 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.606 2.204 . . . . 74.05 112.383 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.17 -31.43 65.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.917 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.01 -25.68 62.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.01 110.804 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.17 -43.99 9.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 65.21 110.811 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -125.5 -98.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.146 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -150.78 174.72 12.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 72.5 111.215 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.54 166.43 15.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 74.14 110.895 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.16 128.98 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 73.41 111.11 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -69.06 157.15 90.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.669 0.747 . . . . 75.41 110.883 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 -22.47 32.53 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.716 2.278 . . . . 74.2 112.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -82.98 0.92 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.933 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 29.2 12.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 52.35 112.415 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.8 m -113.1 179.19 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 65.2 110.878 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 tp -130.15 129.0 42.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.941 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -125.44 130.61 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 74.05 110.857 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.08 129.13 25.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.601 0.715 . . . . 73.21 110.908 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -34.84 13.61 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.645 2.23 . . . . 72.44 112.368 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.75 100.26 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 72.21 111.141 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 m -73.89 112.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.42 111.144 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.34 167.97 41.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 62.51 112.497 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -30.37 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.739 0.304 . . . . 73.05 111.108 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -75.9 -22.17 56.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.04 110.845 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -2.86 35.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 73.05 110.844 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 142.01 53.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 72.01 110.895 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.39 -154.06 25.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 72.01 112.461 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mp -128.08 134.97 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 74.43 111.135 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -102.87 133.89 47.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 73.1 110.838 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.4 ' NE ' ' CE1' ' B' ' 3' ' ' PHE . 0.3 OUTLIER -127.62 131.82 49.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 75.2 110.842 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 35.6 t -120.67 150.49 40.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.35 110.82 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -143.29 127.94 18.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.3 110.917 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.46 162.94 29.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.13 111.038 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.5 mtp -130.9 125.51 33.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 71.54 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -86.66 171.18 11.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.4 110.878 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -72.03 -18.21 61.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 64.33 110.906 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -72.46 -19.62 61.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 53.11 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.46 -18.32 27.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.822 -0.704 . . . . 74.31 112.513 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.06 146.17 27.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 73.45 110.953 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.76 145.02 31.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.834 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.87 127.19 47.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 73.31 111.152 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.048 ' HZ2' ' HD2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -99.77 143.59 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.908 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.26 124.62 13.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 72.53 110.857 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.49 120.52 26.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 74.12 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -130.23 117.18 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.885 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.98 134.08 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 75.32 110.872 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.2 t -120.13 139.53 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 71.3 111.148 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.09 127.92 42.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 74.54 110.873 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.9 m -88.62 -176.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.33 111.151 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.59 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.864 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -69.14 144.96 53.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.975 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.45 159.43 50.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 75.5 111.067 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -179.48 2.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.597 2.198 . . . . 74.32 112.393 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 169.21 68.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 54.22 112.498 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -116.06 159.19 40.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.602 0.715 . . . . 75.33 110.919 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.01 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.716 2.277 . . . . 72.4 112.358 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 72.03 110.905 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.83 0.348 . . . . 63.4 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -123.26 68.42 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 63.55 110.869 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER 50.83 -163.92 0.05 Allowed 'General case' 0 C--O 1.181 -2.504 0 CA-C-O 118.177 -0.916 . . . . 73.31 110.848 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.048 ' HD2' ' HZ2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.4 114.35 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.89 -0.595 . . . . 65.41 111.026 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -91.22 57.66 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.838 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.448 . . . . 44.44 110.789 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.46 -0.256 . . . . 74.21 112.46 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -179.66 115.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 65.44 110.901 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.09 66.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 75.03 111.034 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.59 133.09 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.923 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -87.76 121.98 30.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.916 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mm -125.35 127.69 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 75.34 111.081 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 138.8 32.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.4 111.171 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.33 27.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.12 111.096 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.65 148.25 48.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.281 -0.418 . . . . 64.15 110.839 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 mt -53.32 122.08 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 71.22 111.152 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.09 4.44 78.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 73.13 112.448 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -101.22 139.64 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.561 0.696 . . . . 70.02 110.967 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.67 45.84 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.765 2.31 . . . . 73.15 112.308 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.4 tp -144.7 141.31 29.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 75.21 110.902 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.9 147.15 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 63.13 111.201 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 mt -131.58 148.23 52.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.857 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -111.41 149.81 30.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 65.53 110.85 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.3 t -108.16 101.09 10.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.447 . . . . 73.12 110.882 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.82 101.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 74.1 110.915 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 144.5 -47.9 0.75 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.703 -0.76 . . . . 74.34 112.498 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.15 103.04 10.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.558 0.694 . . . . 75.14 111.189 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.8 Cg_endo -69.69 -161.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.688 2.259 . . . . 75.13 112.311 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -60.52 -10.51 5.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -45.84 167.48 0.13 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.572 0.701 . . . . 75.43 110.916 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 172.37 12.8 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.661 2.241 . . . . 72.32 112.315 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 87.74 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 2.262 . . . . 72.04 112.337 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -174.66 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 73.03 110.941 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -63.05 131.95 50.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.851 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 pp -178.85 161.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 74.43 110.837 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -121.43 135.75 55.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 75.54 110.852 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -120.72 137.95 54.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.0 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -138.31 139.99 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 63.2 110.866 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 tp -137.67 134.59 35.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 64.33 110.935 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.791 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 14.7 t-20 -116.21 121.66 42.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 61.1 110.923 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.9 p -137.72 179.6 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.33 111.098 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -132.06 15.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.463 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -37.63 4.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 74.43 110.874 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 t -179.24 -29.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 73.14 111.12 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.32 33.55 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 75.33 110.935 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.41 -5.33 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 72.23 111.133 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -65.87 130.11 42.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 71.5 110.928 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.66 43.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 74.53 110.95 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -95.67 119.85 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 73.42 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.52 145.29 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 75.42 110.884 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.16 163.56 41.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 72.13 110.886 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 0.94 4.92 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.639 2.226 . . . . 71.43 112.361 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -135.63 71.82 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.929 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.41 32.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.855 -0.688 . . . . 74.2 112.457 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 47.31 -147.41 3.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 74.21 112.509 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -162.95 1.17 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 74.03 112.534 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 119.68 6.58 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.649 2.233 . . . . 70.51 112.322 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -83.13 -34.24 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 74.03 110.929 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -25.74 68.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 70.03 110.821 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.66 -45.89 41.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.853 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.79 -98.38 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.117 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -166.85 172.25 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.087 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.96 160.16 28.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 75.31 110.83 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.47 127.08 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 72.1 111.078 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.6 mt -69.4 157.46 89.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 74.25 110.938 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -22.74 31.33 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.655 2.236 . . . . 73.24 112.403 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -82.67 0.68 42.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.876 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.93 26.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.63 -0.795 . . . . 73.55 112.451 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.1 m -105.51 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.408 . . . . 70.4 110.862 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 tp -131.15 129.5 41.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.897 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -125.52 129.0 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.54 111.0 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.36 131.17 24.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 71.42 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -32.98 17.76 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.664 2.242 . . . . 71.31 112.403 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.79 100.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 72.11 111.087 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 m -76.76 118.58 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 65.43 111.134 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.29 165.42 37.45 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.672 -0.775 . . . . 71.22 112.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -31.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 75.13 111.15 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.2 -22.22 58.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.451 . . . . 75.41 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.08 -5.02 41.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 70.2 110.819 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.59 141.58 51.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.03 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.65 -147.69 16.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.758 . . . . 74.31 112.445 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.546 HD12 ' CB ' ' B' ' 2' ' ' GLU . 0.8 OUTLIER -130.62 134.96 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 75.43 111.224 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -104.43 126.57 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 71.14 110.877 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.441 ' HG3' ' ND2' ' A' ' 92' ' ' ASN . 5.7 ttp85 -124.45 136.54 54.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.42 110.852 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.45 156.26 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 63.42 110.925 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -141.02 126.25 18.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.982 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.46 162.05 33.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 73.11 111.115 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.1 mtp -130.32 125.84 35.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.858 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -86.19 171.6 11.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 75.34 110.866 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -71.66 -17.46 62.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.05 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.93 -26.0 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 62.02 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.61 -19.53 11.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 73.53 112.452 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.97 147.56 26.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.649 0.262 . . . . 65.04 111.01 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.39 144.27 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 74.23 110.906 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.14 126.64 50.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.44 111.133 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.41 142.58 35.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 73.3 110.891 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -146.8 119.01 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 62.11 110.785 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.555 ' OD1' ' CB ' ' B' ' 5' ' ' ALA . 6.4 t-20 -125.76 128.66 48.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 74.55 110.901 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -128.7 118.9 23.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.53 110.883 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.899 ' NH2' ' OE1' ' B' ' 7' ' ' GLU . 0.0 OUTLIER -83.74 128.08 34.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 74.24 110.751 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -119.28 139.59 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.183 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 127.79 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.833 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.94 -176.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 73.33 111.104 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.5 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 75.42 110.932 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.49 145.83 55.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.99 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.33 159.4 50.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 73.41 111.072 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.88 134.76 28.51 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.718 2.279 . . . . 75.32 112.277 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.47 -102.33 0.37 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 65.04 112.497 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -113.72 157.89 40.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.606 0.717 . . . . 64.54 110.809 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 100.26 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.589 2.192 . . . . 61.13 112.384 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.922 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.83 0.348 . . . . 72.42 110.794 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.546 ' CB ' HD12 ' A' ' 76' ' ' ILE . 4.8 pm0 -136.81 77.16 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 72.2 110.805 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.791 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 51.91 -164.85 0.06 Allowed 'General case' 0 C--O 1.182 -2.484 0 CA-C-O 118.156 -0.926 . . . . 75.14 110.859 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.555 ' CB ' ' OD1' ' A' ' 92' ' ' ASN . . . -48.2 104.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 72.44 111.068 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -151.36 64.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 64.2 110.839 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.899 ' OE1' ' NH2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.904 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.489 -0.245 . . . . 72.13 112.489 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 p -107.01 79.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 71.11 110.8 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.22 69.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 74.04 111.094 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.39 133.68 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 72.11 110.874 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.02 122.04 31.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 74.44 110.853 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.72 121.29 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.42 111.071 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -95.16 142.65 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.35 111.06 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -142.55 166.31 25.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 71.3 111.063 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.53 147.62 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.883 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.1 mt -59.05 121.16 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.21 111.159 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.16 0.08 88.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 62.41 112.435 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.62 142.04 23.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.663 0.745 . . . . 73.4 110.927 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 143.85 52.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.651 2.234 . . . . 74.24 112.275 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.8 tp -144.65 143.21 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.14 110.942 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.55 148.66 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 72.2 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mt -130.9 147.96 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.03 110.951 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -112.35 151.98 29.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.946 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 101.97 11.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 54.43 110.88 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.18 120.9 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 72.45 110.81 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.14 -38.5 2.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.811 -0.709 . . . . 42.33 112.532 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.23 128.26 47.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.32 111.119 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.666 2.244 . . . . 74.51 112.374 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.34 -49.39 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.896 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.29 150.09 40.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 75.11 110.912 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.66 110.14 2.46 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.748 2.299 . . . . 75.11 112.338 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -86.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.12 112.338 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.33 -177.13 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -63.65 138.52 58.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 75.33 110.899 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.62 156.31 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.925 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.1 148.35 44.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 70.43 110.896 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -129.63 142.02 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.872 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -146.77 137.01 23.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 75.13 110.876 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.59 139.52 38.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 62.03 110.936 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.9 ' N ' ' HE2' ' B' ' 3' ' ' PHE . 12.3 t-20 -112.42 124.44 52.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 64.52 110.889 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.3 p -138.45 -179.24 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 74.33 111.111 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.01 -130.55 14.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 72.31 112.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.41 -37.84 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 71.42 110.855 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.6 t -179.5 -30.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.22 111.145 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -102.21 33.71 2.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.877 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.33 -7.26 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 73.13 111.127 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.19 129.44 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.52 110.874 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.89 153.41 50.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 74.32 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.73 121.55 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.43 111.111 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.55 146.73 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 74.12 110.974 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.07 164.42 31.76 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.722 0.773 . . . . 75.43 110.848 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 0.26 5.89 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.699 2.266 . . . . 72.35 112.428 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.42 80.78 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 74.42 110.887 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 35.63 4.32 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.696 . . . . 72.41 112.503 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.39 -4.65 57.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.671 -0.776 . . . . 73.54 112.52 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.86 -160.26 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.665 -0.779 . . . . 64.33 112.553 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 99.21 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.717 2.278 . . . . 65.21 112.332 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -71.22 -34.09 70.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 72.14 110.8 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.75 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 73.52 110.825 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.52 -44.7 11.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 71.33 110.793 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.44 -97.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 73.11 111.119 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.08 173.11 13.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 65.22 111.1 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 159.64 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 72.41 110.828 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -109.05 129.94 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.13 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.3 mt -68.56 157.77 87.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.665 0.745 . . . . 72.34 110.877 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -21.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 72.13 112.36 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -83.27 0.25 46.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 73.11 110.89 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.05 9.57 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.795 -0.716 . . . . 45.13 112.397 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.0 m -112.4 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.959 0.409 . . . . 73.31 110.849 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.2 tp -128.48 127.69 42.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 74.23 110.833 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -125.71 133.54 52.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 72.12 110.863 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 mp -119.88 131.27 24.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.522 0.677 . . . . 62.45 110.955 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -36.29 11.13 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.766 2.311 . . . . 73.1 112.35 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.99 101.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 60.44 111.122 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.48 117.78 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 75.13 111.173 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.24 163.09 39.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 75.12 112.476 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -30.93 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 71.22 111.106 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.909 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -5.44 37.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.274 -0.421 . . . . 75.33 110.832 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -58.56 142.06 50.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.886 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.6 -151.83 23.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 44.14 112.478 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.071 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.3 mp -124.29 134.21 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 74.12 111.182 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -102.58 132.73 48.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.938 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.954 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -127.87 134.64 49.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.938 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 146.19 46.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 64.13 110.876 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -141.17 126.12 18.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.924 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.05 164.0 27.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.2 111.055 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 124.82 34.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 72.2 110.881 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -86.81 172.29 10.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 74.23 110.906 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -71.32 -18.1 62.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.214 -0.448 . . . . 74.23 110.878 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.0 -20.12 61.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.87 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.99 -18.24 28.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.2 112.415 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -84.97 146.75 27.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.708 0.289 . . . . 75.4 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -105.17 145.0 31.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 63.12 110.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 m -102.24 129.41 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.53 111.225 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.315 ' CB ' ' O1 ' ' B' ' 4' ' ' MCL . 23.9 mtpp -105.3 146.06 29.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 72.52 110.884 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.95 126.78 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.31 110.826 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.558 ' OD1' ' HB2' ' B' ' 5' ' ' ALA . 18.6 t-20 -121.31 120.4 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.23 110.9 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.98 127.56 40.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 73.51 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.047 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 6.6 mmt85 -89.55 131.07 35.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 72.02 110.865 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.0 t -120.92 130.58 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 75.53 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 mmt-85 -131.72 153.32 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.54 110.83 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.06 -177.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.22 111.179 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.19 -82.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 75.21 110.978 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -59.1 146.69 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.972 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.37 159.66 49.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 61.11 111.076 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 179.03 4.01 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.65 2.233 . . . . 72.43 112.279 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.14 31.52 0.1 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.641 -0.79 . . . . 63.42 112.481 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -117.0 137.78 24.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.628 0.728 . . . . 74.44 110.901 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 108.2 2.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.583 2.189 . . . . 74.12 112.34 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.892 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.825 0.345 . . . . 71.3 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.071 ' CB ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.34 -41.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 60.24 110.902 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.9 ' HE2' ' N ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 175.66 -165.64 0.03 OUTLIER 'General case' 0 C--O 1.182 -2.449 0 CA-C-O 118.183 -0.913 . . . . 74.41 110.904 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.315 ' O1 ' ' CB ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.047 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -40.16 123.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 74.24 111.118 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.67 59.13 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 73.2 110.848 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 75.12 110.93 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.504 -0.239 . . . . 63.44 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m 60.34 99.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 63.3 110.908 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.46 77.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 74.54 111.139 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.51 132.63 37.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.34 110.915 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.66 121.29 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 75.43 110.944 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.22 120.81 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.089 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.8 p -96.95 142.58 28.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 74.1 111.159 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.0 168.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 65.22 111.129 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.32 145.66 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 74.13 110.906 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.3 mt -52.21 120.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.077 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.83 5.8 70.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 70.44 112.492 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -101.67 140.8 21.53 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 121.539 0.685 . . . . 64.55 110.98 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 143.89 52.88 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.752 2.302 . . . . 70.23 112.315 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 tp -142.89 142.13 31.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 75.51 110.841 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -122.41 149.32 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.54 111.115 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.3 mt -130.73 146.91 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 72.54 110.954 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -112.91 152.86 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.897 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.89 100.6 10.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 61.42 110.862 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.32 120.65 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 72.41 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.28 -36.7 2.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 74.12 112.424 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.7 130.37 39.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.624 0.726 . . . . 71.54 111.062 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.66 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 72.05 112.374 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -49.32 -49.36 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 72.34 110.88 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 150.5 40.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 75.23 110.812 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 110.7 2.61 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.684 2.256 . . . . 75.42 112.351 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -84.14 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.652 2.235 . . . . 73.42 112.359 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -103.24 -177.9 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 71.14 110.848 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -64.01 134.85 55.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 74.51 110.889 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.31 146.94 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.874 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -129.07 137.07 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.859 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -124.68 144.95 49.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 74.34 110.85 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -136.33 142.28 43.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.897 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.82 140.06 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.32 110.946 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 16.0 t-20 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 70.33 110.835 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.5 p -136.82 179.91 6.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.11 111.193 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.78 -130.01 19.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.797 -0.716 . . . . 62.32 112.485 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -112.68 -37.38 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 71.12 110.901 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -178.9 -29.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 73.32 111.153 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -102.14 33.6 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 72.25 110.951 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.33 -5.81 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 62.13 111.102 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -59.14 132.22 53.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 65.44 110.956 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 157.17 41.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 71.34 110.857 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.11 123.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.215 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.38 136.68 32.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.941 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.3 165.52 28.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.759 0.79 . . . . 74.13 110.827 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 0.49 5.53 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.702 2.268 . . . . 74.43 112.316 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -126.47 87.69 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 73.5 110.88 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.25 5.58 71.72 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 51.44 112.488 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.53 165.72 0.23 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.847 -0.692 . . . . 70.15 112.497 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.16 -153.21 20.22 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.849 -0.691 . . . . 54.44 112.506 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.86 107.38 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.596 2.197 . . . . 74.42 112.264 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -82.68 -34.19 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 71.12 110.91 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.74 -25.35 66.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 73.32 110.928 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -44.8 21.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 64.22 110.853 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.63 -98.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 75.53 111.14 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -166.93 174.67 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.136 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.85 158.01 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 73.12 110.908 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.8 t -116.35 126.87 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.14 111.139 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.7 mt -69.02 156.4 91.6 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 75.23 110.956 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -21.84 32.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.668 2.246 . . . . 72.32 112.431 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -82.89 -0.19 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.889 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.94 29.64 10.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.723 -0.751 . . . . 60.44 112.438 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -111.4 177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 71.22 110.863 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 tp -128.63 130.02 46.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.02 110.89 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -125.13 131.9 53.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 64.02 110.958 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mp -115.07 130.8 23.92 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.653 0.74 . . . . 70.23 110.855 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -37.84 8.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.785 2.323 . . . . 72.34 112.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.36 102.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.43 111.083 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.2 m -73.7 116.44 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.3 111.077 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 163.12 38.3 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.674 -0.774 . . . . 70.31 112.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.422 ' HA ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.16 -34.04 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.723 0.297 . . . . 71.2 111.115 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.95 -15.92 60.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 75.1 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -4.51 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 62.03 110.921 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.5 141.49 42.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 75.53 110.973 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.08 -156.41 27.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.749 -0.739 . . . . 71.21 112.519 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.921 ' HB ' ' CB ' ' B' ' 3' ' ' PHE . 6.3 mm -125.38 134.09 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 75.15 111.137 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -102.84 126.44 49.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 73.25 110.876 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -125.82 127.86 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.55 110.779 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.84 146.58 46.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.891 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -139.47 132.91 30.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 163.89 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 70.41 111.039 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.6 mtp -129.1 125.01 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 72.52 110.938 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.88 172.81 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 74.11 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -70.71 -18.42 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.828 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -73.21 -19.86 61.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 63.53 110.92 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.92 -15.09 37.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 61.22 112.505 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 146.61 27.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.657 0.265 . . . . 72.31 110.936 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.37 144.81 31.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 75.32 110.89 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 132.59 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 72.35 111.128 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.417 ' CE ' ' H13' ' B' ' 4' ' ' MCL . 0.5 OUTLIER -99.45 145.47 27.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 73.31 110.934 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.2 m -144.72 123.88 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 63.14 110.818 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 4' ' ' MCL . 1.7 t-20 -127.48 121.24 30.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 74.45 110.884 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.58 123.05 32.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 73.41 111.0 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.526 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 19.4 mmm-85 -84.4 134.17 34.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.861 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -120.27 129.29 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 64.04 111.108 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.47 46.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -109.68 -175.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 73.4 111.099 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -65.79 -71.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 75.4 110.952 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -71.05 140.52 50.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.51 110.952 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.27 159.81 48.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.665 0.745 . . . . 65.32 111.138 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 173.26 11.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 75.13 112.394 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.54 -72.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 33.4 112.538 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -156.09 161.24 29.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.63 0.729 . . . . 74.3 110.894 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 141.8 46.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 75.12 112.357 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.861 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.73 0.3 . . . . 73.42 110.915 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.32 139.05 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 72.41 110.866 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.921 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -50.64 163.08 0.2 Allowed 'General case' 0 C--O 1.181 -2.523 0 CA-C-O 118.174 -0.917 . . . . 75.44 110.792 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.417 ' H13' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.526 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -178.33 -80.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 74.43 111.143 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 32.1 t0 47.71 67.61 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.829 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.898 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.549 -0.22 . . . . 62.31 112.549 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -177.7 157.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.862 0.363 . . . . 70.42 110.817 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.4 97.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 72.42 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.62 137.25 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 74.34 110.826 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -89.09 121.13 31.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.86 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.65 121.94 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 75.41 111.15 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -95.31 142.68 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 72.5 111.202 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.61 167.29 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 52.53 111.13 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -119.99 148.68 43.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.408 . . . . 75.13 110.898 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mt -56.81 120.75 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 75.41 111.219 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 5.72 79.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.76 . . . . 72.31 112.46 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -102.05 139.42 20.28 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.657 0.742 . . . . 75.34 110.918 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 143.27 50.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 75.31 112.356 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 tp -145.27 142.43 29.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 70.42 110.891 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.96 145.27 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 74.44 111.134 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.1 mt -130.74 147.27 52.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 62.53 111.0 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -113.46 150.73 32.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.41 110.882 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -108.07 99.73 9.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 53.21 110.846 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -54.26 128.45 31.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.847 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.38 -40.45 1.92 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 65.23 112.468 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.92 128.89 43.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 71.54 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.19 0.15 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.665 2.244 . . . . 64.21 112.376 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -48.95 45.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 74.4 110.945 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -108.57 154.44 41.6 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.565 0.697 . . . . 63.14 110.942 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 109.36 2.29 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.718 2.279 . . . . 72.31 112.335 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.6 Cg_endo -69.69 -86.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.655 2.237 . . . . 54.33 112.394 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -101.27 -176.53 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.52 110.885 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.36 133.02 53.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 75.5 110.88 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 159.13 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 73.22 110.918 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -132.53 146.14 51.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.851 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -123.6 134.25 53.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.922 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -136.36 138.33 41.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 73.53 110.91 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 138.24 38.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 75.51 110.903 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.33 127.8 56.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.89 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.2 p -138.52 -179.87 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 71.15 111.139 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.17 21.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.815 -0.707 . . . . 64.14 112.463 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.89 -37.26 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 75.04 110.869 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.2 t -178.72 -29.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.42 111.015 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -102.06 34.06 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 75.22 110.821 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.71 -5.59 8.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.41 111.114 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -59.57 132.16 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 71.11 110.958 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 152.46 48.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.316 -0.402 . . . . 73.41 110.92 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.1 t -105.26 116.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 72.42 111.131 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.0 mt -96.28 146.03 25.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 74.44 110.823 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.66 157.03 69.94 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.586 0.708 . . . . 74.13 110.865 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 0.23 5.87 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.661 2.24 . . . . 64.25 112.366 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -136.75 71.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 75.31 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.98 78.54 1.0 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 64.2 112.428 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.62 58.45 3.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.68 -0.771 . . . . 63.42 112.52 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.36 179.21 45.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 71.21 112.53 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 106.39 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 73.23 112.316 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -55.57 -34.43 64.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 75.32 110.946 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.98 -26.86 67.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.25 110.809 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -44.5 8.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 74.33 110.859 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.46 -96.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 73.54 111.068 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.408 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -150.17 176.55 10.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 62.23 111.147 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.37 162.41 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 73.42 110.903 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.69 130.72 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.119 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.99 156.46 91.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.596 0.712 . . . . 71.21 110.965 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -22.43 32.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 74.44 112.265 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -81.91 0.15 41.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.3 110.921 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.8 22.92 24.63 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 65.32 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -106.24 178.91 4.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 74.23 110.88 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.5 tp -129.68 129.95 44.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 74.52 110.952 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -124.34 129.96 51.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 75.04 110.86 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.57 127.23 27.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.678 0.752 . . . . 75.42 110.844 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -32.62 18.11 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.24 112.386 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.5 101.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 63.31 111.145 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 m -73.09 115.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 74.22 111.185 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.63 161.81 31.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 72.11 112.457 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -31.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 73.13 111.168 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -77.46 -22.47 51.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.924 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.15 -5.34 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 75.01 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.33 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 74.54 110.822 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.39 -148.91 17.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.793 -0.718 . . . . 64.23 112.516 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.011 HD13 ' HG3' ' B' ' 2' ' ' GLU . 2.0 mp -126.18 133.66 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.89 0.376 . . . . 73.13 111.178 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -103.32 135.2 45.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 63.23 110.908 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 1.244 ' HD3' ' CE1' ' B' ' 3' ' ' PHE . 3.5 ttp85 -125.99 134.61 51.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 75.24 110.813 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.49 147.95 44.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -141.37 129.21 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 63.03 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.73 163.13 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.31 111.12 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 125.09 33.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 63.32 110.937 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -86.84 172.1 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 74.14 110.823 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.47 -18.3 62.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 74.51 110.934 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.07 -19.87 61.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 65.01 110.848 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.03 32.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.545 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -85.02 147.07 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.795 0.331 . . . . 75.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.79 145.14 30.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 72.22 110.955 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.69 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.3 111.107 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.443 ' CE ' ' CX2' ' B' ' 4' ' ' MCL . 8.9 ptpt -98.65 145.31 27.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.943 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 m -144.73 127.76 16.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 70.53 110.748 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -128.14 121.52 29.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 74.23 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.22 126.1 40.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.53 110.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.56 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 17.6 mmm-85 -89.85 132.1 35.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 74.5 110.859 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.82 130.02 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 64.24 111.129 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -131.55 146.17 52.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.886 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.0 m -109.58 -176.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 73.11 111.12 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.86 -79.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.992 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.45 146.21 54.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 73.22 111.032 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.38 159.42 50.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.719 0.771 . . . . 73.04 111.145 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -176.76 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.649 2.233 . . . . 73.11 112.321 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.79 -91.27 2.2 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.811 -0.709 . . . . 72.11 112.456 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -165.65 157.58 12.68 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.563 0.697 . . . . 72.24 110.946 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 176.78 6.28 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.727 2.284 . . . . 73.34 112.327 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.892 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 120.726 0.298 . . . . 74.35 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.011 ' HG3' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -142.24 108.02 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 63.12 110.968 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.244 ' CE1' ' HD3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER 50.87 -166.7 0.04 OUTLIER 'General case' 0 C--O 1.181 -2.519 0 CA-C-O 118.14 -0.933 . . . . 75.31 110.861 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.443 ' CX2' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.56 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -45.24 134.38 6.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.895 -0.593 . . . . 64.41 111.145 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -163.59 57.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 73.05 110.843 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 73.02 110.939 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.452 -0.259 . . . . 73.34 112.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 p -79.88 91.22 5.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 72.42 110.841 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 1.604 ' CB ' ' HA ' ' B' ' 5' ' ' ALA . . . 51.8 65.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.41 111.156 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.12 133.6 36.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.893 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.6 121.27 28.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.884 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.1 mm -125.16 127.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 75.23 111.111 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -91.56 142.52 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 64.15 111.17 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.0 165.85 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 73.24 111.133 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -119.1 149.71 41.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 62.23 110.906 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 10.6 mt -68.43 120.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 71.53 111.108 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.5 -6.99 57.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.815 -0.707 . . . . 64.44 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -102.72 140.76 21.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.71 0.767 . . . . 74.3 110.923 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 146.11 59.7 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.84 2.36 . . . . 74.2 112.323 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.3 tp -138.33 142.8 39.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 75.24 110.966 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.59 148.22 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.54 111.141 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 mt -130.99 147.48 52.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.933 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -112.78 152.04 29.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 73.14 111.002 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -107.33 100.53 9.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.413 . . . . 61.41 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.88 122.41 12.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.839 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.15 -39.8 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 72.13 112.484 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.29 129.32 43.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.522 0.677 . . . . 73.33 111.171 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.91 -165.08 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.64 2.226 . . . . 75.23 112.383 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -49.02 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.981 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.6 152.42 41.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.603 0.716 . . . . 71.51 110.936 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.84 110.18 2.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.617 2.212 . . . . 73.51 112.292 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -81.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.671 2.248 . . . . 63.53 112.356 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -103.31 -177.67 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 64.22 110.914 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.99 133.83 53.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.12 110.86 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.09 151.31 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 73.31 110.912 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.82 148.18 45.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.41 110.834 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -121.81 139.97 52.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 73.4 110.922 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -146.65 135.35 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.23 110.928 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.58 137.84 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.891 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -112.28 125.2 53.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 65.11 110.893 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -139.22 -178.96 5.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 73.53 111.137 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.98 -127.04 9.95 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.703 -0.76 . . . . 55.12 112.53 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' O ' ' HB ' ' A' ' 38' ' ' THR . 1.2 mpp_? -112.9 -38.88 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 75.32 110.863 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 37' ' ' ARG . 3.8 t 179.0 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 73.45 111.171 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -102.03 34.18 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.823 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.12 -6.92 8.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 74.01 111.105 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -71.47 128.71 36.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.57 159.65 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.929 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 t -93.59 121.01 43.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 72.2 111.135 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.05 145.74 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 72.21 110.879 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p -126.06 153.97 74.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 63.25 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 1.65 4.22 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.704 2.269 . . . . 74.1 112.383 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -117.62 69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.906 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.71 -37.45 3.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.835 -0.698 . . . . 64.11 112.489 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.53 43.24 52.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.741 -0.743 . . . . 63.2 112.527 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.16 -176.07 45.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.877 -0.677 . . . . 74.35 112.508 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 105.63 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.648 2.232 . . . . 73.34 112.384 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -55.49 -34.24 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 72.33 110.883 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.03 -26.44 66.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.21 110.929 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -43.64 9.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.875 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.48 -97.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 73.2 111.101 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.419 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . . . -156.77 174.57 15.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.44 111.011 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.18 161.14 25.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.944 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.44 130.28 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.45 111.084 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.5 mt -68.81 157.88 87.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 73.31 110.923 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -21.86 33.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.772 2.315 . . . . 72.44 112.353 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -82.37 0.95 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 75.41 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 26.46 20.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 73.31 112.514 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.8 m -111.97 -179.53 3.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 74.24 110.874 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 tp -129.84 130.54 45.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.12 110.909 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -123.81 133.04 53.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HG ' ' CB ' ' A' ' 56' ' ' ALA . 7.3 mp -114.83 127.08 27.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.651 0.738 . . . . 75.44 110.939 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -32.28 19.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 74.22 112.374 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.64 102.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 74.43 111.084 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 27.5 m -73.07 118.71 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 75.41 111.136 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.01 161.61 21.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 41.31 112.524 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.76 -34.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 73.11 111.212 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.08 -20.2 56.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.45 110.903 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -2.9 28.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.42 110.965 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.22 141.91 49.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 60.51 110.883 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.4 -155.09 26.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 73.04 112.428 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.027 ' HB ' ' CD2' ' B' ' 3' ' ' PHE . 0.6 OUTLIER -124.74 135.34 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 71.54 111.142 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -103.71 126.75 51.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 71.34 110.874 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.997 ' HG3' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER -124.93 127.55 47.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 74.14 110.868 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.01 150.9 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.54 110.857 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -139.65 132.6 29.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.936 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.16 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 73.44 111.176 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.4 ttm -129.48 126.09 37.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 71.34 110.884 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -86.22 172.62 10.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.05 110.915 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -71.26 -18.48 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 74.31 110.814 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -73.13 -19.85 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 73.4 110.874 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.69 -17.36 30.54 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 74.13 112.454 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -85.15 146.58 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 75.41 110.832 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.39 144.86 31.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.866 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 132.8 48.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.12 111.218 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.269 ' HE3' ' O2 ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -98.87 144.08 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.14 111.033 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -145.52 121.66 10.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 64.22 110.9 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.756 ' CG ' ' HB3' ' B' ' 4' ' ' MCL . 0.7 OUTLIER -128.18 122.08 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.836 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -128.0 118.97 24.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 75.32 110.965 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.601 ' CD ' ' CB ' ' B' ' 5' ' ' ALA . 0.5 OUTLIER -86.13 135.79 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.1 110.864 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 68.9 t -120.68 134.2 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 75.12 111.115 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 127.25 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.53 110.88 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 13.1 m -88.32 -177.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.13 111.065 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -68.84 -80.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 72.21 110.942 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.25 144.23 46.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 73.21 110.849 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.13 159.62 48.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.581 0.705 . . . . 74.52 111.131 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -19.93 35.27 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 74.43 112.329 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -175.54 -115.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 53.45 112.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -175.96 137.64 0.5 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.556 0.694 . . . . 75.12 110.86 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.86 115.46 4.12 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 65.14 112.33 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 64.42 110.936 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.836 0.351 . . . . 65.11 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.676 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -134.28 -37.93 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 74.42 110.913 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.027 ' CD2' ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 176.08 -157.89 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.514 0 CA-C-O 118.107 -0.949 . . . . 74.32 110.856 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.269 ' O2 ' ' HE3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.604 ' HA ' ' CB ' ' A' ' 3' ' ' ALA . . . -50.03 -41.04 46.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.882 -0.599 . . . . 74.25 111.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.65 33.0 12.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.87 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.807 ' C ' HH12 ' A' ' 94' ' ' ARG . 5.0 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.51 110.803 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.564 -0.215 . . . . 41.14 112.564 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.72 148.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 70.21 110.851 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 94.78 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 63.21 111.093 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -93.3 133.51 36.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.881 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.0 121.34 27.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 70.54 110.79 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.56 121.88 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.142 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -95.93 142.06 28.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 73.22 111.152 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.72 165.26 30.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 73.5 111.109 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 148.64 45.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 72.13 110.909 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -57.13 122.13 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.094 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.28 4.45 80.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.685 -0.769 . . . . 75.32 112.506 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -101.19 139.4 20.43 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.641 0.734 . . . . 71.15 110.935 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 138.62 38.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.609 2.206 . . . . 44.22 112.359 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 18.4 tp -145.0 141.26 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 74.55 110.861 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.64 147.81 31.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 73.2 111.178 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.88 147.29 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 75.01 110.96 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -111.7 149.11 32.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.13 110.869 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -112.32 101.56 9.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.86 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.53 110.906 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 150.31 -49.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 72.15 112.476 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.52 102.95 11.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 73.3 111.044 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.4 Cg_endo -69.71 -161.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.626 2.217 . . . . 64.33 112.402 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -12.68 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 75.33 110.942 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -45.01 163.6 0.2 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 72.13 110.9 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 172.58 12.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.0 112.368 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.7 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 74.02 112.353 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -97.04 -175.51 3.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 74.35 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -64.1 132.54 50.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.946 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -168.63 174.26 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 75.25 110.927 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 124.1 40.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.931 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.35 143.4 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 73.02 110.866 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -143.96 144.1 31.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 72.12 110.941 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.57 132.83 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 72.33 110.882 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.89 ' CB ' ' CD2' ' B' ' 3' ' ' PHE . 0.2 OUTLIER -116.48 120.43 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 75.44 110.878 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.4 p -140.02 179.6 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 71.52 111.099 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.1 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 74.13 112.434 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.39 -38.46 4.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 74.31 110.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t 179.24 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 71.22 111.152 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -102.03 33.93 2.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 72.54 110.825 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.93 -6.67 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 72.45 111.101 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -68.37 130.2 42.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 65.41 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 159.08 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.42 110.883 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.59 122.1 38.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 72.53 111.181 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.2 mt -92.31 148.84 21.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 72.14 110.862 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.53 164.13 30.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.712 0.768 . . . . 61.22 110.825 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 -0.51 6.95 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.258 . . . . 62.12 112.363 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 82.26 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 73.24 110.945 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.04 44.47 1.49 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.704 -0.76 . . . . 72.12 112.467 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.1 -126.84 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.797 -0.716 . . . . 73.13 112.432 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.25 -149.3 7.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 72.32 112.417 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 98.59 0.7 Allowed 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.785 2.323 . . . . 74.21 112.296 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -83.4 -34.84 25.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.898 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.5 -26.36 68.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 72.41 110.797 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -42.97 22.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.15 110.902 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.08 -97.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 74.14 111.208 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -166.7 171.48 11.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.081 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.25 165.39 23.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 74.24 110.899 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.2 t -106.51 130.13 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 74.04 111.156 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.76 157.84 88.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.577 0.703 . . . . 73.22 110.907 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -22.9 31.79 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.717 2.278 . . . . 65.12 112.37 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.37 2.06 38.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.93 30.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 73.44 112.494 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.7 m -105.67 179.42 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.953 0.406 . . . . 73.15 110.805 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.9 tp -132.3 128.35 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 74.43 110.959 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -129.65 128.16 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 73.22 110.858 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.27 132.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.698 0.761 . . . . 72.15 110.927 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.27 19.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.743 2.295 . . . . 64.12 112.414 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.81 103.5 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 74.3 111.055 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 m -73.2 119.36 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.19 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.82 156.17 26.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.741 . . . . 64.4 112.526 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -29.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 74.11 111.087 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -73.32 -23.5 60.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 74.11 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.26 -5.26 57.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 75.03 110.831 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.55 140.61 57.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 75.41 110.869 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.23 -137.93 5.63 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.778 -0.725 . . . . 64.21 112.485 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.554 HD13 ' CB ' ' B' ' 5' ' ' ALA . 70.9 mt -130.46 135.26 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 74.02 111.197 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -100.85 128.39 46.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.874 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 1.084 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 2.1 tmm_? -127.92 127.72 43.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.902 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -121.24 149.73 42.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.12 110.854 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -146.98 126.68 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.874 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.13 163.74 27.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 72.22 111.101 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.4 mtp -129.96 125.83 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.879 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -86.2 172.03 10.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.52 110.83 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -71.78 -17.95 62.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 62.33 110.843 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.1 -19.61 61.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.13 110.895 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.7 -18.58 29.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 64.43 112.53 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 145.19 27.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 63.34 110.83 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.91 145.0 32.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.893 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.01 131.32 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.3 111.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.122 ' CD ' ' H13' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -105.35 145.6 30.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.936 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -146.04 123.95 12.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.81 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.829 ' OD1' ' HB3' ' B' ' 4' ' ' MCL . 0.5 OUTLIER -128.49 120.39 26.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 74.21 110.913 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.64 127.85 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 75.25 110.989 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.495 ' NE ' ' HB2' ' B' ' 5' ' ' ALA . 4.1 mmm-85 -87.62 136.18 33.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 75.51 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.45 132.29 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.14 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 128.83 41.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.11 110.9 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -92.92 -176.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 73.22 111.083 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -66.49 -81.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 72.11 110.941 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -60.97 142.59 56.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 74.43 110.811 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.67 159.88 48.9 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.548 0.69 . . . . 72.51 111.151 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -174.76 0.95 Allowed 'Trans proline' 0 C--N 1.34 0.086 0 C-N-CA 122.746 2.297 . . . . 72.01 112.339 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 163.51 -51.57 0.3 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.835 -0.698 . . . . 73.51 112.543 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 157.13 40.5 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.601 0.715 . . . . 74.21 110.878 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 127.17 14.26 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 74.13 112.337 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 53.34 110.839 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.858 0.361 . . . . 65.22 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -116.84 -17.95 10.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 75.24 110.924 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.89 ' CD2' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -161.14 -165.15 1.28 Allowed 'General case' 0 C--O 1.181 -2.515 0 CA-C-O 118.15 -0.929 . . . . 70.14 110.851 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.122 ' H13' ' CD ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.554 ' CB ' HD13 ' A' ' 76' ' ' ILE . . . -43.73 127.14 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.595 . . . . 72.44 111.136 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -153.78 58.54 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.92 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.798 ' HG3' ' NH1' ' A' ' 94' ' ' ARG . 9.4 mt-10 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.925 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 112.531 -0.227 . . . . 64.01 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.596 ' HA ' ' O1 ' ' B' ' 4' ' ' MCL . 52.4 p -166.44 -169.14 1.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.8 0.333 . . . . 74.54 110.908 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.35 96.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.32 111.075 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -93.47 133.73 36.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 64.32 110.924 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.7 120.48 26.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.9 121.51 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 75.33 111.144 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.89 140.95 29.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 74.01 111.085 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.62 166.62 27.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 73.45 111.088 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.79 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 71.31 110.904 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.59 120.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.22 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.89 9.3 74.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.685 -0.769 . . . . 71.43 112.463 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -102.66 139.14 19.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 74.45 110.883 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 143.7 51.55 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.686 2.257 . . . . 73.25 112.355 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.2 tp -145.88 143.42 29.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.288 -0.414 . . . . 75.33 110.901 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 142.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.34 111.153 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.5 147.99 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 74.32 110.895 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -113.75 151.19 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 72.34 110.85 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -107.53 101.63 10.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 64.34 110.813 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -50.16 125.66 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 74.2 111.012 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.38 -45.12 1.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.8 -0.714 . . . . 65.11 112.464 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.16 123.84 63.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.595 0.712 . . . . 72.03 111.076 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.667 2.245 . . . . 71.1 112.385 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -47.5 39.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.869 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.74 149.43 37.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 71.31 110.872 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 108.93 2.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.734 2.289 . . . . 54.14 112.332 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 54.3 Cg_endo -69.71 -87.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.709 2.273 . . . . 62.25 112.409 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -104.16 -179.28 3.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 75.12 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -67.56 135.6 53.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 72.42 110.879 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 pp -135.69 163.38 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.34 110.913 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -120.56 149.02 43.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.04 110.913 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.43 143.16 51.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 74.01 110.96 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -143.03 140.79 31.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 75.1 110.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.425 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -137.65 132.82 33.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 65.04 110.916 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.869 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 19.0 t-20 -114.9 120.94 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.25 110.915 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.2 p -139.03 179.52 6.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 63.21 111.172 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.09 -130.03 10.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.644 -0.788 . . . . 60.55 112.537 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.67 -38.34 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 71.34 110.863 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.6 t 179.91 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 53.05 111.151 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -102.7 33.8 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 71.12 110.994 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.97 -7.04 8.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 74.45 111.1 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -64.52 130.93 45.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.31 110.888 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 153.49 47.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.938 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.54 120.84 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 65.24 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.26 149.68 21.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.18 -0.463 . . . . 70.41 110.873 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 p -121.74 156.39 58.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.728 0.775 . . . . 71.41 110.831 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -0.32 6.77 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.229 . . . . 70.33 112.324 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -145.61 71.86 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 75.32 110.889 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.87 84.29 0.85 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 64.12 112.55 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.1 34.46 4.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 63.21 112.435 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.54 -178.73 17.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 73.44 112.488 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 106.72 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.656 2.238 . . . . 75.52 112.355 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -30.84 65.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 72.15 110.897 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.69 -25.72 62.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.411 . . . . 74.44 110.892 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.26 -44.01 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 53.14 110.834 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -125.78 -99.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 73.55 111.093 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -150.87 175.9 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.078 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 168.66 16.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.843 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.9 t -106.45 130.11 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 73.33 111.154 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mp -69.31 156.62 91.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 71.42 110.945 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -20.46 34.72 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.0 112.422 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 1.91 32.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 41.55 110.861 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.3 25.12 27.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.668 -0.777 . . . . 72.43 112.445 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.9 m -113.5 -179.29 3.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 63.22 110.86 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tp -129.59 128.53 42.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 72.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -126.11 132.81 51.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 71.14 110.958 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mp -114.7 128.28 26.03 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 71.13 110.94 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.63 -34.24 15.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.685 2.257 . . . . 74.41 112.395 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.69 99.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 73.3 111.079 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.4 m -74.97 112.22 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.35 111.215 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.18 171.01 43.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 74.23 112.492 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -30.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.729 0.3 . . . . 72.34 111.095 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.49 -23.12 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 73.54 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -3.59 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.05 110.847 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 140.66 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 72.24 110.867 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.18 -149.04 18.76 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 54.43 112.502 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.083 HD12 ' HG3' ' B' ' 2' ' ' GLU . 3.6 mp -130.69 135.26 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 71.24 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -101.17 130.96 47.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 62.22 110.897 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.51 131.02 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 70.41 110.85 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 151.07 40.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 72.42 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -144.98 126.11 14.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.799 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.7 162.8 29.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 75.34 111.056 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.3 ttm -130.18 125.48 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 73.23 110.866 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.08 172.22 10.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -71.33 -19.07 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 75.44 110.886 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -74.21 -20.14 60.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.847 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.96 -9.1 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 75.04 112.531 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -85.11 146.28 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 74.31 110.893 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.73 142.12 36.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.945 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 125.9 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.12 111.043 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -106.87 143.1 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 74.33 110.9 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -146.74 120.61 9.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 63.32 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.63 122.6 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 74.02 110.919 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.19 125.88 43.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.902 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.063 ' NE ' ' CB ' ' B' ' 5' ' ' ALA . 8.9 mmm-85 -86.34 132.68 33.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 74.53 110.902 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.81 133.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.15 111.123 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 128.93 41.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 71.54 110.812 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.0 m -92.58 -176.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 71.35 111.136 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -66.83 -82.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 75.44 110.963 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -62.97 146.34 53.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.886 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.33 159.55 49.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 73.35 111.204 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -174.22 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.244 . . . . 70.32 112.243 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.18 95.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.41 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -142.73 158.92 58.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 75.54 110.88 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 177.86 5.12 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.633 2.222 . . . . 73.03 112.354 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 72.22 110.925 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.702 0.287 . . . . 74.14 110.972 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.083 ' HG3' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -53.92 -37.29 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 74.31 110.907 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.869 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -176.28 -163.82 0.11 Allowed 'General case' 0 C--O 1.182 -2.469 0 CA-C-O 118.102 -0.952 . . . . 65.4 110.915 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.596 ' O1 ' ' HA ' ' A' ' 2' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.063 ' CB ' ' NE ' ' A' ' 94' ' ' ARG . . . -45.53 128.13 7.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 71.02 111.057 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.88 67.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.424 . . . . 73.35 110.961 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.886 ' HG3' HH12 ' A' ' 94' ' ' ARG . 1.2 pp20? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.02 110.877 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.46 -0.256 . . . . 60.42 112.46 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.551 ' OG ' ' O1 ' ' B' ' 4' ' ' MCL . 1.4 t -179.86 148.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 75.03 110.754 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.75 56.32 8.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.082 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -93.33 133.24 36.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.937 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -84.96 122.17 28.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 73.01 110.891 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.6 mm -124.03 120.89 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 75.01 111.153 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -96.05 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 71.13 111.215 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.68 164.86 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.12 111.137 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -124.67 151.31 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.908 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.57 118.6 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 65.31 111.111 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.21 8.84 87.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 63.5 112.465 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -102.19 140.44 21.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 73.2 110.935 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 143.83 51.9 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.638 2.225 . . . . 73.44 112.366 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 tp -145.27 142.22 29.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.11 110.963 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.63 145.12 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 74.42 111.168 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.1 mt -131.66 147.78 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 73.24 110.916 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -113.39 150.32 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 72.41 110.809 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -110.67 100.96 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.852 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.53 128.04 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 72.33 110.956 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -45.02 1.2 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.768 -0.729 . . . . 52.21 112.439 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.85 59.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.602 0.715 . . . . 70.44 111.069 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -163.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 71.32 112.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.31 -47.57 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 75.14 110.939 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -104.54 156.67 35.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.627 0.727 . . . . 72.33 110.878 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 109.46 2.31 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.69 2.26 . . . . 74.12 112.378 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.6 Cg_endo -69.83 -87.32 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.739 2.293 . . . . 74.45 112.322 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -103.45 -178.15 3.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 65.13 110.877 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -65.81 132.46 48.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.22 150.63 37.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 72.22 110.909 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -121.03 149.77 42.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 75.44 110.913 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -107.28 136.64 46.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.903 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.42 145.08 38.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 73.44 110.911 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.79 137.96 13.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.952 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.57 128.89 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 75.35 110.925 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -136.59 179.2 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.11 111.111 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.84 14.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 70.24 112.498 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 74.44 110.865 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.3 t -179.69 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 62.22 111.184 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -102.94 33.46 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.883 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.19 -6.71 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 75.4 111.097 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -59.78 132.23 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 75.01 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.61 151.89 49.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.821 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.7 121.91 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.22 111.166 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.13 146.36 24.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 75.3 110.831 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.64 153.16 72.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.685 0.755 . . . . 74.24 110.877 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -0.26 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.818 2.346 . . . . 72.43 112.366 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -125.0 67.93 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.21 110.924 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.56 62.17 5.57 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.776 -0.726 . . . . 53.25 112.485 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.49 98.32 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 44.43 112.477 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.82 -171.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.73 . . . . 75.4 112.464 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 104.63 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 72.33 112.362 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -53.51 -35.39 60.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 75.03 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.97 -26.79 67.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 74.2 110.838 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.68 -42.72 10.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 74.23 110.895 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.07 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.14 111.065 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -160.3 172.9 16.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 74.3 111.165 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.72 164.76 19.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.13 110.913 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -106.52 130.28 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 73.31 111.144 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 mt -70.39 158.64 87.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 74.42 110.921 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.59 31.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.759 2.306 . . . . 73.31 112.313 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.05 1.65 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.54 17.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 71.23 112.513 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.6 m -112.48 -178.3 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.396 . . . . 73.25 110.829 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.8 tp -127.73 128.66 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.924 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -125.33 137.24 54.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 72.51 110.83 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.48 125.03 28.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.601 0.715 . . . . 75.51 110.969 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -31.92 19.4 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.5 112.343 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.51 100.61 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 74.3 111.091 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.4 118.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 63.44 111.137 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.45 162.77 17.79 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.807 -0.711 . . . . 75.24 112.447 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -29.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 74.52 111.175 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.7 -24.01 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 64.34 110.846 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.8 -4.64 56.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.288 -0.415 . . . . 75.24 110.809 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.3 140.77 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 62.12 110.802 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.03 -138.23 5.56 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.734 . . . . 64.13 112.554 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.622 HD12 ' CG ' ' B' ' 2' ' ' GLU . 3.6 mp -130.63 134.66 61.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.888 0.375 . . . . 73.1 111.142 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -103.5 132.86 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.34 110.894 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HG3' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER -127.22 126.64 43.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 71.34 110.839 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 150.38 34.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.12 110.833 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.73 127.64 22.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 64.22 110.879 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.42 164.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.11 111.129 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.1 ttm -129.52 125.66 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.34 110.878 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.41 171.58 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 72.23 110.876 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -71.52 -17.72 62.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.827 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -72.36 -20.02 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 62.13 110.863 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.8 -21.0 23.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 41.51 112.483 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.69 148.13 26.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 75.31 110.79 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.45 145.16 30.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 73.41 110.953 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.3 132.61 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.149 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -98.51 146.71 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 73.11 110.952 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.66 126.62 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 70.15 110.817 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.667 ' HB3' ' O2 ' ' B' ' 4' ' ' MCL . 2.0 t-20 -129.08 120.83 26.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 62.43 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.56 127.26 41.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.995 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.286 ' NH2' ' HA ' ' B' ' 5' ' ' ALA . 13.8 mmt85 -83.75 135.46 34.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.25 110.925 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 75.5 t -120.19 133.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 72.3 111.142 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 141.82 49.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.35 110.803 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.65 -176.21 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 73.22 111.162 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -75.93 -73.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 65.11 110.89 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 147.77 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 73.5 110.956 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.41 159.61 49.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.657 0.742 . . . . 72.34 111.161 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.13 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.771 2.314 . . . . 62.02 112.313 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.9 -69.29 0.21 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.67 -0.776 . . . . 64.22 112.438 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -171.32 73.61 0.52 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.528 0.68 . . . . 61.33 110.924 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 158.83 55.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.604 2.202 . . . . 73.14 112.363 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 75.32 110.921 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.798 0.333 . . . . 64.25 110.856 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.622 ' CG ' HD12 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -48.05 -59.54 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 52.23 110.891 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.025 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -177.88 104.36 0.05 OUTLIER 'General case' 0 C--O 1.181 -2.502 0 CA-C-O 118.237 -0.887 . . . . 70.15 110.805 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.667 ' O2 ' ' HB3' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.286 ' HA ' ' NH2' ' A' ' 94' ' ' ARG . . . 39.76 81.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 73.43 111.078 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.919 ' N ' ' NH2' ' A' ' 94' ' ' ARG . 4.7 m-20 -82.81 1.71 37.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 75.03 110.863 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.81 ' H ' HH22 ' A' ' 94' ' ' ARG . 7.6 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 72.03 110.911 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.557 -0.217 . . . . 74.44 112.557 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.31 115.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.931 0.396 . . . . 74.11 110.845 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.95 58.64 5.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 62.4 111.026 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.94 133.65 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 74.14 110.918 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.24 121.43 28.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 74.13 110.946 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.0 122.35 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 74.44 111.177 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -95.53 139.93 31.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 73.23 111.224 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.69 167.49 25.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.1 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.8 149.0 43.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 75.53 110.839 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.3 mt -52.73 120.54 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.166 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.7 68.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 74.3 112.516 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -102.81 138.18 19.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 75.41 110.902 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 143.12 49.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.708 2.272 . . . . 74.23 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.9 tp -145.82 142.91 29.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 74.04 110.862 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.86 146.87 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 63.51 111.179 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 mt -133.2 146.96 51.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.51 110.861 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -113.83 153.09 29.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.25 110.876 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.6 101.45 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.897 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.77 123.77 13.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 74.43 110.844 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.56 -40.92 1.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.711 . . . . 71.14 112.544 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.11 129.16 44.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 74.2 111.118 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -164.21 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 73.2 112.325 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -47.46 47.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.825 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.93 156.63 36.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 72.01 110.939 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.92 109.59 2.38 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.666 2.244 . . . . 72.21 112.289 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.1 Cg_endo -69.82 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.719 2.279 . . . . 70.32 112.252 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -103.22 -176.89 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 52.51 110.939 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -63.47 133.91 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 75.22 110.819 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.54 164.75 27.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 75.33 110.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -133.73 146.78 51.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 70.45 110.897 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -121.81 137.43 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 139.2 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 72.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 77' ' ' PHE . 1.3 tm? -138.12 131.89 31.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.404 . . . . 75.22 110.917 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.607 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 23.8 t-20 -115.78 120.55 39.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 71.4 110.901 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.7 p -139.73 179.47 6.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 72.14 111.145 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.11 -133.44 18.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 64.34 112.444 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -112.39 -37.28 5.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 73.31 110.869 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 t -179.28 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 72.32 111.205 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -101.29 33.69 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 72.42 110.947 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.39 -6.08 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 71.55 111.094 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -68.87 130.1 41.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 74.5 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 158.97 43.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 75.41 110.889 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.86 120.56 52.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.064 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 147.79 23.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 74.45 110.836 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -125.08 160.49 54.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 63.21 110.86 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.85 0.19 6.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 60.04 112.285 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -132.68 70.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 75.42 110.887 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 74.51 1.11 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.73 . . . . 62.35 112.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.92 58.9 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.729 -0.748 . . . . 74.44 112.495 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.54 171.84 42.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 54.04 112.465 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 106.76 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.651 2.234 . . . . 73.14 112.354 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -52.91 -34.6 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.945 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -61.93 -31.17 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.11 110.87 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -43.07 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 55.15 110.852 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -126.37 -97.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 70.51 111.135 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -154.31 176.3 12.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 75.24 111.067 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.23 161.38 23.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 75.12 111.004 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -107.9 129.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 70.12 111.119 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.97 157.19 90.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.739 0.78 . . . . 71.23 110.863 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -20.63 35.16 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.63 2.22 . . . . 64.34 112.411 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -82.18 1.39 36.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.917 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.98 20.61 35.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.684 -0.769 . . . . 65.41 112.521 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.9 m -107.52 -179.22 3.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 72.32 110.829 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.4 129.22 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 72.12 110.956 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -126.21 131.64 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 75.01 110.876 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mp -115.17 129.9 24.69 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.586 0.708 . . . . 63.23 110.944 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.84 17.71 Favored 'Trans proline' 0 N--CA 1.466 -0.12 0 C-N-CA 122.74 2.293 . . . . 74.54 112.323 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.21 99.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.42 111.127 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 m -77.46 112.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 71.12 111.053 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.33 175.63 46.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 62.04 112.532 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.18 -31.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 74.34 111.081 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -76.59 -21.96 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 73.23 110.937 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.55 -3.6 35.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.87 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 141.1 56.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 63.1 110.932 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.56 -150.47 21.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 71.42 112.422 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.623 HG13 ' O ' ' B' ' 2' ' ' GLU . 4.4 mm -130.63 137.25 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 74.22 111.115 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HA ' HD21 ' A' ' 33' ' ' LEU . 41.3 m-85 -103.11 127.43 50.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 63.51 110.869 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -124.92 128.37 48.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.932 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.83 151.25 39.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.11 110.871 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 71.11 110.996 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.7 163.07 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 64.34 111.125 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 72.3 mmm -129.8 124.84 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.44 110.905 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -89.71 170.61 10.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.15 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -21.81 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.805 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -73.39 -19.97 60.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 71.11 110.902 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 -7.48 32.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 73.2 112.455 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 146.59 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 72.14 110.959 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.0 144.02 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 64.11 110.934 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.12 126.17 50.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 73.01 111.124 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -102.48 142.39 33.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 74.54 110.98 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -146.46 120.05 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 72.51 110.882 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' B' ' 5' ' ' ALA . 0.6 OUTLIER -129.58 122.47 29.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 72.11 110.955 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.48 119.41 22.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.05 110.915 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.757 ' NH2' ' N ' ' B' ' 7' ' ' GLU . 0.0 OUTLIER -84.46 134.46 34.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 73.52 110.924 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.91 137.24 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 65.42 111.18 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -129.91 130.5 45.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 22.6 m -93.5 -176.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 75.33 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.34 -77.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.42 110.958 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.75 140.64 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 74.23 110.949 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.04 159.69 48.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 73.54 111.19 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 129.74 18.13 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.786 2.324 . . . . 64.11 112.339 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.78 18.53 0.86 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.656 -0.783 . . . . 50.11 112.43 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -77.39 137.68 63.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.615 0.721 . . . . 74.45 110.831 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 101.11 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.622 2.214 . . . . 64.04 112.437 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.874 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.785 0.326 . . . . 71.35 110.864 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.623 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -135.74 63.91 1.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.852 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 66.55 -163.55 0.23 Allowed 'General case' 0 C--O 1.182 -2.497 0 CA-C-O 118.106 -0.949 . . . . 72.44 110.895 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.432 ' HB3' HD22 ' A' ' 92' ' ' ASN . . . -46.22 145.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 75.41 111.155 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.753 ' N ' HH21 ' A' ' 94' ' ' ARG . 37.2 t70 -159.5 113.23 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.54 110.837 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.757 ' N ' ' NH2' ' A' ' 94' ' ' ARG . 4.5 mm-40 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 73.3 110.941 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.446 -0.262 . . . . 53.4 112.446 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -178.33 158.74 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 73.01 110.895 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.78 95.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 75.14 111.134 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -93.14 133.05 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 73.22 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.06 119.84 25.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 73.54 110.896 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mp -125.83 122.0 61.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.122 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -95.84 142.27 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 63.5 111.148 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.14 166.55 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 72.34 111.141 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.29 148.94 44.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 72.34 110.847 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 mt -54.38 119.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 71.1 111.147 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.92 7.85 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 74.44 112.418 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -102.55 140.08 20.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 74.4 110.901 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 143.02 49.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.654 2.236 . . . . 64.44 112.298 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.5 tp -145.27 143.49 30.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 71.32 110.882 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -124.08 147.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 72.5 111.142 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.8 mt -131.39 148.26 52.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 65.12 110.996 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 151.88 28.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 73.21 110.912 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.7 101.5 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.12 110.897 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -58.93 120.98 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 75.31 110.838 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.99 -39.4 2.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.826 -0.702 . . . . 75.03 112.587 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.6 128.32 46.95 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 72.34 111.153 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -165.32 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 72.53 112.387 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.6 52.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.913 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.3 152.04 41.07 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.518 0.675 . . . . 71.33 110.864 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.76 109.56 2.34 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.714 2.276 . . . . 60.51 112.369 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.8 Cg_endo -69.74 -86.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 63.41 112.323 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.01 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.42 110.914 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -63.93 135.58 56.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 71.24 110.803 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.55 158.6 43.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.915 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.25 148.16 44.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 64.15 110.876 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -131.75 128.94 39.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 72.54 110.887 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -137.66 136.0 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.891 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.86 139.37 38.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 72.4 110.892 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.828 ' HB3' ' HD1' ' B' ' 3' ' ' PHE . 2.7 t-20 -111.89 126.65 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 65.41 110.921 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 p -138.52 -179.67 5.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 73.13 111.137 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.3 -130.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 63.33 112.511 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.98 -37.14 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 73.3 110.835 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 t -179.3 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 72.14 111.092 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -102.12 34.3 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 72.33 110.875 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.07 -6.99 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 73.05 111.178 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.1 t90 -59.5 130.44 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 75.43 110.908 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.96 153.67 48.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 63.13 110.831 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.7 t -104.62 113.8 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.43 111.186 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.32 147.2 23.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.916 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.01 161.87 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.7 0.762 . . . . 74.4 110.9 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 0.14 6.13 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.631 2.221 . . . . 74.52 112.303 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 79.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.23 110.951 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 79.28 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 75.14 112.494 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.53 53.42 4.85 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 75.23 112.475 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.2 179.52 38.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.781 -0.724 . . . . 71.34 112.583 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 107.17 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.261 . . . . 53.11 112.304 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -57.11 -33.7 67.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.439 . . . . 74.23 110.935 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.28 -26.89 66.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 75.03 110.884 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -44.76 8.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 62.34 110.895 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.74 -96.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 73.11 111.13 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -150.29 173.3 14.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 72.33 111.093 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 165.55 16.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 75.53 110.875 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -108.63 130.05 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 73.25 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.3 mt -69.28 156.96 90.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 73.02 110.892 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -21.6 33.72 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.769 2.313 . . . . 63.15 112.344 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -82.19 1.0 38.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.927 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.71 26.35 20.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 74.14 112.457 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -111.25 179.39 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 54.51 110.917 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.5 tp -129.89 128.82 42.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.901 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -125.59 131.3 52.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 72.43 110.897 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.4 ' CD2' HG12 ' A' ' 69' ' ' VAL . 3.7 mp -114.34 126.9 27.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.649 0.738 . . . . 74.34 110.978 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -32.02 19.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.74 2.293 . . . . 73.24 112.289 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.34 99.17 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 72.02 111.128 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' A' ' 66' ' ' LEU . 15.9 m -73.94 115.7 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 74.25 111.093 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.53 167.46 28.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 63.41 112.426 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -29.98 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 74.31 111.142 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -75.57 -22.9 56.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.24 110.912 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -7.92 58.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 75.44 110.921 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.25 141.1 55.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 64.21 110.821 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.4 -142.73 8.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 71.23 112.533 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.042 HD12 ' CB ' ' B' ' 2' ' ' GLU . 3.6 mp -130.88 129.29 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 73.2 111.154 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.79 131.07 51.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 72.31 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.3 OUTLIER -127.09 140.86 51.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 71.24 110.915 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.4 153.09 38.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 65.45 110.887 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -139.76 126.5 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 75.3 110.825 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.53 161.78 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 72.11 111.054 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.4 ttm -131.04 125.25 32.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 73.54 110.859 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -86.82 172.21 10.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 74.44 110.863 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.19 -18.28 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.86 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.22 -19.84 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.463 . . . . 65.45 110.919 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.41 -16.54 31.88 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.612 -0.804 . . . . 72.34 112.436 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -85.26 145.93 27.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 74.34 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.49 144.77 31.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.871 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.21 130.84 48.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.35 111.186 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 90' ' ' LYS . 7.1 mmmt -105.08 142.37 34.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.847 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -144.76 125.07 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 65.23 110.99 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.48 127.07 45.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -128.3 124.21 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.03 110.968 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.326 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 19.0 mmm-85 -84.27 132.37 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.23 110.848 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.9 t -120.82 134.46 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 72.14 111.114 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -131.95 128.17 37.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 75.34 110.882 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 m -92.93 -175.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 74.04 111.151 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -70.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 75.14 110.963 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -71.23 139.98 50.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 61.33 110.924 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.5 159.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.535 0.683 . . . . 74.13 111.161 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.92 103.18 1.15 Allowed 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.713 2.276 . . . . 71.4 112.23 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.71 -124.55 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.648 -0.786 . . . . 63.11 112.468 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.18 160.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.528 0.68 . . . . 71.51 110.889 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 175.19 8.45 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.268 . . . . 62.33 112.328 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 72.42 110.894 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.829 0.347 . . . . 71.45 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.042 ' CB ' HD12 ' A' ' 76' ' ' ILE . 2.6 pp20? -59.59 -170.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 75.23 110.934 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.828 ' HD1' ' HB3' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -62.87 -159.94 0.01 OUTLIER 'General case' 0 C--O 1.181 -2.534 0 CA-C-O 118.229 -0.891 . . . . 74.14 110.847 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.498 ' O2 ' ' HD3' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.326 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . 48.42 -166.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.852 -0.613 . . . . 52.32 111.119 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.77 ' H ' ' NH1' ' A' ' 94' ' ' ARG . 8.1 p-10 -139.95 -156.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 70.32 110.835 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 75.21 110.887 -179.883 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.459 -0.256 . . . . 74.14 112.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -179.67 106.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 64.44 110.828 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.66 72.65 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 54.02 111.1 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -93.21 132.61 37.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.02 110.882 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 121.34 27.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 72.24 110.882 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -125.08 120.21 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.101 -0.5 . . . . 74.14 111.198 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -96.76 137.94 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.41 28.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.4 111.11 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.51 148.98 44.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.11 110.937 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.6 mt -51.91 121.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.265 -0.425 . . . . 75.01 111.125 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.58 5.95 74.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 72.42 112.481 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -101.29 139.49 20.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 71.23 110.89 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.13 49.85 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.655 2.237 . . . . 75.35 112.315 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.4 tp -145.18 141.76 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 70.31 110.875 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.81 148.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 73.23 111.081 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.8 mt -132.48 148.27 52.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 74.23 110.957 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.33 153.05 27.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 75.42 110.83 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 t -105.94 102.31 11.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.34 110.831 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.6 121.91 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.42 110.907 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.93 -36.05 2.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.781 -0.723 . . . . 71.31 112.519 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.25 39.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 72.54 111.105 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.5 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.696 2.264 . . . . 63.33 112.331 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -48.49 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 75.33 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.06 153.12 41.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.54 0.686 . . . . 74.45 110.899 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 109.83 2.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.258 . . . . 75.44 112.364 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -83.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.612 2.208 . . . . 64.31 112.432 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -103.36 -177.49 3.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.978 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -64.0 133.14 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 73.33 110.823 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.82 156.57 48.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 74.02 110.892 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.79 148.11 51.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.873 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -117.98 145.52 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 72.43 110.906 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -138.04 144.03 40.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 55.0 110.953 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 75.01 110.868 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.721 ' CB ' ' CD2' ' B' ' 3' ' ' PHE . 13.8 t-20 -115.04 124.01 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.862 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 p -138.87 178.37 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 74.21 111.157 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.31 -130.17 11.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 70.41 112.498 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -112.64 -37.96 4.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.412 . . . . 75.43 110.93 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.1 t -179.71 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 72.04 111.115 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -102.38 33.26 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 71.44 110.918 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.22 -7.07 7.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 75.01 111.072 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -62.47 130.15 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 75.5 110.929 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.98 153.28 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.901 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.57 124.78 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 64.21 111.096 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.57 143.79 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.521 . . . . 72.33 110.969 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.96 164.61 34.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.607 0.718 . . . . 75.14 110.9 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 0.2 5.95 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.668 2.246 . . . . 72.1 112.446 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -127.16 96.97 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.913 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.04 -29.44 62.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 71.43 112.48 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.77 -156.15 18.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 63.35 112.461 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.89 -67.46 1.51 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.789 -0.72 . . . . 64.34 112.48 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.9 102.84 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.272 . . . . 74.53 112.275 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 28.7 p90 -83.89 -34.03 24.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.31 110.927 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.6 -26.69 68.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.399 . . . . 72.23 110.926 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -46.56 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.53 110.891 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -129.5 -98.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.32 111.174 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -166.99 170.68 11.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 72.34 111.192 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -128.18 159.85 33.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 74.32 110.811 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.33 131.85 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 73.31 111.092 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.07 157.71 86.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.649 0.737 . . . . 75.32 110.956 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -23.12 31.55 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.702 2.268 . . . . 71.15 112.339 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.07 1.31 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 25.56 18.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 65.24 112.47 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.65 -179.1 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 73.23 110.849 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 tp -129.09 128.56 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.492 . . . . 64.43 110.848 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -126.16 130.73 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.05 110.853 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.41 131.07 24.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 72.32 110.939 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -34.76 13.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 75.14 112.336 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.73 103.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 64.0 111.049 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 m -73.7 118.93 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.55 111.109 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.38 162.02 31.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 71.2 112.514 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -29.47 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 75.31 111.166 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.16 -22.54 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 74.21 110.835 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.08 -4.76 56.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.31 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.43 140.44 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.954 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.76 -139.83 6.99 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.701 -0.761 . . . . 52.13 112.455 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.407 HD12 ' CG ' ' B' ' 2' ' ' GLU . 3.9 mp -126.81 130.59 71.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 74.52 111.18 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.85 129.02 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 74.24 110.909 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -126.55 126.15 43.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.907 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 154.5 24.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 73.52 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.73 135.11 31.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 75.34 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.08 163.26 29.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.082 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.14 123.98 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 71.42 110.858 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.28 171.72 9.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 73.31 110.877 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -18.71 62.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 62.45 110.851 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -73.38 -20.11 60.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.31 32.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 71.22 112.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -85.27 146.76 26.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 74.44 110.835 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.33 144.95 31.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.41 110.869 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.92 126.69 50.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 64.12 111.153 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.539 ' HG3' ' O1 ' ' B' ' 4' ' ' MCL . 9.9 ptmt -103.14 143.25 32.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 75.55 110.923 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.8 m -143.76 126.75 16.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.41 110.826 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.667 ' OD1' ' HA ' ' B' ' 5' ' ' ALA . 0.6 OUTLIER -122.1 124.31 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 73.02 110.909 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -128.84 126.38 39.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 75.34 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.905 ' NH2' ' C ' ' B' ' 5' ' ' ALA . 14.4 mmt85 -84.46 131.36 34.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 74.53 110.909 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.13 133.87 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 73.53 111.168 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -131.75 128.58 39.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 73.45 110.928 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.3 m -96.45 -176.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.22 111.098 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -61.7 -79.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.925 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -70.71 144.26 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.33 110.848 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.33 159.49 49.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.664 0.745 . . . . 74.14 111.102 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 116.89 4.76 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.694 2.263 . . . . 73.01 112.372 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -154.19 24.34 0.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 71.44 112.484 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -152.33 160.47 31.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.58 0.705 . . . . 75.31 110.96 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.65 38.43 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 74.44 112.319 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 72.41 110.984 179.943 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.805 0.336 . . . . 73.51 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.407 ' CG ' HD12 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -69.49 -169.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 73.25 110.852 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.721 ' CD2' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -66.02 -162.93 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.521 0 CA-C-O 118.138 -0.934 . . . . 73.21 110.867 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.539 ' O1 ' ' HG3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.905 ' C ' ' NH2' ' A' ' 94' ' ' ARG . . . 47.58 -95.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 74.25 111.073 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.662 ' C ' HH22 ' A' ' 94' ' ' ARG . 3.5 t70 64.01 106.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 72.41 110.868 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.756 ' CG ' HH12 ' A' ' 94' ' ' ARG . 2.8 pp20? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 73.54 110.942 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.514 -0.234 . . . . 74.53 112.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -64.63 92.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 74.25 110.91 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.7 74.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 72.41 111.13 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.42 132.57 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.838 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -90.45 120.47 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 73.4 110.855 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.44 122.53 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 74.53 111.146 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -95.45 142.3 27.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.3 111.1 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.49 167.42 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 65.02 111.112 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.26 149.18 42.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.21 110.87 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.4 mt -52.19 120.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 74.34 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 10.09 69.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 63.14 112.475 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -103.31 138.95 19.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.54 0.686 . . . . 74.22 110.88 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.66 51.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.673 2.248 . . . . 74.13 112.308 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.2 tp -144.92 142.02 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.983 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.93 148.29 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 75.11 111.081 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.8 mt -134.77 148.29 50.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.02 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -112.55 151.53 29.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 74.22 110.903 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.1 t -107.28 99.7 9.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 72.31 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -54.37 125.03 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.852 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.97 -41.74 1.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 53.23 112.51 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.12 43.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.581 0.705 . . . . 62.32 111.102 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -165.0 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.709 2.272 . . . . 74.21 112.381 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -49.41 -48.82 46.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.458 . . . . 74.51 110.794 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -107.32 151.96 41.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.545 0.688 . . . . 73.52 110.911 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 109.39 2.31 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.22 112.335 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.9 Cg_endo -69.79 -85.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.707 2.271 . . . . 74.43 112.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.99 -178.41 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 71.33 110.951 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -64.92 137.77 57.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 65.15 110.912 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 pp -135.82 160.33 38.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.981 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -121.26 145.01 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 70.01 110.864 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -128.38 137.33 51.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.891 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -140.81 139.07 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 75.11 110.94 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -137.29 136.0 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.88 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 121.54 43.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 72.11 110.914 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.3 p -137.59 179.36 6.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 63.12 111.146 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.89 -129.18 9.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.712 -0.756 . . . . 71.54 112.442 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -112.48 -38.43 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 74.22 110.827 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t 179.78 -31.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 74.24 111.231 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -103.44 33.96 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 64.42 110.894 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.43 -6.8 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 75.05 111.083 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.55 132.3 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 74.32 110.932 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 158.95 38.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 63.34 110.927 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.07 120.52 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 74.3 111.136 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.12 147.2 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.3 110.893 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -124.46 153.47 69.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.23 110.85 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 -0.25 6.55 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.791 2.327 . . . . 75.53 112.344 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -137.03 72.16 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.833 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.86 75.14 1.14 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 74.52 112.503 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.72 58.34 3.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 75.35 112.509 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 178.95 41.18 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 74.33 112.469 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 107.37 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.642 2.228 . . . . 74.33 112.308 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -54.37 -33.91 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 74.12 110.866 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.28 -29.05 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 71.51 110.945 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.93 -43.45 9.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 75.43 110.851 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -124.85 -98.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.491 . . . . 74.25 111.095 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.436 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -152.99 174.23 14.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 64.51 111.122 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.6 164.13 18.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.876 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.51 130.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.3 111.055 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.63 158.85 85.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 75.15 110.947 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -22.19 32.46 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.721 2.28 . . . . 61.21 112.354 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.57 1.34 42.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.885 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.41 28.5 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 62.11 112.488 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 m -111.87 -178.88 3.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 72.21 110.843 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -128.89 128.93 44.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 74.23 110.92 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -125.57 134.82 51.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.844 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.8 124.45 30.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.657 0.741 . . . . 63.44 110.922 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -31.77 19.77 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 70.34 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.57 101.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 63.21 111.101 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 35.7 m -71.71 114.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 74.12 111.138 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.01 159.18 22.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 71.31 112.493 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -31.0 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 73.34 111.113 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -77.15 -22.82 51.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.929 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.84 -3.87 37.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 74.15 110.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 143.3 39.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 73.41 110.876 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.1 -148.37 17.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 74.12 112.546 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.506 HG23 ' HB1' ' B' ' 5' ' ' ALA . 19.2 mm -131.22 137.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 74.1 111.071 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -101.65 127.84 48.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 75.12 110.899 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.32 126.91 45.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.52 110.855 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.43 149.8 43.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.835 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -141.95 134.18 27.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 73.13 110.97 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.15 163.3 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 74.33 111.114 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ttm -130.55 124.94 32.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 73.34 110.894 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -86.9 172.28 10.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.4 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -70.96 -18.53 62.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 74.3 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.26 -19.9 60.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.31 110.849 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.17 -13.69 37.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 71.02 112.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -85.08 146.38 27.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.705 0.288 . . . . 72.54 110.963 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.43 144.95 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 61.51 110.857 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -102.01 132.63 47.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 74.32 111.13 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.813 ' HE3' ' CX2' ' B' ' 4' ' ' MCL . 11.4 mmmt -98.96 143.48 29.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 75.52 110.9 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 m -144.66 121.14 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 75.52 110.878 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.18 120.13 25.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.873 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -129.67 119.71 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 75.42 110.869 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.181 ' CD ' ' HB3' ' B' ' 5' ' ' ALA . 1.0 OUTLIER -86.79 135.44 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 72.21 110.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.94 136.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 75.33 111.093 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -131.06 142.88 50.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 75.21 110.868 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.0 m -106.3 -175.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 75.1 111.092 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -67.69 -81.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 74.3 110.989 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -62.85 145.45 55.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 64.02 110.855 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.43 159.67 49.24 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.723 0.773 . . . . 71.31 111.052 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 120.19 7.02 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.708 2.272 . . . . 63.13 112.318 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -98.5 -32.06 6.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.824 -0.703 . . . . 55.01 112.507 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt 52.74 70.13 2.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 75.43 110.953 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.654 2.236 . . . . 73.34 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 64.2 110.929 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 71.01 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 166.67 12.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.93 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.496 ' O ' ' C ' ' B' ' 4' ' ' MCL . 0.2 OUTLIER -64.83 -161.38 0.02 OUTLIER 'General case' 0 C--O 1.182 -2.482 0 CA-C-O 118.121 -0.943 . . . . 74.33 110.924 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.813 ' CX2' ' HE3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.181 ' HB3' ' CD ' ' A' ' 94' ' ' ARG . . . -42.23 154.93 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.883 -0.599 . . . . 73.32 111.086 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.471 ' O ' ' NH1' ' A' ' 94' ' ' ARG . 5.2 p-10 -143.29 -163.05 1.56 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 75.34 110.856 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 74.53 110.912 -179.844 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.511 -0.236 . . . . 70.34 112.511 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 59.14 21.29 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 73.25 110.878 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 178.94 62.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 71.31 111.1 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 133.75 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.53 110.849 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -90.3 121.29 32.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 72.22 110.864 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.76 122.15 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 71.33 111.141 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -94.62 140.14 30.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.144 -0.48 . . . . 45.12 111.117 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.66 167.65 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.51 111.076 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.13 43.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.819 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mt -52.12 120.44 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 73.42 111.119 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.61 10.35 70.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 73.31 112.457 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -102.7 139.46 20.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.69 0.757 . . . . 74.51 110.889 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.98 49.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.667 2.245 . . . . 54.3 112.342 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.9 tp -145.42 143.32 30.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 75.32 110.864 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.88 147.75 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 75.12 111.101 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -132.2 150.21 52.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 72.13 110.917 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -111.71 151.52 28.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 75.31 110.904 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -107.3 100.82 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.938 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -54.16 125.09 17.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 71.22 110.827 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.47 -43.21 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.729 . . . . 73.5 112.512 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.45 42.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 74.21 111.012 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -161.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.613 2.209 . . . . 73.45 112.408 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -48.26 -47.02 36.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.21 110.938 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.38 164.18 15.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 65.51 110.866 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 109.68 2.36 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.776 2.317 . . . . 44.0 112.333 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 -91.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 74.21 112.379 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -177.03 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 75.54 110.934 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -63.78 131.57 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.87 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.54 157.28 46.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -121.77 145.86 47.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 72.14 110.848 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -120.24 143.64 48.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 74.5 111.03 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -148.88 135.44 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 74.32 110.896 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.23 138.31 33.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.921 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.49 126.11 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.53 110.807 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.5 p -138.72 -178.9 5.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 74.41 111.038 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -127.27 9.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.713 -0.756 . . . . 75.12 112.517 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -112.79 -38.64 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 73.41 110.875 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t 178.97 -29.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.124 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -102.43 34.08 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 65.12 110.913 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.99 -6.96 8.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 64.43 111.063 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -70.06 129.07 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 73.44 110.952 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.18 159.25 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.4 110.809 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.2 121.96 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.42 111.167 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.23 144.67 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 71.41 110.888 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.2 m -127.02 152.28 75.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 75.0 110.898 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 2.75 3.22 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.753 2.302 . . . . 65.12 112.395 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -116.99 70.35 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 73.32 110.885 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.27 -37.09 3.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 73.32 112.469 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.96 57.12 13.56 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.73 -0.748 . . . . 63.2 112.426 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.09 -176.6 49.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.673 -0.775 . . . . 72.35 112.528 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 107.4 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 74.53 112.307 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -56.88 -34.16 67.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -25.86 66.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 63.33 110.835 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.19 -43.59 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 70.24 110.865 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.81 -98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 73.4 111.164 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.407 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -154.8 175.77 13.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 75.51 111.122 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.79 161.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 71.54 110.904 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.23 130.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 74.34 111.073 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.3 mt -69.01 156.98 90.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 75.23 110.927 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.95 32.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.254 . . . . 74.41 112.331 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -81.48 0.39 38.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 73.34 110.91 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.88 30.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 74.3 112.525 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -106.38 -179.55 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.951 0.405 . . . . 65.01 110.851 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 tp -130.21 130.74 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.969 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -124.89 130.36 52.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.02 110.892 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mp -117.19 127.12 26.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 75.12 110.899 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -32.37 18.57 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.804 2.336 . . . . 64.12 112.382 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.45 100.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 62.34 111.101 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.01 113.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 73.12 111.156 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.82 173.85 43.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 73.2 112.44 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.413 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.7 -32.23 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 75.23 111.109 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -77.26 -21.61 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.15 110.928 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -5.61 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 62.21 110.833 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 142.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 65.14 110.958 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.71 -151.49 22.24 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.734 -0.746 . . . . 63.54 112.463 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mm -131.38 134.85 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 75.41 111.093 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -103.96 132.82 49.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 74.02 110.856 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HE ' ' HE1' ' B' ' 3' ' ' PHE . 0.2 OUTLIER -127.03 134.17 50.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.78 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.73 148.12 45.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 64.53 110.902 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -142.4 127.43 18.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.41 110.903 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.38 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 74.51 111.083 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ttm -130.64 125.66 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.55 110.926 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.58 171.92 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 74.35 110.95 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -19.15 61.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.802 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.9 -20.24 60.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 65.31 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.56 35.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 71.32 112.472 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 146.32 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.662 0.268 . . . . 74.14 110.886 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -105.63 142.62 35.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 73.23 110.863 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.96 131.09 50.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 75.01 111.085 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.033 ' CE ' ' C1 ' ' B' ' 4' ' ' MCL . 0.8 OUTLIER -105.42 142.85 34.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.15 110.892 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.615 ' N ' ' O2 ' ' B' ' 4' ' ' MCL . 3.8 m -146.1 123.61 11.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 62.0 110.816 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.744 ' OD1' ' HB3' ' B' ' 4' ' ' MCL . 0.2 OUTLIER -128.13 122.28 31.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 71.14 110.819 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.02 118.81 24.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 72.44 110.94 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.83 HH22 ' CG ' ' B' ' 7' ' ' GLU . 0.1 OUTLIER -88.72 134.16 34.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.886 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.5 135.73 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 74.23 111.142 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -130.65 131.61 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 75.35 110.854 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -96.51 -176.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.14 111.164 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -67.4 -78.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.939 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 73.42 110.953 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.07 159.45 49.31 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 75.43 111.084 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 169.91 17.74 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.647 2.231 . . . . 70.34 112.415 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.85 106.72 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 52.23 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.24 160.63 36.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.605 0.717 . . . . 71.52 110.859 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 103.67 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.613 2.208 . . . . 62.42 112.39 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 73.45 110.842 -179.874 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.726 0.298 . . . . 62.33 110.963 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -159.85 80.86 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.32 110.914 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.592 ' HE1' ' HE ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER 54.23 -164.87 0.1 Allowed 'General case' 0 C--O 1.182 -2.49 0 CA-C-O 118.26 -0.876 . . . . 74.22 110.864 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.033 ' C1 ' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.44 120.23 4.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 63.03 111.11 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -122.59 50.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 75.32 110.852 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.83 ' CG ' HH22 ' A' ' 94' ' ' ARG . 6.2 tp10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.905 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.514 -0.234 . . . . 73.44 112.514 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 p -173.73 160.33 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 72.03 110.856 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.76 93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 73.12 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -93.92 133.12 37.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.935 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -89.5 121.63 31.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.83 120.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 72.13 111.17 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 p -96.7 142.47 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 73.22 111.13 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.43 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 60.12 111.132 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.69 147.97 40.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 74.1 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 121.3 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 75.12 111.14 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.48 5.89 74.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 64.2 112.497 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -101.47 141.43 22.58 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.606 0.717 . . . . 75.24 110.831 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.78 52.21 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.606 2.204 . . . . 74.04 112.384 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.48 143.14 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.437 . . . . 73.11 110.902 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -121.84 146.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 74.1 111.153 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.5 mt -131.41 148.28 52.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 70.13 110.951 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 152.04 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 74.03 110.972 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.9 t -107.08 99.88 9.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 61.24 110.871 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.66 123.56 14.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 63.54 110.908 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.18 -39.4 2.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.53 112.483 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 131.28 37.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 73.41 111.101 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -163.96 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.675 2.25 . . . . 53.03 112.32 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -50.09 30.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 35.5 mmtt -110.85 153.05 43.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 64.42 110.871 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 109.57 2.33 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 63.22 112.329 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.6 Cg_endo -69.71 -83.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 70.14 112.353 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.32 -177.36 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 74.1 110.875 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -63.92 139.96 58.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.852 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.6 159.11 42.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 75.13 110.93 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.09 139.59 53.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 71.4 110.885 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -121.34 139.09 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.886 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -139.05 137.07 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.23 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.82 134.09 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.918 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.96 ' ND2' ' CZ ' ' B' ' 3' ' ' PHE . 1.8 m-80 -115.77 125.18 52.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.852 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.8 p -138.43 -179.5 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 75.15 111.129 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.61 -130.83 13.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.481 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -112.84 -37.56 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 73.13 110.905 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 t -179.74 -29.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 64.32 111.187 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -101.97 33.6 2.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.896 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.75 -7.23 7.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 73.21 111.121 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -60.26 130.41 46.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 74.32 110.919 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 153.45 49.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 74.14 110.907 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.54 121.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 65.41 111.191 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.65 145.96 24.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.42 110.942 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.3 162.62 47.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.664 0.745 . . . . 74.34 110.88 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 -0.53 6.98 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.677 2.251 . . . . 71.05 112.321 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.11 89.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 74.34 110.946 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.27 74.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.644 -0.789 . . . . 73.24 112.52 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 40.22 38.55 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.844 -0.693 . . . . 75.44 112.414 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.43 -162.55 9.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 62.44 112.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 121.09 7.78 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.244 . . . . 75.33 112.317 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -82.8 -34.61 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 75.05 110.929 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -62.97 -25.8 68.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 74.4 110.779 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -46.85 13.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 75.23 110.946 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -129.49 -99.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 70.13 111.091 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -167.55 173.49 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 63.13 111.07 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -123.25 159.25 29.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.9 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.38 130.17 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 73.53 111.132 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.06 157.64 88.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.54 0.686 . . . . 74.23 110.947 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -21.8 32.77 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.622 2.215 . . . . 75.43 112.357 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -84.24 1.44 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.908 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.86 32.83 8.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.803 -0.713 . . . . 71.4 112.451 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -115.35 179.11 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 73.11 110.868 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -129.47 128.22 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.847 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -126.78 136.61 52.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.81 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mp -118.45 130.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 74.22 110.974 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -34.87 13.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 64.01 112.336 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.58 101.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 74.12 111.1 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 m -72.65 113.22 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 75.34 111.11 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.85 161.82 33.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 64.4 112.478 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.84 -30.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 74.1 111.152 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.1 -20.43 57.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.933 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -3.55 29.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 74.14 110.871 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HG3' HG22 ' A' ' 97' ' ' VAL . 27.5 mt-10 -57.13 142.52 42.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.866 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 34' ' ' ASN . . . 158.75 -153.99 25.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.674 -0.774 . . . . 72.13 112.41 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.469 HD12 ' CG ' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -123.81 134.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 75.53 111.156 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -104.0 127.54 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.852 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.2 128.86 47.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 73.11 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 7.0 t -120.54 150.2 41.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 51.03 110.891 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.85 133.7 29.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 64.1 110.927 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.81 162.99 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 75.31 111.129 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 25.0 mtp -129.69 124.77 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 71.41 110.967 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.21 172.82 9.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 64.41 110.87 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -70.71 -19.03 62.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 75.33 110.922 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.83 -20.05 60.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.43 40.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.82 -0.705 . . . . 62.11 112.547 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.08 146.87 26.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 72.3 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -105.05 142.5 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 75.45 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.72 131.84 50.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.52 111.122 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HB3' ' O2 ' ' B' ' 4' ' ' MCL . 42.9 mtpt -102.53 143.56 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.84 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 t -144.39 125.72 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.24 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.626 HD22 ' HB2' ' B' ' 5' ' ' ALA . 1.6 t-20 -126.83 122.07 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 74.31 110.896 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 121.77 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 74.13 110.883 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.073 HH12 ' HG3' ' B' ' 7' ' ' GLU . 27.5 mmm-85 -83.79 134.01 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 64.54 110.905 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.35 128.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 74.15 111.079 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.09 142.93 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.91 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.8 m -108.86 -174.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 71.14 111.176 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -67.3 -79.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.85 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -63.09 145.99 54.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 70.31 110.932 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.2 159.59 49.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.536 0.684 . . . . 74.3 111.204 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 179.02 3.93 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.756 2.304 . . . . 72.23 112.355 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 164.68 -48.04 0.29 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.673 -0.775 . . . . 75.45 112.456 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -151.53 71.98 8.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 75.41 110.854 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 167.63 23.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.657 2.238 . . . . 65.24 112.35 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.956 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.307 . . . . 74.23 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.469 ' CG ' HD12 ' A' ' 76' ' ' ILE . 1.4 pm0 -123.52 -36.2 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.876 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.96 ' CZ ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 176.28 -159.45 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.513 0 CA-C-O 118.1 -0.952 . . . . 73.25 110.849 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.537 ' O2 ' ' HB3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.95 ' HB1' ' HD3' ' A' ' 94' ' ' ARG . . . -48.7 134.37 16.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.857 -0.611 . . . . 73.44 111.134 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -118.64 13.87 13.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 73.02 110.861 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 1.073 ' HG3' HH12 ' A' ' 94' ' ' ARG . 8.8 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.9 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.411 -0.276 . . . . 73.51 112.411 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -175.01 157.49 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 70.02 110.857 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.47 99.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 75.01 111.078 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.57 132.38 37.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.906 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -83.84 122.49 28.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.53 110.99 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.8 mm -124.6 121.64 61.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 73.3 111.116 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -95.92 141.86 28.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.061 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.52 166.04 29.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 55.3 111.077 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -124.67 148.91 47.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.47 . . . . 75.35 110.92 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.9 mt -54.57 121.21 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 73.14 111.103 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.61 5.44 81.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 61.42 112.541 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -102.26 139.6 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.561 0.696 . . . . 73.14 110.938 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 144.76 55.33 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.69 2.26 . . . . 75.41 112.351 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 tp -143.43 141.35 30.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.86 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.04 145.12 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 65.44 111.061 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.8 mt -131.83 147.12 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 74.32 110.899 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -114.56 154.17 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 64.51 110.858 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.3 t -105.43 100.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.13 110.831 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -57.03 123.38 14.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.899 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.42 -43.52 1.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.782 -0.723 . . . . 63.44 112.496 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.67 131.26 36.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.523 0.678 . . . . 75.43 111.12 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.16 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.661 2.241 . . . . 74.11 112.351 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.1 -53.25 21.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.44 110.812 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -112.37 131.39 22.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 75.54 110.91 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 110.5 2.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.243 . . . . 75.44 112.407 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -53.08 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 61.4 112.322 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -179.9 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 70.04 110.881 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -71.74 145.35 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.841 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.07 155.04 50.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 75.54 110.891 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.89 140.86 51.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 74.25 110.885 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -123.72 141.35 52.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 75.25 110.914 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -144.4 140.38 28.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 73.2 110.844 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 tp -137.55 136.33 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.221 -0.445 . . . . 72.01 110.936 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.917 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 9.0 t-20 -115.4 120.49 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 73.51 110.838 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.3 p -138.08 -179.82 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 73.14 111.131 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.32 -130.36 9.82 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 75.42 112.453 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.45 -38.77 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 72.02 110.912 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.5 t 179.42 -30.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.11 111.143 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -103.22 33.89 3.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 63.44 110.92 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.26 -7.47 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 54.31 111.128 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -61.92 129.8 42.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.927 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 158.42 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 75.32 110.88 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -94.84 122.21 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 74.35 111.152 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.99 144.69 25.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 72.33 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.86 163.66 37.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.718 0.771 . . . . 64.32 110.814 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.85 0.32 5.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.738 2.292 . . . . 73.24 112.321 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.56 86.85 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 74.1 110.824 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.55 -46.12 71.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 75.14 112.474 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 38.43 81.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 74.21 112.469 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.78 -164.33 37.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 64.01 112.485 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 106.91 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 73.24 112.31 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -66.13 -33.71 76.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 74.42 110.948 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.74 -25.1 66.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 71.12 110.881 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -48.01 21.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 75.43 110.914 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.427 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -130.38 -98.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 72.14 111.132 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.427 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -165.72 172.0 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 75.13 111.065 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 mmm-85 -126.79 158.52 36.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 74.45 110.874 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 t -109.14 130.82 61.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.127 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.84 158.3 86.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 53.45 110.851 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -22.24 32.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 72.31 112.413 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.43 1.61 40.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 72.22 110.898 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.91 29.3 13.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 61.12 112.538 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.3 m -112.74 -178.64 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 71.15 110.852 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.1 tp -128.27 128.98 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 75.42 110.906 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -125.64 136.6 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 72.52 110.82 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -119.1 127.63 26.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.574 0.702 . . . . 71.13 110.898 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.93 -32.81 17.15 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.69 2.26 . . . . 75.55 112.336 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.14 102.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 73.35 111.167 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.7 m -71.98 117.19 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 74.41 111.11 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.81 160.11 28.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 73.41 112.525 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.425 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -33.86 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 65.52 111.129 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -77.69 -21.56 51.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.125 -0.489 . . . . 73.21 110.956 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.08 -4.73 40.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.53 110.834 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 142.7 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.875 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.63 -148.32 15.14 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.727 -0.749 . . . . 72.42 112.444 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.946 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.1 mp -130.67 133.71 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 74.41 111.084 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 73.54 110.926 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.98 126.97 44.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.13 110.903 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.6 t -121.16 151.11 40.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.01 110.913 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -139.44 133.9 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.917 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.82 163.63 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 73.24 111.176 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.2 mmm -129.23 124.69 35.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.288 -0.415 . . . . 75.12 110.84 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.93 170.1 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 75.33 110.811 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -73.8 -18.32 60.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 75.2 110.825 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -72.89 -20.12 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 74.04 110.843 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.45 -20.04 21.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.7 -0.762 . . . . 73.22 112.508 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.7 147.86 26.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 74.24 110.916 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -103.67 145.27 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 71.15 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.04 132.51 43.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 74.0 111.073 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.507 ' CE ' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -103.02 139.97 37.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.872 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.1 m -146.7 120.74 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 73.34 110.891 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.903 ' OD1' ' HB3' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -129.42 123.29 31.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 64.51 110.909 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -130.14 120.6 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.818 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.87 136.13 33.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 74.05 110.905 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.1 t -120.54 137.51 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 70.14 111.132 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -128.42 146.61 50.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 75.31 110.937 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 12.4 m -107.11 -176.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 71.3 111.111 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -68.11 -77.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.912 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.31 144.55 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 72.45 110.962 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.15 160.44 45.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.6 0.714 . . . . 62.3 111.17 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 119.73 6.62 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.731 2.287 . . . . 73.52 112.364 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.89 61.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.34 112.489 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -80.37 160.12 68.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 65.24 110.84 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 127.21 14.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.681 2.254 . . . . 73.41 112.404 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 73.15 110.917 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.822 0.344 . . . . 71.12 110.824 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.946 ' CB ' HD13 ' A' ' 76' ' ' ILE . 5.4 pt-20 -173.63 113.08 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.899 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.917 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 61.85 -166.99 0.21 Allowed 'General case' 0 C--O 1.182 -2.461 0 CA-C-O 118.093 -0.956 . . . . 74.22 110.889 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.507 ' CX2' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -40.89 144.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 64.42 111.042 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -142.17 89.83 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 72.34 110.865 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 73.45 110.891 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.569 -0.212 . . . . 74.12 112.569 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -168.71 148.83 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 75.11 110.902 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.773 ' HB2' ' HA ' ' B' ' 5' ' ' ALA . . . -51.22 107.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 72.1 111.128 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 132.46 38.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 74.11 110.89 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.7 121.2 32.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.33 110.876 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.87 122.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 64.43 111.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -96.0 142.13 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 73.41 111.036 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.61 168.23 20.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.44 111.071 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 149.34 46.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 75.14 110.859 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.8 mt -65.06 120.49 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.147 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.77 -12.24 57.82 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.654 -0.784 . . . . 72.31 112.421 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -101.45 140.88 21.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.623 0.725 . . . . 73.14 110.946 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 145.01 55.9 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 71.02 112.348 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.3 tp -137.77 142.46 40.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 74.2 110.921 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.6 t -123.1 146.72 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 74.35 111.128 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.84 151.92 51.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.917 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -111.63 149.71 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.23 110.856 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.81 101.64 9.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 64.34 110.935 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -54.09 99.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.52 110.916 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.61 -47.34 0.65 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.628 -0.796 . . . . 75.11 112.473 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.31 103.58 12.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 74.14 111.128 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.4 Cg_endo -69.79 -161.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.71 2.273 . . . . 63.25 112.325 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.59 -8.08 8.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.853 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -44.5 167.65 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 72.45 110.942 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 172.2 13.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.674 2.25 . . . . 75.22 112.336 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 98.62 0.7 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.653 2.235 . . . . 72.24 112.272 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.25 -175.02 2.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 64.32 110.946 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 139.97 57.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.23 110.936 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -179.22 161.31 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 72.23 111.002 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.43 137.15 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 64.03 110.917 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -125.05 143.82 50.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.477 . . . . 74.05 110.972 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -148.66 136.26 20.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 75.14 110.86 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tp -138.62 138.07 37.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 75.31 110.922 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.62 126.83 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 70.22 110.865 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 p -137.57 179.81 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.2 111.15 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.12 -132.72 17.29 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.65 -37.26 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 75.24 110.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -179.38 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 64.3 111.085 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -101.5 33.67 2.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 74.33 110.885 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.62 -6.5 7.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 71.23 111.085 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -59.53 129.75 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.895 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.74 153.15 50.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 74.1 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.18 123.31 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 74.35 111.045 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.59 145.0 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.32 110.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.3 163.58 43.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.754 . . . . 72.23 110.822 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -0.33 6.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.614 2.209 . . . . 71.04 112.407 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -128.73 87.95 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.35 110.879 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.85 25.73 17.99 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.775 -0.726 . . . . 72.42 112.46 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 167.65 0.32 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 64.31 112.452 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.33 -152.13 20.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.7 -0.762 . . . . 72.35 112.423 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 98.89 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 2.218 . . . . 75.24 112.361 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.44 -14.94 59.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.906 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -62.97 -39.03 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.891 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.9 -42.74 9.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 73.02 110.928 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 m -101.62 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 75.31 111.128 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.8 164.22 30.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 75.33 111.132 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.83 157.33 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 73.43 110.895 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.55 127.02 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 72.3 111.115 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.69 157.91 88.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.662 0.744 . . . . 73.55 110.841 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -22.8 31.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.245 . . . . 73.22 112.295 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -83.52 4.02 29.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 63.3 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.96 13.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.802 -0.713 . . . . 60.52 112.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -114.63 178.6 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.407 . . . . 73.24 110.839 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.09 127.88 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 73.25 110.986 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -126.26 130.27 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.857 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mp -120.93 130.31 24.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.649 0.737 . . . . 73.41 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.64 18.27 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 72.51 112.39 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.66 103.4 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 63.03 111.146 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 m -73.01 121.91 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.469 . . . . 73.12 111.1 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.08 156.42 22.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.683 -0.77 . . . . 75.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -30.18 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.305 . . . . 74.33 111.129 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -73.97 -23.74 59.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 62.45 110.849 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.43 -5.0 45.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.202 -0.454 . . . . 73.41 110.923 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 141.06 58.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.869 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.39 -138.91 6.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 63.4 112.413 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.242 ' CG2' ' HB3' ' B' ' 3' ' ' PHE . 3.4 mp -129.13 127.64 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 70.43 111.152 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -104.5 131.1 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.42 110.859 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 1.233 ' HG3' ' CD1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -127.08 137.36 53.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 74.3 110.944 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.8 t -119.95 149.07 42.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 71.33 110.939 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.99 127.07 19.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.897 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.59 163.87 27.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.11 111.094 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ttm -128.75 125.29 37.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.885 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -86.93 173.21 9.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 71.13 110.887 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -70.32 -18.13 63.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.35 110.848 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.14 -19.93 61.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.33 110.882 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.75 -16.37 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 71.41 112.478 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 146.76 27.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.727 0.299 . . . . 75.14 110.881 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.26 143.4 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 55.04 110.9 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.92 130.38 51.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 74.41 111.193 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.826 ' CE ' ' C1 ' ' B' ' 4' ' ' MCL . 4.0 mtpt -105.49 144.85 31.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.917 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -144.44 125.82 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 74.34 110.824 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.06 123.59 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 74.3 110.943 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.83 118.84 24.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.93 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.623 ' NH2' ' O ' ' B' ' 4' ' ' MCL . 11.1 mmt85 -82.66 129.89 35.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 75.53 110.97 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.97 131.05 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 74.11 111.197 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -130.78 128.32 40.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 74.34 110.826 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 m -95.08 -177.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 72.41 111.095 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -66.95 -82.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.89 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -58.02 137.91 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.873 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 160.08 44.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 75.22 111.188 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 153.01 69.36 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 62.32 112.314 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 171.19 109.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 74.44 112.437 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 160.73 42.06 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 73.41 110.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -174.88 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.656 2.237 . . . . 73.24 112.353 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.11 110.879 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.842 0.354 . . . . 64.44 110.906 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.002 ' CB ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.75 -61.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.03 110.872 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.242 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -179.2 105.62 0.04 OUTLIER 'General case' 0 C--O 1.183 -2.442 0 CA-C-O 118.21 -0.9 . . . . 74.34 110.82 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.826 ' C1 ' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.773 ' HA ' ' HB2' ' A' ' 3' ' ' ALA . . . 73.87 -70.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.805 -0.634 . . . . 73.43 111.133 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 50.69 69.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 52.51 110.872 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 72.34 111.004 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.508 -0.237 . . . . 71.23 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -157.9 142.15 16.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 72.42 110.886 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' B' ' 6' ' ' ASP . . . -52.38 101.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 61.53 111.084 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -93.69 134.94 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.875 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -85.81 121.78 28.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 75.25 110.852 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mm -125.19 121.57 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.085 -0.507 . . . . 74.34 111.211 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -96.55 142.01 29.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.35 111.188 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.27 166.04 29.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 74.51 111.173 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -124.31 148.18 47.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 73.54 110.887 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mt -54.21 121.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 70.24 111.174 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.57 4.34 80.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.776 -0.726 . . . . 72.22 112.465 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -102.08 140.15 20.92 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 71.2 110.931 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 144.07 52.85 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.709 2.272 . . . . 62.22 112.305 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.5 tp -144.41 141.71 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.45 110.871 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.28 147.38 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.33 111.161 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -132.02 148.72 52.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 70.53 110.934 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -111.82 151.3 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 75.42 110.946 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.4 t -107.38 99.9 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 73.14 110.918 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -57.62 121.24 9.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 74.05 110.898 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.01 -39.4 1.91 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.786 -0.721 . . . . 63.24 112.515 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.53 43.67 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.544 0.688 . . . . 72.42 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.676 2.251 . . . . 74.32 112.397 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -49.36 -48.45 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.5 110.918 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.82 148.85 38.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.504 0.669 . . . . 75.45 110.915 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 111.08 2.71 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.65 2.234 . . . . 71.05 112.376 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -84.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.638 2.225 . . . . 72.02 112.387 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -103.14 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 71.54 110.893 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -64.71 136.62 57.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 72.25 110.832 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 pp -136.58 151.83 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 75.33 110.852 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.86 148.14 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.879 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.27 139.91 53.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 73.13 110.946 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -136.34 135.46 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 73.32 110.887 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.575 ' C ' ' HE2' ' B' ' 3' ' ' PHE . 0.5 OUTLIER -138.25 137.62 37.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.943 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 1.107 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 2.8 t-20 -113.52 126.76 55.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 52.43 110.882 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.5 p -136.71 179.78 6.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 73.12 111.181 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.17 -119.69 6.83 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.648 -0.787 . . . . 73.42 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -114.57 -38.96 3.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.53 110.946 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 174.51 -27.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 64.14 111.103 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.64 33.2 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.865 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.27 -7.55 8.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.12 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -60.72 129.77 43.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.33 110.878 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 153.71 51.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 65.15 110.907 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 m -88.81 122.35 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 74.15 111.109 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.2 145.22 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 72.23 110.846 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.54 165.72 25.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.716 0.769 . . . . 71.13 110.798 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.59 0.87 4.9 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.722 2.281 . . . . 73.23 112.421 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.34 97.13 5.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.32 110.878 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.43 -31.7 71.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 62.41 112.513 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.43 -159.0 21.09 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.722 . . . . 74.33 112.548 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.74 -67.91 1.63 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.737 -0.744 . . . . 72.3 112.479 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 95.76 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.648 2.232 . . . . 71.23 112.319 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -84.22 -32.76 24.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.917 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.82 -26.56 68.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.322 -0.399 . . . . 75.23 110.8 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 -44.52 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 72.45 110.856 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -128.17 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 75.11 111.111 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.412 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -166.93 171.42 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 64.32 111.106 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 159.58 33.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 64.02 110.888 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 t -113.33 130.58 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.44 111.158 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.4 mt -68.55 157.55 87.83 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 72.41 110.889 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.632 2.221 . . . . 74.31 112.353 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -83.42 -0.15 48.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 75.12 110.812 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.4 9.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 61.32 112.461 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 m -111.65 179.6 3.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 72.31 110.898 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.34 128.08 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.482 . . . . 75.2 110.947 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -126.68 132.83 51.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 71.44 110.844 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -114.78 128.35 25.98 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.518 0.675 . . . . 73.12 110.985 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.29 19.12 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.651 2.234 . . . . 72.01 112.411 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.8 102.36 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 74.04 111.151 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.09 118.97 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 74.02 111.167 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.37 158.64 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 72.54 112.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -30.37 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 73.25 111.182 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.5 -23.11 56.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.92 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.38 -5.09 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 73.33 110.783 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.03 140.9 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 74.33 110.885 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.66 -139.57 6.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.82 -0.705 . . . . 55.23 112.476 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.339 HD13 ' C ' ' B' ' 2' ' ' GLU . 1.7 mp -131.78 135.34 58.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 73.32 111.11 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -104.67 126.75 52.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.838 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.586 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 1.1 mmm180 -126.39 130.65 51.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.915 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.17 151.22 39.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 73.25 110.86 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -140.54 129.44 23.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 163.35 28.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.3 111.05 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.3 ttm -129.54 125.41 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 65.04 110.876 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.48 171.77 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -17.41 62.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.868 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.58 -25.13 61.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 71.11 110.894 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.94 -20.23 13.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 73.14 112.538 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.09 146.87 26.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.733 0.301 . . . . 73.31 110.868 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.04 145.39 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.834 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.77 131.89 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 74.51 111.212 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' CE ' ' O1 ' ' B' ' 4' ' ' MCL . 12.7 mtpt -105.05 142.66 34.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.917 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -145.93 126.95 14.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 72.24 110.913 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' CG ' ' HA ' ' B' ' 5' ' ' ALA . 0.8 OUTLIER -127.77 127.25 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 72.42 110.822 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -129.03 124.3 34.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 65.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.088 ' NH2' ' HG3' ' B' ' 2' ' ' GLU . 30.3 mmm-85 -82.61 135.53 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 73.23 110.933 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.5 t -123.98 132.5 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.01 111.232 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.0 128.4 40.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.908 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.3 m -93.71 -176.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 73.53 111.149 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -66.35 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 72.1 110.874 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -63.93 145.87 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 70.15 110.945 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.53 159.48 50.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.509 0.671 . . . . 74.55 111.202 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -170.63 0.4 Allowed 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.759 2.306 . . . . 73.11 112.284 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 145.35 50.47 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 64.22 112.492 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -163.7 160.39 17.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.571 0.701 . . . . 73.13 110.893 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -172.35 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.635 2.224 . . . . 72.42 112.305 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.908 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.776 0.322 . . . . 63.3 110.882 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.339 ' C ' HD13 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -127.99 61.94 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.872 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.107 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 61.21 -166.73 0.2 Allowed 'General case' 0 C--O 1.182 -2.476 0 CA-C-O 118.088 -0.958 . . . . 73.14 110.889 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.586 ' O2 ' ' HD3' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.666 ' HB3' HG23 ' A' ' 76' ' ' ILE . . . 42.99 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 72.04 111.087 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 3' ' ' ALA . 4.4 p-10 -112.11 28.96 8.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 72.12 110.83 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.789 ' HG3' HH22 ' A' ' 94' ' ' ARG . 53.5 mm-40 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 72.13 110.933 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.541 -0.224 . . . . 64.21 112.541 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t 63.7 108.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 73.04 110.938 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.54 62.93 2.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 71.54 111.118 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.0 132.9 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.53 110.9 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -86.98 120.97 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.86 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.64 122.74 63.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 73.44 111.076 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.08 142.17 28.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.15 111.075 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.66 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.45 111.11 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.45 148.23 44.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.84 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.77 122.16 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 73.41 111.141 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.13 4.22 78.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.673 -0.775 . . . . 51.54 112.519 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -101.18 140.4 21.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.712 0.768 . . . . 72.2 110.879 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.49 45.46 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.669 2.246 . . . . 73.11 112.375 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.8 tp -144.48 141.98 29.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 73.34 111.029 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.84 148.6 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 71.34 111.081 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.1 mt -130.56 147.94 52.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.896 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.95 31.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.868 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.4 100.79 8.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 72.4 110.875 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.64 122.05 7.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 74.41 110.916 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.426 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 125.55 -47.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.837 -0.697 . . . . 75.34 112.511 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.96 102.2 10.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 63.01 111.065 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.1 Cg_endo -69.75 -161.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.625 2.217 . . . . 52.33 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -11.15 5.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 74.31 110.916 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -46.53 168.65 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.662 0.744 . . . . 72.34 110.866 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 172.17 13.09 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.762 2.308 . . . . 51.12 112.334 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 97.89 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.752 2.302 . . . . 72.24 112.338 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 -175.4 3.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.861 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -64.6 133.09 51.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.92 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.3 pp -172.3 174.23 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.897 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.43 131.16 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.809 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -124.09 128.95 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 75.52 110.856 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -138.41 137.79 37.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.842 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 tp -137.75 136.94 37.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 64.22 110.899 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.92 126.39 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.32 110.85 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.5 p -138.58 -179.35 5.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 75.44 111.083 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.26 -126.64 10.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.817 -0.706 . . . . 71.2 112.489 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.1 mmm-85 -112.61 -38.62 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.04 110.808 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 t 178.93 -29.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 73.03 111.159 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -102.16 34.28 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.822 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.6 -7.01 8.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 70.23 111.14 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -63.07 131.23 47.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 75.14 110.927 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 154.27 47.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 75.13 110.904 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.29 117.01 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 75.53 111.073 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.29 149.71 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 64.4 110.927 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.96 162.14 45.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.751 0.786 . . . . 73.02 110.802 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -0.12 6.45 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.753 2.302 . . . . 73.13 112.316 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -120.11 72.26 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 75.13 110.877 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.5 23.74 32.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.762 . . . . 72.41 112.524 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.71 59.02 3.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.706 -0.759 . . . . 63.31 112.515 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.65 -127.32 2.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 74.15 112.432 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 91.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.313 . . . . 74.13 112.3 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 44.1 p-90 -83.43 -33.92 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 74.45 110.933 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -59.4 -25.9 64.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.315 -0.402 . . . . 75.21 110.881 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.52 -45.83 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.779 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -128.62 -98.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 63.0 111.143 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -166.19 175.21 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 74.22 111.111 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 161.42 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 73.14 110.876 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.9 t -107.65 128.26 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 70.14 111.121 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.4 mt -70.31 158.68 87.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 73.44 110.926 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -22.42 31.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.649 2.233 . . . . 73.54 112.301 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.93 1.6 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 74.43 110.897 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 30.86 11.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 72.3 112.519 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.3 m -112.65 178.26 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 72.33 110.833 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -131.62 130.62 42.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 75.41 110.89 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -124.57 128.2 48.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.32 110.913 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.69 131.65 24.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 74.25 110.918 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -32.7 18.39 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 42.22 112.396 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.62 101.75 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.086 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.3 m -72.98 118.83 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 72.43 111.118 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.51 163.78 35.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 71.54 112.451 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -29.97 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 73.42 111.049 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -74.41 -22.32 59.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 74.24 110.808 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -5.96 47.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 74.52 110.912 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.0 141.99 54.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.841 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.24 -142.28 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 44.1 112.537 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.047 HD13 ' HG3' ' B' ' 2' ' ' GLU . 3.1 mp -130.94 135.48 59.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.887 0.375 . . . . 71.42 111.195 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.6 127.39 48.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.766 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HD3' ' H13' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -125.49 131.62 52.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 74.55 110.886 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.63 150.09 43.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 75.2 110.866 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -148.9 125.65 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 75.21 110.851 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.57 27.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 73.23 111.103 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.22 125.23 27.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.31 110.872 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.59 170.79 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 70.43 110.854 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -72.69 -18.74 61.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 72.25 110.889 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -73.01 -20.03 61.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.31 110.883 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.54 -11.25 33.02 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.772 -0.728 . . . . 73.3 112.527 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -84.77 145.39 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 75.55 110.898 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.42 145.49 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 72.03 110.876 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.28 126.55 48.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 75.33 111.152 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.652 ' HB3' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -105.33 134.54 48.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.97 179.828 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.9 m -144.68 120.08 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 73.02 110.788 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.69 ' OD1' ' HB3' ' B' ' 4' ' ' MCL . 0.3 OUTLIER -130.11 121.02 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 73.51 110.876 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.57 127.16 36.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.96 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.409 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 11.4 mmm-85 -83.88 136.8 33.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 74.55 110.934 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.17 130.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 75.34 111.091 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.84 128.82 39.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 71.23 110.871 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.3 m -93.5 -177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 74.13 111.131 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -63.02 -69.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 75.51 110.884 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.98 138.92 39.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 73.43 110.963 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.29 159.54 49.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.716 0.769 . . . . 63.14 111.114 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.82 6.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 74.42 112.317 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.07 21.92 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 72.25 112.462 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? 57.76 70.12 1.38 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.58 0.705 . . . . 70.02 110.882 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 142.17 47.44 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.691 2.261 . . . . 55.33 112.379 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.11 110.838 -179.938 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 72.5 110.827 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.047 ' HG3' HD13 ' A' ' 76' ' ' ILE . 2.4 pm0 -135.76 -41.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 63.32 110.899 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.449 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -168.35 -168.9 0.99 Allowed 'General case' 0 C--O 1.181 -2.505 0 CA-C-O 118.181 -0.914 . . . . 74.45 110.875 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.69 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.409 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -43.65 154.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 62.55 111.105 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -148.49 17.77 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 73.14 110.895 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.895 ' H ' HH12 ' A' ' 94' ' ' ARG . 4.0 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 63.4 110.943 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.517 -0.233 . . . . 64.31 112.517 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -168.34 148.15 4.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.401 . . . . 61.01 110.806 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.57 100.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 73.03 111.147 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -92.64 134.64 34.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.43 110.92 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -83.21 120.79 26.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.914 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -125.4 120.89 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.174 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -96.53 142.38 28.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 75.24 111.126 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.1 164.98 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 73.43 111.12 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.36 148.94 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.821 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mt -56.13 121.36 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 71.1 111.156 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.6 3.31 86.44 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.668 -0.777 . . . . 53.05 112.536 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -101.17 140.89 21.66 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.564 0.697 . . . . 63.52 110.972 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 143.83 51.94 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.599 2.199 . . . . 72.02 112.411 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.3 tp -144.35 142.88 30.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 74.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.53 146.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 73.05 111.178 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -131.42 147.24 52.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 65.44 110.924 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -113.17 151.08 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 72.31 110.829 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.8 t -108.25 100.48 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 64.21 110.844 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.73 126.97 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 74.11 110.887 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.48 -38.84 2.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 65.25 112.518 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.41 31.1 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.536 0.684 . . . . 72.51 111.15 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -164.23 0.12 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 64.23 112.339 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.1 -50.96 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 75.45 110.88 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -111.18 152.55 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 65.22 110.909 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.67 110.3 2.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.252 . . . . 63.43 112.375 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 -84.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 71.24 112.318 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -100.6 -177.35 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 72.03 110.815 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -63.48 133.89 54.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.895 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.94 144.54 45.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 72.53 110.95 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -122.07 133.01 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.14 110.887 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -121.18 144.76 48.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 74.11 110.887 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -136.49 138.26 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.885 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -134.57 141.44 46.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 73.13 110.886 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.413 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 8.5 t-20 -111.95 125.33 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 70.14 110.886 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.8 p -138.58 -179.24 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 71.11 111.124 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.54 -129.57 9.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 65.4 112.497 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -112.48 -37.23 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.747 0.308 . . . . 65.21 110.83 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t 176.81 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 75.31 111.192 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.52 33.64 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 74.02 110.945 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.54 -6.75 9.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 73.22 111.146 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -59.84 129.16 40.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.32 110.91 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.4 161.11 37.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 61.3 110.85 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.8 t -99.5 122.87 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.175 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.45 143.33 27.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.902 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.95 163.73 41.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 52.11 110.815 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 1.08 4.74 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.753 2.302 . . . . 75.2 112.285 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -138.48 72.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.42 110.888 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.8 -47.01 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 53.21 112.537 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.02 -151.91 1.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 74.31 112.466 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.2 -159.91 1.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.839 -0.696 . . . . 70.24 112.433 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 122.64 9.33 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.645 2.23 . . . . 70.11 112.329 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -83.16 -34.65 25.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.43 110.947 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.88 -26.0 68.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 64.34 110.814 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -46.5 47.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 62.51 110.877 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.45 -98.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 75.1 111.098 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -166.17 172.54 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.41 111.132 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.93 159.52 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 74.21 110.879 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.9 t -108.95 130.34 62.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 74.24 111.181 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.5 mt -69.23 157.15 90.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 75.44 110.933 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.04 32.77 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 74.32 112.273 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -82.88 0.39 44.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 64.02 110.9 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.54 28.2 13.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 72.02 112.418 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -112.0 -179.18 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 75.34 110.919 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 tp -128.53 127.4 42.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 64.34 110.9 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -126.9 132.06 50.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.819 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mp -115.33 130.83 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 73.41 110.921 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.79 -32.83 17.68 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.679 2.253 . . . . 74.12 112.36 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.73 101.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 74.45 111.157 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.2 m -76.58 118.54 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 71.52 111.229 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.99 165.39 34.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.731 . . . . 51.22 112.414 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -31.12 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 71.5 111.136 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.19 -22.59 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 64.34 110.914 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -5.35 44.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.12 110.88 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.7 142.21 50.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.876 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.16 -152.34 23.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.801 -0.714 . . . . 61.44 112.521 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 mm -124.81 135.22 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.25 111.097 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 21.9 t80 -103.38 131.66 50.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 71.53 110.836 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HG3' ' CD1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -124.83 138.4 54.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.837 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.86 42.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.02 110.857 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.36 125.34 19.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.44 110.848 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.38 163.91 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 71.33 111.091 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttm -129.69 125.66 36.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.855 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.86 172.61 10.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 73.43 110.912 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -70.34 -18.04 63.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 72.32 110.914 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 75.03 110.881 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -18.78 32.93 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.733 . . . . 73.03 112.481 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 147.84 26.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.313 . . . . 74.24 110.906 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -103.74 144.8 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.43 110.878 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -101.84 131.86 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 74.53 111.159 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.258 ' CE ' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -99.17 145.43 27.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 75.34 110.918 179.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.91 ' N ' ' CX2' ' B' ' 4' ' ' MCL . 1.8 t -143.79 127.96 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 55.5 110.826 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' B' ' 4' ' ' MCL . 28.7 t-20 -128.31 129.26 46.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 61.54 110.853 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.82 126.03 33.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 64.14 110.919 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.517 ' CZ ' ' HB3' ' B' ' 5' ' ' ALA . 0.6 OUTLIER -84.51 131.42 34.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 74.35 110.858 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.4 t -120.7 130.07 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 73.24 111.115 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 128.64 38.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 75.53 110.863 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -94.26 -177.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 72.21 111.076 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -62.12 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 63.42 110.927 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.66 143.43 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 63.33 110.956 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.41 159.75 48.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 75.54 111.12 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 161.6 45.3 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 72.15 112.319 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.92 -109.54 2.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 73.02 112.502 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -112.36 157.31 40.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 74.54 110.856 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 169.91 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.595 2.196 . . . . 73.33 112.376 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.959 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.791 0.329 . . . . 64.22 110.823 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.82 160.28 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 75.21 110.902 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.612 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -63.33 -164.65 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.472 0 CA-C-O 118.171 -0.919 . . . . 73.43 110.87 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.258 ' CX2' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.517 ' HB3' ' CZ ' ' A' ' 94' ' ' ARG . . . 39.46 -150.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.857 -0.611 . . . . 65.12 111.072 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 1.25 ' H ' ' NH2' ' A' ' 94' ' ' ARG . 16.2 t0 71.75 38.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 74.22 110.893 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.468 . . . . 61.13 110.898 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.54 -0.224 . . . . 74.44 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 63.14 105.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 61.43 110.817 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.87 62.95 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 70.43 111.089 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -93.16 132.72 37.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.44 110.928 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 1.223 ' ND2' ' OE2' ' B' ' 7' ' ' GLU . 2.0 m-20 -89.36 122.78 32.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 74.32 110.849 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.3 mm -124.2 126.27 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.23 111.163 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -94.09 142.37 27.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 75.25 111.233 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.49 168.98 20.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 72.43 111.088 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.63 148.9 40.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 73.41 110.916 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.8 mt -54.17 121.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 73.52 111.111 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.06 12.37 65.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 63.23 112.502 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -102.7 138.31 19.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 74.02 110.908 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 143.14 50.55 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.697 2.265 . . . . 75.0 112.401 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.7 tp -145.68 143.05 29.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.891 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.1 144.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.41 111.106 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.1 mt -131.39 147.55 52.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.854 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -113.77 153.33 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.855 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 t -104.28 100.88 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 62.14 110.832 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -56.01 123.52 14.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 73.33 110.852 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.73 -39.85 2.02 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.663 -0.78 . . . . 71.03 112.504 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.34 129.44 43.23 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.517 0.675 . . . . 73.32 111.152 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -163.91 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.787 2.325 . . . . 63.41 112.313 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -49.01 -48.2 43.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 65.43 110.909 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.98 156.1 37.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.586 0.708 . . . . 75.13 110.928 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 109.77 2.41 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 65.15 112.318 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.89 -87.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.659 2.239 . . . . 74.14 112.308 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -103.96 -178.06 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.836 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm-85 -64.72 135.03 55.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 74.53 110.878 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 pp -135.61 156.06 49.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 75.25 110.932 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -121.55 147.67 45.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 64.14 110.958 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -130.49 130.0 43.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 73.44 110.883 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -136.52 136.91 39.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 71.34 110.844 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.35 138.54 38.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.23 110.926 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -111.83 126.34 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 74.22 110.952 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.1 p -137.99 179.56 6.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 74.12 111.186 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.54 -129.93 14.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.791 -0.719 . . . . 71.41 112.449 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -112.65 -37.68 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 73.14 110.878 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 t -179.12 -31.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.51 111.129 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.57 33.94 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 74.34 110.945 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.93 -6.42 8.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 71.42 111.165 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -59.36 131.72 51.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 64.53 110.985 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.52 153.53 47.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 73.03 110.866 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.68 120.28 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 63.53 111.148 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 mt -95.83 146.75 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 75.02 110.899 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 p -123.71 157.86 61.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.678 0.751 . . . . 74.23 110.847 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 0.28 5.89 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.704 2.27 . . . . 65.44 112.301 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 82.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.945 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.71 95.55 0.94 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 74.34 112.493 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.71 4.28 74.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.754 . . . . 73.32 112.47 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.12 -158.77 15.42 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 74.45 112.597 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 114.67 3.79 Favored 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 122.677 2.252 . . . . 75.1 112.348 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -60.9 -34.24 74.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 74.31 110.915 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.05 -26.57 66.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 75.03 110.886 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -46.98 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.34 110.855 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.02 -98.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 75.43 111.053 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.414 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -165.41 176.31 8.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 71.52 111.052 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -114.36 160.9 18.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 65.22 110.831 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.44 129.68 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 74.03 111.15 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.0 mt -69.47 157.87 88.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.582 0.706 . . . . 75.31 110.883 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -23.0 31.01 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.677 2.251 . . . . 62.0 112.284 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -82.96 1.14 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.899 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.24 29.84 11.86 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.772 -0.728 . . . . 72.31 112.484 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -112.62 -179.43 3.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.399 . . . . 74.31 110.846 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.1 tp -129.14 130.84 46.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 73.13 110.898 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -123.87 130.48 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.909 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.86 124.15 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 73.35 110.929 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -32.8 18.05 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 62.02 112.314 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.48 101.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.42 . . . . 62.54 111.151 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.9 m -72.84 112.2 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 74.43 111.064 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.53 164.69 36.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.745 -0.74 . . . . 73.32 112.475 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.436 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.81 -33.46 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 72.4 111.086 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -77.6 -22.04 51.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 63.34 110.84 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -5.07 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 74.52 110.916 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 142.16 52.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 70.51 110.827 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.48 -148.12 15.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 54.24 112.537 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.283 HG13 ' OE1' ' B' ' 2' ' ' GLU . 1.2 mm -129.71 135.59 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 65.24 111.154 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -104.43 123.97 48.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.877 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 126.95 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 73.53 110.858 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.6 t -121.59 153.93 37.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 75.51 110.923 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -141.0 140.08 34.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 64.13 110.928 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 162.41 30.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 74.34 111.152 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 75.9 mmm -130.14 125.24 34.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 71.31 110.888 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -88.44 170.8 10.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 64.42 110.853 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -72.94 -22.48 60.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 74.42 110.888 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.54 -20.43 60.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.34 110.915 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.8 -2.86 31.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 75.11 112.515 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.56 146.46 27.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 74.44 110.938 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.32 142.42 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 75.21 110.955 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.2 129.67 51.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.165 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.13 ' HB3' ' CX2' ' B' ' 4' ' ' MCL . 0.4 OUTLIER -101.82 141.46 34.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 74.05 110.922 179.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 58.7 m -145.92 120.13 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.34 110.844 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 1.181 ' OD1' ' HB3' ' B' ' 4' ' ' MCL . 0.6 OUTLIER -131.72 121.92 25.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.907 -179.997 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 91' ' ' SER . 6.9 m-85 -131.96 120.61 22.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 75.35 110.906 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.541 ' CZ ' ' CB ' ' B' ' 5' ' ' ALA . 0.9 OUTLIER -85.14 132.6 34.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 74.22 110.881 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.6 t -120.66 136.03 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 74.41 111.199 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.75 151.22 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 63.24 110.89 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 13.5 m -112.06 -175.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 73.21 111.158 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -67.29 -76.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.896 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.02 137.31 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 72.42 110.909 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.01 159.87 47.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.665 0.745 . . . . 72.5 111.135 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 129.9 18.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 73.31 112.325 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.97 -82.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.688 -0.767 . . . . 71.4 112.488 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -134.79 68.42 71.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 74.12 110.915 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 115.1 3.95 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.709 2.272 . . . . 73.55 112.342 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.421 . . . . 52.21 110.929 179.975 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.838 0.351 . . . . 73.43 110.844 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.283 ' OE1' HG13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -117.72 -14.22 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 73.51 110.864 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.514 ' CD2' ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 175.94 -151.95 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.452 0 CA-C-O 118.219 -0.896 . . . . 75.2 110.875 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.181 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.541 ' CB ' ' CZ ' ' A' ' 94' ' ' ARG . . . -52.98 157.38 1.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 72.41 111.086 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -159.98 89.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 75.43 110.876 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 1.223 ' OE2' ' ND2' ' A' ' 5' ' ' ASN . 1.4 mp0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 71.54 110.94 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.495 -0.242 . . . . 72.13 112.495 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -152.89 139.92 19.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 51.5 110.892 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.71 100.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.02 111.04 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -93.65 135.18 35.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 75.12 110.98 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -90.42 122.91 33.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.5 110.875 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -125.39 124.56 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 74.25 111.164 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -89.61 144.17 26.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 73.24 111.147 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -140.54 165.68 26.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 71.34 111.038 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.43 110.887 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.5 mm -61.74 120.47 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 75.12 111.173 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.34 10.84 85.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 75.24 112.472 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -101.44 140.69 21.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.609 0.718 . . . . 74.34 110.841 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 143.48 51.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.236 . . . . 71.34 112.37 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 tp -144.58 142.39 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.01 110.897 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.23 148.19 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.3 111.239 179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.6 mt -131.54 148.05 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 64.41 110.824 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -113.33 152.53 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 74.42 110.877 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.0 t -107.09 102.24 11.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.11 110.868 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -58.19 123.25 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.915 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.57 -37.97 2.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.49 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.66 128.63 45.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.553 0.692 . . . . 73.54 111.109 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -164.28 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.657 2.238 . . . . 72.31 112.345 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -49.31 -48.92 45.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 74.33 110.9 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.04 154.74 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 72.21 110.846 179.903 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 109.17 2.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.678 2.252 . . . . 51.42 112.333 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 54.8 Cg_endo -69.72 -87.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.683 2.255 . . . . 70.25 112.371 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -104.13 -177.26 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 73.01 110.846 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -64.09 137.81 58.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 74.3 110.922 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 pp -135.94 157.93 45.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 74.41 110.899 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -123.08 147.17 47.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 74.41 110.841 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.04 110.988 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -151.84 137.13 17.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 73.53 110.835 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.401 HD22 ' HE3' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -140.9 138.29 33.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 75.23 110.954 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 1.192 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 2.0 t-20 -113.83 127.35 55.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.9 p -140.52 -179.34 5.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 71.12 111.123 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.9 -120.45 5.31 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 72.15 112.528 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -114.68 -39.72 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 74.31 110.863 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 173.66 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.33 111.139 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.37 33.46 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.875 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.42 -7.48 9.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.119 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -63.09 130.43 44.61 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.151 -0.477 . . . . 71.51 110.931 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -135.67 158.91 43.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 73.54 110.885 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.84 121.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 70.33 111.114 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.7 145.27 25.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.871 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.13 164.23 34.91 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 70.51 110.833 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 0.41 5.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.721 2.28 . . . . 71.05 112.35 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.46 85.0 2.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 73.53 110.884 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.85 -39.09 60.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.673 -0.775 . . . . 73.52 112.495 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.42 -161.01 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.636 -0.792 . . . . 71.35 112.484 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.43 -160.64 1.31 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.703 -0.761 . . . . 63.24 112.478 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 127.07 14.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 74.25 112.289 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -83.18 -35.05 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 65.11 110.868 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.9 -25.09 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 72.12 110.809 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.24 -47.29 65.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 73.4 110.848 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG2' ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.8 -97.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 73.12 111.168 179.88 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.417 ' H ' ' CG2' ' A' ' 55' ' ' VAL . . . -163.4 170.63 17.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 71.13 111.071 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -127.14 159.84 33.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 74.01 110.842 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 t -108.71 130.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.171 -0.468 . . . . 75.15 111.149 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.8 mt -68.41 157.93 86.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 71.21 110.936 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -23.04 30.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.754 2.303 . . . . 75.4 112.337 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -83.24 0.68 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 70.14 110.898 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.4 29.38 11.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 73.34 112.484 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -111.43 -178.95 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 54.42 110.881 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -128.76 130.06 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 75.23 110.831 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -124.05 130.72 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 70.41 110.861 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.15 131.0 24.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.594 0.712 . . . . 72.22 110.9 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -38.29 8.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 73.1 112.377 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.19 103.8 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 74.54 111.084 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.97 115.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 70.12 111.135 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.58 165.76 29.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 75.12 112.479 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.408 HG13 ' HB3' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -54.02 -30.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 75.15 111.131 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.09 -22.57 55.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 64.11 110.88 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.65 -1.55 42.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 64.24 110.779 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.21 141.12 58.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.932 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.91 -145.17 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 74.33 112.456 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 1.331 HD13 ' CG ' ' B' ' 2' ' ' GLU . 3.7 mp -130.58 134.72 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 74.22 111.045 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -103.44 135.29 45.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 75.23 110.832 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -128.01 130.71 48.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 71.33 110.874 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 147.93 43.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 64.3 110.875 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -146.09 126.96 14.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.917 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.26 162.67 30.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 72.31 111.084 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 33.8 tpp -130.15 125.76 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.22 110.938 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.52 171.63 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 71.02 110.879 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -18.56 62.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 73.1 110.901 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -73.35 -19.78 60.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 72.12 110.865 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.16 37.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.58 -0.819 . . . . 72.4 112.369 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -84.78 145.73 27.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.689 0.281 . . . . 73.42 110.916 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -105.58 142.22 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 70.23 110.877 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.05 129.7 51.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 70.54 111.054 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -105.72 144.13 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.983 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -145.65 120.63 10.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 75.23 110.877 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.738 ' CB ' ' CX2' ' B' ' 4' ' ' MCL . 25.1 t-20 -121.28 120.76 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 75.53 110.888 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -127.72 126.6 42.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 71.55 110.94 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.152 ' NE ' ' CB ' ' B' ' 5' ' ' ALA . 11.5 mmm-85 -91.11 135.65 33.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.892 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.79 130.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.22 111.211 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.19 127.65 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 71.14 110.949 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.2 m -91.1 -176.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 73.41 111.148 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -75.84 -76.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 73.41 110.93 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' A' ' 71' ' ' ILE . 10.5 tp-100 -58.68 148.03 30.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 75.12 110.917 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.29 159.37 50.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.565 0.698 . . . . 74.25 111.093 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 162.28 42.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.568 2.178 . . . . 70.32 112.343 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.01 56.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 74.02 112.458 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.78 73.12 0.78 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.683 0.754 . . . . 64.24 110.869 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -178.68 2.43 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.787 2.325 . . . . 71.54 112.355 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 73.12 110.917 179.943 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.725 0.298 . . . . 73.42 110.937 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 1.331 ' CG ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -126.97 -38.05 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.2 110.883 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.192 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 178.92 -161.02 0.03 OUTLIER 'General case' 0 C--O 1.183 -2.442 0 CA-C-O 118.216 -0.897 . . . . 75.43 110.906 -179.794 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 0.738 ' CX2' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.152 ' CB ' ' NE ' ' A' ' 94' ' ' ARG . . . -41.57 120.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.819 -0.628 . . . . 74.22 111.132 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.48 80.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.45 110.861 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.855 ' CG ' HH12 ' A' ' 94' ' ' ARG . 55.2 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 64.2 110.862 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.555 -0.218 . . . . 71.21 112.555 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.91 158.08 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 65.44 110.885 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.63 96.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 72.42 111.048 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.61 133.25 37.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.917 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -84.65 120.76 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 70.23 110.91 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mm -125.88 121.98 60.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.119 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -94.19 139.83 30.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 74.44 111.143 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.76 167.0 26.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 74.41 111.088 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.37 148.12 44.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 75.42 110.876 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mt -52.51 121.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 74.53 111.222 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.76 7.72 70.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 74.44 112.476 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -101.76 139.43 20.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 62.31 110.822 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 143.05 49.4 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.682 2.255 . . . . 70.32 112.286 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.7 tp -145.58 141.84 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 75.1 110.95 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.6 t -123.16 146.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.45 111.13 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.4 mt -130.87 146.62 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.921 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.47 152.13 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.31 110.87 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.1 t -107.34 100.73 10.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 65.54 110.869 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -58.96 122.04 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 73.12 110.89 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.53 -38.42 2.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 71.33 112.466 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.35 44.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.519 0.676 . . . . 53.22 111.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.64 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.752 2.301 . . . . 74.24 112.374 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -49.65 -49.89 45.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 74.33 110.913 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 153.6 41.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 74.53 110.91 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 73.34 112.346 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -85.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.757 2.304 . . . . 73.05 112.343 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -100.26 -176.55 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.55 110.917 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.02 137.22 58.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.877 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.19 155.27 50.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.929 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -120.87 148.52 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.03 110.952 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -127.73 145.05 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.948 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -145.08 144.25 30.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.1 110.889 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.92 134.98 41.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 74.34 110.908 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -117.92 120.83 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 71.24 110.867 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -141.44 179.52 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 54.55 111.096 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.81 -133.26 20.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 73.4 112.568 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.7 mmm-85 -112.77 -36.78 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 74.11 110.914 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 t -179.16 -27.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 75.12 111.114 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -100.72 32.59 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 75.14 110.859 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.17 -6.68 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.3 111.089 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 t90 -73.92 128.14 34.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.921 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.63 159.07 43.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 75.24 110.958 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.2 t -87.2 121.54 38.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 74.42 111.094 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.45 146.76 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.917 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.69 162.01 43.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 74.13 110.875 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.61 -0.14 6.37 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.265 . . . . 73.44 112.35 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -140.35 86.53 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 64.14 110.862 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLY . . . -66.41 -45.84 82.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 75.41 112.544 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . 35.76 45.06 0.74 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.671 -0.776 . . . . 63.52 112.539 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -141.43 -165.17 10.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 65.14 112.565 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.87 105.48 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.667 2.244 . . . . 73.0 112.355 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -70.0 -34.73 73.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.32 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.61 -26.8 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 74.52 110.947 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -90.23 -42.64 10.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 72.25 110.832 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 m -124.63 -125.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 75.14 111.141 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.38 172.66 14.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.107 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -122.79 159.74 27.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.815 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.92 129.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 72.23 111.114 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.1 156.13 92.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.521 0.676 . . . . 73.02 110.951 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -22.2 32.39 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.672 2.248 . . . . 71.44 112.309 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -83.32 0.6 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 73.42 110.892 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.51 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.773 -0.727 . . . . 75.14 112.575 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.1 m -113.7 178.88 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 73.55 110.863 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 tp -128.81 127.52 42.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.34 110.905 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -126.17 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 71.42 110.922 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mp -117.83 128.18 26.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.532 0.682 . . . . 70.15 110.942 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.15 17.19 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.661 2.241 . . . . 74.01 112.33 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -167.73 101.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 75.53 111.118 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 m -73.06 113.28 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.45 111.139 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.65 36.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.694 -0.765 . . . . 75.13 112.501 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -30.02 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.777 0.323 . . . . 74.53 111.086 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.14 -23.77 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.918 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.61 -5.18 57.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.9 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.76 141.4 58.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 73.42 110.791 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.66 -138.93 6.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 73.23 112.481 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.966 HD12 ' HG3' ' B' ' 2' ' ' GLU . 3.0 mp -130.1 135.55 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 75.42 111.125 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -102.61 134.8 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.02 110.906 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 1.304 ' NH2' ' NZ ' ' B' ' 4' ' ' MCL . 1.6 mmt180 -128.02 127.66 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 74.23 110.915 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.6 t -121.56 149.48 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 52.03 110.9 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.46 132.55 23.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 75.45 110.878 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 162.26 30.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 72.52 111.082 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.2 ttm -130.36 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 73.55 110.857 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.42 170.96 11.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 74.53 110.857 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -17.81 62.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.91 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -73.37 -25.59 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 74.35 110.841 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.01 19.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 51.43 112.496 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -84.59 146.78 27.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 74.03 110.94 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.24 142.34 35.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.041 0.448 . . . . 74.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.54 131.84 49.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 75.43 111.145 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.088 ' HE3' ' O1 ' ' B' ' 4' ' ' MCL . 7.6 mtpp -104.97 140.86 37.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 74.34 110.984 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.57 127.23 14.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.876 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.74 129.4 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 54.45 110.856 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -127.92 118.01 22.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 75.11 110.884 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 1.571 ' CZ ' ' CB ' ' B' ' 5' ' ' ALA . 11.5 mmm-85 -85.57 130.33 34.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 54.14 110.891 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.4 t -122.54 132.25 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 74.32 111.105 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -131.17 128.26 39.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 74.43 110.976 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 m -93.86 -176.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 75.53 111.126 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.03 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.919 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.86 145.71 54.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.924 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.44 159.58 49.65 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.691 0.758 . . . . 75.41 111.105 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.67 -37.09 9.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 70.34 112.358 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.62 34.93 56.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.716 -0.754 . . . . 73.24 112.581 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.2 tttt 53.04 73.9 0.86 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 73.24 110.937 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 163.22 39.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.737 2.291 . . . . 75.54 112.327 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.879 179.973 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.715 0.293 . . . . 72.24 110.859 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.966 ' HG3' HD12 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -123.17 -41.4 2.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 73.34 110.894 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.113 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -167.77 -166.59 0.76 Allowed 'General case' 0 C--O 1.183 -2.395 0 CA-C-O 118.081 -0.961 . . . . 74.21 110.915 -179.932 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' MCL . . . . . 1.304 ' NZ ' ' NH2' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 1.571 ' CB ' ' CZ ' ' A' ' 94' ' ' ARG . . . -38.78 116.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.789 -0.641 . . . . 61.33 111.082 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -141.72 65.86 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.853 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.899 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.784 0.326 . . . . 74.409999999999997 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.05 132.63 36.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.842 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.5 p-10 -90.05 121.22 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.230000000000004 110.849 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.65 122.42 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 111.178 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -95.07 141.62 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 72.540000000000006 111.134 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.02 167.19 25.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 62.020000000000003 111.015 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.64 148.45 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.239999999999995 110.843 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.424 HD11 HG13 ' A' ' 71' ' ' ILE . 16.0 mt -52.45 120.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 61.439999999999998 111.132 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.82 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 89.28 8.92 67.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 73.230000000000004 112.526 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.791 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.1 mm-40 -101.71 138.32 19.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.652 0.739 . . . . 73.430000000000007 110.889 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 143.14 49.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.677 2.251 . . . . 72.319999999999993 112.258 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 66' ' ' LEU . 12.4 tp -145.92 141.36 27.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 71.420000000000002 110.877 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.443 HG22 ' HD1' ' A' ' 65' ' ' PHE . 45.8 t -127.9 139.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 111.197 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.589 HD12 ' CD2' ' A' ' 77' ' ' PHE . 45.2 mt -132.19 149.02 52.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.445 . . . . 60.5 110.878 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -112.72 153.24 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 64.140000000000001 110.918 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 t -105.83 100.71 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 62.399999999999999 110.895 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -54.19 128.91 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.855 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.439 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.01 -40.84 1.8 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.756 . . . . 64.430000000000007 112.499 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.25 129.74 42.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.539 0.685 . . . . 72.049999999999997 111.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -164.22 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.555 2.17 . . . . 74.540000000000006 112.354 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -48.46 -49.12 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 55.340000000000003 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.897 0.379 . . . . 73.540000000000006 110.835 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.682 HD13 ' CE2' ' A' ' 31' ' ' TRP . 1.5 pp -136.2 149.4 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 60.030000000000001 110.877 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -121.28 127.03 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 75.430000000000007 110.862 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.682 ' CE2' HD13 ' A' ' 29' ' ' LEU . 32.0 m0 -118.08 144.72 45.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 62.310000000000002 110.944 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.667 ' HE2' HG22 ' A' ' 43' ' ' VAL . 5.3 ttmt -136.77 139.27 41.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 73.530000000000001 110.902 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.743 HD22 ' HE3' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -137.42 138.9 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 75.0 110.914 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -115.21 119.31 35.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.846 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.806 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.7 p -136.28 179.49 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 73.540000000000006 111.183 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.4 -132.11 14.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.799 -0.715 . . . . 72.129999999999995 112.499 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -112.68 -37.76 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 73.200000000000003 110.828 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.597 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.3 t -179.47 -29.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 74.209999999999994 111.141 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.597 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.5 mt-10 -102.12 34.26 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.530000000000001 110.84 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.53 -6.24 8.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 73.409999999999997 111.126 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -59.31 128.98 39.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.5 110.861 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.743 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -136.24 158.88 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 61.030000000000001 110.908 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.667 HG22 ' HE2' ' A' ' 32' ' ' LYS . 19.0 t -101.65 123.76 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 111.129 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.1 mt -87.25 144.02 27.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.2 -0.454 . . . . 72.200000000000003 110.941 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.826 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 75.519999999999996 110.854 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.741 0.305 . . . . 75.219999999999999 111.207 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -119.11 160.44 22.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.040000000000006 110.826 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.826 HG21 ' O ' ' A' ' 45' ' ' SER . 43.0 t -108.01 128.73 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 111.108 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.0 mt -68.51 156.46 90.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.686 0.755 . . . . 64.519999999999996 110.893 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -22.97 31.41 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.74 2.293 . . . . 75.099999999999994 112.301 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -82.98 0.05 46.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.903 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.61 13.35 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 52.340000000000003 112.431 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.581 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.4 m -109.68 179.0 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 61.240000000000002 110.868 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 65' ' ' PHE . 9.8 tp -128.36 128.33 44.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 73.310000000000002 110.961 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' N ' HD12 ' A' ' 64' ' ' LEU . 7.1 t80 -125.95 129.73 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 64.299999999999997 110.843 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.707 HD22 HG12 ' A' ' 69' ' ' VAL . 2.3 mp -117.19 130.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 63.439999999999998 110.84 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -34.8 13.91 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 72.420000000000002 112.339 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.82 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.21 100.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 111.111 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.1 m -73.45 114.68 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 71.549999999999997 111.143 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.29 166.94 42.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.824 -0.703 . . . . 55.109999999999999 112.433 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.797 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.93 -31.05 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.308 . . . . 73.049999999999997 111.116 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -76.25 -21.96 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.409999999999997 110.93 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -5.44 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 74.439999999999998 110.909 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.23 140.47 55.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 74.299999999999997 110.877 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.629 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 164.7 -147.46 12.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.654 -0.784 . . . . 71.549999999999997 112.449 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.57 135.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.952 0.406 . . . . 70.049999999999997 111.041 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.589 ' CD2' HD12 ' A' ' 16' ' ' LEU . 8.6 m-85 -100.05 124.92 45.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 71.25 110.852 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 127.25 40.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.884 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 149.45 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 61.100000000000001 110.945 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -142.62 126.24 16.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.48 31.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 111.093 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.9 tpp -130.27 125.86 35.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 63.32 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -86.49 170.79 11.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 74.310000000000002 110.859 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -72.7 -17.58 61.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 71.25 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -72.1 -21.04 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.928 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.05 -21.46 17.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.708 . . . . 24.050000000000001 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 145.88 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.279 . . . . 72.019999999999996 110.903 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.25 145.11 32.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 74.409999999999997 110.903 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.439 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.07 127.86 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.049999999999997 111.102 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 145.5 30.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 62.340000000000003 110.936 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.7 m -144.33 121.23 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 110.916 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -126.63 119.3 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 71.420000000000002 110.913 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -132.03 118.11 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.049999999999997 110.874 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -87.49 133.56 33.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 44.329999999999998 110.851 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.28 138.36 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.219999999999999 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 127.96 39.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 74.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.797 HG21 ' HA ' ' A' ' 71' ' ' ILE . 30.6 m -87.42 -177.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 75.519999999999996 111.102 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -60.64 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 62.509999999999998 110.953 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -72.1 143.53 49.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 63.030000000000001 110.947 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.486 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.28 159.52 49.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.7 0.762 . . . . 54.310000000000002 111.084 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.681 2.254 . . . . 64.409999999999997 112.415 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.751 0.31 . . . . 53.109999999999999 111.117 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.417 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -92.91 138.19 31.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 110.915 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.98 120.88 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.310000000000002 110.887 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 4' ' ' GLN . 4.7 mp -126.13 127.47 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 111.144 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -95.31 141.78 28.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 74.239999999999995 111.215 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.496 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -145.01 165.41 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 34.100000000000001 111.069 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.19 149.5 42.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.019999999999996 110.916 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 15.3 mt -57.41 121.04 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 43.43 111.069 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.48 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.8 8.13 73.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.777 -0.725 . . . . 70.450000000000003 112.586 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.796 ' O ' HG22 ' A' ' 69' ' ' VAL . 35.1 mm-40 -102.7 138.69 19.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.702 . . . . 72.239999999999995 110.911 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 143.95 51.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 72.120000000000005 112.269 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.0 tp -144.96 141.08 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 65' ' ' PHE . 48.9 t -125.44 145.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 51.340000000000003 111.146 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.2 mt -131.25 148.09 52.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 62.020000000000003 110.941 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 152.75 29.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 54.340000000000003 110.961 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.0 t -106.18 100.6 10.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 51.299999999999997 110.897 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 124.35 14.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 71.140000000000001 110.841 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.93 -42.65 1.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.774 -0.726 . . . . 62.240000000000002 112.491 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 128.19 51.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.538 0.685 . . . . 54.219999999999999 111.153 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -164.46 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.62 2.213 . . . . 62.130000000000003 112.316 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -47.89 46.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 53.399999999999999 110.841 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.554 0.693 . . . . 71.109999999999999 110.865 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.889 0.376 . . . . 70.400000000000006 110.829 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.64 161.75 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 110.957 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -121.26 147.63 45.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.895 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -124.23 137.96 54.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 61.450000000000003 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -141.23 140.13 33.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 65.450000000000003 110.859 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.649 HD22 ' CE2' ' A' ' 77' ' ' PHE . 6.1 tp -138.1 134.26 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 74.420000000000002 110.988 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.8 t-20 -116.01 121.17 41.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 64.530000000000001 110.879 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.2 p -138.99 179.37 6.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 63.219999999999999 111.195 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.4 10.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 45.450000000000003 112.412 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -112.42 -36.63 5.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.888 0.375 . . . . 75.450000000000003 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.74 -29.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -102.57 33.78 3.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 62.219999999999999 110.861 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.68 -6.42 8.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 53.329999999999998 111.237 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.65 132.6 54.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 63.350000000000001 110.939 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 158.61 39.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 64.329999999999998 110.931 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.72 120.24 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.053 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 147.95 23.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 62.32 110.938 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG21 ' A' ' 58' ' ' VAL . 2.5 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.699 0.761 . . . . 63.200000000000003 110.846 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.746 0.308 . . . . 74.25 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -125.0 164.22 20.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 75.340000000000003 110.963 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 45' ' ' SER . 43.7 t -106.57 129.95 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 74.430000000000007 111.108 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 63' ' ' SER . 36.8 mt -69.99 159.05 85.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 72.450000000000003 110.882 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -21.75 32.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 55.420000000000002 112.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.33 1.37 41.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.416 . . . . 54.219999999999999 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.08 27.44 21.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 73.340000000000003 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.401 ' HB2' HD12 ' A' ' 59' ' ' LEU . 33.7 m -111.58 -179.0 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 55.210000000000001 110.918 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 57' ' ' ARG . 31.5 tp -128.82 129.99 46.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.84 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 15' ' ' VAL . 42.5 t80 -123.64 133.8 53.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.430000000000007 110.876 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.608 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -115.24 123.88 31.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 73.329999999999998 110.913 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.2 19.44 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.727 2.284 . . . . 74.519999999999996 112.406 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.61 103.15 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.010000000000005 111.116 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 12' ' ' GLU . 23.6 m -71.7 113.0 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 111.188 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.92 156.94 24.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.818 -0.706 . . . . 55.509999999999998 112.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.28 -31.67 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 75.430000000000007 111.11 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -77.34 -24.12 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 54.130000000000003 110.868 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -4.04 54.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 65.439999999999998 110.895 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -58.05 141.84 48.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 70.010000000000005 110.889 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.628 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 161.73 -145.77 11.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.548 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.5 mp -131.41 135.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.841 0.353 . . . . 63.420000000000002 111.165 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.649 ' CE2' HD22 ' A' ' 33' ' ' LEU . 11.7 m-85 -98.88 134.78 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.540000000000006 110.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.91 126.35 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.030000000000001 110.861 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 45.9 t -122.62 150.22 42.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 51.32 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -146.71 129.76 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 64.329999999999998 110.911 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.05 31.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.12 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.6 ttm -130.64 126.75 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.428 . . . . 75.439999999999998 110.86 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -85.81 170.42 12.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 60.219999999999999 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -73.26 -17.62 61.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 72.319999999999993 110.874 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -71.63 -19.66 62.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.928 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.18 -21.95 19.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 65.540000000000006 112.45 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 144.35 28.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 64.200000000000003 110.87 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.64 144.39 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 75.140000000000001 110.918 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.54 132.3 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.497 . . . . 75.150000000000006 111.167 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -105.21 143.19 33.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.88 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -147.37 120.43 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.877 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.66 124.4 41.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 75.129999999999995 110.901 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 118.86 24.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.932 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.78 136.25 33.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.907 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.1 t -124.66 137.27 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 63.329999999999998 111.099 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -130.62 128.26 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.86 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 m -85.65 -176.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 64.200000000000003 111.094 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -70.79 -81.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.848 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -59.65 145.48 44.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 70.040000000000006 110.916 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.29 159.6 49.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.544 0.688 . . . . 71.150000000000006 111.202 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.594 2.196 . . . . 73.219999999999999 112.287 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.726 0.298 . . . . 73.319999999999993 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -93.21 133.2 36.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 64.329999999999998 110.941 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.421 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 8.3 p30 -89.99 122.01 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.400000000000006 110.884 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.754 HG21 HD11 ' A' ' 14' ' ' LEU . 30.1 mm -125.17 122.68 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 111.223 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -94.06 141.2 28.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 42.520000000000003 111.127 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.57 167.33 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 62.100000000000001 111.148 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 149.22 41.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 75.319999999999993 110.885 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.41 HD11 HG13 ' A' ' 71' ' ' ILE . 18.9 mt -52.43 120.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 71.219999999999999 111.101 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.753 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.73 10.17 70.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 71.530000000000001 112.5 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.784 ' O ' HG22 ' A' ' 69' ' ' VAL . 39.2 mm-40 -102.77 139.02 19.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.64 0.733 . . . . 72.439999999999998 110.813 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 143.55 50.89 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.692 2.261 . . . . 53.130000000000003 112.335 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.754 HD11 HG21 ' A' ' 6' ' ' ILE . 23.5 tp -145.76 143.81 29.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 110.89 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.11 145.37 28.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.136 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 64' ' ' LEU . 88.5 mt -130.91 147.51 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.927 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 151.96 31.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.908 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.74 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 124.35 17.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.917 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.56 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.86 -40.63 1.86 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 52.539999999999999 112.462 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.02 128.69 46.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.497 0.665 . . . . 75.340000000000003 111.085 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -164.79 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.65 2.233 . . . . 75.310000000000002 112.271 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.38 -48.31 47.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 63.030000000000001 110.873 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 74.439999999999998 110.851 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.35 . . . . 64.519999999999996 110.877 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.551 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.88 157.71 46.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.979 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.06 146.93 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.209999999999994 110.9 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.551 ' HE1' HD13 ' A' ' 29' ' ' LEU . 15.2 m95 -121.47 141.92 50.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.898 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.6 139.28 38.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 75.400000000000006 110.824 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 35' ' ' THR . 1.3 tm? -138.71 131.41 29.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.864 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.718 ' N ' HD22 ' A' ' 33' ' ' LEU . 2.5 m120 -116.44 121.02 40.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 64.200000000000003 110.949 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.792 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.7 p -139.84 179.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 72.010000000000005 111.119 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.12 -131.42 10.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.703 -0.76 . . . . 42.219999999999999 112.492 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mmm-85 -112.63 -38.43 4.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 63.210000000000001 110.866 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 39' ' ' GLU . 7.8 t 179.83 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 52.100000000000001 111.107 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.1 mt-10 -103.11 33.99 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 110.844 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.23 -6.33 8.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 63.25 111.153 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -63.63 130.95 46.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 73.450000000000003 110.865 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 158.27 41.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 73.299999999999997 110.905 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.0 t -92.68 122.62 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 73.299999999999997 111.061 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.61 147.66 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.9 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.642 0.734 . . . . 71.230000000000004 110.831 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.688 0.28 . . . . 72.5 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.54 166.43 15.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 72.400000000000006 110.895 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 45' ' ' SER . 61.8 t -108.16 128.98 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 111.11 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 63' ' ' SER . 56.4 mt -69.06 157.15 90.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.669 0.747 . . . . 75.409999999999997 110.883 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 -22.47 32.53 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.716 2.278 . . . . 74.200000000000003 112.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -82.98 0.92 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.933 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 29.2 12.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 43.219999999999999 112.415 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.506 ' HB2' HD12 ' A' ' 59' ' ' LEU . 8.8 m -113.1 179.19 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 65.200000000000003 110.878 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 16' ' ' LEU . 6.8 tp -130.15 129.0 42.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 63.439999999999998 110.941 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 46.4 t80 -125.44 130.61 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 70.299999999999997 110.857 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.75 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -115.08 129.13 25.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.601 0.715 . . . . 64.420000000000002 110.908 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -34.84 13.61 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.645 2.23 . . . . 72.439999999999998 112.368 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.75 100.26 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 51.350000000000001 111.141 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.89 112.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 111.144 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.34 167.97 41.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 40.409999999999997 112.497 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.842 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.1 -30.37 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.739 0.304 . . . . 53.100000000000001 111.108 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -75.9 -22.17 56.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 54.340000000000003 110.845 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -2.86 35.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 73.049999999999997 110.844 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 142.01 53.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 70.430000000000007 110.895 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.69 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.39 -154.06 25.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 72.010000000000005 112.461 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.69 HD12 ' C ' ' A' ' 75' ' ' GLY . 2.7 mp -128.08 134.97 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 74.430000000000007 111.135 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 16' ' ' LEU . 26.6 t80 -102.87 133.89 47.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 110.838 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.62 131.82 49.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 75.200000000000003 110.842 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 35.6 t -120.67 150.49 40.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 61.350000000000001 110.82 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -143.29 127.94 18.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 63.149999999999999 110.917 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.46 162.94 29.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 52.409999999999997 111.038 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.5 mtp -130.9 125.51 33.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 65.120000000000005 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -86.66 171.18 11.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.400000000000006 110.878 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -72.03 -18.21 61.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 63.200000000000003 110.906 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -72.46 -19.62 61.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 53.109999999999999 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.46 -18.32 27.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.822 -0.704 . . . . 74.310000000000002 112.513 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.06 146.17 27.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 73.450000000000003 110.953 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.76 145.02 31.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.834 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.56 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -100.87 127.19 47.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 63.409999999999997 111.152 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 143.59 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.908 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -145.26 124.62 13.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 64.120000000000005 110.857 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.49 120.52 26.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 74.120000000000005 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -130.23 117.18 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.885 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -91.98 134.08 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 75.319999999999993 110.872 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.2 t -120.13 139.53 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 42.539999999999999 111.148 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.09 127.92 42.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 110.873 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.842 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.9 m -88.62 -176.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.151 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.59 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.864 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -69.14 144.96 53.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.975 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.488 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.45 159.43 50.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 74.129999999999995 111.067 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.597 2.198 . . . . 74.319999999999993 112.393 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.744 0.307 . . . . 75.030000000000001 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.59 133.09 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.923 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.0 p-10 -87.76 121.98 30.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.439999999999998 110.916 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' HB ' HG22 ' A' ' 95' ' ' VAL . 46.6 mm -125.35 127.69 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 75.340000000000003 111.081 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 138.8 32.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.171 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.33 27.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.120000000000005 111.096 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.65 148.25 48.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.281 -0.418 . . . . 63.439999999999998 110.839 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.489 HD11 HG13 ' A' ' 71' ' ' ILE . 9.7 mt -53.32 122.08 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 71.219999999999999 111.152 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.09 4.44 78.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 73.129999999999995 112.448 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.7 mm-40 -101.22 139.64 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.561 0.696 . . . . 70.019999999999996 110.967 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.67 45.84 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.765 2.31 . . . . 73.150000000000006 112.308 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 66' ' ' LEU . 16.4 tp -144.7 141.31 29.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 64.510000000000005 110.902 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 ' HD1' ' A' ' 65' ' ' PHE . 51.1 t -125.9 147.15 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 42.310000000000002 111.201 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.656 HD12 HD23 ' A' ' 64' ' ' LEU . 8.6 mt -131.58 148.23 52.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.209999999999994 110.857 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -111.41 149.81 30.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 65.530000000000001 110.85 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.3 t -108.16 101.09 10.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.447 . . . . 73.120000000000005 110.882 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.82 101.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 74.099999999999994 110.915 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 144.5 -47.9 0.75 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.703 -0.76 . . . . 70.340000000000003 112.498 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.15 103.04 10.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.558 0.694 . . . . 64.329999999999998 111.189 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.8 Cg_endo -69.69 -161.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.688 2.259 . . . . 75.129999999999995 112.311 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -60.52 -10.51 5.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 110.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-O 121.572 0.701 . . . . 75.430000000000007 110.916 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.86 0.362 . . . . 74.230000000000004 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.5 pp -178.85 161.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 110.837 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -121.43 135.75 55.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 75.540000000000006 110.852 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -120.72 137.95 54.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.0 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -138.31 139.99 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 62.25 110.866 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.763 HD13 ' CD2' ' A' ' 77' ' ' PHE . 6.0 tp -137.67 134.59 35.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 64.230000000000004 110.935 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -116.21 121.66 42.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 61.100000000000001 110.923 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.821 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 66.9 p -137.72 179.6 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.329999999999998 111.098 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -132.06 15.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.729 -0.748 . . . . 74.109999999999999 112.463 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -37.63 4.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 74.430000000000007 110.874 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 t -179.24 -29.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 72.299999999999997 111.12 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.32 33.55 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.935 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.41 -5.33 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -65.87 130.11 42.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 110.928 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.66 43.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 62.420000000000002 110.95 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -95.67 119.85 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 73.420000000000002 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.52 145.29 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 65.310000000000002 110.884 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 72.129999999999995 110.886 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.583 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.789 0.328 . . . . 42.439999999999998 111.087 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.96 160.16 28.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.83 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 45' ' ' SER . 53.6 t -108.47 127.08 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 72.099999999999994 111.078 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' A' ' 63' ' ' SER . 55.6 mt -69.4 157.46 89.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 54.240000000000002 110.938 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -22.74 31.33 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.655 2.236 . . . . 70.310000000000002 112.403 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -82.67 0.68 42.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 110.876 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.93 26.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.63 -0.795 . . . . 41.109999999999999 112.451 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 59' ' ' LEU . 10.1 m -105.51 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.408 . . . . 43.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.656 HD23 HD12 ' A' ' 16' ' ' LEU . 7.0 tp -131.15 129.5 41.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.299999999999997 110.897 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HD1' HG22 ' A' ' 15' ' ' VAL . 7.0 t80 -125.52 129.0 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.540000000000006 111.0 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.671 HD22 HG12 ' A' ' 69' ' ' VAL . 1.9 mp -120.36 131.17 24.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 53.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -32.98 17.76 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.664 2.242 . . . . 63.240000000000002 112.403 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.79 100.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 72.109999999999999 111.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.3 m -76.76 118.58 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 65.430000000000007 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.29 165.42 37.45 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.672 -0.775 . . . . 71.219999999999999 112.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.793 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.94 -31.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 75.129999999999995 111.15 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.2 -22.22 58.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.08 -5.02 41.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 70.200000000000003 110.819 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.59 141.58 51.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.030000000000001 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.65 -147.69 16.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.758 . . . . 74.310000000000002 112.445 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 92' ' ' ASN . 0.8 OUTLIER -130.62 134.96 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 44.439999999999998 111.224 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.763 ' CD2' HD13 ' A' ' 33' ' ' LEU . 21.6 m-85 -104.43 126.57 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 52.530000000000001 110.877 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -124.45 136.54 54.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.852 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.45 156.26 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 24.41 110.925 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -141.02 126.25 18.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 110.982 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.46 162.05 33.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 73.109999999999999 111.115 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.1 mtp -130.32 125.84 35.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.858 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -86.19 171.6 11.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 53.219999999999999 110.866 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -71.66 -17.46 62.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 70.239999999999995 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.93 -26.0 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 62.020000000000003 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.61 -19.53 11.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 23.34 112.452 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.97 147.56 26.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.649 0.262 . . . . 62.310000000000002 111.01 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.39 144.27 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 52.049999999999997 110.906 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.14 126.64 50.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 52.140000000000001 111.133 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.41 142.58 35.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 64.25 110.891 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -146.8 119.01 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 51.130000000000003 110.785 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.554 HD22 HG21 ' A' ' 76' ' ' ILE . 65.5 t30 -125.76 128.66 48.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 74.549999999999997 110.901 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.431 ' HB2' HD22 ' A' ' 16' ' ' LEU . 7.3 m-85 -128.7 118.9 23.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.530000000000001 110.883 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.507 ' HA ' HG23 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -83.74 128.08 34.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 73.140000000000001 110.751 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 6' ' ' ILE . 70.5 t -119.28 139.59 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 54.130000000000003 111.183 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 127.79 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 74.510000000000005 110.833 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 71' ' ' ILE . 35.2 m -86.94 -176.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 111.104 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.5 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 53.219999999999999 110.932 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -64.49 145.83 55.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 43.439999999999998 110.99 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.498 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.4 50.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 73.409999999999997 111.072 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.151 0 C-N-CA 122.718 2.279 . . . . 71.099999999999994 112.277 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.678 0.275 . . . . 70.239999999999995 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.39 133.68 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 61.140000000000001 110.874 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.02 122.04 31.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 65.319999999999993 110.853 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.72 121.29 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 111.071 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -95.16 142.65 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.06 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -142.55 166.31 25.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 52.229999999999997 111.063 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.53 147.62 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 61.100000000000001 110.883 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 71' ' ' ILE . 59.1 mt -59.05 121.16 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 70.430000000000007 111.159 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.668 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.16 0.08 88.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 62.409999999999997 112.435 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.766 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -97.62 142.04 23.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.663 0.745 . . . . 73.400000000000006 110.927 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 143.85 52.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.651 2.234 . . . . 74.239999999999995 112.275 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.8 tp -144.65 143.21 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.140000000000001 110.942 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.59 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.5 t -121.55 148.66 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 72.200000000000003 111.087 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.642 HD13 HD23 ' A' ' 64' ' ' LEU . 1.6 mt -130.9 147.96 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.030000000000001 110.951 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -112.35 151.98 29.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 64.230000000000004 110.946 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 101.97 11.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 33.219999999999999 110.88 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.18 120.9 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 54.32 110.81 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 126.14 -38.5 2.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.811 -0.709 . . . . 23.32 112.532 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.23 128.26 47.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.319999999999993 111.119 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.666 2.244 . . . . 74.510000000000005 112.374 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.34 -49.39 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.109999999999999 110.896 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 75.109999999999999 110.912 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.812 0.339 . . . . 75.329999999999998 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -136.62 156.31 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 53.140000000000001 110.925 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.1 148.35 44.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 70.430000000000007 110.896 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.602 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -129.63 142.02 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 74.219999999999999 110.872 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.712 ' O ' HD23 ' A' ' 33' ' ' LEU . 28.4 mtpt -146.77 137.01 23.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 75.129999999999995 110.876 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.831 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -138.59 139.52 38.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 61.399999999999999 110.936 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -112.42 124.44 52.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 64.519999999999996 110.889 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.792 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 70.3 p -138.45 -179.24 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 74.219999999999999 111.111 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.01 -130.55 14.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 72.310000000000002 112.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.41 -37.84 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 71.319999999999993 110.855 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.6 t -179.5 -30.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 111.145 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.586 ' HG2' HG23 ' A' ' 38' ' ' THR . 6.1 mm-40 -102.21 33.71 2.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.877 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.33 -7.26 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 71.150000000000006 111.127 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.19 129.44 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.420000000000002 110.874 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.89 153.41 50.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 63.310000000000002 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.73 121.55 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.430000000000007 111.111 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -89.55 146.73 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 64.140000000000001 110.974 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.806 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.722 0.773 . . . . 75.430000000000007 110.848 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.818 0.342 . . . . 65.219999999999999 111.1 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 159.64 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 63.299999999999997 110.828 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.806 HG21 ' O ' ' A' ' 45' ' ' SER . 86.7 t -109.05 129.94 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.13 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.557 HD12 ' CB ' ' A' ' 63' ' ' SER . 73.3 mt -68.56 157.77 87.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.665 0.745 . . . . 62.350000000000001 110.877 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -21.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 72.129999999999995 112.36 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -83.27 0.25 46.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 54.149999999999999 110.89 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.05 9.57 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.795 -0.716 . . . . 35.329999999999998 112.397 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.557 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.0 m -112.4 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.959 0.409 . . . . 53.049999999999997 110.849 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.642 HD23 HD13 ' A' ' 16' ' ' LEU . 18.2 tp -128.48 127.69 42.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.833 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CD2' HG22 ' A' ' 15' ' ' VAL . 32.1 t80 -125.71 133.54 52.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 60.140000000000001 110.863 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 56' ' ' ALA . 2.1 mp -119.88 131.27 24.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.522 0.677 . . . . 62.450000000000003 110.955 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -36.29 11.13 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.766 2.311 . . . . 73.099999999999994 112.35 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.668 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -162.99 101.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 60.439999999999998 111.122 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.7 m -73.48 117.78 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.173 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.24 163.09 39.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 75.120000000000005 112.476 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.868 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.89 -30.93 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 65.329999999999998 111.106 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 74.140000000000001 110.909 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -5.44 37.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.274 -0.421 . . . . 75.329999999999998 110.832 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.657 ' HG3' HG22 ' A' ' 97' ' ' VAL . 1.5 mt-10 -58.56 142.06 50.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.886 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.569 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.6 -151.83 23.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 43.43 112.478 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.569 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.3 mp -124.29 134.21 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 74.120000000000005 111.182 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.831 ' CE2' HD13 ' A' ' 33' ' ' LEU . 6.9 m-85 -102.58 132.73 48.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.099999999999994 110.938 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.87 134.64 49.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.099999999999994 110.938 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 146.19 46.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.32 110.876 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -141.17 126.12 18.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 63.5 110.924 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.05 164.0 27.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 111.055 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 124.82 34.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 65.349999999999994 110.881 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -86.81 172.29 10.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 72.140000000000001 110.906 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -71.32 -18.1 62.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.878 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -73.0 -20.12 61.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.87 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.99 -18.24 28.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.200000000000003 112.415 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -84.97 146.75 27.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.708 0.289 . . . . 73.319999999999993 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -105.17 145.0 31.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.441 HG21 ' CA ' ' A' ' 20' ' ' GLY . 1.2 m -102.24 129.41 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.225 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -105.3 146.06 29.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 72.519999999999996 110.884 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.95 126.78 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 110.826 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -121.31 120.4 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.230000000000004 110.9 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.98 127.56 40.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 73.510000000000005 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -89.55 131.07 35.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 72.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.0 t -120.92 130.58 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 75.530000000000001 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.404 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 15.8 mmt-85 -131.72 153.32 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.540000000000006 110.83 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.868 HG21 ' HA ' ' A' ' 71' ' ' ILE . 27.2 m -116.06 -177.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 111.179 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.19 -82.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 75.209999999999994 110.978 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -59.1 146.69 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.972 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.494 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.37 159.66 49.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 61.109999999999999 111.076 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.3 Cg_endo . . . . . 0 C--N 1.343 0.238 0 C-N-CA 122.65 2.233 . . . . 70.439999999999998 112.279 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.778 0.323 . . . . 44.229999999999997 111.139 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.51 132.63 37.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.340000000000003 110.915 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.539 ' C ' HD12 ' A' ' 6' ' ' ILE . 4.2 p-10 -88.66 121.29 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.944 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.644 HG21 HD11 ' A' ' 14' ' ' LEU . 2.6 mp -123.22 120.81 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 111.089 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.8 p -96.95 142.58 28.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 111.159 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.0 168.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 65.219999999999999 111.129 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.32 145.66 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 64.540000000000006 110.906 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 99' ' ' GLN . 11.3 mt -52.21 120.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.077 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 89.83 5.8 70.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 60.109999999999999 112.492 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.82 ' O ' HG22 ' A' ' 69' ' ' VAL . 18.7 mm-40 -101.67 140.8 21.53 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 121.539 0.685 . . . . 63.439999999999998 110.98 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 143.89 52.88 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.752 2.302 . . . . 65.340000000000003 112.315 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 6' ' ' ILE . 37.8 tp -142.89 142.13 31.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 75.510000000000005 110.841 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.7 t -122.41 149.32 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 70.209999999999994 111.115 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.688 HD13 ' CG ' ' A' ' 77' ' ' PHE . 70.3 mt -130.73 146.91 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 52.329999999999998 110.954 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -112.91 152.86 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.010000000000005 110.897 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.89 100.6 10.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 61.420000000000002 110.862 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.32 120.65 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.449 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.28 -36.7 2.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 74.120000000000005 112.424 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.7 130.37 39.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.624 0.726 . . . . 71.030000000000001 111.062 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.66 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 72.049999999999997 112.374 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -49.32 -49.36 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 61.539999999999999 110.88 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 71.099999999999994 110.812 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.79 0.329 . . . . 74.510000000000005 110.889 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -136.31 146.94 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.874 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -129.07 137.07 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.859 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' CE2' HD13 ' A' ' 29' ' ' LEU . 1.1 m0 -124.68 144.95 49.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 110.85 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -136.33 142.28 43.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.897 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.819 HD21 HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -137.82 140.06 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.319999999999993 110.946 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 62.520000000000003 110.835 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.819 HG23 HD21 ' A' ' 33' ' ' LEU . 33.5 p -136.82 179.91 6.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 111.193 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.78 -130.01 19.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.797 -0.716 . . . . 62.32 112.485 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -112.68 -37.38 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 71.120000000000005 110.901 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -178.9 -29.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 73.319999999999993 111.153 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -102.14 33.6 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 64.109999999999999 110.951 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.33 -5.81 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 62.130000000000003 111.102 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -59.14 132.22 53.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 65.439999999999998 110.956 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 157.17 41.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 61.219999999999999 110.857 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.11 123.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.209999999999994 111.215 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.38 136.68 32.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.941 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.835 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 110.827 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.414 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.754 0.311 . . . . 65.430000000000007 111.136 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.85 158.01 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 110.908 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 45' ' ' SER . 49.8 t -116.35 126.87 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 73.140000000000001 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 63' ' ' SER . 38.7 mt -69.02 156.4 91.6 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 75.230000000000004 110.956 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.75 -21.84 32.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.668 2.246 . . . . 72.319999999999993 112.431 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -82.89 -0.19 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.94 29.64 10.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.723 -0.751 . . . . 60.439999999999998 112.438 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 59' ' ' LEU . 3.2 m -111.4 177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 54.109999999999999 110.863 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.683 HD23 HD12 ' A' ' 16' ' ' LEU . 9.2 tp -128.63 130.02 46.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.019999999999996 110.89 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.578 ' N ' HD12 ' A' ' 64' ' ' LEU . 3.4 t80 -125.13 131.9 53.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 64.019999999999996 110.958 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 69' ' ' VAL . 7.2 mp -115.07 130.8 23.92 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.653 0.74 . . . . 61.340000000000003 110.855 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -37.84 8.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.785 2.323 . . . . 63.539999999999999 112.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.614 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.36 102.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 111.083 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.2 m -73.7 116.44 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 111.077 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 163.12 38.3 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.674 -0.774 . . . . 54.240000000000002 112.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.857 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.16 -34.04 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.723 0.297 . . . . 71.200000000000003 111.115 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.95 -15.92 60.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -4.51 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 62.030000000000001 110.921 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.632 ' CD ' HG22 ' A' ' 97' ' ' VAL . 42.6 mt-10 -56.5 141.49 42.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 75.530000000000001 110.973 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.697 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 160.08 -156.41 27.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.749 -0.739 . . . . 71.209999999999994 112.519 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.697 HD13 ' O ' ' A' ' 75' ' ' GLY . 6.3 mm -125.38 134.09 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 75.150000000000006 111.137 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.691 ' HB2' HD12 ' A' ' 33' ' ' LEU . 77.1 t80 -102.84 126.44 49.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 73.25 110.876 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 127.86 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.779 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.84 146.58 46.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 74.120000000000005 110.891 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -139.47 132.91 30.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 163.89 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 70.409999999999997 111.039 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.6 mtp -129.1 125.01 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 72.349999999999994 110.938 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.88 172.81 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 73.150000000000006 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -70.71 -18.42 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 64.519999999999996 110.828 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -73.21 -19.86 61.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 63.530000000000001 110.92 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.92 -15.09 37.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 61.219999999999999 112.505 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 146.61 27.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.657 0.265 . . . . 60.350000000000001 110.936 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.37 144.81 31.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 75.319999999999993 110.89 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.449 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.92 132.59 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 53.539999999999999 111.128 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.45 145.47 27.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 73.310000000000002 110.934 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.2 m -144.72 123.88 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 62.229999999999997 110.818 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -127.48 121.24 30.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 74.450000000000003 110.884 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.58 123.05 32.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.0 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.658 ' HE ' HD12 ' A' ' 76' ' ' ILE . 19.4 mmm-85 -84.4 134.17 34.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.861 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -120.27 129.29 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 63.43 111.108 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.47 46.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.857 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -109.68 -175.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 73.400000000000006 111.099 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -65.79 -71.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 110.952 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.498 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.7 mp0 -71.05 140.52 50.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.952 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.27 159.81 48.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.665 0.745 . . . . 65.319999999999993 111.138 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 74.030000000000001 112.394 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.703 0.287 . . . . 61.130000000000003 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.62 137.25 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 74.340000000000003 110.826 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -89.09 121.13 31.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.86 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.65 121.94 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 75.209999999999994 111.15 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -95.31 142.68 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 72.5 111.202 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.49 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -146.61 167.29 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 45.399999999999999 111.13 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -119.99 148.68 43.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.408 . . . . 64.120000000000005 110.898 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mt -56.81 120.75 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 65.0 111.219 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.31 5.72 79.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.76 . . . . 72.310000000000002 112.46 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.813 ' O ' HG22 ' A' ' 69' ' ' VAL . 51.7 mm-40 -102.05 139.42 20.28 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.657 0.742 . . . . 75.340000000000003 110.918 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 143.27 50.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 75.310000000000002 112.356 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 8' ' ' ALA . 22.7 tp -145.27 142.43 29.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 54.310000000000002 110.891 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.512 HG22 ' CD2' ' A' ' 65' ' ' PHE . 42.5 t -122.96 145.27 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 62.109999999999999 111.134 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.774 HD12 HD23 ' A' ' 64' ' ' LEU . 67.1 mt -130.74 147.27 52.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 62.530000000000001 111.0 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -113.46 150.73 32.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.409999999999997 110.882 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -108.07 99.73 9.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 53.210000000000001 110.846 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -54.26 128.45 31.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.847 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.38 -40.45 1.92 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 42.350000000000001 112.468 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.92 128.89 43.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 62.450000000000003 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.19 0.15 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.665 2.244 . . . . 64.209999999999994 112.376 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -48.95 45.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 71.219999999999999 110.945 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.565 0.697 . . . . 63.140000000000001 110.942 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.883 0.373 . . . . 75.5 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.645 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -137.28 159.13 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 55.310000000000002 110.918 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -132.53 146.14 51.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 110.851 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.645 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 13.7 m95 -123.6 134.25 53.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.400000000000006 110.922 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' C ' HD23 ' A' ' 33' ' ' LEU . 15.0 ttpp -136.36 138.33 41.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 63.450000000000003 110.91 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.739 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -138.29 138.24 38.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 75.120000000000005 110.903 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -113.33 127.8 56.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 74.209999999999994 110.89 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.812 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 21.2 p -138.52 -179.87 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 62.219999999999999 111.139 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.17 21.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.815 -0.707 . . . . 63.43 112.463 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.89 -37.26 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 64.430000000000007 110.869 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.2 t -178.72 -29.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 111.015 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.611 ' HG3' HG23 ' A' ' 38' ' ' THR . 29.3 mt-10 -102.06 34.06 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 75.219999999999999 110.821 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.71 -5.59 8.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.409999999999997 111.114 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -59.57 132.16 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.958 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' CE ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.45 152.46 48.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.316 -0.402 . . . . 64.439999999999998 110.92 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.1 t -105.26 116.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 61.5 111.131 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.717 HD13 HD13 ' A' ' 64' ' ' LEU . 27.0 mt -96.28 146.03 25.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 73.439999999999998 110.823 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 121.586 0.708 . . . . 74.129999999999995 110.865 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.708 0.29 . . . . 52.439999999999998 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.37 162.41 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 73.420000000000002 110.903 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 63' ' ' SER . 46.2 t -108.69 130.72 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 72.400000000000006 111.119 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 63' ' ' SER . 56.4 mt -68.99 156.46 91.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.596 0.712 . . . . 62.509999999999998 110.965 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -22.43 32.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 73.310000000000002 112.265 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -81.91 0.15 41.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.299999999999997 110.921 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.8 22.92 24.63 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 65.319999999999993 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.518 ' HB2' HD12 ' A' ' 59' ' ' LEU . 6.0 m -106.24 178.91 4.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 71.120000000000005 110.88 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.774 HD23 HD12 ' A' ' 16' ' ' LEU . 15.5 tp -129.68 129.95 44.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 74.019999999999996 110.952 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 15' ' ' VAL . 39.3 t80 -124.34 129.96 51.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 75.040000000000006 110.86 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.811 HD22 HG12 ' A' ' 69' ' ' VAL . 5.3 mp -114.57 127.23 27.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.678 0.752 . . . . 75.420000000000002 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -32.62 18.11 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.239999999999995 112.386 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.5 101.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 63.310000000000002 111.145 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.09 115.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 111.185 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.63 161.81 31.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 72.109999999999999 112.457 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.835 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.07 -31.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 73.129999999999995 111.168 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -77.46 -22.47 51.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.924 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.15 -5.34 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 70.109999999999999 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.75 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.33 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 110.822 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.779 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 160.39 -148.91 17.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.793 -0.718 . . . . 53.43 112.516 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.779 HD12 ' C ' ' A' ' 75' ' ' GLY . 2.0 mp -126.18 133.66 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.89 0.376 . . . . 61.509999999999998 111.178 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.739 ' CE2' HD13 ' A' ' 33' ' ' LEU . 11.0 m-85 -103.32 135.2 45.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 45.149999999999999 110.908 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -125.99 134.61 51.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.813 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.49 147.95 44.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -141.37 129.21 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 61.520000000000003 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.73 163.13 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 111.12 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 125.09 33.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 45.340000000000003 110.937 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -86.84 172.1 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 74.140000000000001 110.823 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.47 -18.3 62.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 70.530000000000001 110.934 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.07 -19.87 61.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 65.010000000000005 110.848 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.03 32.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.756 -0.735 . . . . 74.230000000000004 112.545 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -85.02 147.07 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.795 0.331 . . . . 75.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.79 145.14 30.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 72.219999999999999 110.955 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.69 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 63.25 111.107 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -98.65 145.31 27.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 71.430000000000007 110.943 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 m -144.73 127.76 16.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 63.240000000000002 110.748 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -128.14 121.52 29.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 72.349999999999994 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.22 126.1 40.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.530000000000001 110.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.6 mmm-85 -89.85 132.1 35.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 74.5 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.82 130.02 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 64.010000000000005 111.129 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -131.55 146.17 52.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 110.886 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 71' ' ' ILE . 17.0 m -109.58 -176.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 52.020000000000003 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.86 -79.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.992 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.45 146.21 54.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 73.219999999999999 111.032 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.38 159.42 50.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.719 0.771 . . . . 61.350000000000001 111.145 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.649 2.233 . . . . 73.109999999999999 112.321 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.691 0.281 . . . . 64.140000000000001 111.156 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.12 133.6 36.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 73.430000000000007 110.893 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.6 121.27 28.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.510000000000005 110.884 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.1 mm -125.16 127.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 74.25 111.111 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -91.56 142.52 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 64.150000000000006 111.17 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.0 165.85 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 33.140000000000001 111.133 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -119.1 149.71 41.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 62.229999999999997 110.906 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 71' ' ' ILE . 10.6 mt -68.43 120.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 45.119999999999997 111.108 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.5 -6.99 57.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.815 -0.707 . . . . 64.439999999999998 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.837 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -102.72 140.76 21.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.71 0.767 . . . . 74.299999999999997 110.923 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 146.11 59.7 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.84 2.36 . . . . 74.200000000000003 112.323 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.3 tp -138.33 142.8 39.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 73.209999999999994 110.966 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.627 HG22 ' CD1' ' A' ' 65' ' ' PHE . 47.1 t -122.59 148.22 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.540000000000006 111.141 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.68 HD12 HD23 ' A' ' 64' ' ' LEU . 6.6 mt -130.99 147.48 52.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.933 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -112.78 152.04 29.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 72.140000000000001 111.002 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -107.33 100.53 9.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.413 . . . . 61.409999999999997 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.88 122.41 12.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 73.530000000000001 110.839 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.15 -39.8 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 72.129999999999995 112.484 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.29 129.32 43.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.522 0.677 . . . . 73.329999999999998 111.171 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.91 -165.08 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.64 2.226 . . . . 75.230000000000004 112.383 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -49.02 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.981 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.603 0.716 . . . . 61.43 110.936 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.769 0.319 . . . . 75.120000000000005 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.2 pp -136.09 151.31 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 73.310000000000002 110.912 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.82 148.18 45.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.834 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -121.81 139.97 52.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.922 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -146.65 135.35 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.230000000000004 110.928 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.716 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -140.58 137.84 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 70.129999999999995 110.891 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -112.28 125.2 53.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 54.5 110.893 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.84 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 40.4 p -139.22 -178.96 5.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 73.530000000000001 111.137 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.98 -127.04 9.95 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.703 -0.76 . . . . 54.329999999999998 112.53 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' THR . 1.2 mpp_? -112.9 -38.88 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 75.319999999999993 110.863 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 39' ' ' GLU . 3.8 t 179.0 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.171 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -102.03 34.18 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 110.823 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.84 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.12 -6.92 8.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 72.239999999999995 111.105 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -71.47 128.71 36.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.506 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -137.57 159.65 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 54.329999999999998 110.929 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 t -93.59 121.01 43.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 72.030000000000001 111.135 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.05 145.74 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 61.43 110.879 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 63.25 110.91 -179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.894 0.378 . . . . 74.439999999999998 111.011 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.18 161.14 25.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.944 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 63' ' ' SER . 61.6 t -107.44 130.28 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 71.299999999999997 111.084 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 63' ' ' SER . 44.5 mt -68.81 157.88 87.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 71.530000000000001 110.923 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -21.86 33.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.772 2.315 . . . . 72.439999999999998 112.353 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -82.37 0.95 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 75.409999999999997 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 26.46 20.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 73.310000000000002 112.514 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 58' ' ' VAL . 30.8 m -111.97 -179.53 3.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 74.239999999999995 110.874 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.68 HD23 HD12 ' A' ' 16' ' ' LEU . 13.3 tp -129.84 130.54 45.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.32 110.909 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.627 ' CD1' HG22 ' A' ' 15' ' ' VAL . 6.2 t80 -123.81 133.04 53.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.668 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -114.83 127.08 27.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.651 0.738 . . . . 74.439999999999998 110.939 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -32.28 19.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 33.210000000000001 112.374 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.64 102.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 74.430000000000007 111.084 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 12' ' ' GLU . 27.5 m -73.07 118.71 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 75.409999999999997 111.136 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.01 161.61 21.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 41.310000000000002 112.524 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.912 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.76 -34.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 73.109999999999999 111.212 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.08 -20.2 56.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.450000000000003 110.903 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -2.9 28.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.420000000000002 110.965 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.22 141.91 49.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 60.509999999999998 110.883 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.573 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 163.4 -155.09 26.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 73.040000000000006 112.428 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.74 135.34 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 71.540000000000006 111.142 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.716 ' CE2' HD22 ' A' ' 33' ' ' LEU . 80.8 m-85 -103.71 126.75 51.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.874 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.93 127.55 47.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 74.140000000000001 110.868 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.01 150.9 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 65.25 110.857 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -139.65 132.6 29.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.936 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.16 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 73.439999999999998 111.176 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.4 ttm -129.48 126.09 37.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 64.400000000000006 110.884 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -86.22 172.62 10.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.915 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -71.26 -18.48 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 71.129999999999995 110.814 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -73.13 -19.85 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 73.400000000000006 110.874 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.69 -17.36 30.54 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 70.299999999999997 112.454 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -85.15 146.58 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.832 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.39 144.86 31.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.866 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 132.8 48.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.120000000000005 111.218 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 144.08 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.033 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -145.52 121.66 10.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 64.219999999999999 110.9 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 122.08 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 74.230000000000004 110.836 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -128.0 118.97 24.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 73.120000000000005 110.965 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.13 135.79 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.099999999999994 110.864 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 68.9 t -120.68 134.2 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.115 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 127.25 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.88 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.912 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.1 m -88.32 -177.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 52.310000000000002 111.065 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.401 ' CD2' ' NE2' ' A' ' 99' ' ' GLN . 14.0 t80 -68.84 -80.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 72.120000000000005 110.942 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' ' CD2' ' A' ' 98' ' ' TYR . 1.9 mp0 -59.25 144.23 46.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 72.450000000000003 110.849 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.13 159.62 48.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.581 0.705 . . . . 53.509999999999998 111.131 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 61.399999999999999 112.329 179.857 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.702 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.696 0.284 . . . . 63.210000000000001 111.093 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -93.3 133.51 36.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 74.140000000000001 110.881 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.0 121.34 27.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.79 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.56 121.88 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 72.140000000000001 111.142 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -95.93 142.06 28.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 73.219999999999999 111.152 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.72 165.26 30.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 72.400000000000006 111.109 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 148.64 45.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.909 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.426 HD11 ' HB3' ' A' ' 99' ' ' GLN . 70.3 mt -57.13 122.13 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 60.140000000000001 111.094 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.28 4.45 80.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 112.506 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.768 ' O ' HG22 ' A' ' 69' ' ' VAL . 35.7 mm-40 -101.19 139.4 20.43 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.641 0.734 . . . . 32.32 110.935 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 138.62 38.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.609 2.206 . . . . 43.43 112.359 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 66' ' ' LEU . 18.4 tp -145.0 141.26 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 64.430000000000007 110.861 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' CD1' ' A' ' 65' ' ' PHE . 47.2 t -126.64 147.81 31.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 54.439999999999998 111.178 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 77' ' ' PHE . 56.2 mt -131.88 147.29 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 72.349999999999994 110.96 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -111.7 149.11 32.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.869 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -112.32 101.56 9.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 61.020000000000003 110.86 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.530000000000001 110.906 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 150.31 -49.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 72.150000000000006 112.476 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.52 102.95 11.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 73.299999999999997 111.044 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.4 Cg_endo -69.71 -161.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.626 2.217 . . . . 64.329999999999998 112.402 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -12.68 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 71.040000000000006 110.942 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 29.8 mmtm . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 72.129999999999995 110.9 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.86 0.362 . . . . 72.439999999999998 110.946 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -168.63 174.26 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 75.25 110.927 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 124.1 40.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.931 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.35 143.4 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 72.120000000000005 110.866 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -143.96 144.1 31.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 71.430000000000007 110.941 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.698 HD11 ' CE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -136.57 132.83 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 72.329999999999998 110.882 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.41 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -116.48 120.43 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.878 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.814 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.4 p -140.02 179.6 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 71.109999999999999 111.099 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.1 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.434 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.39 -38.46 4.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 74.310000000000002 110.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.1 t 179.24 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 41.409999999999997 111.152 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' HG2' HG23 ' A' ' 38' ' ' THR . 4.7 mm-40 -102.03 33.93 2.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.825 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.93 -6.67 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 63.329999999999998 111.101 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -68.37 130.2 42.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 159.08 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 64.040000000000006 110.883 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.59 122.1 38.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 72.530000000000001 111.181 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 33' ' ' LEU . 11.2 mt -92.31 148.84 21.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 72.140000000000001 110.862 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.717 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.712 0.768 . . . . 61.219999999999999 110.825 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.795 0.331 . . . . 73.129999999999995 111.081 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.47 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -131.25 165.39 23.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 110.899 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.717 HG21 ' O ' ' A' ' 45' ' ' SER . 55.2 t -106.51 130.13 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 111.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 65' ' ' PHE . 6.2 mp -69.76 157.84 88.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.577 0.703 . . . . 61.350000000000001 110.907 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.2 Cg_endo -69.68 -22.9 31.79 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.717 2.278 . . . . 65.120000000000005 112.37 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.37 2.06 38.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 75.439999999999998 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.93 30.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 60.210000000000001 112.494 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 11.7 m -105.67 179.42 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 110.805 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 57' ' ' ARG . 36.9 tp -132.3 128.35 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 74.430000000000007 110.959 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 15' ' ' VAL . 4.5 t80 -129.65 128.16 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 72.150000000000006 110.858 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -121.27 132.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.698 0.761 . . . . 72.150000000000006 110.927 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.27 19.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.743 2.295 . . . . 64.120000000000005 112.414 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -155.81 103.5 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 74.299999999999997 111.055 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.3 m -73.2 119.36 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 111.19 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.82 156.17 26.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.741 . . . . 63.130000000000003 112.526 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.76 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.51 -29.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 74.109999999999999 111.087 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -73.32 -23.5 60.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 61.130000000000003 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.26 -5.26 57.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 72.420000000000002 110.831 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.55 140.61 57.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 75.409999999999997 110.869 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.23 -137.93 5.63 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.778 -0.725 . . . . 64.209999999999994 112.485 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.46 135.26 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 73.049999999999997 111.197 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.698 ' CE2' HD11 ' A' ' 33' ' ' LEU . 5.0 m-85 -100.85 128.39 46.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.874 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.445 ' HG2' ' ND2' ' A' ' 92' ' ' ASN . 2.1 tmm_? -127.92 127.72 43.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 110.902 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -121.24 149.73 42.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.854 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -146.98 126.68 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.874 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.13 163.74 27.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 55.030000000000001 111.101 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.4 mtp -129.96 125.83 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.879 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -86.2 172.03 10.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.519999999999996 110.83 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -71.78 -17.95 62.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.843 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.1 -19.61 61.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.895 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.7 -18.58 29.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 62.299999999999997 112.53 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 145.19 27.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 44.329999999999998 110.83 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.91 145.0 32.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 110.893 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.01 131.32 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.299999999999997 111.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.35 145.6 30.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 62.32 110.936 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -146.04 123.95 12.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 62.210000000000001 110.81 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.445 ' ND2' ' HG2' ' A' ' 78' ' ' ARG . 2.8 t-20 -128.49 120.39 26.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 64.219999999999999 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.64 127.85 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.989 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.702 HH11 ' HB1' ' A' ' 3' ' ' ALA . 4.1 mmm-85 -87.62 136.18 33.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 61.119999999999997 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 77' ' ' PHE . 56.1 t -126.45 132.29 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 111.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 128.83 41.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.9 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 m -92.92 -176.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 62.140000000000001 111.083 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -66.49 -81.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 72.109999999999999 110.941 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.426 ' HB3' HD11 ' A' ' 10' ' ' ILE . 68.8 tp60 -60.97 142.59 56.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 71.25 110.811 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.67 159.88 48.9 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.548 0.69 . . . . 72.510000000000005 111.151 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--N 1.34 0.086 0 C-N-CA 122.746 2.297 . . . . 62.020000000000003 112.339 179.8 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.662 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.773 0.32 . . . . 74.319999999999993 111.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -93.47 133.73 36.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 64.319999999999993 110.924 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.7 120.48 26.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 14' ' ' LEU . 48.7 mm -125.9 121.51 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 75.329999999999998 111.144 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.89 140.95 29.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 74.010000000000005 111.085 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.62 166.62 27.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 35.109999999999999 111.088 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.79 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 71.310000000000002 110.904 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG23 ' HA2' ' A' ' 70' ' ' GLY . 22.1 mt -55.59 120.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 111.22 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.715 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.89 9.3 74.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.685 -0.769 . . . . 53.119999999999997 112.463 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.772 ' O ' HG22 ' A' ' 69' ' ' VAL . 50.3 mm-40 -102.66 139.14 19.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 74.450000000000003 110.883 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 143.7 51.55 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.686 2.257 . . . . 65.530000000000001 112.355 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.616 ' O ' HD12 ' A' ' 66' ' ' LEU . 30.2 tp -145.88 143.42 29.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.288 -0.414 . . . . 63.049999999999997 110.901 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 142.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 111.153 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.5 147.99 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 74.319999999999993 110.895 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -113.75 151.19 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 71.400000000000006 110.85 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -107.53 101.63 10.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 51.340000000000003 110.813 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -50.16 125.66 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 74.200000000000003 111.012 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.38 -45.12 1.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.8 -0.714 . . . . 65.109999999999999 112.464 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.16 123.84 63.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.595 0.712 . . . . 72.030000000000001 111.076 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.667 2.245 . . . . 71.099999999999994 112.385 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -47.5 39.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 72.430000000000007 110.869 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 71.310000000000002 110.872 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.928 0.394 . . . . 71.400000000000006 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.855 HD11 ' CE3' ' A' ' 31' ' ' TRP . 1.1 pp -135.69 163.38 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.340000000000003 110.913 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.8 tp10 -120.56 149.02 43.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.040000000000006 110.913 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.855 ' CE3' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -127.43 143.16 51.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 110.96 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -143.03 140.79 31.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 61.229999999999997 110.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.804 HD11 HG23 ' A' ' 35' ' ' THR . 0.9 OUTLIER -137.65 132.82 33.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 65.030000000000001 110.916 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.768 ' N ' HD22 ' A' ' 33' ' ' LEU . 19.0 t-20 -114.9 120.94 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.25 110.915 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.807 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.2 p -139.03 179.52 6.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 55.119999999999997 111.172 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.09 -130.03 10.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.644 -0.788 . . . . 60.420000000000002 112.537 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.67 -38.34 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 63.310000000000002 110.863 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.6 t 179.91 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 53.020000000000003 111.151 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 38' ' ' THR . 22.6 mt-10 -102.7 33.8 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 63.340000000000003 110.994 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.97 -7.04 8.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 74.109999999999999 111.1 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -64.52 130.93 45.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 110.888 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 153.49 47.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.938 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.54 120.84 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 64.099999999999994 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 2.7 mm? -94.26 149.68 21.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.18 -0.463 . . . . 64.310000000000002 110.873 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.566 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.728 0.775 . . . . 54.439999999999998 110.831 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.799 0.333 . . . . 72.420000000000002 111.078 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 168.66 16.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 63.549999999999997 110.843 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 45' ' ' SER . 49.9 t -106.45 130.11 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 63.409999999999997 111.154 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 65' ' ' PHE . 4.5 mp -69.31 156.62 91.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 60.25 110.945 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -20.46 34.72 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.0 112.422 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 1.91 32.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 41.549999999999997 110.861 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.3 25.12 27.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.668 -0.777 . . . . 72.430000000000007 112.445 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 58' ' ' VAL . 73.9 m -113.5 -179.29 3.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 63.219999999999999 110.86 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tp -129.59 128.53 42.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 71.439999999999998 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.777 ' HB2' HD11 ' A' ' 59' ' ' LEU . 39.9 t80 -126.11 132.81 51.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 71.140000000000001 110.958 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.845 HD22 HG12 ' A' ' 69' ' ' VAL . 2.8 mp -114.7 128.28 26.03 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 71.129999999999995 110.94 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.63 -34.24 15.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.685 2.257 . . . . 74.409999999999997 112.395 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.69 99.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 71.409999999999997 111.079 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.845 HG12 HD22 ' A' ' 66' ' ' LEU . 13.4 m -74.97 112.22 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.349999999999994 111.215 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -86.18 171.01 43.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 72.129999999999995 112.492 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.86 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.69 -30.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.729 0.3 . . . . 72.340000000000003 111.095 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.49 -23.12 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 60.219999999999999 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -3.59 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.049999999999997 110.847 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 140.66 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 72.239999999999995 110.867 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.595 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 159.18 -149.04 18.76 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 54.43 112.502 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.6 mp -130.69 135.26 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 64.209999999999994 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CG ' HD23 ' A' ' 33' ' ' LEU . 32.2 m-85 -101.17 130.96 47.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 62.219999999999999 110.897 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.51 131.02 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 70.319999999999993 110.85 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 151.07 40.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 22.120000000000001 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -144.98 126.11 14.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 72.319999999999993 110.799 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.7 162.8 29.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 35.100000000000001 111.056 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.3 ttm -130.18 125.48 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 60.009999999999998 110.866 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.08 172.22 10.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -71.33 -19.07 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 73.209999999999994 110.886 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -74.21 -20.14 60.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.530000000000001 110.847 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.96 -9.1 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 75.040000000000006 112.531 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -85.11 146.28 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 62.409999999999997 110.893 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.73 142.12 36.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 65.329999999999998 110.945 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.456 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.17 125.9 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 111.043 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -106.87 143.1 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 65.129999999999995 110.9 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -146.74 120.61 9.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 63.32 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.63 122.6 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 74.019999999999996 110.919 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.19 125.88 43.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.902 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.662 HH11 ' HB1' ' A' ' 3' ' ' ALA . 8.9 mmm-85 -86.34 132.68 33.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.902 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.546 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.6 t -120.81 133.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.150000000000006 111.123 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.444 ' NH2' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -130.74 128.93 41.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 70.140000000000001 110.812 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.86 HG21 ' HA ' ' A' ' 71' ' ' ILE . 24.0 m -92.58 -176.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 111.136 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -66.83 -82.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 75.439999999999998 110.963 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -62.97 146.34 53.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.886 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.503 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.55 49.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 73.349999999999994 111.204 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.244 . . . . 70.319999999999993 112.243 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.722 0.296 . . . . 44.140000000000001 111.082 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -93.33 133.24 36.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.439999999999998 110.937 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -84.96 122.17 28.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 110.891 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.488 ' CG2' HD11 ' A' ' 14' ' ' LEU . 48.6 mm -124.03 120.89 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.549999999999997 111.153 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -96.05 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 62.43 111.215 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.033 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -143.68 164.86 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.099999999999994 111.137 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -124.67 151.31 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 72.150000000000006 110.908 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.57 118.6 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 111.111 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 80.21 8.84 87.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 63.119999999999997 112.465 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.793 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.2 mm-40 -102.19 140.44 21.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 73.200000000000003 110.935 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 143.83 51.9 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.638 2.225 . . . . 63.439999999999998 112.366 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 8' ' ' ALA . 22.7 tp -145.27 142.22 29.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 110.963 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 65' ' ' PHE . 40.6 t -122.63 145.12 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.168 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.546 HD12 HD23 ' A' ' 64' ' ' LEU . 65.1 mt -131.66 147.78 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 110.916 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -113.39 150.32 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 65.329999999999998 110.809 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -110.67 100.96 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.852 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.53 128.04 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 71.120000000000005 110.956 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -45.02 1.2 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.768 -0.729 . . . . 52.210000000000001 112.439 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.85 59.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.602 0.715 . . . . 70.439999999999998 111.069 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -163.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 64.230000000000004 112.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.31 -47.57 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 43.520000000000003 110.939 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.627 0.727 . . . . 72.329999999999998 110.878 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.829 0.347 . . . . 75.239999999999995 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -145.22 150.63 37.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 64.010000000000005 110.909 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.428 ' N ' HD12 ' A' ' 29' ' ' LEU . 15.2 tt0 -121.03 149.77 42.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 110.913 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.681 ' CE2' HD11 ' A' ' 29' ' ' LEU . 16.8 m-90 -107.28 136.64 46.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.903 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.42 145.08 38.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 61.350000000000001 110.911 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.816 HD12 ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.79 137.96 13.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.409999999999997 110.952 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 41' ' ' TRP . 8.1 t-20 -112.57 128.89 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 75.349999999999994 110.925 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.813 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.7 p -136.59 179.2 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 111.111 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.84 14.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 70.239999999999995 112.498 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 74.439999999999998 110.865 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.3 t -179.69 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 41.020000000000003 111.184 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -102.94 33.46 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.883 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.19 -6.71 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 52.009999999999998 111.097 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.464 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 15.9 p-90 -59.78 132.23 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 74.510000000000005 110.829 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.816 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -129.61 151.89 49.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 73.239999999999995 110.821 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.7 121.91 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 111.166 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD23 HD21 ' A' ' 33' ' ' LEU . 3.4 mm? -90.13 146.36 24.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 75.299999999999997 110.831 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.685 0.755 . . . . 70.120000000000005 110.877 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.716 0.293 . . . . 74.299999999999997 111.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.72 164.76 19.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.913 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -106.52 130.28 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 61.409999999999997 111.144 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 63' ' ' SER . 25.7 mt -70.39 158.64 87.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 74.099999999999994 110.921 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.59 31.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.759 2.306 . . . . 72.219999999999999 112.313 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.05 1.65 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.54 17.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 52.420000000000002 112.513 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.438 ' HB2' HD12 ' A' ' 59' ' ' LEU . 36.6 m -112.48 -178.3 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.396 . . . . 73.25 110.829 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 77' ' ' PHE . 21.8 tp -127.73 128.66 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.924 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD2' HG22 ' A' ' 15' ' ' VAL . 38.9 t80 -125.33 137.24 54.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 72.319999999999993 110.83 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.883 HD22 HG12 ' A' ' 69' ' ' VAL . 5.5 mp -118.48 125.03 28.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.601 0.715 . . . . 74.120000000000005 110.969 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -31.92 19.4 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.5 112.343 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.51 100.61 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 62.409999999999997 111.091 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.033 HG21 ' HB1' ' A' ' 8' ' ' ALA . 31.3 m -73.4 118.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 63.009999999999998 111.137 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.45 162.77 17.79 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.807 -0.711 . . . . 75.239999999999995 112.447 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.852 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.31 -29.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 70.439999999999998 111.175 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.7 -24.01 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 64.340000000000003 110.846 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.8 -4.64 56.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.288 -0.415 . . . . 75.239999999999995 110.809 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.3 140.77 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 54.340000000000003 110.802 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.589 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 159.03 -138.23 5.56 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.734 . . . . 64.129999999999995 112.554 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.589 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.6 mp -130.63 134.66 61.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.888 0.375 . . . . 72.109999999999999 111.142 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.786 ' CE2' HD13 ' A' ' 33' ' ' LEU . 5.9 m-85 -103.5 132.86 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 71.409999999999997 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.22 126.64 43.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 70.409999999999997 110.839 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 150.38 34.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.833 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.73 127.64 22.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 64.219999999999999 110.879 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.42 164.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 71.450000000000003 111.129 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.1 ttm -129.52 125.66 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.340000000000003 110.878 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.41 171.58 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.876 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -71.52 -17.72 62.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.827 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -72.36 -20.02 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 62.130000000000003 110.863 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.8 -21.0 23.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 24.199999999999999 112.483 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.69 148.13 26.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 75.310000000000002 110.79 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.45 145.16 30.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 64.239999999999995 110.953 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.3 132.61 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.149 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -98.51 146.71 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 63.0 110.952 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.66 126.62 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 65.340000000000003 110.817 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -129.08 120.83 26.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 62.43 110.852 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.56 127.26 41.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 110.995 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -83.75 135.46 34.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 72.329999999999998 110.925 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 77' ' ' PHE . 75.5 t -120.19 133.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 71.120000000000005 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 141.82 49.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.349999999999994 110.803 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.852 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.6 m -109.65 -176.21 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.162 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -75.93 -73.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 65.109999999999999 110.89 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.96 147.77 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 62.200000000000003 110.956 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.41 159.61 49.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.657 0.742 . . . . 51.119999999999997 111.161 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.182 0 C-N-CA 122.771 2.314 . . . . 62.020000000000003 112.313 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.79 0.328 . . . . 62.399999999999999 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.94 133.65 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 74.140000000000001 110.918 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.24 121.43 28.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 63.219999999999999 110.946 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.0 122.35 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 74.439999999999998 111.177 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -95.53 139.93 31.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 70.299999999999997 111.224 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.69 167.49 25.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 70.200000000000003 111.1 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.8 149.0 43.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 75.530000000000001 110.839 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.594 HG23 ' HA2' ' A' ' 70' ' ' GLY . 38.3 mt -52.73 120.54 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 111.166 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.721 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.61 11.7 68.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 61.030000000000001 112.516 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.775 ' O ' HG22 ' A' ' 69' ' ' VAL . 47.4 mm-40 -102.81 138.18 19.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 75.409999999999997 110.902 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 143.12 49.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.708 2.272 . . . . 74.230000000000004 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 66' ' ' LEU . 27.9 tp -145.82 142.91 29.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 110.862 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.86 146.87 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 63.509999999999998 111.179 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.705 HD12 HD23 ' A' ' 64' ' ' LEU . 7.9 mt -133.2 146.96 51.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.510000000000005 110.861 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -113.83 153.09 29.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.25 110.876 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.6 101.45 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 110.897 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.77 123.77 13.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 64.140000000000001 110.844 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.56 -40.92 1.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.711 . . . . 63.049999999999997 112.544 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.11 129.16 44.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 74.200000000000003 111.118 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -164.21 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 73.200000000000003 112.325 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -47.46 47.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 54.020000000000003 110.825 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 53.109999999999999 110.939 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.835 0.35 . . . . 75.209999999999994 110.819 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 29' ' ' LEU . 2.5 pp -135.54 164.75 27.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 64.150000000000006 110.846 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -133.73 146.78 51.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 70.450000000000003 110.897 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -121.81 137.43 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 139.2 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 72.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.783 HD11 HG23 ' A' ' 35' ' ' THR . 1.3 tm? -138.12 131.89 31.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.404 . . . . 75.219999999999999 110.917 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.71 ' N ' HD22 ' A' ' 33' ' ' LEU . 23.8 t-20 -115.78 120.55 39.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 60.32 110.901 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.7 p -139.73 179.47 6.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 72.140000000000001 111.145 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.11 -133.44 18.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 52.439999999999998 112.444 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -112.39 -37.28 5.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 73.310000000000002 110.869 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 t -179.28 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 72.319999999999993 111.205 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -101.29 33.69 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 71.510000000000005 110.947 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.39 -6.08 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 71.549999999999997 111.094 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -68.87 130.1 41.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.040000000000006 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 158.97 43.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 75.409999999999997 110.889 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.86 120.56 52.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.434 . . . . 60.149999999999999 111.064 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 147.79 23.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.836 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 53.420000000000002 110.86 -179.924 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.822 0.344 . . . . 74.510000000000005 111.067 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.681 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -122.23 161.38 23.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 111.004 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 63' ' ' SER . 41.4 t -107.9 129.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 61.219999999999999 111.119 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 65' ' ' PHE . 5.5 mp -69.97 157.19 90.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.739 0.78 . . . . 71.230000000000004 110.863 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -20.63 35.16 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.63 2.22 . . . . 44.32 112.411 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -82.18 1.39 36.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.140000000000001 110.917 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.98 20.61 35.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.684 -0.769 . . . . 65.409999999999997 112.521 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.47 ' O ' HG13 ' A' ' 58' ' ' VAL . 40.9 m -107.52 -179.22 3.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 72.319999999999993 110.829 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.705 HD23 HD12 ' A' ' 16' ' ' LEU . 55.7 tp -130.4 129.22 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 72.120000000000005 110.956 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' HB2' HD11 ' A' ' 59' ' ' LEU . 6.3 t80 -126.21 131.64 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.319999999999993 110.876 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.86 HD22 HG12 ' A' ' 69' ' ' VAL . 2.8 mp -115.17 129.9 24.69 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.586 0.708 . . . . 63.229999999999997 110.944 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.84 17.71 Favored 'Trans proline' 0 N--CA 1.466 -0.12 0 C-N-CA 122.74 2.293 . . . . 72.430000000000007 112.323 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.721 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.21 99.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 111.127 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.86 HG12 HD22 ' A' ' 66' ' ' LEU . 14.5 m -77.46 112.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 60.229999999999997 111.053 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.594 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -87.33 175.63 46.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 33.43 112.532 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.867 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.18 -31.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 73.310000000000002 111.081 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -76.59 -21.96 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 62.439999999999998 110.937 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.55 -3.6 35.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.87 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 141.1 56.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 63.100000000000001 110.932 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.749 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 158.56 -150.47 21.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 71.420000000000002 112.422 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 75' ' ' GLY . 4.4 mm -130.63 137.25 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 73.519999999999996 111.115 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.584 ' CG ' HD23 ' A' ' 33' ' ' LEU . 41.3 m-85 -103.11 127.43 50.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 63.509999999999998 110.869 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -124.92 128.37 48.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 70.099999999999994 110.932 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.83 151.25 39.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.109999999999999 110.871 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 71.109999999999999 110.996 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.525 ' HB3' ' OG1' ' A' ' 89' ' ' THR . . . -131.7 163.07 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 54.43 111.125 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 72.3 mmm -129.8 124.84 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.905 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -89.71 170.61 10.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.150000000000006 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -21.81 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.805 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -73.39 -19.97 60.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 71.109999999999999 110.902 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 -7.48 32.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 73.200000000000003 112.455 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 146.59 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 72.140000000000001 110.959 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.0 144.02 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.934 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -103.12 126.17 50.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 72.239999999999995 111.124 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -102.48 142.39 33.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 74.540000000000006 110.98 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -146.46 120.05 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 41.049999999999997 110.882 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 122.47 29.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.019999999999996 110.955 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.48 119.41 22.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 64.510000000000005 110.915 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.487 ' HA ' HG23 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -84.46 134.46 34.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 55.439999999999998 110.924 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.436 HG21 ' CE1' ' A' ' 77' ' ' PHE . 61.8 t -120.91 137.24 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 111.18 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -129.91 130.5 45.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.867 HG21 ' HA ' ' A' ' 71' ' ' ILE . 22.6 m -93.5 -176.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 75.329999999999998 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.402 ' CD2' ' NE2' ' A' ' 99' ' ' GLN . 9.4 t80 -65.34 -77.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 110.958 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.584 ' HB2' HD11 ' A' ' 10' ' ' ILE . 2.2 mp0 -66.75 140.64 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 74.230000000000004 110.949 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.04 159.69 48.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 72.230000000000004 111.19 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 N--CA 1.465 -0.177 0 C-N-CA 122.786 2.324 . . . . 61.149999999999999 112.339 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.705 0.288 . . . . 75.140000000000001 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -93.14 133.05 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 73.219999999999999 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.69 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -85.06 119.84 25.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 110.896 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.69 HD12 ' O ' ' A' ' 5' ' ' ASN . 1.3 mp -125.83 122.0 61.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.430000000000007 111.122 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -95.84 142.27 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 63.5 111.148 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.14 166.55 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 72.340000000000003 111.141 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.29 148.94 44.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.847 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.597 HD11 ' HB2' ' A' ' 99' ' ' GLN . 38.1 mt -54.38 119.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 53.420000000000002 111.147 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.602 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.92 7.85 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 72.209999999999994 112.418 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.823 ' O ' HG22 ' A' ' 69' ' ' VAL . 37.4 mm-40 -102.55 140.08 20.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 51.25 110.901 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 143.02 49.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.654 2.236 . . . . 64.439999999999998 112.298 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 66' ' ' LEU . 51.5 tp -145.27 143.49 30.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 65.430000000000007 110.882 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.476 HG22 ' CD2' ' A' ' 65' ' ' PHE . 38.3 t -124.08 147.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 71.439999999999998 111.142 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.732 HD12 HD23 ' A' ' 64' ' ' LEU . 59.8 mt -131.39 148.26 52.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.239999999999995 110.996 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 151.88 28.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 72.099999999999994 110.912 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.7 101.5 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.120000000000005 110.897 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -58.93 120.98 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 110.838 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.99 -39.4 2.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.826 -0.702 . . . . 75.030000000000001 112.587 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.6 128.32 46.95 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 72.340000000000003 111.153 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -165.32 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 72.530000000000001 112.387 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.6 52.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 110.913 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.518 0.675 . . . . 55.109999999999999 110.864 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.87 0.367 . . . . 63.240000000000002 110.803 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.405 HD12 ' C ' ' A' ' 29' ' ' LEU . 4.1 pp -135.55 158.6 43.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.915 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.25 148.16 44.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 64.150000000000006 110.876 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -131.75 128.94 39.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 63.350000000000001 110.887 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -137.66 136.0 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 110.891 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.855 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.86 139.37 38.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 72.400000000000006 110.892 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -111.89 126.65 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 63.030000000000001 110.921 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.82 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.6 p -138.52 -179.67 5.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 71.129999999999995 111.137 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.3 -130.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 42.210000000000001 112.511 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.98 -37.14 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 73.299999999999997 110.835 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.0 t -179.3 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 55.149999999999999 111.092 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 38' ' ' THR . 8.3 mm-40 -102.12 34.3 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 72.329999999999998 110.875 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.07 -6.99 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 72.530000000000001 111.178 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.54 ' CZ2' HG22 ' A' ' 43' ' ' VAL . 48.1 t90 -59.5 130.44 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 75.430000000000007 110.908 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.742 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -129.96 153.67 48.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 63.130000000000003 110.831 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.54 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 19.7 t -104.62 113.8 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 62.420000000000002 111.186 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.855 HD22 HD21 ' A' ' 33' ' ' LEU . 10.7 mp -93.32 147.2 23.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 64.209999999999994 110.916 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.7 0.762 . . . . 74.400000000000006 110.9 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.817 0.341 . . . . 72.329999999999998 111.093 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 165.55 16.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 71.120000000000005 110.875 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 45' ' ' SER . 42.6 t -108.63 130.05 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 63.32 111.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 63' ' ' SER . 50.3 mt -69.28 156.96 90.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 73.019999999999996 110.892 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -21.6 33.72 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.769 2.313 . . . . 62.439999999999998 112.344 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -82.19 1.0 38.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.200000000000003 110.927 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.71 26.35 20.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.457 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 58' ' ' VAL . 19.9 m -111.25 179.39 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 54.509999999999998 110.917 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.732 HD23 HD12 ' A' ' 16' ' ' LEU . 11.5 tp -129.89 128.82 42.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.901 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 15' ' ' VAL . 3.8 t80 -125.59 131.3 52.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.897 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.89 HD22 HG12 ' A' ' 69' ' ' VAL . 3.7 mp -114.34 126.9 27.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.649 0.738 . . . . 74.340000000000003 110.978 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -32.02 19.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.74 2.293 . . . . 53.450000000000003 112.289 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.34 99.17 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.128 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 66' ' ' LEU . 15.9 m -73.94 115.7 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 52.329999999999998 111.093 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.53 167.46 28.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 63.409999999999997 112.426 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.854 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.57 -29.98 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 74.109999999999999 111.142 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -75.57 -22.9 56.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.239999999999995 110.912 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -7.92 58.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 75.439999999999998 110.921 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.25 141.1 55.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 64.209999999999994 110.821 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.604 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 157.4 -142.73 8.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 71.230000000000004 112.533 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.604 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.6 mp -130.88 129.29 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 73.200000000000003 111.154 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.737 ' CE2' HD13 ' A' ' 33' ' ' LEU . 18.0 m-85 -103.79 131.07 51.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 71.349999999999994 110.89 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.09 140.86 51.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 71.239999999999995 110.915 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.4 153.09 38.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 65.450000000000003 110.887 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -139.76 126.5 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 74.019999999999996 110.825 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.53 161.78 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 72.109999999999999 111.054 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.4 ttm -131.04 125.25 32.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 73.540000000000006 110.859 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -86.82 172.21 10.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 74.439999999999998 110.863 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.19 -18.28 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.86 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.22 -19.84 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.463 . . . . 65.450000000000003 110.919 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.41 -16.54 31.88 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.612 -0.804 . . . . 72.340000000000003 112.436 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -85.26 145.93 27.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.49 144.77 31.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 64.340000000000003 110.871 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.406 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -102.21 130.84 48.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.349999999999994 111.186 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 90' ' ' LYS . 7.1 mmmt -105.08 142.37 34.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 60.119999999999997 110.847 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -144.76 125.07 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 65.230000000000004 110.99 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.48 127.07 45.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -128.3 124.21 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 71.450000000000003 110.968 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -84.27 132.37 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.230000000000004 110.848 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 77' ' ' PHE . 69.9 t -120.82 134.46 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 72.140000000000001 111.114 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.442 ' NH1' HG21 ' A' ' 100' ' ' ILE . 1.6 mmm180 -131.95 128.17 37.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 63.130000000000003 110.882 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.854 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.2 m -92.93 -175.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 111.151 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -70.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 75.140000000000001 110.963 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 10' ' ' ILE . 2.8 mp0 -71.23 139.98 50.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 61.329999999999998 110.924 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.442 HG21 ' NH1' ' A' ' 96' ' ' ARG . 1.1 pt -121.5 159.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.535 0.683 . . . . 74.129999999999995 111.161 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--N 1.34 0.11 0 C-N-CA 122.713 2.276 . . . . 71.400000000000006 112.23 179.89 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.741 0.305 . . . . 54.020000000000003 111.1 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -93.21 132.61 37.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.019999999999996 110.882 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 121.34 27.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 72.239999999999995 110.882 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.8 mm -125.08 120.21 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.101 -0.5 . . . . 74.140000000000001 111.198 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -96.76 137.94 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.41 28.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 111.11 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.51 148.98 44.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.937 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 51.6 mt -51.91 121.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.265 -0.425 . . . . 75.010000000000005 111.125 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.727 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.58 5.95 74.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 72.420000000000002 112.481 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.779 ' O ' HG22 ' A' ' 69' ' ' VAL . 16.2 mm-40 -101.29 139.49 20.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 71.230000000000004 110.89 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.13 49.85 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.655 2.237 . . . . 72.540000000000006 112.315 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 6' ' ' ILE . 28.4 tp -145.18 141.76 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 70.310000000000002 110.875 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.81 148.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 62.200000000000003 111.081 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.516 HD12 HD23 ' A' ' 64' ' ' LEU . 54.8 mt -132.48 148.27 52.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 74.230000000000004 110.957 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.33 153.05 27.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 75.420000000000002 110.83 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 t -105.94 102.31 11.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.340000000000003 110.831 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.6 121.91 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.420000000000002 110.907 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.93 -36.05 2.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.781 -0.723 . . . . 71.310000000000002 112.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.25 39.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 42.329999999999998 111.105 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.5 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.696 2.264 . . . . 63.329999999999998 112.331 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -48.49 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 64.439999999999998 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.54 0.686 . . . . 74.450000000000003 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.909 0.385 . . . . 61.32 110.823 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -136.82 156.57 48.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 74.019999999999996 110.892 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.79 148.11 51.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 70.239999999999995 110.873 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -117.98 145.52 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 72.430000000000007 110.906 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 33' ' ' LEU . 53.0 mttt -138.04 144.03 40.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 55.0 110.953 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD21 HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 42.030000000000001 110.868 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -115.04 124.01 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 73.319999999999993 110.862 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.799 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.8 p -138.87 178.37 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 74.209999999999994 111.157 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.31 -130.17 11.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 70.409999999999997 112.498 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -112.64 -37.96 4.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.412 . . . . 74.209999999999994 110.93 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.594 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.1 t -179.71 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 72.040000000000006 111.115 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.4 mt-10 -102.38 33.26 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 71.439999999999998 110.918 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.799 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.22 -7.07 7.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 65.040000000000006 111.072 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -62.47 130.15 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 75.5 110.929 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.98 153.28 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.901 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.57 124.78 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 61.100000000000001 111.096 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 HD13 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -86.57 143.79 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.521 . . . . 72.329999999999998 110.969 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.607 0.718 . . . . 53.020000000000003 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.7 0.286 . . . . 60.409999999999997 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -128.18 159.85 33.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 110.811 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.33 131.85 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 64.510000000000005 111.092 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 63' ' ' SER . 36.7 mt -68.07 157.71 86.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.649 0.737 . . . . 61.229999999999997 110.956 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -23.12 31.55 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.702 2.268 . . . . 54.329999999999998 112.339 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.07 1.31 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 25.56 18.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 65.239999999999995 112.47 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.662 ' HB3' HD12 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -106.65 -179.1 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 73.230000000000004 110.849 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.822 HD13 HD11 ' A' ' 44' ' ' LEU . 5.8 tp -129.09 128.56 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.492 . . . . 64.430000000000007 110.848 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' HD12 ' A' ' 64' ' ' LEU . 9.6 t80 -126.16 130.73 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.049999999999997 110.853 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.417 HD22 HG12 ' A' ' 69' ' ' VAL . 3.0 mp -118.41 131.07 24.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 72.319999999999993 110.939 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -34.76 13.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 64.209999999999994 112.336 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.727 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.73 103.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 63.420000000000002 111.049 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.0 m -73.7 118.93 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.549999999999997 111.109 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.38 162.02 31.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 71.200000000000003 112.514 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.823 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.47 -29.47 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 61.399999999999999 111.166 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.16 -22.54 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 61.219999999999999 110.835 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.08 -4.76 56.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.310000000000002 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.43 140.44 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.954 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 154.76 -139.83 6.99 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.701 -0.761 . . . . 43.219999999999999 112.455 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.9 mp -126.81 130.59 71.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 73.340000000000003 111.18 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CD2' HD22 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.85 129.02 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.909 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -126.55 126.15 43.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.907 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 154.5 24.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 52.240000000000002 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.73 135.11 31.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 75.340000000000003 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.08 163.26 29.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 71.109999999999999 111.082 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.14 123.98 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.858 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.28 171.72 9.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 110.877 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -18.71 62.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 62.450000000000003 110.851 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -73.38 -20.11 60.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 53.119999999999997 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.31 32.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 71.219999999999999 112.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -85.27 146.76 26.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 74.439999999999998 110.835 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.33 144.95 31.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.409999999999997 110.869 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.433 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.92 126.69 50.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 62.25 111.153 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -103.14 143.25 32.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.923 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.8 m -143.76 126.75 16.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 110.826 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.1 124.31 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 73.019999999999996 110.909 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -128.84 126.38 39.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 75.340000000000003 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -84.46 131.36 34.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.400000000000006 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.13 133.87 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 62.539999999999999 111.168 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -131.75 128.58 39.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 64.099999999999994 110.928 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.3 m -96.45 -176.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 111.098 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -61.7 -79.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 74.319999999999993 110.925 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -70.71 144.26 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 110.848 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.49 49.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.664 0.745 . . . . 63.210000000000001 111.102 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.694 2.263 . . . . 73.010000000000005 112.372 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.739 0.304 . . . . 60.219999999999999 111.13 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.42 132.57 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 70.430000000000007 110.838 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -90.45 120.47 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 73.400000000000006 110.855 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.916 HG21 HD11 ' A' ' 14' ' ' LEU . 4.6 mp -125.44 122.53 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 65.109999999999999 111.146 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -95.45 142.3 27.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.299999999999997 111.1 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -147.49 167.42 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 65.019999999999996 111.112 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.26 149.18 42.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 65.409999999999997 110.87 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.4 mt -52.19 120.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 51.399999999999999 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.07 10.09 69.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 63.140000000000001 112.475 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.753 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.1 mm-40 -103.31 138.95 19.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.54 0.686 . . . . 74.219999999999999 110.88 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.66 51.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.673 2.248 . . . . 73.109999999999999 112.308 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 6' ' ' ILE . 35.2 tp -144.92 142.02 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.239999999999995 110.983 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' CD2' ' A' ' 65' ' ' PHE . 31.3 t -125.93 148.29 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 75.109999999999999 111.081 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.8 mt -134.77 148.29 50.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.019999999999996 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -112.55 151.53 29.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 110.903 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.1 t -107.28 99.7 9.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 44.5 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -54.37 125.03 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.852 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.97 -41.74 1.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 53.229999999999997 112.51 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.12 43.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.581 0.705 . . . . 62.030000000000001 111.102 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -165.0 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.709 2.272 . . . . 74.209999999999994 112.381 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -49.41 -48.82 46.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.458 . . . . 52.329999999999998 110.794 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.545 0.688 . . . . 73.519999999999996 110.911 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 65.150000000000006 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.8 pp -135.82 160.33 38.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 71.319999999999993 110.981 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -121.26 145.01 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 62.130000000000003 110.864 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -128.38 137.33 51.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.891 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -140.81 139.07 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 75.109999999999999 110.94 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.779 HD22 ' CE2' ' A' ' 77' ' ' PHE . 4.9 tp -137.29 136.0 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 74.140000000000001 110.88 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.3 t-20 -114.48 121.54 43.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 72.109999999999999 110.914 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.79 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 73.3 p -137.59 179.36 6.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 43.310000000000002 111.146 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.89 -129.18 9.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.712 -0.756 . . . . 43.420000000000002 112.442 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -112.48 -38.43 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 74.219999999999999 110.827 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 39' ' ' GLU . 9.7 t 179.78 -31.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 74.239999999999995 111.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 38' ' ' THR . 15.4 mt-10 -103.44 33.96 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 62.439999999999998 110.894 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.43 -6.8 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 75.049999999999997 111.083 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.55 132.3 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 74.319999999999993 110.932 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 158.95 38.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 63.340000000000003 110.927 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.07 120.52 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 73.319999999999993 111.136 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.12 147.2 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.893 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.482 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.9 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.120000000000005 110.85 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.724 0.297 . . . . 54.439999999999998 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.6 164.13 18.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.876 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 45' ' ' SER . 42.1 t -107.51 130.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 54.130000000000003 111.055 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.63 158.85 85.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 72.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -22.19 32.46 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.721 2.28 . . . . 32.219999999999999 112.354 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.57 1.34 42.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 110.885 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.41 28.5 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 62.109999999999999 112.488 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 m -111.87 -178.88 3.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 72.209999999999994 110.843 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -128.89 128.93 44.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 73.349999999999994 110.92 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 15' ' ' VAL . 7.8 t80 -125.57 134.82 51.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.844 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.767 HD22 HG12 ' A' ' 69' ' ' VAL . 5.2 mp -114.8 124.45 30.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.657 0.741 . . . . 61.210000000000001 110.922 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -31.77 19.77 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 70.340000000000003 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.57 101.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 63.210000000000001 111.101 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.767 HG12 HD22 ' A' ' 66' ' ' LEU . 35.7 m -71.71 114.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 73.109999999999999 111.138 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.01 159.18 22.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 43.149999999999999 112.493 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.18 -31.0 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 73.340000000000003 111.113 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -77.15 -22.82 51.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.929 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.84 -3.87 37.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 74.150000000000006 110.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 143.3 39.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 73.409999999999997 110.876 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.707 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 159.1 -148.37 17.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 74.120000000000005 112.546 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 75' ' ' GLY . 19.2 mm -131.22 137.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 74.099999999999994 111.071 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CE2' HD22 ' A' ' 33' ' ' LEU . 10.9 m-85 -101.65 127.84 48.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.899 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.32 126.91 45.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.855 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.43 149.8 43.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.835 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -141.95 134.18 27.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 73.129999999999995 110.97 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.15 163.3 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 74.329999999999998 111.114 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ttm -130.55 124.94 32.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 62.299999999999997 110.894 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -86.9 172.28 10.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.400000000000006 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -70.96 -18.53 62.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 54.210000000000001 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.26 -19.9 60.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.849 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.17 -13.69 37.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 54.140000000000001 112.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -85.08 146.38 27.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.705 0.288 . . . . 72.540000000000006 110.963 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.43 144.95 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 54.240000000000002 110.857 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -102.01 132.63 47.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 72.25 111.13 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -98.96 143.48 29.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 73.010000000000005 110.9 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 m -144.66 121.14 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.878 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.18 120.13 25.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.019999999999996 110.873 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -129.67 119.71 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.869 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.499 ' HG2' HD12 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -86.79 135.44 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 61.340000000000003 110.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.6 t -120.94 136.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 75.329999999999998 111.093 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -131.06 142.88 50.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.868 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.0 m -106.3 -175.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 64.120000000000005 111.092 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -67.69 -81.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 110.989 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -62.85 145.45 55.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 110.855 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.43 159.67 49.24 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.723 0.773 . . . . 63.299999999999997 111.052 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.5 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.708 2.272 . . . . 63.130000000000003 112.318 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.729 0.3 . . . . 61.109999999999999 111.1 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.95 133.75 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.530000000000001 110.849 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -90.3 121.29 32.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 62.420000000000002 110.864 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 14' ' ' LEU . 4.6 mp -124.76 122.15 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 71.329999999999998 111.141 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -94.62 140.14 30.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.144 -0.48 . . . . 44.240000000000002 111.117 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.66 167.65 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.299999999999997 111.076 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.13 43.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 71.310000000000002 110.819 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.614 HD11 ' HB2' ' A' ' 99' ' ' GLN . 28.9 mt -52.12 120.44 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 111.119 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.666 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.61 10.35 70.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 73.310000000000002 112.457 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.785 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.7 mm-40 -102.7 139.46 20.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.69 0.757 . . . . 74.510000000000005 110.889 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.98 49.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.667 2.245 . . . . 54.299999999999997 112.342 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 6' ' ' ILE . 49.9 tp -145.42 143.32 30.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 110.864 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.88 147.75 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 111.101 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -132.2 150.21 52.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 61.329999999999998 110.917 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -111.71 151.52 28.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.240000000000002 110.904 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -107.3 100.82 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 110.938 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -54.16 125.09 17.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 110.827 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.508 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.47 -43.21 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.729 . . . . 50.299999999999997 112.512 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.45 42.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 74.209999999999994 111.012 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -161.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.613 2.209 . . . . 73.450000000000003 112.408 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -48.26 -47.02 36.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 110.938 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 65.510000000000005 110.866 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.841 0.353 . . . . 71.430000000000007 110.87 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 29' ' ' LEU . 4.6 pp -138.54 157.28 46.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 110.879 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -121.77 145.86 47.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 62.240000000000002 110.848 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -120.24 143.64 48.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 74.5 111.03 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -148.88 135.44 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.299999999999997 110.896 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.773 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -141.23 138.31 33.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 72.219999999999999 110.921 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.49 126.11 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.530000000000001 110.807 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.839 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.5 p -138.72 -178.9 5.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 73.530000000000001 111.038 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -127.27 9.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.713 -0.756 . . . . 75.120000000000005 112.517 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' O ' ' HB ' ' A' ' 38' ' ' THR . 12.0 mpt_? -112.79 -38.64 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 73.409999999999997 110.875 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t 178.97 -29.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 111.124 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -102.43 34.08 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 64.219999999999999 110.913 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.99 -6.96 8.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 55.310000000000002 111.063 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -70.06 129.07 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.952 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -137.18 159.25 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.809 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.2 121.96 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 111.167 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' CD1' HD23 ' A' ' 33' ' ' LEU . 6.9 mt -89.23 144.67 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 65.420000000000002 110.888 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 72.510000000000005 110.898 -179.891 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.826 0.346 . . . . 54.450000000000003 111.122 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.79 161.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 61.439999999999998 110.904 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 63' ' ' SER . 50.5 t -108.23 130.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 74.219999999999999 111.073 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 63' ' ' SER . 47.3 mt -69.01 156.98 90.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 64.420000000000002 110.927 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.95 32.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.254 . . . . 65.209999999999994 112.331 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -81.48 0.39 38.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 73.340000000000003 110.91 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.88 30.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 74.299999999999997 112.525 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.7 m -106.38 -179.55 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.951 0.405 . . . . 60.409999999999997 110.851 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.6 tp -130.21 130.74 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.129999999999995 110.969 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.632 ' N ' HD12 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -124.89 130.36 52.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.019999999999996 110.892 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.893 HD22 HG12 ' A' ' 69' ' ' VAL . 3.0 mp -117.19 127.12 26.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 75.120000000000005 110.899 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -32.37 18.57 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.804 2.336 . . . . 64.120000000000005 112.382 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.666 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.45 100.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 32.140000000000001 111.101 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.893 HG12 HD22 ' A' ' 66' ' ' LEU . 15.3 m -78.01 113.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 111.156 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -87.82 173.85 43.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 73.200000000000003 112.44 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.876 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.7 -32.23 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 75.230000000000004 111.109 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -77.26 -21.61 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.928 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -5.61 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 62.210000000000001 110.833 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 142.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 65.140000000000001 110.958 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 159.71 -151.49 22.24 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.734 -0.746 . . . . 53.399999999999999 112.463 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 75' ' ' GLY . 5.4 mm -131.38 134.85 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 75.409999999999997 111.093 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.773 ' CE2' HD22 ' A' ' 33' ' ' LEU . 50.1 m-85 -103.96 132.82 49.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 74.019999999999996 110.856 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.03 134.17 50.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.78 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.73 148.12 45.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 64.530000000000001 110.902 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -142.4 127.43 18.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.903 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.38 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 44.130000000000003 111.083 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ttm -130.64 125.66 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.549999999999997 110.926 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.58 171.92 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 74.349999999999994 110.95 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -19.15 61.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 71.049999999999997 110.802 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.9 -20.24 60.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 61.539999999999999 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.56 35.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 71.319999999999993 112.472 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 146.32 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.662 0.268 . . . . 64.409999999999997 110.886 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -105.63 142.62 35.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 73.230000000000004 110.863 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.508 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.96 131.09 50.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 74.519999999999996 111.085 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.42 142.85 34.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.150000000000006 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -146.1 123.61 11.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 60.140000000000001 110.816 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.13 122.28 31.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 54.219999999999999 110.819 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.02 118.81 24.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 62.229999999999997 110.94 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 134.16 34.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.886 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.415 HG22 HD21 ' A' ' 14' ' ' LEU . 57.7 t -120.5 135.73 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 111.142 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -130.65 131.61 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 75.349999999999994 110.854 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -96.51 -176.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 73.349999999999994 111.164 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.403 ' CD2' ' NE2' ' A' ' 99' ' ' GLN . 9.3 t80 -67.4 -78.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 70.329999999999998 110.939 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.614 ' HB2' HD11 ' A' ' 10' ' ' ILE . 2.3 mp0 -63.81 141.34 58.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 73.420000000000002 110.953 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.07 159.45 49.31 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.319999999999993 111.084 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 C-N-CA 122.647 2.231 . . . . 70.340000000000003 112.415 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.67 0.272 . . . . 52.32 111.031 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -93.92 133.12 37.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 110.935 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -89.5 121.63 31.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.582 HG21 HD11 ' A' ' 14' ' ' LEU . 4.0 mp -123.83 120.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 72.129999999999995 111.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 p -96.7 142.47 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.13 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.43 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 51.219999999999999 111.132 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.69 147.97 40.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 64.450000000000003 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 121.3 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 111.14 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.658 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.48 5.89 74.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 55.25 112.497 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.795 ' O ' HG22 ' A' ' 69' ' ' VAL . 48.7 mm-40 -101.47 141.43 22.58 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.606 0.717 . . . . 75.239999999999995 110.831 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.78 52.21 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.606 2.204 . . . . 74.040000000000006 112.384 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 6' ' ' ILE . 54.8 tp -144.48 143.14 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.437 . . . . 72.310000000000002 110.902 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.436 HG22 ' HD2' ' A' ' 65' ' ' PHE . 20.4 t -121.84 146.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 74.099999999999994 111.153 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.762 HD12 HD23 ' A' ' 64' ' ' LEU . 12.5 mt -131.41 148.28 52.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.951 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 152.04 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 70.019999999999996 110.972 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.9 t -107.08 99.88 9.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 53.109999999999999 110.871 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.66 123.56 14.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 51.450000000000003 110.908 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.18 -39.4 2.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.530000000000001 112.483 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 131.28 37.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 65.209999999999994 111.101 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -163.96 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.675 2.25 . . . . 53.030000000000001 112.32 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -50.09 30.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 64.239999999999995 110.871 179.846 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.875 0.369 . . . . 70.049999999999997 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.48 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.6 159.11 42.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 53.229999999999997 110.93 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.09 139.59 53.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 71.400000000000006 110.885 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.48 ' HE1' HD13 ' A' ' 29' ' ' LEU . 13.2 m95 -121.34 139.09 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -139.05 137.07 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 61.399999999999999 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.623 HD22 HG23 ' A' ' 35' ' ' THR . 2.0 tt -138.82 134.09 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 73.530000000000001 110.918 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.594 ' N ' HD23 ' A' ' 33' ' ' LEU . 2.9 m120 -115.77 125.18 52.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.852 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 44.8 p -138.43 -179.5 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.129 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.61 -130.83 13.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.748 -0.739 . . . . 60.039999999999999 112.481 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -112.84 -37.56 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 73.129999999999995 110.905 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t -179.74 -29.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 61.130000000000003 111.187 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.1 mt-10 -101.97 33.6 2.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.896 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.75 -7.23 7.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 54.100000000000001 111.121 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -60.26 130.41 46.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.919 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HZ2' ' HB3' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.52 153.45 49.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 74.140000000000001 110.907 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.54 121.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 51.219999999999999 111.191 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.65 145.96 24.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 110.942 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.567 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.664 0.745 . . . . 74.150000000000006 110.88 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.819 0.342 . . . . 63.130000000000003 111.07 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -123.25 159.25 29.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.9 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 45' ' ' SER . 18.8 t -108.38 130.17 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 72.420000000000002 111.132 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.5 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.4 mt -69.06 157.64 88.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.54 0.686 . . . . 74.230000000000004 110.947 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -21.8 32.77 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.622 2.215 . . . . 71.420000000000002 112.357 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -84.24 1.44 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.420000000000002 110.908 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.86 32.83 8.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.803 -0.713 . . . . 71.400000000000006 112.451 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.5 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.4 m -115.35 179.11 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 65.010000000000005 110.868 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.762 HD23 HD12 ' A' ' 16' ' ' LEU . 20.4 tp -129.47 128.22 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.847 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HD2' HG22 ' A' ' 15' ' ' VAL . 38.3 t80 -126.78 136.61 52.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.81 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD22 HG12 ' A' ' 69' ' ' VAL . 1.4 mp -118.45 130.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 74.200000000000003 110.974 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -34.87 13.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 64.010000000000005 112.336 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.58 101.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 111.1 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.4 m -72.65 113.22 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 61.350000000000001 111.11 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.85 161.82 33.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 62.009999999999998 112.478 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.871 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.84 -30.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 74.099999999999994 111.152 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.1 -20.43 57.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.933 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -3.55 29.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 73.120000000000005 110.871 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.697 ' CD ' HG22 ' A' ' 97' ' ' VAL . 27.5 mt-10 -57.13 142.52 42.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.340000000000003 110.866 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.651 ' C ' HD13 ' A' ' 76' ' ' ILE . . . 158.75 -153.99 25.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.674 -0.774 . . . . 62.130000000000003 112.41 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD13 ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -123.81 134.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.156 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.4 t80 -104.0 127.54 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.852 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.2 128.86 47.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 63.43 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 7.0 t -120.54 150.2 41.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 51.030000000000001 110.891 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.85 133.7 29.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 62.299999999999997 110.927 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.81 162.99 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 71.099999999999994 111.129 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 25.0 mtp -129.69 124.77 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 71.409999999999997 110.967 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.21 172.82 9.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.87 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -70.71 -19.03 62.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 75.329999999999998 110.922 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.83 -20.05 60.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.43 40.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.82 -0.705 . . . . 60.329999999999998 112.547 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.08 146.87 26.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 71.109999999999999 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -105.05 142.5 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 75.450000000000003 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.462 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -103.72 131.84 50.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.519999999999996 111.122 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -102.53 143.56 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 t -144.39 125.72 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -126.83 122.07 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.896 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 121.77 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 74.129999999999995 110.883 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.549 ' HE ' HG23 ' A' ' 76' ' ' ILE . 27.5 mmm-85 -83.79 134.01 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 64.540000000000006 110.905 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.35 128.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 61.219999999999999 111.079 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.09 142.93 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 110.91 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.871 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.8 m -108.86 -174.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 71.140000000000001 111.176 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -67.3 -79.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 110.85 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -63.09 145.99 54.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 70.310000000000002 110.932 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.2 159.59 49.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 111.204 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.3 Cg_endo . . . . . 0 C--N 1.342 0.222 0 C-N-CA 122.756 2.304 . . . . 72.230000000000004 112.355 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.797 0.332 . . . . 74.409999999999997 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.57 132.38 37.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 75.209999999999994 110.906 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 3.5 p30 -83.84 122.49 28.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.519999999999996 110.99 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.537 ' CG2' HD11 ' A' ' 14' ' ' LEU . 48.8 mm -124.6 121.64 61.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 73.299999999999997 111.116 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -95.92 141.86 28.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.420000000000002 111.061 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.52 166.04 29.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 55.299999999999997 111.077 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -124.67 148.91 47.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.47 . . . . 75.349999999999994 110.92 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 99' ' ' GLN . 55.9 mt -54.57 121.21 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 70.25 111.103 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.526 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.61 5.44 81.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 61.420000000000002 112.541 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 48.8 mm-40 -102.26 139.6 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.561 0.696 . . . . 73.140000000000001 110.938 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 144.76 55.33 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.69 2.26 . . . . 75.409999999999997 112.351 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 6' ' ' ILE . 17.3 tp -143.43 141.35 30.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.86 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG22 ' HD1' ' A' ' 65' ' ' PHE . 41.2 t -126.04 145.12 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 63.340000000000003 111.061 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.8 mt -131.83 147.12 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.899 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -114.56 154.17 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 62.420000000000002 110.858 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.3 t -105.43 100.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.129999999999995 110.831 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -57.03 123.38 14.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.899 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.63 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.42 -43.52 1.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.782 -0.723 . . . . 63.439999999999998 112.496 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.67 131.26 36.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.523 0.678 . . . . 75.430000000000007 111.12 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.16 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.661 2.241 . . . . 74.109999999999999 112.351 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.1 -53.25 21.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.439999999999998 110.812 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptp . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.91 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.914 0.388 . . . . 72.120000000000005 110.841 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -137.07 155.04 50.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 110.891 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.89 140.86 51.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 74.25 110.885 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -123.72 141.35 52.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.914 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HG2' HG13 ' A' ' 43' ' ' VAL . 27.4 mtmt -144.4 140.38 28.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 51.450000000000003 110.844 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.774 HD22 ' CE2' ' A' ' 77' ' ' PHE . 6.0 tp -137.55 136.33 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.221 -0.445 . . . . 72.010000000000005 110.936 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -115.4 120.49 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 110.838 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.3 p -138.08 -179.82 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 73.140000000000001 111.131 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.32 -130.36 9.82 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 32.43 112.453 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -112.45 -38.77 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 72.019999999999996 110.912 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 39' ' ' GLU . 8.5 t 179.42 -30.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.143 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.3 mt-10 -103.22 33.89 3.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 63.439999999999998 110.92 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.26 -7.47 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 54.310000000000002 111.128 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -61.92 129.8 42.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.927 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 158.42 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 75.200000000000003 110.88 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 32' ' ' LYS . 22.8 t -94.84 122.21 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 111.152 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.99 144.69 25.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.517 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.718 0.771 . . . . 64.319999999999993 110.814 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.74 0.305 . . . . 72.129999999999995 111.065 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.534 ' O ' HD12 ' A' ' 64' ' ' LEU . 40.3 mmm-85 -126.79 158.52 36.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 74.450000000000003 110.874 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 45' ' ' SER . 6.8 t -109.14 130.82 61.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.127 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 33.4 mt -68.84 158.3 86.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 50.409999999999997 110.851 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -22.24 32.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 72.310000000000002 112.413 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.43 1.61 40.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 110.898 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.91 29.3 13.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 44.009999999999998 112.538 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 6.3 m -112.74 -178.64 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 71.150000000000006 110.852 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 57' ' ' ARG . 50.1 tp -128.27 128.98 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 61.25 110.906 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HD1' HG22 ' A' ' 15' ' ' VAL . 12.6 t80 -125.64 136.6 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.82 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.776 HD22 HG12 ' A' ' 69' ' ' VAL . 7.0 mp -119.1 127.63 26.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.574 0.702 . . . . 71.129999999999995 110.898 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.93 -32.81 17.15 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.69 2.26 . . . . 75.549999999999997 112.336 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.14 102.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 111.167 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 23.7 m -71.98 117.19 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 55.240000000000002 111.11 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.81 160.11 28.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 73.409999999999997 112.525 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.866 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -33.86 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 65.519999999999996 111.129 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -77.69 -21.56 51.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.125 -0.489 . . . . 70.239999999999995 110.956 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.08 -4.73 40.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.834 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -58.97 142.7 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 110.875 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.745 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 162.63 -148.32 15.14 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.727 -0.749 . . . . 64.230000000000004 112.444 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.1 mp -130.67 133.71 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 74.409999999999997 111.084 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CE2' HD22 ' A' ' 33' ' ' LEU . 11.8 m-85 -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 64.239999999999995 110.926 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.98 126.97 44.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 110.903 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.6 t -121.16 151.11 40.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.010000000000005 110.913 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -139.44 133.9 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 54.340000000000003 110.917 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.82 163.63 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 111.176 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' A' ' 82' ' ' MET . 7.2 mmm -129.23 124.69 35.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.288 -0.415 . . . . 54.049999999999997 110.84 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.93 170.1 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 110.811 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -73.8 -18.32 60.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 63.409999999999997 110.825 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -72.89 -20.12 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 60.439999999999998 110.843 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.45 -20.04 21.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.7 -0.762 . . . . 73.219999999999999 112.508 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.7 147.86 26.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 74.239999999999995 110.916 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -103.67 145.27 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.63 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -98.04 132.51 43.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 71.340000000000003 111.073 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.02 139.97 37.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 71.329999999999998 110.872 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.1 m -146.7 120.74 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 63.439999999999998 110.891 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.42 123.29 31.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 64.510000000000005 110.909 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -130.14 120.6 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.818 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -88.87 136.13 33.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 74.049999999999997 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.1 t -120.54 137.51 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 70.140000000000001 111.132 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -128.42 146.61 50.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.519999999999996 110.937 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.866 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.4 m -107.11 -176.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 111.111 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -68.11 -77.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 65.200000000000003 110.912 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.496 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -64.31 144.55 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.962 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.412 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.15 160.44 45.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.6 0.714 . . . . 61.350000000000001 111.17 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.176 0 C-N-CA 122.731 2.287 . . . . 73.519999999999996 112.364 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.704 0.288 . . . . 64.030000000000001 111.128 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 132.46 38.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 72.5 110.89 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.7 121.2 32.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.329999999999998 110.876 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.87 122.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 111.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -96.0 142.13 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 61.229999999999997 111.036 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -144.61 168.23 20.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 111.071 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 149.34 46.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 75.140000000000001 110.859 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.69 HD11 HG13 ' A' ' 71' ' ' ILE . 27.8 mt -65.06 120.49 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 53.119999999999997 111.147 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.77 -12.24 57.82 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.654 -0.784 . . . . 72.310000000000002 112.421 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.1 pp20? -101.45 140.88 21.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 110.946 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 145.01 55.9 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 71.019999999999996 112.348 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 8' ' ' ALA . 14.3 tp -137.77 142.46 40.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.921 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.6 t -123.1 146.72 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 72.219999999999999 111.128 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.734 HD13 ' CD2' ' A' ' 77' ' ' PHE . 4.6 mt -131.84 151.92 51.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.917 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -111.63 149.71 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.230000000000004 110.856 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.81 101.64 9.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 110.935 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -54.09 99.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 110.916 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.61 -47.34 0.65 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.628 -0.796 . . . . 73.150000000000006 112.473 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.31 103.58 12.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 70.310000000000002 111.128 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.4 Cg_endo -69.79 -161.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.71 2.273 . . . . 63.25 112.325 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.59 -8.08 8.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.853 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ASN . 1.1 mptt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 51.520000000000003 110.942 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.748 0.309 . . . . 72.230000000000004 110.936 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.616 HD13 ' CD1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -179.22 161.31 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 60.119999999999997 111.002 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.43 137.15 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 62.439999999999998 110.917 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.616 ' CD1' HD13 ' A' ' 29' ' ' LEU . 17.0 m95 -125.05 143.82 50.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.477 . . . . 72.310000000000002 110.972 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -148.66 136.26 20.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 73.450000000000003 110.86 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 34' ' ' ASN . 1.1 tp -138.62 138.07 37.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.922 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.631 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -112.62 126.83 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 61.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.828 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 19.7 p -137.57 179.81 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 111.15 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.12 -132.72 17.29 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.736 -0.745 . . . . 74.209999999999994 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.65 -37.26 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 75.239999999999995 110.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.591 HG23 ' HG3' ' A' ' 39' ' ' GLU . 3.5 t -179.38 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 64.299999999999997 111.085 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HG3' HG23 ' A' ' 38' ' ' THR . 14.9 mt-10 -101.5 33.67 2.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 74.329999999999998 110.885 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.62 -6.5 7.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 54.299999999999997 111.085 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -59.53 129.75 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 60.219999999999999 110.895 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.74 153.15 50.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 73.200000000000003 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.18 123.31 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 53.299999999999997 111.045 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.59 145.0 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.319999999999993 110.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.413 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.754 . . . . 72.230000000000004 110.822 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.812 0.339 . . . . 70.209999999999994 111.132 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.83 157.33 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 52.520000000000003 110.895 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 45' ' ' SER . 45.9 t -114.55 127.02 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.115 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 6.4 mp -69.69 157.91 88.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.662 0.744 . . . . 73.549999999999997 110.841 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.77 -22.8 31.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.245 . . . . 73.219999999999999 112.295 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 2.3 p-10 -83.52 4.02 29.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 63.299999999999997 110.86 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.96 13.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.802 -0.713 . . . . 60.520000000000003 112.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 3.2 m -114.63 178.6 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.407 . . . . 45.32 110.839 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.715 HD23 HD12 ' A' ' 16' ' ' LEU . 13.3 tp -130.09 127.88 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 73.25 110.986 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -126.26 130.27 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.857 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mp -120.93 130.31 24.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.649 0.737 . . . . 60.100000000000001 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.64 18.27 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 72.510000000000005 112.39 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.66 103.4 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 62.100000000000001 111.146 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 12' ' ' GLU . 30.9 m -73.01 121.91 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.469 . . . . 73.120000000000005 111.1 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.08 156.42 22.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.683 -0.77 . . . . 62.229999999999997 112.489 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.766 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.91 -30.18 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.305 . . . . 73.349999999999994 111.129 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -73.97 -23.74 59.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 62.299999999999997 110.849 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.43 -5.0 45.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.923 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 141.06 58.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.869 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.583 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.39 -138.91 6.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 63.399999999999999 112.413 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.583 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.4 mp -129.13 127.64 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 52.310000000000002 111.152 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.734 ' CD2' HD13 ' A' ' 16' ' ' LEU . 1.5 t80 -104.5 131.1 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.420000000000002 110.859 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HE ' ' C ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -127.08 137.36 53.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 72.040000000000006 110.944 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.8 t -119.95 149.07 42.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.939 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.99 127.07 19.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.897 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.59 163.87 27.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.109999999999999 111.094 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ttm -128.75 125.29 37.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 65.049999999999997 110.885 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -86.93 173.21 9.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 61.399999999999999 110.887 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -70.32 -18.13 63.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 110.848 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.14 -19.93 61.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.329999999999998 110.882 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.75 -16.37 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 71.409999999999997 112.478 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 146.76 27.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.727 0.299 . . . . 73.099999999999994 110.881 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.26 143.4 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 55.039999999999999 110.9 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.92 130.38 51.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 54.030000000000001 111.193 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -105.49 144.85 31.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 52.310000000000002 110.917 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.417 ' C ' ' HE ' ' A' ' 78' ' ' ARG . 74.0 m -144.44 125.82 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 74.340000000000003 110.824 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.06 123.59 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 74.299999999999997 110.943 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.83 118.84 24.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 110.93 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -82.66 129.89 35.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 74.530000000000001 110.97 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.97 131.05 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 74.109999999999999 111.197 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' HG21 ' A' ' 100' ' ' ILE . 4.1 tpt180 -130.78 128.32 40.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 65.340000000000003 110.826 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.766 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -95.08 -177.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 64.010000000000005 111.095 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -66.95 -82.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.340000000000003 110.89 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -58.02 137.91 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.873 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.403 HG21 ' NH2' ' A' ' 96' ' ' ARG . 1.0 OUTLIER -120.0 160.08 44.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 63.229999999999997 111.188 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 62.32 112.314 179.897 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.741 0.305 . . . . 61.530000000000001 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -93.69 134.94 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.299999999999997 110.875 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -85.81 121.78 28.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 71.519999999999996 110.852 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.602 ' CG2' HD11 ' A' ' 14' ' ' LEU . 45.9 mm -125.19 121.57 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.085 -0.507 . . . . 64.129999999999995 111.211 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -96.55 142.01 29.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 52.109999999999999 111.188 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.27 166.04 29.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 74.510000000000005 111.173 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -124.31 148.18 47.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 72.019999999999996 110.887 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.456 HD11 HG13 ' A' ' 71' ' ' ILE . 25.6 mt -54.21 121.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 64.540000000000006 111.174 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.57 4.34 80.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.776 -0.726 . . . . 72.219999999999999 112.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.777 ' O ' HG22 ' A' ' 69' ' ' VAL . 23.2 mm-40 -102.08 140.15 20.92 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 71.200000000000003 110.931 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 144.07 52.85 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.709 2.272 . . . . 62.219999999999999 112.305 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.602 HD11 ' CG2' ' A' ' 6' ' ' ILE . 25.5 tp -144.41 141.71 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.871 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 65' ' ' PHE . 22.0 t -122.28 147.38 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 61.310000000000002 111.161 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -132.02 148.72 52.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 70.530000000000001 110.934 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -111.82 151.3 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 110.946 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.4 t -107.38 99.9 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 54.32 110.918 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -57.62 121.24 9.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 74.049999999999997 110.898 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.01 -39.4 1.91 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.786 -0.721 . . . . 60.310000000000002 112.515 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.53 43.67 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.544 0.688 . . . . 72.420000000000002 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.676 2.251 . . . . 74.319999999999993 112.397 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -49.36 -48.45 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.030000000000001 110.918 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.504 0.669 . . . . 75.450000000000003 110.915 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.846 0.355 . . . . 62.240000000000002 110.832 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.6 pp -136.58 151.83 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.439999999999998 110.852 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.86 148.14 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.040000000000006 110.879 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.27 139.91 53.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 110.946 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.727 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.34 135.46 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 73.319999999999993 110.887 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.83 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -138.25 137.62 37.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.943 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -113.52 126.76 55.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 52.43 110.882 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.82 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 24.5 p -136.71 179.78 6.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 111.181 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.17 -119.69 6.83 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.648 -0.787 . . . . 71.409999999999997 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 38' ' ' THR . 9.2 mpt_? -114.57 -38.96 3.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.530000000000001 110.946 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 174.51 -27.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 31.5 111.103 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.64 33.2 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.865 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.27 -7.55 8.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 111.12 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -60.72 129.77 43.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.200000000000003 110.878 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 153.71 51.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 65.150000000000006 110.907 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 32' ' ' LYS . 12.0 m -88.81 122.35 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 70.140000000000001 111.109 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -88.2 145.22 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 72.230000000000004 110.846 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.716 0.769 . . . . 71.129999999999995 110.798 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.783 0.325 . . . . 64.319999999999993 111.106 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 159.58 33.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 64.019999999999996 110.888 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 63' ' ' SER . 19.4 t -113.33 130.58 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 111.158 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.64 HD12 ' CB ' ' A' ' 63' ' ' SER . 77.4 mt -68.55 157.55 87.83 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 64.329999999999998 110.889 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.632 2.221 . . . . 71.25 112.353 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -83.42 -0.15 48.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.812 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.4 9.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 15.42 112.461 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.64 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.1 m -111.65 179.6 3.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 72.310000000000002 110.898 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.34 128.08 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.482 . . . . 73.420000000000002 110.947 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CD1' HG22 ' A' ' 15' ' ' VAL . 9.5 t80 -126.68 132.83 51.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.629 HD22 HG12 ' A' ' 69' ' ' VAL . 7.6 mp -114.78 128.35 25.98 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.518 0.675 . . . . 71.400000000000006 110.985 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.29 19.12 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.651 2.234 . . . . 61.340000000000003 112.411 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.44 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -164.8 102.36 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 53.229999999999997 111.151 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 12' ' ' GLU . 28.9 m -72.09 118.97 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 42.119999999999997 111.167 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.37 158.64 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 63.32 112.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.787 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.74 -30.37 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 71.219999999999999 111.182 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.5 -23.11 56.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 74.219999999999999 110.92 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.38 -5.09 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 70.099999999999994 110.783 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.03 140.9 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 74.329999999999998 110.885 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.66 -139.57 6.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.82 -0.705 . . . . 24.300000000000001 112.476 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.648 HG23 ' HD2' ' A' ' 94' ' ' ARG . 1.7 mp -131.78 135.34 58.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 73.319999999999993 111.11 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.83 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.2 m-85 -104.67 126.75 52.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 54.229999999999997 110.838 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.1 mmm180 -126.39 130.65 51.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 110.915 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.17 151.22 39.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 73.25 110.86 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -140.54 129.44 23.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 163.35 28.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 55.119999999999997 111.05 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.3 ttm -129.54 125.41 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 65.040000000000006 110.876 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.48 171.77 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -17.41 62.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.868 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.58 -25.13 61.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 71.109999999999999 110.894 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.94 -20.23 13.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 73.140000000000001 112.538 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.09 146.87 26.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.733 0.301 . . . . 72.530000000000001 110.868 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.04 145.39 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.834 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.77 131.89 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.520000000000003 111.212 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -105.05 142.66 34.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 72.209999999999994 110.917 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -145.93 126.95 14.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 72.239999999999995 110.913 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.77 127.25 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 110.822 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -129.03 124.3 34.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 65.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.648 ' HD2' HG23 ' A' ' 76' ' ' ILE . 30.3 mmm-85 -82.61 135.53 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 72.530000000000001 110.933 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.456 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.5 t -123.98 132.5 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.010000000000005 111.232 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.0 128.4 40.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.340000000000003 110.908 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.3 m -93.71 -176.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 73.530000000000001 111.149 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -66.35 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 64.310000000000002 110.874 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.93 145.87 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 70.150000000000006 110.945 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.53 159.48 50.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.509 0.671 . . . . 74.549999999999997 111.202 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.15 0 C-N-CA 122.759 2.306 . . . . 64.010000000000005 112.284 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.742 0.306 . . . . 44.240000000000002 111.118 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.0 132.9 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 110.9 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -86.98 120.97 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.86 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.64 122.74 63.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 111.076 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.08 142.17 28.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 111.075 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.66 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.450000000000003 111.11 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.45 148.23 44.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.299999999999997 110.84 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 99' ' ' GLN . 21.8 mt -57.77 122.16 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 64.430000000000007 111.141 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.708 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.13 4.22 78.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.673 -0.775 . . . . 51.539999999999999 112.519 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.778 ' O ' HG22 ' A' ' 69' ' ' VAL . 43.7 mm-40 -101.18 140.4 21.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.712 0.768 . . . . 71.349999999999994 110.879 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.49 45.46 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.669 2.246 . . . . 73.109999999999999 112.375 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 66' ' ' LEU . 19.8 tp -144.48 141.98 29.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 73.340000000000003 111.029 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.84 148.6 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 62.509999999999998 111.081 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.956 HD12 HD23 ' A' ' 64' ' ' LEU . 15.1 mt -130.56 147.94 52.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.896 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.95 31.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.868 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.4 100.79 8.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 72.400000000000006 110.875 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.64 122.05 7.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 53.439999999999998 110.916 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.471 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.55 -47.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.837 -0.697 . . . . 43.119999999999997 112.511 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.96 102.2 10.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 61.210000000000001 111.065 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.1 Cg_endo -69.75 -161.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.625 2.217 . . . . 31.239999999999998 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -11.15 5.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 64.439999999999998 110.916 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mptt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.662 0.744 . . . . 71.120000000000005 110.866 179.933 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.843 0.354 . . . . 71.040000000000006 110.92 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 29' ' ' LEU . 2.3 pp -172.3 174.23 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.120000000000005 110.897 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.43 131.16 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.809 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -124.09 128.95 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 75.519999999999996 110.856 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -138.41 137.79 37.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 73.109999999999999 110.842 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 77' ' ' PHE . 2.4 tp -137.75 136.94 37.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 54.130000000000003 110.899 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -113.92 126.39 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.319999999999993 110.85 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.85 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 70.5 p -138.58 -179.35 5.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 62.119999999999997 111.083 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.26 -126.64 10.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.817 -0.706 . . . . 71.200000000000003 112.489 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 38' ' ' THR . 49.1 mmm-85 -112.61 -38.62 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.040000000000006 110.808 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t 178.93 -29.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 72.450000000000003 111.159 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HG3' HG23 ' A' ' 38' ' ' THR . 67.9 mt-10 -102.16 34.28 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.85 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.6 -7.01 8.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 55.219999999999999 111.14 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -63.07 131.23 47.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 75.140000000000001 110.927 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 154.27 47.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 61.240000000000002 110.904 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.29 117.01 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 72.409999999999997 111.073 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.29 149.71 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 64.400000000000006 110.927 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.659 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.751 0.786 . . . . 73.019999999999996 110.802 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.578 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 111.111 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 161.42 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 73.140000000000001 110.876 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 45' ' ' SER . 51.9 t -107.65 128.26 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 111.121 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 63' ' ' SER . 54.4 mt -70.31 158.68 87.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 60.219999999999999 110.926 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.4 Cg_endo -69.83 -22.42 31.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.649 2.233 . . . . 73.540000000000006 112.301 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.93 1.6 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.897 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 30.86 11.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 72.299999999999997 112.519 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.529 ' HB2' HD12 ' A' ' 59' ' ' LEU . 4.3 m -112.65 178.26 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 72.329999999999998 110.833 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.956 HD23 HD12 ' A' ' 16' ' ' LEU . 8.9 tp -131.62 130.62 42.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 64.310000000000002 110.89 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 6.8 t80 -124.57 128.2 48.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 110.913 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.8 mp -119.69 131.65 24.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 64.430000000000007 110.918 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -32.7 18.39 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 42.219999999999999 112.396 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.62 101.75 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.086 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.3 m -72.98 118.83 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 72.430000000000007 111.118 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.51 163.78 35.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 62.420000000000002 112.451 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.5 -29.97 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 54.030000000000001 111.049 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -74.41 -22.32 59.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 74.239999999999995 110.808 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -5.96 47.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 74.519999999999996 110.912 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 8.8 pt-20 -60.0 141.99 54.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.841 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.66 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 158.24 -142.28 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 44.100000000000001 112.537 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.66 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.1 mp -130.94 135.48 59.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 111.195 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -101.6 127.39 48.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 110.766 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 131.62 52.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 74.549999999999997 110.886 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 0.5 OUTLIER -122.63 150.09 43.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 75.200000000000003 110.866 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -148.9 125.65 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 54.109999999999999 110.851 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.57 27.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 72.510000000000005 111.103 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.22 125.23 27.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.310000000000002 110.872 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.59 170.79 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 70.430000000000007 110.854 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -72.69 -18.74 61.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 72.25 110.889 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -73.01 -20.03 61.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 64.319999999999993 110.883 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.54 -11.25 33.02 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.772 -0.728 . . . . 73.299999999999997 112.527 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -84.77 145.39 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 75.549999999999997 110.898 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.42 145.49 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 65.450000000000003 110.876 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.471 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -101.28 126.55 48.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 111.152 -179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 134.54 48.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 64.140000000000001 110.97 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . 73.9 m -144.68 120.08 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 53.200000000000003 110.788 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.11 121.02 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 73.510000000000005 110.876 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.57 127.16 36.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.96 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -83.88 136.8 33.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 63.140000000000001 110.934 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.17 130.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 74.150000000000006 111.091 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.84 128.82 39.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 71.230000000000004 110.871 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.3 m -93.5 -177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 111.131 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -63.02 -69.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 73.540000000000006 110.884 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.588 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -76.98 138.92 39.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.963 179.941 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.29 159.54 49.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.716 0.769 . . . . 51.420000000000002 111.114 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 74.420000000000002 112.317 179.916 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.684 0.278 . . . . 71.219999999999999 111.147 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -92.64 134.64 34.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.92 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -83.21 120.79 26.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 71.510000000000005 110.914 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.478 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.8 mm -125.4 120.89 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.119999999999997 111.174 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -96.53 142.38 28.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 75.040000000000006 111.126 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.534 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -147.1 164.98 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 50.030000000000001 111.12 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.36 148.94 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.821 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mt -56.13 121.36 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 63.409999999999997 111.156 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.572 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.6 3.31 86.44 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.668 -0.777 . . . . 53.049999999999997 112.536 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.79 ' O ' HG22 ' A' ' 69' ' ' VAL . 49.7 mm-40 -101.17 140.89 21.66 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.564 0.697 . . . . 63.520000000000003 110.972 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 143.83 51.94 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.599 2.199 . . . . 72.019999999999996 112.411 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 8' ' ' ALA . 62.3 tp -144.35 142.88 30.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 74.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.53 146.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 62.030000000000001 111.178 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.415 HD13 ' CG ' ' A' ' 77' ' ' PHE . 75.0 mt -131.42 147.24 52.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 65.439999999999998 110.924 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -113.17 151.08 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.829 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.8 t -108.25 100.48 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 64.209999999999994 110.844 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.73 126.97 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 74.109999999999999 110.887 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.48 -38.84 2.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 65.25 112.518 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.41 31.1 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.536 0.684 . . . . 71.010000000000005 111.15 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -164.23 0.12 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 54.350000000000001 112.339 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.1 -50.96 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.88 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 54.450000000000003 110.909 179.791 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.878 0.371 . . . . 74.120000000000005 110.895 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -135.94 144.54 45.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 72.530000000000001 110.95 179.974 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -122.07 133.01 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.887 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.47 ' CE2' HD13 ' A' ' 29' ' ' LEU . 4.6 m0 -121.18 144.76 48.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 73.400000000000006 110.887 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.748 ' C ' HD13 ' A' ' 33' ' ' LEU . 5.7 mptt -136.49 138.26 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 110.885 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.122 HD21 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -134.57 141.44 46.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 110.886 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -111.95 125.33 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 70.140000000000001 110.886 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.829 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 28.8 p -138.58 -179.24 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 111.124 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.54 -129.57 9.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 62.409999999999997 112.497 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -112.48 -37.23 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.747 0.308 . . . . 61.310000000000002 110.83 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t 176.81 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 111.192 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.52 33.64 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 74.019999999999996 110.945 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.829 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.54 -6.75 9.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 64.310000000000002 111.146 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -59.84 129.16 40.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.319999999999993 110.91 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.786 ' HE3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -137.4 161.11 37.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 54.149999999999999 110.85 179.98 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 32' ' ' LYS . 45.8 t -99.5 122.87 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 111.175 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.122 HD23 HD21 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -88.45 143.33 27.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.902 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.607 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 52.109999999999999 110.815 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.748 0.309 . . . . 75.409999999999997 111.132 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.93 159.52 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 74.209999999999994 110.879 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 45' ' ' SER . 7.9 t -108.95 130.34 62.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 111.181 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 63' ' ' SER . 66.5 mt -69.23 157.15 90.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 71.430000000000007 110.933 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.04 32.77 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 74.319999999999993 112.273 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -82.88 0.39 44.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 63.229999999999997 110.9 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.54 28.2 13.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 70.530000000000001 112.418 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 59' ' ' LEU . 6.0 m -112.0 -179.18 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 61.109999999999999 110.919 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD23 HD12 ' A' ' 16' ' ' LEU . 16.5 tp -128.53 127.4 42.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 62.100000000000001 110.9 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -126.9 132.06 50.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 110.819 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.786 HD22 HG12 ' A' ' 69' ' ' VAL . 3.5 mp -115.33 130.83 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 73.409999999999997 110.921 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.79 -32.83 17.68 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.679 2.253 . . . . 74.120000000000005 112.36 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.73 101.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 74.120000000000005 111.157 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.2 m -76.58 118.54 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 53.109999999999999 111.229 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.99 165.39 34.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.731 . . . . 41.420000000000002 112.414 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.731 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.87 -31.12 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 71.5 111.136 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.19 -22.59 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 62.140000000000001 110.914 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -5.35 44.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 110.88 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.7 142.21 50.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.876 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.758 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 156.16 -152.34 23.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.801 -0.714 . . . . 61.439999999999998 112.521 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 75' ' ' GLY . 6.9 mm -124.81 135.22 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.25 111.097 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.778 ' CD2' HD12 ' A' ' 33' ' ' LEU . 21.9 t80 -103.38 131.66 50.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 62.32 110.836 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 138.4 54.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 110.837 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.86 42.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.019999999999996 110.857 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.36 125.34 19.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.848 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.38 163.91 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 33.509999999999998 111.091 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttm -129.69 125.66 36.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.464 . . . . 53.109999999999999 110.855 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.86 172.61 10.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 64.239999999999995 110.912 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -70.34 -18.04 63.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 54.530000000000001 110.914 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 55.43 110.881 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -18.78 32.93 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.733 . . . . 73.030000000000001 112.481 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 147.84 26.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.313 . . . . 74.239999999999995 110.906 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -103.74 144.8 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 110.878 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -101.84 131.86 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 111.159 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 145.43 27.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 72.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 t -143.79 127.96 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 42.539999999999999 110.826 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.401 HD21 HG21 ' A' ' 76' ' ' ILE . 28.7 t-20 -128.31 129.26 46.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 61.539999999999999 110.853 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.82 126.03 33.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.109999999999999 110.919 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.431 ' HD2' HD12 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -84.51 131.42 34.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 74.349999999999994 110.858 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.4 t -120.7 130.07 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 111.115 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 128.64 38.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.150000000000006 110.863 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.4 m -94.26 -177.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 111.076 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -62.12 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 63.229999999999997 110.927 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.66 143.43 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 63.329999999999998 110.956 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.45 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.41 159.75 48.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 70.400000000000006 111.12 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 72.150000000000006 112.319 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.79 0.329 . . . . 61.030000000000001 111.089 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -93.16 132.72 37.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 64.040000000000006 110.928 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.36 122.78 32.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 74.319999999999993 110.849 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.3 mm -124.2 126.27 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.230000000000004 111.163 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -94.09 142.37 27.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 75.25 111.233 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.49 168.98 20.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 72.430000000000007 111.088 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.63 148.9 40.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 63.140000000000001 110.916 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 99' ' ' GLN . 28.8 mt -54.17 121.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 73.519999999999996 111.111 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.697 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.06 12.37 65.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 63.229999999999997 112.502 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 5.3 mm-40 -102.7 138.31 19.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 73.209999999999994 110.908 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 143.14 50.55 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.697 2.265 . . . . 64.239999999999995 112.401 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.7 tp -145.68 143.05 29.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 75.430000000000007 110.891 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.1 144.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 111.106 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 64' ' ' LEU . 52.1 mt -131.39 147.55 52.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.854 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -113.77 153.33 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.855 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 t -104.28 100.88 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 62.140000000000001 110.832 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -56.01 123.52 14.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.852 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.582 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.73 -39.85 2.02 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.663 -0.78 . . . . 33.420000000000002 112.504 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.34 129.44 43.23 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.517 0.675 . . . . 72.099999999999994 111.152 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -163.91 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.787 2.325 . . . . 62.340000000000003 112.313 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -49.01 -48.2 43.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 53.329999999999998 110.909 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.586 0.708 . . . . 72.040000000000006 110.928 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.884 0.373 . . . . 74.530000000000001 110.878 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 29' ' ' LEU . 4.0 pp -135.61 156.06 49.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 75.25 110.932 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -121.55 147.67 45.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 64.140000000000001 110.958 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -130.49 130.0 43.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 73.439999999999998 110.883 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' C ' HD23 ' A' ' 33' ' ' LEU . 11.3 mtmm -136.52 136.91 39.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 71.340000000000003 110.844 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.785 HD21 HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.35 138.54 38.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.926 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -111.83 126.34 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 71.549999999999997 110.952 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 76.1 p -137.99 179.56 6.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 111.186 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.54 -129.93 14.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.791 -0.719 . . . . 71.219999999999999 112.449 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -112.65 -37.68 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 72.120000000000005 110.878 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 39' ' ' GLU . 6.5 t -179.12 -31.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.510000000000005 111.129 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.57 ' HG2' HG23 ' A' ' 38' ' ' THR . 5.0 mm-40 -102.57 33.94 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 74.340000000000003 110.945 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.93 -6.42 8.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 111.165 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -59.36 131.72 51.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 64.530000000000001 110.985 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.703 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -128.52 153.53 47.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 64.099999999999994 110.866 -179.913 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.68 120.28 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 63.530000000000001 111.148 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.785 HD12 HD21 ' A' ' 33' ' ' LEU . 15.4 mt -95.83 146.75 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 75.019999999999996 110.899 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.5 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.1 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.678 0.751 . . . . 74.230000000000004 110.847 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.841 0.353 . . . . 71.519999999999996 111.052 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' HD12 ' A' ' 64' ' ' LEU . 49.4 mmm-85 -114.36 160.9 18.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 65.219999999999999 110.831 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 45' ' ' SER . 49.5 t -109.44 129.68 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 111.15 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 63' ' ' SER . 40.0 mt -69.47 157.87 88.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.582 0.706 . . . . 75.310000000000002 110.883 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -23.0 31.01 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.677 2.251 . . . . 62.0 112.284 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -82.96 1.14 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.899 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.24 29.84 11.86 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.772 -0.728 . . . . 72.310000000000002 112.484 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB2' HD12 ' A' ' 59' ' ' LEU . 14.7 m -112.62 -179.43 3.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.399 . . . . 71.129999999999995 110.846 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.617 HD23 HD12 ' A' ' 16' ' ' LEU . 22.1 tp -129.14 130.84 46.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 110.898 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.46 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 45.1 t80 -123.87 130.48 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 55.229999999999997 110.909 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.757 HD22 HG12 ' A' ' 69' ' ' VAL . 5.1 mp -116.86 124.15 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 73.349999999999994 110.929 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -32.8 18.05 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 62.020000000000003 112.314 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.697 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.48 101.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.42 . . . . 62.539999999999999 111.151 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 13.9 m -72.84 112.2 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 74.430000000000007 111.064 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.53 164.69 36.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.745 -0.74 . . . . 73.319999999999993 112.475 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.894 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.81 -33.46 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 72.400000000000006 111.086 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -77.6 -22.04 51.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 62.299999999999997 110.84 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -5.07 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 62.240000000000002 110.916 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.659 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.15 142.16 52.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 51.439999999999998 110.827 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 161.48 -148.12 15.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 31.309999999999999 112.537 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 75' ' ' GLY . 1.2 mm -129.71 135.59 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 65.239999999999995 111.154 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 33' ' ' LEU . 52.8 m-85 -104.43 123.97 48.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.877 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 126.95 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 73.530000000000001 110.858 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.6 t -121.59 153.93 37.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -141.0 140.08 34.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 64.129999999999995 110.928 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 162.41 30.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 53.130000000000003 111.152 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 75.9 mmm -130.14 125.24 34.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 71.109999999999999 110.888 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -88.44 170.8 10.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 64.420000000000002 110.853 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -72.94 -22.48 60.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 64.040000000000006 110.888 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.54 -20.43 60.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.340000000000003 110.915 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.8 -2.86 31.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 75.109999999999999 112.515 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.56 146.46 27.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 74.439999999999998 110.938 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.32 142.42 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 75.209999999999994 110.955 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.582 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.2 129.67 51.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.165 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.82 141.46 34.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 74.049999999999997 110.922 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 58.7 m -145.92 120.13 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 33.219999999999999 110.844 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.72 121.92 25.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.907 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 91' ' ' SER . 6.9 m-85 -131.96 120.61 22.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 75.349999999999994 110.906 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.476 ' HA ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -85.14 132.6 34.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 71.439999999999998 110.881 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.6 t -120.66 136.03 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 72.109999999999999 111.199 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.75 151.22 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 63.240000000000002 110.89 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.894 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.5 m -112.06 -175.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 73.209999999999994 111.158 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -67.29 -76.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.896 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' A' ' 10' ' ' ILE . 2.5 mp0 -64.02 137.31 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 62.140000000000001 110.909 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.01 159.87 47.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.665 0.745 . . . . 71.25 111.135 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 73.120000000000005 112.325 179.895 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.718 0.294 . . . . 63.350000000000001 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -93.65 135.18 35.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 61.520000000000003 110.98 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.616 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.6 p30 -90.42 122.91 33.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.109999999999999 110.875 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 5' ' ' ASN . 1.7 mp -125.39 124.56 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.239999999999995 111.164 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -89.61 144.17 26.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 61.509999999999998 111.147 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.645 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -140.54 165.68 26.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 71.340000000000003 111.038 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 110.887 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.432 HG12 ' HB3' ' A' ' 98' ' ' TYR . 18.5 mm -61.74 120.47 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 111.173 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.769 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 79.34 10.84 85.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 75.230000000000004 112.472 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.6 mm-40 -101.44 140.69 21.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.609 0.718 . . . . 74.340000000000003 110.841 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 143.48 51.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.236 . . . . 71.340000000000003 112.37 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 tp -144.58 142.39 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 63.32 110.897 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.433 HG22 ' HD1' ' A' ' 65' ' ' PHE . 39.3 t -122.23 148.19 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.230000000000004 111.239 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.6 mt -131.54 148.05 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 61.509999999999998 110.824 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -113.33 152.53 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 71.430000000000007 110.877 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.0 t -107.09 102.24 11.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.109999999999999 110.868 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -58.19 123.25 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.915 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.668 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.57 -37.97 2.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 51.039999999999999 112.49 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.66 128.63 45.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.553 0.692 . . . . 73.540000000000006 111.109 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -164.28 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.657 2.238 . . . . 72.310000000000002 112.345 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -49.31 -48.92 45.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 52.240000000000002 110.9 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 72.209999999999994 110.846 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.772 0.32 . . . . 74.299999999999997 110.922 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.9 pp -135.94 157.93 45.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.899 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -123.08 147.17 47.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 74.409999999999997 110.841 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 44' ' ' LEU . 2.7 m95 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.040000000000006 110.988 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -151.84 137.13 17.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 73.129999999999995 110.835 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.769 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -140.9 138.29 33.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 75.230000000000004 110.954 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -113.83 127.35 55.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 65.239999999999995 110.818 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 42.9 p -140.52 -179.34 5.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 71.120000000000005 111.123 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.9 -120.45 5.31 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 72.150000000000006 112.528 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.67 ' O ' HG23 ' A' ' 38' ' ' THR . 29.6 mmm180 -114.68 -39.72 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 110.863 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 173.66 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.329999999999998 111.139 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.37 33.46 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.875 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.42 -7.48 9.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 111.119 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -63.09 130.43 44.61 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.151 -0.477 . . . . 71.439999999999998 110.931 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.432 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -135.67 158.91 43.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 71.019999999999996 110.885 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.84 121.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 70.329999999999998 111.114 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.549 ' CD1' HD23 ' A' ' 33' ' ' LEU . 8.7 mp -89.7 145.27 25.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.871 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.536 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 70.510000000000005 110.833 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.836 0.35 . . . . 64.239999999999995 111.071 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -127.14 159.84 33.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.842 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 45' ' ' SER . 14.4 t -108.71 130.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.171 -0.468 . . . . 61.340000000000003 111.149 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.8 mt -68.41 157.93 86.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 71.209999999999994 110.936 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -23.04 30.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.754 2.303 . . . . 75.400000000000006 112.337 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -83.24 0.68 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.898 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.4 29.38 11.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 73.340000000000003 112.484 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.506 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.43 -178.95 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 54.420000000000002 110.881 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -128.76 130.06 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.129999999999995 110.831 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HD1' HG22 ' A' ' 15' ' ' VAL . 12.9 t80 -124.05 130.72 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 70.409999999999997 110.861 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD22 HG12 ' A' ' 69' ' ' VAL . 7.1 mp -118.15 131.0 24.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.594 0.712 . . . . 72.150000000000006 110.9 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -38.29 8.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 73.099999999999994 112.377 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -164.19 103.8 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 42.329999999999998 111.084 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.7 m -73.97 115.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 51.439999999999998 111.135 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.58 165.76 29.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 75.120000000000005 112.479 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.803 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.02 -30.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 75.150000000000006 111.131 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.09 -22.57 55.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 64.109999999999999 110.88 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.463 ' O ' HG21 ' A' ' 35' ' ' THR . 0.4 OUTLIER -80.65 -1.55 42.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.779 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.21 141.12 58.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 63.020000000000003 110.932 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.602 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 160.91 -145.17 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 74.329999999999998 112.456 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.7 mp -130.58 134.72 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 74.219999999999999 111.045 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.769 ' CE2' HD22 ' A' ' 33' ' ' LEU . 13.3 m-85 -103.44 135.29 45.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 75.230000000000004 110.832 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.01 130.71 48.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 64.120000000000005 110.874 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 147.93 43.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 41.030000000000001 110.875 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -146.09 126.96 14.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 110.917 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.26 162.67 30.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 60.32 111.084 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 33.8 tpp -130.15 125.76 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.938 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.52 171.63 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 65.420000000000002 110.879 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -18.56 62.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 64.340000000000003 110.901 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -73.35 -19.78 60.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 51.509999999999998 110.865 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.16 37.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.58 -0.819 . . . . 72.400000000000006 112.369 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -84.78 145.73 27.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.689 0.281 . . . . 73.420000000000002 110.916 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -105.58 142.22 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 50.200000000000003 110.877 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.668 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -104.05 129.7 51.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 64.420000000000002 111.054 -179.894 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -105.72 144.13 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.983 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -145.65 120.63 10.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 54.310000000000002 110.877 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -121.28 120.76 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 75.530000000000001 110.888 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -127.72 126.6 42.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 70.329999999999998 110.94 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.5 mmm-85 -91.11 135.65 33.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.892 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 77' ' ' PHE . 56.4 t -120.79 130.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 111.211 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.19 127.65 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 71.140000000000001 110.949 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.803 HG21 ' HA ' ' A' ' 71' ' ' ILE . 18.2 m -91.1 -176.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 72.310000000000002 111.148 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.432 ' HB3' HG12 ' A' ' 10' ' ' ILE . 40.5 t80 -75.84 -76.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -58.68 148.03 30.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 75.120000000000005 110.917 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.464 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.29 159.37 50.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.565 0.698 . . . . 70.019999999999996 111.093 -179.975 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 100' ' ' ILE . 52.8 Cg_endo . . . . . 0 C--O 1.231 0.167 0 C-N-CA 122.568 2.178 . . . . 65.540000000000006 112.343 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.666 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.751 0.31 . . . . 65.239999999999995 111.048 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.61 133.25 37.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 53.219999999999999 110.917 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -84.65 120.76 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 110.91 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.584 HG21 HD11 ' A' ' 14' ' ' LEU . 46.2 mm -125.88 121.98 60.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 65.239999999999995 111.119 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -94.19 139.83 30.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 74.439999999999998 111.143 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.76 167.0 26.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 111.088 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.37 148.12 44.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 73.030000000000001 110.876 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 71' ' ' ILE . 32.1 mt -52.51 121.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 74.530000000000001 111.222 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.72 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.76 7.72 70.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 74.439999999999998 112.476 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.7 mm-40 -101.76 139.43 20.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 62.310000000000002 110.822 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 143.05 49.4 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.682 2.255 . . . . 70.319999999999993 112.286 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.584 HD11 HG21 ' A' ' 6' ' ' ILE . 25.7 tp -145.58 141.84 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 75.099999999999994 110.95 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.6 t -123.16 146.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 111.13 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.536 HD12 HD23 ' A' ' 64' ' ' LEU . 58.4 mt -130.87 146.62 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.921 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.47 152.13 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 110.87 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.1 t -107.34 100.73 10.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 44.229999999999997 110.869 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -58.96 122.04 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 63.140000000000001 110.89 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.583 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.53 -38.42 2.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 42.100000000000001 112.466 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.35 44.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.519 0.676 . . . . 53.219999999999999 111.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.64 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.752 2.301 . . . . 74.239999999999995 112.374 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -49.65 -49.89 45.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 72.329999999999998 110.913 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 72.109999999999999 110.91 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 51.020000000000003 110.877 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -136.19 155.27 50.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.929 179.974 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -120.87 148.52 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.030000000000001 110.952 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 1.1 m95 -127.73 145.05 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.948 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -145.08 144.25 30.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 110.889 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -134.92 134.98 41.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 73.109999999999999 110.908 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -117.92 120.83 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 34.32 110.867 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.809 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.1 p -141.44 179.52 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 53.030000000000001 111.096 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.81 -133.26 20.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 73.400000000000006 112.568 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.7 mmm-85 -112.77 -36.78 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 72.200000000000003 110.914 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.535 HG23 ' HG3' ' A' ' 39' ' ' GLU . 2.3 t -179.16 -27.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 75.120000000000005 111.114 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.0 mt-10 -100.72 32.59 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 74.219999999999999 110.859 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -126.17 -6.68 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.299999999999997 111.089 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 t90 -73.92 128.14 34.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.921 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.71 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -137.63 159.07 43.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 75.239999999999995 110.958 179.939 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.2 t -87.2 121.54 38.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 111.094 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.45 146.76 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.917 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.574 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 61.340000000000003 110.875 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.758 0.313 . . . . 73.310000000000002 111.107 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -122.79 159.74 27.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.815 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 45' ' ' SER . 52.9 t -107.92 129.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 72.230000000000004 111.114 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 63' ' ' SER . 45.4 mt -69.1 156.13 92.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.521 0.676 . . . . 53.43 110.951 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.3 Cg_endo -69.76 -22.2 32.39 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.672 2.248 . . . . 71.439999999999998 112.309 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -83.32 0.6 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 73.420000000000002 110.892 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.51 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.773 -0.727 . . . . 75.140000000000001 112.575 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.687 ' HB2' HD12 ' A' ' 59' ' ' LEU . 9.1 m -113.7 178.88 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 73.430000000000007 110.863 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD23 HD12 ' A' ' 16' ' ' LEU . 12.9 tp -128.81 127.52 42.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.905 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' HD12 ' A' ' 64' ' ' LEU . 46.5 t80 -126.17 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 71.420000000000002 110.922 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.707 HD22 HG12 ' A' ' 69' ' ' VAL . 2.9 mp -117.83 128.18 26.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.532 0.682 . . . . 45.119999999999997 110.942 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.15 17.19 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.661 2.241 . . . . 74.010000000000005 112.33 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.72 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.73 101.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 51.310000000000002 111.118 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.06 113.28 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 111.139 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.65 36.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.694 -0.765 . . . . 75.129999999999995 112.501 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.66 -30.02 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.777 0.323 . . . . 73.150000000000006 111.086 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.14 -23.77 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 73.230000000000004 110.918 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.61 -5.18 57.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.9 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.76 141.4 58.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 73.420000000000002 110.791 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.632 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 157.66 -138.93 6.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 32.520000000000003 112.481 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.632 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.0 mp -130.1 135.55 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 75.420000000000002 111.125 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.826 ' CE2' HD12 ' A' ' 33' ' ' LEU . 8.4 m-85 -102.61 134.8 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.019999999999996 110.906 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 92' ' ' ASN . 1.6 mmt180 -128.02 127.66 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.530000000000001 110.915 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.6 t -121.56 149.48 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 52.030000000000001 110.9 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.46 132.55 23.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 62.210000000000001 110.878 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 162.26 30.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 62.140000000000001 111.082 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.2 ttm -130.36 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 73.549999999999997 110.857 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.42 170.96 11.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 74.530000000000001 110.857 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -17.81 62.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.91 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -73.37 -25.59 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 71.219999999999999 110.841 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.01 19.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 24.039999999999999 112.496 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -84.59 146.78 27.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 74.030000000000001 110.94 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.24 142.34 35.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.041 0.448 . . . . 74.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.583 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.54 131.84 49.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 70.209999999999994 111.145 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -104.97 140.86 37.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 73.030000000000001 110.984 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.57 127.23 14.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 61.32 110.876 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -124.74 129.4 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 54.450000000000003 110.856 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.439 ' CG ' HD22 ' A' ' 16' ' ' LEU . 8.4 m-85 -127.92 118.01 22.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 75.109999999999999 110.884 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.666 HH11 ' HB1' ' A' ' 3' ' ' ALA . 11.5 mmm-85 -85.57 130.33 34.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 54.140000000000001 110.891 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 77' ' ' PHE . 77.4 t -122.54 132.25 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 70.109999999999999 111.105 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -131.17 128.26 39.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.976 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.4 m -93.86 -176.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 75.530000000000001 111.126 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.03 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 110.919 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -62.86 145.71 54.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 110.924 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.58 49.65 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.691 0.758 . . . . 75.409999999999997 111.105 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.5 Cg_endo . . . . . 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 70.340000000000003 112.358 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.528 -0.229 . . . . 65.209999999999994 112.528 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 61.76 102.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 75.129999999999995 110.798 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.46 69.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 74.409999999999997 111.136 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.05 132.63 36.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.842 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.5 p-10 -90.05 121.22 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.230000000000004 110.849 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.65 122.42 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 111.178 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -95.07 141.62 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 72.540000000000006 111.134 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.02 167.19 25.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 62.020000000000003 111.015 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.64 148.45 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.239999999999995 110.843 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.424 HD11 HG13 ' A' ' 71' ' ' ILE . 16.0 mt -52.45 120.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 61.439999999999998 111.132 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.82 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 89.28 8.92 67.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 73.230000000000004 112.526 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.791 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.1 mm-40 -101.71 138.32 19.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.652 0.739 . . . . 73.430000000000007 110.889 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 143.14 49.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.677 2.251 . . . . 72.319999999999993 112.258 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 66' ' ' LEU . 12.4 tp -145.92 141.36 27.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 71.420000000000002 110.877 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.443 HG22 ' HD1' ' A' ' 65' ' ' PHE . 45.8 t -127.9 139.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 111.197 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.589 HD12 ' CD2' ' A' ' 77' ' ' PHE . 45.2 mt -132.19 149.02 52.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.445 . . . . 60.5 110.878 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -112.72 153.24 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 64.140000000000001 110.918 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 t -105.83 100.71 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 62.399999999999999 110.895 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -54.19 128.91 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.855 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.439 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.01 -40.84 1.8 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.756 . . . . 64.430000000000007 112.499 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.25 129.74 42.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.539 0.685 . . . . 72.049999999999997 111.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -164.22 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.555 2.17 . . . . 74.540000000000006 112.354 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -48.46 -49.12 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -110.11 150.4 41.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 55.340000000000003 110.934 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 109.83 2.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.756 2.304 . . . . 54.109999999999999 112.326 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.3 Cg_endo -69.77 -85.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.657 2.238 . . . . 44.409999999999997 112.339 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -103.44 -177.54 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 52.43 110.854 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 143.2 58.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 73.540000000000006 110.835 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.682 HD13 ' CE2' ' A' ' 31' ' ' TRP . 1.5 pp -136.2 149.4 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 60.030000000000001 110.877 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -121.28 127.03 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 75.430000000000007 110.862 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.682 ' CE2' HD13 ' A' ' 29' ' ' LEU . 32.0 m0 -118.08 144.72 45.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 62.310000000000002 110.944 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.667 ' HE2' HG22 ' A' ' 43' ' ' VAL . 5.3 ttmt -136.77 139.27 41.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 73.530000000000001 110.902 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.743 HD22 ' HE3' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -137.42 138.9 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 75.0 110.914 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -115.21 119.31 35.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.846 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.806 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.7 p -136.28 179.49 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 73.540000000000006 111.183 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.4 -132.11 14.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.799 -0.715 . . . . 72.129999999999995 112.499 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -112.68 -37.76 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 73.200000000000003 110.828 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.597 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.3 t -179.47 -29.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 74.209999999999994 111.141 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.597 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.5 mt-10 -102.12 34.26 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.530000000000001 110.84 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.53 -6.24 8.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 73.409999999999997 111.126 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -59.31 128.98 39.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.5 110.861 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.743 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -136.24 158.88 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 61.030000000000001 110.908 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.667 HG22 ' HE2' ' A' ' 32' ' ' LYS . 19.0 t -101.65 123.76 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 111.129 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.1 mt -87.25 144.02 27.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.2 -0.454 . . . . 72.200000000000003 110.941 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.826 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -127.41 163.43 42.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 75.519999999999996 110.854 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.76 0.31 5.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.702 2.268 . . . . 60.340000000000003 112.311 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -149.61 89.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 70.230000000000004 110.953 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.08 -43.17 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 51.32 112.566 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 43.14 37.4 3.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.744 -0.741 . . . . 60.140000000000001 112.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.55 -175.24 13.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 72.140000000000001 112.47 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 130.21 18.96 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.697 2.265 . . . . 62.329999999999998 112.405 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -83.7 -34.12 25.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 72.109999999999999 110.841 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -25.83 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 75.409999999999997 110.927 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.03 -47.6 8.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 63.520000000000003 110.888 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.528 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -130.13 -99.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 63.030000000000001 111.035 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -165.26 173.74 10.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 75.219999999999999 111.207 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -119.11 160.44 22.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.040000000000006 110.826 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.826 HG21 ' O ' ' A' ' 45' ' ' SER . 43.0 t -108.01 128.73 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 111.108 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.0 mt -68.51 156.46 90.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.686 0.755 . . . . 64.519999999999996 110.893 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -22.97 31.41 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.74 2.293 . . . . 75.099999999999994 112.301 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -82.98 0.05 46.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.903 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.61 13.35 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 52.340000000000003 112.431 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.581 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.4 m -109.68 179.0 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 61.240000000000002 110.868 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 65' ' ' PHE . 9.8 tp -128.36 128.33 44.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 73.310000000000002 110.961 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' N ' HD12 ' A' ' 64' ' ' LEU . 7.1 t80 -125.95 129.73 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 64.299999999999997 110.843 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.707 HD22 HG12 ' A' ' 69' ' ' VAL . 2.3 mp -117.19 130.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 63.439999999999998 110.84 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -34.8 13.91 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 72.420000000000002 112.339 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.82 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.21 100.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 111.111 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.1 m -73.45 114.68 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 71.549999999999997 111.143 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.29 166.94 42.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.824 -0.703 . . . . 55.109999999999999 112.433 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.797 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.93 -31.05 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.308 . . . . 73.049999999999997 111.116 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -76.25 -21.96 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.409999999999997 110.93 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -5.44 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 74.439999999999998 110.909 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.23 140.47 55.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 74.299999999999997 110.877 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.629 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 164.7 -147.46 12.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.654 -0.784 . . . . 71.549999999999997 112.449 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.57 135.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.952 0.406 . . . . 70.049999999999997 111.041 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.589 ' CD2' HD12 ' A' ' 16' ' ' LEU . 8.6 m-85 -100.05 124.92 45.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 71.25 110.852 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 127.25 40.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.884 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 149.45 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 61.100000000000001 110.945 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -142.62 126.24 16.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.48 31.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 111.093 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.9 tpp -130.27 125.86 35.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 63.32 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -86.49 170.79 11.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 74.310000000000002 110.859 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -72.7 -17.58 61.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 71.25 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -72.1 -21.04 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.928 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.05 -21.46 17.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.708 . . . . 24.050000000000001 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 145.88 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.279 . . . . 72.019999999999996 110.903 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.25 145.11 32.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 74.409999999999997 110.903 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.439 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.07 127.86 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.049999999999997 111.102 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 145.5 30.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 62.340000000000003 110.936 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.7 m -144.33 121.23 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 110.916 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' B' ' 5' ' ' ALA . 3.8 t-20 -126.63 119.3 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 71.420000000000002 110.913 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -132.03 118.11 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.049999999999997 110.874 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -87.49 133.56 33.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 44.329999999999998 110.851 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.28 138.36 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.219999999999999 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 127.96 39.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 74.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.797 HG21 ' HA ' ' A' ' 71' ' ' ILE . 30.6 m -87.42 -177.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 75.519999999999996 111.102 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -60.64 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 62.509999999999998 110.953 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -72.1 143.53 49.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 63.030000000000001 110.947 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.486 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.28 159.52 49.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.7 0.762 . . . . 54.310000000000002 111.084 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.7 Cg_endo -69.74 178.5 4.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.681 2.254 . . . . 64.409999999999997 112.415 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.49 -36.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.707 -0.759 . . . . 73.049999999999997 112.533 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.34 68.5 7.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.703 . . . . 74.099999999999994 110.857 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 171.52 14.34 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.59 2.194 . . . . 64.019999999999996 112.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 65.319999999999993 110.85 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.818 0.342 . . . . 63.229999999999997 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.96 67.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 73.310000000000002 110.887 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER 60.04 -167.2 0.18 Allowed 'General case' 0 C--O 1.182 -2.497 0 CA-C-O 118.201 -0.904 . . . . 73.439999999999998 110.853 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.432 ' C ' ' O ' ' B' ' 3' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 94' ' ' ARG . . . -53.01 152.06 4.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 54.329999999999998 111.145 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -172.64 115.97 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.030000000000001 110.885 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 70.420000000000002 110.904 -179.905 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 112.501 -0.239 . . . . 50.439999999999998 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 65.05 112.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 70.219999999999999 110.85 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.51 55.16 9.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 53.109999999999999 111.117 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.417 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -92.91 138.19 31.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 110.915 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.98 120.88 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.310000000000002 110.887 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 4' ' ' GLN . 4.7 mp -126.13 127.47 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 111.144 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -95.31 141.78 28.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 74.239999999999995 111.215 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.496 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -145.01 165.41 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 34.100000000000001 111.069 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.19 149.5 42.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.019999999999996 110.916 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 15.3 mt -57.41 121.04 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 43.43 111.069 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.48 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.8 8.13 73.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.777 -0.725 . . . . 70.450000000000003 112.586 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.796 ' O ' HG22 ' A' ' 69' ' ' VAL . 35.1 mm-40 -102.7 138.69 19.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.702 . . . . 72.239999999999995 110.911 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 143.95 51.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 72.120000000000005 112.269 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.0 tp -144.96 141.08 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 65' ' ' PHE . 48.9 t -125.44 145.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 51.340000000000003 111.146 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.2 mt -131.25 148.09 52.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 62.020000000000003 110.941 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 152.75 29.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 54.340000000000003 110.961 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.0 t -106.18 100.6 10.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 51.299999999999997 110.897 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 124.35 14.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 71.140000000000001 110.841 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.93 -42.65 1.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.774 -0.726 . . . . 62.240000000000002 112.491 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 128.19 51.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.538 0.685 . . . . 54.219999999999999 111.153 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.6 Cg_endo -69.8 -164.46 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.62 2.213 . . . . 62.130000000000003 112.316 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -47.89 46.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 53.399999999999999 110.841 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.71 154.95 38.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.554 0.693 . . . . 71.109999999999999 110.865 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.467 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.0 Cg_endo -69.75 109.56 2.34 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.781 2.321 . . . . 44.350000000000001 112.359 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 52.9 Cg_endo -69.76 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.754 2.303 . . . . 73.230000000000004 112.291 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -104.04 -178.19 3.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 64.409999999999997 110.927 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -64.82 135.77 56.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 70.400000000000006 110.829 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 46' ' ' PRO . 3.4 pp -135.64 161.75 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 110.957 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -121.26 147.63 45.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.895 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -124.23 137.96 54.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 61.450000000000003 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -141.23 140.13 33.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 65.450000000000003 110.859 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.649 HD22 ' CE2' ' A' ' 77' ' ' PHE . 6.1 tp -138.1 134.26 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 74.420000000000002 110.988 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.91 ' HB3' ' CE2' ' B' ' 3' ' ' PHE . 12.8 t-20 -116.01 121.17 41.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 64.530000000000001 110.879 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.2 p -138.99 179.37 6.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 63.219999999999999 111.195 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.4 10.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 45.450000000000003 112.412 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -112.42 -36.63 5.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.888 0.375 . . . . 75.450000000000003 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.74 -29.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -102.57 33.78 3.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 62.219999999999999 110.861 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.68 -6.42 8.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 53.329999999999998 111.237 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.65 132.6 54.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 63.350000000000001 110.939 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 158.61 39.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 64.329999999999998 110.931 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.72 120.24 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.053 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.741 HD23 ' HA3' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -96.35 147.95 23.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 62.32 110.938 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG21 ' A' ' 58' ' ' VAL . 2.5 p -124.2 155.87 67.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.699 0.761 . . . . 63.200000000000003 110.846 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.783 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.76 -0.58 7.12 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 2.238 . . . . 64.019999999999996 112.376 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.94 75.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 74.150000000000006 110.947 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.25 73.67 1.08 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 64.519999999999996 112.478 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.741 ' HA3' HD23 ' A' ' 44' ' ' LEU . . . -76.76 58.23 3.45 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.772 -0.728 . . . . 70.219999999999999 112.445 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -179.08 38.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 72.010000000000005 112.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 105.76 1.54 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.683 2.255 . . . . 74.129999999999995 112.374 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -55.05 -34.43 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 71.109999999999999 110.908 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -26.65 66.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 55.520000000000003 110.872 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.81 -43.36 9.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.841 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.27 -97.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 44.210000000000001 111.126 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -151.83 173.71 14.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.25 111.136 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -125.0 164.22 20.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 75.340000000000003 110.963 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.783 HG11 ' HA ' ' A' ' 46' ' ' PRO . 43.7 t -106.57 129.95 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 74.430000000000007 111.108 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 63' ' ' SER . 36.8 mt -69.99 159.05 85.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 72.450000000000003 110.882 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -21.75 32.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 55.420000000000002 112.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.33 1.37 41.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.416 . . . . 54.219999999999999 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.08 27.44 21.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 73.340000000000003 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.401 ' HB2' HD12 ' A' ' 59' ' ' LEU . 33.7 m -111.58 -179.0 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 55.210000000000001 110.918 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 57' ' ' ARG . 31.5 tp -128.82 129.99 46.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.84 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 15' ' ' VAL . 42.5 t80 -123.64 133.8 53.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.430000000000007 110.876 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.608 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -115.24 123.88 31.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 73.329999999999998 110.913 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.2 19.44 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.727 2.284 . . . . 74.519999999999996 112.406 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.61 103.15 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.010000000000005 111.116 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 12' ' ' GLU . 23.6 m -71.7 113.0 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 111.188 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.92 156.94 24.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.818 -0.706 . . . . 55.509999999999998 112.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.28 -31.67 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 75.430000000000007 111.11 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -77.34 -24.12 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 54.130000000000003 110.868 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -4.04 54.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 65.439999999999998 110.895 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -58.05 141.84 48.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 70.010000000000005 110.889 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.628 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 161.73 -145.77 11.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.548 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.5 mp -131.41 135.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.841 0.353 . . . . 63.420000000000002 111.165 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.649 ' CE2' HD22 ' A' ' 33' ' ' LEU . 11.7 m-85 -98.88 134.78 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.540000000000006 110.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.91 126.35 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.030000000000001 110.861 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 45.9 t -122.62 150.22 42.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 51.32 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -146.71 129.76 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 64.329999999999998 110.911 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.05 31.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.12 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.6 ttm -130.64 126.75 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.428 . . . . 75.439999999999998 110.86 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -85.81 170.42 12.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 60.219999999999999 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -73.26 -17.62 61.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 72.319999999999993 110.874 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -71.63 -19.66 62.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.928 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.18 -21.95 19.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 65.540000000000006 112.45 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 144.35 28.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 64.200000000000003 110.87 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.64 144.39 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 75.140000000000001 110.918 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.54 132.3 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.497 . . . . 75.150000000000006 111.167 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.43 ' CE ' ' H11' ' B' ' 4' ' ' MCL . 9.3 ptmm? -105.21 143.19 33.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.88 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -147.37 120.43 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.877 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.736 ' OD1' ' HE3' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -125.66 124.4 41.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 75.129999999999995 110.901 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 118.86 24.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.932 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.41 ' HD2' ' CB ' ' B' ' 5' ' ' ALA . 0.8 OUTLIER -88.78 136.25 33.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.907 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.1 t -124.66 137.27 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 63.329999999999998 111.099 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -130.62 128.26 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.86 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 m -85.65 -176.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 64.200000000000003 111.094 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -70.79 -81.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.848 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -59.65 145.48 44.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 70.040000000000006 110.916 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.29 159.6 49.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.544 0.688 . . . . 71.150000000000006 111.202 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo -69.81 133.85 26.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.594 2.196 . . . . 73.219999999999999 112.287 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.39 35.76 0.22 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.671 -0.776 . . . . 72.030000000000001 112.438 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -155.23 160.57 30.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.657 0.742 . . . . 53.450000000000003 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.752 2.301 . . . . 73.239999999999995 112.293 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 73.420000000000002 110.83 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.806 0.336 . . . . 73.519999999999996 110.829 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -119.91 -37.41 3.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 45.020000000000003 110.86 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.91 ' CE2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -174.75 -165.31 0.19 Allowed 'General case' 0 C--O 1.181 -2.508 0 CA-C-O 118.116 -0.945 . . . . 52.310000000000002 110.878 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.43 ' H11' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.41 ' CB ' ' HD2' ' A' ' 94' ' ' ARG . . . -49.81 136.98 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 74.430000000000007 111.058 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -148.51 109.23 4.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 55.329999999999998 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 1.317 ' CG ' ' NH2' ' A' ' 94' ' ' ARG . 13.5 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 75.150000000000006 110.881 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.204 0 N-CA-C 112.486 -0.245 . . . . 74.310000000000002 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.29 122.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 55.119999999999997 110.902 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.28 65.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.319999999999993 111.105 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -93.21 133.2 36.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 64.329999999999998 110.941 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.421 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 8.3 p30 -89.99 122.01 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.400000000000006 110.884 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.754 HG21 HD11 ' A' ' 14' ' ' LEU . 30.1 mm -125.17 122.68 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 111.223 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -94.06 141.2 28.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 42.520000000000003 111.127 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.57 167.33 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 62.100000000000001 111.148 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 149.22 41.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 75.319999999999993 110.885 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.41 HD11 HG13 ' A' ' 71' ' ' ILE . 18.9 mt -52.43 120.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 71.219999999999999 111.101 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.753 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.73 10.17 70.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 71.530000000000001 112.5 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.784 ' O ' HG22 ' A' ' 69' ' ' VAL . 39.2 mm-40 -102.77 139.02 19.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.64 0.733 . . . . 72.439999999999998 110.813 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 143.55 50.89 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.692 2.261 . . . . 53.130000000000003 112.335 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.754 HD11 HG21 ' A' ' 6' ' ' ILE . 23.5 tp -145.76 143.81 29.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 110.89 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.11 145.37 28.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.136 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 64' ' ' LEU . 88.5 mt -130.91 147.51 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.927 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 151.96 31.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.908 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.74 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 124.35 17.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.917 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.86 -40.63 1.86 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 52.539999999999999 112.462 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.02 128.69 46.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.497 0.665 . . . . 75.340000000000003 111.085 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.8 -164.79 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.65 2.233 . . . . 75.310000000000002 112.271 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.38 -48.31 47.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 63.030000000000001 110.873 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -108.45 151.86 41.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 74.439999999999998 110.851 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.6 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 64.120000000000005 112.354 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.4 Cg_endo -69.83 -84.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.759 2.306 . . . . 72.519999999999996 112.296 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.9 OUTLIER -103.43 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 75.099999999999994 110.947 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -64.43 137.8 58.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 64.519999999999996 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.551 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.88 157.71 46.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.979 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.06 146.93 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.209999999999994 110.9 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.551 ' HE1' HD13 ' A' ' 29' ' ' LEU . 15.2 m95 -121.47 141.92 50.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.898 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.6 139.28 38.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 75.400000000000006 110.824 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 35' ' ' THR . 1.3 tm? -138.71 131.41 29.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.864 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.718 ' N ' HD22 ' A' ' 33' ' ' LEU . 2.5 m120 -116.44 121.02 40.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 64.200000000000003 110.949 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.792 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.7 p -139.84 179.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 72.010000000000005 111.119 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.12 -131.42 10.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.703 -0.76 . . . . 42.219999999999999 112.492 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mmm-85 -112.63 -38.43 4.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 63.210000000000001 110.866 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 39' ' ' GLU . 7.8 t 179.83 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 52.100000000000001 111.107 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.1 mt-10 -103.11 33.99 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 110.844 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.23 -6.33 8.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 63.25 111.153 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -63.63 130.95 46.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 73.450000000000003 110.865 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 158.27 41.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 73.299999999999997 110.905 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.0 t -92.68 122.62 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 73.299999999999997 111.061 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.61 147.66 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.9 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -125.65 149.42 65.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.642 0.734 . . . . 71.230000000000004 110.831 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.723 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.72 1.38 4.46 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.653 2.235 . . . . 63.219999999999999 112.356 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -118.99 69.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 61.439999999999998 110.941 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.97 5.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 52.229999999999997 112.556 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.47 40.94 32.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 31.030000000000001 112.49 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.98 -173.97 26.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 72.040000000000006 112.423 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 54.2 Cg_endo -69.72 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.606 2.204 . . . . 71.049999999999997 112.383 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.17 -31.43 65.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.917 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.01 -25.68 62.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 110.804 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -91.17 -43.99 9.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 65.209999999999994 110.811 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -125.5 -98.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 63.329999999999998 111.146 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -150.78 174.72 12.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 72.5 111.215 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.54 166.43 15.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 72.400000000000006 110.895 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 46' ' ' PRO . 61.8 t -108.16 128.98 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 111.11 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 63' ' ' SER . 56.4 mt -69.06 157.15 90.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.669 0.747 . . . . 75.409999999999997 110.883 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 -22.47 32.53 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.716 2.278 . . . . 74.200000000000003 112.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -82.98 0.92 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.933 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 29.2 12.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 43.219999999999999 112.415 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.506 ' HB2' HD12 ' A' ' 59' ' ' LEU . 8.8 m -113.1 179.19 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 65.200000000000003 110.878 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 16' ' ' LEU . 6.8 tp -130.15 129.0 42.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 63.439999999999998 110.941 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 46.4 t80 -125.44 130.61 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 70.299999999999997 110.857 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.75 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -115.08 129.13 25.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.601 0.715 . . . . 64.420000000000002 110.908 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -34.84 13.61 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.645 2.23 . . . . 72.439999999999998 112.368 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.75 100.26 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 51.350000000000001 111.141 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.89 112.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 111.144 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.34 167.97 41.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 40.409999999999997 112.497 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.842 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.1 -30.37 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.739 0.304 . . . . 53.100000000000001 111.108 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -75.9 -22.17 56.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 54.340000000000003 110.845 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -2.86 35.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 73.049999999999997 110.844 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 142.01 53.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 70.430000000000007 110.895 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.69 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.39 -154.06 25.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 72.010000000000005 112.461 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.69 HD12 ' C ' ' A' ' 75' ' ' GLY . 2.7 mp -128.08 134.97 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 74.430000000000007 111.135 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 16' ' ' LEU . 26.6 t80 -102.87 133.89 47.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 110.838 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.438 ' HB2' ' CZ ' ' B' ' 3' ' ' PHE . 0.3 OUTLIER -127.62 131.82 49.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 75.200000000000003 110.842 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 35.6 t -120.67 150.49 40.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 61.350000000000001 110.82 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -143.29 127.94 18.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 63.149999999999999 110.917 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.46 162.94 29.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 52.409999999999997 111.038 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.5 mtp -130.9 125.51 33.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 65.120000000000005 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -86.66 171.18 11.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.400000000000006 110.878 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -72.03 -18.21 61.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 63.200000000000003 110.906 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -72.46 -19.62 61.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 53.109999999999999 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.46 -18.32 27.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.822 -0.704 . . . . 74.310000000000002 112.513 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.06 146.17 27.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 73.450000000000003 110.953 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.76 145.02 31.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.834 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.56 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -100.87 127.19 47.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 63.409999999999997 111.152 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.275 ' CE ' ' HZ ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -99.77 143.59 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.908 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -145.26 124.62 13.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 64.120000000000005 110.857 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.49 120.52 26.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 74.120000000000005 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -130.23 117.18 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.885 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -91.98 134.08 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 75.319999999999993 110.872 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.2 t -120.13 139.53 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 42.539999999999999 111.148 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.09 127.92 42.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 110.873 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.842 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.9 m -88.62 -176.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.151 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.59 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.864 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -69.14 144.96 53.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.975 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.488 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.45 159.43 50.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 74.129999999999995 111.067 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.8 Cg_endo -69.82 -179.48 2.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.597 2.198 . . . . 74.319999999999993 112.393 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 169.21 68.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 54.109999999999999 112.498 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -116.06 159.19 40.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.602 0.715 . . . . 53.340000000000003 110.919 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.01 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.716 2.277 . . . . 72.400000000000006 112.358 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.905 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.83 0.348 . . . . 63.399999999999999 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -123.26 68.42 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 63.5 110.869 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.1 OUTLIER 50.83 -163.92 0.05 Allowed 'General case' 0 C--O 1.181 -2.504 0 CA-C-O 118.177 -0.916 . . . . 73.310000000000002 110.848 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.275 ' HZ ' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.4 114.35 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.89 -0.595 . . . . 65.409999999999997 111.026 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -91.22 57.66 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 110.838 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.448 . . . . 44.439999999999998 110.789 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.46 -0.256 . . . . 74.209999999999994 112.46 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -179.66 115.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 60.32 110.901 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.09 66.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 75.030000000000001 111.034 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.59 133.09 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.923 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.0 p-10 -87.76 121.98 30.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.439999999999998 110.916 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' HB ' HG22 ' A' ' 95' ' ' VAL . 46.6 mm -125.35 127.69 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 75.340000000000003 111.081 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 138.8 32.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.171 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.33 27.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.120000000000005 111.096 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.65 148.25 48.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.281 -0.418 . . . . 63.439999999999998 110.839 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.489 HD11 HG13 ' A' ' 71' ' ' ILE . 9.7 mt -53.32 122.08 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 71.219999999999999 111.152 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.09 4.44 78.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 73.129999999999995 112.448 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.7 mm-40 -101.22 139.64 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.561 0.696 . . . . 70.019999999999996 110.967 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.67 45.84 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.765 2.31 . . . . 73.150000000000006 112.308 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 66' ' ' LEU . 16.4 tp -144.7 141.31 29.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 64.510000000000005 110.902 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 ' HD1' ' A' ' 65' ' ' PHE . 51.1 t -125.9 147.15 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 42.310000000000002 111.201 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.656 HD12 HD23 ' A' ' 64' ' ' LEU . 8.6 mt -131.58 148.23 52.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.209999999999994 110.857 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -111.41 149.81 30.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 65.530000000000001 110.85 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.3 t -108.16 101.09 10.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.447 . . . . 73.120000000000005 110.882 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.82 101.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 74.099999999999994 110.915 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 144.5 -47.9 0.75 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.703 -0.76 . . . . 70.340000000000003 112.498 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.15 103.04 10.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.558 0.694 . . . . 64.329999999999998 111.189 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.8 Cg_endo -69.69 -161.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.688 2.259 . . . . 75.129999999999995 112.311 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -60.52 -10.51 5.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 110.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -45.84 167.48 0.13 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.572 0.701 . . . . 75.430000000000007 110.916 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 54.5 Cg_endo -69.8 172.37 12.8 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.661 2.241 . . . . 72.319999999999993 112.315 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.5 Cg_endo -69.75 87.74 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 2.262 . . . . 72.040000000000006 112.337 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -174.66 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 73.030000000000001 110.941 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -63.05 131.95 50.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 74.230000000000004 110.851 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.5 pp -178.85 161.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 110.837 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -121.43 135.75 55.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 75.540000000000006 110.852 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -120.72 137.95 54.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.0 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -138.31 139.99 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 62.25 110.866 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.763 HD13 ' CD2' ' A' ' 77' ' ' PHE . 6.0 tp -137.67 134.59 35.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 64.230000000000004 110.935 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.815 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 14.7 t-20 -116.21 121.66 42.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 61.100000000000001 110.923 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.821 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 66.9 p -137.72 179.6 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.329999999999998 111.098 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -132.06 15.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.729 -0.748 . . . . 74.109999999999999 112.463 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -37.63 4.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 74.430000000000007 110.874 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 t -179.24 -29.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 72.299999999999997 111.12 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.32 33.55 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.935 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.41 -5.33 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -65.87 130.11 42.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 110.928 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.66 43.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 62.420000000000002 110.95 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -95.67 119.85 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 73.420000000000002 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.52 145.29 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 65.310000000000002 110.884 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.16 163.56 41.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 72.129999999999995 110.886 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.502 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.4 Cg_endo -69.77 0.94 4.92 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.639 2.226 . . . . 63.109999999999999 112.361 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -135.63 71.82 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.929 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.41 32.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.855 -0.688 . . . . 74.200000000000003 112.457 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 47.31 -147.41 3.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 74.209999999999994 112.509 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -162.95 1.17 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 64.019999999999996 112.534 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 119.68 6.58 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.649 2.233 . . . . 63.0 112.322 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -83.13 -34.24 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 72.030000000000001 110.929 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -25.74 68.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 62.340000000000003 110.821 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.66 -45.89 41.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.853 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.511 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -128.79 -98.38 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.117 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.583 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -166.85 172.25 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 42.439999999999998 111.087 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.96 160.16 28.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.83 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 45' ' ' SER . 53.6 t -108.47 127.08 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 72.099999999999994 111.078 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' A' ' 63' ' ' SER . 55.6 mt -69.4 157.46 89.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 54.240000000000002 110.938 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -22.74 31.33 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.655 2.236 . . . . 70.310000000000002 112.403 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -82.67 0.68 42.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 110.876 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.93 26.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.63 -0.795 . . . . 41.109999999999999 112.451 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 59' ' ' LEU . 10.1 m -105.51 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.408 . . . . 43.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.656 HD23 HD12 ' A' ' 16' ' ' LEU . 7.0 tp -131.15 129.5 41.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.299999999999997 110.897 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HD1' HG22 ' A' ' 15' ' ' VAL . 7.0 t80 -125.52 129.0 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.540000000000006 111.0 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.671 HD22 HG12 ' A' ' 69' ' ' VAL . 1.9 mp -120.36 131.17 24.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 53.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -32.98 17.76 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.664 2.242 . . . . 63.240000000000002 112.403 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.79 100.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 72.109999999999999 111.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.3 m -76.76 118.58 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 65.430000000000007 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.29 165.42 37.45 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.672 -0.775 . . . . 71.219999999999999 112.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.793 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.94 -31.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 75.129999999999995 111.15 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.2 -22.22 58.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.08 -5.02 41.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 70.200000000000003 110.819 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.59 141.58 51.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.030000000000001 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.65 -147.69 16.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.758 . . . . 74.310000000000002 112.445 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.0 HD11 ' HB2' ' B' ' 2' ' ' GLU . 0.8 OUTLIER -130.62 134.96 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 44.439999999999998 111.224 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.763 ' CD2' HD13 ' A' ' 33' ' ' LEU . 21.6 m-85 -104.43 126.57 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 52.530000000000001 110.877 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HD2' ' HE2' ' B' ' 4' ' ' MCL . 5.7 ttp85 -124.45 136.54 54.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.852 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.45 156.26 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 24.41 110.925 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -141.02 126.25 18.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 110.982 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.46 162.05 33.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 73.109999999999999 111.115 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.1 mtp -130.32 125.84 35.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.858 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -86.19 171.6 11.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 53.219999999999999 110.866 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -71.66 -17.46 62.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 70.239999999999995 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.93 -26.0 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 62.020000000000003 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.61 -19.53 11.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 23.34 112.452 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.97 147.56 26.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.649 0.262 . . . . 62.310000000000002 111.01 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.39 144.27 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 52.049999999999997 110.906 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.14 126.64 50.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 52.140000000000001 111.133 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.41 142.58 35.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 64.25 110.891 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -146.8 119.01 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 51.130000000000003 110.785 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.584 ' OD1' ' HB2' ' B' ' 5' ' ' ALA . 6.4 t-20 -125.76 128.66 48.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 74.549999999999997 110.901 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.431 ' HB2' HD22 ' A' ' 16' ' ' LEU . 7.3 m-85 -128.7 118.9 23.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.530000000000001 110.883 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.899 ' NH2' ' OE1' ' B' ' 7' ' ' GLU . 0.0 OUTLIER -83.74 128.08 34.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 73.140000000000001 110.751 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 6' ' ' ILE . 70.5 t -119.28 139.59 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 54.130000000000003 111.183 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 127.79 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 74.510000000000005 110.833 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 71' ' ' ILE . 35.2 m -86.94 -176.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 111.104 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.5 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 53.219999999999999 110.932 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -64.49 145.83 55.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 43.439999999999998 110.99 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.498 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.4 50.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 73.409999999999997 111.072 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo -69.88 134.76 28.51 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.718 2.279 . . . . 71.099999999999994 112.277 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.47 -102.33 0.37 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 25.41 112.497 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -113.72 157.89 40.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.606 0.717 . . . . 64.540000000000006 110.809 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 100.26 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.589 2.192 . . . . 52.100000000000001 112.384 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 73.530000000000001 110.922 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.83 0.348 . . . . 72.420000000000002 110.794 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.0 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.8 pm0 -136.81 77.16 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 53.009999999999998 110.805 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.815 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 51.91 -164.85 0.06 Allowed 'General case' 0 C--O 1.182 -2.484 0 CA-C-O 118.156 -0.926 . . . . 75.140000000000001 110.859 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.515 ' HE2' ' HD2' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.741 ' HB3' HG21 ' A' ' 76' ' ' ILE . . . -48.2 104.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 54.119999999999997 111.068 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -151.36 64.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 54.43 110.839 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.899 ' OE1' ' NH2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 74.329999999999998 110.904 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.489 -0.245 . . . . 72.019999999999996 112.489 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 p -107.01 79.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 71.109999999999999 110.8 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.22 69.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.239999999999995 111.094 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.39 133.68 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 61.140000000000001 110.874 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.02 122.04 31.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 65.319999999999993 110.853 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.72 121.29 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 111.071 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -95.16 142.65 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.06 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -142.55 166.31 25.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 52.229999999999997 111.063 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.53 147.62 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 61.100000000000001 110.883 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 71' ' ' ILE . 59.1 mt -59.05 121.16 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 70.430000000000007 111.159 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.668 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.16 0.08 88.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 62.409999999999997 112.435 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.766 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -97.62 142.04 23.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.663 0.745 . . . . 73.400000000000006 110.927 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 143.85 52.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.651 2.234 . . . . 74.239999999999995 112.275 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.8 tp -144.65 143.21 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.140000000000001 110.942 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.59 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.5 t -121.55 148.66 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 72.200000000000003 111.087 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.642 HD13 HD23 ' A' ' 64' ' ' LEU . 1.6 mt -130.9 147.96 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.030000000000001 110.951 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -112.35 151.98 29.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 64.230000000000004 110.946 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 101.97 11.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 33.219999999999999 110.88 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.18 120.9 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 54.32 110.81 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 126.14 -38.5 2.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.811 -0.709 . . . . 23.32 112.532 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.23 128.26 47.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.319999999999993 111.119 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.666 2.244 . . . . 74.510000000000005 112.374 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.34 -49.39 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.109999999999999 110.896 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.29 150.09 40.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 75.109999999999999 110.912 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.444 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.6 Cg_endo -69.66 110.14 2.46 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.748 2.299 . . . . 75.109999999999999 112.338 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.5 Cg_endo -69.78 -86.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.120000000000005 112.338 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.33 -177.13 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 72.299999999999997 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -63.65 138.52 58.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 75.329999999999998 110.899 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -136.62 156.31 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 53.140000000000001 110.925 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.1 148.35 44.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 70.430000000000007 110.896 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.602 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -129.63 142.02 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 74.219999999999999 110.872 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.712 ' O ' HD23 ' A' ' 33' ' ' LEU . 28.4 mtpt -146.77 137.01 23.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 75.129999999999995 110.876 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.831 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -138.59 139.52 38.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 61.399999999999999 110.936 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.9 ' N ' ' HE2' ' B' ' 3' ' ' PHE . 12.3 t-20 -112.42 124.44 52.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 64.519999999999996 110.889 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.792 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 70.3 p -138.45 -179.24 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 74.219999999999999 111.111 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.01 -130.55 14.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 72.310000000000002 112.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.41 -37.84 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 71.319999999999993 110.855 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.6 t -179.5 -30.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 111.145 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.586 ' HG2' HG23 ' A' ' 38' ' ' THR . 6.1 mm-40 -102.21 33.71 2.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.877 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.33 -7.26 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 71.150000000000006 111.127 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.19 129.44 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.420000000000002 110.874 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.89 153.41 50.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 63.310000000000002 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.73 121.55 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.430000000000007 111.111 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -89.55 146.73 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 64.140000000000001 110.974 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.806 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -125.07 164.42 31.76 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.722 0.773 . . . . 75.430000000000007 110.848 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HB3' HD11 ' A' ' 29' ' ' LEU . 54.1 Cg_endo -69.75 0.26 5.89 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.699 2.266 . . . . 62.43 112.428 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.42 80.78 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 74.420000000000002 110.887 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 35.63 4.32 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.696 . . . . 62.520000000000003 112.503 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.39 -4.65 57.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.671 -0.776 . . . . 71.239999999999995 112.52 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.86 -160.26 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.665 -0.779 . . . . 64.329999999999998 112.553 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 53.5 Cg_endo -69.8 99.21 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.717 2.278 . . . . 65.209999999999994 112.332 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -71.22 -34.09 70.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 72.140000000000001 110.8 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.75 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 52.240000000000002 110.825 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -87.52 -44.7 11.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 70.430000000000007 110.793 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.49 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.44 -97.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 64.230000000000004 111.119 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -163.08 173.11 13.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 65.219999999999999 111.1 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 159.64 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 63.299999999999997 110.828 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.806 HG21 ' O ' ' A' ' 45' ' ' SER . 86.7 t -109.05 129.94 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.13 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.557 HD12 ' CB ' ' A' ' 63' ' ' SER . 73.3 mt -68.56 157.77 87.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.665 0.745 . . . . 62.350000000000001 110.877 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -21.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 72.129999999999995 112.36 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -83.27 0.25 46.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 54.149999999999999 110.89 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.05 9.57 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.795 -0.716 . . . . 35.329999999999998 112.397 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.557 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.0 m -112.4 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.959 0.409 . . . . 53.049999999999997 110.849 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.642 HD23 HD13 ' A' ' 16' ' ' LEU . 18.2 tp -128.48 127.69 42.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.833 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CD2' HG22 ' A' ' 15' ' ' VAL . 32.1 t80 -125.71 133.54 52.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 60.140000000000001 110.863 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 56' ' ' ALA . 2.1 mp -119.88 131.27 24.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.522 0.677 . . . . 62.450000000000003 110.955 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -36.29 11.13 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.766 2.311 . . . . 73.099999999999994 112.35 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.668 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -162.99 101.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 60.439999999999998 111.122 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.7 m -73.48 117.78 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.173 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.24 163.09 39.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 75.120000000000005 112.476 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.868 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.89 -30.93 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 65.329999999999998 111.106 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 74.140000000000001 110.909 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -5.44 37.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.274 -0.421 . . . . 75.329999999999998 110.832 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.657 ' HG3' HG22 ' A' ' 97' ' ' VAL . 1.5 mt-10 -58.56 142.06 50.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.886 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.569 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.6 -151.83 23.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 43.43 112.478 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.222 ' CD1' ' HB2' ' B' ' 2' ' ' GLU . 3.3 mp -124.29 134.21 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 74.120000000000005 111.182 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.831 ' CE2' HD13 ' A' ' 33' ' ' LEU . 6.9 m-85 -102.58 132.73 48.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.099999999999994 110.938 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.97 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -127.87 134.64 49.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.099999999999994 110.938 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 146.19 46.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.32 110.876 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -141.17 126.12 18.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 63.5 110.924 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.05 164.0 27.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 111.055 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 124.82 34.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 65.349999999999994 110.881 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -86.81 172.29 10.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 72.140000000000001 110.906 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -71.32 -18.1 62.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.878 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -73.0 -20.12 61.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.87 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.99 -18.24 28.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.200000000000003 112.415 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -84.97 146.75 27.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.708 0.289 . . . . 73.319999999999993 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -105.17 145.0 31.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.441 HG21 ' CA ' ' A' ' 20' ' ' GLY . 1.2 m -102.24 129.41 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.225 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.315 ' CB ' ' O1 ' ' B' ' 4' ' ' MCL . 23.9 mtpp -105.3 146.06 29.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 72.519999999999996 110.884 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.95 126.78 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 110.826 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' B' ' 5' ' ' ALA . 18.6 t-20 -121.31 120.4 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.230000000000004 110.9 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.98 127.56 40.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 73.510000000000005 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.198 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 6.6 mmt85 -89.55 131.07 35.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 72.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.0 t -120.92 130.58 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 75.530000000000001 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.404 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 15.8 mmt-85 -131.72 153.32 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.540000000000006 110.83 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.868 HG21 ' HA ' ' A' ' 71' ' ' ILE . 27.2 m -116.06 -177.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 111.179 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.19 -82.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 75.209999999999994 110.978 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -59.1 146.69 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.972 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.494 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.37 159.66 49.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 61.109999999999999 111.076 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.3 Cg_endo -69.81 179.03 4.01 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.65 2.233 . . . . 70.439999999999998 112.279 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.14 31.52 0.1 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.641 -0.79 . . . . 50.350000000000001 112.481 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -117.0 137.78 24.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.628 0.728 . . . . 74.439999999999998 110.901 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 108.2 2.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.583 2.189 . . . . 70.040000000000006 112.34 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.892 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.825 0.345 . . . . 71.299999999999997 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.222 ' HB2' ' CD1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.34 -41.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 41.020000000000003 110.902 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.9 ' HE2' ' N ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 175.66 -165.64 0.03 OUTLIER 'General case' 0 C--O 1.182 -2.449 0 CA-C-O 118.183 -0.913 . . . . 74.409999999999997 110.904 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.315 ' O1 ' ' CB ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.198 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -40.16 123.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 74.239999999999995 111.118 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.67 59.13 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 110.848 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 73.409999999999997 110.93 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.504 -0.239 . . . . 63.439999999999998 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m 60.34 99.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 51.420000000000002 110.908 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.46 77.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 44.229999999999997 111.139 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.51 132.63 37.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.340000000000003 110.915 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.539 ' C ' HD12 ' A' ' 6' ' ' ILE . 4.2 p-10 -88.66 121.29 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.944 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.644 HG21 HD11 ' A' ' 14' ' ' LEU . 2.6 mp -123.22 120.81 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 111.089 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.8 p -96.95 142.58 28.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 111.159 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.0 168.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 65.219999999999999 111.129 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.32 145.66 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 64.540000000000006 110.906 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 99' ' ' GLN . 11.3 mt -52.21 120.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.077 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 89.83 5.8 70.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 60.109999999999999 112.492 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.82 ' O ' HG22 ' A' ' 69' ' ' VAL . 18.7 mm-40 -101.67 140.8 21.53 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 121.539 0.685 . . . . 63.439999999999998 110.98 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 143.89 52.88 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.752 2.302 . . . . 65.340000000000003 112.315 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 6' ' ' ILE . 37.8 tp -142.89 142.13 31.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 75.510000000000005 110.841 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.7 t -122.41 149.32 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 70.209999999999994 111.115 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.688 HD13 ' CG ' ' A' ' 77' ' ' PHE . 70.3 mt -130.73 146.91 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 52.329999999999998 110.954 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -112.91 152.86 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.010000000000005 110.897 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.89 100.6 10.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 61.420000000000002 110.862 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.32 120.65 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.28 -36.7 2.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 74.120000000000005 112.424 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.7 130.37 39.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.624 0.726 . . . . 71.030000000000001 111.062 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.66 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 72.049999999999997 112.374 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -49.32 -49.36 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 61.539999999999999 110.88 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 150.5 40.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 71.099999999999994 110.812 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 110.7 2.61 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.684 2.256 . . . . 62.119999999999997 112.351 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 53.8 Cg_endo -69.75 -84.14 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.652 2.235 . . . . 73.420000000000002 112.359 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 2.2 mp0 -103.24 -177.9 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 71.140000000000001 110.848 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -64.01 134.85 55.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 110.889 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -136.31 146.94 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.874 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -129.07 137.07 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.859 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' CE2' HD13 ' A' ' 29' ' ' LEU . 1.1 m0 -124.68 144.95 49.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 110.85 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -136.33 142.28 43.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.897 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.819 HD21 HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -137.82 140.06 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.319999999999993 110.946 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.503 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 16.0 t-20 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 62.520000000000003 110.835 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.819 HG23 HD21 ' A' ' 33' ' ' LEU . 33.5 p -136.82 179.91 6.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 111.193 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.78 -130.01 19.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.797 -0.716 . . . . 62.32 112.485 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -112.68 -37.38 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 71.120000000000005 110.901 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -178.9 -29.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 73.319999999999993 111.153 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -102.14 33.6 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 64.109999999999999 110.951 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.33 -5.81 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 62.130000000000003 111.102 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -59.14 132.22 53.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 65.439999999999998 110.956 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 157.17 41.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 61.219999999999999 110.857 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.11 123.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.209999999999994 111.215 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.38 136.68 32.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.941 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.835 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.3 165.52 28.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 110.827 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 45' ' ' SER . 54.5 Cg_endo -69.72 0.49 5.53 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.702 2.268 . . . . 74.430000000000007 112.316 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -126.47 87.69 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 73.5 110.88 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.25 5.58 71.72 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 32.439999999999998 112.488 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.53 165.72 0.23 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.847 -0.692 . . . . 70.150000000000006 112.497 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.16 -153.21 20.22 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.849 -0.691 . . . . 53.039999999999999 112.506 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.86 107.38 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.596 2.197 . . . . 65.200000000000003 112.264 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -82.68 -34.19 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 71.120000000000005 110.91 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.74 -25.35 66.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 72.010000000000005 110.928 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -44.8 21.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 64.219999999999999 110.853 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -127.63 -98.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 75.530000000000001 111.14 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.93 174.67 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 65.430000000000007 111.136 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.85 158.01 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 110.908 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 45' ' ' SER . 49.8 t -116.35 126.87 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 73.140000000000001 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 63' ' ' SER . 38.7 mt -69.02 156.4 91.6 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 75.230000000000004 110.956 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.75 -21.84 32.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.668 2.246 . . . . 72.319999999999993 112.431 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -82.89 -0.19 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.94 29.64 10.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.723 -0.751 . . . . 60.439999999999998 112.438 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 59' ' ' LEU . 3.2 m -111.4 177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 54.109999999999999 110.863 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.683 HD23 HD12 ' A' ' 16' ' ' LEU . 9.2 tp -128.63 130.02 46.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.019999999999996 110.89 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.578 ' N ' HD12 ' A' ' 64' ' ' LEU . 3.4 t80 -125.13 131.9 53.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 64.019999999999996 110.958 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 69' ' ' VAL . 7.2 mp -115.07 130.8 23.92 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.653 0.74 . . . . 61.340000000000003 110.855 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -37.84 8.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.785 2.323 . . . . 63.539999999999999 112.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.614 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.36 102.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 111.083 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.2 m -73.7 116.44 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 111.077 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 163.12 38.3 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.674 -0.774 . . . . 54.240000000000002 112.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.857 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.16 -34.04 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.723 0.297 . . . . 71.200000000000003 111.115 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.95 -15.92 60.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -4.51 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 62.030000000000001 110.921 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.632 ' CD ' HG22 ' A' ' 97' ' ' VAL . 42.6 mt-10 -56.5 141.49 42.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 75.530000000000001 110.973 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.697 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 160.08 -156.41 27.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.749 -0.739 . . . . 71.209999999999994 112.519 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.932 ' HB ' ' CB ' ' B' ' 3' ' ' PHE . 6.3 mm -125.38 134.09 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 75.150000000000006 111.137 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.691 ' HB2' HD12 ' A' ' 33' ' ' LEU . 77.1 t80 -102.84 126.44 49.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 73.25 110.876 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.618 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -125.82 127.86 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.779 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.84 146.58 46.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 74.120000000000005 110.891 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -139.47 132.91 30.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 163.89 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 70.409999999999997 111.039 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.6 mtp -129.1 125.01 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 72.349999999999994 110.938 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.88 172.81 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 73.150000000000006 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -70.71 -18.42 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 64.519999999999996 110.828 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -73.21 -19.86 61.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 63.530000000000001 110.92 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.92 -15.09 37.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 61.219999999999999 112.505 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 146.61 27.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.657 0.265 . . . . 60.350000000000001 110.936 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.37 144.81 31.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 75.319999999999993 110.89 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.449 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.92 132.59 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 53.539999999999999 111.128 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.589 ' HB2' ' CX2' ' B' ' 4' ' ' MCL . 0.5 OUTLIER -99.45 145.47 27.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 73.310000000000002 110.934 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.2 m -144.72 123.88 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 62.229999999999997 110.818 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 4' ' ' MCL . 1.7 t-20 -127.48 121.24 30.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 74.450000000000003 110.884 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.58 123.05 32.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.0 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.548 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 19.4 mmm-85 -84.4 134.17 34.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.861 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -120.27 129.29 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 63.43 111.108 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.47 46.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.857 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -109.68 -175.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 73.400000000000006 111.099 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -65.79 -71.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 110.952 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.498 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.7 mp0 -71.05 140.52 50.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.952 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.27 159.81 48.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.665 0.745 . . . . 65.319999999999993 111.138 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 173.26 11.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 74.030000000000001 112.394 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.54 -72.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 33.25 112.538 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -156.09 161.24 29.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.63 0.729 . . . . 71.310000000000002 110.894 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 141.8 46.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 75.120000000000005 112.357 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.861 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.73 0.3 . . . . 73.420000000000002 110.915 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.32 139.05 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 110.866 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.932 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -50.64 163.08 0.2 Allowed 'General case' 0 C--O 1.181 -2.523 0 CA-C-O 118.174 -0.917 . . . . 75.439999999999998 110.792 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.589 ' CX2' ' HB2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.548 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -178.33 -80.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 74.430000000000007 111.143 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 32.1 t0 47.71 67.61 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.230000000000004 110.829 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.611 ' HB2' HH12 ' A' ' 94' ' ' ARG . 72.1 mm-40 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 64.349999999999994 110.898 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.549 -0.22 . . . . 62.310000000000002 112.549 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -177.7 157.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.862 0.363 . . . . 70.420000000000002 110.817 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.4 97.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 61.130000000000003 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.62 137.25 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 74.340000000000003 110.826 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -89.09 121.13 31.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.86 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.65 121.94 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 75.209999999999994 111.15 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -95.31 142.68 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 72.5 111.202 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.49 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -146.61 167.29 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 45.399999999999999 111.13 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -119.99 148.68 43.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.408 . . . . 64.120000000000005 110.898 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mt -56.81 120.75 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 65.0 111.219 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.31 5.72 79.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.76 . . . . 72.310000000000002 112.46 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.813 ' O ' HG22 ' A' ' 69' ' ' VAL . 51.7 mm-40 -102.05 139.42 20.28 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.657 0.742 . . . . 75.340000000000003 110.918 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 143.27 50.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 75.310000000000002 112.356 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 8' ' ' ALA . 22.7 tp -145.27 142.43 29.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 54.310000000000002 110.891 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.512 HG22 ' CD2' ' A' ' 65' ' ' PHE . 42.5 t -122.96 145.27 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 62.109999999999999 111.134 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.774 HD12 HD23 ' A' ' 64' ' ' LEU . 67.1 mt -130.74 147.27 52.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 62.530000000000001 111.0 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -113.46 150.73 32.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.409999999999997 110.882 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -108.07 99.73 9.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 53.210000000000001 110.846 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -54.26 128.45 31.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.847 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.38 -40.45 1.92 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 42.350000000000001 112.468 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.92 128.89 43.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 62.450000000000003 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.6 Cg_endo -69.8 -165.19 0.15 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.665 2.244 . . . . 64.209999999999994 112.376 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -48.95 45.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 71.219999999999999 110.945 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -108.57 154.44 41.6 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.565 0.697 . . . . 63.140000000000001 110.942 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.3 Cg_endo -69.75 109.36 2.29 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.718 2.279 . . . . 72.310000000000002 112.335 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.69 -86.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.655 2.237 . . . . 54.329999999999998 112.394 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -101.27 -176.53 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.519999999999996 110.885 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.36 133.02 53.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 75.5 110.88 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.645 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -137.28 159.13 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 55.310000000000002 110.918 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -132.53 146.14 51.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 110.851 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.645 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 13.7 m95 -123.6 134.25 53.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.400000000000006 110.922 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' C ' HD23 ' A' ' 33' ' ' LEU . 15.0 ttpp -136.36 138.33 41.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 63.450000000000003 110.91 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.739 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -138.29 138.24 38.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 75.120000000000005 110.903 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -113.33 127.8 56.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 74.209999999999994 110.89 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.812 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 21.2 p -138.52 -179.87 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 62.219999999999999 111.139 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.17 21.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.815 -0.707 . . . . 63.43 112.463 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.89 -37.26 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 64.430000000000007 110.869 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.2 t -178.72 -29.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 111.015 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.611 ' HG3' HG23 ' A' ' 38' ' ' THR . 29.3 mt-10 -102.06 34.06 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 75.219999999999999 110.821 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.71 -5.59 8.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.409999999999997 111.114 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -59.57 132.16 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.958 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' CE ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.45 152.46 48.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.316 -0.402 . . . . 64.439999999999998 110.92 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.1 t -105.26 116.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 61.5 111.131 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.717 HD13 HD13 ' A' ' 64' ' ' LEU . 27.0 mt -96.28 146.03 25.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 73.439999999999998 110.823 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.66 157.03 69.94 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.586 0.708 . . . . 74.129999999999995 110.865 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HG3' HD12 ' A' ' 29' ' ' LEU . 54.0 Cg_endo -69.67 0.23 5.87 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.661 2.24 . . . . 64.25 112.366 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -136.75 71.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 65.340000000000003 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.98 78.54 1.0 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 64.200000000000003 112.428 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.62 58.45 3.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.68 -0.771 . . . . 63.420000000000002 112.52 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.36 179.21 45.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 61.310000000000002 112.53 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 106.39 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 60.240000000000002 112.316 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -55.57 -34.43 64.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 75.319999999999993 110.946 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.98 -26.86 67.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.25 110.809 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -44.5 8.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 70.219999999999999 110.859 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.509 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.46 -96.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 63.140000000000001 111.068 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -150.17 176.55 10.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 52.439999999999998 111.147 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.37 162.41 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 73.420000000000002 110.903 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 63' ' ' SER . 46.2 t -108.69 130.72 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 72.400000000000006 111.119 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 63' ' ' SER . 56.4 mt -68.99 156.46 91.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.596 0.712 . . . . 62.509999999999998 110.965 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -22.43 32.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 73.310000000000002 112.265 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -81.91 0.15 41.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.299999999999997 110.921 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.8 22.92 24.63 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 65.319999999999993 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.518 ' HB2' HD12 ' A' ' 59' ' ' LEU . 6.0 m -106.24 178.91 4.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 71.120000000000005 110.88 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.774 HD23 HD12 ' A' ' 16' ' ' LEU . 15.5 tp -129.68 129.95 44.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 74.019999999999996 110.952 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 15' ' ' VAL . 39.3 t80 -124.34 129.96 51.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 75.040000000000006 110.86 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.811 HD22 HG12 ' A' ' 69' ' ' VAL . 5.3 mp -114.57 127.23 27.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.678 0.752 . . . . 75.420000000000002 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -32.62 18.11 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.239999999999995 112.386 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.5 101.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 63.310000000000002 111.145 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.09 115.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 111.185 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.63 161.81 31.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 72.109999999999999 112.457 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.835 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.07 -31.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 73.129999999999995 111.168 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -77.46 -22.47 51.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.924 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.15 -5.34 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 70.109999999999999 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.75 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.33 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 110.822 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.779 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 160.39 -148.91 17.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.793 -0.718 . . . . 53.43 112.516 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.779 HD12 ' C ' ' A' ' 75' ' ' GLY . 2.0 mp -126.18 133.66 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.89 0.376 . . . . 61.509999999999998 111.178 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.739 ' CE2' HD13 ' A' ' 33' ' ' LEU . 11.0 m-85 -103.32 135.2 45.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 45.149999999999999 110.908 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 1.232 ' HD3' ' CE1' ' B' ' 3' ' ' PHE . 3.5 ttp85 -125.99 134.61 51.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.813 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.49 147.95 44.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -141.37 129.21 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 61.520000000000003 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.73 163.13 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 111.12 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 125.09 33.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 45.340000000000003 110.937 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -86.84 172.1 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 74.140000000000001 110.823 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.47 -18.3 62.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 70.530000000000001 110.934 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.07 -19.87 61.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 65.010000000000005 110.848 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.03 32.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.756 -0.735 . . . . 74.230000000000004 112.545 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -85.02 147.07 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.795 0.331 . . . . 75.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.79 145.14 30.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 72.219999999999999 110.955 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.69 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 63.25 111.107 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.477 ' HE2' ' CX2' ' B' ' 4' ' ' MCL . 8.9 ptpt -98.65 145.31 27.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 71.430000000000007 110.943 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 m -144.73 127.76 16.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 63.240000000000002 110.748 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.523 ' HB2' ' HE3' ' B' ' 4' ' ' MCL . 20.3 t-20 -128.14 121.52 29.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 72.349999999999994 110.931 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.22 126.1 40.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.530000000000001 110.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.55 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 17.6 mmm-85 -89.85 132.1 35.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 74.5 110.859 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.82 130.02 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 64.010000000000005 111.129 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -131.55 146.17 52.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 110.886 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 71' ' ' ILE . 17.0 m -109.58 -176.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 52.020000000000003 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.86 -79.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.992 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.45 146.21 54.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 73.219999999999999 111.032 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.38 159.42 50.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.719 0.771 . . . . 61.350000000000001 111.145 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo -69.75 -176.76 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.649 2.233 . . . . 73.109999999999999 112.321 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.79 -91.27 2.2 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.811 -0.709 . . . . 71.409999999999997 112.456 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -165.65 157.58 12.68 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.563 0.697 . . . . 72.239999999999995 110.946 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 176.78 6.28 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.727 2.284 . . . . 64.010000000000005 112.327 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 43.219999999999999 110.892 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 120.726 0.298 . . . . 74.349999999999994 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.75 ' HB2' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -142.24 108.02 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 63.119999999999997 110.968 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.232 ' CE1' ' HD3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER 50.87 -166.7 0.04 OUTLIER 'General case' 0 C--O 1.181 -2.519 0 CA-C-O 118.14 -0.933 . . . . 75.310000000000002 110.861 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.477 ' CX2' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.55 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -45.24 134.38 6.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.895 -0.593 . . . . 64.409999999999997 111.145 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -163.59 57.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 71.150000000000006 110.843 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.635 ' HG2' HH12 ' A' ' 94' ' ' ARG . 26.7 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 62.32 110.939 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.452 -0.259 . . . . 73.340000000000003 112.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 p -79.88 91.22 5.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.841 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 1.602 ' CB ' ' HA ' ' B' ' 5' ' ' ALA . . . 51.8 65.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 64.140000000000001 111.156 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.12 133.6 36.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 73.430000000000007 110.893 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.6 121.27 28.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.510000000000005 110.884 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.1 mm -125.16 127.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 74.25 111.111 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -91.56 142.52 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 64.150000000000006 111.17 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.0 165.85 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 33.140000000000001 111.133 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -119.1 149.71 41.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 62.229999999999997 110.906 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 71' ' ' ILE . 10.6 mt -68.43 120.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 45.119999999999997 111.108 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.5 -6.99 57.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.815 -0.707 . . . . 64.439999999999998 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.837 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -102.72 140.76 21.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.71 0.767 . . . . 74.299999999999997 110.923 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 146.11 59.7 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.84 2.36 . . . . 74.200000000000003 112.323 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.3 tp -138.33 142.8 39.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 73.209999999999994 110.966 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.627 HG22 ' CD1' ' A' ' 65' ' ' PHE . 47.1 t -122.59 148.22 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.540000000000006 111.141 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.68 HD12 HD23 ' A' ' 64' ' ' LEU . 6.6 mt -130.99 147.48 52.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.933 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -112.78 152.04 29.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 72.140000000000001 111.002 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -107.33 100.53 9.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.413 . . . . 61.409999999999997 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.88 122.41 12.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 73.530000000000001 110.839 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.15 -39.8 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 72.129999999999995 112.484 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.29 129.32 43.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.522 0.677 . . . . 73.329999999999998 111.171 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.91 -165.08 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.64 2.226 . . . . 75.230000000000004 112.383 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -49.02 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.981 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.6 152.42 41.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.603 0.716 . . . . 61.43 110.936 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 52.1 Cg_endo -69.84 110.18 2.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.617 2.212 . . . . 73.510000000000005 112.292 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.73 -81.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.671 2.248 . . . . 63.530000000000001 112.356 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.438 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 79.4 mm-40 -103.31 -177.67 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 64.219999999999999 110.914 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.99 133.83 53.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.120000000000005 110.86 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.2 pp -136.09 151.31 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 73.310000000000002 110.912 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.82 148.18 45.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.834 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -121.81 139.97 52.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.922 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -146.65 135.35 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.230000000000004 110.928 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.716 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -140.58 137.84 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 70.129999999999995 110.891 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -112.28 125.2 53.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 54.5 110.893 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.84 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 40.4 p -139.22 -178.96 5.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 73.530000000000001 111.137 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.98 -127.04 9.95 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.703 -0.76 . . . . 54.329999999999998 112.53 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' THR . 1.2 mpp_? -112.9 -38.88 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 75.319999999999993 110.863 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 39' ' ' GLU . 3.8 t 179.0 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.171 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -102.03 34.18 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 110.823 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.84 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.12 -6.92 8.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 72.239999999999995 111.105 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -71.47 128.71 36.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.506 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -137.57 159.65 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 54.329999999999998 110.929 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 t -93.59 121.01 43.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 72.030000000000001 111.135 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.05 145.74 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 61.43 110.879 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p -126.06 153.97 74.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 63.25 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 1.65 4.22 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.704 2.269 . . . . 74.099999999999994 112.383 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -117.62 69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 73.299999999999997 110.906 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.71 -37.45 3.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.835 -0.698 . . . . 55.219999999999999 112.489 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.53 43.24 52.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.741 -0.743 . . . . 53.149999999999999 112.527 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.16 -176.07 45.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.877 -0.677 . . . . 44.5 112.508 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 105.63 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.648 2.232 . . . . 73.340000000000003 112.384 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -55.49 -34.24 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 70.349999999999994 110.883 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.03 -26.44 66.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.209999999999994 110.929 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -43.64 9.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.875 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.48 -97.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 73.200000000000003 111.101 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -156.77 174.57 15.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.439999999999998 111.011 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.18 161.14 25.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.944 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 63' ' ' SER . 61.6 t -107.44 130.28 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 71.299999999999997 111.084 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 63' ' ' SER . 44.5 mt -68.81 157.88 87.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 71.530000000000001 110.923 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -21.86 33.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.772 2.315 . . . . 72.439999999999998 112.353 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -82.37 0.95 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 75.409999999999997 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 26.46 20.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 73.310000000000002 112.514 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 58' ' ' VAL . 30.8 m -111.97 -179.53 3.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 74.239999999999995 110.874 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.68 HD23 HD12 ' A' ' 16' ' ' LEU . 13.3 tp -129.84 130.54 45.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.32 110.909 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.627 ' CD1' HG22 ' A' ' 15' ' ' VAL . 6.2 t80 -123.81 133.04 53.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.668 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -114.83 127.08 27.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.651 0.738 . . . . 74.439999999999998 110.939 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -32.28 19.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 33.210000000000001 112.374 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.64 102.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 74.430000000000007 111.084 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 12' ' ' GLU . 27.5 m -73.07 118.71 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 75.409999999999997 111.136 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.01 161.61 21.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 41.310000000000002 112.524 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.912 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.76 -34.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 73.109999999999999 111.212 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.08 -20.2 56.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.450000000000003 110.903 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -2.9 28.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.420000000000002 110.965 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.22 141.91 49.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 60.509999999999998 110.883 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.573 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 163.4 -155.09 26.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 73.040000000000006 112.428 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.036 ' HB ' ' CD2' ' B' ' 3' ' ' PHE . 0.6 OUTLIER -124.74 135.34 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 71.540000000000006 111.142 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.716 ' CE2' HD22 ' A' ' 33' ' ' LEU . 80.8 m-85 -103.71 126.75 51.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.874 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 1.006 ' HG3' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER -124.93 127.55 47.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 74.140000000000001 110.868 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.01 150.9 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 65.25 110.857 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -139.65 132.6 29.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.936 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.16 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 73.439999999999998 111.176 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.4 ttm -129.48 126.09 37.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 64.400000000000006 110.884 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -86.22 172.62 10.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.915 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -71.26 -18.48 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 71.129999999999995 110.814 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -73.13 -19.85 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 73.400000000000006 110.874 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.69 -17.36 30.54 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 70.299999999999997 112.454 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -85.15 146.58 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.832 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.39 144.86 31.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.866 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 132.8 48.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.120000000000005 111.218 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.246 ' HE3' ' O2 ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -98.87 144.08 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.033 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -145.52 121.66 10.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 64.219999999999999 110.9 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.841 ' CG ' ' HB2' ' B' ' 4' ' ' MCL . 0.7 OUTLIER -128.18 122.08 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 74.230000000000004 110.836 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -128.0 118.97 24.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 73.120000000000005 110.965 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.599 ' CD ' ' CB ' ' B' ' 5' ' ' ALA . 0.5 OUTLIER -86.13 135.79 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.099999999999994 110.864 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 68.9 t -120.68 134.2 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.115 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 127.25 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.88 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.912 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.1 m -88.32 -177.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 52.310000000000002 111.065 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.401 ' CD2' ' NE2' ' A' ' 99' ' ' GLN . 14.0 t80 -68.84 -80.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 72.120000000000005 110.942 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' ' CD2' ' A' ' 98' ' ' TYR . 1.9 mp0 -59.25 144.23 46.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 72.450000000000003 110.849 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.13 159.62 48.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.581 0.705 . . . . 53.509999999999998 111.131 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -19.93 35.27 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 61.399999999999999 112.329 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -175.54 -115.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 53.450000000000003 112.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -175.96 137.64 0.5 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.556 0.694 . . . . 53.229999999999997 110.86 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.86 115.46 4.12 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 64.25 112.33 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 55.32 110.936 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.836 0.351 . . . . 65.109999999999999 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.894 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -134.28 -37.93 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 74.420000000000002 110.913 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.036 ' CD2' ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 176.08 -157.89 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.514 0 CA-C-O 118.107 -0.949 . . . . 74.319999999999993 110.856 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.246 ' O2 ' ' HE3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.602 ' HA ' ' CB ' ' A' ' 3' ' ' ALA . . . -50.03 -41.04 46.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.882 -0.599 . . . . 73.099999999999994 111.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.65 33.0 12.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 72.200000000000003 110.87 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 94' ' ' ARG . 5.0 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.299999999999997 110.803 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.564 -0.215 . . . . 32.200000000000003 112.564 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.72 148.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 70.209999999999994 110.851 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.702 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . -61.93 94.78 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 63.210000000000001 111.093 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -93.3 133.51 36.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 74.140000000000001 110.881 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.0 121.34 27.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.79 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.56 121.88 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 72.140000000000001 111.142 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -95.93 142.06 28.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 73.219999999999999 111.152 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.72 165.26 30.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 72.400000000000006 111.109 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 148.64 45.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.909 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 HD11 ' HB3' ' A' ' 99' ' ' GLN . 70.3 mt -57.13 122.13 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 60.140000000000001 111.094 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.28 4.45 80.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 112.506 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.768 ' O ' HG22 ' A' ' 69' ' ' VAL . 35.7 mm-40 -101.19 139.4 20.43 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.641 0.734 . . . . 32.32 110.935 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 138.62 38.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.609 2.206 . . . . 43.43 112.359 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 66' ' ' LEU . 18.4 tp -145.0 141.26 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 64.430000000000007 110.861 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' CD1' ' A' ' 65' ' ' PHE . 47.2 t -126.64 147.81 31.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 54.439999999999998 111.178 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 77' ' ' PHE . 56.2 mt -131.88 147.29 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 72.349999999999994 110.96 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -111.7 149.11 32.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.869 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -112.32 101.56 9.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 61.020000000000003 110.86 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.530000000000001 110.906 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 150.31 -49.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 72.150000000000006 112.476 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.52 102.95 11.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 73.299999999999997 111.044 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.4 Cg_endo -69.71 -161.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.626 2.217 . . . . 64.329999999999998 112.402 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -12.68 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 71.040000000000006 110.942 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.508 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 29.8 mmtm -45.01 163.6 0.2 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 72.129999999999995 110.9 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 53.4 Cg_endo -69.72 172.58 12.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.0 112.368 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.76 92.7 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 72.319999999999993 112.353 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -97.04 -175.51 3.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 74.349999999999994 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -64.1 132.54 50.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 110.946 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 46' ' ' PRO . 1.7 pp -168.63 174.26 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 75.25 110.927 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 124.1 40.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.931 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.35 143.4 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 72.120000000000005 110.866 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -143.96 144.1 31.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 71.430000000000007 110.941 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.698 HD11 ' CE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -136.57 132.83 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 72.329999999999998 110.882 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.158 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 0.2 OUTLIER -116.48 120.43 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.878 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.814 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.4 p -140.02 179.6 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 71.109999999999999 111.099 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.1 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.434 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.39 -38.46 4.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 74.310000000000002 110.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.1 t 179.24 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 41.409999999999997 111.152 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' HG2' HG23 ' A' ' 38' ' ' THR . 4.7 mm-40 -102.03 33.93 2.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.825 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.93 -6.67 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 63.329999999999998 111.101 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -68.37 130.2 42.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 159.08 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 64.040000000000006 110.883 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.59 122.1 38.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 72.530000000000001 111.181 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 33' ' ' LEU . 11.2 mt -92.31 148.84 21.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 72.140000000000001 110.862 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.717 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -123.53 164.13 30.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.712 0.768 . . . . 61.219999999999999 110.825 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.793 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.8 Cg_endo -69.68 -0.51 6.95 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.258 . . . . 62.119999999999997 112.363 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 82.26 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 73.239999999999995 110.945 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.04 44.47 1.49 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.704 -0.76 . . . . 72.120000000000005 112.467 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.1 -126.84 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.797 -0.716 . . . . 72.450000000000003 112.432 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.25 -149.3 7.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 72.319999999999993 112.417 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 98.59 0.7 Allowed 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.785 2.323 . . . . 74.209999999999994 112.296 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -83.4 -34.84 25.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.898 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.5 -26.36 68.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 72.409999999999997 110.797 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -42.97 22.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.150000000000006 110.902 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.08 -97.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 74.140000000000001 111.208 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.7 171.48 11.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 111.081 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.47 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -131.25 165.39 23.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 110.899 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.793 HG11 ' HA ' ' A' ' 46' ' ' PRO . 55.2 t -106.51 130.13 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 111.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 65' ' ' PHE . 6.2 mp -69.76 157.84 88.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.577 0.703 . . . . 61.350000000000001 110.907 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.2 Cg_endo -69.68 -22.9 31.79 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.717 2.278 . . . . 65.120000000000005 112.37 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.37 2.06 38.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 75.439999999999998 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.93 30.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 60.210000000000001 112.494 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 11.7 m -105.67 179.42 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 110.805 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 57' ' ' ARG . 36.9 tp -132.3 128.35 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 74.430000000000007 110.959 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 15' ' ' VAL . 4.5 t80 -129.65 128.16 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 72.150000000000006 110.858 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -121.27 132.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.698 0.761 . . . . 72.150000000000006 110.927 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.27 19.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.743 2.295 . . . . 64.120000000000005 112.414 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -155.81 103.5 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 74.299999999999997 111.055 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.3 m -73.2 119.36 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 111.19 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.82 156.17 26.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.741 . . . . 63.130000000000003 112.526 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.76 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.51 -29.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 74.109999999999999 111.087 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -73.32 -23.5 60.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 61.130000000000003 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.26 -5.26 57.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 72.420000000000002 110.831 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.55 140.61 57.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 75.409999999999997 110.869 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.23 -137.93 5.63 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.778 -0.725 . . . . 64.209999999999994 112.485 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.444 HD13 ' CB ' ' B' ' 5' ' ' ALA . 70.9 mt -130.46 135.26 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 73.049999999999997 111.197 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.698 ' CE2' HD11 ' A' ' 33' ' ' LEU . 5.0 m-85 -100.85 128.39 46.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.874 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 1.108 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 2.1 tmm_? -127.92 127.72 43.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 110.902 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -121.24 149.73 42.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.854 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -146.98 126.68 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.874 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.13 163.74 27.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 55.030000000000001 111.101 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.4 mtp -129.96 125.83 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.879 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -86.2 172.03 10.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.519999999999996 110.83 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -71.78 -17.95 62.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.843 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.1 -19.61 61.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.895 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.7 -18.58 29.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 62.299999999999997 112.53 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 145.19 27.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 44.329999999999998 110.83 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.91 145.0 32.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 110.893 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.01 131.32 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.299999999999997 111.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.262 ' HD2' ' C1 ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -105.35 145.6 30.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 62.32 110.936 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -146.04 123.95 12.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 62.210000000000001 110.81 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.885 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.5 OUTLIER -128.49 120.39 26.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 64.219999999999999 110.913 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.64 127.85 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.989 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.349 ' NE ' ' HB1' ' B' ' 5' ' ' ALA . 4.1 mmm-85 -87.62 136.18 33.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 61.119999999999997 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 77' ' ' PHE . 56.1 t -126.45 132.29 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 111.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 128.83 41.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.9 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 m -92.92 -176.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 62.140000000000001 111.083 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -66.49 -81.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 72.109999999999999 110.941 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.426 ' HB3' HD11 ' A' ' 10' ' ' ILE . 68.8 tp60 -60.97 142.59 56.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 71.25 110.811 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.67 159.88 48.9 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.548 0.69 . . . . 72.510000000000005 111.151 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -174.76 0.95 Allowed 'Trans proline' 0 C--N 1.34 0.086 0 C-N-CA 122.746 2.297 . . . . 62.020000000000003 112.339 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 163.51 -51.57 0.3 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.835 -0.698 . . . . 73.510000000000005 112.543 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 157.13 40.5 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.601 0.715 . . . . 53.020000000000003 110.878 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 127.17 14.26 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 74.129999999999995 112.337 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 53.340000000000003 110.839 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.858 0.361 . . . . 63.210000000000001 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -116.84 -17.95 10.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 64.150000000000006 110.924 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.158 ' CD2' ' HB2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -161.14 -165.15 1.28 Allowed 'General case' 0 C--O 1.181 -2.515 0 CA-C-O 118.15 -0.929 . . . . 70.140000000000001 110.851 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.262 ' C1 ' ' HD2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.444 ' CB ' HD13 ' A' ' 76' ' ' ILE . . . -43.73 127.14 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.595 . . . . 72.439999999999998 111.136 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -153.78 58.54 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 71.230000000000004 110.92 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.815 ' HG3' ' NH1' ' A' ' 94' ' ' ARG . 9.4 mt-10 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 110.925 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 112.531 -0.227 . . . . 62.149999999999999 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.605 ' HA ' ' O1 ' ' B' ' 4' ' ' MCL . 52.4 p -166.44 -169.14 1.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.8 0.333 . . . . 71.310000000000002 110.908 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.662 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . -60.35 96.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.075 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -93.47 133.73 36.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 64.319999999999993 110.924 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.7 120.48 26.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 14' ' ' LEU . 48.7 mm -125.9 121.51 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 75.329999999999998 111.144 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.89 140.95 29.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 74.010000000000005 111.085 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.62 166.62 27.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 35.109999999999999 111.088 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.79 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 71.310000000000002 110.904 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG23 ' HA2' ' A' ' 70' ' ' GLY . 22.1 mt -55.59 120.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 111.22 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.715 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.89 9.3 74.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.685 -0.769 . . . . 53.119999999999997 112.463 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.772 ' O ' HG22 ' A' ' 69' ' ' VAL . 50.3 mm-40 -102.66 139.14 19.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 74.450000000000003 110.883 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 143.7 51.55 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.686 2.257 . . . . 65.530000000000001 112.355 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.616 ' O ' HD12 ' A' ' 66' ' ' LEU . 30.2 tp -145.88 143.42 29.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.288 -0.414 . . . . 63.049999999999997 110.901 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 142.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 111.153 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.5 147.99 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 74.319999999999993 110.895 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -113.75 151.19 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 71.400000000000006 110.85 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -107.53 101.63 10.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 51.340000000000003 110.813 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -50.16 125.66 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 74.200000000000003 111.012 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.38 -45.12 1.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.8 -0.714 . . . . 65.109999999999999 112.464 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.16 123.84 63.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.595 0.712 . . . . 72.030000000000001 111.076 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.9 Cg_endo -69.75 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.667 2.245 . . . . 71.099999999999994 112.385 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -47.5 39.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 72.430000000000007 110.869 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.74 149.43 37.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 71.310000000000002 110.872 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.82 108.93 2.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.734 2.289 . . . . 52.119999999999997 112.332 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.45 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 54.3 Cg_endo -69.71 -87.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.709 2.273 . . . . 55.350000000000001 112.409 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -104.16 -179.28 3.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 75.120000000000005 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -67.56 135.6 53.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 71.400000000000006 110.879 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.855 HD11 ' CE3' ' A' ' 31' ' ' TRP . 1.1 pp -135.69 163.38 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.340000000000003 110.913 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.8 tp10 -120.56 149.02 43.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.040000000000006 110.913 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.855 ' CE3' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -127.43 143.16 51.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 110.96 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -143.03 140.79 31.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 61.229999999999997 110.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.804 HD11 HG23 ' A' ' 35' ' ' THR . 0.9 OUTLIER -137.65 132.82 33.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 65.030000000000001 110.916 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.887 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 19.0 t-20 -114.9 120.94 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.25 110.915 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.807 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.2 p -139.03 179.52 6.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 55.119999999999997 111.172 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.09 -130.03 10.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.644 -0.788 . . . . 60.420000000000002 112.537 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.67 -38.34 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 63.310000000000002 110.863 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.6 t 179.91 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 53.020000000000003 111.151 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 38' ' ' THR . 22.6 mt-10 -102.7 33.8 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 63.340000000000003 110.994 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.97 -7.04 8.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 74.109999999999999 111.1 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -64.52 130.93 45.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 110.888 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 153.49 47.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.938 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.54 120.84 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 64.099999999999994 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.755 HD13 ' HA3' ' A' ' 49' ' ' GLY . 2.7 mm? -94.26 149.68 21.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.18 -0.463 . . . . 64.310000000000002 110.873 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.566 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.5 p -121.74 156.39 58.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.728 0.775 . . . . 54.439999999999998 110.831 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -0.32 6.77 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.229 . . . . 70.329999999999998 112.324 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -145.61 71.86 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 75.299999999999997 110.889 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.87 84.29 0.85 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 63.25 112.55 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.755 ' HA3' HD13 ' A' ' 44' ' ' LEU . . . -93.1 34.46 4.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 63.210000000000001 112.435 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.54 -178.73 17.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 73.439999999999998 112.488 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 53.6 Cg_endo -69.74 106.72 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.656 2.238 . . . . 75.519999999999996 112.355 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -30.84 65.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 71.25 110.897 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.69 -25.72 62.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.411 . . . . 74.439999999999998 110.892 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -91.26 -44.01 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 34.130000000000003 110.834 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -125.78 -99.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 73.049999999999997 111.093 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -150.87 175.9 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 111.078 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 168.66 16.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 63.549999999999997 110.843 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 45' ' ' SER . 49.9 t -106.45 130.11 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 63.409999999999997 111.154 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 65' ' ' PHE . 4.5 mp -69.31 156.62 91.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 60.25 110.945 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -20.46 34.72 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.0 112.422 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 1.91 32.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 41.549999999999997 110.861 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.3 25.12 27.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.668 -0.777 . . . . 72.430000000000007 112.445 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 58' ' ' VAL . 73.9 m -113.5 -179.29 3.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 63.219999999999999 110.86 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tp -129.59 128.53 42.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 71.439999999999998 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.777 ' HB2' HD11 ' A' ' 59' ' ' LEU . 39.9 t80 -126.11 132.81 51.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 71.140000000000001 110.958 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.845 HD22 HG12 ' A' ' 69' ' ' VAL . 2.8 mp -114.7 128.28 26.03 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 71.129999999999995 110.94 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.63 -34.24 15.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.685 2.257 . . . . 74.409999999999997 112.395 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.69 99.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 71.409999999999997 111.079 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.845 HG12 HD22 ' A' ' 66' ' ' LEU . 13.4 m -74.97 112.22 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.349999999999994 111.215 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -86.18 171.01 43.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 72.129999999999995 112.492 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.86 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.69 -30.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.729 0.3 . . . . 72.340000000000003 111.095 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.49 -23.12 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 60.219999999999999 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -3.59 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.049999999999997 110.847 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 140.66 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 72.239999999999995 110.867 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.595 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 159.18 -149.04 18.76 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 54.43 112.502 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.761 ' CD1' ' HG3' ' B' ' 2' ' ' GLU . 3.6 mp -130.69 135.26 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 64.209999999999994 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CG ' HD23 ' A' ' 33' ' ' LEU . 32.2 m-85 -101.17 130.96 47.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 62.219999999999999 110.897 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HG2' ' ND2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -127.51 131.02 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 70.319999999999993 110.85 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 151.07 40.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 22.120000000000001 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -144.98 126.11 14.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 72.319999999999993 110.799 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.7 162.8 29.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 35.100000000000001 111.056 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.3 ttm -130.18 125.48 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 60.009999999999998 110.866 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.08 172.22 10.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -71.33 -19.07 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 73.209999999999994 110.886 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -74.21 -20.14 60.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.530000000000001 110.847 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.96 -9.1 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 75.040000000000006 112.531 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -85.11 146.28 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 62.409999999999997 110.893 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.73 142.12 36.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 65.329999999999998 110.945 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.456 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.17 125.9 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 111.043 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -106.87 143.1 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 65.129999999999995 110.9 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -146.74 120.61 9.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 63.32 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' ND2' ' HG2' ' A' ' 78' ' ' ARG . 19.1 t-20 -125.63 122.6 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 74.019999999999996 110.919 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.19 125.88 43.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.902 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.528 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 8.9 mmm-85 -86.34 132.68 33.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.902 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.546 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.6 t -120.81 133.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.150000000000006 111.123 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.444 ' NH2' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -130.74 128.93 41.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 70.140000000000001 110.812 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.86 HG21 ' HA ' ' A' ' 71' ' ' ILE . 24.0 m -92.58 -176.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 111.136 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -66.83 -82.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 75.439999999999998 110.963 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -62.97 146.34 53.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.886 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.503 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.55 49.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 73.349999999999994 111.204 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.5 Cg_endo -69.83 -174.22 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.244 . . . . 70.319999999999993 112.243 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.18 95.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.409999999999997 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -142.73 158.92 58.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 54.240000000000002 110.88 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 177.86 5.12 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.633 2.222 . . . . 43.43 112.354 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 110.925 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.702 0.287 . . . . 74.140000000000001 110.972 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.761 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -53.92 -37.29 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 110.907 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.887 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -176.28 -163.82 0.11 Allowed 'General case' 0 C--O 1.182 -2.469 0 CA-C-O 118.102 -0.952 . . . . 62.43 110.915 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.605 ' O1 ' ' HA ' ' A' ' 2' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.528 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -45.53 128.13 7.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 55.340000000000003 111.057 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.88 67.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.424 . . . . 72.310000000000002 110.961 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.905 ' HG3' HH12 ' A' ' 94' ' ' ARG . 1.2 pp20? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.019999999999996 110.877 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.46 -0.256 . . . . 51.299999999999997 112.46 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.549 ' OG ' ' O1 ' ' B' ' 4' ' ' MCL . 1.4 t -179.86 148.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 34.420000000000002 110.754 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.75 56.32 8.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 44.140000000000001 111.082 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -93.33 133.24 36.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.439999999999998 110.937 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -84.96 122.17 28.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 110.891 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.488 ' CG2' HD11 ' A' ' 14' ' ' LEU . 48.6 mm -124.03 120.89 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.549999999999997 111.153 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -96.05 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 62.43 111.215 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.033 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -143.68 164.86 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.099999999999994 111.137 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -124.67 151.31 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 72.150000000000006 110.908 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.57 118.6 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 111.111 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 80.21 8.84 87.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 63.119999999999997 112.465 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.793 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.2 mm-40 -102.19 140.44 21.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 73.200000000000003 110.935 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 143.83 51.9 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.638 2.225 . . . . 63.439999999999998 112.366 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 8' ' ' ALA . 22.7 tp -145.27 142.22 29.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 110.963 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 65' ' ' PHE . 40.6 t -122.63 145.12 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.168 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.546 HD12 HD23 ' A' ' 64' ' ' LEU . 65.1 mt -131.66 147.78 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 110.916 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -113.39 150.32 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 65.329999999999998 110.809 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -110.67 100.96 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.852 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.53 128.04 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 71.120000000000005 110.956 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -45.02 1.2 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.768 -0.729 . . . . 52.210000000000001 112.439 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.85 59.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.602 0.715 . . . . 70.439999999999998 111.069 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.8 Cg_endo -69.84 -163.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 64.230000000000004 112.381 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.31 -47.57 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 43.520000000000003 110.939 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -104.54 156.67 35.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.627 0.727 . . . . 72.329999999999998 110.878 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.74 109.46 2.31 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.69 2.26 . . . . 71.329999999999998 112.378 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.6 Cg_endo -69.83 -87.32 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.739 2.293 . . . . 73.219999999999999 112.322 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -103.45 -178.15 3.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 65.129999999999995 110.877 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -65.81 132.46 48.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -145.22 150.63 37.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 64.010000000000005 110.909 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.428 ' N ' HD12 ' A' ' 29' ' ' LEU . 15.2 tt0 -121.03 149.77 42.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 110.913 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.681 ' CE2' HD11 ' A' ' 29' ' ' LEU . 16.8 m-90 -107.28 136.64 46.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.903 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.42 145.08 38.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 61.350000000000001 110.911 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.816 HD12 ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.79 137.96 13.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.409999999999997 110.952 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 41' ' ' TRP . 8.1 t-20 -112.57 128.89 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 75.349999999999994 110.925 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.813 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.7 p -136.59 179.2 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 111.111 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.84 14.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 70.239999999999995 112.498 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 74.439999999999998 110.865 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.3 t -179.69 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 41.020000000000003 111.184 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -102.94 33.46 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.883 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.19 -6.71 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 52.009999999999998 111.097 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.464 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 15.9 p-90 -59.78 132.23 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 74.510000000000005 110.829 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.816 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -129.61 151.89 49.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 73.239999999999995 110.821 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.7 121.91 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 111.166 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD23 HD21 ' A' ' 33' ' ' LEU . 3.4 mm? -90.13 146.36 24.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 75.299999999999997 110.831 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.64 153.16 72.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.685 0.755 . . . . 70.120000000000005 110.877 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -0.26 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.818 2.346 . . . . 54.340000000000003 112.366 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -125.0 67.93 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.209999999999994 110.924 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.56 62.17 5.57 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.776 -0.726 . . . . 23.32 112.485 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.49 98.32 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 33.219999999999999 112.477 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.82 -171.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.73 . . . . 75.400000000000006 112.464 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 104.63 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 65.129999999999995 112.362 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -53.51 -35.39 60.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.97 -26.79 67.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 72.299999999999997 110.838 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.68 -42.72 10.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 110.895 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -123.07 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 63.350000000000001 111.065 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -160.3 172.9 16.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 111.165 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.72 164.76 19.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.913 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -106.52 130.28 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 61.409999999999997 111.144 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 63' ' ' SER . 25.7 mt -70.39 158.64 87.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 74.099999999999994 110.921 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.59 31.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.759 2.306 . . . . 72.219999999999999 112.313 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.05 1.65 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.54 17.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 52.420000000000002 112.513 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.438 ' HB2' HD12 ' A' ' 59' ' ' LEU . 36.6 m -112.48 -178.3 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.396 . . . . 73.25 110.829 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 77' ' ' PHE . 21.8 tp -127.73 128.66 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.924 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD2' HG22 ' A' ' 15' ' ' VAL . 38.9 t80 -125.33 137.24 54.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 72.319999999999993 110.83 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.883 HD22 HG12 ' A' ' 69' ' ' VAL . 5.5 mp -118.48 125.03 28.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.601 0.715 . . . . 74.120000000000005 110.969 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -31.92 19.4 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.5 112.343 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.51 100.61 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 62.409999999999997 111.091 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.033 HG21 ' HB1' ' A' ' 8' ' ' ALA . 31.3 m -73.4 118.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 63.009999999999998 111.137 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.45 162.77 17.79 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.807 -0.711 . . . . 75.239999999999995 112.447 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.852 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.31 -29.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 70.439999999999998 111.175 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.7 -24.01 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 64.340000000000003 110.846 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.8 -4.64 56.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.288 -0.415 . . . . 75.239999999999995 110.809 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.3 140.77 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 54.340000000000003 110.802 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.589 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 159.03 -138.23 5.56 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.734 . . . . 64.129999999999995 112.554 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.431 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.6 mp -130.63 134.66 61.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.888 0.375 . . . . 72.109999999999999 111.142 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.786 ' CE2' HD13 ' A' ' 33' ' ' LEU . 5.9 m-85 -103.5 132.86 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 71.409999999999997 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HG3' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER -127.22 126.64 43.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 70.409999999999997 110.839 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 150.38 34.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.833 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.73 127.64 22.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 64.219999999999999 110.879 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.42 164.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 71.450000000000003 111.129 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.1 ttm -129.52 125.66 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.340000000000003 110.878 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.41 171.58 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.876 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -71.52 -17.72 62.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.827 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -72.36 -20.02 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 62.130000000000003 110.863 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.8 -21.0 23.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 24.199999999999999 112.483 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.69 148.13 26.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 75.310000000000002 110.79 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.45 145.16 30.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 64.239999999999995 110.953 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.3 132.61 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.149 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -98.51 146.71 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 63.0 110.952 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.66 126.62 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 65.340000000000003 110.817 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.688 ' HB3' ' O2 ' ' B' ' 4' ' ' MCL . 2.0 t-20 -129.08 120.83 26.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 62.43 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.56 127.26 41.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 110.995 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.3 ' NH2' ' HA ' ' B' ' 5' ' ' ALA . 13.8 mmt85 -83.75 135.46 34.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 72.329999999999998 110.925 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 77' ' ' PHE . 75.5 t -120.19 133.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 71.120000000000005 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 141.82 49.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.349999999999994 110.803 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.852 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.6 m -109.65 -176.21 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.162 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -75.93 -73.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 65.109999999999999 110.89 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.96 147.77 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 62.200000000000003 110.956 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.41 159.61 49.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.657 0.742 . . . . 51.119999999999997 111.161 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.13 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.771 2.314 . . . . 62.020000000000003 112.313 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.9 -69.29 0.21 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.67 -0.776 . . . . 54.109999999999999 112.438 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -171.32 73.61 0.52 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.528 0.68 . . . . 61.329999999999998 110.924 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 158.83 55.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.604 2.202 . . . . 73.140000000000001 112.363 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 75.319999999999993 110.921 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.798 0.333 . . . . 52.049999999999997 110.856 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.431 ' CB ' HD13 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -48.05 -59.54 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 51.149999999999999 110.891 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.037 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -177.88 104.36 0.05 OUTLIER 'General case' 0 C--O 1.181 -2.502 0 CA-C-O 118.237 -0.887 . . . . 70.150000000000006 110.805 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.688 ' O2 ' ' HB3' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.3 ' HA ' ' NH2' ' A' ' 94' ' ' ARG . . . 39.76 81.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 61.350000000000001 111.078 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.919 ' N ' ' NH2' ' A' ' 94' ' ' ARG . 4.7 m-20 -82.81 1.71 37.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 75.030000000000001 110.863 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.83 ' HG3' HH12 ' A' ' 94' ' ' ARG . 7.6 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 72.030000000000001 110.911 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.557 -0.217 . . . . 74.439999999999998 112.557 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.31 115.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.931 0.396 . . . . 74.109999999999999 110.845 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.95 58.64 5.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 62.399999999999999 111.026 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.94 133.65 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 74.140000000000001 110.918 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.24 121.43 28.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 63.219999999999999 110.946 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.0 122.35 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 74.439999999999998 111.177 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -95.53 139.93 31.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 70.299999999999997 111.224 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.69 167.49 25.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 70.200000000000003 111.1 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.8 149.0 43.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 75.530000000000001 110.839 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.594 HG23 ' HA2' ' A' ' 70' ' ' GLY . 38.3 mt -52.73 120.54 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 111.166 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.721 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.61 11.7 68.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 61.030000000000001 112.516 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.775 ' O ' HG22 ' A' ' 69' ' ' VAL . 47.4 mm-40 -102.81 138.18 19.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 75.409999999999997 110.902 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 143.12 49.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.708 2.272 . . . . 74.230000000000004 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 66' ' ' LEU . 27.9 tp -145.82 142.91 29.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 110.862 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.86 146.87 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 63.509999999999998 111.179 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.705 HD12 HD23 ' A' ' 64' ' ' LEU . 7.9 mt -133.2 146.96 51.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.510000000000005 110.861 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -113.83 153.09 29.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.25 110.876 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.6 101.45 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 110.897 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.77 123.77 13.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 64.140000000000001 110.844 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.56 -40.92 1.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.711 . . . . 63.049999999999997 112.544 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.11 129.16 44.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 74.200000000000003 111.118 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.83 -164.21 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 73.200000000000003 112.325 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -47.46 47.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 54.020000000000003 110.825 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.93 156.63 36.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 53.109999999999999 110.939 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.92 109.59 2.38 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.666 2.244 . . . . 72.209999999999994 112.289 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.1 Cg_endo -69.82 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.719 2.279 . . . . 70.319999999999993 112.252 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -103.22 -176.89 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 45.520000000000003 110.939 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -63.47 133.91 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 110.819 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 46' ' ' PRO . 2.5 pp -135.54 164.75 27.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 64.150000000000006 110.846 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -133.73 146.78 51.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 70.450000000000003 110.897 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -121.81 137.43 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 139.2 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 72.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.783 HD11 HG23 ' A' ' 35' ' ' THR . 1.3 tm? -138.12 131.89 31.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.404 . . . . 75.219999999999999 110.917 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.71 ' N ' HD22 ' A' ' 33' ' ' LEU . 23.8 t-20 -115.78 120.55 39.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 60.32 110.901 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.7 p -139.73 179.47 6.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 72.140000000000001 111.145 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.11 -133.44 18.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 52.439999999999998 112.444 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -112.39 -37.28 5.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 73.310000000000002 110.869 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 t -179.28 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 72.319999999999993 111.205 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -101.29 33.69 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 71.510000000000005 110.947 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.39 -6.08 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 71.549999999999997 111.094 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -68.87 130.1 41.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.040000000000006 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.665 ' HE2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -136.26 158.97 43.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 75.409999999999997 110.889 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.86 120.56 52.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.434 . . . . 60.149999999999999 111.064 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 147.79 23.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.836 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -125.08 160.49 54.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 53.420000000000002 110.86 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HB3' HD11 ' A' ' 29' ' ' LEU . 52.9 Cg_endo -69.85 0.19 6.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 60.039999999999999 112.285 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -132.68 70.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 75.420000000000002 110.887 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 74.51 1.11 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.73 . . . . 62.350000000000001 112.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.92 58.9 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.729 -0.748 . . . . 72.310000000000002 112.495 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.54 171.84 42.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 44.119999999999997 112.465 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 106.76 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.651 2.234 . . . . 73.140000000000001 112.354 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -52.91 -34.6 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 110.945 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -61.93 -31.17 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.87 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -43.07 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 55.149999999999999 110.852 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.665 HG11 ' HE2' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -126.37 -97.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 70.510000000000005 111.135 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -154.31 176.3 12.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 74.510000000000005 111.067 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.681 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -122.23 161.38 23.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 111.004 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 63' ' ' SER . 41.4 t -107.9 129.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 61.219999999999999 111.119 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 65' ' ' PHE . 5.5 mp -69.97 157.19 90.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.739 0.78 . . . . 71.230000000000004 110.863 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -20.63 35.16 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.63 2.22 . . . . 44.32 112.411 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -82.18 1.39 36.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.140000000000001 110.917 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.98 20.61 35.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.684 -0.769 . . . . 65.409999999999997 112.521 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.47 ' O ' HG13 ' A' ' 58' ' ' VAL . 40.9 m -107.52 -179.22 3.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 72.319999999999993 110.829 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.705 HD23 HD12 ' A' ' 16' ' ' LEU . 55.7 tp -130.4 129.22 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 72.120000000000005 110.956 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' HB2' HD11 ' A' ' 59' ' ' LEU . 6.3 t80 -126.21 131.64 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.319999999999993 110.876 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.86 HD22 HG12 ' A' ' 69' ' ' VAL . 2.8 mp -115.17 129.9 24.69 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.586 0.708 . . . . 63.229999999999997 110.944 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.84 17.71 Favored 'Trans proline' 0 N--CA 1.466 -0.12 0 C-N-CA 122.74 2.293 . . . . 72.430000000000007 112.323 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.721 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.21 99.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 111.127 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.86 HG12 HD22 ' A' ' 66' ' ' LEU . 14.5 m -77.46 112.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 60.229999999999997 111.053 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.594 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -87.33 175.63 46.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 33.43 112.532 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.867 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.18 -31.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 73.310000000000002 111.081 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -76.59 -21.96 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 62.439999999999998 110.937 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.55 -3.6 35.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.87 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 141.1 56.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 63.100000000000001 110.932 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.749 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 158.56 -150.47 21.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 71.420000000000002 112.422 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 75' ' ' GLY . 4.4 mm -130.63 137.25 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 73.519999999999996 111.115 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.584 ' CG ' HD23 ' A' ' 33' ' ' LEU . 41.3 m-85 -103.11 127.43 50.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 63.509999999999998 110.869 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.438 ' HG2' ' ND2' ' A' ' 92' ' ' ASN . 4.2 mmm180 -124.92 128.37 48.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 70.099999999999994 110.932 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.83 151.25 39.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.109999999999999 110.871 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 71.109999999999999 110.996 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.525 ' HB3' ' OG1' ' A' ' 89' ' ' THR . . . -131.7 163.07 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 54.43 111.125 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 72.3 mmm -129.8 124.84 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.905 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -89.71 170.61 10.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.150000000000006 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -21.81 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.805 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -73.39 -19.97 60.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 71.109999999999999 110.902 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 -7.48 32.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 73.200000000000003 112.455 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 146.59 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 72.140000000000001 110.959 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.0 144.02 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.934 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -103.12 126.17 50.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 72.239999999999995 111.124 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -102.48 142.39 33.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 74.540000000000006 110.98 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -146.46 120.05 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 41.049999999999997 110.882 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' B' ' 5' ' ' ALA . 19.3 t-20 -129.58 122.47 29.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.019999999999996 110.955 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.48 119.41 22.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 64.510000000000005 110.915 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.772 HH21 ' N ' ' B' ' 6' ' ' ASP . 0.0 OUTLIER -84.46 134.46 34.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 55.439999999999998 110.924 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.436 HG21 ' CE1' ' A' ' 77' ' ' PHE . 61.8 t -120.91 137.24 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 111.18 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -129.91 130.5 45.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.867 HG21 ' HA ' ' A' ' 71' ' ' ILE . 22.6 m -93.5 -176.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 75.329999999999998 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.402 ' CD2' ' NE2' ' A' ' 99' ' ' GLN . 9.4 t80 -65.34 -77.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 110.958 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.584 ' HB2' HD11 ' A' ' 10' ' ' ILE . 2.2 mp0 -66.75 140.64 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 74.230000000000004 110.949 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.04 159.69 48.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 72.230000000000004 111.19 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 129.74 18.13 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.786 2.324 . . . . 61.149999999999999 112.339 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.78 18.53 0.86 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.656 -0.783 . . . . 50.109999999999999 112.43 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -77.39 137.68 63.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.615 0.721 . . . . 74.450000000000003 110.831 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 101.11 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.622 2.214 . . . . 64.040000000000006 112.437 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 110.874 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.785 0.326 . . . . 71.349999999999994 110.864 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -135.74 63.91 1.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.852 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.658 ' CE2' ' HB2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 66.55 -163.55 0.23 Allowed 'General case' 0 C--O 1.182 -2.497 0 CA-C-O 118.106 -0.949 . . . . 70.340000000000003 110.895 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.42 ' C ' ' HE3' ' B' ' 4' ' ' MCL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.713 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -46.22 145.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 62.130000000000003 111.155 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.772 ' N ' HH21 ' A' ' 94' ' ' ARG . 37.2 t70 -159.5 113.23 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.540000000000006 110.837 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.757 ' N ' ' NH2' ' A' ' 94' ' ' ARG . 4.5 mm-40 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 73.299999999999997 110.941 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.446 -0.262 . . . . 53.399999999999999 112.446 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -178.33 158.74 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 64.420000000000002 110.895 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.78 95.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 75.140000000000001 111.134 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -93.14 133.05 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 73.219999999999999 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.69 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -85.06 119.84 25.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 110.896 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.69 HD12 ' O ' ' A' ' 5' ' ' ASN . 1.3 mp -125.83 122.0 61.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.430000000000007 111.122 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -95.84 142.27 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 63.5 111.148 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.14 166.55 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 72.340000000000003 111.141 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.29 148.94 44.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.847 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.597 HD11 ' HB2' ' A' ' 99' ' ' GLN . 38.1 mt -54.38 119.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 53.420000000000002 111.147 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.602 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.92 7.85 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 72.209999999999994 112.418 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.823 ' O ' HG22 ' A' ' 69' ' ' VAL . 37.4 mm-40 -102.55 140.08 20.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 51.25 110.901 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 143.02 49.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.654 2.236 . . . . 64.439999999999998 112.298 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 66' ' ' LEU . 51.5 tp -145.27 143.49 30.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 65.430000000000007 110.882 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.476 HG22 ' CD2' ' A' ' 65' ' ' PHE . 38.3 t -124.08 147.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 71.439999999999998 111.142 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.732 HD12 HD23 ' A' ' 64' ' ' LEU . 59.8 mt -131.39 148.26 52.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.239999999999995 110.996 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 151.88 28.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 72.099999999999994 110.912 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.7 101.5 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.120000000000005 110.897 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -58.93 120.98 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 110.838 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.99 -39.4 2.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.826 -0.702 . . . . 75.030000000000001 112.587 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.6 128.32 46.95 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 72.340000000000003 111.153 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 54.5 Cg_endo -69.71 -165.32 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 72.530000000000001 112.387 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.6 52.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 110.913 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.3 152.04 41.07 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.518 0.675 . . . . 55.109999999999999 110.864 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.7 Cg_endo -69.76 109.56 2.34 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.714 2.276 . . . . 60.509999999999998 112.369 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.8 Cg_endo -69.74 -86.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 63.409999999999997 112.323 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.01 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.420000000000002 110.914 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -63.93 135.58 56.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 110.803 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 46' ' ' PRO . 4.1 pp -135.55 158.6 43.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.915 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.25 148.16 44.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 64.150000000000006 110.876 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -131.75 128.94 39.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 63.350000000000001 110.887 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -137.66 136.0 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 110.891 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.855 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.86 139.37 38.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 72.400000000000006 110.892 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.852 ' HB3' ' HD1' ' B' ' 3' ' ' PHE . 2.7 t-20 -111.89 126.65 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 63.030000000000001 110.921 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.82 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.6 p -138.52 -179.67 5.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 71.129999999999995 111.137 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.3 -130.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 42.210000000000001 112.511 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.98 -37.14 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 73.299999999999997 110.835 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.0 t -179.3 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 55.149999999999999 111.092 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 38' ' ' THR . 8.3 mm-40 -102.12 34.3 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 72.329999999999998 110.875 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.07 -6.99 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 72.530000000000001 111.178 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.54 ' CZ2' HG22 ' A' ' 43' ' ' VAL . 48.1 t90 -59.5 130.44 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 75.430000000000007 110.908 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.742 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -129.96 153.67 48.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 63.130000000000003 110.831 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.54 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 19.7 t -104.62 113.8 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 62.420000000000002 111.186 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.855 HD22 HD21 ' A' ' 33' ' ' LEU . 10.7 mp -93.32 147.2 23.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 64.209999999999994 110.916 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -125.01 161.87 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.7 0.762 . . . . 74.400000000000006 110.9 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.615 ' HB3' HD11 ' A' ' 29' ' ' LEU . 52.8 Cg_endo -69.84 0.14 6.13 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.631 2.221 . . . . 54.109999999999999 112.303 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 79.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.230000000000004 110.951 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 79.28 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 74.230000000000004 112.494 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.53 53.42 4.85 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 75.230000000000004 112.475 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.2 179.52 38.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.781 -0.724 . . . . 71.340000000000003 112.583 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 107.17 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.261 . . . . 51.420000000000002 112.304 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -57.11 -33.7 67.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.439 . . . . 74.230000000000004 110.935 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.28 -26.89 66.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 75.030000000000001 110.884 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -44.76 8.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 53.109999999999999 110.895 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.74 -96.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 52.030000000000001 111.13 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -150.29 173.3 14.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 111.093 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 165.55 16.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 71.120000000000005 110.875 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 45' ' ' SER . 42.6 t -108.63 130.05 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 63.32 111.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 63' ' ' SER . 50.3 mt -69.28 156.96 90.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 73.019999999999996 110.892 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -21.6 33.72 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.769 2.313 . . . . 62.439999999999998 112.344 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -82.19 1.0 38.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.200000000000003 110.927 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.71 26.35 20.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.457 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 58' ' ' VAL . 19.9 m -111.25 179.39 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 54.509999999999998 110.917 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.732 HD23 HD12 ' A' ' 16' ' ' LEU . 11.5 tp -129.89 128.82 42.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.901 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 15' ' ' VAL . 3.8 t80 -125.59 131.3 52.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.897 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.89 HD22 HG12 ' A' ' 69' ' ' VAL . 3.7 mp -114.34 126.9 27.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.649 0.738 . . . . 74.340000000000003 110.978 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -32.02 19.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.74 2.293 . . . . 53.450000000000003 112.289 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.34 99.17 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.128 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 66' ' ' LEU . 15.9 m -73.94 115.7 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 52.329999999999998 111.093 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.53 167.46 28.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 63.409999999999997 112.426 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.854 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.57 -29.98 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 74.109999999999999 111.142 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -75.57 -22.9 56.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.239999999999995 110.912 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -7.92 58.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 75.439999999999998 110.921 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.25 141.1 55.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 64.209999999999994 110.821 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.604 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 157.4 -142.73 8.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 71.230000000000004 112.533 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.168 ' CD1' ' HB2' ' B' ' 2' ' ' GLU . 3.6 mp -130.88 129.29 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 73.200000000000003 111.154 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.737 ' CE2' HD13 ' A' ' 33' ' ' LEU . 18.0 m-85 -103.79 131.07 51.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 71.349999999999994 110.89 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.3 OUTLIER -127.09 140.86 51.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 71.239999999999995 110.915 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.4 153.09 38.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 65.450000000000003 110.887 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -139.76 126.5 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 74.019999999999996 110.825 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.53 161.78 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 72.109999999999999 111.054 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.4 ttm -131.04 125.25 32.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 73.540000000000006 110.859 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -86.82 172.21 10.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 74.439999999999998 110.863 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.19 -18.28 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.86 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.22 -19.84 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.463 . . . . 65.450000000000003 110.919 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.41 -16.54 31.88 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.612 -0.804 . . . . 72.340000000000003 112.436 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -85.26 145.93 27.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.49 144.77 31.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 64.340000000000003 110.871 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.406 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -102.21 130.84 48.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.349999999999994 111.186 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 90' ' ' LYS . 7.1 mmmt -105.08 142.37 34.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 60.119999999999997 110.847 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -144.76 125.07 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 65.230000000000004 110.99 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.48 127.07 45.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -128.3 124.21 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 71.450000000000003 110.968 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.393 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 19.0 mmm-85 -84.27 132.37 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.230000000000004 110.848 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 77' ' ' PHE . 69.9 t -120.82 134.46 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 72.140000000000001 111.114 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.442 ' NH1' HG21 ' A' ' 100' ' ' ILE . 1.6 mmm180 -131.95 128.17 37.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 63.130000000000003 110.882 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.854 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.2 m -92.93 -175.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 111.151 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -70.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 75.140000000000001 110.963 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 10' ' ' ILE . 2.8 mp0 -71.23 139.98 50.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 61.329999999999998 110.924 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.442 HG21 ' NH1' ' A' ' 96' ' ' ARG . 1.1 pt -121.5 159.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.535 0.683 . . . . 74.129999999999995 111.161 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.92 103.18 1.15 Allowed 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.713 2.276 . . . . 71.400000000000006 112.23 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.71 -124.55 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.648 -0.786 . . . . 63.109999999999999 112.468 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.18 160.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.528 0.68 . . . . 71.510000000000005 110.889 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 175.19 8.45 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.268 . . . . 62.329999999999998 112.328 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 61.5 110.894 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.829 0.347 . . . . 71.450000000000003 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.168 ' HB2' ' CD1' ' A' ' 76' ' ' ILE . 2.6 pp20? -59.59 -170.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 75.230000000000004 110.934 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.852 ' HD1' ' HB3' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -62.87 -159.94 0.01 OUTLIER 'General case' 0 C--O 1.181 -2.534 0 CA-C-O 118.229 -0.891 . . . . 74.140000000000001 110.847 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.52 ' O2 ' ' HD3' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.393 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . 48.42 -166.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.852 -0.613 . . . . 32.32 111.119 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.812 ' H ' ' NH1' ' A' ' 94' ' ' ARG . 8.1 p-10 -139.95 -156.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 70.319999999999993 110.835 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.887 -179.883 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.459 -0.256 . . . . 74.140000000000001 112.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -179.67 106.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 64.439999999999998 110.828 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.66 72.65 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 54.020000000000003 111.1 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -93.21 132.61 37.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.019999999999996 110.882 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 121.34 27.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 72.239999999999995 110.882 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.8 mm -125.08 120.21 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.101 -0.5 . . . . 74.140000000000001 111.198 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -96.76 137.94 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.41 28.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 111.11 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.51 148.98 44.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.937 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 51.6 mt -51.91 121.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.265 -0.425 . . . . 75.010000000000005 111.125 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.727 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.58 5.95 74.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 72.420000000000002 112.481 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.779 ' O ' HG22 ' A' ' 69' ' ' VAL . 16.2 mm-40 -101.29 139.49 20.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 71.230000000000004 110.89 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.13 49.85 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.655 2.237 . . . . 72.540000000000006 112.315 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 6' ' ' ILE . 28.4 tp -145.18 141.76 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 70.310000000000002 110.875 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.81 148.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 62.200000000000003 111.081 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.516 HD12 HD23 ' A' ' 64' ' ' LEU . 54.8 mt -132.48 148.27 52.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 74.230000000000004 110.957 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.33 153.05 27.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 75.420000000000002 110.83 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 t -105.94 102.31 11.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.340000000000003 110.831 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.6 121.91 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.420000000000002 110.907 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.93 -36.05 2.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.781 -0.723 . . . . 71.310000000000002 112.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.25 39.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 42.329999999999998 111.105 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.78 -165.5 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.696 2.264 . . . . 63.329999999999998 112.331 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -48.49 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 64.439999999999998 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -108.06 153.12 41.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.54 0.686 . . . . 74.450000000000003 110.899 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.72 109.83 2.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.258 . . . . 70.25 112.364 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.4 Cg_endo -69.73 -83.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.612 2.208 . . . . 64.310000000000002 112.432 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 9.0 mm100 -103.36 -177.49 3.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.978 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -64.0 133.14 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 61.32 110.823 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -136.82 156.57 48.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 74.019999999999996 110.892 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.79 148.11 51.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 70.239999999999995 110.873 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -117.98 145.52 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 72.430000000000007 110.906 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 33' ' ' LEU . 53.0 mttt -138.04 144.03 40.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 55.0 110.953 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD21 HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 42.030000000000001 110.868 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.872 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 13.8 t-20 -115.04 124.01 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 73.319999999999993 110.862 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.799 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.8 p -138.87 178.37 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 74.209999999999994 111.157 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.31 -130.17 11.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 70.409999999999997 112.498 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -112.64 -37.96 4.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.412 . . . . 74.209999999999994 110.93 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.594 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.1 t -179.71 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 72.040000000000006 111.115 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.4 mt-10 -102.38 33.26 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 71.439999999999998 110.918 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.799 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.22 -7.07 7.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 65.040000000000006 111.072 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -62.47 130.15 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 75.5 110.929 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.98 153.28 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.901 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.57 124.78 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 61.100000000000001 111.096 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 HD13 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -86.57 143.79 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.521 . . . . 72.329999999999998 110.969 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.96 164.61 34.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.607 0.718 . . . . 53.020000000000003 110.9 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.71 0.2 5.95 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.668 2.246 . . . . 72.099999999999994 112.446 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -127.16 96.97 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 110.913 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.04 -29.44 62.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 70.239999999999995 112.48 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.77 -156.15 18.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 53.119999999999997 112.461 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.89 -67.46 1.51 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.789 -0.72 . . . . 52.439999999999998 112.48 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.9 102.84 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.272 . . . . 74.530000000000001 112.275 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 28.7 p90 -83.89 -34.03 24.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.049999999999997 110.927 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.6 -26.69 68.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.399 . . . . 60.329999999999998 110.926 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -46.56 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 110.891 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -129.5 -98.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 111.174 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.99 170.68 11.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 60.409999999999997 111.192 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -128.18 159.85 33.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 110.811 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 46' ' ' PRO . 2.7 t -113.33 131.85 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 64.510000000000005 111.092 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 63' ' ' SER . 36.7 mt -68.07 157.71 86.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.649 0.737 . . . . 61.229999999999997 110.956 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -23.12 31.55 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.702 2.268 . . . . 54.329999999999998 112.339 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.07 1.31 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 25.56 18.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 65.239999999999995 112.47 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.662 ' HB3' HD12 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -106.65 -179.1 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 73.230000000000004 110.849 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.822 HD13 HD11 ' A' ' 44' ' ' LEU . 5.8 tp -129.09 128.56 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.492 . . . . 64.430000000000007 110.848 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' HD12 ' A' ' 64' ' ' LEU . 9.6 t80 -126.16 130.73 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.049999999999997 110.853 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.417 HD22 HG12 ' A' ' 69' ' ' VAL . 3.0 mp -118.41 131.07 24.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 72.319999999999993 110.939 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -34.76 13.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 64.209999999999994 112.336 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.727 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.73 103.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 63.420000000000002 111.049 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.0 m -73.7 118.93 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.549999999999997 111.109 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.38 162.02 31.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 71.200000000000003 112.514 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.823 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.47 -29.47 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 61.399999999999999 111.166 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.16 -22.54 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 61.219999999999999 110.835 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.08 -4.76 56.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.310000000000002 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.43 140.44 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.954 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 154.76 -139.83 6.99 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.701 -0.761 . . . . 43.219999999999999 112.455 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.487 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.9 mp -126.81 130.59 71.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 73.340000000000003 111.18 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CD2' HD22 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.85 129.02 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.909 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD2' ' HE2' ' B' ' 4' ' ' MCL . 7.8 ttp85 -126.55 126.15 43.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.907 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 154.5 24.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 52.240000000000002 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.73 135.11 31.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 75.340000000000003 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.08 163.26 29.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 71.109999999999999 111.082 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.14 123.98 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.858 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.28 171.72 9.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 110.877 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -18.71 62.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 62.450000000000003 110.851 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -73.38 -20.11 60.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 53.119999999999997 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.31 32.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 71.219999999999999 112.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -85.27 146.76 26.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 74.439999999999998 110.835 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.33 144.95 31.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.409999999999997 110.869 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.433 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.92 126.69 50.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 62.25 111.153 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.898 ' HE2' ' HX1' ' B' ' 4' ' ' MCL . 9.9 ptmt -103.14 143.25 32.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.923 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.8 m -143.76 126.75 16.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 110.826 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.682 ' OD1' ' HA ' ' B' ' 5' ' ' ALA . 0.6 OUTLIER -122.1 124.31 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 73.019999999999996 110.909 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -128.84 126.38 39.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 75.340000000000003 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.905 ' NH2' ' C ' ' B' ' 5' ' ' ALA . 14.4 mmt85 -84.46 131.36 34.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.400000000000006 110.909 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.13 133.87 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 62.539999999999999 111.168 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -131.75 128.58 39.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 64.099999999999994 110.928 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.3 m -96.45 -176.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 111.098 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -61.7 -79.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 74.319999999999993 110.925 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -70.71 144.26 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 110.848 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.49 49.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.664 0.745 . . . . 63.210000000000001 111.102 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo -69.69 116.89 4.76 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.694 2.263 . . . . 73.010000000000005 112.372 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -154.19 24.34 0.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 71.219999999999999 112.484 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -152.33 160.47 31.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.58 0.705 . . . . 64.510000000000005 110.96 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.65 38.43 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 74.439999999999998 112.319 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 110.984 179.943 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.805 0.336 . . . . 71.230000000000004 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.487 ' CB ' HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -69.49 -169.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 54.329999999999998 110.852 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.872 ' CD2' ' HB2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -66.02 -162.93 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.521 0 CA-C-O 118.138 -0.934 . . . . 73.209999999999994 110.867 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.898 ' HX1' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.905 ' C ' ' NH2' ' A' ' 94' ' ' ARG . . . 47.58 -95.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 74.200000000000003 111.073 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.679 ' C ' HH22 ' A' ' 94' ' ' ARG . 3.5 t70 64.01 106.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 72.409999999999997 110.868 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.773 ' CG ' HH12 ' A' ' 94' ' ' ARG . 2.8 pp20? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 73.540000000000006 110.942 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.514 -0.234 . . . . 43.539999999999999 112.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -64.63 92.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 74.25 110.91 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.7 74.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 60.219999999999999 111.13 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.42 132.57 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 70.430000000000007 110.838 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -90.45 120.47 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 73.400000000000006 110.855 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.916 HG21 HD11 ' A' ' 14' ' ' LEU . 4.6 mp -125.44 122.53 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 65.109999999999999 111.146 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -95.45 142.3 27.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.299999999999997 111.1 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -147.49 167.42 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 65.019999999999996 111.112 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.26 149.18 42.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 65.409999999999997 110.87 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.4 mt -52.19 120.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 51.399999999999999 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.07 10.09 69.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 63.140000000000001 112.475 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.753 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.1 mm-40 -103.31 138.95 19.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.54 0.686 . . . . 74.219999999999999 110.88 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.66 51.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.673 2.248 . . . . 73.109999999999999 112.308 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 6' ' ' ILE . 35.2 tp -144.92 142.02 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.239999999999995 110.983 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' CD2' ' A' ' 65' ' ' PHE . 31.3 t -125.93 148.29 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 75.109999999999999 111.081 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.8 mt -134.77 148.29 50.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.019999999999996 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -112.55 151.53 29.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 110.903 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.1 t -107.28 99.7 9.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 44.5 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -54.37 125.03 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.852 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.97 -41.74 1.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 53.229999999999997 112.51 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.12 43.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.581 0.705 . . . . 62.030000000000001 111.102 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.76 -165.0 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.709 2.272 . . . . 74.209999999999994 112.381 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -49.41 -48.82 46.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.458 . . . . 52.329999999999998 110.794 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -107.32 151.96 41.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.545 0.688 . . . . 73.519999999999996 110.911 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 109.39 2.31 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.219999999999999 112.335 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.9 Cg_endo -69.79 -85.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.707 2.271 . . . . 74.430000000000007 112.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.99 -178.41 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 65.340000000000003 110.951 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -64.92 137.77 57.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 65.150000000000006 110.912 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 46' ' ' PRO . 3.8 pp -135.82 160.33 38.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 71.319999999999993 110.981 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -121.26 145.01 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 62.130000000000003 110.864 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -128.38 137.33 51.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.891 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -140.81 139.07 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 75.109999999999999 110.94 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.779 HD22 ' CE2' ' A' ' 77' ' ' PHE . 4.9 tp -137.29 136.0 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 74.140000000000001 110.88 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.3 t-20 -114.48 121.54 43.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 72.109999999999999 110.914 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.79 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 73.3 p -137.59 179.36 6.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 43.310000000000002 111.146 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.89 -129.18 9.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.712 -0.756 . . . . 43.420000000000002 112.442 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -112.48 -38.43 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 74.219999999999999 110.827 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 39' ' ' GLU . 9.7 t 179.78 -31.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 74.239999999999995 111.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 38' ' ' THR . 15.4 mt-10 -103.44 33.96 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 62.439999999999998 110.894 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.43 -6.8 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 75.049999999999997 111.083 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.55 132.3 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 74.319999999999993 110.932 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 158.95 38.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 63.340000000000003 110.927 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.07 120.52 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 73.319999999999993 111.136 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.12 147.2 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.893 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.482 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.9 m -124.46 153.47 69.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.120000000000005 110.85 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.832 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.5 Cg_endo -69.65 -0.25 6.55 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.791 2.327 . . . . 75.530000000000001 112.344 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -137.03 72.16 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.150000000000006 110.833 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.86 75.14 1.14 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 63.219999999999999 112.503 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.72 58.34 3.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 75.349999999999994 112.509 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 178.95 41.18 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 74.329999999999998 112.469 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 107.37 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.642 2.228 . . . . 60.310000000000002 112.308 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -54.37 -33.91 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 73.530000000000001 110.866 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.28 -29.05 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 71.510000000000005 110.945 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.93 -43.45 9.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 75.430000000000007 110.851 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.526 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -124.85 -98.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.491 . . . . 71.530000000000001 111.095 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -152.99 174.23 14.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 54.439999999999998 111.122 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.6 164.13 18.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.876 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.832 HG11 ' HA ' ' A' ' 46' ' ' PRO . 42.1 t -107.51 130.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 54.130000000000003 111.055 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.63 158.85 85.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 72.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -22.19 32.46 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.721 2.28 . . . . 32.219999999999999 112.354 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.57 1.34 42.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 110.885 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.41 28.5 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 62.109999999999999 112.488 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 m -111.87 -178.88 3.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 72.209999999999994 110.843 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -128.89 128.93 44.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 73.349999999999994 110.92 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 15' ' ' VAL . 7.8 t80 -125.57 134.82 51.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.844 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.767 HD22 HG12 ' A' ' 69' ' ' VAL . 5.2 mp -114.8 124.45 30.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.657 0.741 . . . . 61.210000000000001 110.922 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -31.77 19.77 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 70.340000000000003 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.57 101.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 63.210000000000001 111.101 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.767 HG12 HD22 ' A' ' 66' ' ' LEU . 35.7 m -71.71 114.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 73.109999999999999 111.138 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.01 159.18 22.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 43.149999999999999 112.493 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.18 -31.0 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 73.340000000000003 111.113 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -77.15 -22.82 51.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.929 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.84 -3.87 37.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 74.150000000000006 110.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 143.3 39.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 73.409999999999997 110.876 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.707 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 159.1 -148.37 17.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 74.120000000000005 112.546 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 75' ' ' GLY . 19.2 mm -131.22 137.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 74.099999999999994 111.071 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CE2' HD22 ' A' ' 33' ' ' LEU . 10.9 m-85 -101.65 127.84 48.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.899 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.32 126.91 45.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.855 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.43 149.8 43.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.835 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -141.95 134.18 27.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 73.129999999999995 110.97 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.15 163.3 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 74.329999999999998 111.114 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ttm -130.55 124.94 32.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 62.299999999999997 110.894 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -86.9 172.28 10.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.400000000000006 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -70.96 -18.53 62.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 54.210000000000001 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.26 -19.9 60.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.849 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.17 -13.69 37.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 54.140000000000001 112.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -85.08 146.38 27.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.705 0.288 . . . . 72.540000000000006 110.963 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.43 144.95 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 54.240000000000002 110.857 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -102.01 132.63 47.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 72.25 111.13 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.823 ' HE3' ' CX2' ' B' ' 4' ' ' MCL . 11.4 mmmt -98.96 143.48 29.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 73.010000000000005 110.9 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 m -144.66 121.14 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.878 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.18 120.13 25.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.019999999999996 110.873 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -129.67 119.71 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.869 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.087 ' HD2' ' HB1' ' B' ' 5' ' ' ALA . 1.0 OUTLIER -86.79 135.44 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 61.340000000000003 110.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.6 t -120.94 136.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 75.329999999999998 111.093 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -131.06 142.88 50.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.868 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.0 m -106.3 -175.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 64.120000000000005 111.092 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -67.69 -81.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 110.989 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -62.85 145.45 55.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 110.855 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.43 159.67 49.24 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.723 0.773 . . . . 63.299999999999997 111.052 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.5 Cg_endo -69.73 120.19 7.02 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.708 2.272 . . . . 63.130000000000003 112.318 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -98.5 -32.06 6.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.824 -0.703 . . . . 54.299999999999997 112.507 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt 52.74 70.13 2.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 73.310000000000002 110.953 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.654 2.236 . . . . 73.340000000000003 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 64.200000000000003 110.929 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 71.010000000000005 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 166.67 12.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.93 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.694 ' HB2' ' HB ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -64.83 -161.38 0.02 OUTLIER 'General case' 0 C--O 1.182 -2.482 0 CA-C-O 118.121 -0.943 . . . . 74.329999999999998 110.924 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.823 ' CX2' ' HE3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.087 ' HB1' ' HD2' ' A' ' 94' ' ' ARG . . . -42.23 154.93 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.883 -0.599 . . . . 73.319999999999993 111.086 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.471 ' O ' ' NH1' ' A' ' 94' ' ' ARG . 5.2 p-10 -143.29 -163.05 1.56 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.856 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.4 ' HG2' HH22 ' A' ' 94' ' ' ARG . 2.8 mm-40 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 74.530000000000001 110.912 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.511 -0.236 . . . . 70.340000000000003 112.511 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 1.3 m 59.14 21.29 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 73.25 110.878 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 2' ' ' SER . . . 178.94 62.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 61.109999999999999 111.1 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.95 133.75 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.530000000000001 110.849 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -90.3 121.29 32.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 62.420000000000002 110.864 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 14' ' ' LEU . 4.6 mp -124.76 122.15 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 71.329999999999998 111.141 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -94.62 140.14 30.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.144 -0.48 . . . . 44.240000000000002 111.117 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.66 167.65 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.299999999999997 111.076 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.13 43.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 71.310000000000002 110.819 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.614 HD11 ' HB2' ' A' ' 99' ' ' GLN . 28.9 mt -52.12 120.44 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 111.119 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.666 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.61 10.35 70.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 73.310000000000002 112.457 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.785 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.7 mm-40 -102.7 139.46 20.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.69 0.757 . . . . 74.510000000000005 110.889 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.98 49.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.667 2.245 . . . . 54.299999999999997 112.342 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 6' ' ' ILE . 49.9 tp -145.42 143.32 30.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 110.864 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.88 147.75 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 111.101 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -132.2 150.21 52.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 61.329999999999998 110.917 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -111.71 151.52 28.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.240000000000002 110.904 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -107.3 100.82 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 110.938 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -54.16 125.09 17.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 110.827 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.508 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.47 -43.21 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.729 . . . . 50.299999999999997 112.512 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.45 42.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 74.209999999999994 111.012 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.491 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 54.5 Cg_endo -69.66 -161.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.613 2.209 . . . . 73.450000000000003 112.408 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -48.26 -47.02 36.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 110.938 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.38 164.18 15.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 65.510000000000005 110.866 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.73 109.68 2.36 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.776 2.317 . . . . 44.0 112.333 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 54.4 Cg_endo -69.8 -91.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 64.439999999999998 112.379 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -177.03 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 75.540000000000006 110.934 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -63.78 131.57 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.430000000000007 110.87 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 29' ' ' LEU . 4.6 pp -138.54 157.28 46.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 110.879 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -121.77 145.86 47.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 62.240000000000002 110.848 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -120.24 143.64 48.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 74.5 111.03 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -148.88 135.44 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.299999999999997 110.896 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.773 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -141.23 138.31 33.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 72.219999999999999 110.921 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.49 126.11 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.530000000000001 110.807 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.839 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.5 p -138.72 -178.9 5.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 73.530000000000001 111.038 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -127.27 9.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.713 -0.756 . . . . 75.120000000000005 112.517 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' O ' ' HB ' ' A' ' 38' ' ' THR . 12.0 mpt_? -112.79 -38.64 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 73.409999999999997 110.875 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t 178.97 -29.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 111.124 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -102.43 34.08 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 64.219999999999999 110.913 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.99 -6.96 8.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 55.310000000000002 111.063 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -70.06 129.07 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.952 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -137.18 159.25 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.809 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.2 121.96 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 111.167 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' CD1' HD23 ' A' ' 33' ' ' LEU . 6.9 mt -89.23 144.67 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 65.420000000000002 110.888 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.2 m -127.02 152.28 75.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 72.510000000000005 110.898 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 2.75 3.22 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.753 2.302 . . . . 65.120000000000005 112.395 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -116.99 70.35 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 73.109999999999999 110.885 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.27 -37.09 3.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 71.109999999999999 112.469 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.96 57.12 13.56 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.73 -0.748 . . . . 63.200000000000003 112.426 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.09 -176.6 49.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.673 -0.775 . . . . 72.349999999999994 112.528 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 53.1 Cg_endo -69.79 107.4 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 74.530000000000001 112.307 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -56.88 -34.16 67.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 71.230000000000004 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -25.86 66.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 50.130000000000003 110.835 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -91.19 -43.59 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 61.130000000000003 110.865 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.488 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.81 -98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 65.040000000000006 111.164 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -154.8 175.77 13.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 54.450000000000003 111.122 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.79 161.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 61.439999999999998 110.904 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 63' ' ' SER . 50.5 t -108.23 130.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 74.219999999999999 111.073 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 63' ' ' SER . 47.3 mt -69.01 156.98 90.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 64.420000000000002 110.927 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.95 32.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.254 . . . . 65.209999999999994 112.331 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -81.48 0.39 38.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 73.340000000000003 110.91 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.88 30.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 74.299999999999997 112.525 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.7 m -106.38 -179.55 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.951 0.405 . . . . 60.409999999999997 110.851 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.6 tp -130.21 130.74 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.129999999999995 110.969 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.632 ' N ' HD12 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -124.89 130.36 52.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.019999999999996 110.892 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.893 HD22 HG12 ' A' ' 69' ' ' VAL . 3.0 mp -117.19 127.12 26.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 75.120000000000005 110.899 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -32.37 18.57 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.804 2.336 . . . . 64.120000000000005 112.382 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.666 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.45 100.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 32.140000000000001 111.101 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.893 HG12 HD22 ' A' ' 66' ' ' LEU . 15.3 m -78.01 113.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 111.156 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -87.82 173.85 43.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 73.200000000000003 112.44 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.876 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.7 -32.23 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 75.230000000000004 111.109 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -77.26 -21.61 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.928 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -5.61 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 62.210000000000001 110.833 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 142.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 65.140000000000001 110.958 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 159.71 -151.49 22.24 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.734 -0.746 . . . . 53.399999999999999 112.463 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' B' ' 2' ' ' GLU . 5.4 mm -131.38 134.85 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 75.409999999999997 111.093 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.773 ' CE2' HD22 ' A' ' 33' ' ' LEU . 50.1 m-85 -103.96 132.82 49.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 74.019999999999996 110.856 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.62 ' HE ' ' HE1' ' B' ' 3' ' ' PHE . 0.2 OUTLIER -127.03 134.17 50.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.78 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.73 148.12 45.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 64.530000000000001 110.902 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -142.4 127.43 18.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.903 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.38 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 44.130000000000003 111.083 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ttm -130.64 125.66 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.549999999999997 110.926 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.58 171.92 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 74.349999999999994 110.95 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -19.15 61.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 71.049999999999997 110.802 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.9 -20.24 60.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 61.539999999999999 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.56 35.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 71.319999999999993 112.472 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 146.32 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.662 0.268 . . . . 64.409999999999997 110.886 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -105.63 142.62 35.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 73.230000000000004 110.863 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.508 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.96 131.09 50.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 74.519999999999996 111.085 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.398 ' HE2' ' C1 ' ' B' ' 4' ' ' MCL . 0.8 OUTLIER -105.42 142.85 34.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.150000000000006 110.892 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.615 ' N ' ' O2 ' ' B' ' 4' ' ' MCL . 3.8 m -146.1 123.61 11.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 60.140000000000001 110.816 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.825 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.2 OUTLIER -128.13 122.28 31.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 54.219999999999999 110.819 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.02 118.81 24.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 62.229999999999997 110.94 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.056 HH12 ' HB2' ' B' ' 7' ' ' GLU . 0.1 OUTLIER -88.72 134.16 34.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.886 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG22 HD21 ' A' ' 14' ' ' LEU . 57.7 t -120.5 135.73 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 111.142 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -130.65 131.61 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 75.349999999999994 110.854 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -96.51 -176.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 73.349999999999994 111.164 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.403 ' CD2' ' NE2' ' A' ' 99' ' ' GLN . 9.3 t80 -67.4 -78.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 70.329999999999998 110.939 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.614 ' HB2' HD11 ' A' ' 10' ' ' ILE . 2.3 mp0 -63.81 141.34 58.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 73.420000000000002 110.953 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.07 159.45 49.31 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.319999999999993 111.084 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 169.91 17.74 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.647 2.231 . . . . 70.340000000000003 112.415 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.85 106.72 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 52.229999999999997 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.24 160.63 36.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.605 0.717 . . . . 63.399999999999999 110.859 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 103.67 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.613 2.208 . . . . 62.420000000000002 112.39 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 62.420000000000002 110.842 -179.874 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.726 0.298 . . . . 62.329999999999998 110.963 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.459 ' HB2' HG13 ' A' ' 76' ' ' ILE . 2.5 pm0 -159.85 80.86 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 110.914 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.62 ' HE1' ' HE ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER 54.23 -164.87 0.1 Allowed 'General case' 0 C--O 1.182 -2.49 0 CA-C-O 118.26 -0.876 . . . . 74.219999999999999 110.864 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.398 ' C1 ' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.614 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . -51.44 120.23 4.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 43.32 111.11 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -122.59 50.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 75.319999999999993 110.852 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 1.056 ' HB2' HH12 ' A' ' 94' ' ' ARG . 6.2 tp10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 74.319999999999993 110.905 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.514 -0.234 . . . . 73.439999999999998 112.514 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 p -173.73 160.33 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 72.030000000000001 110.856 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.76 93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 52.32 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -93.92 133.12 37.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 110.935 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -89.5 121.63 31.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.582 HG21 HD11 ' A' ' 14' ' ' LEU . 4.0 mp -123.83 120.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 72.129999999999995 111.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 p -96.7 142.47 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.13 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.43 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 51.219999999999999 111.132 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.69 147.97 40.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 64.450000000000003 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 121.3 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 111.14 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.658 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.48 5.89 74.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 55.25 112.497 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.795 ' O ' HG22 ' A' ' 69' ' ' VAL . 48.7 mm-40 -101.47 141.43 22.58 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.606 0.717 . . . . 75.239999999999995 110.831 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.78 52.21 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.606 2.204 . . . . 74.040000000000006 112.384 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 6' ' ' ILE . 54.8 tp -144.48 143.14 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.437 . . . . 72.310000000000002 110.902 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.436 HG22 ' HD2' ' A' ' 65' ' ' PHE . 20.4 t -121.84 146.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 74.099999999999994 111.153 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.762 HD12 HD23 ' A' ' 64' ' ' LEU . 12.5 mt -131.41 148.28 52.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.951 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 152.04 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 70.019999999999996 110.972 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.9 t -107.08 99.88 9.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 53.109999999999999 110.871 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.66 123.56 14.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 51.450000000000003 110.908 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.18 -39.4 2.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.530000000000001 112.483 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 131.28 37.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 65.209999999999994 111.101 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -163.96 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.675 2.25 . . . . 53.030000000000001 112.32 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -50.09 30.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 35.5 mmtt -110.85 153.05 43.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 64.239999999999995 110.871 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.9 Cg_endo -69.68 109.57 2.33 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 63.219999999999999 112.329 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 53.6 Cg_endo -69.71 -83.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 70.140000000000001 112.353 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -103.32 -177.36 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 74.099999999999994 110.875 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -63.92 139.96 58.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 70.049999999999997 110.852 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -135.6 159.11 42.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 53.229999999999997 110.93 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.09 139.59 53.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 71.400000000000006 110.885 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.48 ' HE1' HD13 ' A' ' 29' ' ' LEU . 13.2 m95 -121.34 139.09 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -139.05 137.07 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 61.399999999999999 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.623 HD22 HG23 ' A' ' 35' ' ' THR . 2.0 tt -138.82 134.09 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 73.530000000000001 110.918 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.065 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 2.9 m120 -115.77 125.18 52.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.852 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 44.8 p -138.43 -179.5 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.129 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.61 -130.83 13.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.748 -0.739 . . . . 60.039999999999999 112.481 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -112.84 -37.56 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 73.129999999999995 110.905 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t -179.74 -29.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 61.130000000000003 111.187 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.1 mt-10 -101.97 33.6 2.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.896 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.75 -7.23 7.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 54.100000000000001 111.121 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -60.26 130.41 46.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.919 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HZ2' ' HB3' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.52 153.45 49.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 74.140000000000001 110.907 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.54 121.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 51.219999999999999 111.191 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.65 145.96 24.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 110.942 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.567 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -127.3 162.62 47.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.664 0.745 . . . . 74.150000000000006 110.88 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.586 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.67 -0.53 6.98 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.677 2.251 . . . . 65.230000000000004 112.321 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.11 89.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 42.130000000000003 110.946 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.27 74.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.644 -0.789 . . . . 73.239999999999995 112.52 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 40.22 38.55 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.844 -0.693 . . . . 75.439999999999998 112.414 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.43 -162.55 9.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 62.439999999999998 112.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 121.09 7.78 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.244 . . . . 75.329999999999998 112.317 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -82.8 -34.61 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 74.319999999999993 110.929 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -62.97 -25.8 68.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 74.400000000000006 110.779 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -46.85 13.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 65.219999999999999 110.946 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.496 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -129.49 -99.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 63.439999999999998 111.091 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -167.55 173.49 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 63.130000000000003 111.07 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -123.25 159.25 29.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.9 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 46' ' ' PRO . 18.8 t -108.38 130.17 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 72.420000000000002 111.132 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.5 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.4 mt -69.06 157.64 88.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.54 0.686 . . . . 74.230000000000004 110.947 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -21.8 32.77 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.622 2.215 . . . . 71.420000000000002 112.357 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 1.4 p-10 -84.24 1.44 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.420000000000002 110.908 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.86 32.83 8.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.803 -0.713 . . . . 71.400000000000006 112.451 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.5 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.4 m -115.35 179.11 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 65.010000000000005 110.868 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.762 HD23 HD12 ' A' ' 16' ' ' LEU . 20.4 tp -129.47 128.22 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.847 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HD2' HG22 ' A' ' 15' ' ' VAL . 38.3 t80 -126.78 136.61 52.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.81 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD22 HG12 ' A' ' 69' ' ' VAL . 1.4 mp -118.45 130.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 74.200000000000003 110.974 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -34.87 13.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 64.010000000000005 112.336 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.58 101.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 111.1 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.4 m -72.65 113.22 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 61.350000000000001 111.11 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.85 161.82 33.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 62.009999999999998 112.478 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.871 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.84 -30.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 74.099999999999994 111.152 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.1 -20.43 57.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.933 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -3.55 29.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 73.120000000000005 110.871 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.697 ' CD ' HG22 ' A' ' 97' ' ' VAL . 27.5 mt-10 -57.13 142.52 42.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.340000000000003 110.866 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.651 ' C ' HD13 ' A' ' 76' ' ' ILE . . . 158.75 -153.99 25.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.674 -0.774 . . . . 62.130000000000003 112.41 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.46 HD11 ' CB ' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -123.81 134.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.156 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.4 t80 -104.0 127.54 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.852 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.2 128.86 47.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 63.43 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 7.0 t -120.54 150.2 41.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 51.030000000000001 110.891 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.85 133.7 29.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 62.299999999999997 110.927 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.81 162.99 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 71.099999999999994 111.129 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 25.0 mtp -129.69 124.77 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 71.409999999999997 110.967 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.21 172.82 9.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.87 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -70.71 -19.03 62.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 75.329999999999998 110.922 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.83 -20.05 60.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.43 40.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.82 -0.705 . . . . 60.329999999999998 112.547 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.08 146.87 26.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 71.109999999999999 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -105.05 142.5 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 75.450000000000003 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.462 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -103.72 131.84 50.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.519999999999996 111.122 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.72 ' HE2' ' O2 ' ' B' ' 4' ' ' MCL . 42.9 mtpt -102.53 143.56 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.84 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 t -144.39 125.72 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.625 HD21 ' HB2' ' B' ' 5' ' ' ALA . 1.6 t-20 -126.83 122.07 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.896 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 121.77 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 74.129999999999995 110.883 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.098 HH12 ' HG3' ' B' ' 7' ' ' GLU . 27.5 mmm-85 -83.79 134.01 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 64.540000000000006 110.905 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.35 128.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 61.219999999999999 111.079 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.09 142.93 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 110.91 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.871 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.8 m -108.86 -174.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 71.140000000000001 111.176 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -67.3 -79.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 110.85 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -63.09 145.99 54.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 70.310000000000002 110.932 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.2 159.59 49.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 111.204 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.3 Cg_endo -69.66 179.02 3.93 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.756 2.304 . . . . 72.230000000000004 112.355 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 164.68 -48.04 0.29 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.673 -0.775 . . . . 75.450000000000003 112.456 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -151.53 71.98 8.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 73.400000000000006 110.854 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 167.63 23.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.657 2.238 . . . . 41.43 112.35 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.956 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.307 . . . . 74.120000000000005 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.46 ' CB ' HD11 ' A' ' 76' ' ' ILE . 1.4 pm0 -123.52 -36.2 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 63.100000000000001 110.876 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.112 ' HB2' ' CG1' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 176.28 -159.45 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.513 0 CA-C-O 118.1 -0.952 . . . . 63.030000000000001 110.849 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.72 ' O2 ' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.839 ' CB ' ' HD3' ' A' ' 94' ' ' ARG . . . -48.7 134.37 16.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.857 -0.611 . . . . 73.439999999999998 111.134 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -118.64 13.87 13.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 70.209999999999994 110.861 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 1.098 ' HG3' HH12 ' A' ' 94' ' ' ARG . 8.8 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.9 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.411 -0.276 . . . . 52.25 112.411 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -175.01 157.49 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 70.019999999999996 110.857 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.47 99.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 74.409999999999997 111.078 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.57 132.38 37.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 75.209999999999994 110.906 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 3.5 p30 -83.84 122.49 28.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.519999999999996 110.99 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.537 ' CG2' HD11 ' A' ' 14' ' ' LEU . 48.8 mm -124.6 121.64 61.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 73.299999999999997 111.116 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -95.92 141.86 28.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.420000000000002 111.061 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.52 166.04 29.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 55.299999999999997 111.077 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -124.67 148.91 47.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.47 . . . . 75.349999999999994 110.92 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 99' ' ' GLN . 55.9 mt -54.57 121.21 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 70.25 111.103 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.526 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.61 5.44 81.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 61.420000000000002 112.541 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 48.8 mm-40 -102.26 139.6 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.561 0.696 . . . . 73.140000000000001 110.938 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 144.76 55.33 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.69 2.26 . . . . 75.409999999999997 112.351 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 6' ' ' ILE . 17.3 tp -143.43 141.35 30.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.86 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG22 ' HD1' ' A' ' 65' ' ' PHE . 41.2 t -126.04 145.12 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 63.340000000000003 111.061 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.8 mt -131.83 147.12 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.899 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -114.56 154.17 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 62.420000000000002 110.858 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.3 t -105.43 100.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.129999999999995 110.831 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -57.03 123.38 14.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.899 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.63 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.42 -43.52 1.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.782 -0.723 . . . . 63.439999999999998 112.496 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.67 131.26 36.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.523 0.678 . . . . 75.430000000000007 111.12 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.16 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.661 2.241 . . . . 74.109999999999999 112.351 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.1 -53.25 21.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.439999999999998 110.812 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -112.37 131.39 22.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.91 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 55.1 Cg_endo -69.71 110.5 2.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.243 . . . . 74.030000000000001 112.407 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.0 Cg_endo -69.74 -53.08 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 22.32 112.322 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -179.9 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 52.200000000000003 110.881 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -71.74 145.35 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 110.841 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -137.07 155.04 50.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 110.891 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.89 140.86 51.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 74.25 110.885 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -123.72 141.35 52.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.914 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HG2' HG13 ' A' ' 43' ' ' VAL . 27.4 mtmt -144.4 140.38 28.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 51.450000000000003 110.844 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.774 HD22 ' CE2' ' A' ' 77' ' ' PHE . 6.0 tp -137.55 136.33 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.221 -0.445 . . . . 72.010000000000005 110.936 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.935 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 9.0 t-20 -115.4 120.49 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 110.838 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.3 p -138.08 -179.82 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 73.140000000000001 111.131 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.32 -130.36 9.82 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 32.43 112.453 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -112.45 -38.77 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 72.019999999999996 110.912 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 39' ' ' GLU . 8.5 t 179.42 -30.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.143 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.3 mt-10 -103.22 33.89 3.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 63.439999999999998 110.92 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.26 -7.47 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 54.310000000000002 111.128 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -61.92 129.8 42.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.927 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 158.42 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 75.200000000000003 110.88 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 32' ' ' LYS . 22.8 t -94.84 122.21 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 111.152 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.99 144.69 25.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.517 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -125.86 163.66 37.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.718 0.771 . . . . 64.319999999999993 110.814 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.787 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.9 Cg_endo -69.85 0.32 5.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.738 2.292 . . . . 64.120000000000005 112.321 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.56 86.85 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 72.230000000000004 110.824 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.55 -46.12 71.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 61.219999999999999 112.474 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 38.43 81.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 74.209999999999994 112.469 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.78 -164.33 37.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 64.010000000000005 112.485 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 106.91 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 73.239999999999995 112.31 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -66.13 -33.71 76.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 74.150000000000006 110.948 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.74 -25.1 66.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 63.310000000000002 110.881 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -48.01 21.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 75.430000000000007 110.914 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.524 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -130.38 -98.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 71.010000000000005 111.132 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -165.72 172.0 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 72.129999999999995 111.065 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.534 ' O ' HD12 ' A' ' 64' ' ' LEU . 40.3 mmm-85 -126.79 158.52 36.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 74.450000000000003 110.874 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 46' ' ' PRO . 6.8 t -109.14 130.82 61.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.127 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 33.4 mt -68.84 158.3 86.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 50.409999999999997 110.851 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -22.24 32.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 72.310000000000002 112.413 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.43 1.61 40.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 110.898 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.91 29.3 13.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 44.009999999999998 112.538 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 6.3 m -112.74 -178.64 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 71.150000000000006 110.852 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 57' ' ' ARG . 50.1 tp -128.27 128.98 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 61.25 110.906 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HD1' HG22 ' A' ' 15' ' ' VAL . 12.6 t80 -125.64 136.6 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.82 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.776 HD22 HG12 ' A' ' 69' ' ' VAL . 7.0 mp -119.1 127.63 26.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.574 0.702 . . . . 71.129999999999995 110.898 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.93 -32.81 17.15 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.69 2.26 . . . . 75.549999999999997 112.336 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.14 102.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 111.167 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 23.7 m -71.98 117.19 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 55.240000000000002 111.11 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.81 160.11 28.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 73.409999999999997 112.525 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.866 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -33.86 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 65.519999999999996 111.129 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -77.69 -21.56 51.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.125 -0.489 . . . . 70.239999999999995 110.956 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.08 -4.73 40.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.834 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -58.97 142.7 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 110.875 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.745 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 162.63 -148.32 15.14 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.727 -0.749 . . . . 64.230000000000004 112.444 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.953 HD13 ' HB2' ' B' ' 2' ' ' GLU . 3.1 mp -130.67 133.71 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 74.409999999999997 111.084 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CE2' HD22 ' A' ' 33' ' ' LEU . 11.8 m-85 -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 64.239999999999995 110.926 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.98 126.97 44.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 110.903 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.6 t -121.16 151.11 40.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.010000000000005 110.913 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -139.44 133.9 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 54.340000000000003 110.917 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.82 163.63 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 111.176 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' A' ' 82' ' ' MET . 7.2 mmm -129.23 124.69 35.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.288 -0.415 . . . . 54.049999999999997 110.84 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.93 170.1 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 110.811 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -73.8 -18.32 60.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 63.409999999999997 110.825 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -72.89 -20.12 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 60.439999999999998 110.843 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.45 -20.04 21.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.7 -0.762 . . . . 73.219999999999999 112.508 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.7 147.86 26.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 74.239999999999995 110.916 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -103.67 145.27 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.63 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -98.04 132.51 43.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 71.340000000000003 111.073 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.523 ' HB2' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -103.02 139.97 37.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 71.329999999999998 110.872 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.1 m -146.7 120.74 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 63.439999999999998 110.891 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.984 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -129.42 123.29 31.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 64.510000000000005 110.909 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -130.14 120.6 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.818 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -88.87 136.13 33.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 74.049999999999997 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.1 t -120.54 137.51 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 70.140000000000001 111.132 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -128.42 146.61 50.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.519999999999996 110.937 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.866 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.4 m -107.11 -176.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 111.111 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -68.11 -77.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 65.200000000000003 110.912 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.496 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -64.31 144.55 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.962 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.412 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.15 160.44 45.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.6 0.714 . . . . 61.350000000000001 111.17 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo -69.79 119.73 6.62 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.731 2.287 . . . . 73.519999999999996 112.364 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.89 61.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.340000000000003 112.489 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -80.37 160.12 68.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 65.239999999999995 110.84 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 127.21 14.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.681 2.254 . . . . 72.329999999999998 112.404 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 73.150000000000006 110.917 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.822 0.344 . . . . 71.120000000000005 110.824 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.953 ' HB2' HD13 ' A' ' 76' ' ' ILE . 5.4 pt-20 -173.63 113.08 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.899 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.935 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 61.85 -166.99 0.21 Allowed 'General case' 0 C--O 1.182 -2.461 0 CA-C-O 118.093 -0.956 . . . . 51.140000000000001 110.889 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.523 ' CX2' ' HB2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -40.89 144.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 33.409999999999997 111.042 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -142.17 89.83 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 72.340000000000003 110.865 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 73.450000000000003 110.891 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.569 -0.212 . . . . 74.120000000000005 112.569 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -168.71 148.83 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 75.109999999999999 110.902 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' B' ' 5' ' ' ALA . . . -51.22 107.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 64.030000000000001 111.128 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 132.46 38.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 72.5 110.89 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.7 121.2 32.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.329999999999998 110.876 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.87 122.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 111.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -96.0 142.13 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 61.229999999999997 111.036 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -144.61 168.23 20.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 111.071 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 149.34 46.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 75.140000000000001 110.859 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.69 HD11 HG13 ' A' ' 71' ' ' ILE . 27.8 mt -65.06 120.49 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 53.119999999999997 111.147 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.77 -12.24 57.82 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.654 -0.784 . . . . 72.310000000000002 112.421 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.1 pp20? -101.45 140.88 21.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 110.946 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 145.01 55.9 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 71.019999999999996 112.348 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 8' ' ' ALA . 14.3 tp -137.77 142.46 40.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.921 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.6 t -123.1 146.72 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 72.219999999999999 111.128 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.734 HD13 ' CD2' ' A' ' 77' ' ' PHE . 4.6 mt -131.84 151.92 51.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.917 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -111.63 149.71 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.230000000000004 110.856 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.81 101.64 9.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 110.935 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -54.09 99.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 110.916 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.61 -47.34 0.65 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.628 -0.796 . . . . 73.150000000000006 112.473 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.31 103.58 12.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 70.310000000000002 111.128 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.4 Cg_endo -69.79 -161.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.71 2.273 . . . . 63.25 112.325 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.59 -8.08 8.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.853 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 1.1 mptt -44.5 167.65 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 51.520000000000003 110.942 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.4 Cg_endo -69.79 172.2 13.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.674 2.25 . . . . 75.219999999999999 112.336 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 98.62 0.7 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.653 2.235 . . . . 61.240000000000002 112.272 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.25 -175.02 2.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 64.319999999999993 110.946 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 139.97 57.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.230000000000004 110.936 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.616 HD13 ' CD1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -179.22 161.31 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 60.119999999999997 111.002 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.43 137.15 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 62.439999999999998 110.917 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.616 ' CD1' HD13 ' A' ' 29' ' ' LEU . 17.0 m95 -125.05 143.82 50.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.477 . . . . 72.310000000000002 110.972 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -148.66 136.26 20.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 73.450000000000003 110.86 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 34' ' ' ASN . 1.1 tp -138.62 138.07 37.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.922 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.631 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -112.62 126.83 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 61.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.828 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 19.7 p -137.57 179.81 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 111.15 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.12 -132.72 17.29 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.736 -0.745 . . . . 74.209999999999994 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.65 -37.26 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 75.239999999999995 110.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.591 HG23 ' HG3' ' A' ' 39' ' ' GLU . 3.5 t -179.38 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 64.299999999999997 111.085 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HG3' HG23 ' A' ' 38' ' ' THR . 14.9 mt-10 -101.5 33.67 2.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 74.329999999999998 110.885 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.62 -6.5 7.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 54.299999999999997 111.085 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -59.53 129.75 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 60.219999999999999 110.895 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.74 153.15 50.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 73.200000000000003 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.18 123.31 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 53.299999999999997 111.045 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.59 145.0 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.319999999999993 110.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.413 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -128.3 163.58 43.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.754 . . . . 72.230000000000004 110.822 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.571 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.3 Cg_endo -69.79 -0.33 6.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.614 2.209 . . . . 71.040000000000006 112.407 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -128.73 87.95 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.349999999999994 110.879 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.85 25.73 17.99 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.775 -0.726 . . . . 72.420000000000002 112.46 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 167.65 0.32 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 64.310000000000002 112.452 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.33 -152.13 20.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.7 -0.762 . . . . 72.349999999999994 112.423 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.742 ' O ' HG22 ' A' ' 55' ' ' VAL . 53.8 Cg_endo -69.71 98.89 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 2.218 . . . . 73.420000000000002 112.361 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.44 -14.94 59.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 75.430000000000007 110.906 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -62.97 -39.03 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 75.439999999999998 110.891 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.9 -42.74 9.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 73.019999999999996 110.928 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 51' ' ' PRO . 14.0 m -101.62 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 72.200000000000003 111.128 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 55' ' ' VAL . . . -142.8 164.22 30.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 70.209999999999994 111.132 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.83 157.33 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 52.520000000000003 110.895 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 45' ' ' SER . 45.9 t -114.55 127.02 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.115 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 6.4 mp -69.69 157.91 88.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.662 0.744 . . . . 73.549999999999997 110.841 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.77 -22.8 31.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.245 . . . . 73.219999999999999 112.295 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 2.3 p-10 -83.52 4.02 29.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 63.299999999999997 110.86 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.96 13.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.802 -0.713 . . . . 60.520000000000003 112.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 3.2 m -114.63 178.6 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.407 . . . . 45.32 110.839 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.715 HD23 HD12 ' A' ' 16' ' ' LEU . 13.3 tp -130.09 127.88 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 73.25 110.986 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -126.26 130.27 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.857 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mp -120.93 130.31 24.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.649 0.737 . . . . 60.100000000000001 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.64 18.27 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 72.510000000000005 112.39 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.66 103.4 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 62.100000000000001 111.146 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 12' ' ' GLU . 30.9 m -73.01 121.91 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.469 . . . . 73.120000000000005 111.1 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.08 156.42 22.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.683 -0.77 . . . . 62.229999999999997 112.489 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.766 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.91 -30.18 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.305 . . . . 73.349999999999994 111.129 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -73.97 -23.74 59.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 62.299999999999997 110.849 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.43 -5.0 45.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.923 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 141.06 58.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.869 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.583 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.39 -138.91 6.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 63.399999999999999 112.413 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.437 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.4 mp -129.13 127.64 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 52.310000000000002 111.152 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.734 ' CD2' HD13 ' A' ' 16' ' ' LEU . 1.5 t80 -104.5 131.1 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.420000000000002 110.859 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 1.237 ' HG3' ' CD1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -127.08 137.36 53.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 72.040000000000006 110.944 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.8 t -119.95 149.07 42.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.939 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.99 127.07 19.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.897 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.59 163.87 27.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.109999999999999 111.094 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ttm -128.75 125.29 37.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 65.049999999999997 110.885 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -86.93 173.21 9.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 61.399999999999999 110.887 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -70.32 -18.13 63.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 110.848 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.14 -19.93 61.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.329999999999998 110.882 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.75 -16.37 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 71.409999999999997 112.478 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 146.76 27.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.727 0.299 . . . . 73.099999999999994 110.881 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.26 143.4 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 55.039999999999999 110.9 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.92 130.38 51.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 54.030000000000001 111.193 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.003 ' HE2' ' H11' ' B' ' 4' ' ' MCL . 4.0 mtpt -105.49 144.85 31.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 52.310000000000002 110.917 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.417 ' C ' ' HE ' ' A' ' 78' ' ' ARG . 74.0 m -144.44 125.82 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 74.340000000000003 110.824 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.06 123.59 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 74.299999999999997 110.943 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.83 118.84 24.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 110.93 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.623 ' NH2' ' O ' ' B' ' 4' ' ' MCL . 11.1 mmt85 -82.66 129.89 35.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 74.530000000000001 110.97 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.97 131.05 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 74.109999999999999 111.197 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' HG21 ' A' ' 100' ' ' ILE . 4.1 tpt180 -130.78 128.32 40.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 65.340000000000003 110.826 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.766 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -95.08 -177.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 64.010000000000005 111.095 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -66.95 -82.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.340000000000003 110.89 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -58.02 137.91 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.873 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.403 HG21 ' NH2' ' A' ' 96' ' ' ARG . 1.0 OUTLIER -120.0 160.08 44.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 63.229999999999997 111.188 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 153.01 69.36 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 62.32 112.314 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 171.19 109.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 74.439999999999998 112.437 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 160.73 42.06 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 73.010000000000005 110.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -174.88 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.656 2.237 . . . . 73.239999999999995 112.353 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.879 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.842 0.354 . . . . 64.439999999999998 110.906 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.437 ' CB ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.75 -61.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.030000000000001 110.872 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.263 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -179.2 105.62 0.04 OUTLIER 'General case' 0 C--O 1.183 -2.442 0 CA-C-O 118.21 -0.9 . . . . 74.340000000000003 110.82 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.003 ' H11' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 3' ' ' ALA . . . 73.87 -70.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.805 -0.634 . . . . 72.400000000000006 111.133 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 50.69 69.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 51.439999999999998 110.872 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 72.340000000000003 111.004 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.508 -0.237 . . . . 71.230000000000004 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -157.9 142.15 16.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 72.420000000000002 110.886 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.38 101.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 61.530000000000001 111.084 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -93.69 134.94 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.299999999999997 110.875 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -85.81 121.78 28.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 71.519999999999996 110.852 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.602 ' CG2' HD11 ' A' ' 14' ' ' LEU . 45.9 mm -125.19 121.57 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.085 -0.507 . . . . 64.129999999999995 111.211 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -96.55 142.01 29.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 52.109999999999999 111.188 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.27 166.04 29.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 74.510000000000005 111.173 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -124.31 148.18 47.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 72.019999999999996 110.887 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.456 HD11 HG13 ' A' ' 71' ' ' ILE . 25.6 mt -54.21 121.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 64.540000000000006 111.174 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.57 4.34 80.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.776 -0.726 . . . . 72.219999999999999 112.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.777 ' O ' HG22 ' A' ' 69' ' ' VAL . 23.2 mm-40 -102.08 140.15 20.92 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 71.200000000000003 110.931 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 144.07 52.85 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.709 2.272 . . . . 62.219999999999999 112.305 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.602 HD11 ' CG2' ' A' ' 6' ' ' ILE . 25.5 tp -144.41 141.71 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.871 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 65' ' ' PHE . 22.0 t -122.28 147.38 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 61.310000000000002 111.161 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -132.02 148.72 52.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 70.530000000000001 110.934 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -111.82 151.3 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 110.946 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.4 t -107.38 99.9 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 54.32 110.918 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -57.62 121.24 9.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 74.049999999999997 110.898 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.01 -39.4 1.91 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.786 -0.721 . . . . 60.310000000000002 112.515 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.53 43.67 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.544 0.688 . . . . 72.420000000000002 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.676 2.251 . . . . 74.319999999999993 112.397 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -49.36 -48.45 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.030000000000001 110.918 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.82 148.85 38.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.504 0.669 . . . . 75.450000000000003 110.915 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.5 Cg_endo -69.75 111.08 2.71 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.65 2.234 . . . . 71.049999999999997 112.376 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.1 Cg_endo -69.7 -84.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.638 2.225 . . . . 72.019999999999996 112.387 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 29.1 mm100 -103.14 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 71.540000000000006 110.893 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -64.71 136.62 57.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 62.240000000000002 110.832 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.6 pp -136.58 151.83 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.439999999999998 110.852 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.86 148.14 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.040000000000006 110.879 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.27 139.91 53.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 110.946 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.727 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.34 135.46 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 73.319999999999993 110.887 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.83 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -138.25 137.62 37.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.943 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.127 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 6.9 t30 -113.52 126.76 55.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 52.43 110.882 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.82 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 24.5 p -136.71 179.78 6.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 111.181 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.17 -119.69 6.83 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.648 -0.787 . . . . 71.409999999999997 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 38' ' ' THR . 9.2 mpt_? -114.57 -38.96 3.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.530000000000001 110.946 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 174.51 -27.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 31.5 111.103 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.64 33.2 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.865 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.27 -7.55 8.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 111.12 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -60.72 129.77 43.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.200000000000003 110.878 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 153.71 51.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 65.150000000000006 110.907 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 32' ' ' LYS . 12.0 m -88.81 122.35 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 70.140000000000001 111.109 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -88.2 145.22 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 72.230000000000004 110.846 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.54 165.72 25.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.716 0.769 . . . . 71.129999999999995 110.798 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.59 0.87 4.9 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.722 2.281 . . . . 73.230000000000004 112.421 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.34 97.13 5.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.878 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.43 -31.7 71.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 43.299999999999997 112.513 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.43 -159.0 21.09 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.722 . . . . 74.329999999999998 112.548 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.74 -67.91 1.63 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.737 -0.744 . . . . 72.299999999999997 112.479 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 95.76 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.648 2.232 . . . . 51.43 112.319 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -84.22 -32.76 24.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 110.917 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.82 -26.56 68.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.322 -0.399 . . . . 75.230000000000004 110.8 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 -44.52 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 72.450000000000003 110.856 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -128.17 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 71.420000000000002 111.111 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.93 171.42 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 64.319999999999993 111.106 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 159.58 33.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 64.019999999999996 110.888 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 63' ' ' SER . 19.4 t -113.33 130.58 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 111.158 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD12 ' CB ' ' A' ' 63' ' ' SER . 77.4 mt -68.55 157.55 87.83 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 64.329999999999998 110.889 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.632 2.221 . . . . 71.25 112.353 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -83.42 -0.15 48.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.812 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.4 9.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 15.42 112.461 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.64 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.1 m -111.65 179.6 3.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 72.310000000000002 110.898 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.34 128.08 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.482 . . . . 73.420000000000002 110.947 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CD1' HG22 ' A' ' 15' ' ' VAL . 9.5 t80 -126.68 132.83 51.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.629 HD22 HG12 ' A' ' 69' ' ' VAL . 7.6 mp -114.78 128.35 25.98 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.518 0.675 . . . . 71.400000000000006 110.985 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.29 19.12 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.651 2.234 . . . . 61.340000000000003 112.411 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.44 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -164.8 102.36 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 53.229999999999997 111.151 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 12' ' ' GLU . 28.9 m -72.09 118.97 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 42.119999999999997 111.167 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.37 158.64 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 63.32 112.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.787 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.74 -30.37 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 71.219999999999999 111.182 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.5 -23.11 56.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 74.219999999999999 110.92 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.38 -5.09 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 70.099999999999994 110.783 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.03 140.9 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 74.329999999999998 110.885 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.66 -139.57 6.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.82 -0.705 . . . . 24.300000000000001 112.476 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.322 HD13 ' C ' ' B' ' 2' ' ' GLU . 1.7 mp -131.78 135.34 58.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 73.319999999999993 111.11 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.83 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.2 m-85 -104.67 126.75 52.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 54.229999999999997 110.838 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.598 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 1.1 mmm180 -126.39 130.65 51.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 110.915 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.17 151.22 39.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 73.25 110.86 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -140.54 129.44 23.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 163.35 28.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 55.119999999999997 111.05 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.3 ttm -129.54 125.41 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 65.040000000000006 110.876 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.48 171.77 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -17.41 62.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.868 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.58 -25.13 61.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 71.109999999999999 110.894 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.94 -20.23 13.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 73.140000000000001 112.538 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.09 146.87 26.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.733 0.301 . . . . 72.530000000000001 110.868 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.04 145.39 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.834 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.77 131.89 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.520000000000003 111.212 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.723 ' HE2' ' O1 ' ' B' ' 4' ' ' MCL . 12.7 mtpt -105.05 142.66 34.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 72.209999999999994 110.917 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -145.93 126.95 14.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 72.239999999999995 110.913 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' CG ' ' HA ' ' B' ' 5' ' ' ALA . 0.8 OUTLIER -127.77 127.25 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 110.822 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -129.03 124.3 34.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 65.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.093 ' NH2' ' HG3' ' B' ' 2' ' ' GLU . 30.3 mmm-85 -82.61 135.53 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 72.530000000000001 110.933 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.456 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.5 t -123.98 132.5 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.010000000000005 111.232 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.0 128.4 40.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.340000000000003 110.908 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.3 m -93.71 -176.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 73.530000000000001 111.149 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -66.35 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 64.310000000000002 110.874 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.93 145.87 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 70.150000000000006 110.945 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.53 159.48 50.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.509 0.671 . . . . 74.549999999999997 111.202 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo -69.74 -170.63 0.4 Allowed 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.759 2.306 . . . . 64.010000000000005 112.284 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 145.35 50.47 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 64.219999999999999 112.492 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -163.7 160.39 17.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.571 0.701 . . . . 71.450000000000003 110.893 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -172.35 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.635 2.224 . . . . 72.420000000000002 112.305 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.908 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.776 0.322 . . . . 63.299999999999997 110.882 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.322 ' C ' HD13 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -127.99 61.94 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.872 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.127 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 61.21 -166.73 0.2 Allowed 'General case' 0 C--O 1.182 -2.476 0 CA-C-O 118.088 -0.958 . . . . 55.140000000000001 110.889 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.723 ' O1 ' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 76' ' ' ILE . . . 42.99 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 72.040000000000006 111.087 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.11 28.96 8.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 110.83 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.82 ' HG3' HH22 ' A' ' 94' ' ' ARG . 53.5 mm-40 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 72.129999999999995 110.933 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.541 -0.224 . . . . 64.209999999999994 112.541 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t 63.7 108.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 73.040000000000006 110.938 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.54 62.93 2.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 44.240000000000002 111.118 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.0 132.9 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 110.9 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -86.98 120.97 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.86 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.64 122.74 63.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 111.076 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.08 142.17 28.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 111.075 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.66 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.450000000000003 111.11 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.45 148.23 44.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.299999999999997 110.84 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 99' ' ' GLN . 21.8 mt -57.77 122.16 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 64.430000000000007 111.141 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.708 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.13 4.22 78.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.673 -0.775 . . . . 51.539999999999999 112.519 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.778 ' O ' HG22 ' A' ' 69' ' ' VAL . 43.7 mm-40 -101.18 140.4 21.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.712 0.768 . . . . 71.349999999999994 110.879 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.49 45.46 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.669 2.246 . . . . 73.109999999999999 112.375 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 66' ' ' LEU . 19.8 tp -144.48 141.98 29.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 73.340000000000003 111.029 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.84 148.6 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 62.509999999999998 111.081 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.956 HD12 HD23 ' A' ' 64' ' ' LEU . 15.1 mt -130.56 147.94 52.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.896 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.95 31.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.868 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.4 100.79 8.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 72.400000000000006 110.875 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.64 122.05 7.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 53.439999999999998 110.916 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.55 -47.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.837 -0.697 . . . . 43.119999999999997 112.511 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.96 102.2 10.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 61.210000000000001 111.065 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.1 Cg_endo -69.75 -161.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.625 2.217 . . . . 31.239999999999998 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -11.15 5.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 64.439999999999998 110.916 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.466 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 2.7 mptt -46.53 168.65 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.662 0.744 . . . . 71.120000000000005 110.866 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 54.3 Cg_endo -69.72 172.17 13.09 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.762 2.308 . . . . 43.0 112.334 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 97.89 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.752 2.302 . . . . 71.5 112.338 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 -175.4 3.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.861 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -64.6 133.09 51.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 71.040000000000006 110.92 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 46' ' ' PRO . 2.3 pp -172.3 174.23 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.120000000000005 110.897 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.43 131.16 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.809 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -124.09 128.95 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 75.519999999999996 110.856 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -138.41 137.79 37.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 73.109999999999999 110.842 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 77' ' ' PHE . 2.4 tp -137.75 136.94 37.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 54.130000000000003 110.899 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -113.92 126.39 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.319999999999993 110.85 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.85 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 70.5 p -138.58 -179.35 5.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 62.119999999999997 111.083 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.26 -126.64 10.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.817 -0.706 . . . . 71.200000000000003 112.489 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 38' ' ' THR . 49.1 mmm-85 -112.61 -38.62 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.040000000000006 110.808 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t 178.93 -29.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 72.450000000000003 111.159 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HG3' HG23 ' A' ' 38' ' ' THR . 67.9 mt-10 -102.16 34.28 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.85 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.6 -7.01 8.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 55.219999999999999 111.14 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -63.07 131.23 47.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 75.140000000000001 110.927 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 154.27 47.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 61.240000000000002 110.904 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.29 117.01 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 72.409999999999997 111.073 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.29 149.71 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 64.400000000000006 110.927 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.659 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -124.96 162.14 45.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.751 0.786 . . . . 73.019999999999996 110.802 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.696 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.7 Cg_endo -69.75 -0.12 6.45 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.753 2.302 . . . . 73.129999999999995 112.316 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -120.11 72.26 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 73.439999999999998 110.877 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.5 23.74 32.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.762 . . . . 64.019999999999996 112.524 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.71 59.02 3.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.706 -0.759 . . . . 63.310000000000002 112.515 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.65 -127.32 2.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 74.150000000000006 112.432 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 91.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.313 . . . . 73.510000000000005 112.3 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 44.1 p-90 -83.43 -33.92 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 74.450000000000003 110.933 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -59.4 -25.9 64.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.315 -0.402 . . . . 72.120000000000005 110.881 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.52 -45.83 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 70.519999999999996 110.779 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -128.62 -98.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 63.0 111.143 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.578 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -166.19 175.21 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 74.219999999999999 111.111 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 161.42 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 73.140000000000001 110.876 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 46' ' ' PRO . 51.9 t -107.65 128.26 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 111.121 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 63' ' ' SER . 54.4 mt -70.31 158.68 87.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 60.219999999999999 110.926 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.4 Cg_endo -69.83 -22.42 31.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.649 2.233 . . . . 73.540000000000006 112.301 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.93 1.6 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.897 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 30.86 11.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 72.299999999999997 112.519 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.529 ' HB2' HD12 ' A' ' 59' ' ' LEU . 4.3 m -112.65 178.26 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 72.329999999999998 110.833 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.956 HD23 HD12 ' A' ' 16' ' ' LEU . 8.9 tp -131.62 130.62 42.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 64.310000000000002 110.89 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 6.8 t80 -124.57 128.2 48.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 110.913 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.8 mp -119.69 131.65 24.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 64.430000000000007 110.918 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -32.7 18.39 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 42.219999999999999 112.396 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.62 101.75 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.086 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.3 m -72.98 118.83 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 72.430000000000007 111.118 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.51 163.78 35.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 62.420000000000002 112.451 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.5 -29.97 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 54.030000000000001 111.049 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -74.41 -22.32 59.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 74.239999999999995 110.808 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -5.96 47.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 74.519999999999996 110.912 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 8.8 pt-20 -60.0 141.99 54.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.841 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.66 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 158.24 -142.28 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 44.100000000000001 112.537 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.098 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.1 mp -130.94 135.48 59.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 111.195 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -101.6 127.39 48.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 110.766 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.717 ' HD3' ' H13' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -125.49 131.62 52.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 74.549999999999997 110.886 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 0.5 OUTLIER -122.63 150.09 43.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 75.200000000000003 110.866 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -148.9 125.65 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 54.109999999999999 110.851 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.57 27.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 72.510000000000005 111.103 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.22 125.23 27.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.310000000000002 110.872 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.59 170.79 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 70.430000000000007 110.854 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -72.69 -18.74 61.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 72.25 110.889 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -73.01 -20.03 61.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 64.319999999999993 110.883 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.54 -11.25 33.02 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.772 -0.728 . . . . 73.299999999999997 112.527 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -84.77 145.39 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 75.549999999999997 110.898 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.42 145.49 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 65.450000000000003 110.876 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.471 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -101.28 126.55 48.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 111.152 -179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.648 ' HB3' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -105.33 134.54 48.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 64.140000000000001 110.97 179.828 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . 73.9 m -144.68 120.08 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 53.200000000000003 110.788 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.771 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.3 OUTLIER -130.11 121.02 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 73.510000000000005 110.876 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.57 127.16 36.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.96 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.256 ' NH1' ' HB1' ' B' ' 5' ' ' ALA . 11.4 mmm-85 -83.88 136.8 33.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 63.140000000000001 110.934 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.17 130.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 74.150000000000006 111.091 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.84 128.82 39.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 71.230000000000004 110.871 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.3 m -93.5 -177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 111.131 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -63.02 -69.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 73.540000000000006 110.884 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.588 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -76.98 138.92 39.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.963 179.941 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.29 159.54 49.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.716 0.769 . . . . 51.420000000000002 111.114 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.82 6.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 74.420000000000002 112.317 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.07 21.92 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 45.210000000000001 112.462 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? 57.76 70.12 1.38 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.58 0.705 . . . . 52.530000000000001 110.882 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 142.17 47.44 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.691 2.261 . . . . 43.119999999999997 112.379 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 110.838 -179.938 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 72.5 110.827 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.098 ' CB ' HD13 ' A' ' 76' ' ' ILE . 2.4 pm0 -135.76 -41.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 55.119999999999997 110.899 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -168.35 -168.9 0.99 Allowed 'General case' 0 C--O 1.181 -2.505 0 CA-C-O 118.181 -0.914 . . . . 74.450000000000003 110.875 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 0.771 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.256 ' HB1' ' NH1' ' A' ' 94' ' ' ARG . . . -43.65 154.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 62.549999999999997 111.105 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -148.49 17.77 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 65.409999999999997 110.895 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.796 ' H ' HH12 ' A' ' 94' ' ' ARG . 4.0 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 63.399999999999999 110.943 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.517 -0.233 . . . . 64.310000000000002 112.517 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -168.34 148.15 4.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.401 . . . . 51.340000000000003 110.806 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.57 100.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 71.219999999999999 111.147 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -92.64 134.64 34.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.92 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -83.21 120.79 26.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 71.510000000000005 110.914 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.478 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.8 mm -125.4 120.89 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.119999999999997 111.174 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -96.53 142.38 28.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 75.040000000000006 111.126 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.534 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -147.1 164.98 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 50.030000000000001 111.12 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.36 148.94 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.821 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mt -56.13 121.36 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 63.409999999999997 111.156 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.572 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.6 3.31 86.44 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.668 -0.777 . . . . 53.049999999999997 112.536 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.79 ' O ' HG22 ' A' ' 69' ' ' VAL . 49.7 mm-40 -101.17 140.89 21.66 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.564 0.697 . . . . 63.520000000000003 110.972 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 143.83 51.94 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.599 2.199 . . . . 72.019999999999996 112.411 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 8' ' ' ALA . 62.3 tp -144.35 142.88 30.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 74.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.53 146.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 62.030000000000001 111.178 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.415 HD13 ' CG ' ' A' ' 77' ' ' PHE . 75.0 mt -131.42 147.24 52.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 65.439999999999998 110.924 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -113.17 151.08 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.829 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.8 t -108.25 100.48 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 64.209999999999994 110.844 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.73 126.97 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 74.109999999999999 110.887 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.48 -38.84 2.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 65.25 112.518 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.41 31.1 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.536 0.684 . . . . 71.010000000000005 111.15 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -164.23 0.12 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 54.350000000000001 112.339 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.1 -50.96 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.88 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -111.18 152.55 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 54.450000000000003 110.909 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.5 Cg_endo -69.67 110.3 2.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.252 . . . . 44.229999999999997 112.375 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 52.7 Cg_endo -69.82 -84.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 55.240000000000002 112.318 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.404 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 36.8 mm-40 -100.6 -177.35 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.815 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -63.48 133.89 54.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 110.895 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -135.94 144.54 45.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 72.530000000000001 110.95 179.974 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -122.07 133.01 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.887 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.47 ' CE2' HD13 ' A' ' 29' ' ' LEU . 4.6 m0 -121.18 144.76 48.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 73.400000000000006 110.887 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.748 ' C ' HD13 ' A' ' 33' ' ' LEU . 5.7 mptt -136.49 138.26 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 110.885 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.122 HD21 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -134.57 141.44 46.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 110.886 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 8.5 t-20 -111.95 125.33 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 70.140000000000001 110.886 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.829 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 28.8 p -138.58 -179.24 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 111.124 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.54 -129.57 9.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 62.409999999999997 112.497 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -112.48 -37.23 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.747 0.308 . . . . 61.310000000000002 110.83 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t 176.81 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 111.192 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.52 33.64 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 74.019999999999996 110.945 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.829 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.54 -6.75 9.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 64.310000000000002 111.146 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -59.84 129.16 40.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.319999999999993 110.91 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.786 ' HE3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -137.4 161.11 37.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 54.149999999999999 110.85 179.98 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 32' ' ' LYS . 45.8 t -99.5 122.87 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 111.175 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.122 HD23 HD21 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -88.45 143.33 27.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.902 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.607 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.95 163.73 41.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 52.109999999999999 110.815 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.765 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.74 1.08 4.74 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.753 2.302 . . . . 75.200000000000003 112.285 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -138.48 72.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.888 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.8 -47.01 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 53.210000000000001 112.537 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.02 -151.91 1.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 40.310000000000002 112.466 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.2 -159.91 1.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.839 -0.696 . . . . 35.420000000000002 112.433 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 122.64 9.33 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.645 2.23 . . . . 70.109999999999999 112.329 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -83.16 -34.65 25.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.947 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.88 -26.0 68.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 54.439999999999998 110.814 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -46.5 47.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 34.539999999999999 110.877 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.45 -98.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 71.299999999999997 111.098 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.17 172.54 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.409999999999997 111.132 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.93 159.52 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 74.209999999999994 110.879 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.765 HG11 ' HA ' ' A' ' 46' ' ' PRO . 7.9 t -108.95 130.34 62.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 111.181 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 63' ' ' SER . 66.5 mt -69.23 157.15 90.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 71.430000000000007 110.933 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.04 32.77 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 74.319999999999993 112.273 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -82.88 0.39 44.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 63.229999999999997 110.9 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.54 28.2 13.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 70.530000000000001 112.418 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 59' ' ' LEU . 6.0 m -112.0 -179.18 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 61.109999999999999 110.919 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD23 HD12 ' A' ' 16' ' ' LEU . 16.5 tp -128.53 127.4 42.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 62.100000000000001 110.9 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -126.9 132.06 50.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 110.819 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.786 HD22 HG12 ' A' ' 69' ' ' VAL . 3.5 mp -115.33 130.83 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 73.409999999999997 110.921 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.79 -32.83 17.68 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.679 2.253 . . . . 74.120000000000005 112.36 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.73 101.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 74.120000000000005 111.157 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.2 m -76.58 118.54 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 53.109999999999999 111.229 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.99 165.39 34.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.731 . . . . 41.420000000000002 112.414 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.731 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.87 -31.12 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 71.5 111.136 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.19 -22.59 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 62.140000000000001 110.914 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -5.35 44.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 110.88 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.7 142.21 50.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.876 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.758 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 156.16 -152.34 23.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.801 -0.714 . . . . 61.439999999999998 112.521 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 75' ' ' GLY . 6.9 mm -124.81 135.22 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.25 111.097 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.778 ' CD2' HD12 ' A' ' 33' ' ' LEU . 21.9 t80 -103.38 131.66 50.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 62.32 110.836 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HG3' ' CD1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -124.83 138.4 54.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 110.837 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.86 42.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.019999999999996 110.857 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.36 125.34 19.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.848 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.38 163.91 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 33.509999999999998 111.091 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttm -129.69 125.66 36.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.464 . . . . 53.109999999999999 110.855 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.86 172.61 10.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 64.239999999999995 110.912 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -70.34 -18.04 63.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 54.530000000000001 110.914 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 55.43 110.881 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -18.78 32.93 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.733 . . . . 73.030000000000001 112.481 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 147.84 26.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.313 . . . . 74.239999999999995 110.906 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -103.74 144.8 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 110.878 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -101.84 131.86 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 111.159 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.426 ' HE2' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -99.17 145.43 27.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 72.0 110.918 179.878 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.91 ' N ' ' CX2' ' B' ' 4' ' ' MCL . 1.8 t -143.79 127.96 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 42.539999999999999 110.826 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.555 ' ND2' ' HB3' ' B' ' 4' ' ' MCL . 28.7 t-20 -128.31 129.26 46.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 61.539999999999999 110.853 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.82 126.03 33.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.109999999999999 110.919 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.442 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 0.6 OUTLIER -84.51 131.42 34.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 74.349999999999994 110.858 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.4 t -120.7 130.07 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 111.115 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 128.64 38.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.150000000000006 110.863 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.4 m -94.26 -177.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 111.076 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -62.12 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 63.229999999999997 110.927 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.66 143.43 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 63.329999999999998 110.956 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.45 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.41 159.75 48.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 70.400000000000006 111.12 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo -69.78 161.6 45.3 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 72.150000000000006 112.319 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.92 -109.54 2.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 73.019999999999996 112.502 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -112.36 157.31 40.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 74.540000000000006 110.856 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 169.91 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.595 2.196 . . . . 71.230000000000004 112.376 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 64.420000000000002 110.959 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.791 0.329 . . . . 42.329999999999998 110.823 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.82 160.28 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 73.409999999999997 110.902 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.612 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -63.33 -164.65 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.472 0 CA-C-O 118.171 -0.919 . . . . 73.430000000000007 110.87 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.426 ' CX2' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.442 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . 39.46 -150.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.857 -0.611 . . . . 61.049999999999997 111.072 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 1.293 ' H ' ' NH2' ' A' ' 94' ' ' ARG . 16.2 t0 71.75 38.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 74.219999999999999 110.893 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.468 . . . . 61.130000000000003 110.898 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.54 -0.224 . . . . 74.439999999999998 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 63.14 105.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 61.43 110.817 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.87 62.95 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 61.030000000000001 111.089 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -93.16 132.72 37.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 64.040000000000006 110.928 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 1.223 ' ND2' ' OE2' ' B' ' 7' ' ' GLU . 2.0 m-20 -89.36 122.78 32.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 74.319999999999993 110.849 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.3 mm -124.2 126.27 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.230000000000004 111.163 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -94.09 142.37 27.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 75.25 111.233 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.49 168.98 20.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 72.430000000000007 111.088 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.63 148.9 40.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 63.140000000000001 110.916 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 99' ' ' GLN . 28.8 mt -54.17 121.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 73.519999999999996 111.111 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.697 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.06 12.37 65.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 63.229999999999997 112.502 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 5.3 mm-40 -102.7 138.31 19.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 73.209999999999994 110.908 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 143.14 50.55 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.697 2.265 . . . . 64.239999999999995 112.401 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.7 tp -145.68 143.05 29.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 75.430000000000007 110.891 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.1 144.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 111.106 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 64' ' ' LEU . 52.1 mt -131.39 147.55 52.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.854 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -113.77 153.33 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.855 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 t -104.28 100.88 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 62.140000000000001 110.832 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -56.01 123.52 14.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.852 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.582 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.73 -39.85 2.02 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.663 -0.78 . . . . 33.420000000000002 112.504 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.34 129.44 43.23 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.517 0.675 . . . . 72.099999999999994 111.152 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.75 -163.91 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.787 2.325 . . . . 62.340000000000003 112.313 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -49.01 -48.2 43.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 53.329999999999998 110.909 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.98 156.1 37.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.586 0.708 . . . . 72.040000000000006 110.928 179.806 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.2 Cg_endo -69.84 109.77 2.41 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 65.150000000000006 112.318 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.486 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.1 Cg_endo -69.89 -87.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.659 2.239 . . . . 61.520000000000003 112.308 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -103.96 -178.06 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 71.450000000000003 110.836 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm-85 -64.72 135.03 55.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 74.530000000000001 110.878 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.641 HD11 ' HB3' ' A' ' 46' ' ' PRO . 4.0 pp -135.61 156.06 49.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 75.25 110.932 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -121.55 147.67 45.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 64.140000000000001 110.958 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -130.49 130.0 43.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 73.439999999999998 110.883 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' C ' HD23 ' A' ' 33' ' ' LEU . 11.3 mtmm -136.52 136.91 39.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 71.340000000000003 110.844 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.785 HD21 HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.35 138.54 38.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.926 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -111.83 126.34 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 71.549999999999997 110.952 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 76.1 p -137.99 179.56 6.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 111.186 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.54 -129.93 14.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.791 -0.719 . . . . 71.219999999999999 112.449 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -112.65 -37.68 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 72.120000000000005 110.878 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 39' ' ' GLU . 6.5 t -179.12 -31.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.510000000000005 111.129 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.57 ' HG2' HG23 ' A' ' 38' ' ' THR . 5.0 mm-40 -102.57 33.94 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 74.340000000000003 110.945 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.93 -6.42 8.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 111.165 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -59.36 131.72 51.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 64.530000000000001 110.985 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.703 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -128.52 153.53 47.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 64.099999999999994 110.866 -179.913 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.68 120.28 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 63.530000000000001 111.148 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.785 HD12 HD21 ' A' ' 33' ' ' LEU . 15.4 mt -95.83 146.75 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 75.019999999999996 110.899 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.5 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.1 p -123.71 157.86 61.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.678 0.751 . . . . 74.230000000000004 110.847 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.683 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.3 Cg_endo -69.79 0.28 5.89 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.704 2.27 . . . . 43.329999999999998 112.301 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 82.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.945 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.71 95.55 0.94 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 70.230000000000004 112.493 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.414 ' HA3' HD22 ' A' ' 44' ' ' LEU . . . -81.71 4.28 74.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.754 . . . . 73.319999999999993 112.47 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.12 -158.77 15.42 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 55.520000000000003 112.597 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 114.67 3.79 Favored 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 122.677 2.252 . . . . 74.099999999999994 112.348 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -60.9 -34.24 74.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 72.239999999999995 110.915 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.05 -26.57 66.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 74.510000000000005 110.886 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -46.98 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.340000000000003 110.855 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.02 -98.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 75.430000000000007 111.053 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -165.41 176.31 8.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 71.519999999999996 111.052 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' HD12 ' A' ' 64' ' ' LEU . 49.4 mmm-85 -114.36 160.9 18.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 65.219999999999999 110.831 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.683 HG11 ' HA ' ' A' ' 46' ' ' PRO . 49.5 t -109.44 129.68 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 111.15 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 63' ' ' SER . 40.0 mt -69.47 157.87 88.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.582 0.706 . . . . 75.310000000000002 110.883 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -23.0 31.01 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.677 2.251 . . . . 62.0 112.284 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -82.96 1.14 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.899 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.24 29.84 11.86 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.772 -0.728 . . . . 72.310000000000002 112.484 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB2' HD12 ' A' ' 59' ' ' LEU . 14.7 m -112.62 -179.43 3.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.399 . . . . 71.129999999999995 110.846 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.617 HD23 HD12 ' A' ' 16' ' ' LEU . 22.1 tp -129.14 130.84 46.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 110.898 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.46 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 45.1 t80 -123.87 130.48 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 55.229999999999997 110.909 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.757 HD22 HG12 ' A' ' 69' ' ' VAL . 5.1 mp -116.86 124.15 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 73.349999999999994 110.929 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -32.8 18.05 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 62.020000000000003 112.314 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.697 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.48 101.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.42 . . . . 62.539999999999999 111.151 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 13.9 m -72.84 112.2 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 74.430000000000007 111.064 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.53 164.69 36.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.745 -0.74 . . . . 73.319999999999993 112.475 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.894 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.81 -33.46 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 72.400000000000006 111.086 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -77.6 -22.04 51.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 62.299999999999997 110.84 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -5.07 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 62.240000000000002 110.916 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.659 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.15 142.16 52.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 51.439999999999998 110.827 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 161.48 -148.12 15.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 31.309999999999999 112.537 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.285 HG13 ' OE1' ' B' ' 2' ' ' GLU . 1.2 mm -129.71 135.59 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 65.239999999999995 111.154 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 33' ' ' LEU . 52.8 m-85 -104.43 123.97 48.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.877 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HB2' ' CZ ' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -122.99 126.95 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 73.530000000000001 110.858 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.6 t -121.59 153.93 37.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -141.0 140.08 34.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 64.129999999999995 110.928 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 162.41 30.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 53.130000000000003 111.152 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 75.9 mmm -130.14 125.24 34.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 71.109999999999999 110.888 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -88.44 170.8 10.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 64.420000000000002 110.853 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -72.94 -22.48 60.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 64.040000000000006 110.888 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.54 -20.43 60.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.340000000000003 110.915 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.8 -2.86 31.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 75.109999999999999 112.515 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.56 146.46 27.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 74.439999999999998 110.938 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.32 142.42 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 75.209999999999994 110.955 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.582 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.2 129.67 51.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.165 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.144 ' HB3' ' CX2' ' B' ' 4' ' ' MCL . 0.4 OUTLIER -101.82 141.46 34.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 74.049999999999997 110.922 179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 58.7 m -145.92 120.13 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 33.219999999999999 110.844 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 1.222 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.6 OUTLIER -131.72 121.92 25.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.907 -179.997 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 91' ' ' SER . 6.9 m-85 -131.96 120.61 22.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 75.349999999999994 110.906 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.539 ' CZ ' ' CB ' ' B' ' 5' ' ' ALA . 0.9 OUTLIER -85.14 132.6 34.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 71.439999999999998 110.881 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.6 t -120.66 136.03 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 72.109999999999999 111.199 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.75 151.22 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 63.240000000000002 110.89 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.894 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.5 m -112.06 -175.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 73.209999999999994 111.158 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -67.29 -76.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.896 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' A' ' 10' ' ' ILE . 2.5 mp0 -64.02 137.31 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 62.140000000000001 110.909 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.01 159.87 47.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.665 0.745 . . . . 71.25 111.135 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 129.9 18.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 73.120000000000005 112.325 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.97 -82.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.688 -0.767 . . . . 71.400000000000006 112.488 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -134.79 68.42 71.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 61.020000000000003 110.915 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 115.1 3.95 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.709 2.272 . . . . 61.100000000000001 112.342 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.421 . . . . 44.130000000000003 110.929 179.975 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.838 0.351 . . . . 73.430000000000007 110.844 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.285 ' OE1' HG13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -117.72 -14.22 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.864 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.525 ' CD2' ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 175.94 -151.95 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.452 0 CA-C-O 118.219 -0.896 . . . . 75.200000000000003 110.875 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.222 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.539 ' CB ' ' CZ ' ' A' ' 94' ' ' ARG . . . -52.98 157.38 1.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 23.219999999999999 111.086 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -159.98 89.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 75.430000000000007 110.876 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 1.223 ' OE2' ' ND2' ' A' ' 5' ' ' ASN . 1.4 mp0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 64.120000000000005 110.94 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.495 -0.242 . . . . 72.129999999999995 112.495 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -152.89 139.92 19.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 44.43 110.892 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.71 100.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 63.350000000000001 111.04 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -93.65 135.18 35.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 61.520000000000003 110.98 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.616 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.6 p30 -90.42 122.91 33.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.109999999999999 110.875 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 5' ' ' ASN . 1.7 mp -125.39 124.56 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.239999999999995 111.164 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -89.61 144.17 26.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 61.509999999999998 111.147 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.645 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -140.54 165.68 26.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 71.340000000000003 111.038 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 110.887 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.432 HG12 ' HB3' ' A' ' 98' ' ' TYR . 18.5 mm -61.74 120.47 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 111.173 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.769 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 79.34 10.84 85.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 75.230000000000004 112.472 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.6 mm-40 -101.44 140.69 21.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.609 0.718 . . . . 74.340000000000003 110.841 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 143.48 51.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.236 . . . . 71.340000000000003 112.37 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 tp -144.58 142.39 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 63.32 110.897 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.433 HG22 ' HD1' ' A' ' 65' ' ' PHE . 39.3 t -122.23 148.19 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.230000000000004 111.239 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.6 mt -131.54 148.05 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 61.509999999999998 110.824 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -113.33 152.53 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 71.430000000000007 110.877 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.0 t -107.09 102.24 11.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.109999999999999 110.868 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -58.19 123.25 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.915 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.668 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.57 -37.97 2.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 51.039999999999999 112.49 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.66 128.63 45.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.553 0.692 . . . . 73.540000000000006 111.109 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.6 Cg_endo -69.81 -164.28 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.657 2.238 . . . . 72.310000000000002 112.345 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -49.31 -48.92 45.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 52.240000000000002 110.9 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.04 154.74 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 72.209999999999994 110.846 179.903 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.1 Cg_endo -69.79 109.17 2.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.678 2.252 . . . . 51.420000000000002 112.333 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.8 Cg_endo -69.72 -87.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.683 2.255 . . . . 65.200000000000003 112.371 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -104.13 -177.26 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 73.010000000000005 110.846 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -64.09 137.81 58.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 74.299999999999997 110.922 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.9 pp -135.94 157.93 45.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.899 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -123.08 147.17 47.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 74.409999999999997 110.841 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 44' ' ' LEU . 2.7 m95 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.040000000000006 110.988 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -151.84 137.13 17.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 73.129999999999995 110.835 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.769 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -140.9 138.29 33.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 75.230000000000004 110.954 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.269 ' ND2' ' O ' ' B' ' 2' ' ' GLU . 5.1 t30 -113.83 127.35 55.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 65.239999999999995 110.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 42.9 p -140.52 -179.34 5.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 71.120000000000005 111.123 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.9 -120.45 5.31 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 72.150000000000006 112.528 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.67 ' O ' HG23 ' A' ' 38' ' ' THR . 29.6 mmm180 -114.68 -39.72 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 110.863 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 173.66 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.329999999999998 111.139 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.37 33.46 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.875 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.42 -7.48 9.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 111.119 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -63.09 130.43 44.61 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.151 -0.477 . . . . 71.439999999999998 110.931 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.432 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -135.67 158.91 43.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 71.019999999999996 110.885 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.84 121.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 70.329999999999998 111.114 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.549 ' CD1' HD23 ' A' ' 33' ' ' LEU . 8.7 mp -89.7 145.27 25.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.871 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.536 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -126.13 164.23 34.91 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 70.510000000000005 110.833 -179.918 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.734 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.74 0.41 5.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.721 2.28 . . . . 62.32 112.35 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.46 85.0 2.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 73.129999999999995 110.884 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.85 -39.09 60.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.673 -0.775 . . . . 73.519999999999996 112.495 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.42 -161.01 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.636 -0.792 . . . . 71.349999999999994 112.484 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.43 -160.64 1.31 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.703 -0.761 . . . . 63.240000000000002 112.478 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 127.07 14.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 74.25 112.289 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -83.18 -35.05 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 63.310000000000002 110.868 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.9 -25.09 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 72.120000000000005 110.809 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.24 -47.29 65.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 73.400000000000006 110.848 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.8 -97.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 52.509999999999998 111.168 179.88 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -163.4 170.63 17.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 64.239999999999995 111.071 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -127.14 159.84 33.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.842 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 46' ' ' PRO . 14.4 t -108.71 130.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.171 -0.468 . . . . 61.340000000000003 111.149 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.8 mt -68.41 157.93 86.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 71.209999999999994 110.936 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -23.04 30.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.754 2.303 . . . . 75.400000000000006 112.337 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -83.24 0.68 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.898 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.4 29.38 11.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 73.340000000000003 112.484 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.506 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.43 -178.95 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 54.420000000000002 110.881 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -128.76 130.06 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.129999999999995 110.831 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HD1' HG22 ' A' ' 15' ' ' VAL . 12.9 t80 -124.05 130.72 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 70.409999999999997 110.861 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD22 HG12 ' A' ' 69' ' ' VAL . 7.1 mp -118.15 131.0 24.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.594 0.712 . . . . 72.150000000000006 110.9 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -38.29 8.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 73.099999999999994 112.377 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -164.19 103.8 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 42.329999999999998 111.084 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.7 m -73.97 115.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 51.439999999999998 111.135 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.58 165.76 29.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 75.120000000000005 112.479 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.803 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.02 -30.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 75.150000000000006 111.131 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.09 -22.57 55.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 64.109999999999999 110.88 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.463 ' O ' HG21 ' A' ' 35' ' ' THR . 0.4 OUTLIER -80.65 -1.55 42.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.779 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.21 141.12 58.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 63.020000000000003 110.932 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.602 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 160.91 -145.17 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 74.329999999999998 112.456 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.266 ' CD1' ' HG3' ' B' ' 2' ' ' GLU . 3.7 mp -130.58 134.72 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 74.219999999999999 111.045 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.769 ' CE2' HD22 ' A' ' 33' ' ' LEU . 13.3 m-85 -103.44 135.29 45.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 75.230000000000004 110.832 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.466 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -128.01 130.71 48.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 64.120000000000005 110.874 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 147.93 43.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 41.030000000000001 110.875 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -146.09 126.96 14.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 110.917 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.26 162.67 30.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 60.32 111.084 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 33.8 tpp -130.15 125.76 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.938 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.52 171.63 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 65.420000000000002 110.879 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -18.56 62.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 64.340000000000003 110.901 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -73.35 -19.78 60.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 51.509999999999998 110.865 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.16 37.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.58 -0.819 . . . . 72.400000000000006 112.369 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -84.78 145.73 27.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.689 0.281 . . . . 73.420000000000002 110.916 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -105.58 142.22 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 50.200000000000003 110.877 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.668 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -104.05 129.7 51.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 64.420000000000002 111.054 -179.894 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -105.72 144.13 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.983 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -145.65 120.63 10.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 54.310000000000002 110.877 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 1.011 ' HB2' ' CX2' ' B' ' 4' ' ' MCL . 25.1 t-20 -121.28 120.76 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 75.530000000000001 110.888 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -127.72 126.6 42.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 70.329999999999998 110.94 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.466 ' NE ' ' HB1' ' B' ' 5' ' ' ALA . 11.5 mmm-85 -91.11 135.65 33.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.892 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 77' ' ' PHE . 56.4 t -120.79 130.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 111.211 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.19 127.65 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 71.140000000000001 110.949 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.803 HG21 ' HA ' ' A' ' 71' ' ' ILE . 18.2 m -91.1 -176.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 72.310000000000002 111.148 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.432 ' HB3' HG12 ' A' ' 10' ' ' ILE . 40.5 t80 -75.84 -76.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -58.68 148.03 30.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 75.120000000000005 110.917 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.464 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.29 159.37 50.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.565 0.698 . . . . 70.019999999999996 111.093 -179.975 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 100' ' ' ILE . 52.8 Cg_endo -69.8 162.28 42.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.568 2.178 . . . . 65.540000000000006 112.343 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.01 56.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 74.019999999999996 112.458 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.78 73.12 0.78 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.683 0.754 . . . . 64.239999999999995 110.869 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -178.68 2.43 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.787 2.325 . . . . 71.540000000000006 112.355 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 73.120000000000005 110.917 179.943 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.725 0.298 . . . . 73.420000000000002 110.937 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 1.269 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -126.97 -38.05 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.200000000000003 110.883 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.214 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 178.92 -161.02 0.03 OUTLIER 'General case' 0 C--O 1.183 -2.442 0 CA-C-O 118.216 -0.897 . . . . 75.430000000000007 110.906 -179.794 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.011 ' CX2' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.466 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -41.57 120.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.819 -0.628 . . . . 31.030000000000001 111.132 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.48 80.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.450000000000003 110.861 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 1.029 ' HG2' HH12 ' A' ' 94' ' ' ARG . 55.2 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 64.200000000000003 110.862 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.555 -0.218 . . . . 71.209999999999994 112.555 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.91 158.08 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 52.439999999999998 110.885 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.666 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . -59.63 96.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 65.239999999999995 111.048 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.61 133.25 37.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 53.219999999999999 110.917 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -84.65 120.76 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 110.91 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.584 HG21 HD11 ' A' ' 14' ' ' LEU . 46.2 mm -125.88 121.98 60.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 65.239999999999995 111.119 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -94.19 139.83 30.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 74.439999999999998 111.143 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.76 167.0 26.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 111.088 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.37 148.12 44.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 73.030000000000001 110.876 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 71' ' ' ILE . 32.1 mt -52.51 121.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 74.530000000000001 111.222 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.72 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.76 7.72 70.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 74.439999999999998 112.476 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.7 mm-40 -101.76 139.43 20.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 62.310000000000002 110.822 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 143.05 49.4 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.682 2.255 . . . . 70.319999999999993 112.286 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.584 HD11 HG21 ' A' ' 6' ' ' ILE . 25.7 tp -145.58 141.84 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 75.099999999999994 110.95 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.6 t -123.16 146.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 111.13 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.536 HD12 HD23 ' A' ' 64' ' ' LEU . 58.4 mt -130.87 146.62 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.921 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.47 152.13 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 110.87 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.1 t -107.34 100.73 10.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 44.229999999999997 110.869 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -58.96 122.04 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 63.140000000000001 110.89 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.583 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.53 -38.42 2.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 42.100000000000001 112.466 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.35 44.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.519 0.676 . . . . 53.219999999999999 111.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.64 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.752 2.301 . . . . 74.239999999999995 112.374 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -49.65 -49.89 45.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 72.329999999999998 110.913 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 153.6 41.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 72.109999999999999 110.91 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.4 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 73.340000000000003 112.346 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.3 Cg_endo -69.71 -85.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.757 2.304 . . . . 71.219999999999999 112.343 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -100.26 -176.55 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.549999999999997 110.917 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.02 137.22 58.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 51.020000000000003 110.877 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -136.19 155.27 50.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.929 179.974 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -120.87 148.52 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.030000000000001 110.952 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 1.1 m95 -127.73 145.05 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.948 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -145.08 144.25 30.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 110.889 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -134.92 134.98 41.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 73.109999999999999 110.908 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -117.92 120.83 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 34.32 110.867 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.809 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.1 p -141.44 179.52 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 53.030000000000001 111.096 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.81 -133.26 20.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 73.400000000000006 112.568 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.7 mmm-85 -112.77 -36.78 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 72.200000000000003 110.914 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.535 HG23 ' HG3' ' A' ' 39' ' ' GLU . 2.3 t -179.16 -27.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 75.120000000000005 111.114 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.0 mt-10 -100.72 32.59 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 74.219999999999999 110.859 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -126.17 -6.68 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.299999999999997 111.089 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 t90 -73.92 128.14 34.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.921 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.71 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -137.63 159.07 43.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 75.239999999999995 110.958 179.939 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.2 t -87.2 121.54 38.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 111.094 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.45 146.76 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.917 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.574 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -123.69 162.01 43.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 61.340000000000003 110.875 -179.936 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.703 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.61 -0.14 6.37 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.265 . . . . 73.439999999999998 112.35 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -140.35 86.53 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 55.009999999999998 110.862 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLY . . . -66.41 -45.84 82.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 75.409999999999997 112.544 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . 35.76 45.06 0.74 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.671 -0.776 . . . . 50.409999999999997 112.539 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -141.43 -165.17 10.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 65.140000000000001 112.565 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 55' ' ' VAL . 53.3 Cg_endo -69.87 105.48 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.667 2.244 . . . . 73.0 112.355 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -70.0 -34.73 73.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.319999999999993 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.61 -26.8 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 110.947 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -90.23 -42.64 10.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 72.25 110.832 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 51' ' ' PRO . 9.2 m -124.63 -125.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 75.140000000000001 111.141 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -148.38 172.66 14.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.107 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -122.79 159.74 27.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.815 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 46' ' ' PRO . 52.9 t -107.92 129.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 72.230000000000004 111.114 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 63' ' ' SER . 45.4 mt -69.1 156.13 92.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.521 0.676 . . . . 53.43 110.951 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.3 Cg_endo -69.76 -22.2 32.39 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.672 2.248 . . . . 71.439999999999998 112.309 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -83.32 0.6 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 73.420000000000002 110.892 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.51 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.773 -0.727 . . . . 75.140000000000001 112.575 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.687 ' HB2' HD12 ' A' ' 59' ' ' LEU . 9.1 m -113.7 178.88 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 73.430000000000007 110.863 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD23 HD12 ' A' ' 16' ' ' LEU . 12.9 tp -128.81 127.52 42.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.905 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' HD12 ' A' ' 64' ' ' LEU . 46.5 t80 -126.17 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 71.420000000000002 110.922 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.707 HD22 HG12 ' A' ' 69' ' ' VAL . 2.9 mp -117.83 128.18 26.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.532 0.682 . . . . 45.119999999999997 110.942 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.15 17.19 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.661 2.241 . . . . 74.010000000000005 112.33 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.72 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.73 101.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 51.310000000000002 111.118 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.06 113.28 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 111.139 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.65 36.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.694 -0.765 . . . . 75.129999999999995 112.501 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.66 -30.02 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.777 0.323 . . . . 73.150000000000006 111.086 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.14 -23.77 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 73.230000000000004 110.918 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.61 -5.18 57.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.9 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.76 141.4 58.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 73.420000000000002 110.791 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.632 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 157.66 -138.93 6.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 32.520000000000003 112.481 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.632 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.0 mp -130.1 135.55 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 75.420000000000002 111.125 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.826 ' CE2' HD12 ' A' ' 33' ' ' LEU . 8.4 m-85 -102.61 134.8 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.019999999999996 110.906 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 1.304 ' NH2' ' NZ ' ' B' ' 4' ' ' MCL . 1.6 mmt180 -128.02 127.66 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.530000000000001 110.915 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.6 t -121.56 149.48 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 52.030000000000001 110.9 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.46 132.55 23.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 62.210000000000001 110.878 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 162.26 30.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 62.140000000000001 111.082 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.2 ttm -130.36 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 73.549999999999997 110.857 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.42 170.96 11.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 74.530000000000001 110.857 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -17.81 62.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.91 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -73.37 -25.59 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 71.219999999999999 110.841 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.01 19.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 24.039999999999999 112.496 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -84.59 146.78 27.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 74.030000000000001 110.94 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.24 142.34 35.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.041 0.448 . . . . 74.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.583 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.54 131.84 49.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 70.209999999999994 111.145 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.196 ' CE ' ' H11' ' B' ' 4' ' ' MCL . 7.6 mtpp -104.97 140.86 37.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 73.030000000000001 110.984 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.57 127.23 14.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 61.32 110.876 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -124.74 129.4 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 54.450000000000003 110.856 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.439 ' CG ' HD22 ' A' ' 16' ' ' LEU . 8.4 m-85 -127.92 118.01 22.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 75.109999999999999 110.884 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 1.571 ' CZ ' ' CB ' ' B' ' 5' ' ' ALA . 11.5 mmm-85 -85.57 130.33 34.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 54.140000000000001 110.891 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 77' ' ' PHE . 77.4 t -122.54 132.25 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 70.109999999999999 111.105 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -131.17 128.26 39.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.976 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.4 m -93.86 -176.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 75.530000000000001 111.126 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.03 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 110.919 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -62.86 145.71 54.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 110.924 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.58 49.65 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.691 0.758 . . . . 75.409999999999997 111.105 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.5 Cg_endo -69.67 -37.09 9.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 70.340000000000003 112.358 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.62 34.93 56.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.716 -0.754 . . . . 41.32 112.581 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.2 tttt 53.04 73.9 0.86 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 71.140000000000001 110.937 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 163.22 39.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.737 2.291 . . . . 75.540000000000006 112.327 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 73.450000000000003 110.879 179.973 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.715 0.293 . . . . 72.239999999999995 110.859 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.632 ' HB2' HD13 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -123.17 -41.4 2.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 73.340000000000003 110.894 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.126 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -167.77 -166.59 0.76 Allowed 'General case' 0 C--O 1.183 -2.395 0 CA-C-O 118.081 -0.961 . . . . 74.209999999999994 110.915 -179.932 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 4' ' ' MCL . . . . . 1.304 ' NZ ' ' NH2' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 1.571 ' CB ' ' CZ ' ' A' ' 94' ' ' ARG . . . -38.78 116.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.789 -0.641 . . . . 43.520000000000003 111.082 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -141.72 65.86 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.853 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 71.299999999999997 110.899 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.784 0.326 . . . . 74.409999999999997 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.05 132.63 36.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.842 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 3.1 p30 -90.05 121.22 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.230000000000004 110.849 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.65 122.42 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 111.178 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -95.07 141.62 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 72.540000000000006 111.134 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.02 167.19 25.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 62.020000000000003 111.015 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.64 148.45 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.239999999999995 110.843 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.424 HD11 HG13 ' A' ' 71' ' ' ILE . 16.0 mt -52.45 120.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 61.439999999999998 111.132 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.82 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 89.28 8.92 67.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 73.230000000000004 112.526 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.791 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.1 mm-40 -101.71 138.32 19.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.652 0.739 . . . . 73.430000000000007 110.889 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 143.14 49.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.677 2.251 . . . . 72.319999999999993 112.258 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 66' ' ' LEU . 12.4 tp -145.92 141.36 27.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 71.420000000000002 110.877 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.443 HG22 ' HD1' ' A' ' 65' ' ' PHE . 45.8 t -127.9 139.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 111.197 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.589 HD12 ' CD2' ' A' ' 77' ' ' PHE . 45.2 mt -132.19 149.02 52.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.445 . . . . 60.5 110.878 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -112.72 153.24 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 64.140000000000001 110.918 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 t -105.83 100.71 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 62.399999999999999 110.895 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -54.19 128.91 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.855 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.439 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.01 -40.84 1.8 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.756 . . . . 64.430000000000007 112.499 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.25 129.74 42.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.539 0.685 . . . . 72.049999999999997 111.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -164.22 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.555 2.17 . . . . 74.540000000000006 112.354 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -48.46 -49.12 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 55.340000000000003 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.897 0.379 . . . . 73.540000000000006 110.835 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.682 HD13 ' CE2' ' A' ' 31' ' ' TRP . 1.5 pp -136.2 149.4 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 60.030000000000001 110.877 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -121.28 127.03 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 75.430000000000007 110.862 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.682 ' CE2' HD13 ' A' ' 29' ' ' LEU . 32.0 m0 -118.08 144.72 45.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 62.310000000000002 110.944 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.667 ' HE2' HG22 ' A' ' 43' ' ' VAL . 5.3 ttmt -136.77 139.27 41.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 73.530000000000001 110.902 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.743 HD22 ' HE3' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -137.42 138.9 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 75.0 110.914 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -115.21 119.31 35.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.846 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.806 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.7 p -136.28 179.49 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 73.540000000000006 111.183 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.4 -132.11 14.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.799 -0.715 . . . . 72.129999999999995 112.499 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -112.68 -37.76 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 73.200000000000003 110.828 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.597 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.3 t -179.47 -29.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 74.209999999999994 111.141 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.597 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.5 mt-10 -102.12 34.26 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.530000000000001 110.84 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.53 -6.24 8.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 73.409999999999997 111.126 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -59.31 128.98 39.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.5 110.861 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.743 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -136.24 158.88 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 61.030000000000001 110.908 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.667 HG22 ' HE2' ' A' ' 32' ' ' LYS . 19.0 t -101.65 123.76 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 111.129 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.1 mt -87.25 144.02 27.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.2 -0.454 . . . . 72.200000000000003 110.941 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.826 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 75.519999999999996 110.854 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.741 0.305 . . . . 75.219999999999999 111.207 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -119.11 160.44 22.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.040000000000006 110.826 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.826 HG21 ' O ' ' A' ' 45' ' ' SER . 43.0 t -108.01 128.73 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 111.108 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.0 mt -68.51 156.46 90.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.686 0.755 . . . . 64.519999999999996 110.893 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -22.97 31.41 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.74 2.293 . . . . 75.099999999999994 112.301 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -82.98 0.05 46.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.903 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.61 13.35 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 52.340000000000003 112.431 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.581 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.4 m -109.68 179.0 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 61.240000000000002 110.868 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 65' ' ' PHE . 9.8 tp -128.36 128.33 44.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 73.310000000000002 110.961 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' N ' HD12 ' A' ' 64' ' ' LEU . 7.1 t80 -125.95 129.73 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 64.299999999999997 110.843 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.707 HD22 HG12 ' A' ' 69' ' ' VAL . 2.3 mp -117.19 130.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 63.439999999999998 110.84 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -34.8 13.91 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 72.420000000000002 112.339 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.82 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.21 100.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 111.111 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.1 m -73.45 114.68 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 71.549999999999997 111.143 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.29 166.94 42.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.824 -0.703 . . . . 55.109999999999999 112.433 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.797 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.93 -31.05 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.308 . . . . 73.049999999999997 111.116 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -76.25 -21.96 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.409999999999997 110.93 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -5.44 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 74.439999999999998 110.909 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.23 140.47 55.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 74.299999999999997 110.877 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.629 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 164.7 -147.46 12.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.654 -0.784 . . . . 71.549999999999997 112.449 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.57 135.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.952 0.406 . . . . 70.049999999999997 111.041 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.589 ' CD2' HD12 ' A' ' 16' ' ' LEU . 8.6 m-85 -100.05 124.92 45.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 71.25 110.852 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 127.25 40.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.884 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 149.45 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 61.100000000000001 110.945 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -142.62 126.24 16.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.48 31.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 111.093 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.9 tpp -130.27 125.86 35.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 63.32 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -86.49 170.79 11.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 74.310000000000002 110.859 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -72.7 -17.58 61.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 71.25 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -72.1 -21.04 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.928 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.05 -21.46 17.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.708 . . . . 24.050000000000001 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 145.88 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.279 . . . . 72.019999999999996 110.903 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.25 145.11 32.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 74.409999999999997 110.903 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.439 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.07 127.86 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.049999999999997 111.102 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 145.5 30.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 62.340000000000003 110.936 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.7 m -144.33 121.23 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 110.916 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -126.63 119.3 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 71.420000000000002 110.913 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -132.03 118.11 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.049999999999997 110.874 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -87.49 133.56 33.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 44.329999999999998 110.851 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.28 138.36 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.219999999999999 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 127.96 39.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 74.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.797 HG21 ' HA ' ' A' ' 71' ' ' ILE . 30.6 m -87.42 -177.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 75.519999999999996 111.102 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -60.64 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 62.509999999999998 110.953 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -72.1 143.53 49.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 63.030000000000001 110.947 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.486 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.28 159.52 49.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.7 0.762 . . . . 54.310000000000002 111.084 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.681 2.254 . . . . 64.409999999999997 112.415 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.751 0.31 . . . . 53.109999999999999 111.117 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.417 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -92.91 138.19 31.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 110.915 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.98 120.88 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.310000000000002 110.887 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 4' ' ' GLN . 4.7 mp -126.13 127.47 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 111.144 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -95.31 141.78 28.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 74.239999999999995 111.215 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.496 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -145.01 165.41 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 34.100000000000001 111.069 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.19 149.5 42.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.019999999999996 110.916 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 15.3 mt -57.41 121.04 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 43.43 111.069 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.48 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.8 8.13 73.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.777 -0.725 . . . . 70.450000000000003 112.586 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.796 ' O ' HG22 ' A' ' 69' ' ' VAL . 35.1 mm-40 -102.7 138.69 19.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.702 . . . . 72.239999999999995 110.911 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 143.95 51.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 72.120000000000005 112.269 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.0 tp -144.96 141.08 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 65' ' ' PHE . 48.9 t -125.44 145.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 51.340000000000003 111.146 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.2 mt -131.25 148.09 52.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 62.020000000000003 110.941 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 152.75 29.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 54.340000000000003 110.961 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.0 t -106.18 100.6 10.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 51.299999999999997 110.897 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 124.35 14.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 71.140000000000001 110.841 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.93 -42.65 1.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.774 -0.726 . . . . 62.240000000000002 112.491 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 128.19 51.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.538 0.685 . . . . 54.219999999999999 111.153 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -164.46 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.62 2.213 . . . . 62.130000000000003 112.316 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -47.89 46.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 53.399999999999999 110.841 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.554 0.693 . . . . 71.109999999999999 110.865 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.889 0.376 . . . . 70.400000000000006 110.829 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.64 161.75 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 110.957 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -121.26 147.63 45.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.895 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -124.23 137.96 54.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 61.450000000000003 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -141.23 140.13 33.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 65.450000000000003 110.859 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.649 HD22 ' CE2' ' A' ' 77' ' ' PHE . 6.1 tp -138.1 134.26 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 74.420000000000002 110.988 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.8 t-20 -116.01 121.17 41.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 64.530000000000001 110.879 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.2 p -138.99 179.37 6.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 63.219999999999999 111.195 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.4 10.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 45.450000000000003 112.412 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -112.42 -36.63 5.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.888 0.375 . . . . 75.450000000000003 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.74 -29.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -102.57 33.78 3.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 62.219999999999999 110.861 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.68 -6.42 8.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 53.329999999999998 111.237 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.65 132.6 54.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 63.350000000000001 110.939 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 158.61 39.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 64.329999999999998 110.931 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.72 120.24 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.053 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 147.95 23.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 62.32 110.938 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG21 ' A' ' 58' ' ' VAL . 2.5 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.699 0.761 . . . . 63.200000000000003 110.846 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.746 0.308 . . . . 74.25 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -125.0 164.22 20.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 75.340000000000003 110.963 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 45' ' ' SER . 43.7 t -106.57 129.95 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 74.430000000000007 111.108 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 63' ' ' SER . 36.8 mt -69.99 159.05 85.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 72.450000000000003 110.882 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -21.75 32.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 55.420000000000002 112.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.33 1.37 41.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.416 . . . . 54.219999999999999 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.08 27.44 21.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 73.340000000000003 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.401 ' HB2' HD12 ' A' ' 59' ' ' LEU . 33.7 m -111.58 -179.0 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 55.210000000000001 110.918 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 57' ' ' ARG . 31.5 tp -128.82 129.99 46.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.84 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 15' ' ' VAL . 42.5 t80 -123.64 133.8 53.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.430000000000007 110.876 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.608 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -115.24 123.88 31.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 73.329999999999998 110.913 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.2 19.44 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.727 2.284 . . . . 74.519999999999996 112.406 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.61 103.15 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.010000000000005 111.116 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 12' ' ' GLU . 23.6 m -71.7 113.0 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 111.188 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.92 156.94 24.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.818 -0.706 . . . . 55.509999999999998 112.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.28 -31.67 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 75.430000000000007 111.11 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -77.34 -24.12 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 54.130000000000003 110.868 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -4.04 54.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 65.439999999999998 110.895 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -58.05 141.84 48.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 70.010000000000005 110.889 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.628 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 161.73 -145.77 11.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.548 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.5 mp -131.41 135.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.841 0.353 . . . . 63.420000000000002 111.165 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.649 ' CE2' HD22 ' A' ' 33' ' ' LEU . 11.7 m-85 -98.88 134.78 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.540000000000006 110.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.91 126.35 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.030000000000001 110.861 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 45.9 t -122.62 150.22 42.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 51.32 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -146.71 129.76 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 64.329999999999998 110.911 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.05 31.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.12 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.6 ttm -130.64 126.75 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.428 . . . . 75.439999999999998 110.86 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -85.81 170.42 12.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 60.219999999999999 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -73.26 -17.62 61.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 72.319999999999993 110.874 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -71.63 -19.66 62.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.928 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.18 -21.95 19.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 65.540000000000006 112.45 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 144.35 28.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 64.200000000000003 110.87 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.64 144.39 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 75.140000000000001 110.918 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.54 132.3 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.497 . . . . 75.150000000000006 111.167 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -105.21 143.19 33.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.88 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -147.37 120.43 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.877 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.66 124.4 41.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 75.129999999999995 110.901 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 118.86 24.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.932 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.78 136.25 33.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.907 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.1 t -124.66 137.27 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 63.329999999999998 111.099 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -130.62 128.26 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.86 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 m -85.65 -176.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 64.200000000000003 111.094 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -70.79 -81.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.848 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -59.65 145.48 44.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 70.040000000000006 110.916 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.29 159.6 49.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.544 0.688 . . . . 71.150000000000006 111.202 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.594 2.196 . . . . 73.219999999999999 112.287 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.726 0.298 . . . . 73.319999999999993 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -93.21 133.2 36.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 64.329999999999998 110.941 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.421 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 8.3 p30 -89.99 122.01 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.400000000000006 110.884 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.754 HG21 HD11 ' A' ' 14' ' ' LEU . 30.1 mm -125.17 122.68 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 111.223 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -94.06 141.2 28.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 42.520000000000003 111.127 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.57 167.33 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 62.100000000000001 111.148 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 149.22 41.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 75.319999999999993 110.885 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.41 HD11 HG13 ' A' ' 71' ' ' ILE . 18.9 mt -52.43 120.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 71.219999999999999 111.101 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.753 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.73 10.17 70.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 71.530000000000001 112.5 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.784 ' O ' HG22 ' A' ' 69' ' ' VAL . 39.2 mm-40 -102.77 139.02 19.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.64 0.733 . . . . 72.439999999999998 110.813 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 143.55 50.89 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.692 2.261 . . . . 53.130000000000003 112.335 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.754 HD11 HG21 ' A' ' 6' ' ' ILE . 23.5 tp -145.76 143.81 29.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 110.89 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.11 145.37 28.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.136 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 64' ' ' LEU . 88.5 mt -130.91 147.51 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.927 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 151.96 31.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.908 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.74 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 124.35 17.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.917 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.56 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.86 -40.63 1.86 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 52.539999999999999 112.462 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.02 128.69 46.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.497 0.665 . . . . 75.340000000000003 111.085 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -164.79 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.65 2.233 . . . . 75.310000000000002 112.271 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.38 -48.31 47.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 63.030000000000001 110.873 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 74.439999999999998 110.851 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.35 . . . . 64.519999999999996 110.877 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.551 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.88 157.71 46.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.979 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.06 146.93 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.209999999999994 110.9 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.551 ' HE1' HD13 ' A' ' 29' ' ' LEU . 15.2 m95 -121.47 141.92 50.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.898 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.6 139.28 38.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 75.400000000000006 110.824 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 35' ' ' THR . 1.3 tm? -138.71 131.41 29.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.864 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.718 ' N ' HD22 ' A' ' 33' ' ' LEU . 1.7 m-80 -116.44 121.02 40.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 64.200000000000003 110.949 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.792 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.7 p -139.84 179.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 72.010000000000005 111.119 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.12 -131.42 10.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.703 -0.76 . . . . 42.219999999999999 112.492 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mmm-85 -112.63 -38.43 4.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 63.210000000000001 110.866 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 39' ' ' GLU . 7.8 t 179.83 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 52.100000000000001 111.107 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.1 mt-10 -103.11 33.99 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 110.844 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.23 -6.33 8.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 63.25 111.153 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -63.63 130.95 46.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 73.450000000000003 110.865 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 158.27 41.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 73.299999999999997 110.905 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.0 t -92.68 122.62 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 73.299999999999997 111.061 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.61 147.66 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.9 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.642 0.734 . . . . 71.230000000000004 110.831 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.688 0.28 . . . . 72.5 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.54 166.43 15.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 72.400000000000006 110.895 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 45' ' ' SER . 61.8 t -108.16 128.98 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 111.11 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 63' ' ' SER . 56.4 mt -69.06 157.15 90.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.669 0.747 . . . . 75.409999999999997 110.883 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 -22.47 32.53 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.716 2.278 . . . . 74.200000000000003 112.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -82.98 0.92 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.933 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 29.2 12.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 43.219999999999999 112.415 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.506 ' HB2' HD12 ' A' ' 59' ' ' LEU . 8.8 m -113.1 179.19 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 65.200000000000003 110.878 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 16' ' ' LEU . 6.8 tp -130.15 129.0 42.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 63.439999999999998 110.941 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 46.4 t80 -125.44 130.61 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 70.299999999999997 110.857 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.75 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -115.08 129.13 25.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.601 0.715 . . . . 64.420000000000002 110.908 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -34.84 13.61 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.645 2.23 . . . . 72.439999999999998 112.368 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.75 100.26 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 51.350000000000001 111.141 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.89 112.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 111.144 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.34 167.97 41.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 40.409999999999997 112.497 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.842 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.1 -30.37 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.739 0.304 . . . . 53.100000000000001 111.108 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -75.9 -22.17 56.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 54.340000000000003 110.845 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -2.86 35.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 73.049999999999997 110.844 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 142.01 53.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 70.430000000000007 110.895 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.69 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.39 -154.06 25.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 72.010000000000005 112.461 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.69 HD12 ' C ' ' A' ' 75' ' ' GLY . 2.7 mp -128.08 134.97 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 74.430000000000007 111.135 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 16' ' ' LEU . 26.6 t80 -102.87 133.89 47.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 110.838 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.62 131.82 49.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 75.200000000000003 110.842 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 35.6 t -120.67 150.49 40.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 61.350000000000001 110.82 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -143.29 127.94 18.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 63.149999999999999 110.917 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.46 162.94 29.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 52.409999999999997 111.038 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.5 mtp -130.9 125.51 33.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 65.120000000000005 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -86.66 171.18 11.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.400000000000006 110.878 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -72.03 -18.21 61.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 63.200000000000003 110.906 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -72.46 -19.62 61.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 53.109999999999999 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.46 -18.32 27.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.822 -0.704 . . . . 74.310000000000002 112.513 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.06 146.17 27.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 73.450000000000003 110.953 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.76 145.02 31.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.834 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.56 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -100.87 127.19 47.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 63.409999999999997 111.152 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 143.59 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.908 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -145.26 124.62 13.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 64.120000000000005 110.857 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.49 120.52 26.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 74.120000000000005 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -130.23 117.18 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.885 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -91.98 134.08 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 75.319999999999993 110.872 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.2 t -120.13 139.53 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 42.539999999999999 111.148 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.09 127.92 42.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 110.873 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.842 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.9 m -88.62 -176.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.151 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.59 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.864 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -69.14 144.96 53.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.975 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.488 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.45 159.43 50.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 74.129999999999995 111.067 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.597 2.198 . . . . 74.319999999999993 112.393 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.744 0.307 . . . . 75.030000000000001 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.59 133.09 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.923 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.0 p-10 -87.76 121.98 30.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.439999999999998 110.916 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' HB ' HG22 ' A' ' 95' ' ' VAL . 46.6 mm -125.35 127.69 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 75.340000000000003 111.081 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 138.8 32.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.171 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.33 27.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.120000000000005 111.096 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.65 148.25 48.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.281 -0.418 . . . . 63.439999999999998 110.839 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.489 HD11 HG13 ' A' ' 71' ' ' ILE . 9.7 mt -53.32 122.08 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 71.219999999999999 111.152 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.09 4.44 78.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 73.129999999999995 112.448 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.7 mm-40 -101.22 139.64 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.561 0.696 . . . . 70.019999999999996 110.967 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.67 45.84 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.765 2.31 . . . . 73.150000000000006 112.308 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 66' ' ' LEU . 16.4 tp -144.7 141.31 29.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 64.510000000000005 110.902 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 ' HD1' ' A' ' 65' ' ' PHE . 51.1 t -125.9 147.15 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 42.310000000000002 111.201 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.656 HD12 HD23 ' A' ' 64' ' ' LEU . 8.6 mt -131.58 148.23 52.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.209999999999994 110.857 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -111.41 149.81 30.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 65.530000000000001 110.85 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.3 t -108.16 101.09 10.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.447 . . . . 73.120000000000005 110.882 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.82 101.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 74.099999999999994 110.915 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 144.5 -47.9 0.75 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.703 -0.76 . . . . 70.340000000000003 112.498 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.15 103.04 10.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.558 0.694 . . . . 64.329999999999998 111.189 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.8 Cg_endo -69.69 -161.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.688 2.259 . . . . 75.129999999999995 112.311 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -60.52 -10.51 5.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 110.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-O 121.572 0.701 . . . . 75.430000000000007 110.916 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.86 0.362 . . . . 74.230000000000004 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.5 pp -178.85 161.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 110.837 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -121.43 135.75 55.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 75.540000000000006 110.852 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -120.72 137.95 54.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.0 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -138.31 139.99 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 62.25 110.866 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.763 HD13 ' CD2' ' A' ' 77' ' ' PHE . 6.0 tp -137.67 134.59 35.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 64.230000000000004 110.935 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -116.21 121.66 42.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 61.100000000000001 110.923 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.821 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 66.9 p -137.72 179.6 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.329999999999998 111.098 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -132.06 15.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.729 -0.748 . . . . 74.109999999999999 112.463 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -37.63 4.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 74.430000000000007 110.874 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 t -179.24 -29.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 72.299999999999997 111.12 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.32 33.55 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.935 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.41 -5.33 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -65.87 130.11 42.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 110.928 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.66 43.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 62.420000000000002 110.95 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -95.67 119.85 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 73.420000000000002 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.52 145.29 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 65.310000000000002 110.884 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 72.129999999999995 110.886 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.583 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.789 0.328 . . . . 42.439999999999998 111.087 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.96 160.16 28.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.83 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 45' ' ' SER . 53.6 t -108.47 127.08 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 72.099999999999994 111.078 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' A' ' 63' ' ' SER . 55.6 mt -69.4 157.46 89.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 54.240000000000002 110.938 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -22.74 31.33 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.655 2.236 . . . . 70.310000000000002 112.403 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -82.67 0.68 42.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 110.876 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.93 26.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.63 -0.795 . . . . 41.109999999999999 112.451 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 59' ' ' LEU . 10.1 m -105.51 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.408 . . . . 43.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.656 HD23 HD12 ' A' ' 16' ' ' LEU . 7.0 tp -131.15 129.5 41.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.299999999999997 110.897 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HD1' HG22 ' A' ' 15' ' ' VAL . 7.0 t80 -125.52 129.0 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.540000000000006 111.0 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.671 HD22 HG12 ' A' ' 69' ' ' VAL . 1.9 mp -120.36 131.17 24.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 53.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -32.98 17.76 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.664 2.242 . . . . 63.240000000000002 112.403 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.79 100.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 72.109999999999999 111.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.3 m -76.76 118.58 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 65.430000000000007 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.29 165.42 37.45 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.672 -0.775 . . . . 71.219999999999999 112.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.793 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.94 -31.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 75.129999999999995 111.15 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.2 -22.22 58.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.08 -5.02 41.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 70.200000000000003 110.819 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.59 141.58 51.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.030000000000001 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.65 -147.69 16.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.758 . . . . 74.310000000000002 112.445 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.507 HG23 ' HA ' ' A' ' 94' ' ' ARG . 0.8 OUTLIER -130.62 134.96 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 44.439999999999998 111.224 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.763 ' CD2' HD13 ' A' ' 33' ' ' LEU . 21.6 m-85 -104.43 126.57 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 52.530000000000001 110.877 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HG3' ' ND2' ' A' ' 92' ' ' ASN . 5.7 ttp85 -124.45 136.54 54.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.852 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.45 156.26 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 24.41 110.925 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -141.02 126.25 18.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 110.982 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.46 162.05 33.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 73.109999999999999 111.115 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.1 mtp -130.32 125.84 35.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.858 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -86.19 171.6 11.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 53.219999999999999 110.866 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -71.66 -17.46 62.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 70.239999999999995 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.93 -26.0 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 62.020000000000003 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.61 -19.53 11.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 23.34 112.452 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.97 147.56 26.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.649 0.262 . . . . 62.310000000000002 111.01 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.39 144.27 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 52.049999999999997 110.906 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.14 126.64 50.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 52.140000000000001 111.133 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.41 142.58 35.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 64.25 110.891 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -146.8 119.01 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 51.130000000000003 110.785 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.451 HD21 HG22 ' A' ' 76' ' ' ILE . 6.4 t-20 -125.76 128.66 48.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 74.549999999999997 110.901 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.431 ' HB2' HD22 ' A' ' 16' ' ' LEU . 7.3 m-85 -128.7 118.9 23.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.530000000000001 110.883 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.507 ' HA ' HG23 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -83.74 128.08 34.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 73.140000000000001 110.751 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 6' ' ' ILE . 70.5 t -119.28 139.59 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 54.130000000000003 111.183 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 127.79 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 74.510000000000005 110.833 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 71' ' ' ILE . 35.2 m -86.94 -176.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 111.104 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.5 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 53.219999999999999 110.932 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.49 145.83 55.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 43.439999999999998 110.99 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.498 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.4 50.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 73.409999999999997 111.072 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.151 0 C-N-CA 122.718 2.279 . . . . 71.099999999999994 112.277 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.678 0.275 . . . . 70.239999999999995 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.39 133.68 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 61.140000000000001 110.874 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.02 122.04 31.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 65.319999999999993 110.853 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.72 121.29 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 111.071 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -95.16 142.65 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.06 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -142.55 166.31 25.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 52.229999999999997 111.063 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.53 147.62 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 61.100000000000001 110.883 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 71' ' ' ILE . 59.1 mt -59.05 121.16 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 70.430000000000007 111.159 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.668 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.16 0.08 88.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 62.409999999999997 112.435 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.766 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -97.62 142.04 23.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.663 0.745 . . . . 73.400000000000006 110.927 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 143.85 52.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.651 2.234 . . . . 74.239999999999995 112.275 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.8 tp -144.65 143.21 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.140000000000001 110.942 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.59 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.5 t -121.55 148.66 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 72.200000000000003 111.087 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.642 HD13 HD23 ' A' ' 64' ' ' LEU . 1.6 mt -130.9 147.96 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.030000000000001 110.951 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -112.35 151.98 29.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 64.230000000000004 110.946 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 101.97 11.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 33.219999999999999 110.88 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.18 120.9 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 54.32 110.81 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 126.14 -38.5 2.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.811 -0.709 . . . . 23.32 112.532 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.23 128.26 47.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.319999999999993 111.119 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.666 2.244 . . . . 74.510000000000005 112.374 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.34 -49.39 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.109999999999999 110.896 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 75.109999999999999 110.912 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.812 0.339 . . . . 75.329999999999998 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -136.62 156.31 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 53.140000000000001 110.925 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.1 148.35 44.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 70.430000000000007 110.896 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.602 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -129.63 142.02 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 74.219999999999999 110.872 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.712 ' O ' HD23 ' A' ' 33' ' ' LEU . 28.4 mtpt -146.77 137.01 23.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 75.129999999999995 110.876 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.831 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -138.59 139.52 38.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 61.399999999999999 110.936 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -112.42 124.44 52.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 64.519999999999996 110.889 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.792 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 70.3 p -138.45 -179.24 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 74.219999999999999 111.111 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.01 -130.55 14.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 72.310000000000002 112.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.41 -37.84 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 71.319999999999993 110.855 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.6 t -179.5 -30.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 111.145 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.586 ' HG2' HG23 ' A' ' 38' ' ' THR . 6.1 mm-40 -102.21 33.71 2.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.877 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.33 -7.26 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 71.150000000000006 111.127 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.19 129.44 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.420000000000002 110.874 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.89 153.41 50.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 63.310000000000002 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.73 121.55 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.430000000000007 111.111 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -89.55 146.73 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 64.140000000000001 110.974 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.806 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.722 0.773 . . . . 75.430000000000007 110.848 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.818 0.342 . . . . 65.219999999999999 111.1 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 159.64 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 63.299999999999997 110.828 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.806 HG21 ' O ' ' A' ' 45' ' ' SER . 86.7 t -109.05 129.94 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.13 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.557 HD12 ' CB ' ' A' ' 63' ' ' SER . 73.3 mt -68.56 157.77 87.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.665 0.745 . . . . 62.350000000000001 110.877 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -21.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 72.129999999999995 112.36 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -83.27 0.25 46.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 54.149999999999999 110.89 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.05 9.57 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.795 -0.716 . . . . 35.329999999999998 112.397 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.557 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.0 m -112.4 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.959 0.409 . . . . 53.049999999999997 110.849 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.642 HD23 HD13 ' A' ' 16' ' ' LEU . 18.2 tp -128.48 127.69 42.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.833 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CD2' HG22 ' A' ' 15' ' ' VAL . 32.1 t80 -125.71 133.54 52.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 60.140000000000001 110.863 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 56' ' ' ALA . 2.1 mp -119.88 131.27 24.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.522 0.677 . . . . 62.450000000000003 110.955 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -36.29 11.13 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.766 2.311 . . . . 73.099999999999994 112.35 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.668 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -162.99 101.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 60.439999999999998 111.122 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.7 m -73.48 117.78 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.173 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.24 163.09 39.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 75.120000000000005 112.476 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.868 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.89 -30.93 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 65.329999999999998 111.106 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 74.140000000000001 110.909 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -5.44 37.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.274 -0.421 . . . . 75.329999999999998 110.832 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.657 ' HG3' HG22 ' A' ' 97' ' ' VAL . 1.5 mt-10 -58.56 142.06 50.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.886 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.569 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.6 -151.83 23.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 43.43 112.478 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.569 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.3 mp -124.29 134.21 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 74.120000000000005 111.182 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.831 ' CE2' HD13 ' A' ' 33' ' ' LEU . 6.9 m-85 -102.58 132.73 48.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.099999999999994 110.938 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.87 134.64 49.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.099999999999994 110.938 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 146.19 46.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.32 110.876 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -141.17 126.12 18.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 63.5 110.924 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.05 164.0 27.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 111.055 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 124.82 34.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 65.349999999999994 110.881 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -86.81 172.29 10.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 72.140000000000001 110.906 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -71.32 -18.1 62.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.878 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.0 -20.12 61.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.87 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.99 -18.24 28.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.200000000000003 112.415 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -84.97 146.75 27.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.708 0.289 . . . . 73.319999999999993 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -105.17 145.0 31.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.441 HG21 ' CA ' ' A' ' 20' ' ' GLY . 1.2 m -102.24 129.41 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.225 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -105.3 146.06 29.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 72.519999999999996 110.884 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.95 126.78 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 110.826 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -121.31 120.4 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.230000000000004 110.9 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.98 127.56 40.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 73.510000000000005 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -89.55 131.07 35.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 72.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.0 t -120.92 130.58 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 75.530000000000001 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.404 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 15.8 mmt-85 -131.72 153.32 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.540000000000006 110.83 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.868 HG21 ' HA ' ' A' ' 71' ' ' ILE . 27.2 m -116.06 -177.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 111.179 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.19 -82.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 75.209999999999994 110.978 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -59.1 146.69 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.972 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.494 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.37 159.66 49.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 61.109999999999999 111.076 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.3 Cg_endo . . . . . 0 C--N 1.343 0.238 0 C-N-CA 122.65 2.233 . . . . 70.439999999999998 112.279 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.778 0.323 . . . . 44.229999999999997 111.139 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.51 132.63 37.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.340000000000003 110.915 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.539 ' C ' HD12 ' A' ' 6' ' ' ILE . 3.6 p30 -88.66 121.29 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.944 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.644 HG21 HD11 ' A' ' 14' ' ' LEU . 2.6 mp -123.22 120.81 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 111.089 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.8 p -96.95 142.58 28.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 111.159 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.0 168.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 65.219999999999999 111.129 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.32 145.66 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 64.540000000000006 110.906 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 99' ' ' GLN . 11.3 mt -52.21 120.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.077 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 89.83 5.8 70.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 60.109999999999999 112.492 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.82 ' O ' HG22 ' A' ' 69' ' ' VAL . 18.7 mm-40 -101.67 140.8 21.53 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 121.539 0.685 . . . . 63.439999999999998 110.98 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 143.89 52.88 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.752 2.302 . . . . 65.340000000000003 112.315 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 6' ' ' ILE . 37.8 tp -142.89 142.13 31.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 75.510000000000005 110.841 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.7 t -122.41 149.32 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 70.209999999999994 111.115 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.688 HD13 ' CG ' ' A' ' 77' ' ' PHE . 70.3 mt -130.73 146.91 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 52.329999999999998 110.954 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -112.91 152.86 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.010000000000005 110.897 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.89 100.6 10.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 61.420000000000002 110.862 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.32 120.65 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.449 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.28 -36.7 2.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 74.120000000000005 112.424 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.7 130.37 39.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.624 0.726 . . . . 71.030000000000001 111.062 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.66 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 72.049999999999997 112.374 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -49.32 -49.36 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 61.539999999999999 110.88 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 71.099999999999994 110.812 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.79 0.329 . . . . 74.510000000000005 110.889 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -136.31 146.94 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.874 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -129.07 137.07 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.859 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' CE2' HD13 ' A' ' 29' ' ' LEU . 1.1 m0 -124.68 144.95 49.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 110.85 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -136.33 142.28 43.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.897 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.819 HD21 HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -137.82 140.06 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.319999999999993 110.946 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 62.520000000000003 110.835 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.819 HG23 HD21 ' A' ' 33' ' ' LEU . 33.5 p -136.82 179.91 6.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 111.193 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.78 -130.01 19.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.797 -0.716 . . . . 62.32 112.485 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -112.68 -37.38 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 71.120000000000005 110.901 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -178.9 -29.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 73.319999999999993 111.153 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -102.14 33.6 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 64.109999999999999 110.951 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.33 -5.81 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 62.130000000000003 111.102 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -59.14 132.22 53.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 65.439999999999998 110.956 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 157.17 41.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 61.219999999999999 110.857 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.11 123.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.209999999999994 111.215 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.38 136.68 32.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.941 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.835 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 110.827 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.414 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.754 0.311 . . . . 65.430000000000007 111.136 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.85 158.01 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 110.908 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 45' ' ' SER . 49.8 t -116.35 126.87 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 73.140000000000001 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 63' ' ' SER . 38.7 mt -69.02 156.4 91.6 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 75.230000000000004 110.956 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.75 -21.84 32.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.668 2.246 . . . . 72.319999999999993 112.431 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -82.89 -0.19 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.94 29.64 10.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.723 -0.751 . . . . 60.439999999999998 112.438 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 59' ' ' LEU . 3.2 m -111.4 177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 54.109999999999999 110.863 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.683 HD23 HD12 ' A' ' 16' ' ' LEU . 9.2 tp -128.63 130.02 46.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.019999999999996 110.89 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.578 ' N ' HD12 ' A' ' 64' ' ' LEU . 3.4 t80 -125.13 131.9 53.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 64.019999999999996 110.958 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 69' ' ' VAL . 7.2 mp -115.07 130.8 23.92 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.653 0.74 . . . . 61.340000000000003 110.855 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -37.84 8.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.785 2.323 . . . . 63.539999999999999 112.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.614 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.36 102.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 111.083 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.2 m -73.7 116.44 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 111.077 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 163.12 38.3 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.674 -0.774 . . . . 54.240000000000002 112.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.857 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.16 -34.04 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.723 0.297 . . . . 71.200000000000003 111.115 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.95 -15.92 60.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -4.51 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 62.030000000000001 110.921 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.632 ' CD ' HG22 ' A' ' 97' ' ' VAL . 42.6 mt-10 -56.5 141.49 42.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 75.530000000000001 110.973 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.697 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 160.08 -156.41 27.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.749 -0.739 . . . . 71.209999999999994 112.519 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.697 HD13 ' O ' ' A' ' 75' ' ' GLY . 6.3 mm -125.38 134.09 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 75.150000000000006 111.137 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.691 ' HB2' HD12 ' A' ' 33' ' ' LEU . 77.1 t80 -102.84 126.44 49.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 73.25 110.876 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 127.86 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.779 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.84 146.58 46.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 74.120000000000005 110.891 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -139.47 132.91 30.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 163.89 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 70.409999999999997 111.039 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.6 mtp -129.1 125.01 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 72.349999999999994 110.938 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.88 172.81 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 73.150000000000006 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -70.71 -18.42 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 64.519999999999996 110.828 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -73.21 -19.86 61.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 63.530000000000001 110.92 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.92 -15.09 37.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 61.219999999999999 112.505 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 146.61 27.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.657 0.265 . . . . 60.350000000000001 110.936 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.37 144.81 31.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 75.319999999999993 110.89 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.449 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.92 132.59 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 53.539999999999999 111.128 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.45 145.47 27.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 73.310000000000002 110.934 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.2 m -144.72 123.88 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 62.229999999999997 110.818 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -127.48 121.24 30.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 74.450000000000003 110.884 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.58 123.05 32.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.0 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.658 ' HE ' HD12 ' A' ' 76' ' ' ILE . 19.4 mmm-85 -84.4 134.17 34.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.861 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -120.27 129.29 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 63.43 111.108 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.47 46.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.857 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -109.68 -175.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 73.400000000000006 111.099 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -65.79 -71.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 110.952 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.498 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.7 mp0 -71.05 140.52 50.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.952 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.27 159.81 48.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.665 0.745 . . . . 65.319999999999993 111.138 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 74.030000000000001 112.394 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.703 0.287 . . . . 61.130000000000003 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.62 137.25 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 74.340000000000003 110.826 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -89.09 121.13 31.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.86 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.65 121.94 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 75.209999999999994 111.15 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -95.31 142.68 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 72.5 111.202 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.49 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -146.61 167.29 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 45.399999999999999 111.13 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -119.99 148.68 43.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.408 . . . . 64.120000000000005 110.898 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mt -56.81 120.75 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 65.0 111.219 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.31 5.72 79.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.76 . . . . 72.310000000000002 112.46 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.813 ' O ' HG22 ' A' ' 69' ' ' VAL . 51.7 mm-40 -102.05 139.42 20.28 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.657 0.742 . . . . 75.340000000000003 110.918 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 143.27 50.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 75.310000000000002 112.356 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 8' ' ' ALA . 22.7 tp -145.27 142.43 29.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 54.310000000000002 110.891 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.512 HG22 ' CD2' ' A' ' 65' ' ' PHE . 42.5 t -122.96 145.27 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 62.109999999999999 111.134 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.774 HD12 HD23 ' A' ' 64' ' ' LEU . 67.1 mt -130.74 147.27 52.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 62.530000000000001 111.0 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -113.46 150.73 32.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.409999999999997 110.882 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -108.07 99.73 9.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 53.210000000000001 110.846 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -54.26 128.45 31.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.847 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.38 -40.45 1.92 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 42.350000000000001 112.468 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.92 128.89 43.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 62.450000000000003 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.19 0.15 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.665 2.244 . . . . 64.209999999999994 112.376 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -48.95 45.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 71.219999999999999 110.945 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.565 0.697 . . . . 63.140000000000001 110.942 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.883 0.373 . . . . 75.5 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.645 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -137.28 159.13 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 55.310000000000002 110.918 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -132.53 146.14 51.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 110.851 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.645 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 13.7 m95 -123.6 134.25 53.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.400000000000006 110.922 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' C ' HD23 ' A' ' 33' ' ' LEU . 15.0 ttpp -136.36 138.33 41.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 63.450000000000003 110.91 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.739 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -138.29 138.24 38.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 75.120000000000005 110.903 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.33 127.8 56.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 74.209999999999994 110.89 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.812 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 21.2 p -138.52 -179.87 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 62.219999999999999 111.139 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.17 21.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.815 -0.707 . . . . 63.43 112.463 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.89 -37.26 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 64.430000000000007 110.869 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.2 t -178.72 -29.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 111.015 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.611 ' HG3' HG23 ' A' ' 38' ' ' THR . 29.3 mt-10 -102.06 34.06 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 75.219999999999999 110.821 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.71 -5.59 8.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.409999999999997 111.114 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -59.57 132.16 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.958 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' CE ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.45 152.46 48.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.316 -0.402 . . . . 64.439999999999998 110.92 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.1 t -105.26 116.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 61.5 111.131 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.717 HD13 HD13 ' A' ' 64' ' ' LEU . 27.0 mt -96.28 146.03 25.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 73.439999999999998 110.823 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 121.586 0.708 . . . . 74.129999999999995 110.865 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.708 0.29 . . . . 52.439999999999998 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.37 162.41 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 73.420000000000002 110.903 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 63' ' ' SER . 46.2 t -108.69 130.72 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 72.400000000000006 111.119 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 63' ' ' SER . 56.4 mt -68.99 156.46 91.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.596 0.712 . . . . 62.509999999999998 110.965 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -22.43 32.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 73.310000000000002 112.265 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -81.91 0.15 41.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.299999999999997 110.921 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.8 22.92 24.63 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 65.319999999999993 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.518 ' HB2' HD12 ' A' ' 59' ' ' LEU . 6.0 m -106.24 178.91 4.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 71.120000000000005 110.88 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.774 HD23 HD12 ' A' ' 16' ' ' LEU . 15.5 tp -129.68 129.95 44.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 74.019999999999996 110.952 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 15' ' ' VAL . 39.3 t80 -124.34 129.96 51.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 75.040000000000006 110.86 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.811 HD22 HG12 ' A' ' 69' ' ' VAL . 5.3 mp -114.57 127.23 27.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.678 0.752 . . . . 75.420000000000002 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -32.62 18.11 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.239999999999995 112.386 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.5 101.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 63.310000000000002 111.145 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.09 115.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 111.185 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.63 161.81 31.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 72.109999999999999 112.457 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.835 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.07 -31.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 73.129999999999995 111.168 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -77.46 -22.47 51.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.924 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.15 -5.34 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 70.109999999999999 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.75 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.33 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 110.822 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.779 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 160.39 -148.91 17.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.793 -0.718 . . . . 53.43 112.516 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.779 HD12 ' C ' ' A' ' 75' ' ' GLY . 2.0 mp -126.18 133.66 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.89 0.376 . . . . 61.509999999999998 111.178 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.739 ' CE2' HD13 ' A' ' 33' ' ' LEU . 11.0 m-85 -103.32 135.2 45.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 45.149999999999999 110.908 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ttp85 -125.99 134.61 51.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.813 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.49 147.95 44.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -141.37 129.21 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 61.520000000000003 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.73 163.13 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 111.12 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 125.09 33.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 45.340000000000003 110.937 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -86.84 172.1 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 74.140000000000001 110.823 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.47 -18.3 62.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 70.530000000000001 110.934 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.07 -19.87 61.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 65.010000000000005 110.848 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.03 32.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.756 -0.735 . . . . 74.230000000000004 112.545 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -85.02 147.07 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.795 0.331 . . . . 75.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.79 145.14 30.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 72.219999999999999 110.955 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.69 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 63.25 111.107 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -98.65 145.31 27.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 71.430000000000007 110.943 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 m -144.73 127.76 16.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 63.240000000000002 110.748 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -128.14 121.52 29.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 72.349999999999994 110.931 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.22 126.1 40.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.530000000000001 110.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.6 mmm-85 -89.85 132.1 35.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 74.5 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.82 130.02 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 64.010000000000005 111.129 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -131.55 146.17 52.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 110.886 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 71' ' ' ILE . 17.0 m -109.58 -176.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 52.020000000000003 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.86 -79.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.992 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.45 146.21 54.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 73.219999999999999 111.032 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.38 159.42 50.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.719 0.771 . . . . 61.350000000000001 111.145 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.649 2.233 . . . . 73.109999999999999 112.321 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.691 0.281 . . . . 64.140000000000001 111.156 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.12 133.6 36.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 73.430000000000007 110.893 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.6 121.27 28.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.510000000000005 110.884 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.1 mm -125.16 127.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 74.25 111.111 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -91.56 142.52 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 64.150000000000006 111.17 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.0 165.85 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 33.140000000000001 111.133 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -119.1 149.71 41.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 62.229999999999997 110.906 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 71' ' ' ILE . 10.6 mt -68.43 120.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 45.119999999999997 111.108 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.5 -6.99 57.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.815 -0.707 . . . . 64.439999999999998 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.837 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -102.72 140.76 21.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.71 0.767 . . . . 74.299999999999997 110.923 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 146.11 59.7 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.84 2.36 . . . . 74.200000000000003 112.323 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.3 tp -138.33 142.8 39.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 73.209999999999994 110.966 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.627 HG22 ' CD1' ' A' ' 65' ' ' PHE . 47.1 t -122.59 148.22 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.540000000000006 111.141 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.68 HD12 HD23 ' A' ' 64' ' ' LEU . 6.6 mt -130.99 147.48 52.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.933 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -112.78 152.04 29.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 72.140000000000001 111.002 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -107.33 100.53 9.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.413 . . . . 61.409999999999997 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.88 122.41 12.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 73.530000000000001 110.839 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.15 -39.8 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 72.129999999999995 112.484 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.29 129.32 43.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.522 0.677 . . . . 73.329999999999998 111.171 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.91 -165.08 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.64 2.226 . . . . 75.230000000000004 112.383 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -49.02 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.981 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.603 0.716 . . . . 61.43 110.936 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.769 0.319 . . . . 75.120000000000005 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.2 pp -136.09 151.31 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 73.310000000000002 110.912 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.82 148.18 45.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.834 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -121.81 139.97 52.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.922 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -146.65 135.35 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.230000000000004 110.928 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.716 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -140.58 137.84 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 70.129999999999995 110.891 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -112.28 125.2 53.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 54.5 110.893 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.84 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 40.4 p -139.22 -178.96 5.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 73.530000000000001 111.137 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.98 -127.04 9.95 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.703 -0.76 . . . . 54.329999999999998 112.53 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' THR . 1.2 mpp_? -112.9 -38.88 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 75.319999999999993 110.863 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 39' ' ' GLU . 3.8 t 179.0 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.171 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -102.03 34.18 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 110.823 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.84 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.12 -6.92 8.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 72.239999999999995 111.105 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -71.47 128.71 36.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.506 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -137.57 159.65 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 54.329999999999998 110.929 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 t -93.59 121.01 43.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 72.030000000000001 111.135 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.05 145.74 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 61.43 110.879 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 63.25 110.91 -179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.894 0.378 . . . . 74.439999999999998 111.011 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.18 161.14 25.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.944 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 63' ' ' SER . 61.6 t -107.44 130.28 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 71.299999999999997 111.084 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 63' ' ' SER . 44.5 mt -68.81 157.88 87.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 71.530000000000001 110.923 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -21.86 33.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.772 2.315 . . . . 72.439999999999998 112.353 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -82.37 0.95 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 75.409999999999997 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 26.46 20.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 73.310000000000002 112.514 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 58' ' ' VAL . 30.8 m -111.97 -179.53 3.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 74.239999999999995 110.874 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.68 HD23 HD12 ' A' ' 16' ' ' LEU . 13.3 tp -129.84 130.54 45.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.32 110.909 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.627 ' CD1' HG22 ' A' ' 15' ' ' VAL . 6.2 t80 -123.81 133.04 53.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.668 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -114.83 127.08 27.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.651 0.738 . . . . 74.439999999999998 110.939 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -32.28 19.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 33.210000000000001 112.374 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.64 102.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 74.430000000000007 111.084 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 12' ' ' GLU . 27.5 m -73.07 118.71 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 75.409999999999997 111.136 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.01 161.61 21.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 41.310000000000002 112.524 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.912 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.76 -34.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 73.109999999999999 111.212 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.08 -20.2 56.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.450000000000003 110.903 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -2.9 28.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.420000000000002 110.965 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.22 141.91 49.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 60.509999999999998 110.883 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.573 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 163.4 -155.09 26.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 73.040000000000006 112.428 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.74 135.34 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 71.540000000000006 111.142 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.716 ' CE2' HD22 ' A' ' 33' ' ' LEU . 80.8 m-85 -103.71 126.75 51.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.874 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.93 127.55 47.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 74.140000000000001 110.868 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.01 150.9 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 65.25 110.857 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -139.65 132.6 29.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.936 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.16 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 73.439999999999998 111.176 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.4 ttm -129.48 126.09 37.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 64.400000000000006 110.884 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -86.22 172.62 10.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.915 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -71.26 -18.48 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 71.129999999999995 110.814 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -73.13 -19.85 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 73.400000000000006 110.874 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.69 -17.36 30.54 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 70.299999999999997 112.454 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -85.15 146.58 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.832 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.39 144.86 31.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.866 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 132.8 48.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.120000000000005 111.218 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 144.08 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.033 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -145.52 121.66 10.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 64.219999999999999 110.9 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.18 122.08 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 74.230000000000004 110.836 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -128.0 118.97 24.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 73.120000000000005 110.965 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.13 135.79 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.099999999999994 110.864 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 68.9 t -120.68 134.2 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.115 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 127.25 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.88 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.912 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.1 m -88.32 -177.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 52.310000000000002 111.065 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -68.84 -80.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 72.120000000000005 110.942 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.25 144.23 46.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 72.450000000000003 110.849 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.13 159.62 48.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.581 0.705 . . . . 53.509999999999998 111.131 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 61.399999999999999 112.329 179.857 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.702 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.696 0.284 . . . . 63.210000000000001 111.093 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -93.3 133.51 36.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 74.140000000000001 110.881 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.0 121.34 27.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.79 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.56 121.88 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 72.140000000000001 111.142 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -95.93 142.06 28.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 73.219999999999999 111.152 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.72 165.26 30.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 72.400000000000006 111.109 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 148.64 45.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.909 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.426 HD11 ' HB3' ' A' ' 99' ' ' GLN . 70.3 mt -57.13 122.13 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 60.140000000000001 111.094 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.28 4.45 80.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 112.506 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.768 ' O ' HG22 ' A' ' 69' ' ' VAL . 35.7 mm-40 -101.19 139.4 20.43 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.641 0.734 . . . . 32.32 110.935 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 138.62 38.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.609 2.206 . . . . 43.43 112.359 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 66' ' ' LEU . 18.4 tp -145.0 141.26 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 64.430000000000007 110.861 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' CD1' ' A' ' 65' ' ' PHE . 47.2 t -126.64 147.81 31.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 54.439999999999998 111.178 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 77' ' ' PHE . 56.2 mt -131.88 147.29 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 72.349999999999994 110.96 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -111.7 149.11 32.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.869 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -112.32 101.56 9.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 61.020000000000003 110.86 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.530000000000001 110.906 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 150.31 -49.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 72.150000000000006 112.476 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.52 102.95 11.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 73.299999999999997 111.044 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.4 Cg_endo -69.71 -161.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.626 2.217 . . . . 64.329999999999998 112.402 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -12.68 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 71.040000000000006 110.942 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 29.8 mmtm . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 72.129999999999995 110.9 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.86 0.362 . . . . 72.439999999999998 110.946 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pp -168.63 174.26 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 75.25 110.927 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 124.1 40.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.931 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.35 143.4 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 72.120000000000005 110.866 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -143.96 144.1 31.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 71.430000000000007 110.941 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.698 HD11 ' CE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -136.57 132.83 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 72.329999999999998 110.882 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.41 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -116.48 120.43 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.878 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.814 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.4 p -140.02 179.6 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 71.109999999999999 111.099 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.1 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.434 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.39 -38.46 4.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 74.310000000000002 110.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.1 t 179.24 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 41.409999999999997 111.152 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' HG2' HG23 ' A' ' 38' ' ' THR . 4.7 mm-40 -102.03 33.93 2.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.825 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.93 -6.67 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 63.329999999999998 111.101 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -68.37 130.2 42.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 159.08 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 64.040000000000006 110.883 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.59 122.1 38.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 72.530000000000001 111.181 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 33' ' ' LEU . 11.2 mt -92.31 148.84 21.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 72.140000000000001 110.862 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.717 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.712 0.768 . . . . 61.219999999999999 110.825 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.795 0.331 . . . . 73.129999999999995 111.081 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.47 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -131.25 165.39 23.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 110.899 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.717 HG21 ' O ' ' A' ' 45' ' ' SER . 55.2 t -106.51 130.13 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 111.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 65' ' ' PHE . 6.2 mp -69.76 157.84 88.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.577 0.703 . . . . 61.350000000000001 110.907 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.2 Cg_endo -69.68 -22.9 31.79 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.717 2.278 . . . . 65.120000000000005 112.37 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.37 2.06 38.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 75.439999999999998 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.93 30.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 60.210000000000001 112.494 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 11.7 m -105.67 179.42 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 110.805 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 57' ' ' ARG . 36.9 tp -132.3 128.35 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 74.430000000000007 110.959 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 15' ' ' VAL . 4.5 t80 -129.65 128.16 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 72.150000000000006 110.858 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -121.27 132.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.698 0.761 . . . . 72.150000000000006 110.927 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.27 19.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.743 2.295 . . . . 64.120000000000005 112.414 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -155.81 103.5 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 74.299999999999997 111.055 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.3 m -73.2 119.36 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 111.19 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.82 156.17 26.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.741 . . . . 63.130000000000003 112.526 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.76 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.51 -29.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 74.109999999999999 111.087 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -73.32 -23.5 60.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 61.130000000000003 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.26 -5.26 57.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 72.420000000000002 110.831 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.55 140.61 57.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 75.409999999999997 110.869 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.23 -137.93 5.63 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.778 -0.725 . . . . 64.209999999999994 112.485 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.46 135.26 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 73.049999999999997 111.197 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.698 ' CE2' HD11 ' A' ' 33' ' ' LEU . 5.0 m-85 -100.85 128.39 46.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.874 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -127.92 127.72 43.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 110.902 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -121.24 149.73 42.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.854 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -146.98 126.68 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.874 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.13 163.74 27.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 55.030000000000001 111.101 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.4 mtp -129.96 125.83 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.879 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -86.2 172.03 10.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.519999999999996 110.83 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -71.78 -17.95 62.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.843 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.1 -19.61 61.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.895 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.7 -18.58 29.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 62.299999999999997 112.53 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 145.19 27.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 44.329999999999998 110.83 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.91 145.0 32.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 110.893 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.01 131.32 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.299999999999997 111.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.35 145.6 30.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 62.32 110.936 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -146.04 123.95 12.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 62.210000000000001 110.81 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.49 120.39 26.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 64.219999999999999 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.64 127.85 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.989 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.702 HH11 ' HB1' ' A' ' 3' ' ' ALA . 4.1 mmm-85 -87.62 136.18 33.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 61.119999999999997 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 77' ' ' PHE . 56.1 t -126.45 132.29 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 111.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 128.83 41.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.9 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 m -92.92 -176.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 62.140000000000001 111.083 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -66.49 -81.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 72.109999999999999 110.941 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.426 ' HB3' HD11 ' A' ' 10' ' ' ILE . 11.2 tp-100 -60.97 142.59 56.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 71.25 110.811 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.67 159.88 48.9 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.548 0.69 . . . . 72.510000000000005 111.151 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--N 1.34 0.086 0 C-N-CA 122.746 2.297 . . . . 62.020000000000003 112.339 179.8 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.662 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.773 0.32 . . . . 74.319999999999993 111.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -93.47 133.73 36.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 64.319999999999993 110.924 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.7 120.48 26.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 14' ' ' LEU . 48.7 mm -125.9 121.51 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 75.329999999999998 111.144 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.89 140.95 29.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 74.010000000000005 111.085 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.62 166.62 27.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 35.109999999999999 111.088 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.79 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 71.310000000000002 110.904 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG23 ' HA2' ' A' ' 70' ' ' GLY . 22.1 mt -55.59 120.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 111.22 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.715 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.89 9.3 74.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.685 -0.769 . . . . 53.119999999999997 112.463 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.772 ' O ' HG22 ' A' ' 69' ' ' VAL . 50.3 mm-40 -102.66 139.14 19.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 74.450000000000003 110.883 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 143.7 51.55 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.686 2.257 . . . . 65.530000000000001 112.355 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.616 ' O ' HD12 ' A' ' 66' ' ' LEU . 30.2 tp -145.88 143.42 29.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.288 -0.414 . . . . 63.049999999999997 110.901 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 142.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 111.153 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.5 147.99 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 74.319999999999993 110.895 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -113.75 151.19 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 71.400000000000006 110.85 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -107.53 101.63 10.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 51.340000000000003 110.813 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -50.16 125.66 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 74.200000000000003 111.012 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.38 -45.12 1.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.8 -0.714 . . . . 65.109999999999999 112.464 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.16 123.84 63.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.595 0.712 . . . . 72.030000000000001 111.076 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.667 2.245 . . . . 71.099999999999994 112.385 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -47.5 39.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 72.430000000000007 110.869 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 71.310000000000002 110.872 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.928 0.394 . . . . 71.400000000000006 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.855 HD11 ' CE3' ' A' ' 31' ' ' TRP . 1.1 pp -135.69 163.38 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.340000000000003 110.913 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.8 tp10 -120.56 149.02 43.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.040000000000006 110.913 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.855 ' CE3' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -127.43 143.16 51.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 110.96 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -143.03 140.79 31.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 61.229999999999997 110.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.804 HD11 HG23 ' A' ' 35' ' ' THR . 0.9 OUTLIER -137.65 132.82 33.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 65.030000000000001 110.916 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.768 ' N ' HD22 ' A' ' 33' ' ' LEU . 19.0 t-20 -114.9 120.94 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.25 110.915 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.807 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.2 p -139.03 179.52 6.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 55.119999999999997 111.172 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.09 -130.03 10.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.644 -0.788 . . . . 60.420000000000002 112.537 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.67 -38.34 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 63.310000000000002 110.863 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.6 t 179.91 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 53.020000000000003 111.151 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 38' ' ' THR . 22.6 mt-10 -102.7 33.8 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 63.340000000000003 110.994 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.97 -7.04 8.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 74.109999999999999 111.1 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -64.52 130.93 45.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 110.888 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 153.49 47.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.938 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.54 120.84 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 64.099999999999994 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 2.7 mm? -94.26 149.68 21.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.18 -0.463 . . . . 64.310000000000002 110.873 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.566 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.728 0.775 . . . . 54.439999999999998 110.831 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.799 0.333 . . . . 72.420000000000002 111.078 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 168.66 16.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 63.549999999999997 110.843 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 45' ' ' SER . 49.9 t -106.45 130.11 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 63.409999999999997 111.154 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 65' ' ' PHE . 4.5 mp -69.31 156.62 91.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 60.25 110.945 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -20.46 34.72 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.0 112.422 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 1.91 32.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 41.549999999999997 110.861 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.3 25.12 27.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.668 -0.777 . . . . 72.430000000000007 112.445 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 58' ' ' VAL . 73.9 m -113.5 -179.29 3.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 63.219999999999999 110.86 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tp -129.59 128.53 42.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 71.439999999999998 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.777 ' HB2' HD11 ' A' ' 59' ' ' LEU . 39.9 t80 -126.11 132.81 51.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 71.140000000000001 110.958 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.845 HD22 HG12 ' A' ' 69' ' ' VAL . 2.8 mp -114.7 128.28 26.03 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 71.129999999999995 110.94 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.63 -34.24 15.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.685 2.257 . . . . 74.409999999999997 112.395 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.69 99.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 71.409999999999997 111.079 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.845 HG12 HD22 ' A' ' 66' ' ' LEU . 13.4 m -74.97 112.22 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.349999999999994 111.215 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -86.18 171.01 43.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 72.129999999999995 112.492 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.86 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.69 -30.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.729 0.3 . . . . 72.340000000000003 111.095 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.49 -23.12 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 60.219999999999999 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -3.59 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.049999999999997 110.847 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 140.66 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 72.239999999999995 110.867 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.595 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 159.18 -149.04 18.76 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 54.43 112.502 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.6 mp -130.69 135.26 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 64.209999999999994 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CG ' HD23 ' A' ' 33' ' ' LEU . 32.2 m-85 -101.17 130.96 47.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 62.219999999999999 110.897 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.51 131.02 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 70.319999999999993 110.85 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 151.07 40.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 22.120000000000001 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -144.98 126.11 14.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 72.319999999999993 110.799 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.7 162.8 29.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 35.100000000000001 111.056 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.3 ttm -130.18 125.48 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 60.009999999999998 110.866 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.08 172.22 10.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -71.33 -19.07 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 73.209999999999994 110.886 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -74.21 -20.14 60.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.530000000000001 110.847 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.96 -9.1 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 75.040000000000006 112.531 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -85.11 146.28 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 62.409999999999997 110.893 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.73 142.12 36.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 65.329999999999998 110.945 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.456 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.17 125.9 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 111.043 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -106.87 143.1 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 65.129999999999995 110.9 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -146.74 120.61 9.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 63.32 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.63 122.6 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 74.019999999999996 110.919 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.19 125.88 43.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.902 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.662 HH11 ' HB1' ' A' ' 3' ' ' ALA . 8.9 mmm-85 -86.34 132.68 33.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.902 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.546 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.6 t -120.81 133.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.150000000000006 111.123 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.444 ' NH2' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -130.74 128.93 41.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 70.140000000000001 110.812 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.86 HG21 ' HA ' ' A' ' 71' ' ' ILE . 24.0 m -92.58 -176.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 111.136 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -66.83 -82.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 75.439999999999998 110.963 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -62.97 146.34 53.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.886 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.503 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.55 49.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 73.349999999999994 111.204 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.244 . . . . 70.319999999999993 112.243 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.722 0.296 . . . . 44.140000000000001 111.082 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -93.33 133.24 36.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.439999999999998 110.937 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 2.2 p30 -84.96 122.17 28.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 110.891 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.488 ' CG2' HD11 ' A' ' 14' ' ' LEU . 48.6 mm -124.03 120.89 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.549999999999997 111.153 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -96.05 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 62.43 111.215 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.033 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -143.68 164.86 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.099999999999994 111.137 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -124.67 151.31 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 72.150000000000006 110.908 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.57 118.6 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 111.111 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 80.21 8.84 87.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 63.119999999999997 112.465 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.793 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.2 mm-40 -102.19 140.44 21.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 73.200000000000003 110.935 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 143.83 51.9 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.638 2.225 . . . . 63.439999999999998 112.366 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 8' ' ' ALA . 22.7 tp -145.27 142.22 29.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 110.963 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 65' ' ' PHE . 40.6 t -122.63 145.12 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.168 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.546 HD12 HD23 ' A' ' 64' ' ' LEU . 65.1 mt -131.66 147.78 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 110.916 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -113.39 150.32 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 65.329999999999998 110.809 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -110.67 100.96 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.852 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.53 128.04 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 71.120000000000005 110.956 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -45.02 1.2 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.768 -0.729 . . . . 52.210000000000001 112.439 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.85 59.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.602 0.715 . . . . 70.439999999999998 111.069 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -163.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 64.230000000000004 112.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.31 -47.57 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 43.520000000000003 110.939 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.627 0.727 . . . . 72.329999999999998 110.878 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.829 0.347 . . . . 75.239999999999995 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -145.22 150.63 37.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 64.010000000000005 110.909 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.428 ' N ' HD12 ' A' ' 29' ' ' LEU . 15.2 tt0 -121.03 149.77 42.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 110.913 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.681 ' CE2' HD11 ' A' ' 29' ' ' LEU . 16.8 m-90 -107.28 136.64 46.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.903 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.42 145.08 38.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 61.350000000000001 110.911 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.816 HD12 ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.79 137.96 13.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.409999999999997 110.952 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.57 128.89 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 75.349999999999994 110.925 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.813 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.7 p -136.59 179.2 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 111.111 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.84 14.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 70.239999999999995 112.498 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 74.439999999999998 110.865 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.3 t -179.69 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 41.020000000000003 111.184 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -102.94 33.46 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.883 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.19 -6.71 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 52.009999999999998 111.097 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -59.78 132.23 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 74.510000000000005 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.816 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -129.61 151.89 49.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 73.239999999999995 110.821 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.7 121.91 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 111.166 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD23 HD21 ' A' ' 33' ' ' LEU . 3.4 mm? -90.13 146.36 24.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 75.299999999999997 110.831 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.685 0.755 . . . . 70.120000000000005 110.877 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.716 0.293 . . . . 74.299999999999997 111.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.72 164.76 19.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.913 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -106.52 130.28 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 61.409999999999997 111.144 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 63' ' ' SER . 25.7 mt -70.39 158.64 87.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 74.099999999999994 110.921 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.59 31.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.759 2.306 . . . . 72.219999999999999 112.313 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.05 1.65 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.54 17.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 52.420000000000002 112.513 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.438 ' HB2' HD12 ' A' ' 59' ' ' LEU . 36.6 m -112.48 -178.3 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.396 . . . . 73.25 110.829 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 77' ' ' PHE . 21.8 tp -127.73 128.66 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.924 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD2' HG22 ' A' ' 15' ' ' VAL . 38.9 t80 -125.33 137.24 54.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 72.319999999999993 110.83 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.883 HD22 HG12 ' A' ' 69' ' ' VAL . 5.5 mp -118.48 125.03 28.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.601 0.715 . . . . 74.120000000000005 110.969 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -31.92 19.4 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.5 112.343 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.51 100.61 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 62.409999999999997 111.091 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.033 HG21 ' HB1' ' A' ' 8' ' ' ALA . 31.3 m -73.4 118.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 63.009999999999998 111.137 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.45 162.77 17.79 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.807 -0.711 . . . . 75.239999999999995 112.447 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.852 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.31 -29.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 70.439999999999998 111.175 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.7 -24.01 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 64.340000000000003 110.846 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.8 -4.64 56.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.288 -0.415 . . . . 75.239999999999995 110.809 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.3 140.77 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 54.340000000000003 110.802 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.589 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 159.03 -138.23 5.56 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.734 . . . . 64.129999999999995 112.554 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.589 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.6 mp -130.63 134.66 61.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.888 0.375 . . . . 72.109999999999999 111.142 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.786 ' CE2' HD13 ' A' ' 33' ' ' LEU . 5.9 m-85 -103.5 132.86 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 71.409999999999997 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.22 126.64 43.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 70.409999999999997 110.839 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 150.38 34.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.833 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.73 127.64 22.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 64.219999999999999 110.879 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.42 164.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 71.450000000000003 111.129 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.1 ttm -129.52 125.66 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.340000000000003 110.878 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.41 171.58 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.876 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -71.52 -17.72 62.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.827 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -72.36 -20.02 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 62.130000000000003 110.863 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.8 -21.0 23.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 24.199999999999999 112.483 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.69 148.13 26.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 75.310000000000002 110.79 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.45 145.16 30.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 64.239999999999995 110.953 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.3 132.61 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.149 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -98.51 146.71 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 63.0 110.952 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.66 126.62 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 65.340000000000003 110.817 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -129.08 120.83 26.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 62.43 110.852 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.56 127.26 41.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 110.995 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -83.75 135.46 34.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 72.329999999999998 110.925 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 77' ' ' PHE . 75.5 t -120.19 133.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 71.120000000000005 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 141.82 49.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.349999999999994 110.803 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.852 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.6 m -109.65 -176.21 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.162 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -75.93 -73.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 65.109999999999999 110.89 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 147.77 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 62.200000000000003 110.956 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.41 159.61 49.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.657 0.742 . . . . 51.119999999999997 111.161 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.182 0 C-N-CA 122.771 2.314 . . . . 62.020000000000003 112.313 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.79 0.328 . . . . 62.399999999999999 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.94 133.65 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 74.140000000000001 110.918 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.24 121.43 28.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 63.219999999999999 110.946 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.0 122.35 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 74.439999999999998 111.177 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -95.53 139.93 31.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 70.299999999999997 111.224 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.69 167.49 25.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 70.200000000000003 111.1 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.8 149.0 43.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 75.530000000000001 110.839 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.594 HG23 ' HA2' ' A' ' 70' ' ' GLY . 38.3 mt -52.73 120.54 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 111.166 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.721 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.61 11.7 68.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 61.030000000000001 112.516 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.775 ' O ' HG22 ' A' ' 69' ' ' VAL . 47.4 mm-40 -102.81 138.18 19.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 75.409999999999997 110.902 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 143.12 49.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.708 2.272 . . . . 74.230000000000004 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 66' ' ' LEU . 27.9 tp -145.82 142.91 29.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 110.862 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.86 146.87 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 63.509999999999998 111.179 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.705 HD12 HD23 ' A' ' 64' ' ' LEU . 7.9 mt -133.2 146.96 51.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.510000000000005 110.861 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -113.83 153.09 29.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.25 110.876 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.6 101.45 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 110.897 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.77 123.77 13.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 64.140000000000001 110.844 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.56 -40.92 1.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.711 . . . . 63.049999999999997 112.544 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.11 129.16 44.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 74.200000000000003 111.118 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -164.21 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 73.200000000000003 112.325 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -47.46 47.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 54.020000000000003 110.825 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 53.109999999999999 110.939 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.835 0.35 . . . . 75.209999999999994 110.819 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 29' ' ' LEU . 2.5 pp -135.54 164.75 27.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 64.150000000000006 110.846 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -133.73 146.78 51.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 70.450000000000003 110.897 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -121.81 137.43 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 139.2 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 72.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.783 HD11 HG23 ' A' ' 35' ' ' THR . 1.3 tm? -138.12 131.89 31.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.404 . . . . 75.219999999999999 110.917 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.71 ' N ' HD22 ' A' ' 33' ' ' LEU . 23.8 t-20 -115.78 120.55 39.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 60.32 110.901 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.7 p -139.73 179.47 6.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 72.140000000000001 111.145 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.11 -133.44 18.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 52.439999999999998 112.444 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -112.39 -37.28 5.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 73.310000000000002 110.869 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 t -179.28 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 72.319999999999993 111.205 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -101.29 33.69 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 71.510000000000005 110.947 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.39 -6.08 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 71.549999999999997 111.094 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -68.87 130.1 41.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.040000000000006 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 158.97 43.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 75.409999999999997 110.889 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.86 120.56 52.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.434 . . . . 60.149999999999999 111.064 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 147.79 23.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.836 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 53.420000000000002 110.86 -179.924 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.822 0.344 . . . . 74.510000000000005 111.067 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.681 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -122.23 161.38 23.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 111.004 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 63' ' ' SER . 41.4 t -107.9 129.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 61.219999999999999 111.119 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 65' ' ' PHE . 5.5 mp -69.97 157.19 90.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.739 0.78 . . . . 71.230000000000004 110.863 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -20.63 35.16 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.63 2.22 . . . . 44.32 112.411 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -82.18 1.39 36.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.140000000000001 110.917 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.98 20.61 35.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.684 -0.769 . . . . 65.409999999999997 112.521 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.47 ' O ' HG13 ' A' ' 58' ' ' VAL . 40.9 m -107.52 -179.22 3.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 72.319999999999993 110.829 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.705 HD23 HD12 ' A' ' 16' ' ' LEU . 55.7 tp -130.4 129.22 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 72.120000000000005 110.956 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' HB2' HD11 ' A' ' 59' ' ' LEU . 6.3 t80 -126.21 131.64 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.319999999999993 110.876 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.86 HD22 HG12 ' A' ' 69' ' ' VAL . 2.8 mp -115.17 129.9 24.69 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.586 0.708 . . . . 63.229999999999997 110.944 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.84 17.71 Favored 'Trans proline' 0 N--CA 1.466 -0.12 0 C-N-CA 122.74 2.293 . . . . 72.430000000000007 112.323 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.721 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.21 99.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 111.127 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.86 HG12 HD22 ' A' ' 66' ' ' LEU . 14.5 m -77.46 112.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 60.229999999999997 111.053 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.594 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -87.33 175.63 46.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 33.43 112.532 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.867 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.18 -31.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 73.310000000000002 111.081 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -76.59 -21.96 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 62.439999999999998 110.937 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.55 -3.6 35.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.87 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 141.1 56.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 63.100000000000001 110.932 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.749 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 158.56 -150.47 21.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 71.420000000000002 112.422 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 75' ' ' GLY . 4.4 mm -130.63 137.25 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 73.519999999999996 111.115 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.584 ' CG ' HD23 ' A' ' 33' ' ' LEU . 41.3 m-85 -103.11 127.43 50.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 63.509999999999998 110.869 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -124.92 128.37 48.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 70.099999999999994 110.932 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.83 151.25 39.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.109999999999999 110.871 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 71.109999999999999 110.996 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.525 ' HB3' ' OG1' ' A' ' 89' ' ' THR . . . -131.7 163.07 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 54.43 111.125 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 72.3 mmm -129.8 124.84 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.905 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -89.71 170.61 10.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.150000000000006 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -21.81 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.805 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -73.39 -19.97 60.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 71.109999999999999 110.902 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 -7.48 32.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 73.200000000000003 112.455 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 146.59 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 72.140000000000001 110.959 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.0 144.02 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.934 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -103.12 126.17 50.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 72.239999999999995 111.124 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -102.48 142.39 33.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 74.540000000000006 110.98 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -146.46 120.05 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 41.049999999999997 110.882 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 122.47 29.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.019999999999996 110.955 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.48 119.41 22.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 64.510000000000005 110.915 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.487 ' HA ' HG23 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -84.46 134.46 34.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 55.439999999999998 110.924 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.436 HG21 ' CE1' ' A' ' 77' ' ' PHE . 61.8 t -120.91 137.24 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 111.18 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -129.91 130.5 45.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.867 HG21 ' HA ' ' A' ' 71' ' ' ILE . 22.6 m -93.5 -176.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 75.329999999999998 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.34 -77.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 110.958 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.584 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -66.75 140.64 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 74.230000000000004 110.949 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.04 159.69 48.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 72.230000000000004 111.19 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 N--CA 1.465 -0.177 0 C-N-CA 122.786 2.324 . . . . 61.149999999999999 112.339 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.705 0.288 . . . . 75.140000000000001 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -93.14 133.05 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 73.219999999999999 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.69 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -85.06 119.84 25.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 110.896 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.69 HD12 ' O ' ' A' ' 5' ' ' ASN . 1.3 mp -125.83 122.0 61.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.430000000000007 111.122 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -95.84 142.27 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 63.5 111.148 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.14 166.55 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 72.340000000000003 111.141 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.29 148.94 44.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.847 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.597 HD11 ' HB2' ' A' ' 99' ' ' GLN . 38.1 mt -54.38 119.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 53.420000000000002 111.147 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.602 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.92 7.85 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 72.209999999999994 112.418 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.823 ' O ' HG22 ' A' ' 69' ' ' VAL . 37.4 mm-40 -102.55 140.08 20.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 51.25 110.901 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 143.02 49.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.654 2.236 . . . . 64.439999999999998 112.298 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 66' ' ' LEU . 51.5 tp -145.27 143.49 30.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 65.430000000000007 110.882 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.476 HG22 ' CD2' ' A' ' 65' ' ' PHE . 38.3 t -124.08 147.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 71.439999999999998 111.142 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.732 HD12 HD23 ' A' ' 64' ' ' LEU . 59.8 mt -131.39 148.26 52.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.239999999999995 110.996 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 151.88 28.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 72.099999999999994 110.912 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.7 101.5 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.120000000000005 110.897 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -58.93 120.98 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 110.838 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.99 -39.4 2.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.826 -0.702 . . . . 75.030000000000001 112.587 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.6 128.32 46.95 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 72.340000000000003 111.153 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -165.32 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 72.530000000000001 112.387 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.6 52.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 110.913 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.518 0.675 . . . . 55.109999999999999 110.864 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.87 0.367 . . . . 63.240000000000002 110.803 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.405 HD12 ' C ' ' A' ' 29' ' ' LEU . 4.1 pp -135.55 158.6 43.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.915 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.25 148.16 44.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 64.150000000000006 110.876 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -131.75 128.94 39.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 63.350000000000001 110.887 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -137.66 136.0 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 110.891 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.855 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.86 139.37 38.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 72.400000000000006 110.892 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -111.89 126.65 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 63.030000000000001 110.921 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.82 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.6 p -138.52 -179.67 5.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 71.129999999999995 111.137 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.3 -130.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 42.210000000000001 112.511 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.98 -37.14 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 73.299999999999997 110.835 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.0 t -179.3 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 55.149999999999999 111.092 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 38' ' ' THR . 8.3 mm-40 -102.12 34.3 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 72.329999999999998 110.875 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.07 -6.99 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 72.530000000000001 111.178 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.54 ' CZ2' HG22 ' A' ' 43' ' ' VAL . 48.1 t90 -59.5 130.44 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 75.430000000000007 110.908 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.742 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -129.96 153.67 48.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 63.130000000000003 110.831 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.54 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 19.7 t -104.62 113.8 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 62.420000000000002 111.186 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.855 HD22 HD21 ' A' ' 33' ' ' LEU . 10.7 mp -93.32 147.2 23.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 64.209999999999994 110.916 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.7 0.762 . . . . 74.400000000000006 110.9 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.817 0.341 . . . . 72.329999999999998 111.093 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 165.55 16.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 71.120000000000005 110.875 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 45' ' ' SER . 42.6 t -108.63 130.05 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 63.32 111.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 63' ' ' SER . 50.3 mt -69.28 156.96 90.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 73.019999999999996 110.892 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -21.6 33.72 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.769 2.313 . . . . 62.439999999999998 112.344 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -82.19 1.0 38.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.200000000000003 110.927 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.71 26.35 20.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.457 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 58' ' ' VAL . 19.9 m -111.25 179.39 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 54.509999999999998 110.917 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.732 HD23 HD12 ' A' ' 16' ' ' LEU . 11.5 tp -129.89 128.82 42.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.901 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 15' ' ' VAL . 3.8 t80 -125.59 131.3 52.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.897 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.89 HD22 HG12 ' A' ' 69' ' ' VAL . 3.7 mp -114.34 126.9 27.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.649 0.738 . . . . 74.340000000000003 110.978 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -32.02 19.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.74 2.293 . . . . 53.450000000000003 112.289 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.34 99.17 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.128 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 66' ' ' LEU . 15.9 m -73.94 115.7 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 52.329999999999998 111.093 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.53 167.46 28.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 63.409999999999997 112.426 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.854 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.57 -29.98 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 74.109999999999999 111.142 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -75.57 -22.9 56.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.239999999999995 110.912 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -7.92 58.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 75.439999999999998 110.921 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.25 141.1 55.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 64.209999999999994 110.821 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.604 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 157.4 -142.73 8.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 71.230000000000004 112.533 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.604 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.6 mp -130.88 129.29 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 73.200000000000003 111.154 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.737 ' CE2' HD13 ' A' ' 33' ' ' LEU . 18.0 m-85 -103.79 131.07 51.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 71.349999999999994 110.89 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -127.09 140.86 51.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 71.239999999999995 110.915 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.4 153.09 38.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 65.450000000000003 110.887 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -139.76 126.5 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 74.019999999999996 110.825 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.53 161.78 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 72.109999999999999 111.054 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.4 ttm -131.04 125.25 32.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 73.540000000000006 110.859 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -86.82 172.21 10.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 74.439999999999998 110.863 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.19 -18.28 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.86 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.22 -19.84 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.463 . . . . 65.450000000000003 110.919 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.41 -16.54 31.88 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.612 -0.804 . . . . 72.340000000000003 112.436 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -85.26 145.93 27.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.49 144.77 31.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 64.340000000000003 110.871 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.406 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -102.21 130.84 48.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.349999999999994 111.186 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 90' ' ' LYS . 7.1 mmmt -105.08 142.37 34.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 60.119999999999997 110.847 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -144.76 125.07 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 65.230000000000004 110.99 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.48 127.07 45.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -128.3 124.21 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 71.450000000000003 110.968 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 -84.27 132.37 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.230000000000004 110.848 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 77' ' ' PHE . 69.9 t -120.82 134.46 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 72.140000000000001 111.114 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.442 ' NH1' HG21 ' A' ' 100' ' ' ILE . 1.6 mmm180 -131.95 128.17 37.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 63.130000000000003 110.882 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.854 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.2 m -92.93 -175.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 111.151 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -70.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 75.140000000000001 110.963 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.1 mp0 -71.23 139.98 50.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 61.329999999999998 110.924 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.442 HG21 ' NH1' ' A' ' 96' ' ' ARG . 1.1 pt -121.5 159.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.535 0.683 . . . . 74.129999999999995 111.161 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--N 1.34 0.11 0 C-N-CA 122.713 2.276 . . . . 71.400000000000006 112.23 179.89 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.741 0.305 . . . . 54.020000000000003 111.1 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -93.21 132.61 37.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.019999999999996 110.882 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 121.34 27.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 72.239999999999995 110.882 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.8 mm -125.08 120.21 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.101 -0.5 . . . . 74.140000000000001 111.198 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -96.76 137.94 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.41 28.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 111.11 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.51 148.98 44.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.937 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 51.6 mt -51.91 121.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.265 -0.425 . . . . 75.010000000000005 111.125 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.727 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.58 5.95 74.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 72.420000000000002 112.481 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.779 ' O ' HG22 ' A' ' 69' ' ' VAL . 16.2 mm-40 -101.29 139.49 20.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 71.230000000000004 110.89 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.13 49.85 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.655 2.237 . . . . 72.540000000000006 112.315 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 6' ' ' ILE . 28.4 tp -145.18 141.76 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 70.310000000000002 110.875 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.81 148.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 62.200000000000003 111.081 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.516 HD12 HD23 ' A' ' 64' ' ' LEU . 54.8 mt -132.48 148.27 52.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 74.230000000000004 110.957 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.33 153.05 27.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 75.420000000000002 110.83 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 t -105.94 102.31 11.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.340000000000003 110.831 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.6 121.91 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.420000000000002 110.907 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.93 -36.05 2.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.781 -0.723 . . . . 71.310000000000002 112.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.25 39.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 42.329999999999998 111.105 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.5 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.696 2.264 . . . . 63.329999999999998 112.331 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -48.49 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 64.439999999999998 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.54 0.686 . . . . 74.450000000000003 110.899 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.909 0.385 . . . . 61.32 110.823 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -136.82 156.57 48.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 74.019999999999996 110.892 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.79 148.11 51.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 70.239999999999995 110.873 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -117.98 145.52 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 72.430000000000007 110.906 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 33' ' ' LEU . 53.0 mttt -138.04 144.03 40.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 55.0 110.953 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD21 HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 42.030000000000001 110.868 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -115.04 124.01 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 73.319999999999993 110.862 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.799 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.8 p -138.87 178.37 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 74.209999999999994 111.157 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.31 -130.17 11.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 70.409999999999997 112.498 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -112.64 -37.96 4.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.412 . . . . 74.209999999999994 110.93 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.594 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.1 t -179.71 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 72.040000000000006 111.115 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.4 mt-10 -102.38 33.26 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 71.439999999999998 110.918 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.799 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.22 -7.07 7.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 65.040000000000006 111.072 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -62.47 130.15 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 75.5 110.929 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.98 153.28 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.901 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.57 124.78 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 61.100000000000001 111.096 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 HD13 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -86.57 143.79 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.521 . . . . 72.329999999999998 110.969 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.607 0.718 . . . . 53.020000000000003 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.7 0.286 . . . . 60.409999999999997 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -128.18 159.85 33.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 110.811 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.33 131.85 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 64.510000000000005 111.092 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 63' ' ' SER . 36.7 mt -68.07 157.71 86.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.649 0.737 . . . . 61.229999999999997 110.956 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -23.12 31.55 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.702 2.268 . . . . 54.329999999999998 112.339 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.07 1.31 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 25.56 18.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 65.239999999999995 112.47 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.662 ' HB3' HD12 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -106.65 -179.1 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 73.230000000000004 110.849 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.822 HD13 HD11 ' A' ' 44' ' ' LEU . 5.8 tp -129.09 128.56 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.492 . . . . 64.430000000000007 110.848 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' HD12 ' A' ' 64' ' ' LEU . 9.6 t80 -126.16 130.73 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.049999999999997 110.853 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.417 HD22 HG12 ' A' ' 69' ' ' VAL . 3.0 mp -118.41 131.07 24.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 72.319999999999993 110.939 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -34.76 13.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 64.209999999999994 112.336 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.727 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.73 103.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 63.420000000000002 111.049 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.0 m -73.7 118.93 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.549999999999997 111.109 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.38 162.02 31.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 71.200000000000003 112.514 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.823 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.47 -29.47 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 61.399999999999999 111.166 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.16 -22.54 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 61.219999999999999 110.835 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.08 -4.76 56.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.310000000000002 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.43 140.44 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.954 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 154.76 -139.83 6.99 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.701 -0.761 . . . . 43.219999999999999 112.455 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.9 mp -126.81 130.59 71.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 73.340000000000003 111.18 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CD2' HD22 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.85 129.02 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.909 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -126.55 126.15 43.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.907 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 154.5 24.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 52.240000000000002 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.73 135.11 31.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 75.340000000000003 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.08 163.26 29.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 71.109999999999999 111.082 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.14 123.98 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.858 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.28 171.72 9.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 110.877 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -18.71 62.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 62.450000000000003 110.851 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -73.38 -20.11 60.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 53.119999999999997 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.31 32.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 71.219999999999999 112.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -85.27 146.76 26.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 74.439999999999998 110.835 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.33 144.95 31.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.409999999999997 110.869 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.433 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.92 126.69 50.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 62.25 111.153 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -103.14 143.25 32.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.923 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.8 m -143.76 126.75 16.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 110.826 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.1 124.31 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 73.019999999999996 110.909 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -128.84 126.38 39.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 75.340000000000003 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -84.46 131.36 34.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.400000000000006 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.13 133.87 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 62.539999999999999 111.168 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -131.75 128.58 39.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 64.099999999999994 110.928 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.3 m -96.45 -176.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 111.098 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -61.7 -79.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 74.319999999999993 110.925 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -70.71 144.26 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 110.848 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.49 49.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.664 0.745 . . . . 63.210000000000001 111.102 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.694 2.263 . . . . 73.010000000000005 112.372 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.739 0.304 . . . . 60.219999999999999 111.13 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.42 132.57 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 70.430000000000007 110.838 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -90.45 120.47 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 73.400000000000006 110.855 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.916 HG21 HD11 ' A' ' 14' ' ' LEU . 4.6 mp -125.44 122.53 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 65.109999999999999 111.146 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -95.45 142.3 27.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.299999999999997 111.1 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -147.49 167.42 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 65.019999999999996 111.112 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.26 149.18 42.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 65.409999999999997 110.87 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.4 mt -52.19 120.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 51.399999999999999 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.07 10.09 69.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 63.140000000000001 112.475 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.753 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.1 mm-40 -103.31 138.95 19.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.54 0.686 . . . . 74.219999999999999 110.88 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.66 51.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.673 2.248 . . . . 73.109999999999999 112.308 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 6' ' ' ILE . 35.2 tp -144.92 142.02 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.239999999999995 110.983 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' CD2' ' A' ' 65' ' ' PHE . 31.3 t -125.93 148.29 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 75.109999999999999 111.081 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.8 mt -134.77 148.29 50.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.019999999999996 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -112.55 151.53 29.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 110.903 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.1 t -107.28 99.7 9.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 44.5 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -54.37 125.03 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.852 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.97 -41.74 1.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 53.229999999999997 112.51 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.12 43.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.581 0.705 . . . . 62.030000000000001 111.102 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -165.0 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.709 2.272 . . . . 74.209999999999994 112.381 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -49.41 -48.82 46.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.458 . . . . 52.329999999999998 110.794 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.545 0.688 . . . . 73.519999999999996 110.911 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 65.150000000000006 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.8 pp -135.82 160.33 38.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 71.319999999999993 110.981 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -121.26 145.01 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 62.130000000000003 110.864 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -128.38 137.33 51.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.891 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -140.81 139.07 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 75.109999999999999 110.94 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.779 HD22 ' CE2' ' A' ' 77' ' ' PHE . 4.9 tp -137.29 136.0 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 74.140000000000001 110.88 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -114.48 121.54 43.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 72.109999999999999 110.914 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.79 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 73.3 p -137.59 179.36 6.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 43.310000000000002 111.146 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.89 -129.18 9.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.712 -0.756 . . . . 43.420000000000002 112.442 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -112.48 -38.43 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 74.219999999999999 110.827 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 39' ' ' GLU . 9.7 t 179.78 -31.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 74.239999999999995 111.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 38' ' ' THR . 15.4 mt-10 -103.44 33.96 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 62.439999999999998 110.894 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.43 -6.8 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 75.049999999999997 111.083 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.55 132.3 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 74.319999999999993 110.932 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 158.95 38.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 63.340000000000003 110.927 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.07 120.52 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 73.319999999999993 111.136 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.12 147.2 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.893 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.482 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.9 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.120000000000005 110.85 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.724 0.297 . . . . 54.439999999999998 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.6 164.13 18.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.876 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 45' ' ' SER . 42.1 t -107.51 130.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 54.130000000000003 111.055 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.63 158.85 85.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 72.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -22.19 32.46 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.721 2.28 . . . . 32.219999999999999 112.354 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.57 1.34 42.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 110.885 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.41 28.5 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 62.109999999999999 112.488 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 m -111.87 -178.88 3.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 72.209999999999994 110.843 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -128.89 128.93 44.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 73.349999999999994 110.92 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 15' ' ' VAL . 7.8 t80 -125.57 134.82 51.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.844 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.767 HD22 HG12 ' A' ' 69' ' ' VAL . 5.2 mp -114.8 124.45 30.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.657 0.741 . . . . 61.210000000000001 110.922 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -31.77 19.77 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 70.340000000000003 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.57 101.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 63.210000000000001 111.101 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.767 HG12 HD22 ' A' ' 66' ' ' LEU . 35.7 m -71.71 114.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 73.109999999999999 111.138 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.01 159.18 22.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 43.149999999999999 112.493 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.18 -31.0 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 73.340000000000003 111.113 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -77.15 -22.82 51.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.929 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.84 -3.87 37.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 74.150000000000006 110.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 143.3 39.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 73.409999999999997 110.876 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.707 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 159.1 -148.37 17.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 74.120000000000005 112.546 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 75' ' ' GLY . 19.2 mm -131.22 137.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 74.099999999999994 111.071 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CE2' HD22 ' A' ' 33' ' ' LEU . 10.9 m-85 -101.65 127.84 48.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.899 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.32 126.91 45.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.855 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.43 149.8 43.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.835 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -141.95 134.18 27.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 73.129999999999995 110.97 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.15 163.3 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 74.329999999999998 111.114 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ttm -130.55 124.94 32.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 62.299999999999997 110.894 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -86.9 172.28 10.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.400000000000006 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -70.96 -18.53 62.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 54.210000000000001 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.26 -19.9 60.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.849 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.17 -13.69 37.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 54.140000000000001 112.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -85.08 146.38 27.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.705 0.288 . . . . 72.540000000000006 110.963 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.43 144.95 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 54.240000000000002 110.857 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -102.01 132.63 47.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 72.25 111.13 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -98.96 143.48 29.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 73.010000000000005 110.9 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 m -144.66 121.14 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.878 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.18 120.13 25.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.019999999999996 110.873 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -129.67 119.71 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.869 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.499 ' HG2' HD12 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -86.79 135.44 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 61.340000000000003 110.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.6 t -120.94 136.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 75.329999999999998 111.093 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -131.06 142.88 50.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.868 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.0 m -106.3 -175.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 64.120000000000005 111.092 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -67.69 -81.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 110.989 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -62.85 145.45 55.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 110.855 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.43 159.67 49.24 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.723 0.773 . . . . 63.299999999999997 111.052 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.5 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.708 2.272 . . . . 63.130000000000003 112.318 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.729 0.3 . . . . 61.109999999999999 111.1 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 133.75 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.530000000000001 110.849 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -90.3 121.29 32.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 62.420000000000002 110.864 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 14' ' ' LEU . 4.6 mp -124.76 122.15 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 71.329999999999998 111.141 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -94.62 140.14 30.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.144 -0.48 . . . . 44.240000000000002 111.117 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.66 167.65 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.299999999999997 111.076 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.13 43.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 71.310000000000002 110.819 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.614 HD11 ' HB2' ' A' ' 99' ' ' GLN . 28.9 mt -52.12 120.44 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 111.119 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.666 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.61 10.35 70.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 73.310000000000002 112.457 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.785 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.7 mm-40 -102.7 139.46 20.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.69 0.757 . . . . 74.510000000000005 110.889 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.98 49.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.667 2.245 . . . . 54.299999999999997 112.342 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 6' ' ' ILE . 49.9 tp -145.42 143.32 30.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 110.864 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.88 147.75 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 111.101 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -132.2 150.21 52.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 61.329999999999998 110.917 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -111.71 151.52 28.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.240000000000002 110.904 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -107.3 100.82 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 110.938 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -54.16 125.09 17.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 110.827 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.508 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.47 -43.21 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.729 . . . . 50.299999999999997 112.512 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.45 42.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 74.209999999999994 111.012 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 -161.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.613 2.209 . . . . 73.450000000000003 112.408 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -48.26 -47.02 36.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 110.938 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 65.510000000000005 110.866 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.841 0.353 . . . . 71.430000000000007 110.87 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 29' ' ' LEU . 4.6 pp -138.54 157.28 46.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 110.879 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -121.77 145.86 47.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 62.240000000000002 110.848 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -120.24 143.64 48.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 74.5 111.03 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -148.88 135.44 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.299999999999997 110.896 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.773 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -141.23 138.31 33.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 72.219999999999999 110.921 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.49 126.11 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.530000000000001 110.807 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.839 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.5 p -138.72 -178.9 5.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 73.530000000000001 111.038 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -127.27 9.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.713 -0.756 . . . . 75.120000000000005 112.517 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' O ' ' HB ' ' A' ' 38' ' ' THR . 12.0 mpt_? -112.79 -38.64 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 73.409999999999997 110.875 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t 178.97 -29.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 111.124 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -102.43 34.08 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 64.219999999999999 110.913 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.99 -6.96 8.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 55.310000000000002 111.063 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -70.06 129.07 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.952 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -137.18 159.25 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.809 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.2 121.96 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 111.167 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' CD1' HD23 ' A' ' 33' ' ' LEU . 6.9 mt -89.23 144.67 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 65.420000000000002 110.888 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 72.510000000000005 110.898 -179.891 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.826 0.346 . . . . 54.450000000000003 111.122 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.79 161.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 61.439999999999998 110.904 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 63' ' ' SER . 50.5 t -108.23 130.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 74.219999999999999 111.073 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 63' ' ' SER . 47.3 mt -69.01 156.98 90.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 64.420000000000002 110.927 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.95 32.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.254 . . . . 65.209999999999994 112.331 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -81.48 0.39 38.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 73.340000000000003 110.91 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.88 30.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 74.299999999999997 112.525 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.7 m -106.38 -179.55 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.951 0.405 . . . . 60.409999999999997 110.851 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.6 tp -130.21 130.74 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.129999999999995 110.969 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.632 ' N ' HD12 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -124.89 130.36 52.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.019999999999996 110.892 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.893 HD22 HG12 ' A' ' 69' ' ' VAL . 3.0 mp -117.19 127.12 26.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 75.120000000000005 110.899 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -32.37 18.57 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.804 2.336 . . . . 64.120000000000005 112.382 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.666 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.45 100.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 32.140000000000001 111.101 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.893 HG12 HD22 ' A' ' 66' ' ' LEU . 15.3 m -78.01 113.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 111.156 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -87.82 173.85 43.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 73.200000000000003 112.44 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.876 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.7 -32.23 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 75.230000000000004 111.109 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -77.26 -21.61 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.928 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -5.61 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 62.210000000000001 110.833 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 142.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 65.140000000000001 110.958 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 159.71 -151.49 22.24 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.734 -0.746 . . . . 53.399999999999999 112.463 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 75' ' ' GLY . 5.4 mm -131.38 134.85 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 75.409999999999997 111.093 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.773 ' CE2' HD22 ' A' ' 33' ' ' LEU . 50.1 m-85 -103.96 132.82 49.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 74.019999999999996 110.856 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.03 134.17 50.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.78 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.73 148.12 45.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 64.530000000000001 110.902 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -142.4 127.43 18.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.903 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.38 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 44.130000000000003 111.083 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ttm -130.64 125.66 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.549999999999997 110.926 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.58 171.92 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 74.349999999999994 110.95 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -19.15 61.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 71.049999999999997 110.802 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.9 -20.24 60.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 61.539999999999999 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.56 35.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 71.319999999999993 112.472 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 146.32 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.662 0.268 . . . . 64.409999999999997 110.886 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -105.63 142.62 35.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 73.230000000000004 110.863 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.508 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.96 131.09 50.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 74.519999999999996 111.085 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.42 142.85 34.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.150000000000006 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -146.1 123.61 11.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 60.140000000000001 110.816 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.13 122.28 31.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 54.219999999999999 110.819 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.02 118.81 24.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 62.229999999999997 110.94 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 134.16 34.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.886 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.415 HG22 HD21 ' A' ' 14' ' ' LEU . 57.7 t -120.5 135.73 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 111.142 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -130.65 131.61 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 75.349999999999994 110.854 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -96.51 -176.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 73.349999999999994 111.164 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -67.4 -78.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 70.329999999999998 110.939 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.614 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 73.420000000000002 110.953 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.07 159.45 49.31 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.319999999999993 111.084 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 C-N-CA 122.647 2.231 . . . . 70.340000000000003 112.415 179.918 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.67 0.272 . . . . 52.32 111.031 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -93.92 133.12 37.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 110.935 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -89.5 121.63 31.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.582 HG21 HD11 ' A' ' 14' ' ' LEU . 4.0 mp -123.83 120.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 72.129999999999995 111.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 p -96.7 142.47 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.13 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.43 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 51.219999999999999 111.132 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.69 147.97 40.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 64.450000000000003 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 121.3 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 111.14 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.658 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.48 5.89 74.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 55.25 112.497 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.795 ' O ' HG22 ' A' ' 69' ' ' VAL . 48.7 mm-40 -101.47 141.43 22.58 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.606 0.717 . . . . 75.239999999999995 110.831 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.78 52.21 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.606 2.204 . . . . 74.040000000000006 112.384 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 6' ' ' ILE . 54.8 tp -144.48 143.14 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.437 . . . . 72.310000000000002 110.902 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.436 HG22 ' HD2' ' A' ' 65' ' ' PHE . 20.4 t -121.84 146.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 74.099999999999994 111.153 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.762 HD12 HD23 ' A' ' 64' ' ' LEU . 12.5 mt -131.41 148.28 52.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.951 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 152.04 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 70.019999999999996 110.972 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.9 t -107.08 99.88 9.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 53.109999999999999 110.871 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.66 123.56 14.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 51.450000000000003 110.908 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.18 -39.4 2.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.530000000000001 112.483 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 131.28 37.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 65.209999999999994 111.101 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -163.96 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.675 2.25 . . . . 53.030000000000001 112.32 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -50.09 30.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 64.239999999999995 110.871 179.846 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.875 0.369 . . . . 70.049999999999997 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.48 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.6 159.11 42.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 53.229999999999997 110.93 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.09 139.59 53.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 71.400000000000006 110.885 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.48 ' HE1' HD13 ' A' ' 29' ' ' LEU . 13.2 m95 -121.34 139.09 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -139.05 137.07 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 61.399999999999999 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.623 HD22 HG23 ' A' ' 35' ' ' THR . 2.0 tt -138.82 134.09 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 73.530000000000001 110.918 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.594 ' N ' HD23 ' A' ' 33' ' ' LEU . 1.8 m-80 -115.77 125.18 52.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.852 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 44.8 p -138.43 -179.5 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.129 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.61 -130.83 13.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.748 -0.739 . . . . 60.039999999999999 112.481 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -112.84 -37.56 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 73.129999999999995 110.905 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t -179.74 -29.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 61.130000000000003 111.187 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.1 mt-10 -101.97 33.6 2.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.896 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.75 -7.23 7.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 54.100000000000001 111.121 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -60.26 130.41 46.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.919 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HZ2' ' HB3' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.52 153.45 49.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 74.140000000000001 110.907 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.54 121.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 51.219999999999999 111.191 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.65 145.96 24.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 110.942 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.567 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.664 0.745 . . . . 74.150000000000006 110.88 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.819 0.342 . . . . 63.130000000000003 111.07 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -123.25 159.25 29.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.9 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 45' ' ' SER . 18.8 t -108.38 130.17 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 72.420000000000002 111.132 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.5 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.4 mt -69.06 157.64 88.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.54 0.686 . . . . 74.230000000000004 110.947 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -21.8 32.77 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.622 2.215 . . . . 71.420000000000002 112.357 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -84.24 1.44 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.420000000000002 110.908 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.86 32.83 8.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.803 -0.713 . . . . 71.400000000000006 112.451 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.5 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.4 m -115.35 179.11 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 65.010000000000005 110.868 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.762 HD23 HD12 ' A' ' 16' ' ' LEU . 20.4 tp -129.47 128.22 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.847 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HD2' HG22 ' A' ' 15' ' ' VAL . 38.3 t80 -126.78 136.61 52.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.81 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD22 HG12 ' A' ' 69' ' ' VAL . 1.4 mp -118.45 130.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 74.200000000000003 110.974 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -34.87 13.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 64.010000000000005 112.336 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.58 101.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 111.1 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.4 m -72.65 113.22 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 61.350000000000001 111.11 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.85 161.82 33.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 62.009999999999998 112.478 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.871 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.84 -30.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 74.099999999999994 111.152 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.1 -20.43 57.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.933 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -3.55 29.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 73.120000000000005 110.871 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.697 ' CD ' HG22 ' A' ' 97' ' ' VAL . 27.5 mt-10 -57.13 142.52 42.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.340000000000003 110.866 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.651 ' C ' HD13 ' A' ' 76' ' ' ILE . . . 158.75 -153.99 25.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.674 -0.774 . . . . 62.130000000000003 112.41 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD13 ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -123.81 134.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.156 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.4 t80 -104.0 127.54 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.852 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.2 128.86 47.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 63.43 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 7.0 t -120.54 150.2 41.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 51.030000000000001 110.891 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.85 133.7 29.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 62.299999999999997 110.927 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.81 162.99 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 71.099999999999994 111.129 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 25.0 mtp -129.69 124.77 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 71.409999999999997 110.967 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.21 172.82 9.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.87 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -70.71 -19.03 62.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 75.329999999999998 110.922 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.83 -20.05 60.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.43 40.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.82 -0.705 . . . . 60.329999999999998 112.547 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.08 146.87 26.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 71.109999999999999 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -105.05 142.5 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 75.450000000000003 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.462 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -103.72 131.84 50.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.519999999999996 111.122 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -102.53 143.56 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.84 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 t -144.39 125.72 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -126.83 122.07 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.896 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 121.77 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 74.129999999999995 110.883 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.549 ' HE ' HG23 ' A' ' 76' ' ' ILE . 27.5 mmm-85 -83.79 134.01 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 64.540000000000006 110.905 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.35 128.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 61.219999999999999 111.079 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.09 142.93 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 110.91 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.871 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.8 m -108.86 -174.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 71.140000000000001 111.176 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -67.3 -79.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 110.85 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -63.09 145.99 54.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 70.310000000000002 110.932 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.2 159.59 49.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 111.204 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.3 Cg_endo . . . . . 0 C--N 1.342 0.222 0 C-N-CA 122.756 2.304 . . . . 72.230000000000004 112.355 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.797 0.332 . . . . 74.409999999999997 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.57 132.38 37.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 75.209999999999994 110.906 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 3.5 p30 -83.84 122.49 28.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.519999999999996 110.99 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.537 ' CG2' HD11 ' A' ' 14' ' ' LEU . 48.8 mm -124.6 121.64 61.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 73.299999999999997 111.116 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -95.92 141.86 28.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.420000000000002 111.061 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.52 166.04 29.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 55.299999999999997 111.077 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -124.67 148.91 47.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.47 . . . . 75.349999999999994 110.92 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 99' ' ' GLN . 55.9 mt -54.57 121.21 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 70.25 111.103 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.526 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.61 5.44 81.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 61.420000000000002 112.541 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 48.8 mm-40 -102.26 139.6 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.561 0.696 . . . . 73.140000000000001 110.938 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 144.76 55.33 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.69 2.26 . . . . 75.409999999999997 112.351 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 6' ' ' ILE . 17.3 tp -143.43 141.35 30.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.86 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG22 ' HD1' ' A' ' 65' ' ' PHE . 41.2 t -126.04 145.12 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 63.340000000000003 111.061 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.8 mt -131.83 147.12 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.899 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -114.56 154.17 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 62.420000000000002 110.858 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.3 t -105.43 100.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.129999999999995 110.831 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -57.03 123.38 14.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.899 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.63 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.42 -43.52 1.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.782 -0.723 . . . . 63.439999999999998 112.496 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.67 131.26 36.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.523 0.678 . . . . 75.430000000000007 111.12 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.16 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.661 2.241 . . . . 74.109999999999999 112.351 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.1 -53.25 21.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.439999999999998 110.812 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptp . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.91 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.914 0.388 . . . . 72.120000000000005 110.841 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -137.07 155.04 50.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 110.891 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.89 140.86 51.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 74.25 110.885 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -123.72 141.35 52.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.914 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HG2' HG13 ' A' ' 43' ' ' VAL . 27.4 mtmt -144.4 140.38 28.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 51.450000000000003 110.844 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.774 HD22 ' CE2' ' A' ' 77' ' ' PHE . 6.0 tp -137.55 136.33 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.221 -0.445 . . . . 72.010000000000005 110.936 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -115.4 120.49 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 110.838 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.3 p -138.08 -179.82 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 73.140000000000001 111.131 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.32 -130.36 9.82 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 32.43 112.453 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -112.45 -38.77 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 72.019999999999996 110.912 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 39' ' ' GLU . 8.5 t 179.42 -30.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.143 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.3 mt-10 -103.22 33.89 3.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 63.439999999999998 110.92 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.26 -7.47 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 54.310000000000002 111.128 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -61.92 129.8 42.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.927 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 158.42 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 75.200000000000003 110.88 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 32' ' ' LYS . 22.8 t -94.84 122.21 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 111.152 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.99 144.69 25.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.517 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.718 0.771 . . . . 64.319999999999993 110.814 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.74 0.305 . . . . 72.129999999999995 111.065 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.534 ' O ' HD12 ' A' ' 64' ' ' LEU . 40.3 mmm-85 -126.79 158.52 36.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 74.450000000000003 110.874 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 45' ' ' SER . 6.8 t -109.14 130.82 61.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.127 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 33.4 mt -68.84 158.3 86.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 50.409999999999997 110.851 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -22.24 32.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 72.310000000000002 112.413 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.43 1.61 40.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 110.898 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.91 29.3 13.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 44.009999999999998 112.538 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 6.3 m -112.74 -178.64 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 71.150000000000006 110.852 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 57' ' ' ARG . 50.1 tp -128.27 128.98 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 61.25 110.906 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HD1' HG22 ' A' ' 15' ' ' VAL . 12.6 t80 -125.64 136.6 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.82 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.776 HD22 HG12 ' A' ' 69' ' ' VAL . 7.0 mp -119.1 127.63 26.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.574 0.702 . . . . 71.129999999999995 110.898 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.93 -32.81 17.15 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.69 2.26 . . . . 75.549999999999997 112.336 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.14 102.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 111.167 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 23.7 m -71.98 117.19 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 55.240000000000002 111.11 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.81 160.11 28.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 73.409999999999997 112.525 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.866 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -33.86 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 65.519999999999996 111.129 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -77.69 -21.56 51.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.125 -0.489 . . . . 70.239999999999995 110.956 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.08 -4.73 40.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.834 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -58.97 142.7 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 110.875 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.745 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 162.63 -148.32 15.14 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.727 -0.749 . . . . 64.230000000000004 112.444 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.1 mp -130.67 133.71 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 74.409999999999997 111.084 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CE2' HD22 ' A' ' 33' ' ' LEU . 11.8 m-85 -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 64.239999999999995 110.926 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.98 126.97 44.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 110.903 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.6 t -121.16 151.11 40.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.010000000000005 110.913 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -139.44 133.9 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 54.340000000000003 110.917 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.82 163.63 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 111.176 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' A' ' 82' ' ' MET . 7.2 mmm -129.23 124.69 35.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.288 -0.415 . . . . 54.049999999999997 110.84 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.93 170.1 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 110.811 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -73.8 -18.32 60.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 63.409999999999997 110.825 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -72.89 -20.12 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 60.439999999999998 110.843 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.45 -20.04 21.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.7 -0.762 . . . . 73.219999999999999 112.508 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.7 147.86 26.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 74.239999999999995 110.916 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -103.67 145.27 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.63 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -98.04 132.51 43.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 71.340000000000003 111.073 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.02 139.97 37.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 71.329999999999998 110.872 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.1 m -146.7 120.74 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 63.439999999999998 110.891 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.42 123.29 31.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 64.510000000000005 110.909 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -130.14 120.6 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.818 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -88.87 136.13 33.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 74.049999999999997 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.1 t -120.54 137.51 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 70.140000000000001 111.132 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -128.42 146.61 50.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.519999999999996 110.937 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.866 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.4 m -107.11 -176.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 111.111 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -68.11 -77.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 65.200000000000003 110.912 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.496 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -64.31 144.55 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.962 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.412 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.15 160.44 45.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.6 0.714 . . . . 61.350000000000001 111.17 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.176 0 C-N-CA 122.731 2.287 . . . . 73.519999999999996 112.364 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.704 0.288 . . . . 64.030000000000001 111.128 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 132.46 38.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 72.5 110.89 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.7 121.2 32.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.329999999999998 110.876 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.87 122.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 111.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -96.0 142.13 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 61.229999999999997 111.036 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -144.61 168.23 20.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 111.071 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 149.34 46.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 75.140000000000001 110.859 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.69 HD11 HG13 ' A' ' 71' ' ' ILE . 27.8 mt -65.06 120.49 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 53.119999999999997 111.147 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.77 -12.24 57.82 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.654 -0.784 . . . . 72.310000000000002 112.421 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.1 pp20? -101.45 140.88 21.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 110.946 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 145.01 55.9 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 71.019999999999996 112.348 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 8' ' ' ALA . 14.3 tp -137.77 142.46 40.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.921 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.6 t -123.1 146.72 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 72.219999999999999 111.128 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.734 HD13 ' CD2' ' A' ' 77' ' ' PHE . 4.6 mt -131.84 151.92 51.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.917 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -111.63 149.71 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.230000000000004 110.856 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.81 101.64 9.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 110.935 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -54.09 99.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 110.916 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.61 -47.34 0.65 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.628 -0.796 . . . . 73.150000000000006 112.473 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.31 103.58 12.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 70.310000000000002 111.128 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.4 Cg_endo -69.79 -161.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.71 2.273 . . . . 63.25 112.325 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.59 -8.08 8.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.853 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ASN . 1.1 mptt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 51.520000000000003 110.942 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.748 0.309 . . . . 72.230000000000004 110.936 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.616 HD13 ' CD1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -179.22 161.31 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 60.119999999999997 111.002 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.43 137.15 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 62.439999999999998 110.917 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.616 ' CD1' HD13 ' A' ' 29' ' ' LEU . 17.0 m95 -125.05 143.82 50.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.477 . . . . 72.310000000000002 110.972 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -148.66 136.26 20.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 73.450000000000003 110.86 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 34' ' ' ASN . 1.1 tp -138.62 138.07 37.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.922 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.631 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -112.62 126.83 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 61.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.828 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 19.7 p -137.57 179.81 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 111.15 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.12 -132.72 17.29 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.736 -0.745 . . . . 74.209999999999994 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.65 -37.26 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 75.239999999999995 110.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.591 HG23 ' HG3' ' A' ' 39' ' ' GLU . 3.5 t -179.38 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 64.299999999999997 111.085 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HG3' HG23 ' A' ' 38' ' ' THR . 14.9 mt-10 -101.5 33.67 2.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 74.329999999999998 110.885 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.62 -6.5 7.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 54.299999999999997 111.085 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -59.53 129.75 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 60.219999999999999 110.895 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.74 153.15 50.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 73.200000000000003 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.18 123.31 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 53.299999999999997 111.045 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.59 145.0 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.319999999999993 110.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.413 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.754 . . . . 72.230000000000004 110.822 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.812 0.339 . . . . 70.209999999999994 111.132 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.83 157.33 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 52.520000000000003 110.895 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 45' ' ' SER . 45.9 t -114.55 127.02 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.115 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 6.4 mp -69.69 157.91 88.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.662 0.744 . . . . 73.549999999999997 110.841 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.77 -22.8 31.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.245 . . . . 73.219999999999999 112.295 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 2.3 p-10 -83.52 4.02 29.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 63.299999999999997 110.86 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.96 13.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.802 -0.713 . . . . 60.520000000000003 112.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 3.2 m -114.63 178.6 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.407 . . . . 45.32 110.839 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.715 HD23 HD12 ' A' ' 16' ' ' LEU . 13.3 tp -130.09 127.88 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 73.25 110.986 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -126.26 130.27 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.857 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mp -120.93 130.31 24.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.649 0.737 . . . . 60.100000000000001 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.64 18.27 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 72.510000000000005 112.39 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.66 103.4 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 62.100000000000001 111.146 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 12' ' ' GLU . 30.9 m -73.01 121.91 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.469 . . . . 73.120000000000005 111.1 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.08 156.42 22.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.683 -0.77 . . . . 62.229999999999997 112.489 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.766 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.91 -30.18 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.305 . . . . 73.349999999999994 111.129 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -73.97 -23.74 59.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 62.299999999999997 110.849 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.43 -5.0 45.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.923 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 141.06 58.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.869 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.583 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.39 -138.91 6.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 63.399999999999999 112.413 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.583 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.4 mp -129.13 127.64 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 52.310000000000002 111.152 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.734 ' CD2' HD13 ' A' ' 16' ' ' LEU . 1.5 t80 -104.5 131.1 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.420000000000002 110.859 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HE ' ' C ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -127.08 137.36 53.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 72.040000000000006 110.944 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.8 t -119.95 149.07 42.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.939 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.99 127.07 19.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.897 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.59 163.87 27.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.109999999999999 111.094 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ttm -128.75 125.29 37.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 65.049999999999997 110.885 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -86.93 173.21 9.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 61.399999999999999 110.887 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -70.32 -18.13 63.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 110.848 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.14 -19.93 61.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.329999999999998 110.882 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.75 -16.37 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 71.409999999999997 112.478 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 146.76 27.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.727 0.299 . . . . 73.099999999999994 110.881 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.26 143.4 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 55.039999999999999 110.9 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.92 130.38 51.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 54.030000000000001 111.193 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -105.49 144.85 31.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 52.310000000000002 110.917 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.417 ' C ' ' HE ' ' A' ' 78' ' ' ARG . 74.0 m -144.44 125.82 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 74.340000000000003 110.824 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.06 123.59 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 74.299999999999997 110.943 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.83 118.84 24.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 110.93 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -82.66 129.89 35.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 74.530000000000001 110.97 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.97 131.05 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 74.109999999999999 111.197 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' HG21 ' A' ' 100' ' ' ILE . 4.1 tpt180 -130.78 128.32 40.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 65.340000000000003 110.826 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.766 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -95.08 -177.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 64.010000000000005 111.095 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -66.95 -82.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.340000000000003 110.89 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -58.02 137.91 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.873 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.403 HG21 ' NH2' ' A' ' 96' ' ' ARG . 1.0 OUTLIER -120.0 160.08 44.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 63.229999999999997 111.188 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 62.32 112.314 179.897 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.741 0.305 . . . . 61.530000000000001 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -93.69 134.94 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.299999999999997 110.875 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -85.81 121.78 28.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 71.519999999999996 110.852 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.602 ' CG2' HD11 ' A' ' 14' ' ' LEU . 45.9 mm -125.19 121.57 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.085 -0.507 . . . . 64.129999999999995 111.211 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -96.55 142.01 29.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 52.109999999999999 111.188 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.27 166.04 29.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 74.510000000000005 111.173 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -124.31 148.18 47.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 72.019999999999996 110.887 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.456 HD11 HG13 ' A' ' 71' ' ' ILE . 25.6 mt -54.21 121.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 64.540000000000006 111.174 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.57 4.34 80.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.776 -0.726 . . . . 72.219999999999999 112.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.777 ' O ' HG22 ' A' ' 69' ' ' VAL . 23.2 mm-40 -102.08 140.15 20.92 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 71.200000000000003 110.931 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 144.07 52.85 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.709 2.272 . . . . 62.219999999999999 112.305 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.602 HD11 ' CG2' ' A' ' 6' ' ' ILE . 25.5 tp -144.41 141.71 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.871 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 65' ' ' PHE . 22.0 t -122.28 147.38 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 61.310000000000002 111.161 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -132.02 148.72 52.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 70.530000000000001 110.934 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -111.82 151.3 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 110.946 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.4 t -107.38 99.9 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 54.32 110.918 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -57.62 121.24 9.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 74.049999999999997 110.898 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.01 -39.4 1.91 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.786 -0.721 . . . . 60.310000000000002 112.515 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.53 43.67 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.544 0.688 . . . . 72.420000000000002 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.676 2.251 . . . . 74.319999999999993 112.397 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -49.36 -48.45 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.030000000000001 110.918 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.504 0.669 . . . . 75.450000000000003 110.915 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.846 0.355 . . . . 62.240000000000002 110.832 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.6 pp -136.58 151.83 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.439999999999998 110.852 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.86 148.14 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.040000000000006 110.879 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.27 139.91 53.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 110.946 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.727 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.34 135.46 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 73.319999999999993 110.887 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.83 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -138.25 137.62 37.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.943 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -113.52 126.76 55.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 52.43 110.882 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.82 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 24.5 p -136.71 179.78 6.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 111.181 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.17 -119.69 6.83 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.648 -0.787 . . . . 71.409999999999997 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 38' ' ' THR . 9.2 mpt_? -114.57 -38.96 3.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.530000000000001 110.946 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 174.51 -27.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 31.5 111.103 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.64 33.2 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.865 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.27 -7.55 8.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 111.12 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -60.72 129.77 43.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.200000000000003 110.878 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 153.71 51.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 65.150000000000006 110.907 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 32' ' ' LYS . 12.0 m -88.81 122.35 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 70.140000000000001 111.109 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -88.2 145.22 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 72.230000000000004 110.846 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.716 0.769 . . . . 71.129999999999995 110.798 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.783 0.325 . . . . 64.319999999999993 111.106 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 159.58 33.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 64.019999999999996 110.888 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 63' ' ' SER . 19.4 t -113.33 130.58 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 111.158 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.64 HD12 ' CB ' ' A' ' 63' ' ' SER . 77.4 mt -68.55 157.55 87.83 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 64.329999999999998 110.889 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.632 2.221 . . . . 71.25 112.353 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -83.42 -0.15 48.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.812 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.4 9.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 15.42 112.461 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.64 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.1 m -111.65 179.6 3.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 72.310000000000002 110.898 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.34 128.08 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.482 . . . . 73.420000000000002 110.947 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CD1' HG22 ' A' ' 15' ' ' VAL . 9.5 t80 -126.68 132.83 51.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.629 HD22 HG12 ' A' ' 69' ' ' VAL . 7.6 mp -114.78 128.35 25.98 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.518 0.675 . . . . 71.400000000000006 110.985 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.29 19.12 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.651 2.234 . . . . 61.340000000000003 112.411 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.44 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -164.8 102.36 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 53.229999999999997 111.151 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 12' ' ' GLU . 28.9 m -72.09 118.97 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 42.119999999999997 111.167 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.37 158.64 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 63.32 112.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.787 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.74 -30.37 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 71.219999999999999 111.182 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.5 -23.11 56.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 74.219999999999999 110.92 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.38 -5.09 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 70.099999999999994 110.783 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.03 140.9 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 74.329999999999998 110.885 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.66 -139.57 6.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.82 -0.705 . . . . 24.300000000000001 112.476 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.648 HG23 ' HD2' ' A' ' 94' ' ' ARG . 1.7 mp -131.78 135.34 58.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 73.319999999999993 111.11 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.83 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.2 m-85 -104.67 126.75 52.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 54.229999999999997 110.838 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.1 mmm180 -126.39 130.65 51.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 110.915 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.17 151.22 39.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 73.25 110.86 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -140.54 129.44 23.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 163.35 28.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 55.119999999999997 111.05 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.3 ttm -129.54 125.41 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 65.040000000000006 110.876 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.48 171.77 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -17.41 62.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.868 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.58 -25.13 61.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 71.109999999999999 110.894 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.94 -20.23 13.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 73.140000000000001 112.538 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.09 146.87 26.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.733 0.301 . . . . 72.530000000000001 110.868 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.04 145.39 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.834 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.77 131.89 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.520000000000003 111.212 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -105.05 142.66 34.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 72.209999999999994 110.917 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -145.93 126.95 14.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 72.239999999999995 110.913 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.77 127.25 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 110.822 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -129.03 124.3 34.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 65.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.648 ' HD2' HG23 ' A' ' 76' ' ' ILE . 30.3 mmm-85 -82.61 135.53 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 72.530000000000001 110.933 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.456 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.5 t -123.98 132.5 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.010000000000005 111.232 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.0 128.4 40.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.340000000000003 110.908 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.3 m -93.71 -176.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 73.530000000000001 111.149 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -66.35 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 64.310000000000002 110.874 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -63.93 145.87 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 70.150000000000006 110.945 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.53 159.48 50.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.509 0.671 . . . . 74.549999999999997 111.202 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.15 0 C-N-CA 122.759 2.306 . . . . 64.010000000000005 112.284 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.742 0.306 . . . . 44.240000000000002 111.118 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.0 132.9 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 110.9 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -86.98 120.97 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.86 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.64 122.74 63.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 111.076 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.08 142.17 28.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 111.075 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.66 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.450000000000003 111.11 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.45 148.23 44.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.299999999999997 110.84 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 99' ' ' GLN . 21.8 mt -57.77 122.16 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 64.430000000000007 111.141 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.708 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.13 4.22 78.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.673 -0.775 . . . . 51.539999999999999 112.519 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.778 ' O ' HG22 ' A' ' 69' ' ' VAL . 43.7 mm-40 -101.18 140.4 21.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.712 0.768 . . . . 71.349999999999994 110.879 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.49 45.46 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.669 2.246 . . . . 73.109999999999999 112.375 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 66' ' ' LEU . 19.8 tp -144.48 141.98 29.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 73.340000000000003 111.029 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.84 148.6 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 62.509999999999998 111.081 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.956 HD12 HD23 ' A' ' 64' ' ' LEU . 15.1 mt -130.56 147.94 52.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.896 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.95 31.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.868 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.4 100.79 8.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 72.400000000000006 110.875 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.64 122.05 7.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 53.439999999999998 110.916 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.471 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.55 -47.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.837 -0.697 . . . . 43.119999999999997 112.511 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.96 102.2 10.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 61.210000000000001 111.065 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.1 Cg_endo -69.75 -161.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.625 2.217 . . . . 31.239999999999998 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -11.15 5.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 64.439999999999998 110.916 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mptt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.662 0.744 . . . . 71.120000000000005 110.866 179.933 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.843 0.354 . . . . 71.040000000000006 110.92 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 29' ' ' LEU . 2.3 pp -172.3 174.23 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.120000000000005 110.897 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.43 131.16 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.809 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -124.09 128.95 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 75.519999999999996 110.856 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -138.41 137.79 37.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 73.109999999999999 110.842 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 77' ' ' PHE . 2.4 tp -137.75 136.94 37.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 54.130000000000003 110.899 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.92 126.39 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.319999999999993 110.85 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.85 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 70.5 p -138.58 -179.35 5.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 62.119999999999997 111.083 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.26 -126.64 10.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.817 -0.706 . . . . 71.200000000000003 112.489 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 38' ' ' THR . 49.1 mmm-85 -112.61 -38.62 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.040000000000006 110.808 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t 178.93 -29.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 72.450000000000003 111.159 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HG3' HG23 ' A' ' 38' ' ' THR . 67.9 mt-10 -102.16 34.28 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.85 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.6 -7.01 8.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 55.219999999999999 111.14 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -63.07 131.23 47.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 75.140000000000001 110.927 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 154.27 47.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 61.240000000000002 110.904 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.29 117.01 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 72.409999999999997 111.073 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.29 149.71 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 64.400000000000006 110.927 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.659 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.751 0.786 . . . . 73.019999999999996 110.802 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.578 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 111.111 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 161.42 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 73.140000000000001 110.876 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 45' ' ' SER . 51.9 t -107.65 128.26 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 111.121 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 63' ' ' SER . 54.4 mt -70.31 158.68 87.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 60.219999999999999 110.926 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.4 Cg_endo -69.83 -22.42 31.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.649 2.233 . . . . 73.540000000000006 112.301 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.93 1.6 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.897 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 30.86 11.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 72.299999999999997 112.519 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.529 ' HB2' HD12 ' A' ' 59' ' ' LEU . 4.3 m -112.65 178.26 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 72.329999999999998 110.833 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.956 HD23 HD12 ' A' ' 16' ' ' LEU . 8.9 tp -131.62 130.62 42.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 64.310000000000002 110.89 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 6.8 t80 -124.57 128.2 48.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 110.913 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.8 mp -119.69 131.65 24.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 64.430000000000007 110.918 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -32.7 18.39 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 42.219999999999999 112.396 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.62 101.75 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.086 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.3 m -72.98 118.83 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 72.430000000000007 111.118 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.51 163.78 35.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 62.420000000000002 112.451 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.5 -29.97 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 54.030000000000001 111.049 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -74.41 -22.32 59.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 74.239999999999995 110.808 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -5.96 47.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 74.519999999999996 110.912 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 8.8 pt-20 -60.0 141.99 54.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.841 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.66 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 158.24 -142.28 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 44.100000000000001 112.537 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.66 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.1 mp -130.94 135.48 59.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 111.195 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -101.6 127.39 48.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 110.766 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 131.62 52.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 74.549999999999997 110.886 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 0.5 OUTLIER -122.63 150.09 43.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 75.200000000000003 110.866 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -148.9 125.65 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 54.109999999999999 110.851 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.57 27.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 72.510000000000005 111.103 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.22 125.23 27.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.310000000000002 110.872 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.59 170.79 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 70.430000000000007 110.854 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -72.69 -18.74 61.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 72.25 110.889 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -73.01 -20.03 61.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 64.319999999999993 110.883 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.54 -11.25 33.02 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.772 -0.728 . . . . 73.299999999999997 112.527 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -84.77 145.39 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 75.549999999999997 110.898 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.42 145.49 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 65.450000000000003 110.876 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.471 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -101.28 126.55 48.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 111.152 -179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 134.54 48.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 64.140000000000001 110.97 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . 73.9 m -144.68 120.08 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 53.200000000000003 110.788 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.11 121.02 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 73.510000000000005 110.876 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.57 127.16 36.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.96 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -83.88 136.8 33.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 63.140000000000001 110.934 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.17 130.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 74.150000000000006 111.091 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.84 128.82 39.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 71.230000000000004 110.871 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.3 m -93.5 -177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 111.131 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -63.02 -69.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 73.540000000000006 110.884 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.588 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -76.98 138.92 39.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.963 179.941 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.29 159.54 49.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.716 0.769 . . . . 51.420000000000002 111.114 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 74.420000000000002 112.317 179.916 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.684 0.278 . . . . 71.219999999999999 111.147 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -92.64 134.64 34.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.92 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -83.21 120.79 26.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 71.510000000000005 110.914 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.478 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.8 mm -125.4 120.89 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.119999999999997 111.174 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -96.53 142.38 28.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 75.040000000000006 111.126 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.534 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -147.1 164.98 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 50.030000000000001 111.12 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.36 148.94 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.821 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mt -56.13 121.36 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 63.409999999999997 111.156 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.572 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.6 3.31 86.44 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.668 -0.777 . . . . 53.049999999999997 112.536 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.79 ' O ' HG22 ' A' ' 69' ' ' VAL . 49.7 mm-40 -101.17 140.89 21.66 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.564 0.697 . . . . 63.520000000000003 110.972 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 143.83 51.94 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.599 2.199 . . . . 72.019999999999996 112.411 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 8' ' ' ALA . 62.3 tp -144.35 142.88 30.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 74.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.53 146.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 62.030000000000001 111.178 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.415 HD13 ' CG ' ' A' ' 77' ' ' PHE . 75.0 mt -131.42 147.24 52.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 65.439999999999998 110.924 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -113.17 151.08 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.829 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.8 t -108.25 100.48 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 64.209999999999994 110.844 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.73 126.97 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 74.109999999999999 110.887 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.48 -38.84 2.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 65.25 112.518 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.41 31.1 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.536 0.684 . . . . 71.010000000000005 111.15 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -164.23 0.12 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 54.350000000000001 112.339 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.1 -50.96 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.88 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 54.450000000000003 110.909 179.791 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.878 0.371 . . . . 74.120000000000005 110.895 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -135.94 144.54 45.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 72.530000000000001 110.95 179.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -122.07 133.01 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.887 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.47 ' CE2' HD13 ' A' ' 29' ' ' LEU . 4.6 m0 -121.18 144.76 48.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 73.400000000000006 110.887 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.748 ' C ' HD13 ' A' ' 33' ' ' LEU . 5.7 mptt -136.49 138.26 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 110.885 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.122 HD21 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -134.57 141.44 46.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 110.886 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -111.95 125.33 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 70.140000000000001 110.886 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.829 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 28.8 p -138.58 -179.24 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 111.124 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.54 -129.57 9.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 62.409999999999997 112.497 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -112.48 -37.23 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.747 0.308 . . . . 61.310000000000002 110.83 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t 176.81 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 111.192 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.52 33.64 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 74.019999999999996 110.945 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.829 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.54 -6.75 9.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 64.310000000000002 111.146 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -59.84 129.16 40.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.319999999999993 110.91 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.786 ' HE3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -137.4 161.11 37.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 54.149999999999999 110.85 179.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 32' ' ' LYS . 45.8 t -99.5 122.87 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 111.175 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.122 HD23 HD21 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -88.45 143.33 27.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.902 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.607 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 52.109999999999999 110.815 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.748 0.309 . . . . 75.409999999999997 111.132 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.93 159.52 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 74.209999999999994 110.879 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 45' ' ' SER . 7.9 t -108.95 130.34 62.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 111.181 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 63' ' ' SER . 66.5 mt -69.23 157.15 90.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 71.430000000000007 110.933 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.04 32.77 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 74.319999999999993 112.273 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -82.88 0.39 44.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 63.229999999999997 110.9 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.54 28.2 13.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 70.530000000000001 112.418 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 59' ' ' LEU . 6.0 m -112.0 -179.18 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 61.109999999999999 110.919 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD23 HD12 ' A' ' 16' ' ' LEU . 16.5 tp -128.53 127.4 42.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 62.100000000000001 110.9 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -126.9 132.06 50.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 110.819 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.786 HD22 HG12 ' A' ' 69' ' ' VAL . 3.5 mp -115.33 130.83 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 73.409999999999997 110.921 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.79 -32.83 17.68 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.679 2.253 . . . . 74.120000000000005 112.36 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.73 101.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 74.120000000000005 111.157 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.2 m -76.58 118.54 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 53.109999999999999 111.229 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.99 165.39 34.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.731 . . . . 41.420000000000002 112.414 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.731 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.87 -31.12 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 71.5 111.136 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.19 -22.59 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 62.140000000000001 110.914 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -5.35 44.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 110.88 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.7 142.21 50.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.876 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.758 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 156.16 -152.34 23.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.801 -0.714 . . . . 61.439999999999998 112.521 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 75' ' ' GLY . 6.9 mm -124.81 135.22 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.25 111.097 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.778 ' CD2' HD12 ' A' ' 33' ' ' LEU . 21.9 t80 -103.38 131.66 50.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 62.32 110.836 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 138.4 54.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 110.837 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.86 42.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.019999999999996 110.857 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.36 125.34 19.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.848 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.38 163.91 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 33.509999999999998 111.091 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttm -129.69 125.66 36.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.464 . . . . 53.109999999999999 110.855 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.86 172.61 10.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 64.239999999999995 110.912 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -70.34 -18.04 63.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 54.530000000000001 110.914 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 55.43 110.881 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -18.78 32.93 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.733 . . . . 73.030000000000001 112.481 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 147.84 26.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.313 . . . . 74.239999999999995 110.906 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -103.74 144.8 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 110.878 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -101.84 131.86 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 111.159 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 145.43 27.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 72.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 t -143.79 127.96 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 42.539999999999999 110.826 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.401 HD21 HG21 ' A' ' 76' ' ' ILE . 28.7 t-20 -128.31 129.26 46.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 61.539999999999999 110.853 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.82 126.03 33.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.109999999999999 110.919 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.431 ' HD2' HD12 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -84.51 131.42 34.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 74.349999999999994 110.858 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.4 t -120.7 130.07 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 111.115 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 128.64 38.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.150000000000006 110.863 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.4 m -94.26 -177.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 111.076 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -62.12 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 63.229999999999997 110.927 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.66 143.43 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 63.329999999999998 110.956 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.45 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.41 159.75 48.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 70.400000000000006 111.12 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 72.150000000000006 112.319 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.79 0.329 . . . . 61.030000000000001 111.089 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -93.16 132.72 37.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 64.040000000000006 110.928 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.36 122.78 32.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 74.319999999999993 110.849 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.3 mm -124.2 126.27 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.230000000000004 111.163 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -94.09 142.37 27.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 75.25 111.233 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.49 168.98 20.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 72.430000000000007 111.088 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.63 148.9 40.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 63.140000000000001 110.916 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 99' ' ' GLN . 28.8 mt -54.17 121.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 73.519999999999996 111.111 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.697 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.06 12.37 65.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 63.229999999999997 112.502 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 5.3 mm-40 -102.7 138.31 19.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 73.209999999999994 110.908 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 143.14 50.55 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.697 2.265 . . . . 64.239999999999995 112.401 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.7 tp -145.68 143.05 29.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 75.430000000000007 110.891 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.1 144.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 111.106 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 64' ' ' LEU . 52.1 mt -131.39 147.55 52.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.854 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -113.77 153.33 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.855 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 t -104.28 100.88 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 62.140000000000001 110.832 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -56.01 123.52 14.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.852 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.582 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.73 -39.85 2.02 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.663 -0.78 . . . . 33.420000000000002 112.504 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.34 129.44 43.23 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.517 0.675 . . . . 72.099999999999994 111.152 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -163.91 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.787 2.325 . . . . 62.340000000000003 112.313 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -49.01 -48.2 43.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 53.329999999999998 110.909 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.586 0.708 . . . . 72.040000000000006 110.928 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.884 0.373 . . . . 74.530000000000001 110.878 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 29' ' ' LEU . 4.0 pp -135.61 156.06 49.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 75.25 110.932 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -121.55 147.67 45.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 64.140000000000001 110.958 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -130.49 130.0 43.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 73.439999999999998 110.883 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' C ' HD23 ' A' ' 33' ' ' LEU . 11.3 mtmm -136.52 136.91 39.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 71.340000000000003 110.844 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.785 HD21 HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.35 138.54 38.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.926 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -111.83 126.34 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 71.549999999999997 110.952 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 76.1 p -137.99 179.56 6.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 111.186 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.54 -129.93 14.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.791 -0.719 . . . . 71.219999999999999 112.449 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -112.65 -37.68 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 72.120000000000005 110.878 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 39' ' ' GLU . 6.5 t -179.12 -31.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.510000000000005 111.129 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.57 ' HG2' HG23 ' A' ' 38' ' ' THR . 5.0 mm-40 -102.57 33.94 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 74.340000000000003 110.945 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.93 -6.42 8.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 111.165 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -59.36 131.72 51.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 64.530000000000001 110.985 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.703 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -128.52 153.53 47.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 64.099999999999994 110.866 -179.913 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.68 120.28 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 63.530000000000001 111.148 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.785 HD12 HD21 ' A' ' 33' ' ' LEU . 15.4 mt -95.83 146.75 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 75.019999999999996 110.899 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.5 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.1 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.678 0.751 . . . . 74.230000000000004 110.847 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 65' ' ' PHE . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.841 0.353 . . . . 71.519999999999996 111.052 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' HD12 ' A' ' 64' ' ' LEU . 49.4 mmm-85 -114.36 160.9 18.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 65.219999999999999 110.831 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 45' ' ' SER . 49.5 t -109.44 129.68 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 111.15 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 63' ' ' SER . 40.0 mt -69.47 157.87 88.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.582 0.706 . . . . 75.310000000000002 110.883 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -23.0 31.01 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.677 2.251 . . . . 62.0 112.284 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -82.96 1.14 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.899 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.24 29.84 11.86 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.772 -0.728 . . . . 72.310000000000002 112.484 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB2' HD12 ' A' ' 59' ' ' LEU . 14.7 m -112.62 -179.43 3.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.399 . . . . 71.129999999999995 110.846 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.617 HD23 HD12 ' A' ' 16' ' ' LEU . 22.1 tp -129.14 130.84 46.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 110.898 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.46 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 45.1 t80 -123.87 130.48 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 55.229999999999997 110.909 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.757 HD22 HG12 ' A' ' 69' ' ' VAL . 5.1 mp -116.86 124.15 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 73.349999999999994 110.929 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -32.8 18.05 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 62.020000000000003 112.314 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.697 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.48 101.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.42 . . . . 62.539999999999999 111.151 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 13.9 m -72.84 112.2 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 74.430000000000007 111.064 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.53 164.69 36.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.745 -0.74 . . . . 73.319999999999993 112.475 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.894 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.81 -33.46 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 72.400000000000006 111.086 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -77.6 -22.04 51.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 62.299999999999997 110.84 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -5.07 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 62.240000000000002 110.916 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.659 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.15 142.16 52.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 51.439999999999998 110.827 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 161.48 -148.12 15.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 31.309999999999999 112.537 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 75' ' ' GLY . 1.2 mm -129.71 135.59 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 65.239999999999995 111.154 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 33' ' ' LEU . 52.8 m-85 -104.43 123.97 48.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.877 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 126.95 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 73.530000000000001 110.858 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.6 t -121.59 153.93 37.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -141.0 140.08 34.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 64.129999999999995 110.928 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 162.41 30.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 53.130000000000003 111.152 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 75.9 mmm -130.14 125.24 34.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 71.109999999999999 110.888 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -88.44 170.8 10.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 64.420000000000002 110.853 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -72.94 -22.48 60.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 64.040000000000006 110.888 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.54 -20.43 60.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.340000000000003 110.915 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.8 -2.86 31.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 75.109999999999999 112.515 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.56 146.46 27.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 74.439999999999998 110.938 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.32 142.42 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 75.209999999999994 110.955 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.582 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.2 129.67 51.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.165 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.82 141.46 34.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 74.049999999999997 110.922 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 58.7 m -145.92 120.13 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 33.219999999999999 110.844 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.72 121.92 25.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.907 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 91' ' ' SER . 6.9 m-85 -131.96 120.61 22.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 75.349999999999994 110.906 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.476 ' HA ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -85.14 132.6 34.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 71.439999999999998 110.881 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.6 t -120.66 136.03 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 72.109999999999999 111.199 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.75 151.22 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 63.240000000000002 110.89 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.894 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.5 m -112.06 -175.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 73.209999999999994 111.158 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -67.29 -76.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.896 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -64.02 137.31 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 62.140000000000001 110.909 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.01 159.87 47.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.665 0.745 . . . . 71.25 111.135 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 73.120000000000005 112.325 179.895 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.718 0.294 . . . . 63.350000000000001 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.521 HE21 HD11 ' A' ' 6' ' ' ILE . 1.1 tt0 -93.65 135.18 35.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 61.520000000000003 110.98 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.616 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.6 p30 -90.42 122.91 33.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.109999999999999 110.875 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 5' ' ' ASN . 1.7 mp -125.39 124.56 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.239999999999995 111.164 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -89.61 144.17 26.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 61.509999999999998 111.147 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.645 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -140.54 165.68 26.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 71.340000000000003 111.038 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 110.887 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.432 HG12 ' HB3' ' A' ' 98' ' ' TYR . 18.5 mm -61.74 120.47 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 111.173 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.769 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 79.34 10.84 85.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 75.230000000000004 112.472 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.6 mm-40 -101.44 140.69 21.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.609 0.718 . . . . 74.340000000000003 110.841 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 143.48 51.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.236 . . . . 71.340000000000003 112.37 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 tp -144.58 142.39 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 63.32 110.897 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.433 HG22 ' HD1' ' A' ' 65' ' ' PHE . 39.3 t -122.23 148.19 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.230000000000004 111.239 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.6 mt -131.54 148.05 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 61.509999999999998 110.824 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -113.33 152.53 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 71.430000000000007 110.877 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.0 t -107.09 102.24 11.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.109999999999999 110.868 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -58.19 123.25 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.915 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.668 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.57 -37.97 2.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 51.039999999999999 112.49 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.66 128.63 45.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.553 0.692 . . . . 73.540000000000006 111.109 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -164.28 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.657 2.238 . . . . 72.310000000000002 112.345 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -49.31 -48.92 45.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 52.240000000000002 110.9 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 72.209999999999994 110.846 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.772 0.32 . . . . 74.299999999999997 110.922 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.9 pp -135.94 157.93 45.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.899 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -123.08 147.17 47.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 74.409999999999997 110.841 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 44' ' ' LEU . 2.7 m95 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.040000000000006 110.988 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -151.84 137.13 17.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 73.129999999999995 110.835 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.769 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -140.9 138.29 33.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 75.230000000000004 110.954 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.83 127.35 55.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 65.239999999999995 110.818 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 42.9 p -140.52 -179.34 5.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 71.120000000000005 111.123 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.9 -120.45 5.31 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 72.150000000000006 112.528 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.67 ' O ' HG23 ' A' ' 38' ' ' THR . 29.6 mmm180 -114.68 -39.72 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 110.863 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 173.66 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.329999999999998 111.139 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.37 33.46 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.875 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.42 -7.48 9.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 111.119 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -63.09 130.43 44.61 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.151 -0.477 . . . . 71.439999999999998 110.931 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.432 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -135.67 158.91 43.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 71.019999999999996 110.885 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.84 121.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 70.329999999999998 111.114 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.549 ' CD1' HD23 ' A' ' 33' ' ' LEU . 8.7 mp -89.7 145.27 25.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.871 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.536 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 70.510000000000005 110.833 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.836 0.35 . . . . 64.239999999999995 111.071 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -127.14 159.84 33.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.842 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 45' ' ' SER . 14.4 t -108.71 130.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.171 -0.468 . . . . 61.340000000000003 111.149 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.8 mt -68.41 157.93 86.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 71.209999999999994 110.936 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -23.04 30.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.754 2.303 . . . . 75.400000000000006 112.337 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -83.24 0.68 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.898 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.4 29.38 11.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 73.340000000000003 112.484 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.506 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.43 -178.95 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 54.420000000000002 110.881 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -128.76 130.06 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.129999999999995 110.831 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HD1' HG22 ' A' ' 15' ' ' VAL . 12.9 t80 -124.05 130.72 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 70.409999999999997 110.861 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD22 HG12 ' A' ' 69' ' ' VAL . 7.1 mp -118.15 131.0 24.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.594 0.712 . . . . 72.150000000000006 110.9 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -38.29 8.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 73.099999999999994 112.377 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -164.19 103.8 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 42.329999999999998 111.084 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.7 m -73.97 115.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 51.439999999999998 111.135 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.58 165.76 29.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 75.120000000000005 112.479 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.803 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.02 -30.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 75.150000000000006 111.131 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.09 -22.57 55.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 64.109999999999999 110.88 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.463 ' O ' HG21 ' A' ' 35' ' ' THR . 0.4 OUTLIER -80.65 -1.55 42.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.779 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.21 141.12 58.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 63.020000000000003 110.932 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.602 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 160.91 -145.17 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 74.329999999999998 112.456 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.7 mp -130.58 134.72 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 74.219999999999999 111.045 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.769 ' CE2' HD22 ' A' ' 33' ' ' LEU . 13.3 m-85 -103.44 135.29 45.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 75.230000000000004 110.832 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.01 130.71 48.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 64.120000000000005 110.874 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 147.93 43.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 41.030000000000001 110.875 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -146.09 126.96 14.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 110.917 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.26 162.67 30.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 60.32 111.084 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 33.8 tpp -130.15 125.76 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.938 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.52 171.63 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 65.420000000000002 110.879 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -18.56 62.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 64.340000000000003 110.901 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -73.35 -19.78 60.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 51.509999999999998 110.865 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.16 37.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.58 -0.819 . . . . 72.400000000000006 112.369 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -84.78 145.73 27.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.689 0.281 . . . . 73.420000000000002 110.916 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -105.58 142.22 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 50.200000000000003 110.877 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.668 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -104.05 129.7 51.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 64.420000000000002 111.054 -179.894 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -105.72 144.13 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.983 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -145.65 120.63 10.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 54.310000000000002 110.877 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -121.28 120.76 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 75.530000000000001 110.888 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -127.72 126.6 42.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 70.329999999999998 110.94 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.5 mmm-85 -91.11 135.65 33.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.892 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 77' ' ' PHE . 56.4 t -120.79 130.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 111.211 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.19 127.65 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 71.140000000000001 110.949 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.803 HG21 ' HA ' ' A' ' 71' ' ' ILE . 18.2 m -91.1 -176.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 72.310000000000002 111.148 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.432 ' HB3' HG12 ' A' ' 10' ' ' ILE . 40.5 t80 -75.84 -76.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -58.68 148.03 30.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 75.120000000000005 110.917 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.464 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.29 159.37 50.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.565 0.698 . . . . 70.019999999999996 111.093 -179.975 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 100' ' ' ILE . 52.8 Cg_endo . . . . . 0 C--O 1.231 0.167 0 C-N-CA 122.568 2.178 . . . . 65.540000000000006 112.343 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.666 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.751 0.31 . . . . 65.239999999999995 111.048 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.61 133.25 37.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 53.219999999999999 110.917 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -84.65 120.76 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 110.91 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.584 HG21 HD11 ' A' ' 14' ' ' LEU . 46.2 mm -125.88 121.98 60.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 65.239999999999995 111.119 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -94.19 139.83 30.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 74.439999999999998 111.143 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.76 167.0 26.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 111.088 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.37 148.12 44.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 73.030000000000001 110.876 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 71' ' ' ILE . 32.1 mt -52.51 121.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 74.530000000000001 111.222 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.72 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.76 7.72 70.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 74.439999999999998 112.476 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.7 mm-40 -101.76 139.43 20.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 62.310000000000002 110.822 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 143.05 49.4 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.682 2.255 . . . . 70.319999999999993 112.286 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.584 HD11 HG21 ' A' ' 6' ' ' ILE . 25.7 tp -145.58 141.84 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 75.099999999999994 110.95 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.6 t -123.16 146.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 111.13 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.536 HD12 HD23 ' A' ' 64' ' ' LEU . 58.4 mt -130.87 146.62 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.921 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.47 152.13 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 110.87 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.1 t -107.34 100.73 10.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 44.229999999999997 110.869 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -58.96 122.04 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 63.140000000000001 110.89 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.583 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.53 -38.42 2.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 42.100000000000001 112.466 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.35 44.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.519 0.676 . . . . 53.219999999999999 111.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.64 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.752 2.301 . . . . 74.239999999999995 112.374 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -49.65 -49.89 45.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 72.329999999999998 110.913 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 72.109999999999999 110.91 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.798 0.332 . . . . 51.020000000000003 110.877 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -136.19 155.27 50.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.929 179.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -120.87 148.52 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.030000000000001 110.952 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 1.1 m95 -127.73 145.05 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.948 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -145.08 144.25 30.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 110.889 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -134.92 134.98 41.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 73.109999999999999 110.908 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -117.92 120.83 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 34.32 110.867 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.809 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.1 p -141.44 179.52 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 53.030000000000001 111.096 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.81 -133.26 20.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 73.400000000000006 112.568 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.7 mmm-85 -112.77 -36.78 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 72.200000000000003 110.914 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.535 HG23 ' HG3' ' A' ' 39' ' ' GLU . 2.3 t -179.16 -27.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 75.120000000000005 111.114 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.0 mt-10 -100.72 32.59 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 74.219999999999999 110.859 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -126.17 -6.68 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.299999999999997 111.089 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 t90 -73.92 128.14 34.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.921 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.71 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -137.63 159.07 43.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 75.239999999999995 110.958 179.939 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.2 t -87.2 121.54 38.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 111.094 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.45 146.76 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.917 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.574 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 61.340000000000003 110.875 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.758 0.313 . . . . 73.310000000000002 111.107 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -122.79 159.74 27.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.815 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 45' ' ' SER . 52.9 t -107.92 129.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 72.230000000000004 111.114 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 63' ' ' SER . 45.4 mt -69.1 156.13 92.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.521 0.676 . . . . 53.43 110.951 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.3 Cg_endo -69.76 -22.2 32.39 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.672 2.248 . . . . 71.439999999999998 112.309 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -83.32 0.6 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 73.420000000000002 110.892 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.51 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.773 -0.727 . . . . 75.140000000000001 112.575 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.687 ' HB2' HD12 ' A' ' 59' ' ' LEU . 9.1 m -113.7 178.88 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 73.430000000000007 110.863 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD23 HD12 ' A' ' 16' ' ' LEU . 12.9 tp -128.81 127.52 42.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.905 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' HD12 ' A' ' 64' ' ' LEU . 46.5 t80 -126.17 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 71.420000000000002 110.922 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.707 HD22 HG12 ' A' ' 69' ' ' VAL . 2.9 mp -117.83 128.18 26.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.532 0.682 . . . . 45.119999999999997 110.942 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.15 17.19 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.661 2.241 . . . . 74.010000000000005 112.33 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.72 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.73 101.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 51.310000000000002 111.118 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.06 113.28 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 111.139 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.65 36.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.694 -0.765 . . . . 75.129999999999995 112.501 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.66 -30.02 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.777 0.323 . . . . 73.150000000000006 111.086 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.14 -23.77 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 73.230000000000004 110.918 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.61 -5.18 57.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.9 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.76 141.4 58.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 73.420000000000002 110.791 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.632 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 157.66 -138.93 6.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 32.520000000000003 112.481 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.632 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.0 mp -130.1 135.55 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 75.420000000000002 111.125 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.826 ' CE2' HD12 ' A' ' 33' ' ' LEU . 8.4 m-85 -102.61 134.8 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.019999999999996 110.906 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 92' ' ' ASN . 1.6 mmt180 -128.02 127.66 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.530000000000001 110.915 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.6 t -121.56 149.48 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 52.030000000000001 110.9 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.46 132.55 23.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 62.210000000000001 110.878 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 162.26 30.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 62.140000000000001 111.082 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.2 ttm -130.36 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 73.549999999999997 110.857 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.42 170.96 11.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 74.530000000000001 110.857 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -17.81 62.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.91 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -73.37 -25.59 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 71.219999999999999 110.841 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.01 19.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 24.039999999999999 112.496 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -84.59 146.78 27.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 74.030000000000001 110.94 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.24 142.34 35.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.041 0.448 . . . . 74.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.583 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.54 131.84 49.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 70.209999999999994 111.145 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -104.97 140.86 37.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 73.030000000000001 110.984 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.57 127.23 14.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 61.32 110.876 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -124.74 129.4 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 54.450000000000003 110.856 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.439 ' CG ' HD22 ' A' ' 16' ' ' LEU . 8.4 m-85 -127.92 118.01 22.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 75.109999999999999 110.884 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.666 HH11 ' HB1' ' A' ' 3' ' ' ALA . 11.5 mmm-85 -85.57 130.33 34.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 54.140000000000001 110.891 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 77' ' ' PHE . 77.4 t -122.54 132.25 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 70.109999999999999 111.105 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -131.17 128.26 39.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.976 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.4 m -93.86 -176.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 75.530000000000001 111.126 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.03 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 110.919 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.86 145.71 54.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 110.924 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.58 49.65 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.691 0.758 . . . . 75.409999999999997 111.105 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.5 Cg_endo . . . . . 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 70.340000000000003 112.358 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.528 -0.229 . . . . 65.209999999999994 112.528 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 61.76 102.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 75.129999999999995 110.798 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.46 69.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 74.409999999999997 111.136 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.05 132.63 36.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.842 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 3.1 p30 -90.05 121.22 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.230000000000004 110.849 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.65 122.42 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 111.178 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -95.07 141.62 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 72.540000000000006 111.134 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.02 167.19 25.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 62.020000000000003 111.015 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.64 148.45 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.239999999999995 110.843 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.424 HD11 HG13 ' A' ' 71' ' ' ILE . 16.0 mt -52.45 120.43 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 61.439999999999998 111.132 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.82 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 89.28 8.92 67.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.712 -0.756 . . . . 73.230000000000004 112.526 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.791 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.1 mm-40 -101.71 138.32 19.81 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.652 0.739 . . . . 73.430000000000007 110.889 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 143.14 49.57 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.677 2.251 . . . . 72.319999999999993 112.258 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 66' ' ' LEU . 12.4 tp -145.92 141.36 27.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 71.420000000000002 110.877 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.443 HG22 ' HD1' ' A' ' 65' ' ' PHE . 45.8 t -127.9 139.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 111.197 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.589 HD12 ' CD2' ' A' ' 77' ' ' PHE . 45.2 mt -132.19 149.02 52.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.445 . . . . 60.5 110.878 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -112.72 153.24 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 64.140000000000001 110.918 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 t -105.83 100.71 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 62.399999999999999 110.895 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -54.19 128.91 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.855 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.439 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.01 -40.84 1.8 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.711 -0.756 . . . . 64.430000000000007 112.499 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.25 129.74 42.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.539 0.685 . . . . 72.049999999999997 111.078 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -164.22 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.555 2.17 . . . . 74.540000000000006 112.354 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -48.46 -49.12 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.923 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -110.11 150.4 41.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 55.340000000000003 110.934 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 109.83 2.4 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.756 2.304 . . . . 54.109999999999999 112.326 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.3 Cg_endo -69.77 -85.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.657 2.238 . . . . 44.409999999999997 112.339 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -103.44 -177.54 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 52.43 110.854 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 143.2 58.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 73.540000000000006 110.835 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.682 HD13 ' CE2' ' A' ' 31' ' ' TRP . 1.5 pp -136.2 149.4 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.477 . . . . 60.030000000000001 110.877 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -121.28 127.03 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 75.430000000000007 110.862 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.682 ' CE2' HD13 ' A' ' 29' ' ' LEU . 32.0 m0 -118.08 144.72 45.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 62.310000000000002 110.944 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.667 ' HE2' HG22 ' A' ' 43' ' ' VAL . 5.3 ttmt -136.77 139.27 41.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 73.530000000000001 110.902 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.743 HD22 ' HE3' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -137.42 138.9 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 75.0 110.914 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -115.21 119.31 35.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.846 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.806 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.7 p -136.28 179.49 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 73.540000000000006 111.183 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.4 -132.11 14.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.799 -0.715 . . . . 72.129999999999995 112.499 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -112.68 -37.76 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 73.200000000000003 110.828 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.597 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.3 t -179.47 -29.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 74.209999999999994 111.141 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.597 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.5 mt-10 -102.12 34.26 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.530000000000001 110.84 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.53 -6.24 8.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 73.409999999999997 111.126 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -59.31 128.98 39.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.5 110.861 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.743 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -136.24 158.88 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 61.030000000000001 110.908 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.667 HG22 ' HE2' ' A' ' 32' ' ' LYS . 19.0 t -101.65 123.76 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 111.129 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.1 mt -87.25 144.02 27.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.2 -0.454 . . . . 72.200000000000003 110.941 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.826 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -127.41 163.43 42.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 75.519999999999996 110.854 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.0 Cg_endo -69.76 0.31 5.82 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.702 2.268 . . . . 60.340000000000003 112.311 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -149.61 89.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 70.230000000000004 110.953 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.08 -43.17 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 51.32 112.566 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 43.14 37.4 3.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.744 -0.741 . . . . 60.140000000000001 112.522 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.55 -175.24 13.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 72.140000000000001 112.47 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 130.21 18.96 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.697 2.265 . . . . 62.329999999999998 112.405 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -83.7 -34.12 25.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 72.109999999999999 110.841 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -25.83 67.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 75.409999999999997 110.927 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.03 -47.6 8.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 63.520000000000003 110.888 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.528 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -130.13 -99.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 63.030000000000001 111.035 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.572 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -165.26 173.74 10.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 75.219999999999999 111.207 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -119.11 160.44 22.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.040000000000006 110.826 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.826 HG21 ' O ' ' A' ' 45' ' ' SER . 43.0 t -108.01 128.73 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 111.108 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.0 mt -68.51 156.46 90.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.686 0.755 . . . . 64.519999999999996 110.893 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -22.97 31.41 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.74 2.293 . . . . 75.099999999999994 112.301 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -82.98 0.05 46.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.903 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.61 13.35 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.769 -0.729 . . . . 52.340000000000003 112.431 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.581 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.4 m -109.68 179.0 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.386 . . . . 61.240000000000002 110.868 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 65' ' ' PHE . 9.8 tp -128.36 128.33 44.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 73.310000000000002 110.961 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' N ' HD12 ' A' ' 64' ' ' LEU . 7.1 t80 -125.95 129.73 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 64.299999999999997 110.843 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.707 HD22 HG12 ' A' ' 69' ' ' VAL . 2.3 mp -117.19 130.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 63.439999999999998 110.84 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -34.8 13.91 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.718 2.278 . . . . 72.420000000000002 112.339 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.82 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.21 100.86 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 111.111 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.1 m -73.45 114.68 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 71.549999999999997 111.143 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.29 166.94 42.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.824 -0.703 . . . . 55.109999999999999 112.433 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.797 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.93 -31.05 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.308 . . . . 73.049999999999997 111.116 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -76.25 -21.96 55.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.409999999999997 110.93 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -5.44 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 74.439999999999998 110.909 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.23 140.47 55.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 74.299999999999997 110.877 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.629 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 164.7 -147.46 12.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.654 -0.784 . . . . 71.549999999999997 112.449 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.57 135.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.952 0.406 . . . . 70.049999999999997 111.041 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.589 ' CD2' HD12 ' A' ' 16' ' ' LEU . 8.6 m-85 -100.05 124.92 45.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 71.25 110.852 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 127.25 40.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.884 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 149.45 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 61.100000000000001 110.945 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -142.62 126.24 16.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.13 162.48 31.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 111.093 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.9 tpp -130.27 125.86 35.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 63.32 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -86.49 170.79 11.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 74.310000000000002 110.859 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -72.7 -17.58 61.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 71.25 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -72.1 -21.04 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.928 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.05 -21.46 17.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.708 . . . . 24.050000000000001 112.496 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 145.88 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.279 . . . . 72.019999999999996 110.903 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.25 145.11 32.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 74.409999999999997 110.903 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.439 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.07 127.86 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.049999999999997 111.102 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.18 145.5 30.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 62.340000000000003 110.936 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.7 m -144.33 121.23 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 110.916 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' B' ' 5' ' ' ALA . 3.8 t-20 -126.63 119.3 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 71.420000000000002 110.913 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -132.03 118.11 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.049999999999997 110.874 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -87.49 133.56 33.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 44.329999999999998 110.851 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.7 t -120.28 138.36 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.219999999999999 111.114 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 127.96 39.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 74.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.797 HG21 ' HA ' ' A' ' 71' ' ' ILE . 30.6 m -87.42 -177.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 75.519999999999996 111.102 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -60.64 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 62.509999999999998 110.953 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -72.1 143.53 49.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 63.030000000000001 110.947 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.486 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.28 159.52 49.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.7 0.762 . . . . 54.310000000000002 111.084 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.486 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.7 Cg_endo -69.74 178.5 4.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.681 2.254 . . . . 64.409999999999997 112.415 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.49 -36.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.707 -0.759 . . . . 73.049999999999997 112.533 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.34 68.5 7.18 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.575 0.703 . . . . 74.099999999999994 110.857 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 171.52 14.34 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.59 2.194 . . . . 64.019999999999996 112.311 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 65.319999999999993 110.85 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.818 0.342 . . . . 63.229999999999997 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.96 67.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 73.310000000000002 110.887 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER 60.04 -167.2 0.18 Allowed 'General case' 0 C--O 1.182 -2.497 0 CA-C-O 118.201 -0.904 . . . . 73.439999999999998 110.853 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.432 ' C ' ' O ' ' B' ' 3' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 94' ' ' ARG . . . -53.01 152.06 4.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 54.329999999999998 111.145 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -172.64 115.97 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.030000000000001 110.885 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 70.420000000000002 110.904 -179.905 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 112.501 -0.239 . . . . 50.439999999999998 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 65.05 112.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 70.219999999999999 110.85 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.51 55.16 9.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 53.109999999999999 111.117 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.417 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -92.91 138.19 31.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 110.915 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.98 120.88 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.310000000000002 110.887 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 4' ' ' GLN . 4.7 mp -126.13 127.47 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 111.144 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -95.31 141.78 28.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 74.239999999999995 111.215 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.496 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -145.01 165.41 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 34.100000000000001 111.069 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.19 149.5 42.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.019999999999996 110.916 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 15.3 mt -57.41 121.04 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 43.43 111.069 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.48 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.8 8.13 73.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.777 -0.725 . . . . 70.450000000000003 112.586 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.796 ' O ' HG22 ' A' ' 69' ' ' VAL . 35.1 mm-40 -102.7 138.69 19.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.573 0.702 . . . . 72.239999999999995 110.911 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 143.95 51.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 72.120000000000005 112.269 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.0 tp -144.96 141.08 28.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 65' ' ' PHE . 48.9 t -125.44 145.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 51.340000000000003 111.146 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.2 mt -131.25 148.09 52.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 62.020000000000003 110.941 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 152.75 29.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 54.340000000000003 110.961 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.0 t -106.18 100.6 10.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 51.299999999999997 110.897 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 124.35 14.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 71.140000000000001 110.841 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.93 -42.65 1.49 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.774 -0.726 . . . . 62.240000000000002 112.491 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.51 128.19 51.82 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.538 0.685 . . . . 54.219999999999999 111.153 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.6 Cg_endo -69.8 -164.46 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.62 2.213 . . . . 62.130000000000003 112.316 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.32 -47.89 46.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 53.399999999999999 110.841 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.71 154.95 38.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.554 0.693 . . . . 71.109999999999999 110.865 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.467 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.0 Cg_endo -69.75 109.56 2.34 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.781 2.321 . . . . 44.350000000000001 112.359 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 52.9 Cg_endo -69.76 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.754 2.303 . . . . 73.230000000000004 112.291 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -104.04 -178.19 3.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 64.409999999999997 110.927 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -64.82 135.77 56.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 70.400000000000006 110.829 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 46' ' ' PRO . 3.4 pp -135.64 161.75 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 110.957 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -121.26 147.63 45.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.895 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -124.23 137.96 54.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 61.450000000000003 110.891 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -141.23 140.13 33.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 65.450000000000003 110.859 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.649 HD22 ' CE2' ' A' ' 77' ' ' PHE . 6.1 tp -138.1 134.26 34.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 74.420000000000002 110.988 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.91 ' HB3' ' CE2' ' B' ' 3' ' ' PHE . 12.8 t-20 -116.01 121.17 41.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 64.530000000000001 110.879 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 4.2 p -138.99 179.37 6.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 63.219999999999999 111.195 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.4 10.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 45.450000000000003 112.412 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -112.42 -36.63 5.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.888 0.375 . . . . 75.450000000000003 110.859 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 t 176.74 -29.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -102.57 33.78 3.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 62.219999999999999 110.861 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.68 -6.42 8.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 53.329999999999998 111.237 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.65 132.6 54.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 63.350000000000001 110.939 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 158.61 39.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 64.329999999999998 110.931 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.72 120.24 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.053 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.741 HD23 ' HA3' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -96.35 147.95 23.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 62.32 110.938 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG21 ' A' ' 58' ' ' VAL . 2.5 p -124.2 155.87 67.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.699 0.761 . . . . 63.200000000000003 110.846 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.783 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.2 Cg_endo -69.76 -0.58 7.12 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 2.238 . . . . 64.019999999999996 112.376 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.94 75.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 74.150000000000006 110.947 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.25 73.67 1.08 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 64.519999999999996 112.478 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.741 ' HA3' HD23 ' A' ' 44' ' ' LEU . . . -76.76 58.23 3.45 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.772 -0.728 . . . . 70.219999999999999 112.445 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -179.08 38.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.752 -0.737 . . . . 72.010000000000005 112.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 105.76 1.54 Allowed 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.683 2.255 . . . . 74.129999999999995 112.374 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -55.05 -34.43 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.443 . . . . 71.109999999999999 110.908 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -26.65 66.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 55.520000000000003 110.872 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.81 -43.36 9.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.841 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.27 -97.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 44.210000000000001 111.126 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -151.83 173.71 14.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.25 111.136 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -125.0 164.22 20.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 75.340000000000003 110.963 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.783 HG11 ' HA ' ' A' ' 46' ' ' PRO . 43.7 t -106.57 129.95 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 74.430000000000007 111.108 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 63' ' ' SER . 36.8 mt -69.99 159.05 85.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.627 0.727 . . . . 72.450000000000003 110.882 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -21.75 32.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 55.420000000000002 112.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.33 1.37 41.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.416 . . . . 54.219999999999999 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.08 27.44 21.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 73.340000000000003 112.496 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.401 ' HB2' HD12 ' A' ' 59' ' ' LEU . 33.7 m -111.58 -179.0 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 55.210000000000001 110.918 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 57' ' ' ARG . 31.5 tp -128.82 129.99 46.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.84 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 15' ' ' VAL . 42.5 t80 -123.64 133.8 53.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.430000000000007 110.876 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.608 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -115.24 123.88 31.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.643 0.735 . . . . 73.329999999999998 110.913 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -32.2 19.44 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.727 2.284 . . . . 74.519999999999996 112.406 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.61 103.15 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.010000000000005 111.116 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 12' ' ' GLU . 23.6 m -71.7 113.0 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 111.188 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.92 156.94 24.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.818 -0.706 . . . . 55.509999999999998 112.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.28 -31.67 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 75.430000000000007 111.11 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -77.34 -24.12 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 54.130000000000003 110.868 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -4.04 54.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 65.439999999999998 110.895 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -58.05 141.84 48.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 70.010000000000005 110.889 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.628 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 161.73 -145.77 11.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.548 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.5 mp -131.41 135.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.841 0.353 . . . . 63.420000000000002 111.165 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.649 ' CE2' HD22 ' A' ' 33' ' ' LEU . 11.7 m-85 -98.88 134.78 41.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.540000000000006 110.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.91 126.35 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 72.030000000000001 110.861 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 45.9 t -122.62 150.22 42.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 51.32 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -146.71 129.76 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 64.329999999999998 110.911 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.05 31.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.12 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 18.6 ttm -130.64 126.75 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.428 . . . . 75.439999999999998 110.86 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -85.81 170.42 12.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 60.219999999999999 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -73.26 -17.62 61.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 72.319999999999993 110.874 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -71.63 -19.66 62.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.928 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.18 -21.95 19.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 65.540000000000006 112.45 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 144.35 28.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 64.200000000000003 110.87 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.64 144.39 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 75.140000000000001 110.918 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.54 132.3 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.497 . . . . 75.150000000000006 111.167 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.43 ' CE ' ' H11' ' B' ' 4' ' ' MCL . 9.3 ptmm? -105.21 143.19 33.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.88 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -147.37 120.43 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.877 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.736 ' OD1' ' HE3' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -125.66 124.4 41.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 75.129999999999995 110.901 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 118.86 24.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.932 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.41 ' HD2' ' CB ' ' B' ' 5' ' ' ALA . 0.8 OUTLIER -88.78 136.25 33.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.907 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.1 t -124.66 137.27 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 63.329999999999998 111.099 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -130.62 128.26 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.86 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 m -85.65 -176.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 64.200000000000003 111.094 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -70.79 -81.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.848 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -59.65 145.48 44.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 70.040000000000006 110.916 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.29 159.6 49.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.544 0.688 . . . . 71.150000000000006 111.202 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.4 Cg_endo -69.81 133.85 26.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.594 2.196 . . . . 73.219999999999999 112.287 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.39 35.76 0.22 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.671 -0.776 . . . . 72.030000000000001 112.438 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -155.23 160.57 30.77 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.657 0.742 . . . . 53.450000000000003 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.752 2.301 . . . . 73.239999999999995 112.293 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 73.420000000000002 110.83 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.806 0.336 . . . . 73.519999999999996 110.829 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -119.91 -37.41 3.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 45.020000000000003 110.86 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.91 ' CE2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -174.75 -165.31 0.19 Allowed 'General case' 0 C--O 1.181 -2.508 0 CA-C-O 118.116 -0.945 . . . . 52.310000000000002 110.878 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.43 ' H11' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.41 ' CB ' ' HD2' ' A' ' 94' ' ' ARG . . . -49.81 136.98 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.921 -0.581 . . . . 74.430000000000007 111.058 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -148.51 109.23 4.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 55.329999999999998 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 1.317 ' CG ' ' NH2' ' A' ' 94' ' ' ARG . 13.5 pt-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 75.150000000000006 110.881 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.204 0 N-CA-C 112.486 -0.245 . . . . 74.310000000000002 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.29 122.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 55.119999999999997 110.902 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.28 65.77 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.319999999999993 111.105 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -93.21 133.2 36.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 64.329999999999998 110.941 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.421 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 8.3 p30 -89.99 122.01 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.400000000000006 110.884 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.754 HG21 HD11 ' A' ' 14' ' ' LEU . 30.1 mm -125.17 122.68 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 111.223 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -94.06 141.2 28.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 42.520000000000003 111.127 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.57 167.33 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 62.100000000000001 111.148 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 149.22 41.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 75.319999999999993 110.885 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.41 HD11 HG13 ' A' ' 71' ' ' ILE . 18.9 mt -52.43 120.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 71.219999999999999 111.101 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.753 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.73 10.17 70.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 71.530000000000001 112.5 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.784 ' O ' HG22 ' A' ' 69' ' ' VAL . 39.2 mm-40 -102.77 139.02 19.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.64 0.733 . . . . 72.439999999999998 110.813 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 143.55 50.89 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.692 2.261 . . . . 53.130000000000003 112.335 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.754 HD11 HG21 ' A' ' 6' ' ' ILE . 23.5 tp -145.76 143.81 29.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 110.89 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.7 t -122.11 145.37 28.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.136 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 64' ' ' LEU . 88.5 mt -130.91 147.51 52.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.927 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 151.96 31.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.908 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.74 99.69 9.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 124.35 17.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.917 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.86 -40.63 1.86 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 52.539999999999999 112.462 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.02 128.69 46.77 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.497 0.665 . . . . 75.340000000000003 111.085 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.8 -164.79 0.14 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.65 2.233 . . . . 75.310000000000002 112.271 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.38 -48.31 47.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 63.030000000000001 110.873 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -108.45 151.86 41.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 74.439999999999998 110.851 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.6 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 64.120000000000005 112.354 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.4 Cg_endo -69.83 -84.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.759 2.306 . . . . 72.519999999999996 112.296 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.9 OUTLIER -103.43 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 75.099999999999994 110.947 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -64.43 137.8 58.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 64.519999999999996 110.877 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.551 HD13 ' HE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -135.88 157.71 46.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.979 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.06 146.93 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.209999999999994 110.9 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.551 ' HE1' HD13 ' A' ' 29' ' ' LEU . 15.2 m95 -121.47 141.92 50.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.898 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.6 139.28 38.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 75.400000000000006 110.824 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.749 HD11 HG23 ' A' ' 35' ' ' THR . 1.3 tm? -138.71 131.41 29.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.864 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.718 ' N ' HD22 ' A' ' 33' ' ' LEU . 1.7 m-80 -116.44 121.02 40.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 64.200000000000003 110.949 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.792 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.7 p -139.84 179.34 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 72.010000000000005 111.119 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.12 -131.42 10.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.703 -0.76 . . . . 42.219999999999999 112.492 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mmm-85 -112.63 -38.43 4.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 63.210000000000001 110.866 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 39' ' ' GLU . 7.8 t 179.83 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 52.100000000000001 111.107 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.1 mt-10 -103.11 33.99 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 110.844 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.23 -6.33 8.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 63.25 111.153 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -63.63 130.95 46.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 73.450000000000003 110.865 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 158.27 41.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 73.299999999999997 110.905 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.0 t -92.68 122.62 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 73.299999999999997 111.061 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.61 147.66 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.9 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -125.65 149.42 65.17 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.642 0.734 . . . . 71.230000000000004 110.831 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.723 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.72 1.38 4.46 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.653 2.235 . . . . 63.219999999999999 112.356 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -118.99 69.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 61.439999999999998 110.941 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.97 5.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 52.229999999999997 112.556 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.47 40.94 32.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 31.030000000000001 112.49 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.98 -173.97 26.05 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 72.040000000000006 112.423 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 54.2 Cg_endo -69.72 107.02 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.606 2.204 . . . . 71.049999999999997 112.383 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.17 -31.43 65.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.917 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.01 -25.68 62.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 110.804 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -91.17 -43.99 9.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 65.209999999999994 110.811 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -125.5 -98.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 63.329999999999998 111.146 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.75 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -150.78 174.72 12.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 72.5 111.215 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.54 166.43 15.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.266 -0.425 . . . . 72.400000000000006 110.895 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 46' ' ' PRO . 61.8 t -108.16 128.98 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 111.11 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 63' ' ' SER . 56.4 mt -69.06 157.15 90.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.669 0.747 . . . . 75.409999999999997 110.883 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 -22.47 32.53 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.716 2.278 . . . . 74.200000000000003 112.381 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -82.98 0.92 42.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.933 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 29.2 12.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 43.219999999999999 112.415 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.506 ' HB2' HD12 ' A' ' 59' ' ' LEU . 8.8 m -113.1 179.19 4.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 65.200000000000003 110.878 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 16' ' ' LEU . 6.8 tp -130.15 129.0 42.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 63.439999999999998 110.941 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 46.4 t80 -125.44 130.61 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 70.299999999999997 110.857 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.75 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.1 mp -115.08 129.13 25.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.601 0.715 . . . . 64.420000000000002 110.908 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -34.84 13.61 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.645 2.23 . . . . 72.439999999999998 112.368 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.75 100.26 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 51.350000000000001 111.141 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.89 112.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 111.144 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.34 167.97 41.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 40.409999999999997 112.497 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.842 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.1 -30.37 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.739 0.304 . . . . 53.100000000000001 111.108 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -75.9 -22.17 56.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 54.340000000000003 110.845 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -2.86 35.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.43 . . . . 73.049999999999997 110.844 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 142.01 53.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.175 -0.466 . . . . 70.430000000000007 110.895 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.69 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.39 -154.06 25.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 72.010000000000005 112.461 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.69 HD12 ' C ' ' A' ' 75' ' ' GLY . 2.7 mp -128.08 134.97 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 74.430000000000007 111.135 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 16' ' ' LEU . 26.6 t80 -102.87 133.89 47.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 110.838 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.438 ' HB2' ' CZ ' ' B' ' 3' ' ' PHE . 0.3 OUTLIER -127.62 131.82 49.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 75.200000000000003 110.842 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 35.6 t -120.67 150.49 40.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 61.350000000000001 110.82 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -143.29 127.94 18.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 63.149999999999999 110.917 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.46 162.94 29.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 52.409999999999997 111.038 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.5 mtp -130.9 125.51 33.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 65.120000000000005 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -86.66 171.18 11.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.400000000000006 110.878 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -72.03 -18.21 61.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.499 . . . . 63.200000000000003 110.906 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -72.46 -19.62 61.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 53.109999999999999 110.91 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.46 -18.32 27.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.822 -0.704 . . . . 74.310000000000002 112.513 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.06 146.17 27.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 73.450000000000003 110.953 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.76 145.02 31.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.834 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.56 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -100.87 127.19 47.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 63.409999999999997 111.152 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.275 ' CE ' ' HZ ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -99.77 143.59 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.908 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -145.26 124.62 13.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 64.120000000000005 110.857 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.49 120.52 26.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 74.120000000000005 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -130.23 117.18 19.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.885 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -91.98 134.08 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 75.319999999999993 110.872 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.2 t -120.13 139.53 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 42.539999999999999 111.148 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.09 127.92 42.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 110.873 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.842 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.9 m -88.62 -176.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.151 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.59 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.864 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -69.14 144.96 53.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.975 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.488 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.45 159.43 50.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 74.129999999999995 111.067 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.8 Cg_endo -69.82 -179.48 2.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.597 2.198 . . . . 74.319999999999993 112.393 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 169.21 68.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 54.109999999999999 112.498 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -116.06 159.19 40.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.602 0.715 . . . . 53.340000000000003 110.919 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.01 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.716 2.277 . . . . 72.400000000000006 112.358 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.905 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.83 0.348 . . . . 63.399999999999999 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -123.26 68.42 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 63.5 110.869 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.1 OUTLIER 50.83 -163.92 0.05 Allowed 'General case' 0 C--O 1.181 -2.504 0 CA-C-O 118.177 -0.916 . . . . 73.310000000000002 110.848 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.275 ' HZ ' ' CE ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -49.4 114.35 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.89 -0.595 . . . . 65.409999999999997 111.026 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -91.22 57.66 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 110.838 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.213 -0.448 . . . . 44.439999999999998 110.789 -179.897 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.46 -0.256 . . . . 74.209999999999994 112.46 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -179.66 115.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 60.32 110.901 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.09 66.47 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 75.030000000000001 111.034 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.59 133.09 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.923 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.0 p-10 -87.76 121.98 30.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.439999999999998 110.916 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' HB ' HG22 ' A' ' 95' ' ' VAL . 46.6 mm -125.35 127.69 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 75.340000000000003 111.081 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 138.8 32.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.171 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.33 27.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.120000000000005 111.096 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.65 148.25 48.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.281 -0.418 . . . . 63.439999999999998 110.839 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.489 HD11 HG13 ' A' ' 71' ' ' ILE . 9.7 mt -53.32 122.08 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 71.219999999999999 111.152 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.09 4.44 78.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 73.129999999999995 112.448 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.7 mm-40 -101.22 139.64 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.561 0.696 . . . . 70.019999999999996 110.967 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 141.67 45.84 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.765 2.31 . . . . 73.150000000000006 112.308 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 66' ' ' LEU . 16.4 tp -144.7 141.31 29.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 64.510000000000005 110.902 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.468 HG22 ' HD1' ' A' ' 65' ' ' PHE . 51.1 t -125.9 147.15 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 42.310000000000002 111.201 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.656 HD12 HD23 ' A' ' 64' ' ' LEU . 8.6 mt -131.58 148.23 52.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.209999999999994 110.857 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -111.41 149.81 30.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 65.530000000000001 110.85 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.3 t -108.16 101.09 10.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.218 -0.447 . . . . 73.120000000000005 110.882 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -51.82 101.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 74.099999999999994 110.915 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 144.5 -47.9 0.75 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.703 -0.76 . . . . 70.340000000000003 112.498 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.15 103.04 10.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.558 0.694 . . . . 64.329999999999998 111.189 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.8 Cg_endo -69.69 -161.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.688 2.259 . . . . 75.129999999999995 112.311 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -60.52 -10.51 5.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 110.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -45.84 167.48 0.13 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.572 0.701 . . . . 75.430000000000007 110.916 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 54.5 Cg_endo -69.8 172.37 12.8 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.661 2.241 . . . . 72.319999999999993 112.315 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.5 Cg_endo -69.75 87.74 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.693 2.262 . . . . 72.040000000000006 112.337 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -174.66 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 73.030000000000001 110.941 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -63.05 131.95 50.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 74.230000000000004 110.851 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.5 pp -178.85 161.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 110.837 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -121.43 135.75 55.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 75.540000000000006 110.852 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -120.72 137.95 54.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.0 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -138.31 139.99 39.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 62.25 110.866 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.763 HD13 ' CD2' ' A' ' 77' ' ' PHE . 6.0 tp -137.67 134.59 35.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 64.230000000000004 110.935 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.815 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 14.7 t-20 -116.21 121.66 42.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 61.100000000000001 110.923 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.821 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 66.9 p -137.72 179.6 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 74.329999999999998 111.098 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.74 -132.06 15.19 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.729 -0.748 . . . . 74.109999999999999 112.463 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -37.63 4.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 74.430000000000007 110.874 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 t -179.24 -29.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 72.299999999999997 111.12 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -101.32 33.55 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.935 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.41 -5.33 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -65.87 130.11 42.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 110.928 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 158.66 43.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 62.420000000000002 110.95 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.9 t -95.67 119.85 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.41 . . . . 73.420000000000002 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.52 145.29 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 65.310000000000002 110.884 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.16 163.56 41.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 72.129999999999995 110.886 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.502 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.4 Cg_endo -69.77 0.94 4.92 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.639 2.226 . . . . 63.109999999999999 112.361 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -135.63 71.82 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.929 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.41 32.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.855 -0.688 . . . . 74.200000000000003 112.457 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 47.31 -147.41 3.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.693 -0.765 . . . . 74.209999999999994 112.509 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.14 -162.95 1.17 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 64.019999999999996 112.534 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 119.68 6.58 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.649 2.233 . . . . 63.0 112.322 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -83.13 -34.24 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 72.030000000000001 110.929 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -25.74 68.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 62.340000000000003 110.821 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.66 -45.89 41.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.853 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.511 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -128.79 -98.38 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.117 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.583 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -166.85 172.25 10.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 42.439999999999998 111.087 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.96 160.16 28.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.83 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 45' ' ' SER . 53.6 t -108.47 127.08 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 72.099999999999994 111.078 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' A' ' 63' ' ' SER . 55.6 mt -69.4 157.46 89.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.559 0.695 . . . . 54.240000000000002 110.938 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -22.74 31.33 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.655 2.236 . . . . 70.310000000000002 112.403 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -82.67 0.68 42.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 110.876 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.93 26.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.63 -0.795 . . . . 41.109999999999999 112.451 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 59' ' ' LEU . 10.1 m -105.51 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.408 . . . . 43.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.656 HD23 HD12 ' A' ' 16' ' ' LEU . 7.0 tp -131.15 129.5 41.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.299999999999997 110.897 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HD1' HG22 ' A' ' 15' ' ' VAL . 7.0 t80 -125.52 129.0 48.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.540000000000006 111.0 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.671 HD22 HG12 ' A' ' 69' ' ' VAL . 1.9 mp -120.36 131.17 24.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 53.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -32.98 17.76 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.664 2.242 . . . . 63.240000000000002 112.403 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.589 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.79 100.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 72.109999999999999 111.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.3 m -76.76 118.58 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 65.430000000000007 111.134 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.29 165.42 37.45 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.672 -0.775 . . . . 71.219999999999999 112.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.793 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.94 -31.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 75.129999999999995 111.15 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.2 -22.22 58.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.08 -5.02 41.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 70.200000000000003 110.819 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.59 141.58 51.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.030000000000001 110.939 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.65 -147.69 16.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.758 . . . . 74.310000000000002 112.445 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.0 HD11 ' HB2' ' B' ' 2' ' ' GLU . 0.8 OUTLIER -130.62 134.96 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 44.439999999999998 111.224 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.763 ' CD2' HD13 ' A' ' 33' ' ' LEU . 21.6 m-85 -104.43 126.57 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 52.530000000000001 110.877 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HD2' ' HE2' ' B' ' 4' ' ' MCL . 5.7 ttp85 -124.45 136.54 54.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.852 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.45 156.26 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 24.41 110.925 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -141.02 126.25 18.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 110.982 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.46 162.05 33.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 73.109999999999999 111.115 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.1 mtp -130.32 125.84 35.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 110.858 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -86.19 171.6 11.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 53.219999999999999 110.866 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -71.66 -17.46 62.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 70.239999999999995 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.93 -26.0 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 62.020000000000003 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.61 -19.53 11.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 23.34 112.452 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.97 147.56 26.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.649 0.262 . . . . 62.310000000000002 111.01 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.39 144.27 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 52.049999999999997 110.906 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.14 126.64 50.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 52.140000000000001 111.133 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.41 142.58 35.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 64.25 110.891 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -146.8 119.01 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 51.130000000000003 110.785 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.584 ' OD1' ' HB2' ' B' ' 5' ' ' ALA . 6.4 t-20 -125.76 128.66 48.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 74.549999999999997 110.901 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.431 ' HB2' HD22 ' A' ' 16' ' ' LEU . 7.3 m-85 -128.7 118.9 23.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.530000000000001 110.883 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.899 ' NH2' ' OE1' ' B' ' 7' ' ' GLU . 0.0 OUTLIER -83.74 128.08 34.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 73.140000000000001 110.751 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 6' ' ' ILE . 70.5 t -119.28 139.59 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 54.130000000000003 111.183 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.78 127.79 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 74.510000000000005 110.833 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 71' ' ' ILE . 35.2 m -86.94 -176.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 111.104 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.5 -82.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 53.219999999999999 110.932 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.49 145.83 55.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 43.439999999999998 110.99 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.498 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.4 50.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.646 0.736 . . . . 73.409999999999997 111.072 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo -69.88 134.76 28.51 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.718 2.279 . . . . 71.099999999999994 112.277 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.47 -102.33 0.37 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 25.41 112.497 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -113.72 157.89 40.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.606 0.717 . . . . 64.540000000000006 110.809 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 100.26 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.589 2.192 . . . . 52.100000000000001 112.384 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 73.530000000000001 110.922 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.83 0.348 . . . . 72.420000000000002 110.794 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.0 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.8 pm0 -136.81 77.16 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 53.009999999999998 110.805 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.815 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 51.91 -164.85 0.06 Allowed 'General case' 0 C--O 1.182 -2.484 0 CA-C-O 118.156 -0.926 . . . . 75.140000000000001 110.859 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.515 ' HE2' ' HD2' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.741 ' HB3' HG21 ' A' ' 76' ' ' ILE . . . -48.2 104.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 54.119999999999997 111.068 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -151.36 64.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 54.43 110.839 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.899 ' OE1' ' NH2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 74.329999999999998 110.904 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.489 -0.245 . . . . 72.019999999999996 112.489 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 p -107.01 79.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 71.109999999999999 110.8 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.22 69.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.239999999999995 111.094 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.39 133.68 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 61.140000000000001 110.874 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.02 122.04 31.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 65.319999999999993 110.853 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.72 121.29 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 111.071 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -95.16 142.65 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.06 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -142.55 166.31 25.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 52.229999999999997 111.063 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.53 147.62 48.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 61.100000000000001 110.883 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 71' ' ' ILE . 59.1 mt -59.05 121.16 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 70.430000000000007 111.159 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.668 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.16 0.08 88.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 62.409999999999997 112.435 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.766 ' O ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -97.62 142.04 23.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.663 0.745 . . . . 73.400000000000006 110.927 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 143.85 52.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.651 2.234 . . . . 74.239999999999995 112.275 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.8 tp -144.65 143.21 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.140000000000001 110.942 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.59 HG22 ' CD2' ' A' ' 65' ' ' PHE . 21.5 t -121.55 148.66 24.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 72.200000000000003 111.087 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.642 HD13 HD23 ' A' ' 64' ' ' LEU . 1.6 mt -130.9 147.96 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.030000000000001 110.951 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -112.35 151.98 29.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 64.230000000000004 110.946 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 101.97 11.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 33.219999999999999 110.88 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.18 120.9 10.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 54.32 110.81 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 126.14 -38.5 2.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.811 -0.709 . . . . 23.32 112.532 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.23 128.26 47.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.319999999999993 111.119 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.666 2.244 . . . . 74.510000000000005 112.374 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.34 -49.39 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.109999999999999 110.896 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.29 150.09 40.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 75.109999999999999 110.912 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.444 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.6 Cg_endo -69.66 110.14 2.46 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.748 2.299 . . . . 75.109999999999999 112.338 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.5 Cg_endo -69.78 -86.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 74.120000000000005 112.338 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.33 -177.13 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 72.299999999999997 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -63.65 138.52 58.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 75.329999999999998 110.899 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -136.62 156.31 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 53.140000000000001 110.925 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.1 148.35 44.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 70.430000000000007 110.896 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.602 ' CZ3' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -129.63 142.02 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 74.219999999999999 110.872 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.712 ' O ' HD23 ' A' ' 33' ' ' LEU . 28.4 mtpt -146.77 137.01 23.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 75.129999999999995 110.876 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.831 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -138.59 139.52 38.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 61.399999999999999 110.936 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.9 ' N ' ' HE2' ' B' ' 3' ' ' PHE . 12.3 t-20 -112.42 124.44 52.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 64.519999999999996 110.889 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.792 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 70.3 p -138.45 -179.24 5.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 74.219999999999999 111.111 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.01 -130.55 14.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 72.310000000000002 112.535 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.41 -37.84 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 71.319999999999993 110.855 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.6 t -179.5 -30.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 111.145 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.586 ' HG2' HG23 ' A' ' 38' ' ' THR . 6.1 mm-40 -102.21 33.71 2.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.877 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.33 -7.26 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 71.150000000000006 111.127 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.19 129.44 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.420000000000002 110.874 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.89 153.41 50.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 63.310000000000002 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.73 121.55 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.430000000000007 111.111 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -89.55 146.73 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 64.140000000000001 110.974 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.806 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -125.07 164.42 31.76 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.722 0.773 . . . . 75.430000000000007 110.848 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HB3' HD11 ' A' ' 29' ' ' LEU . 54.1 Cg_endo -69.75 0.26 5.89 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.699 2.266 . . . . 62.43 112.428 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.42 80.78 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 74.420000000000002 110.887 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.87 35.63 4.32 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.696 . . . . 62.520000000000003 112.503 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.39 -4.65 57.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.671 -0.776 . . . . 71.239999999999995 112.52 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.86 -160.26 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.665 -0.779 . . . . 64.329999999999998 112.553 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 53.5 Cg_endo -69.8 99.21 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.717 2.278 . . . . 65.209999999999994 112.332 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -71.22 -34.09 70.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 72.140000000000001 110.8 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.75 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 52.240000000000002 110.825 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -87.52 -44.7 11.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 70.430000000000007 110.793 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.49 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.44 -97.64 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 64.230000000000004 111.119 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -163.08 173.11 13.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 65.219999999999999 111.1 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 159.64 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 63.299999999999997 110.828 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.806 HG21 ' O ' ' A' ' 45' ' ' SER . 86.7 t -109.05 129.94 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.13 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.557 HD12 ' CB ' ' A' ' 63' ' ' SER . 73.3 mt -68.56 157.77 87.22 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.665 0.745 . . . . 62.350000000000001 110.877 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -21.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 72.129999999999995 112.36 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -83.27 0.25 46.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 54.149999999999999 110.89 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.05 9.57 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.795 -0.716 . . . . 35.329999999999998 112.397 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.557 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.0 m -112.4 177.23 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.959 0.409 . . . . 53.049999999999997 110.849 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.642 HD23 HD13 ' A' ' 16' ' ' LEU . 18.2 tp -128.48 127.69 42.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.833 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CD2' HG22 ' A' ' 15' ' ' VAL . 32.1 t80 -125.71 133.54 52.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 60.140000000000001 110.863 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 56' ' ' ALA . 2.1 mp -119.88 131.27 24.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.522 0.677 . . . . 62.450000000000003 110.955 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -36.29 11.13 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.766 2.311 . . . . 73.099999999999994 112.35 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.668 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -162.99 101.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 60.439999999999998 111.122 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.7 m -73.48 117.78 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.173 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.24 163.09 39.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 75.120000000000005 112.476 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.868 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.89 -30.93 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 65.329999999999998 111.106 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 74.140000000000001 110.909 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -5.44 37.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.274 -0.421 . . . . 75.329999999999998 110.832 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.657 ' HG3' HG22 ' A' ' 97' ' ' VAL . 1.5 mt-10 -58.56 142.06 50.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.886 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.569 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.6 -151.83 23.35 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 43.43 112.478 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.222 ' CD1' ' HB2' ' B' ' 2' ' ' GLU . 3.3 mp -124.29 134.21 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 74.120000000000005 111.182 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.831 ' CE2' HD13 ' A' ' 33' ' ' LEU . 6.9 m-85 -102.58 132.73 48.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.099999999999994 110.938 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.97 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -127.87 134.64 49.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.099999999999994 110.938 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 146.19 46.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.32 110.876 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -141.17 126.12 18.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 63.5 110.924 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.05 164.0 27.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 111.055 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.56 124.82 34.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 65.349999999999994 110.881 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -86.81 172.29 10.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.285 -0.416 . . . . 72.140000000000001 110.906 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -71.32 -18.1 62.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.878 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.0 -20.12 61.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.87 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.99 -18.24 28.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 74.200000000000003 112.415 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -84.97 146.75 27.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.708 0.289 . . . . 73.319999999999993 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -105.17 145.0 31.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.441 HG21 ' CA ' ' A' ' 20' ' ' GLY . 1.2 m -102.24 129.41 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.225 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.315 ' CB ' ' O1 ' ' B' ' 4' ' ' MCL . 23.9 mtpp -105.3 146.06 29.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 72.519999999999996 110.884 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.95 126.78 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 110.826 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' B' ' 5' ' ' ALA . 18.6 t-20 -121.31 120.4 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.230000000000004 110.9 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.98 127.56 40.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 73.510000000000005 110.881 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.198 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 6.6 mmt85 -89.55 131.07 35.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 72.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.0 t -120.92 130.58 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 75.530000000000001 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.404 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . 15.8 mmt-85 -131.72 153.32 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.540000000000006 110.83 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.868 HG21 ' HA ' ' A' ' 71' ' ' ILE . 27.2 m -116.06 -177.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 111.179 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.19 -82.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 75.209999999999994 110.978 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -59.1 146.69 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.972 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.494 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.37 159.66 49.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 61.109999999999999 111.076 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.3 Cg_endo -69.81 179.03 4.01 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.65 2.233 . . . . 70.439999999999998 112.279 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.14 31.52 0.1 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.641 -0.79 . . . . 50.350000000000001 112.481 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -117.0 137.78 24.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.628 0.728 . . . . 74.439999999999998 110.901 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.85 108.2 2.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.583 2.189 . . . . 70.040000000000006 112.34 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.892 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.825 0.345 . . . . 71.299999999999997 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.222 ' HB2' ' CD1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.34 -41.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 41.020000000000003 110.902 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.9 ' HE2' ' N ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 175.66 -165.64 0.03 OUTLIER 'General case' 0 C--O 1.182 -2.449 0 CA-C-O 118.183 -0.913 . . . . 74.409999999999997 110.904 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.315 ' O1 ' ' CB ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.198 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -40.16 123.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 74.239999999999995 111.118 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.67 59.13 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 110.848 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 73.409999999999997 110.93 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.504 -0.239 . . . . 63.439999999999998 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m 60.34 99.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 51.420000000000002 110.908 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.46 77.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 44.229999999999997 111.139 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.51 132.63 37.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.340000000000003 110.915 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.539 ' C ' HD12 ' A' ' 6' ' ' ILE . 3.6 p30 -88.66 121.29 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.944 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.644 HG21 HD11 ' A' ' 14' ' ' LEU . 2.6 mp -123.22 120.81 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 111.089 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.8 p -96.95 142.58 28.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 111.159 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.0 168.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 65.219999999999999 111.129 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.32 145.66 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 64.540000000000006 110.906 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 99' ' ' GLN . 11.3 mt -52.21 120.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.077 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 89.83 5.8 70.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 60.109999999999999 112.492 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.82 ' O ' HG22 ' A' ' 69' ' ' VAL . 18.7 mm-40 -101.67 140.8 21.53 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 121.539 0.685 . . . . 63.439999999999998 110.98 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 143.89 52.88 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.752 2.302 . . . . 65.340000000000003 112.315 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 6' ' ' ILE . 37.8 tp -142.89 142.13 31.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 75.510000000000005 110.841 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' CD2' ' A' ' 65' ' ' PHE . 23.7 t -122.41 149.32 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 70.209999999999994 111.115 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.688 HD13 ' CG ' ' A' ' 77' ' ' PHE . 70.3 mt -130.73 146.91 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 52.329999999999998 110.954 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -112.91 152.86 28.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.010000000000005 110.897 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.89 100.6 10.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 61.420000000000002 110.862 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.32 120.65 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.28 -36.7 2.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 74.120000000000005 112.424 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.7 130.37 39.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.624 0.726 . . . . 71.030000000000001 111.062 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.66 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 72.049999999999997 112.374 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -49.32 -49.36 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 61.539999999999999 110.88 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 150.5 40.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 71.099999999999994 110.812 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 110.7 2.61 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.684 2.256 . . . . 62.119999999999997 112.351 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 53.8 Cg_endo -69.75 -84.14 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.652 2.235 . . . . 73.420000000000002 112.359 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 3.9 mp0 -103.24 -177.9 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 71.140000000000001 110.848 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -64.01 134.85 55.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 110.889 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -136.31 146.94 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.874 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -129.07 137.07 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 75.310000000000002 110.859 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' CE2' HD13 ' A' ' 29' ' ' LEU . 1.1 m0 -124.68 144.95 49.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 110.85 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -136.33 142.28 43.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.897 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.819 HD21 HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -137.82 140.06 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.319999999999993 110.946 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.503 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 16.0 t-20 -112.56 128.2 56.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 62.520000000000003 110.835 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.819 HG23 HD21 ' A' ' 33' ' ' LEU . 33.5 p -136.82 179.91 6.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 111.193 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.78 -130.01 19.56 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.797 -0.716 . . . . 62.32 112.485 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -112.68 -37.38 4.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 71.120000000000005 110.901 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -178.9 -29.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 73.319999999999993 111.153 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -102.14 33.6 3.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 64.109999999999999 110.951 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.33 -5.81 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 62.130000000000003 111.102 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -59.14 132.22 53.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 65.439999999999998 110.956 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 157.17 41.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 61.219999999999999 110.857 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.11 123.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.209999999999994 111.215 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.38 136.68 32.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.941 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.835 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.3 165.52 28.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 110.827 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 45' ' ' SER . 54.5 Cg_endo -69.72 0.49 5.53 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.702 2.268 . . . . 74.430000000000007 112.316 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -126.47 87.69 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 73.5 110.88 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.25 5.58 71.72 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.741 -0.742 . . . . 32.439999999999998 112.488 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.53 165.72 0.23 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.847 -0.692 . . . . 70.150000000000006 112.497 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.16 -153.21 20.22 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.849 -0.691 . . . . 53.039999999999999 112.506 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.86 107.38 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.596 2.197 . . . . 65.200000000000003 112.264 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -82.68 -34.19 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 71.120000000000005 110.91 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.74 -25.35 66.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.307 -0.406 . . . . 72.010000000000005 110.928 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -44.8 21.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 64.219999999999999 110.853 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -127.63 -98.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 75.530000000000001 111.14 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.93 174.67 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 65.430000000000007 111.136 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.85 158.01 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 110.908 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 45' ' ' SER . 49.8 t -116.35 126.87 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 73.140000000000001 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 63' ' ' SER . 38.7 mt -69.02 156.4 91.6 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 75.230000000000004 110.956 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.6 Cg_endo -69.75 -21.84 32.97 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.668 2.246 . . . . 72.319999999999993 112.431 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -82.89 -0.19 47.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.94 29.64 10.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.723 -0.751 . . . . 60.439999999999998 112.438 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 59' ' ' LEU . 3.2 m -111.4 177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.926 0.393 . . . . 54.109999999999999 110.863 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.683 HD23 HD12 ' A' ' 16' ' ' LEU . 9.2 tp -128.63 130.02 46.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.019999999999996 110.89 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.578 ' N ' HD12 ' A' ' 64' ' ' LEU . 3.4 t80 -125.13 131.9 53.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 64.019999999999996 110.958 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 69' ' ' VAL . 7.2 mp -115.07 130.8 23.92 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.653 0.74 . . . . 61.340000000000003 110.855 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -37.84 8.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.785 2.323 . . . . 63.539999999999999 112.303 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.614 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.36 102.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 111.083 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.2 m -73.7 116.44 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 111.077 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 163.12 38.3 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.674 -0.774 . . . . 54.240000000000002 112.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.857 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.16 -34.04 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.723 0.297 . . . . 71.200000000000003 111.115 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -75.95 -15.92 60.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -4.51 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 62.030000000000001 110.921 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.632 ' CD ' HG22 ' A' ' 97' ' ' VAL . 42.6 mt-10 -56.5 141.49 42.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 75.530000000000001 110.973 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.697 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 160.08 -156.41 27.64 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.749 -0.739 . . . . 71.209999999999994 112.519 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.932 ' HB ' ' CB ' ' B' ' 3' ' ' PHE . 6.3 mm -125.38 134.09 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 75.150000000000006 111.137 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.691 ' HB2' HD12 ' A' ' 33' ' ' LEU . 77.1 t80 -102.84 126.44 49.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 73.25 110.876 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.618 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -125.82 127.86 46.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.779 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.84 146.58 46.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 74.120000000000005 110.891 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -139.47 132.91 30.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 163.89 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 70.409999999999997 111.039 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 11.6 mtp -129.1 125.01 36.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 72.349999999999994 110.938 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.88 172.81 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 73.150000000000006 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -70.71 -18.42 62.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 64.519999999999996 110.828 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -73.21 -19.86 61.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 63.530000000000001 110.92 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.92 -15.09 37.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 61.219999999999999 112.505 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 146.61 27.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.657 0.265 . . . . 60.350000000000001 110.936 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -105.37 144.81 31.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 75.319999999999993 110.89 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.449 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.92 132.59 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 53.539999999999999 111.128 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.589 ' HB2' ' CX2' ' B' ' 4' ' ' MCL . 0.5 OUTLIER -99.45 145.47 27.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 73.310000000000002 110.934 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.2 m -144.72 123.88 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 62.229999999999997 110.818 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 4' ' ' MCL . 1.7 t-20 -127.48 121.24 30.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 74.450000000000003 110.884 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.58 123.05 32.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.0 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.548 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 19.4 mmm-85 -84.4 134.17 34.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.861 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.3 t -120.27 129.29 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 63.43 111.108 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.47 46.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.857 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.1 m -109.68 -175.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 73.400000000000006 111.099 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -65.79 -71.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 110.952 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.498 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.7 mp0 -71.05 140.52 50.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.952 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.27 159.81 48.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.665 0.745 . . . . 65.319999999999993 111.138 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 173.26 11.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.675 2.25 . . . . 74.030000000000001 112.394 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.54 -72.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 33.25 112.538 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -156.09 161.24 29.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.63 0.729 . . . . 71.310000000000002 110.894 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 141.8 46.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 75.120000000000005 112.357 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.861 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.73 0.3 . . . . 73.420000000000002 110.915 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.32 139.05 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 110.866 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.932 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -50.64 163.08 0.2 Allowed 'General case' 0 C--O 1.181 -2.523 0 CA-C-O 118.174 -0.917 . . . . 75.439999999999998 110.792 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.589 ' CX2' ' HB2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.548 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -178.33 -80.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 74.430000000000007 111.143 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 32.1 t0 47.71 67.61 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.230000000000004 110.829 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.611 ' HB2' HH12 ' A' ' 94' ' ' ARG . 72.1 mm-40 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 64.349999999999994 110.898 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.549 -0.22 . . . . 62.310000000000002 112.549 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -177.7 157.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.862 0.363 . . . . 70.420000000000002 110.817 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.4 97.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 61.130000000000003 111.076 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.62 137.25 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 74.340000000000003 110.826 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -89.09 121.13 31.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.86 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.65 121.94 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 75.209999999999994 111.15 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -95.31 142.68 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 72.5 111.202 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.49 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -146.61 167.29 24.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 45.399999999999999 111.13 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -119.99 148.68 43.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.408 . . . . 64.120000000000005 110.898 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mt -56.81 120.75 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 65.0 111.219 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.31 5.72 79.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.76 . . . . 72.310000000000002 112.46 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.813 ' O ' HG22 ' A' ' 69' ' ' VAL . 51.7 mm-40 -102.05 139.42 20.28 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.657 0.742 . . . . 75.340000000000003 110.918 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 143.27 50.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 75.310000000000002 112.356 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 8' ' ' ALA . 22.7 tp -145.27 142.43 29.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 54.310000000000002 110.891 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.512 HG22 ' CD2' ' A' ' 65' ' ' PHE . 42.5 t -122.96 145.27 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 62.109999999999999 111.134 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.774 HD12 HD23 ' A' ' 64' ' ' LEU . 67.1 mt -130.74 147.27 52.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 62.530000000000001 111.0 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -113.46 150.73 32.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.409999999999997 110.882 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -108.07 99.73 9.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 53.210000000000001 110.846 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -54.26 128.45 31.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.847 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.38 -40.45 1.92 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.669 -0.777 . . . . 42.350000000000001 112.468 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.92 128.89 43.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.53 0.681 . . . . 62.450000000000003 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.6 Cg_endo -69.8 -165.19 0.15 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.665 2.244 . . . . 64.209999999999994 112.376 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -48.95 45.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 71.219999999999999 110.945 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -108.57 154.44 41.6 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.565 0.697 . . . . 63.140000000000001 110.942 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.3 Cg_endo -69.75 109.36 2.29 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.718 2.279 . . . . 72.310000000000002 112.335 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.69 -86.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.655 2.237 . . . . 54.329999999999998 112.394 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -101.27 -176.53 3.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.519999999999996 110.885 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.36 133.02 53.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 75.5 110.88 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.645 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -137.28 159.13 42.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 55.310000000000002 110.918 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -132.53 146.14 51.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 110.851 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.645 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 13.7 m95 -123.6 134.25 53.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.400000000000006 110.922 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' C ' HD23 ' A' ' 33' ' ' LEU . 15.0 ttpp -136.36 138.33 41.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 63.450000000000003 110.91 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.739 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -138.29 138.24 38.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 75.120000000000005 110.903 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.33 127.8 56.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 74.209999999999994 110.89 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.812 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 21.2 p -138.52 -179.87 6.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 62.219999999999999 111.139 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.98 -130.17 21.88 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.815 -0.707 . . . . 63.43 112.463 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.89 -37.26 4.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 64.430000000000007 110.869 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.2 t -178.72 -29.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 111.015 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.611 ' HG3' HG23 ' A' ' 38' ' ' THR . 29.3 mt-10 -102.06 34.06 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 75.219999999999999 110.821 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.71 -5.59 8.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.409999999999997 111.114 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -59.57 132.16 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.958 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' CE ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.45 152.46 48.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.316 -0.402 . . . . 64.439999999999998 110.92 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.1 t -105.26 116.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 61.5 111.131 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.717 HD13 HD13 ' A' ' 64' ' ' LEU . 27.0 mt -96.28 146.03 25.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.489 . . . . 73.439999999999998 110.823 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.66 157.03 69.94 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.586 0.708 . . . . 74.129999999999995 110.865 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HG3' HD12 ' A' ' 29' ' ' LEU . 54.0 Cg_endo -69.67 0.23 5.87 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.661 2.24 . . . . 64.25 112.366 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -136.75 71.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 65.340000000000003 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.98 78.54 1.0 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 64.200000000000003 112.428 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.62 58.45 3.79 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.68 -0.771 . . . . 63.420000000000002 112.52 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.36 179.21 45.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 61.310000000000002 112.53 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 106.39 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 60.240000000000002 112.316 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -55.57 -34.43 64.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 75.319999999999993 110.946 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.98 -26.86 67.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.25 110.809 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -44.5 8.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 70.219999999999999 110.859 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.509 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.46 -96.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 63.140000000000001 111.068 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -150.17 176.55 10.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 52.439999999999998 111.147 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.37 162.41 24.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 73.420000000000002 110.903 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 63' ' ' SER . 46.2 t -108.69 130.72 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 72.400000000000006 111.119 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 63' ' ' SER . 56.4 mt -68.99 156.46 91.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.596 0.712 . . . . 62.509999999999998 110.965 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -22.43 32.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 73.310000000000002 112.265 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -81.91 0.15 41.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.299999999999997 110.921 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.8 22.92 24.63 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 65.319999999999993 112.486 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.518 ' HB2' HD12 ' A' ' 59' ' ' LEU . 6.0 m -106.24 178.91 4.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 71.120000000000005 110.88 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.774 HD23 HD12 ' A' ' 16' ' ' LEU . 15.5 tp -129.68 129.95 44.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 74.019999999999996 110.952 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 15' ' ' VAL . 39.3 t80 -124.34 129.96 51.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.268 -0.424 . . . . 75.040000000000006 110.86 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.811 HD22 HG12 ' A' ' 69' ' ' VAL . 5.3 mp -114.57 127.23 27.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.678 0.752 . . . . 75.420000000000002 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -32.62 18.11 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.239999999999995 112.386 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.5 101.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 63.310000000000002 111.145 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.09 115.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 111.185 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.63 161.81 31.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.771 -0.728 . . . . 72.109999999999999 112.457 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.835 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.07 -31.87 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 73.129999999999995 111.168 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -77.46 -22.47 51.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.924 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.15 -5.34 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 70.109999999999999 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.75 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.33 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 110.822 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.779 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 160.39 -148.91 17.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.793 -0.718 . . . . 53.43 112.516 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.779 HD12 ' C ' ' A' ' 75' ' ' GLY . 2.0 mp -126.18 133.66 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.89 0.376 . . . . 61.509999999999998 111.178 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.739 ' CE2' HD13 ' A' ' 33' ' ' LEU . 11.0 m-85 -103.32 135.2 45.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 45.149999999999999 110.908 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 1.232 ' HD3' ' CE1' ' B' ' 3' ' ' PHE . 3.5 ttp85 -125.99 134.61 51.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.813 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.4 m -120.49 147.95 44.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -141.37 129.21 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 61.520000000000003 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.73 163.13 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 111.12 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 125.09 33.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 45.340000000000003 110.937 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -86.84 172.1 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 74.140000000000001 110.823 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.47 -18.3 62.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 70.530000000000001 110.934 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.07 -19.87 61.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 65.010000000000005 110.848 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.03 32.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.756 -0.735 . . . . 74.230000000000004 112.545 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -85.02 147.07 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.795 0.331 . . . . 75.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.79 145.14 30.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 72.219999999999999 110.955 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.69 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 63.25 111.107 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.477 ' HE2' ' CX2' ' B' ' 4' ' ' MCL . 8.9 ptpt -98.65 145.31 27.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 71.430000000000007 110.943 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 m -144.73 127.76 16.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 63.240000000000002 110.748 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.523 ' HB2' ' HE3' ' B' ' 4' ' ' MCL . 20.3 t-20 -128.14 121.52 29.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 72.349999999999994 110.931 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.22 126.1 40.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.530000000000001 110.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.55 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 17.6 mmm-85 -89.85 132.1 35.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 74.5 110.859 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.82 130.02 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 64.010000000000005 111.129 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -131.55 146.17 52.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 110.886 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 71' ' ' ILE . 17.0 m -109.58 -176.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.456 . . . . 52.020000000000003 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.86 -79.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.992 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -64.45 146.21 54.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 73.219999999999999 111.032 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.38 159.42 50.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.719 0.771 . . . . 61.350000000000001 111.145 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.1 Cg_endo -69.75 -176.76 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.649 2.233 . . . . 73.109999999999999 112.321 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.79 -91.27 2.2 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.811 -0.709 . . . . 71.409999999999997 112.456 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -165.65 157.58 12.68 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.563 0.697 . . . . 72.239999999999995 110.946 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 176.78 6.28 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.727 2.284 . . . . 64.010000000000005 112.327 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 43.219999999999999 110.892 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.526 0.048 0 CA-C-O 120.726 0.298 . . . . 74.349999999999994 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.75 ' HB2' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -142.24 108.02 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 63.119999999999997 110.968 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.232 ' CE1' ' HD3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER 50.87 -166.7 0.04 OUTLIER 'General case' 0 C--O 1.181 -2.519 0 CA-C-O 118.14 -0.933 . . . . 75.310000000000002 110.861 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.477 ' CX2' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.55 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -45.24 134.38 6.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.895 -0.593 . . . . 64.409999999999997 111.145 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -163.59 57.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 71.150000000000006 110.843 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.635 ' HG2' HH12 ' A' ' 94' ' ' ARG . 26.7 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 62.32 110.939 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.452 -0.259 . . . . 73.340000000000003 112.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 p -79.88 91.22 5.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.841 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 1.602 ' CB ' ' HA ' ' B' ' 5' ' ' ALA . . . 51.8 65.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 64.140000000000001 111.156 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.12 133.6 36.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 73.430000000000007 110.893 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.6 121.27 28.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.510000000000005 110.884 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.1 mm -125.16 127.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 74.25 111.111 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -91.56 142.52 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 64.150000000000006 111.17 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.0 165.85 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 33.140000000000001 111.133 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -119.1 149.71 41.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 62.229999999999997 110.906 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 71' ' ' ILE . 10.6 mt -68.43 120.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 45.119999999999997 111.108 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.5 -6.99 57.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.815 -0.707 . . . . 64.439999999999998 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.837 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.2 pp20? -102.72 140.76 21.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.71 0.767 . . . . 74.299999999999997 110.923 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 146.11 59.7 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.84 2.36 . . . . 74.200000000000003 112.323 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.3 tp -138.33 142.8 39.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 73.209999999999994 110.966 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.627 HG22 ' CD1' ' A' ' 65' ' ' PHE . 47.1 t -122.59 148.22 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.540000000000006 111.141 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.68 HD12 HD23 ' A' ' 64' ' ' LEU . 6.6 mt -130.99 147.48 52.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.933 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -112.78 152.04 29.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 72.140000000000001 111.002 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -107.33 100.53 9.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.413 . . . . 61.409999999999997 110.885 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.88 122.41 12.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 73.530000000000001 110.839 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.15 -39.8 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.747 . . . . 72.129999999999995 112.484 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.29 129.32 43.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.522 0.677 . . . . 73.329999999999998 111.171 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.91 -165.08 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.64 2.226 . . . . 75.230000000000004 112.383 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.56 -49.02 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.981 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.6 152.42 41.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.603 0.716 . . . . 61.43 110.936 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 52.1 Cg_endo -69.84 110.18 2.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.617 2.212 . . . . 73.510000000000005 112.292 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.2 Cg_endo -69.73 -81.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.671 2.248 . . . . 63.530000000000001 112.356 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.438 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 79.4 mm-40 -103.31 -177.67 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 64.219999999999999 110.914 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.99 133.83 53.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.120000000000005 110.86 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.2 pp -136.09 151.31 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.312 -0.404 . . . . 73.310000000000002 110.912 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.82 148.18 45.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.834 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -121.81 139.97 52.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.922 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -146.65 135.35 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.230000000000004 110.928 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.716 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -140.58 137.84 34.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 70.129999999999995 110.891 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -112.28 125.2 53.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 54.5 110.893 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.84 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 40.4 p -139.22 -178.96 5.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 73.530000000000001 111.137 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.98 -127.04 9.95 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.703 -0.76 . . . . 54.329999999999998 112.53 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' ' HB ' ' A' ' 38' ' ' THR . 1.2 mpp_? -112.9 -38.88 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 75.319999999999993 110.863 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 39' ' ' GLU . 3.8 t 179.0 -28.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.171 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -102.03 34.18 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 110.823 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.84 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.12 -6.92 8.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 72.239999999999995 111.105 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -71.47 128.71 36.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.506 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -137.57 159.65 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 54.329999999999998 110.929 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 t -93.59 121.01 43.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 72.030000000000001 111.135 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.05 145.74 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 61.43 110.879 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p -126.06 153.97 74.03 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 63.25 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 1.65 4.22 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.704 2.269 . . . . 74.099999999999994 112.383 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -117.62 69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 73.299999999999997 110.906 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.71 -37.45 3.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.835 -0.698 . . . . 55.219999999999999 112.489 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.53 43.24 52.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.741 -0.743 . . . . 53.149999999999999 112.527 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.16 -176.07 45.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.877 -0.677 . . . . 44.5 112.508 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 105.63 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.648 2.232 . . . . 73.340000000000003 112.384 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -55.49 -34.24 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 70.349999999999994 110.883 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.03 -26.44 66.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.209999999999994 110.929 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.33 -43.64 9.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 110.875 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.48 -97.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 73.200000000000003 111.101 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -156.77 174.57 15.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.439999999999998 111.011 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -123.18 161.14 25.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.944 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 63' ' ' SER . 61.6 t -107.44 130.28 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 71.299999999999997 111.084 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 63' ' ' SER . 44.5 mt -68.81 157.88 87.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.611 0.719 . . . . 71.530000000000001 110.923 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -21.86 33.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.772 2.315 . . . . 72.439999999999998 112.353 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -82.37 0.95 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.428 . . . . 75.409999999999997 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 26.46 20.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 73.310000000000002 112.514 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 58' ' ' VAL . 30.8 m -111.97 -179.53 3.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 74.239999999999995 110.874 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.68 HD23 HD12 ' A' ' 16' ' ' LEU . 13.3 tp -129.84 130.54 45.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 63.32 110.909 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.627 ' CD1' HG22 ' A' ' 15' ' ' VAL . 6.2 t80 -123.81 133.04 53.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 110.884 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.668 ' CD2' HG12 ' A' ' 69' ' ' VAL . 7.3 mp -114.83 127.08 27.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.651 0.738 . . . . 74.439999999999998 110.939 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -32.28 19.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 33.210000000000001 112.374 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -168.64 102.26 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 74.430000000000007 111.084 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 12' ' ' GLU . 27.5 m -73.07 118.71 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 75.409999999999997 111.136 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.01 161.61 21.77 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.698 -0.763 . . . . 41.310000000000002 112.524 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.912 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.76 -34.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 73.109999999999999 111.212 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.08 -20.2 56.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.450000000000003 110.903 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -2.9 28.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.420000000000002 110.965 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.22 141.91 49.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 60.509999999999998 110.883 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.573 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 163.4 -155.09 26.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 73.040000000000006 112.428 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.036 ' HB ' ' CD2' ' B' ' 3' ' ' PHE . 0.6 OUTLIER -124.74 135.34 64.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 71.540000000000006 111.142 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.716 ' CE2' HD22 ' A' ' 33' ' ' LEU . 80.8 m-85 -103.71 126.75 51.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.874 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 1.006 ' HG3' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER -124.93 127.55 47.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 74.140000000000001 110.868 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.01 150.9 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 65.25 110.857 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -139.65 132.6 29.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.936 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.16 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 73.439999999999998 111.176 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.4 ttm -129.48 126.09 37.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 64.400000000000006 110.884 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -86.22 172.62 10.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.915 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -71.26 -18.48 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 71.129999999999995 110.814 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -73.13 -19.85 61.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 73.400000000000006 110.874 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.69 -17.36 30.54 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 70.299999999999997 112.454 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -85.15 146.58 27.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.832 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.39 144.86 31.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.866 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.7 132.8 48.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.120000000000005 111.218 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.246 ' HE3' ' O2 ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -98.87 144.08 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.033 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -145.52 121.66 10.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 64.219999999999999 110.9 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.841 ' CG ' ' HB2' ' B' ' 4' ' ' MCL . 0.7 OUTLIER -128.18 122.08 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 74.230000000000004 110.836 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -128.0 118.97 24.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 73.120000000000005 110.965 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.599 ' CD ' ' CB ' ' B' ' 5' ' ' ALA . 0.5 OUTLIER -86.13 135.79 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.099999999999994 110.864 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 68.9 t -120.68 134.2 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.115 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.67 127.25 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.88 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.912 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.1 m -88.32 -177.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 52.310000000000002 111.065 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -68.84 -80.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 72.120000000000005 110.942 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.25 144.23 46.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 72.450000000000003 110.849 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.13 159.62 48.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.581 0.705 . . . . 53.509999999999998 111.131 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -19.93 35.27 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 61.399999999999999 112.329 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -175.54 -115.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 53.450000000000003 112.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -175.96 137.64 0.5 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.556 0.694 . . . . 53.229999999999997 110.86 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.86 115.46 4.12 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 64.25 112.33 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 55.32 110.936 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.836 0.351 . . . . 65.109999999999999 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.894 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -134.28 -37.93 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.486 . . . . 74.420000000000002 110.913 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.036 ' CD2' ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 176.08 -157.89 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.514 0 CA-C-O 118.107 -0.949 . . . . 74.319999999999993 110.856 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.246 ' O2 ' ' HE3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.602 ' HA ' ' CB ' ' A' ' 3' ' ' ALA . . . -50.03 -41.04 46.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.882 -0.599 . . . . 73.099999999999994 111.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.2 t70 52.65 33.0 12.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 72.200000000000003 110.87 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 94' ' ' ARG . 5.0 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.299999999999997 110.803 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.564 -0.215 . . . . 32.200000000000003 112.564 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.72 148.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 70.209999999999994 110.851 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.702 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . -61.93 94.78 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 63.210000000000001 111.093 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -93.3 133.51 36.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 74.140000000000001 110.881 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.0 121.34 27.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.79 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.56 121.88 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 72.140000000000001 111.142 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -95.93 142.06 28.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 73.219999999999999 111.152 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.72 165.26 30.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 72.400000000000006 111.109 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.86 148.64 45.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.909 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 HD11 ' HB3' ' A' ' 99' ' ' GLN . 70.3 mt -57.13 122.13 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 60.140000000000001 111.094 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.28 4.45 80.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 112.506 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.768 ' O ' HG22 ' A' ' 69' ' ' VAL . 35.7 mm-40 -101.19 139.4 20.43 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.641 0.734 . . . . 32.32 110.935 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 138.62 38.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.609 2.206 . . . . 43.43 112.359 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 66' ' ' LEU . 18.4 tp -145.0 141.26 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 64.430000000000007 110.861 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' CD1' ' A' ' 65' ' ' PHE . 47.2 t -126.64 147.81 31.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 54.439999999999998 111.178 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 77' ' ' PHE . 56.2 mt -131.88 147.29 52.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 72.349999999999994 110.96 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -111.7 149.11 32.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.869 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -112.32 101.56 9.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 61.020000000000003 110.86 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.530000000000001 110.906 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 150.31 -49.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 72.150000000000006 112.476 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.52 102.95 11.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 73.299999999999997 111.044 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 54.4 Cg_endo -69.71 -161.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.626 2.217 . . . . 64.329999999999998 112.402 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -12.68 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 71.040000000000006 110.942 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.508 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 29.8 mmtm -45.01 163.6 0.2 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 72.129999999999995 110.9 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 53.4 Cg_endo -69.72 172.58 12.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.0 112.368 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 53.6 Cg_endo -69.76 92.7 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 72.319999999999993 112.353 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -97.04 -175.51 3.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 74.349999999999994 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -64.1 132.54 50.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 110.946 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 46' ' ' PRO . 1.7 pp -168.63 174.26 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 75.25 110.927 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 124.1 40.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.931 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.35 143.4 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 72.120000000000005 110.866 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -143.96 144.1 31.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 71.430000000000007 110.941 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.698 HD11 ' CE2' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -136.57 132.83 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 72.329999999999998 110.882 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.158 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 0.2 OUTLIER -116.48 120.43 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.878 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.814 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 10.4 p -140.02 179.6 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 71.109999999999999 111.099 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.05 -130.1 10.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.434 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.39 -38.46 4.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 74.310000000000002 110.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.1 t 179.24 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 41.409999999999997 111.152 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' HG2' HG23 ' A' ' 38' ' ' THR . 4.7 mm-40 -102.03 33.93 2.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.825 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.93 -6.67 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 63.329999999999998 111.101 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -68.37 130.2 42.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 159.08 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 64.040000000000006 110.883 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.59 122.1 38.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 72.530000000000001 111.181 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 33' ' ' LEU . 11.2 mt -92.31 148.84 21.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 72.140000000000001 110.862 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.717 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -123.53 164.13 30.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.712 0.768 . . . . 61.219999999999999 110.825 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.793 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.8 Cg_endo -69.68 -0.51 6.95 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.258 . . . . 62.119999999999997 112.363 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 82.26 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 73.239999999999995 110.945 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.04 44.47 1.49 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.704 -0.76 . . . . 72.120000000000005 112.467 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.1 -126.84 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.797 -0.716 . . . . 72.450000000000003 112.432 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.25 -149.3 7.74 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.741 -0.742 . . . . 72.319999999999993 112.417 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 98.59 0.7 Allowed 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.785 2.323 . . . . 74.209999999999994 112.296 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -83.4 -34.84 25.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.898 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.5 -26.36 68.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 72.409999999999997 110.797 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -42.97 22.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.150000000000006 110.902 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.08 -97.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 74.140000000000001 111.208 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.7 171.48 11.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 111.081 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.47 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -131.25 165.39 23.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 110.899 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.793 HG11 ' HA ' ' A' ' 46' ' ' PRO . 55.2 t -106.51 130.13 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 111.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 65' ' ' PHE . 6.2 mp -69.76 157.84 88.61 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.577 0.703 . . . . 61.350000000000001 110.907 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 54.2 Cg_endo -69.68 -22.9 31.79 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.717 2.278 . . . . 65.120000000000005 112.37 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.37 2.06 38.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 75.439999999999998 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.93 30.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 60.210000000000001 112.494 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 11.7 m -105.67 179.42 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 110.805 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 57' ' ' ARG . 36.9 tp -132.3 128.35 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 74.430000000000007 110.959 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 15' ' ' VAL . 4.5 t80 -129.65 128.16 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 72.150000000000006 110.858 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -121.27 132.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.698 0.761 . . . . 72.150000000000006 110.927 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 -32.27 19.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.743 2.295 . . . . 64.120000000000005 112.414 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -155.81 103.5 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 74.299999999999997 111.055 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.3 m -73.2 119.36 20.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 111.19 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.82 156.17 26.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.745 -0.741 . . . . 63.130000000000003 112.526 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.76 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.51 -29.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.807 0.337 . . . . 74.109999999999999 111.087 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -73.32 -23.5 60.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 61.130000000000003 110.887 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.26 -5.26 57.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 72.420000000000002 110.831 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.55 140.61 57.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 75.409999999999997 110.869 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.23 -137.93 5.63 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.778 -0.725 . . . . 64.209999999999994 112.485 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.444 HD13 ' CB ' ' B' ' 5' ' ' ALA . 70.9 mt -130.46 135.26 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 73.049999999999997 111.197 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.698 ' CE2' HD11 ' A' ' 33' ' ' LEU . 5.0 m-85 -100.85 128.39 46.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.874 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 1.108 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 2.1 tmm_? -127.92 127.72 43.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 110.902 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -121.24 149.73 42.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.854 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -146.98 126.68 13.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.874 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.13 163.74 27.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 55.030000000000001 111.101 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.4 mtp -129.96 125.83 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.879 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -86.2 172.03 10.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.519999999999996 110.83 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -71.78 -17.95 62.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.843 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.1 -19.61 61.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.895 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.7 -18.58 29.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 62.299999999999997 112.53 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 145.19 27.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 44.329999999999998 110.83 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -106.91 145.0 32.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 110.893 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.01 131.32 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 70.299999999999997 111.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.262 ' HD2' ' C1 ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -105.35 145.6 30.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 62.32 110.936 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -146.04 123.95 12.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 62.210000000000001 110.81 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.885 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.5 OUTLIER -128.49 120.39 26.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 64.219999999999999 110.913 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.64 127.85 39.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.989 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.349 ' NE ' ' HB1' ' B' ' 5' ' ' ALA . 4.1 mmm-85 -87.62 136.18 33.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 61.119999999999997 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 77' ' ' PHE . 56.1 t -126.45 132.29 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 111.14 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 128.83 41.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.109999999999999 110.9 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 m -92.92 -176.31 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 62.140000000000001 111.083 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -66.49 -81.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 72.109999999999999 110.941 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.426 ' HB3' HD11 ' A' ' 10' ' ' ILE . 11.2 tp-100 -60.97 142.59 56.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 71.25 110.811 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.67 159.88 48.9 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.548 0.69 . . . . 72.510000000000005 111.151 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 -174.76 0.95 Allowed 'Trans proline' 0 C--N 1.34 0.086 0 C-N-CA 122.746 2.297 . . . . 62.020000000000003 112.339 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 163.51 -51.57 0.3 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.835 -0.698 . . . . 73.510000000000005 112.543 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 157.13 40.5 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.601 0.715 . . . . 53.020000000000003 110.878 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 127.17 14.26 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 74.129999999999995 112.337 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 53.340000000000003 110.839 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.858 0.361 . . . . 63.210000000000001 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -116.84 -17.95 10.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 64.150000000000006 110.924 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.158 ' CD2' ' HB2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -161.14 -165.15 1.28 Allowed 'General case' 0 C--O 1.181 -2.515 0 CA-C-O 118.15 -0.929 . . . . 70.140000000000001 110.851 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.262 ' C1 ' ' HD2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.444 ' CB ' HD13 ' A' ' 76' ' ' ILE . . . -43.73 127.14 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.595 . . . . 72.439999999999998 111.136 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -153.78 58.54 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 71.230000000000004 110.92 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.815 ' HG3' ' NH1' ' A' ' 94' ' ' ARG . 9.4 mt-10 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 110.925 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 112.531 -0.227 . . . . 62.149999999999999 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.605 ' HA ' ' O1 ' ' B' ' 4' ' ' MCL . 52.4 p -166.44 -169.14 1.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.8 0.333 . . . . 71.310000000000002 110.908 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.662 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . -60.35 96.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.075 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -93.47 133.73 36.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 64.319999999999993 110.924 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.7 120.48 26.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 14' ' ' LEU . 48.7 mm -125.9 121.51 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 75.329999999999998 111.144 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.89 140.95 29.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 74.010000000000005 111.085 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.62 166.62 27.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 35.109999999999999 111.088 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.79 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 71.310000000000002 110.904 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG23 ' HA2' ' A' ' 70' ' ' GLY . 22.1 mt -55.59 120.3 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 111.22 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.715 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.89 9.3 74.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.685 -0.769 . . . . 53.119999999999997 112.463 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.772 ' O ' HG22 ' A' ' 69' ' ' VAL . 50.3 mm-40 -102.66 139.14 19.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 74.450000000000003 110.883 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 143.7 51.55 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.686 2.257 . . . . 65.530000000000001 112.355 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.616 ' O ' HD12 ' A' ' 66' ' ' LEU . 30.2 tp -145.88 143.42 29.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.288 -0.414 . . . . 63.049999999999997 110.901 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 142.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 111.153 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.5 147.99 52.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 74.319999999999993 110.895 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -113.75 151.19 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 71.400000000000006 110.85 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -107.53 101.63 10.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 51.340000000000003 110.813 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -50.16 125.66 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 74.200000000000003 111.012 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.38 -45.12 1.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.8 -0.714 . . . . 65.109999999999999 112.464 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.16 123.84 63.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.595 0.712 . . . . 72.030000000000001 111.076 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.9 Cg_endo -69.75 -163.86 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.667 2.245 . . . . 71.099999999999994 112.385 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -47.5 39.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 72.430000000000007 110.869 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.74 149.43 37.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 71.310000000000002 110.872 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.82 108.93 2.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.734 2.289 . . . . 52.119999999999997 112.332 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.45 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 54.3 Cg_endo -69.71 -87.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.709 2.273 . . . . 55.350000000000001 112.409 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -104.16 -179.28 3.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 75.120000000000005 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -67.56 135.6 53.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 71.400000000000006 110.879 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.855 HD11 ' CE3' ' A' ' 31' ' ' TRP . 1.1 pp -135.69 163.38 30.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.340000000000003 110.913 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.8 tp10 -120.56 149.02 43.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.040000000000006 110.913 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.855 ' CE3' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -127.43 143.16 51.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 110.96 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -143.03 140.79 31.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 61.229999999999997 110.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.804 HD11 HG23 ' A' ' 35' ' ' THR . 0.9 OUTLIER -137.65 132.82 33.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 65.030000000000001 110.916 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.887 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 19.0 t-20 -114.9 120.94 41.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.25 110.915 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.807 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.2 p -139.03 179.52 6.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 55.119999999999997 111.172 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.09 -130.03 10.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.644 -0.788 . . . . 60.420000000000002 112.537 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.67 -38.34 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 63.310000000000002 110.863 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.6 t 179.91 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 53.020000000000003 111.151 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 38' ' ' THR . 22.6 mt-10 -102.7 33.8 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 63.340000000000003 110.994 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.97 -7.04 8.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 74.109999999999999 111.1 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -64.52 130.93 45.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 110.888 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 153.49 47.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.938 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.54 120.84 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 64.099999999999994 111.135 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.755 HD13 ' HA3' ' A' ' 49' ' ' GLY . 2.7 mm? -94.26 149.68 21.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.18 -0.463 . . . . 64.310000000000002 110.873 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.566 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.5 p -121.74 156.39 58.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.728 0.775 . . . . 54.439999999999998 110.831 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -0.32 6.77 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.229 . . . . 70.329999999999998 112.324 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -145.61 71.86 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 75.299999999999997 110.889 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.87 84.29 0.85 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 63.25 112.55 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.755 ' HA3' HD13 ' A' ' 44' ' ' LEU . . . -93.1 34.46 4.55 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 63.210000000000001 112.435 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.54 -178.73 17.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 73.439999999999998 112.488 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 53.6 Cg_endo -69.74 106.72 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.656 2.238 . . . . 75.519999999999996 112.355 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -30.84 65.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 71.25 110.897 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.69 -25.72 62.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.411 . . . . 74.439999999999998 110.892 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -91.26 -44.01 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 34.130000000000003 110.834 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -125.78 -99.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 73.049999999999997 111.093 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -150.87 175.9 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 111.078 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 168.66 16.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 63.549999999999997 110.843 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 45' ' ' SER . 49.9 t -106.45 130.11 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 63.409999999999997 111.154 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 65' ' ' PHE . 4.5 mp -69.31 156.62 91.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 60.25 110.945 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -20.46 34.72 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.631 2.221 . . . . 74.0 112.422 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 1.91 32.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 41.549999999999997 110.861 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.3 25.12 27.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.668 -0.777 . . . . 72.430000000000007 112.445 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 58' ' ' VAL . 73.9 m -113.5 -179.29 3.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 63.219999999999999 110.86 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tp -129.59 128.53 42.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 71.439999999999998 110.871 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.777 ' HB2' HD11 ' A' ' 59' ' ' LEU . 39.9 t80 -126.11 132.81 51.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 71.140000000000001 110.958 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.845 HD22 HG12 ' A' ' 69' ' ' VAL . 2.8 mp -114.7 128.28 26.03 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 71.129999999999995 110.94 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.63 -34.24 15.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.685 2.257 . . . . 74.409999999999997 112.395 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.69 99.33 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 71.409999999999997 111.079 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.845 HG12 HD22 ' A' ' 66' ' ' LEU . 13.4 m -74.97 112.22 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.349999999999994 111.215 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -86.18 171.01 43.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 72.129999999999995 112.492 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.86 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.69 -30.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.729 0.3 . . . . 72.340000000000003 111.095 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -76.49 -23.12 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 60.219999999999999 110.896 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -3.59 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.049999999999997 110.847 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 140.66 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 72.239999999999995 110.867 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.595 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 159.18 -149.04 18.76 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 54.43 112.502 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.761 ' CD1' ' HG3' ' B' ' 2' ' ' GLU . 3.6 mp -130.69 135.26 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.895 0.379 . . . . 64.209999999999994 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CG ' HD23 ' A' ' 33' ' ' LEU . 32.2 m-85 -101.17 130.96 47.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 62.219999999999999 110.897 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.51 131.02 50.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 70.319999999999993 110.85 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 151.07 40.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 22.120000000000001 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -144.98 126.11 14.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 72.319999999999993 110.799 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.7 162.8 29.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 35.100000000000001 111.056 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.3 ttm -130.18 125.48 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 60.009999999999998 110.866 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -87.08 172.22 10.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -71.33 -19.07 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 73.209999999999994 110.886 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -74.21 -20.14 60.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.530000000000001 110.847 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.96 -9.1 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 75.040000000000006 112.531 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -85.11 146.28 27.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 62.409999999999997 110.893 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -105.73 142.12 36.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 65.329999999999998 110.945 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.456 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.17 125.9 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 111.043 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -106.87 143.1 35.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 65.129999999999995 110.9 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -146.74 120.61 9.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 63.32 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.483 HD21 ' HB2' ' B' ' 5' ' ' ALA . 0.7 OUTLIER -125.63 122.6 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 74.019999999999996 110.919 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -126.19 125.88 43.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.902 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.528 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 8.9 mmm-85 -86.34 132.68 33.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.902 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.546 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.6 t -120.81 133.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.150000000000006 111.123 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.444 ' NH2' HG22 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -130.74 128.93 41.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 70.140000000000001 110.812 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.86 HG21 ' HA ' ' A' ' 71' ' ' ILE . 24.0 m -92.58 -176.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 111.136 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -66.83 -82.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 75.439999999999998 110.963 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -62.97 146.34 53.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.886 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.503 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.55 49.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 73.349999999999994 111.204 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.5 Cg_endo -69.83 -174.22 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.244 . . . . 70.319999999999993 112.243 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.18 95.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.699 -0.762 . . . . 54.409999999999997 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -142.73 158.92 58.79 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 54.240000000000002 110.88 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 177.86 5.12 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.633 2.222 . . . . 43.43 112.354 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 110.925 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.702 0.287 . . . . 74.140000000000001 110.972 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.761 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -53.92 -37.29 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 110.907 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.887 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -176.28 -163.82 0.11 Allowed 'General case' 0 C--O 1.182 -2.469 0 CA-C-O 118.102 -0.952 . . . . 62.43 110.915 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.605 ' O1 ' ' HA ' ' A' ' 2' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.528 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . -45.53 128.13 7.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 55.340000000000003 111.057 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.88 67.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.424 . . . . 72.310000000000002 110.961 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.905 ' HG3' HH12 ' A' ' 94' ' ' ARG . 1.2 pp20? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.019999999999996 110.877 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.46 -0.256 . . . . 51.299999999999997 112.46 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.549 ' OG ' ' O1 ' ' B' ' 4' ' ' MCL . 1.4 t -179.86 148.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 34.420000000000002 110.754 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.75 56.32 8.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 44.140000000000001 111.082 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -93.33 133.24 36.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 75.439999999999998 110.937 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 2.2 p30 -84.96 122.17 28.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 110.891 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.488 ' CG2' HD11 ' A' ' 14' ' ' LEU . 48.6 mm -124.03 120.89 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.549999999999997 111.153 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -96.05 142.44 28.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 62.43 111.215 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.033 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -143.68 164.86 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.099999999999994 111.137 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -124.67 151.31 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 72.150000000000006 110.908 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.57 118.6 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 65.310000000000002 111.111 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 80.21 8.84 87.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 63.119999999999997 112.465 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.793 ' O ' HG22 ' A' ' 69' ' ' VAL . 9.2 mm-40 -102.19 140.44 21.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 73.200000000000003 110.935 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 143.83 51.9 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.638 2.225 . . . . 63.439999999999998 112.366 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 8' ' ' ALA . 22.7 tp -145.27 142.22 29.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 110.963 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 65' ' ' PHE . 40.6 t -122.63 145.12 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.168 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.546 HD12 HD23 ' A' ' 64' ' ' LEU . 65.1 mt -131.66 147.78 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 110.916 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -113.39 150.32 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 65.329999999999998 110.809 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -110.67 100.96 9.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.852 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.53 128.04 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 71.120000000000005 110.956 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.01 -45.02 1.2 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.768 -0.729 . . . . 52.210000000000001 112.439 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.45 124.85 59.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.602 0.715 . . . . 70.439999999999998 111.069 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.481 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.8 Cg_endo -69.84 -163.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.681 2.254 . . . . 64.230000000000004 112.381 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.31 -47.57 36.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 43.520000000000003 110.939 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -104.54 156.67 35.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.627 0.727 . . . . 72.329999999999998 110.878 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.74 109.46 2.31 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.69 2.26 . . . . 71.329999999999998 112.378 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.6 Cg_endo -69.83 -87.32 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.739 2.293 . . . . 73.219999999999999 112.322 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -103.45 -178.15 3.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 65.129999999999995 110.877 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -65.81 132.46 48.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -145.22 150.63 37.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 64.010000000000005 110.909 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.428 ' N ' HD12 ' A' ' 29' ' ' LEU . 15.2 tt0 -121.03 149.77 42.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 110.913 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.681 ' CE2' HD11 ' A' ' 29' ' ' LEU . 16.8 m-90 -107.28 136.64 46.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.903 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' C ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.42 145.08 38.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 61.350000000000001 110.911 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.816 HD12 ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -156.79 137.96 13.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 71.409999999999997 110.952 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 0.3 OUTLIER -112.57 128.89 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 75.349999999999994 110.925 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.813 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 2.7 p -136.59 179.2 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 111.111 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.84 14.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 70.239999999999995 112.498 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -112.57 -37.86 4.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 74.439999999999998 110.865 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.3 t -179.69 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 41.020000000000003 111.184 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -102.94 33.46 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.883 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.19 -6.71 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 52.009999999999998 111.097 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -59.78 132.23 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 74.510000000000005 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.816 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -129.61 151.89 49.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 73.239999999999995 110.821 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.7 121.91 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 111.166 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD23 HD21 ' A' ' 33' ' ' LEU . 3.4 mm? -90.13 146.36 24.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 75.299999999999997 110.831 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.64 153.16 72.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.685 0.755 . . . . 70.120000000000005 110.877 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -0.26 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.818 2.346 . . . . 54.340000000000003 112.366 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -125.0 67.93 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.209999999999994 110.924 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.56 62.17 5.57 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.776 -0.726 . . . . 23.32 112.485 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.49 98.32 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 33.219999999999999 112.477 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.82 -171.3 0.19 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.73 . . . . 75.400000000000006 112.464 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 104.63 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 65.129999999999995 112.362 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -53.51 -35.39 60.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.919 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.97 -26.79 67.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 72.299999999999997 110.838 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.68 -42.72 10.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 110.895 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -123.07 -97.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 63.350000000000001 111.065 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -160.3 172.9 16.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 111.165 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.72 164.76 19.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.913 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -106.52 130.28 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 61.409999999999997 111.144 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 63' ' ' SER . 25.7 mt -70.39 158.64 87.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 74.099999999999994 110.921 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -22.59 31.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.759 2.306 . . . . 72.219999999999999 112.313 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.05 1.65 42.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.54 17.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.775 -0.726 . . . . 52.420000000000002 112.513 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.438 ' HB2' HD12 ' A' ' 59' ' ' LEU . 36.6 m -112.48 -178.3 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.933 0.396 . . . . 73.25 110.829 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 77' ' ' PHE . 21.8 tp -127.73 128.66 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.924 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD2' HG22 ' A' ' 15' ' ' VAL . 38.9 t80 -125.33 137.24 54.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 72.319999999999993 110.83 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.883 HD22 HG12 ' A' ' 69' ' ' VAL . 5.5 mp -118.48 125.03 28.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.601 0.715 . . . . 74.120000000000005 110.969 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -31.92 19.4 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.5 112.343 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.51 100.61 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 62.409999999999997 111.091 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.033 HG21 ' HB1' ' A' ' 8' ' ' ALA . 31.3 m -73.4 118.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 63.009999999999998 111.137 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.45 162.77 17.79 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.807 -0.711 . . . . 75.239999999999995 112.447 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.852 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.31 -29.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 70.439999999999998 111.175 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.7 -24.01 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 64.340000000000003 110.846 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -81.8 -4.64 56.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.288 -0.415 . . . . 75.239999999999995 110.809 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.3 140.77 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 54.340000000000003 110.802 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.589 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 159.03 -138.23 5.56 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.734 . . . . 64.129999999999995 112.554 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.431 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.6 mp -130.63 134.66 61.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.888 0.375 . . . . 72.109999999999999 111.142 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.786 ' CE2' HD13 ' A' ' 33' ' ' LEU . 5.9 m-85 -103.5 132.86 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 71.409999999999997 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HG3' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER -127.22 126.64 43.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 70.409999999999997 110.839 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 150.38 34.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.833 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -139.73 127.64 22.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 64.219999999999999 110.879 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.42 164.01 26.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 71.450000000000003 111.129 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.1 ttm -129.52 125.66 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 75.340000000000003 110.878 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.41 171.58 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.876 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -71.52 -17.72 62.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.827 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -72.36 -20.02 61.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 62.130000000000003 110.863 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.8 -21.0 23.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 24.199999999999999 112.483 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.69 148.13 26.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 75.310000000000002 110.79 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.45 145.16 30.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 64.239999999999995 110.953 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.3 132.61 46.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.149 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -98.51 146.71 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 63.0 110.952 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.66 126.62 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 65.340000000000003 110.817 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.688 ' HB3' ' O2 ' ' B' ' 4' ' ' MCL . 2.0 t-20 -129.08 120.83 26.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 62.43 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -128.56 127.26 41.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 110.995 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.3 ' NH2' ' HA ' ' B' ' 5' ' ' ALA . 13.8 mmt85 -83.75 135.46 34.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 72.329999999999998 110.925 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 77' ' ' PHE . 75.5 t -120.19 133.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 71.120000000000005 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 141.82 49.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.349999999999994 110.803 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.852 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.6 m -109.65 -176.21 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.162 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -75.93 -73.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 65.109999999999999 110.89 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 147.77 33.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 62.200000000000003 110.956 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.41 159.61 49.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.657 0.742 . . . . 51.119999999999997 111.161 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.13 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.771 2.314 . . . . 62.020000000000003 112.313 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.9 -69.29 0.21 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.67 -0.776 . . . . 54.109999999999999 112.438 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -171.32 73.61 0.52 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.528 0.68 . . . . 61.329999999999998 110.924 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 158.83 55.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.604 2.202 . . . . 73.140000000000001 112.363 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 75.319999999999993 110.921 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.798 0.333 . . . . 52.049999999999997 110.856 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.431 ' CB ' HD13 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -48.05 -59.54 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 51.149999999999999 110.891 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.037 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -177.88 104.36 0.05 OUTLIER 'General case' 0 C--O 1.181 -2.502 0 CA-C-O 118.237 -0.887 . . . . 70.150000000000006 110.805 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.688 ' O2 ' ' HB3' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.3 ' HA ' ' NH2' ' A' ' 94' ' ' ARG . . . 39.76 81.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 61.350000000000001 111.078 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.919 ' N ' ' NH2' ' A' ' 94' ' ' ARG . 4.7 m-20 -82.81 1.71 37.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 75.030000000000001 110.863 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.83 ' HG3' HH12 ' A' ' 94' ' ' ARG . 7.6 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 72.030000000000001 110.911 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.557 -0.217 . . . . 74.439999999999998 112.557 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.31 115.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.931 0.396 . . . . 74.109999999999999 110.845 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.95 58.64 5.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 62.399999999999999 111.026 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.94 133.65 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 74.140000000000001 110.918 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -86.24 121.43 28.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 63.219999999999999 110.946 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mm -125.0 122.35 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.431 . . . . 74.439999999999998 111.177 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -95.53 139.93 31.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 70.299999999999997 111.224 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.69 167.49 25.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 70.200000000000003 111.1 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.8 149.0 43.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 75.530000000000001 110.839 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.594 HG23 ' HA2' ' A' ' 70' ' ' GLY . 38.3 mt -52.73 120.54 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 111.166 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.721 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.61 11.7 68.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 61.030000000000001 112.516 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.775 ' O ' HG22 ' A' ' 69' ' ' VAL . 47.4 mm-40 -102.81 138.18 19.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 75.409999999999997 110.902 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 143.12 49.98 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.708 2.272 . . . . 74.230000000000004 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 66' ' ' LEU . 27.9 tp -145.82 142.91 29.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 110.862 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.86 146.87 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 63.509999999999998 111.179 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.705 HD12 HD23 ' A' ' 64' ' ' LEU . 7.9 mt -133.2 146.96 51.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.510000000000005 110.861 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -113.83 153.09 29.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 72.25 110.876 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.6 101.45 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 110.897 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.77 123.77 13.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 64.140000000000001 110.844 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.56 -40.92 1.81 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.711 . . . . 63.049999999999997 112.544 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.11 129.16 44.76 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 74.200000000000003 111.118 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.489 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.83 -164.21 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.679 2.253 . . . . 73.200000000000003 112.325 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.4 -47.46 47.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 54.020000000000003 110.825 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.93 156.63 36.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.541 0.686 . . . . 53.109999999999999 110.939 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.92 109.59 2.38 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.666 2.244 . . . . 72.209999999999994 112.289 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.1 Cg_endo -69.82 -86.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.719 2.279 . . . . 70.319999999999993 112.252 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -103.22 -176.89 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 45.520000000000003 110.939 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.7 mtp85 -63.47 133.91 54.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 110.819 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 46' ' ' PRO . 2.5 pp -135.54 164.75 27.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 64.150000000000006 110.846 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -133.73 146.78 51.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 70.450000000000003 110.897 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -121.81 137.43 54.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.873 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 139.2 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 72.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.783 HD11 HG23 ' A' ' 35' ' ' THR . 1.3 tm? -138.12 131.89 31.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.404 . . . . 75.219999999999999 110.917 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.71 ' N ' HD22 ' A' ' 33' ' ' LEU . 23.8 t-20 -115.78 120.55 39.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 60.32 110.901 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 41.7 p -139.73 179.47 6.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 72.140000000000001 111.145 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.11 -133.44 18.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 52.439999999999998 112.444 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -112.39 -37.28 5.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 73.310000000000002 110.869 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.7 t -179.28 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 72.319999999999993 111.205 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -101.29 33.69 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.106 -0.497 . . . . 71.510000000000005 110.947 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -125.39 -6.08 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 71.549999999999997 111.094 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -68.87 130.1 41.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.040000000000006 110.919 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.665 ' HE2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -136.26 158.97 43.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 75.409999999999997 110.889 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.86 120.56 52.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.434 . . . . 60.149999999999999 111.064 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 147.79 23.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.836 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -125.08 160.49 54.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 53.420000000000002 110.86 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HB3' HD11 ' A' ' 29' ' ' LEU . 52.9 Cg_endo -69.85 0.19 6.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 60.039999999999999 112.285 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -132.68 70.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 75.420000000000002 110.887 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 74.51 1.11 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.766 -0.73 . . . . 62.350000000000001 112.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.92 58.9 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.729 -0.748 . . . . 72.310000000000002 112.495 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.54 171.84 42.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 44.119999999999997 112.465 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 106.76 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.651 2.234 . . . . 73.140000000000001 112.354 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -52.91 -34.6 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 110.945 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -61.93 -31.17 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.87 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.46 -43.07 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 55.149999999999999 110.852 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.665 HG11 ' HE2' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -126.37 -97.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 70.510000000000005 111.135 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -154.31 176.3 12.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 74.510000000000005 111.067 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.681 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -122.23 161.38 23.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 111.004 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 63' ' ' SER . 41.4 t -107.9 129.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 61.219999999999999 111.119 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 65' ' ' PHE . 5.5 mp -69.97 157.19 90.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.739 0.78 . . . . 71.230000000000004 110.863 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 -20.63 35.16 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.63 2.22 . . . . 44.32 112.411 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -82.18 1.39 36.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.140000000000001 110.917 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.98 20.61 35.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.684 -0.769 . . . . 65.409999999999997 112.521 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.47 ' O ' HG13 ' A' ' 58' ' ' VAL . 40.9 m -107.52 -179.22 3.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 72.319999999999993 110.829 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.705 HD23 HD12 ' A' ' 16' ' ' LEU . 55.7 tp -130.4 129.22 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 72.120000000000005 110.956 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' HB2' HD11 ' A' ' 59' ' ' LEU . 6.3 t80 -126.21 131.64 51.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.319999999999993 110.876 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.86 HD22 HG12 ' A' ' 69' ' ' VAL . 2.8 mp -115.17 129.9 24.69 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.586 0.708 . . . . 63.229999999999997 110.944 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.84 17.71 Favored 'Trans proline' 0 N--CA 1.466 -0.12 0 C-N-CA 122.74 2.293 . . . . 72.430000000000007 112.323 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.721 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -171.21 99.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 111.127 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.86 HG12 HD22 ' A' ' 66' ' ' LEU . 14.5 m -77.46 112.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 60.229999999999997 111.053 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.594 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -87.33 175.63 46.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.721 -0.752 . . . . 33.43 112.532 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.867 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.18 -31.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 73.310000000000002 111.081 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -76.59 -21.96 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 62.439999999999998 110.937 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.55 -3.6 35.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.87 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 141.1 56.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 63.100000000000001 110.932 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.749 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 158.56 -150.47 21.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.741 . . . . 71.420000000000002 112.422 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 75' ' ' GLY . 4.4 mm -130.63 137.25 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 73.519999999999996 111.115 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.584 ' CG ' HD23 ' A' ' 33' ' ' LEU . 41.3 m-85 -103.11 127.43 50.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 63.509999999999998 110.869 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -124.92 128.37 48.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 70.099999999999994 110.932 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.83 151.25 39.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.109999999999999 110.871 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 71.109999999999999 110.996 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.525 ' HB3' ' OG1' ' A' ' 89' ' ' THR . . . -131.7 163.07 28.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 54.43 111.125 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 72.3 mmm -129.8 124.84 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.905 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -89.71 170.61 10.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.150000000000006 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -21.81 60.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.805 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -73.39 -19.97 60.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 71.109999999999999 110.902 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.2 -7.48 32.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 73.200000000000003 112.455 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 146.59 27.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 72.140000000000001 110.959 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -105.0 144.02 32.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.934 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -103.12 126.17 50.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 72.239999999999995 111.124 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -102.48 142.39 33.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 74.540000000000006 110.98 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -146.46 120.05 9.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 41.049999999999997 110.882 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.951 HD21 ' HB2' ' B' ' 5' ' ' ALA . 0.6 OUTLIER -129.58 122.47 29.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.019999999999996 110.955 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.48 119.41 22.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 64.510000000000005 110.915 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.772 HH21 ' N ' ' B' ' 6' ' ' ASP . 0.0 OUTLIER -84.46 134.46 34.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 55.439999999999998 110.924 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.436 HG21 ' CE1' ' A' ' 77' ' ' PHE . 61.8 t -120.91 137.24 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 111.18 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -129.91 130.5 45.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.867 HG21 ' HA ' ' A' ' 71' ' ' ILE . 22.6 m -93.5 -176.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 75.329999999999998 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -65.34 -77.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 110.958 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.584 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -66.75 140.64 57.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 74.230000000000004 110.949 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.04 159.69 48.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.61 0.719 . . . . 72.230000000000004 111.19 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 129.74 18.13 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.786 2.324 . . . . 61.149999999999999 112.339 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.78 18.53 0.86 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.656 -0.783 . . . . 50.109999999999999 112.43 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -77.39 137.68 63.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.615 0.721 . . . . 74.450000000000003 110.831 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 101.11 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.622 2.214 . . . . 64.040000000000006 112.437 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 110.874 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.785 0.326 . . . . 71.349999999999994 110.864 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -135.74 63.91 1.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.852 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.658 ' CE2' ' HB2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 66.55 -163.55 0.23 Allowed 'General case' 0 C--O 1.182 -2.497 0 CA-C-O 118.106 -0.949 . . . . 70.340000000000003 110.895 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.42 ' C ' ' HE3' ' B' ' 4' ' ' MCL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.951 ' HB2' HD21 ' A' ' 92' ' ' ASN . . . -46.22 145.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 62.130000000000003 111.155 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.772 ' N ' HH21 ' A' ' 94' ' ' ARG . 37.2 t70 -159.5 113.23 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.540000000000006 110.837 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.757 ' N ' ' NH2' ' A' ' 94' ' ' ARG . 4.5 mm-40 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 73.299999999999997 110.941 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.446 -0.262 . . . . 53.399999999999999 112.446 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -178.33 158.74 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 64.420000000000002 110.895 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.78 95.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 75.140000000000001 111.134 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -93.14 133.05 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 73.219999999999999 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.69 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -85.06 119.84 25.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 110.896 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.69 HD12 ' O ' ' A' ' 5' ' ' ASN . 1.3 mp -125.83 122.0 61.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.430000000000007 111.122 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -95.84 142.27 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 63.5 111.148 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.14 166.55 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 72.340000000000003 111.141 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.29 148.94 44.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.847 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.597 HD11 ' HB2' ' A' ' 99' ' ' GLN . 38.1 mt -54.38 119.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 53.420000000000002 111.147 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.602 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.92 7.85 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 72.209999999999994 112.418 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.823 ' O ' HG22 ' A' ' 69' ' ' VAL . 37.4 mm-40 -102.55 140.08 20.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 51.25 110.901 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 143.02 49.04 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.654 2.236 . . . . 64.439999999999998 112.298 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 66' ' ' LEU . 51.5 tp -145.27 143.49 30.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 65.430000000000007 110.882 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.476 HG22 ' CD2' ' A' ' 65' ' ' PHE . 38.3 t -124.08 147.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 71.439999999999998 111.142 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.732 HD12 HD23 ' A' ' 64' ' ' LEU . 59.8 mt -131.39 148.26 52.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.239999999999995 110.996 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 151.88 28.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 72.099999999999994 110.912 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.7 101.5 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.120000000000005 110.897 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -58.93 120.98 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 110.838 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.99 -39.4 2.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.826 -0.702 . . . . 75.030000000000001 112.587 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.6 128.32 46.95 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 72.340000000000003 111.153 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 54.5 Cg_endo -69.71 -165.32 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 72.530000000000001 112.387 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -47.6 52.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 73.400000000000006 110.913 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.3 152.04 41.07 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.518 0.675 . . . . 55.109999999999999 110.864 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.7 Cg_endo -69.76 109.56 2.34 Favored 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.714 2.276 . . . . 60.509999999999998 112.369 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 53.8 Cg_endo -69.74 -86.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.249 . . . . 63.409999999999997 112.323 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.01 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.420000000000002 110.914 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -63.93 135.58 56.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 110.803 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 46' ' ' PRO . 4.1 pp -135.55 158.6 43.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.915 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -121.25 148.16 44.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 64.150000000000006 110.876 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -131.75 128.94 39.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 63.350000000000001 110.887 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -137.66 136.0 37.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 110.891 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.855 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.86 139.37 38.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 72.400000000000006 110.892 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.852 ' HB3' ' HD1' ' B' ' 3' ' ' PHE . 2.7 t-20 -111.89 126.65 55.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 63.030000000000001 110.921 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.82 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 14.6 p -138.52 -179.67 5.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 71.129999999999995 111.137 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.3 -130.11 20.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.748 -0.739 . . . . 42.210000000000001 112.511 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.98 -37.14 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 73.299999999999997 110.835 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 39' ' ' GLU . 5.0 t -179.3 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 55.149999999999999 111.092 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 38' ' ' THR . 8.3 mm-40 -102.12 34.3 2.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 72.329999999999998 110.875 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.07 -6.99 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 72.530000000000001 111.178 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.54 ' CZ2' HG22 ' A' ' 43' ' ' VAL . 48.1 t90 -59.5 130.44 46.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 75.430000000000007 110.908 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.742 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -129.96 153.67 48.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 63.130000000000003 110.831 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.54 HG22 ' CZ2' ' A' ' 41' ' ' TRP . 19.7 t -104.62 113.8 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 62.420000000000002 111.186 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.855 HD22 HD21 ' A' ' 33' ' ' LEU . 10.7 mp -93.32 147.2 23.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 64.209999999999994 110.916 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -125.01 161.87 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.7 0.762 . . . . 74.400000000000006 110.9 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.615 ' HB3' HD11 ' A' ' 29' ' ' LEU . 52.8 Cg_endo -69.84 0.14 6.13 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.631 2.221 . . . . 54.109999999999999 112.303 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 79.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 65.230000000000004 110.951 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 79.28 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.709 -0.758 . . . . 74.230000000000004 112.494 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.53 53.42 4.85 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.706 -0.759 . . . . 75.230000000000004 112.475 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.2 179.52 38.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.781 -0.724 . . . . 71.340000000000003 112.583 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 107.17 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.261 . . . . 51.420000000000002 112.304 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -57.11 -33.7 67.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.233 -0.439 . . . . 74.230000000000004 110.935 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.28 -26.89 66.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 75.030000000000001 110.884 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -44.76 8.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 53.109999999999999 110.895 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -127.74 -96.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 52.030000000000001 111.13 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -150.29 173.3 14.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 111.093 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 165.55 16.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 71.120000000000005 110.875 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 45' ' ' SER . 42.6 t -108.63 130.05 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 63.32 111.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 63' ' ' SER . 50.3 mt -69.28 156.96 90.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 73.019999999999996 110.892 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 -21.6 33.72 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.769 2.313 . . . . 62.439999999999998 112.344 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -82.19 1.0 38.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.200000000000003 110.927 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.71 26.35 20.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.457 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 58' ' ' VAL . 19.9 m -111.25 179.39 4.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 54.509999999999998 110.917 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.732 HD23 HD12 ' A' ' 16' ' ' LEU . 11.5 tp -129.89 128.82 42.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.901 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 15' ' ' VAL . 3.8 t80 -125.59 131.3 52.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.897 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.89 HD22 HG12 ' A' ' 69' ' ' VAL . 3.7 mp -114.34 126.9 27.39 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.649 0.738 . . . . 74.340000000000003 110.978 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -32.02 19.45 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.74 2.293 . . . . 53.450000000000003 112.289 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.34 99.17 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.128 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 66' ' ' LEU . 15.9 m -73.94 115.7 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 52.329999999999998 111.093 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.53 167.46 28.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 63.409999999999997 112.426 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.854 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.57 -29.98 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 74.109999999999999 111.142 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -75.57 -22.9 56.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.239999999999995 110.912 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -7.92 58.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 75.439999999999998 110.921 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.25 141.1 55.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 64.209999999999994 110.821 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.604 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 157.4 -142.73 8.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 71.230000000000004 112.533 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.168 ' CD1' ' HB2' ' B' ' 2' ' ' GLU . 3.6 mp -130.88 129.29 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 73.200000000000003 111.154 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.737 ' CE2' HD13 ' A' ' 33' ' ' LEU . 18.0 m-85 -103.79 131.07 51.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 71.349999999999994 110.89 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.3 OUTLIER -127.09 140.86 51.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 71.239999999999995 110.915 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.4 153.09 38.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 65.450000000000003 110.887 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -139.76 126.5 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 74.019999999999996 110.825 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.53 161.78 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 72.109999999999999 111.054 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.4 ttm -131.04 125.25 32.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 73.540000000000006 110.859 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -86.82 172.21 10.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.316 -0.402 . . . . 74.439999999999998 110.863 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.19 -18.28 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.86 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.22 -19.84 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.463 . . . . 65.450000000000003 110.919 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.41 -16.54 31.88 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.612 -0.804 . . . . 72.340000000000003 112.436 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -85.26 145.93 27.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.49 144.77 31.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 64.340000000000003 110.871 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.406 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -102.21 130.84 48.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 75.349999999999994 111.186 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 90' ' ' LYS . 7.1 mmmt -105.08 142.37 34.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 60.119999999999997 110.847 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -144.76 125.07 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 65.230000000000004 110.99 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.48 127.07 45.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -128.3 124.21 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 71.450000000000003 110.968 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.393 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 19.0 mmm-85 -84.27 132.37 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.230000000000004 110.848 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.403 HG21 ' CE1' ' A' ' 77' ' ' PHE . 69.9 t -120.82 134.46 64.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 72.140000000000001 111.114 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.442 ' NH1' HG21 ' A' ' 100' ' ' ILE . 1.6 mmm180 -131.95 128.17 37.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 63.130000000000003 110.882 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.854 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.2 m -92.93 -175.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 111.151 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -70.66 0.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 75.140000000000001 110.963 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.1 mp0 -71.23 139.98 50.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 61.329999999999998 110.924 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.442 HG21 ' NH1' ' A' ' 96' ' ' ARG . 1.1 pt -121.5 159.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.535 0.683 . . . . 74.129999999999995 111.161 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.92 103.18 1.15 Allowed 'Trans proline' 0 C--N 1.34 0.11 0 C-N-CA 122.713 2.276 . . . . 71.400000000000006 112.23 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.71 -124.55 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.648 -0.786 . . . . 63.109999999999999 112.468 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.18 160.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.528 0.68 . . . . 71.510000000000005 110.889 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 175.19 8.45 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.268 . . . . 62.329999999999998 112.328 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 61.5 110.894 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.829 0.347 . . . . 71.450000000000003 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.168 ' HB2' ' CD1' ' A' ' 76' ' ' ILE . 2.6 pp20? -59.59 -170.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 75.230000000000004 110.934 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.852 ' HD1' ' HB3' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -62.87 -159.94 0.01 OUTLIER 'General case' 0 C--O 1.181 -2.534 0 CA-C-O 118.229 -0.891 . . . . 74.140000000000001 110.847 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.52 ' O2 ' ' HD3' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.393 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . 48.42 -166.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.852 -0.613 . . . . 32.32 111.119 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.812 ' H ' ' NH1' ' A' ' 94' ' ' ARG . 8.1 p-10 -139.95 -156.46 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 70.319999999999993 110.835 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.887 -179.883 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.459 -0.256 . . . . 74.140000000000001 112.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -179.67 106.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 64.439999999999998 110.828 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.66 72.65 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 54.020000000000003 111.1 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -93.21 132.61 37.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.019999999999996 110.882 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 121.34 27.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 72.239999999999995 110.882 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.8 mm -125.08 120.21 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.101 -0.5 . . . . 74.140000000000001 111.198 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -96.76 137.94 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.58 166.41 28.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 111.11 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.51 148.98 44.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.937 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 71' ' ' ILE . 51.6 mt -51.91 121.33 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.265 -0.425 . . . . 75.010000000000005 111.125 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.727 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.58 5.95 74.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 72.420000000000002 112.481 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.779 ' O ' HG22 ' A' ' 69' ' ' VAL . 16.2 mm-40 -101.29 139.49 20.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 71.230000000000004 110.89 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 143.13 49.85 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.655 2.237 . . . . 72.540000000000006 112.315 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 6' ' ' ILE . 28.4 tp -145.18 141.76 28.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 70.310000000000002 110.875 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.81 148.2 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 62.200000000000003 111.081 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.516 HD12 HD23 ' A' ' 64' ' ' LEU . 54.8 mt -132.48 148.27 52.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 74.230000000000004 110.957 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.33 153.05 27.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 75.420000000000002 110.83 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 t -105.94 102.31 11.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.340000000000003 110.831 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.6 121.91 12.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.420000000000002 110.907 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.93 -36.05 2.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.781 -0.723 . . . . 71.310000000000002 112.519 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.74 130.25 39.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 42.329999999999998 111.105 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.3 Cg_endo -69.78 -165.5 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.696 2.264 . . . . 63.329999999999998 112.331 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -48.49 49.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.427 . . . . 64.439999999999998 110.933 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -108.06 153.12 41.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.54 0.686 . . . . 74.450000000000003 110.899 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.72 109.83 2.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.258 . . . . 70.25 112.364 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.4 Cg_endo -69.73 -83.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.612 2.208 . . . . 64.310000000000002 112.432 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 9.0 mm100 -103.36 -177.49 3.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.978 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -64.0 133.14 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 61.32 110.823 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -136.82 156.57 48.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 74.019999999999996 110.892 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.79 148.11 51.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 70.239999999999995 110.873 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -117.98 145.52 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 72.430000000000007 110.906 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 33' ' ' LEU . 53.0 mttt -138.04 144.03 40.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 55.0 110.953 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD21 HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 42.030000000000001 110.868 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.872 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 13.8 t-20 -115.04 124.01 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 73.319999999999993 110.862 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.799 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 1.8 p -138.87 178.37 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 74.209999999999994 111.157 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.31 -130.17 11.09 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 70.409999999999997 112.498 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -112.64 -37.96 4.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.412 . . . . 74.209999999999994 110.93 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.594 HG23 ' HG3' ' A' ' 39' ' ' GLU . 6.1 t -179.71 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 72.040000000000006 111.115 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.4 mt-10 -102.38 33.26 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 71.439999999999998 110.918 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.799 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.22 -7.07 7.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 65.040000000000006 111.072 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -62.47 130.15 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 75.5 110.929 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.98 153.28 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.901 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.57 124.78 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 61.100000000000001 111.096 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 HD13 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -86.57 143.79 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.521 . . . . 72.329999999999998 110.969 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.96 164.61 34.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.607 0.718 . . . . 53.020000000000003 110.9 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.71 0.2 5.95 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.668 2.246 . . . . 72.099999999999994 112.446 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -127.16 96.97 4.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 110.913 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.04 -29.44 62.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 70.239999999999995 112.48 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.77 -156.15 18.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.696 -0.764 . . . . 53.119999999999997 112.461 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.89 -67.46 1.51 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.789 -0.72 . . . . 52.439999999999998 112.48 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.9 102.84 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.272 . . . . 74.530000000000001 112.275 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 28.7 p90 -83.89 -34.03 24.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.049999999999997 110.927 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.6 -26.69 68.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.321 -0.399 . . . . 60.329999999999998 110.926 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -46.56 72.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 110.891 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -129.5 -98.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 111.174 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.99 170.68 11.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 60.409999999999997 111.192 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -128.18 159.85 33.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 110.811 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 46' ' ' PRO . 2.7 t -113.33 131.85 63.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 64.510000000000005 111.092 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 63' ' ' SER . 36.7 mt -68.07 157.71 86.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.649 0.737 . . . . 61.229999999999997 110.956 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -23.12 31.55 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.702 2.268 . . . . 54.329999999999998 112.339 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.07 1.31 40.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 25.56 18.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 65.239999999999995 112.47 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.662 ' HB3' HD12 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -106.65 -179.1 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 73.230000000000004 110.849 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.822 HD13 HD11 ' A' ' 44' ' ' LEU . 5.8 tp -129.09 128.56 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.492 . . . . 64.430000000000007 110.848 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' N ' HD12 ' A' ' 64' ' ' LEU . 9.6 t80 -126.16 130.73 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.049999999999997 110.853 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.417 HD22 HG12 ' A' ' 69' ' ' VAL . 3.0 mp -118.41 131.07 24.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 72.319999999999993 110.939 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -34.76 13.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.715 2.277 . . . . 64.209999999999994 112.336 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.727 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -163.73 103.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 63.420000000000002 111.049 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 12' ' ' GLU . 16.0 m -73.7 118.93 19.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.549999999999997 111.109 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.38 162.02 31.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 71.200000000000003 112.514 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.823 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.47 -29.47 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 61.399999999999999 111.166 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.16 -22.54 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 61.219999999999999 110.835 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.08 -4.76 56.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.310000000000002 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.43 140.44 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 110.954 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 154.76 -139.83 6.99 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.701 -0.761 . . . . 43.219999999999999 112.455 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.487 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.9 mp -126.81 130.59 71.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 73.340000000000003 111.18 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CD2' HD22 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.85 129.02 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.909 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD2' ' HE2' ' B' ' 4' ' ' MCL . 7.8 ttp85 -126.55 126.15 43.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.907 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 154.5 24.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 52.240000000000002 110.906 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.73 135.11 31.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 75.340000000000003 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.08 163.26 29.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 71.109999999999999 111.082 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.14 123.98 31.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.858 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.28 171.72 9.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 110.877 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -18.71 62.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 62.450000000000003 110.851 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -73.38 -20.11 60.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 53.119999999999997 110.913 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.31 32.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 71.219999999999999 112.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -85.27 146.76 26.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 74.439999999999998 110.835 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.33 144.95 31.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.409999999999997 110.869 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.433 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.92 126.69 50.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 62.25 111.153 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.898 ' HE2' ' HX1' ' B' ' 4' ' ' MCL . 9.9 ptmt -103.14 143.25 32.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.923 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.8 m -143.76 126.75 16.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 110.826 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.682 ' OD1' ' HA ' ' B' ' 5' ' ' ALA . 0.6 OUTLIER -122.1 124.31 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 73.019999999999996 110.909 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -128.84 126.38 39.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 75.340000000000003 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.905 ' NH2' ' C ' ' B' ' 5' ' ' ALA . 14.4 mmt85 -84.46 131.36 34.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 73.400000000000006 110.909 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.13 133.87 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 62.539999999999999 111.168 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -131.75 128.58 39.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 64.099999999999994 110.928 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.3 m -96.45 -176.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 111.098 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -61.7 -79.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 74.319999999999993 110.925 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -70.71 144.26 51.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 110.848 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.33 159.49 49.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.664 0.745 . . . . 63.210000000000001 111.102 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo -69.69 116.89 4.76 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.694 2.263 . . . . 73.010000000000005 112.372 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -154.19 24.34 0.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 71.219999999999999 112.484 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -152.33 160.47 31.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.58 0.705 . . . . 64.510000000000005 110.96 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.65 38.43 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.668 2.245 . . . . 74.439999999999998 112.319 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 110.984 179.943 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.805 0.336 . . . . 71.230000000000004 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.487 ' CB ' HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -69.49 -169.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 54.329999999999998 110.852 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.872 ' CD2' ' HB2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -66.02 -162.93 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.521 0 CA-C-O 118.138 -0.934 . . . . 73.209999999999994 110.867 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.898 ' HX1' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.905 ' C ' ' NH2' ' A' ' 94' ' ' ARG . . . 47.58 -95.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.581 . . . . 74.200000000000003 111.073 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.679 ' C ' HH22 ' A' ' 94' ' ' ARG . 3.5 t70 64.01 106.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 72.409999999999997 110.868 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.773 ' CG ' HH12 ' A' ' 94' ' ' ARG . 2.8 pp20? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 73.540000000000006 110.942 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.514 -0.234 . . . . 43.539999999999999 112.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -64.63 92.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 74.25 110.91 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.7 74.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 60.219999999999999 111.13 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.42 132.57 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 70.430000000000007 110.838 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -90.45 120.47 31.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 73.400000000000006 110.855 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.916 HG21 HD11 ' A' ' 14' ' ' LEU . 4.6 mp -125.44 122.53 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 65.109999999999999 111.146 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -95.45 142.3 27.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.299999999999997 111.1 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -147.49 167.42 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 65.019999999999996 111.112 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.26 149.18 42.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 65.409999999999997 110.87 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.4 mt -52.19 120.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 51.399999999999999 111.145 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.414 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.07 10.09 69.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 63.140000000000001 112.475 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.753 ' O ' HG22 ' A' ' 69' ' ' VAL . 41.1 mm-40 -103.31 138.95 19.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.54 0.686 . . . . 74.219999999999999 110.88 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.66 51.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.673 2.248 . . . . 73.109999999999999 112.308 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 6' ' ' ILE . 35.2 tp -144.92 142.02 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.239999999999995 110.983 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' CD2' ' A' ' 65' ' ' PHE . 31.3 t -125.93 148.29 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 75.109999999999999 111.081 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.8 mt -134.77 148.29 50.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.019999999999996 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -112.55 151.53 29.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 110.903 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.1 t -107.28 99.7 9.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 44.5 110.868 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -54.37 125.03 17.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.852 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.97 -41.74 1.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 53.229999999999997 112.51 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.12 43.74 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.581 0.705 . . . . 62.030000000000001 111.102 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.5 Cg_endo -69.76 -165.0 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.709 2.272 . . . . 74.209999999999994 112.381 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -49.41 -48.82 46.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.458 . . . . 52.329999999999998 110.794 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -107.32 151.96 41.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.545 0.688 . . . . 73.519999999999996 110.911 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 109.39 2.31 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.219999999999999 112.335 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 53.9 Cg_endo -69.79 -85.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.707 2.271 . . . . 74.430000000000007 112.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.99 -178.41 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 65.340000000000003 110.951 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -64.92 137.77 57.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 65.150000000000006 110.912 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 46' ' ' PRO . 3.8 pp -135.82 160.33 38.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 71.319999999999993 110.981 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -121.26 145.01 48.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 62.130000000000003 110.864 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -128.38 137.33 51.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.891 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -140.81 139.07 34.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 75.109999999999999 110.94 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.779 HD22 ' CE2' ' A' ' 77' ' ' PHE . 4.9 tp -137.29 136.0 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 74.140000000000001 110.88 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -114.48 121.54 43.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 72.109999999999999 110.914 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.79 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 73.3 p -137.59 179.36 6.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 43.310000000000002 111.146 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.89 -129.18 9.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.712 -0.756 . . . . 43.420000000000002 112.442 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -112.48 -38.43 4.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 74.219999999999999 110.827 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 39' ' ' GLU . 9.7 t 179.78 -31.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 74.239999999999995 111.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 38' ' ' THR . 15.4 mt-10 -103.44 33.96 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 62.439999999999998 110.894 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.43 -6.8 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 75.049999999999997 111.083 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.55 132.3 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 74.319999999999993 110.932 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 158.95 38.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 63.340000000000003 110.927 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.07 120.52 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.479 . . . . 73.319999999999993 111.136 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.12 147.2 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.893 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.482 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.9 m -124.46 153.47 69.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.120000000000005 110.85 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.832 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.5 Cg_endo -69.65 -0.25 6.55 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.791 2.327 . . . . 75.530000000000001 112.344 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -137.03 72.16 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.150000000000006 110.833 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.86 75.14 1.14 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 63.219999999999999 112.503 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.72 58.34 3.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 75.349999999999994 112.509 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 178.95 41.18 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 74.329999999999998 112.469 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 107.37 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.642 2.228 . . . . 60.310000000000002 112.308 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -54.37 -33.91 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 73.530000000000001 110.866 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.28 -29.05 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 71.510000000000005 110.945 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.93 -43.45 9.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 75.430000000000007 110.851 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.526 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -124.85 -98.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.491 . . . . 71.530000000000001 111.095 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -152.99 174.23 14.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 54.439999999999998 111.122 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.6 164.13 18.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.876 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.832 HG11 ' HA ' ' A' ' 46' ' ' PRO . 42.1 t -107.51 130.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 54.130000000000003 111.055 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.63 158.85 85.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 72.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -22.19 32.46 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.721 2.28 . . . . 32.219999999999999 112.354 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -83.57 1.34 42.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 110.885 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.41 28.5 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 62.109999999999999 112.488 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 m -111.87 -178.88 3.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 72.209999999999994 110.843 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.9 tp -128.89 128.93 44.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 73.349999999999994 110.92 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 15' ' ' VAL . 7.8 t80 -125.57 134.82 51.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.844 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.767 HD22 HG12 ' A' ' 69' ' ' VAL . 5.2 mp -114.8 124.45 30.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.657 0.741 . . . . 61.210000000000001 110.922 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -31.77 19.77 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 70.340000000000003 112.341 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.57 101.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 63.210000000000001 111.101 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.767 HG12 HD22 ' A' ' 66' ' ' LEU . 35.7 m -71.71 114.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 73.109999999999999 111.138 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.01 159.18 22.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 43.149999999999999 112.493 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.18 -31.0 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 73.340000000000003 111.113 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -77.15 -22.82 51.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.929 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.84 -3.87 37.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 74.150000000000006 110.804 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 143.3 39.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 73.409999999999997 110.876 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.707 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 159.1 -148.37 17.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 74.120000000000005 112.546 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 75' ' ' GLY . 19.2 mm -131.22 137.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 74.099999999999994 111.071 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.779 ' CE2' HD22 ' A' ' 33' ' ' LEU . 10.9 m-85 -101.65 127.84 48.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.899 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.32 126.91 45.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.855 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 42.8 t -122.43 149.8 43.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.835 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -141.95 134.18 27.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 73.129999999999995 110.97 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.15 163.3 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 74.329999999999998 111.114 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ttm -130.55 124.94 32.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 62.299999999999997 110.894 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -86.9 172.28 10.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.400000000000006 110.95 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -70.96 -18.53 62.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 54.210000000000001 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.26 -19.9 60.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.849 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.17 -13.69 37.05 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 54.140000000000001 112.505 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -85.08 146.38 27.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.705 0.288 . . . . 72.540000000000006 110.963 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.43 144.95 31.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 54.240000000000002 110.857 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -102.01 132.63 47.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 72.25 111.13 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.823 ' HE3' ' CX2' ' B' ' 4' ' ' MCL . 11.4 mmmt -98.96 143.48 29.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 73.010000000000005 110.9 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 m -144.66 121.14 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.878 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.18 120.13 25.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 72.019999999999996 110.873 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -129.67 119.71 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.869 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.087 ' HD2' ' HB1' ' B' ' 5' ' ' ALA . 1.0 OUTLIER -86.79 135.44 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 61.340000000000003 110.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.411 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.6 t -120.94 136.46 57.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 75.329999999999998 111.093 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -131.06 142.88 50.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.868 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 71' ' ' ILE . 7.0 m -106.3 -175.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 64.120000000000005 111.092 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -67.69 -81.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 110.989 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -62.85 145.45 55.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 110.855 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.43 159.67 49.24 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.723 0.773 . . . . 63.299999999999997 111.052 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.5 Cg_endo -69.73 120.19 7.02 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.708 2.272 . . . . 63.130000000000003 112.318 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -98.5 -32.06 6.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.824 -0.703 . . . . 54.299999999999997 112.507 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt 52.74 70.13 2.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 73.310000000000002 110.953 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 171.36 14.56 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.654 2.236 . . . . 73.340000000000003 112.388 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 64.200000000000003 110.929 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 71.010000000000005 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.83 166.67 12.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.93 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.694 ' HB2' ' HB ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -64.83 -161.38 0.02 OUTLIER 'General case' 0 C--O 1.182 -2.482 0 CA-C-O 118.121 -0.943 . . . . 74.329999999999998 110.924 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.823 ' CX2' ' HE3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.087 ' HB1' ' HD2' ' A' ' 94' ' ' ARG . . . -42.23 154.93 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.883 -0.599 . . . . 73.319999999999993 111.086 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.471 ' O ' ' NH1' ' A' ' 94' ' ' ARG . 5.2 p-10 -143.29 -163.05 1.56 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.856 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.4 ' HG2' HH22 ' A' ' 94' ' ' ARG . 2.8 mm-40 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 74.530000000000001 110.912 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.511 -0.236 . . . . 70.340000000000003 112.511 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 1.3 m 59.14 21.29 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 73.25 110.878 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 2' ' ' SER . . . 178.94 62.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 61.109999999999999 111.1 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 133.75 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.530000000000001 110.849 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -90.3 121.29 32.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 62.420000000000002 110.864 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 14' ' ' LEU . 4.6 mp -124.76 122.15 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 71.329999999999998 111.141 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -94.62 140.14 30.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.144 -0.48 . . . . 44.240000000000002 111.117 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.66 167.65 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.299999999999997 111.076 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.13 43.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 71.310000000000002 110.819 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.614 HD11 ' HB2' ' A' ' 99' ' ' GLN . 28.9 mt -52.12 120.44 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 111.119 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.666 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.61 10.35 70.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 73.310000000000002 112.457 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.785 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.7 mm-40 -102.7 139.46 20.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.69 0.757 . . . . 74.510000000000005 110.889 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.98 49.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.667 2.245 . . . . 54.299999999999997 112.342 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.655 HD11 HG21 ' A' ' 6' ' ' ILE . 49.9 tp -145.42 143.32 30.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 110.864 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.88 147.75 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 111.101 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.8 mt -132.2 150.21 52.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 61.329999999999998 110.917 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -111.71 151.52 28.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.240000000000002 110.904 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -107.3 100.82 10.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 110.938 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -54.16 125.09 17.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 110.827 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.508 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.47 -43.21 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.729 . . . . 50.299999999999997 112.512 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.63 129.45 42.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 74.209999999999994 111.012 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.491 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 54.5 Cg_endo -69.66 -161.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.613 2.209 . . . . 73.450000000000003 112.408 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -48.26 -47.02 36.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 110.938 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.38 164.18 15.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 65.510000000000005 110.866 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.73 109.68 2.36 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.776 2.317 . . . . 44.0 112.333 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 54.4 Cg_endo -69.8 -91.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.67 2.247 . . . . 64.439999999999998 112.379 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.79 -177.03 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 75.540000000000006 110.934 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -63.78 131.57 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.430000000000007 110.87 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 29' ' ' LEU . 4.6 pp -138.54 157.28 46.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 110.879 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -121.77 145.86 47.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 62.240000000000002 110.848 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -120.24 143.64 48.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 74.5 111.03 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -148.88 135.44 19.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.299999999999997 110.896 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.773 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -141.23 138.31 33.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 72.219999999999999 110.921 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.49 126.11 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.530000000000001 110.807 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.839 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.5 p -138.72 -178.9 5.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 73.530000000000001 111.038 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -127.27 9.11 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.713 -0.756 . . . . 75.120000000000005 112.517 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' O ' ' HB ' ' A' ' 38' ' ' THR . 12.0 mpt_? -112.79 -38.64 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 73.409999999999997 110.875 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.7 t 178.97 -29.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 111.124 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HG3' HG23 ' A' ' 38' ' ' THR . 18.2 mt-10 -102.43 34.08 2.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 64.219999999999999 110.913 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.99 -6.96 8.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 55.310000000000002 111.063 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -70.06 129.07 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.952 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -137.18 159.25 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.809 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.6 t -90.2 121.96 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 111.167 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' CD1' HD23 ' A' ' 33' ' ' LEU . 6.9 mt -89.23 144.67 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 65.420000000000002 110.888 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.2 m -127.02 152.28 75.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 72.510000000000005 110.898 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 2.75 3.22 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.753 2.302 . . . . 65.120000000000005 112.395 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -116.99 70.35 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 73.109999999999999 110.885 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.27 -37.09 3.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.837 -0.697 . . . . 71.109999999999999 112.469 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.96 57.12 13.56 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.73 -0.748 . . . . 63.200000000000003 112.426 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.09 -176.6 49.43 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.673 -0.775 . . . . 72.349999999999994 112.528 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 53.1 Cg_endo -69.79 107.4 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.712 2.274 . . . . 74.530000000000001 112.307 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -56.88 -34.16 67.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 71.230000000000004 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -25.86 66.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 50.130000000000003 110.835 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -91.19 -43.59 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 61.130000000000003 110.865 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.488 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -126.81 -98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 65.040000000000006 111.164 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -154.8 175.77 13.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 54.450000000000003 111.122 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.79 161.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 61.439999999999998 110.904 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 63' ' ' SER . 50.5 t -108.23 130.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.169 -0.469 . . . . 74.219999999999999 111.073 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 63' ' ' SER . 47.3 mt -69.01 156.98 90.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 64.420000000000002 110.927 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -21.95 32.76 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.254 . . . . 65.209999999999994 112.331 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -81.48 0.39 38.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 73.340000000000003 110.91 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.88 30.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.796 -0.716 . . . . 74.299999999999997 112.525 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.7 m -106.38 -179.55 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.951 0.405 . . . . 60.409999999999997 110.851 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 65' ' ' PHE . 7.6 tp -130.21 130.74 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 75.129999999999995 110.969 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.632 ' N ' HD12 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -124.89 130.36 52.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.019999999999996 110.892 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.893 HD22 HG12 ' A' ' 69' ' ' VAL . 3.0 mp -117.19 127.12 26.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 75.120000000000005 110.899 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -32.37 18.57 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.804 2.336 . . . . 64.120000000000005 112.382 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.666 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.45 100.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 32.140000000000001 111.101 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.893 HG12 HD22 ' A' ' 66' ' ' LEU . 15.3 m -78.01 113.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 111.156 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' HA2' HG23 ' A' ' 10' ' ' ILE . . . -87.82 173.85 43.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 73.200000000000003 112.44 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.876 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.7 -32.23 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 75.230000000000004 111.109 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -77.26 -21.61 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.928 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -5.61 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 62.210000000000001 110.833 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 142.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 65.140000000000001 110.958 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 35' ' ' THR . . . 159.71 -151.49 22.24 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.734 -0.746 . . . . 53.399999999999999 112.463 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' B' ' 2' ' ' GLU . 5.4 mm -131.38 134.85 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 75.409999999999997 111.093 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.773 ' CE2' HD22 ' A' ' 33' ' ' LEU . 50.1 m-85 -103.96 132.82 49.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 74.019999999999996 110.856 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.62 ' HE ' ' HE1' ' B' ' 3' ' ' PHE . 0.2 OUTLIER -127.03 134.17 50.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.78 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.73 148.12 45.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 64.530000000000001 110.902 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -142.4 127.43 18.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.903 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.8 162.38 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 44.130000000000003 111.083 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ttm -130.64 125.66 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.549999999999997 110.926 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.58 171.92 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 74.349999999999994 110.95 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -19.15 61.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 71.049999999999997 110.802 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.9 -20.24 60.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 61.539999999999999 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.56 35.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.793 -0.717 . . . . 71.319999999999993 112.472 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 146.32 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.662 0.268 . . . . 64.409999999999997 110.886 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -105.63 142.62 35.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 73.230000000000004 110.863 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.508 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.96 131.09 50.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 74.519999999999996 111.085 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.398 ' HE2' ' C1 ' ' B' ' 4' ' ' MCL . 0.8 OUTLIER -105.42 142.85 34.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.150000000000006 110.892 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.615 ' N ' ' O2 ' ' B' ' 4' ' ' MCL . 3.8 m -146.1 123.61 11.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.459 . . . . 60.140000000000001 110.816 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.825 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.2 OUTLIER -128.13 122.28 31.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 54.219999999999999 110.819 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.02 118.81 24.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 62.229999999999997 110.94 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.056 HH12 ' HB2' ' B' ' 7' ' ' GLU . 0.1 OUTLIER -88.72 134.16 34.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.886 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG22 HD21 ' A' ' 14' ' ' LEU . 57.7 t -120.5 135.73 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 111.142 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -130.65 131.61 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 75.349999999999994 110.854 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -96.51 -176.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 73.349999999999994 111.164 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -67.4 -78.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 70.329999999999998 110.939 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.614 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 73.420000000000002 110.953 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.07 159.45 49.31 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.319999999999993 111.084 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 169.91 17.74 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.647 2.231 . . . . 70.340000000000003 112.415 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.85 106.72 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 52.229999999999997 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.24 160.63 36.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.605 0.717 . . . . 63.399999999999999 110.859 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 103.67 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.613 2.208 . . . . 62.420000000000002 112.39 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 62.420000000000002 110.842 -179.874 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.726 0.298 . . . . 62.329999999999998 110.963 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.459 ' HB2' HG13 ' A' ' 76' ' ' ILE . 2.5 pm0 -159.85 80.86 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 110.914 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.62 ' HE1' ' HE ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER 54.23 -164.87 0.1 Allowed 'General case' 0 C--O 1.182 -2.49 0 CA-C-O 118.26 -0.876 . . . . 74.219999999999999 110.864 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.398 ' C1 ' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.614 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . -51.44 120.23 4.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.926 -0.579 . . . . 43.32 111.11 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -122.59 50.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 75.319999999999993 110.852 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 1.056 ' HB2' HH12 ' A' ' 94' ' ' ARG . 6.2 tp10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 74.319999999999993 110.905 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.514 -0.234 . . . . 73.439999999999998 112.514 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 p -173.73 160.33 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 72.030000000000001 110.856 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.76 93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 52.32 111.031 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -93.92 133.12 37.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 110.935 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -89.5 121.63 31.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.582 HG21 HD11 ' A' ' 14' ' ' LEU . 4.0 mp -123.83 120.86 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 72.129999999999995 111.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 p -96.7 142.47 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.13 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.43 22.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 51.219999999999999 111.132 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.69 147.97 40.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 64.450000000000003 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 121.3 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 111.14 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.658 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.48 5.89 74.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 55.25 112.497 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.795 ' O ' HG22 ' A' ' 69' ' ' VAL . 48.7 mm-40 -101.47 141.43 22.58 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.606 0.717 . . . . 75.239999999999995 110.831 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.78 52.21 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.606 2.204 . . . . 74.040000000000006 112.384 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 6' ' ' ILE . 54.8 tp -144.48 143.14 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.437 . . . . 72.310000000000002 110.902 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.436 HG22 ' HD2' ' A' ' 65' ' ' PHE . 20.4 t -121.84 146.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 74.099999999999994 111.153 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.762 HD12 HD23 ' A' ' 64' ' ' LEU . 12.5 mt -131.41 148.28 52.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 70.129999999999995 110.951 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 152.04 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 70.019999999999996 110.972 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.9 t -107.08 99.88 9.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 53.109999999999999 110.871 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.66 123.56 14.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 51.450000000000003 110.908 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.18 -39.4 2.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 74.530000000000001 112.483 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.15 131.28 37.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 65.209999999999994 111.101 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -163.96 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.675 2.25 . . . . 53.030000000000001 112.32 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -50.09 30.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 35.5 mmtt -110.85 153.05 43.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 64.239999999999995 110.871 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.9 Cg_endo -69.68 109.57 2.33 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 63.219999999999999 112.329 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HG2' ' H ' ' A' ' 27' ' ' GLN . 53.6 Cg_endo -69.71 -83.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 70.140000000000001 112.353 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -103.32 -177.36 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 74.099999999999994 110.875 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -63.92 139.96 58.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 70.049999999999997 110.852 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 46' ' ' PRO . 0.3 OUTLIER -135.6 159.11 42.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 53.229999999999997 110.93 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -121.09 139.59 53.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 71.400000000000006 110.885 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.48 ' HE1' HD13 ' A' ' 29' ' ' LEU . 13.2 m95 -121.34 139.09 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -139.05 137.07 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 61.399999999999999 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.623 HD22 HG23 ' A' ' 35' ' ' THR . 2.0 tt -138.82 134.09 32.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 73.530000000000001 110.918 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.065 ' HB2' ' CD2' ' B' ' 3' ' ' PHE . 1.8 m-80 -115.77 125.18 52.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.852 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 44.8 p -138.43 -179.5 5.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.129 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.61 -130.83 13.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.748 -0.739 . . . . 60.039999999999999 112.481 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -112.84 -37.56 4.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 73.129999999999995 110.905 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t -179.74 -29.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 61.130000000000003 111.187 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.62 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.1 mt-10 -101.97 33.6 2.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.896 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -123.75 -7.23 7.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 54.100000000000001 111.121 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -60.26 130.41 46.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.919 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HZ2' ' HB3' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.52 153.45 49.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 74.140000000000001 110.907 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.54 121.81 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 51.219999999999999 111.191 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.65 145.96 24.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 110.942 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.567 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -127.3 162.62 47.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.664 0.745 . . . . 74.150000000000006 110.88 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.586 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.67 -0.53 6.98 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.677 2.251 . . . . 65.230000000000004 112.321 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.11 89.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 42.130000000000003 110.946 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.08 -46.27 74.19 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.644 -0.789 . . . . 73.239999999999995 112.52 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 40.22 38.55 1.35 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.844 -0.693 . . . . 75.439999999999998 112.414 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.43 -162.55 9.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 62.439999999999998 112.446 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 121.09 7.78 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.244 . . . . 75.329999999999998 112.317 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -82.8 -34.61 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 74.319999999999993 110.929 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -62.97 -25.8 68.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 74.400000000000006 110.779 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -46.85 13.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 65.219999999999999 110.946 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.496 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -129.49 -99.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 63.439999999999998 111.091 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -167.55 173.49 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 63.130000000000003 111.07 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -123.25 159.25 29.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.9 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 46' ' ' PRO . 18.8 t -108.38 130.17 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 72.420000000000002 111.132 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.5 HD12 ' CB ' ' A' ' 63' ' ' SER . 55.4 mt -69.06 157.64 88.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.54 0.686 . . . . 74.230000000000004 110.947 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -21.8 32.77 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.622 2.215 . . . . 71.420000000000002 112.357 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 1.4 p-10 -84.24 1.44 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.420000000000002 110.908 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.86 32.83 8.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.803 -0.713 . . . . 71.400000000000006 112.451 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.5 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.4 m -115.35 179.11 4.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 65.010000000000005 110.868 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.762 HD23 HD12 ' A' ' 16' ' ' LEU . 20.4 tp -129.47 128.22 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.847 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HD2' HG22 ' A' ' 15' ' ' VAL . 38.3 t80 -126.78 136.61 52.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.81 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD22 HG12 ' A' ' 69' ' ' VAL . 1.4 mp -118.45 130.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 74.200000000000003 110.974 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -34.87 13.63 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 64.010000000000005 112.336 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -166.58 101.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 111.1 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.4 m -72.65 113.22 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 61.350000000000001 111.11 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.85 161.82 33.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 62.009999999999998 112.478 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.871 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.84 -30.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 74.099999999999994 111.152 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.1 -20.43 57.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.933 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -3.55 29.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 73.120000000000005 110.871 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.697 ' CD ' HG22 ' A' ' 97' ' ' VAL . 27.5 mt-10 -57.13 142.52 42.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.340000000000003 110.866 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.651 ' C ' HD13 ' A' ' 76' ' ' ILE . . . 158.75 -153.99 25.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.674 -0.774 . . . . 62.130000000000003 112.41 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.46 HD11 ' CB ' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -123.81 134.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.156 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD2' HD13 ' A' ' 16' ' ' LEU . 4.4 t80 -104.0 127.54 51.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.852 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.2 128.86 47.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 63.43 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 7.0 t -120.54 150.2 41.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 51.030000000000001 110.891 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.85 133.7 29.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 62.299999999999997 110.927 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.81 162.99 29.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 71.099999999999994 111.129 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 25.0 mtp -129.69 124.77 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 71.409999999999997 110.967 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.21 172.82 9.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.87 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -70.71 -19.03 62.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 75.329999999999998 110.922 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.83 -20.05 60.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 73.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.65 -9.43 40.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.82 -0.705 . . . . 60.329999999999998 112.547 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.08 146.87 26.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.763 0.316 . . . . 71.109999999999999 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -105.05 142.5 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 75.450000000000003 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.462 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -103.72 131.84 50.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.519999999999996 111.122 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.72 ' HE2' ' O2 ' ' B' ' 4' ' ' MCL . 42.9 mtpt -102.53 143.56 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.84 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 t -144.39 125.72 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.863 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.625 HD21 ' HB2' ' B' ' 5' ' ' ALA . 1.6 t-20 -126.83 122.07 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.896 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -128.23 121.77 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 74.129999999999995 110.883 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.098 HH12 ' HG3' ' B' ' 7' ' ' GLU . 27.5 mmm-85 -83.79 134.01 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 64.540000000000006 110.905 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.35 128.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 61.219999999999999 111.079 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.09 142.93 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 110.91 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.871 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.8 m -108.86 -174.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 71.140000000000001 111.176 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -67.3 -79.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 110.85 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -63.09 145.99 54.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 70.310000000000002 110.932 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.2 159.59 49.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 111.204 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.3 Cg_endo -69.66 179.02 3.93 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.756 2.304 . . . . 72.230000000000004 112.355 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 164.68 -48.04 0.29 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.673 -0.775 . . . . 75.450000000000003 112.456 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -151.53 71.98 8.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 73.400000000000006 110.854 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 167.63 23.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.657 2.238 . . . . 41.43 112.35 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.956 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.307 . . . . 74.120000000000005 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.46 ' CB ' HD11 ' A' ' 76' ' ' ILE . 1.4 pm0 -123.52 -36.2 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 63.100000000000001 110.876 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.112 ' HB2' ' CG1' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 176.28 -159.45 0.02 OUTLIER 'General case' 0 C--O 1.181 -2.513 0 CA-C-O 118.1 -0.952 . . . . 63.030000000000001 110.849 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.72 ' O2 ' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.839 ' CB ' ' HD3' ' A' ' 94' ' ' ARG . . . -48.7 134.37 16.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.857 -0.611 . . . . 73.439999999999998 111.134 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -118.64 13.87 13.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 70.209999999999994 110.861 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 1.098 ' HG3' HH12 ' A' ' 94' ' ' ARG . 8.8 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.9 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.411 -0.276 . . . . 52.25 112.411 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -175.01 157.49 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.876 0.37 . . . . 70.019999999999996 110.857 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.47 99.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 74.409999999999997 111.078 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.57 132.38 37.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 75.209999999999994 110.906 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 3.5 p30 -83.84 122.49 28.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.519999999999996 110.99 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.537 ' CG2' HD11 ' A' ' 14' ' ' LEU . 48.8 mm -124.6 121.64 61.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 73.299999999999997 111.116 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -95.92 141.86 28.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.420000000000002 111.061 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.52 166.04 29.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 55.299999999999997 111.077 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -124.67 148.91 47.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.47 . . . . 75.349999999999994 110.92 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 99' ' ' GLN . 55.9 mt -54.57 121.21 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 70.25 111.103 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.526 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 86.61 5.44 81.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 61.420000000000002 112.541 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 48.8 mm-40 -102.26 139.6 20.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.561 0.696 . . . . 73.140000000000001 110.938 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 144.76 55.33 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.69 2.26 . . . . 75.409999999999997 112.351 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 6' ' ' ILE . 17.3 tp -143.43 141.35 30.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.86 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG22 ' HD1' ' A' ' 65' ' ' PHE . 41.2 t -126.04 145.12 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 63.340000000000003 111.061 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.8 mt -131.83 147.12 52.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.899 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -114.56 154.17 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 62.420000000000002 110.858 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.3 t -105.43 100.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.129999999999995 110.831 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -57.03 123.38 14.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.899 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.63 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.42 -43.52 1.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.782 -0.723 . . . . 63.439999999999998 112.496 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.67 131.26 36.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.523 0.678 . . . . 75.430000000000007 111.12 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.16 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.661 2.241 . . . . 74.109999999999999 112.351 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.1 -53.25 21.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 75.439999999999998 110.812 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -112.37 131.39 22.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.91 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 55.1 Cg_endo -69.71 110.5 2.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.664 2.243 . . . . 74.030000000000001 112.407 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.0 Cg_endo -69.74 -53.08 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 22.32 112.322 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -179.9 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 52.200000000000003 110.881 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -71.74 145.35 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 110.841 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -137.07 155.04 50.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 110.891 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.89 140.86 51.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 74.25 110.885 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -123.72 141.35 52.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.914 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HG2' HG13 ' A' ' 43' ' ' VAL . 27.4 mtmt -144.4 140.38 28.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 51.450000000000003 110.844 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.774 HD22 ' CE2' ' A' ' 77' ' ' PHE . 6.0 tp -137.55 136.33 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.221 -0.445 . . . . 72.010000000000005 110.936 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.935 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 9.0 t-20 -115.4 120.49 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 110.838 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.3 p -138.08 -179.82 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 73.140000000000001 111.131 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.32 -130.36 9.82 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.751 . . . . 32.43 112.453 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -112.45 -38.77 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 72.019999999999996 110.912 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 39' ' ' GLU . 8.5 t 179.42 -30.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.143 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.603 ' HG3' HG23 ' A' ' 38' ' ' THR . 17.3 mt-10 -103.22 33.89 3.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 63.439999999999998 110.92 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.26 -7.47 8.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 54.310000000000002 111.128 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -61.92 129.8 42.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.927 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 158.42 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 75.200000000000003 110.88 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 32' ' ' LYS . 22.8 t -94.84 122.21 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 111.152 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.99 144.69 25.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.517 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -125.86 163.66 37.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.718 0.771 . . . . 64.319999999999993 110.814 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.787 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.9 Cg_endo -69.85 0.32 5.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.738 2.292 . . . . 64.120000000000005 112.321 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.56 86.85 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 72.230000000000004 110.824 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.55 -46.12 71.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.798 -0.715 . . . . 61.219999999999999 112.474 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 38.43 81.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 74.209999999999994 112.469 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.78 -164.33 37.0 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 64.010000000000005 112.485 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 106.91 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 73.239999999999995 112.31 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -66.13 -33.71 76.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 74.150000000000006 110.948 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.74 -25.1 66.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 63.310000000000002 110.881 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -48.01 21.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 75.430000000000007 110.914 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.524 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -130.38 -98.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.486 . . . . 71.010000000000005 111.132 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -165.72 172.0 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 72.129999999999995 111.065 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.534 ' O ' HD12 ' A' ' 64' ' ' LEU . 40.3 mmm-85 -126.79 158.52 36.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 74.450000000000003 110.874 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 46' ' ' PRO . 6.8 t -109.14 130.82 61.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.127 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 33.4 mt -68.84 158.3 86.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 50.409999999999997 110.851 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -22.24 32.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 72.310000000000002 112.413 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -83.43 1.61 40.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 110.898 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.91 29.3 13.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 44.009999999999998 112.538 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 6.3 m -112.74 -178.64 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 71.150000000000006 110.852 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 57' ' ' ARG . 50.1 tp -128.27 128.98 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 61.25 110.906 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' HD1' HG22 ' A' ' 15' ' ' VAL . 12.6 t80 -125.64 136.6 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.82 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.776 HD22 HG12 ' A' ' 69' ' ' VAL . 7.0 mp -119.1 127.63 26.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.574 0.702 . . . . 71.129999999999995 110.898 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.93 -32.81 17.15 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.69 2.26 . . . . 75.549999999999997 112.336 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -168.14 102.38 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 111.167 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 23.7 m -71.98 117.19 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 55.240000000000002 111.11 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.81 160.11 28.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 73.409999999999997 112.525 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.866 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.09 -33.86 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.831 0.348 . . . . 65.519999999999996 111.129 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -77.69 -21.56 51.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.125 -0.489 . . . . 70.239999999999995 110.956 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.08 -4.73 40.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.834 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -58.97 142.7 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 110.875 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.745 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 162.63 -148.32 15.14 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.727 -0.749 . . . . 64.230000000000004 112.444 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.953 HD13 ' HB2' ' B' ' 2' ' ' GLU . 3.1 mp -130.67 133.71 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 74.409999999999997 111.084 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CE2' HD22 ' A' ' 33' ' ' LEU . 11.8 m-85 -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 64.239999999999995 110.926 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.98 126.97 44.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 110.903 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 48.6 t -121.16 151.11 40.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.010000000000005 110.913 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -139.44 133.9 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 54.340000000000003 110.917 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.82 163.63 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 111.176 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' A' ' 82' ' ' MET . 7.2 mmm -129.23 124.69 35.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.288 -0.415 . . . . 54.049999999999997 110.84 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -87.93 170.1 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 110.811 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -73.8 -18.32 60.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 63.409999999999997 110.825 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -72.89 -20.12 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 60.439999999999998 110.843 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.45 -20.04 21.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.7 -0.762 . . . . 73.219999999999999 112.508 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.7 147.86 26.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 74.239999999999995 110.916 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -103.67 145.27 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.63 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -98.04 132.51 43.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 71.340000000000003 111.073 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.523 ' HB2' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -103.02 139.97 37.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 71.329999999999998 110.872 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.1 m -146.7 120.74 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 63.439999999999998 110.891 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.984 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.1 OUTLIER -129.42 123.29 31.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 64.510000000000005 110.909 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -130.14 120.6 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.818 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -88.87 136.13 33.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 74.049999999999997 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.1 t -120.54 137.51 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 70.140000000000001 111.132 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -128.42 146.61 50.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.519999999999996 110.937 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.866 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.4 m -107.11 -176.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 111.111 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -68.11 -77.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 65.200000000000003 110.912 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.496 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -64.31 144.55 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.962 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.412 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -121.15 160.44 45.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.6 0.714 . . . . 61.350000000000001 111.17 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo -69.79 119.73 6.62 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.731 2.287 . . . . 73.519999999999996 112.364 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.89 61.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.340000000000003 112.489 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -80.37 160.12 68.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 65.239999999999995 110.84 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 127.21 14.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.681 2.254 . . . . 72.329999999999998 112.404 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 73.150000000000006 110.917 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.822 0.344 . . . . 71.120000000000005 110.824 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.953 ' HB2' HD13 ' A' ' 76' ' ' ILE . 5.4 pt-20 -173.63 113.08 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.899 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.935 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 61.85 -166.99 0.21 Allowed 'General case' 0 C--O 1.182 -2.461 0 CA-C-O 118.093 -0.956 . . . . 51.140000000000001 110.889 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.523 ' CX2' ' HB2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -40.89 144.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 33.409999999999997 111.042 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -142.17 89.83 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 72.340000000000003 110.865 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 73.450000000000003 110.891 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.569 -0.212 . . . . 74.120000000000005 112.569 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -168.71 148.83 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 75.109999999999999 110.902 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' B' ' 5' ' ' ALA . . . -51.22 107.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 64.030000000000001 111.128 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 132.46 38.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 72.5 110.89 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.7 121.2 32.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.329999999999998 110.876 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mm -125.87 122.29 61.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 111.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -96.0 142.13 28.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 61.229999999999997 111.036 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -144.61 168.23 20.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 111.071 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.44 149.34 46.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 75.140000000000001 110.859 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.69 HD11 HG13 ' A' ' 71' ' ' ILE . 27.8 mt -65.06 120.49 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 53.119999999999997 111.147 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.77 -12.24 57.82 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.654 -0.784 . . . . 72.310000000000002 112.421 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 69' ' ' VAL . 1.1 pp20? -101.45 140.88 21.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 110.946 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 145.01 55.9 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 71.019999999999996 112.348 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 8' ' ' ALA . 14.3 tp -137.77 142.46 40.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.921 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.6 t -123.1 146.72 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 72.219999999999999 111.128 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.734 HD13 ' CD2' ' A' ' 77' ' ' PHE . 4.6 mt -131.84 151.92 51.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.917 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -111.63 149.71 31.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.230000000000004 110.856 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.81 101.64 9.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 110.935 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -54.09 99.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 110.916 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 22' ' ' PRO . . . 148.61 -47.34 0.65 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.628 -0.796 . . . . 73.150000000000006 112.473 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.31 103.58 12.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 70.310000000000002 111.128 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.4 Cg_endo -69.79 -161.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.71 2.273 . . . . 63.25 112.325 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.59 -8.08 8.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.853 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 1.1 mptt -44.5 167.65 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.53 0.681 . . . . 51.520000000000003 110.942 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 53.4 Cg_endo -69.79 172.2 13.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.674 2.25 . . . . 75.219999999999999 112.336 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 98.62 0.7 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.653 2.235 . . . . 61.240000000000002 112.272 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.25 -175.02 2.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 64.319999999999993 110.946 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 139.97 57.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.230000000000004 110.936 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.616 HD13 ' CD1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -179.22 161.31 1.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 60.119999999999997 111.002 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.43 137.15 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 62.439999999999998 110.917 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.616 ' CD1' HD13 ' A' ' 29' ' ' LEU . 17.0 m95 -125.05 143.82 50.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.477 . . . . 72.310000000000002 110.972 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -148.66 136.26 20.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.329 -0.396 . . . . 73.450000000000003 110.86 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 34' ' ' ASN . 1.1 tp -138.62 138.07 37.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 74.150000000000006 110.922 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.631 ' N ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -112.62 126.83 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 61.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.828 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 19.7 p -137.57 179.81 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 111.15 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.12 -132.72 17.29 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.736 -0.745 . . . . 74.209999999999994 112.501 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.65 -37.26 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 75.239999999999995 110.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.591 HG23 ' HG3' ' A' ' 39' ' ' GLU . 3.5 t -179.38 -28.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 64.299999999999997 111.085 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HG3' HG23 ' A' ' 38' ' ' THR . 14.9 mt-10 -101.5 33.67 2.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 74.329999999999998 110.885 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -124.62 -6.5 7.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 54.299999999999997 111.085 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -59.53 129.75 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 60.219999999999999 110.895 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.74 153.15 50.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 73.200000000000003 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.18 123.31 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 53.299999999999997 111.045 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.59 145.0 26.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.319999999999993 110.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.413 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -128.3 163.58 43.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.754 . . . . 72.230000000000004 110.822 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.571 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.3 Cg_endo -69.79 -0.33 6.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.614 2.209 . . . . 71.040000000000006 112.407 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -128.73 87.95 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.349999999999994 110.879 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.85 25.73 17.99 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.775 -0.726 . . . . 72.420000000000002 112.46 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.92 167.65 0.32 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 64.310000000000002 112.452 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.33 -152.13 20.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.7 -0.762 . . . . 72.349999999999994 112.423 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.742 ' O ' HG22 ' A' ' 55' ' ' VAL . 53.8 Cg_endo -69.71 98.89 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.627 2.218 . . . . 73.420000000000002 112.361 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.44 -14.94 59.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 75.430000000000007 110.906 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -62.97 -39.03 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 75.439999999999998 110.891 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.9 -42.74 9.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 73.019999999999996 110.928 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 51' ' ' PRO . 14.0 m -101.62 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 72.200000000000003 111.128 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 55' ' ' VAL . . . -142.8 164.22 30.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 70.209999999999994 111.132 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.515 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -114.83 157.33 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 52.520000000000003 110.895 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 45' ' ' SER . 45.9 t -114.55 127.02 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.115 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 63' ' ' SER . 6.4 mp -69.69 157.91 88.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.662 0.744 . . . . 73.549999999999997 110.841 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.7 Cg_endo -69.77 -22.8 31.52 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.245 . . . . 73.219999999999999 112.295 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 2.3 p-10 -83.52 4.02 29.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 63.299999999999997 110.86 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.96 13.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.802 -0.713 . . . . 60.520000000000003 112.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 3.2 m -114.63 178.6 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.407 . . . . 45.32 110.839 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.715 HD23 HD12 ' A' ' 16' ' ' LEU . 13.3 tp -130.09 127.88 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 73.25 110.986 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -126.26 130.27 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.857 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mp -120.93 130.31 24.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.649 0.737 . . . . 60.100000000000001 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.64 18.27 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 72.510000000000005 112.39 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.66 103.4 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 62.100000000000001 111.146 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 12' ' ' GLU . 30.9 m -73.01 121.91 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.469 . . . . 73.120000000000005 111.1 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.08 156.42 22.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.683 -0.77 . . . . 62.229999999999997 112.489 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.766 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.91 -30.18 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.305 . . . . 73.349999999999994 111.129 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -73.97 -23.74 59.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 62.299999999999997 110.849 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.43 -5.0 45.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.923 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.41 141.06 58.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.869 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.583 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 155.39 -138.91 6.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 63.399999999999999 112.413 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.437 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.4 mp -129.13 127.64 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 52.310000000000002 111.152 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.734 ' CD2' HD13 ' A' ' 16' ' ' LEU . 1.5 t80 -104.5 131.1 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.420000000000002 110.859 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 1.237 ' HG3' ' CD1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -127.08 137.36 53.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 72.040000000000006 110.944 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.8 t -119.95 149.07 42.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.939 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -140.99 127.07 19.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.897 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.59 163.87 27.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.109999999999999 111.094 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ttm -128.75 125.29 37.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 65.049999999999997 110.885 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -86.93 173.21 9.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 61.399999999999999 110.887 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -70.32 -18.13 63.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 110.848 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.14 -19.93 61.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.329999999999998 110.882 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.75 -16.37 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 71.409999999999997 112.478 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.87 146.76 27.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.727 0.299 . . . . 73.099999999999994 110.881 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.26 143.4 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 55.039999999999999 110.9 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.92 130.38 51.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 54.030000000000001 111.193 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.003 ' HE2' ' H11' ' B' ' 4' ' ' MCL . 4.0 mtpt -105.49 144.85 31.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 52.310000000000002 110.917 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.417 ' C ' ' HE ' ' A' ' 78' ' ' ARG . 74.0 m -144.44 125.82 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 74.340000000000003 110.824 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -120.06 123.59 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 74.299999999999997 110.943 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.83 118.84 24.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 110.93 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.623 ' NH2' ' O ' ' B' ' 4' ' ' MCL . 11.1 mmt85 -82.66 129.89 35.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 74.530000000000001 110.97 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.97 131.05 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 74.109999999999999 111.197 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NH2' HG21 ' A' ' 100' ' ' ILE . 4.1 tpt180 -130.78 128.32 40.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 65.340000000000003 110.826 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.766 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.5 m -95.08 -177.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 64.010000000000005 111.095 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -66.95 -82.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.340000000000003 110.89 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -58.02 137.91 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.873 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.403 HG21 ' NH2' ' A' ' 96' ' ' ARG . 1.0 OUTLIER -120.0 160.08 44.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 63.229999999999997 111.188 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 153.01 69.36 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 62.32 112.314 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 171.19 109.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 74.439999999999998 112.437 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 160.73 42.06 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 73.010000000000005 110.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -174.88 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.656 2.237 . . . . 73.239999999999995 112.353 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.879 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.842 0.354 . . . . 64.439999999999998 110.906 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.437 ' CB ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.75 -61.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.030000000000001 110.872 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.263 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -179.2 105.62 0.04 OUTLIER 'General case' 0 C--O 1.183 -2.442 0 CA-C-O 118.21 -0.9 . . . . 74.340000000000003 110.82 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.003 ' H11' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 3' ' ' ALA . . . 73.87 -70.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.805 -0.634 . . . . 72.400000000000006 111.133 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 50.69 69.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 51.439999999999998 110.872 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 72.340000000000003 111.004 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.508 -0.237 . . . . 71.230000000000004 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -157.9 142.15 16.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 72.420000000000002 110.886 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.38 101.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 61.530000000000001 111.084 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -93.69 134.94 35.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.299999999999997 110.875 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -85.81 121.78 28.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 71.519999999999996 110.852 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.602 ' CG2' HD11 ' A' ' 14' ' ' LEU . 45.9 mm -125.19 121.57 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.085 -0.507 . . . . 64.129999999999995 111.211 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -96.55 142.01 29.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 52.109999999999999 111.188 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -148.27 166.04 29.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 74.510000000000005 111.173 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -124.31 148.18 47.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 72.019999999999996 110.887 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.456 HD11 HG13 ' A' ' 71' ' ' ILE . 25.6 mt -54.21 121.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 64.540000000000006 111.174 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 87.57 4.34 80.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.776 -0.726 . . . . 72.219999999999999 112.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.777 ' O ' HG22 ' A' ' 69' ' ' VAL . 23.2 mm-40 -102.08 140.15 20.92 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 71.200000000000003 110.931 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 144.07 52.85 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.709 2.272 . . . . 62.219999999999999 112.305 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.602 HD11 ' CG2' ' A' ' 6' ' ' ILE . 25.5 tp -144.41 141.71 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.871 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 65' ' ' PHE . 22.0 t -122.28 147.38 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 61.310000000000002 111.161 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.3 mt -132.02 148.72 52.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 70.530000000000001 110.934 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -111.82 151.3 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 110.946 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.4 t -107.38 99.9 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 54.32 110.918 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -57.62 121.24 9.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 74.049999999999997 110.898 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.01 -39.4 1.91 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.786 -0.721 . . . . 60.310000000000002 112.515 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.53 43.67 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.544 0.688 . . . . 72.420000000000002 111.135 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -165.64 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.676 2.251 . . . . 74.319999999999993 112.397 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -49.36 -48.45 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.030000000000001 110.918 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.82 148.85 38.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.504 0.669 . . . . 75.450000000000003 110.915 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.5 Cg_endo -69.75 111.08 2.71 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.65 2.234 . . . . 71.049999999999997 112.376 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.1 Cg_endo -69.7 -84.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.638 2.225 . . . . 72.019999999999996 112.387 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 29.1 mm100 -103.14 -178.54 3.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 71.540000000000006 110.893 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -64.71 136.62 57.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 62.240000000000002 110.832 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.6 pp -136.58 151.83 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.439999999999998 110.852 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.86 148.14 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.040000000000006 110.879 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.27 139.91 53.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 110.946 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.727 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.34 135.46 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 73.319999999999993 110.887 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.83 HD13 ' CE2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -138.25 137.62 37.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.943 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.127 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 2.8 t-20 -113.52 126.76 55.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 52.43 110.882 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.82 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 24.5 p -136.71 179.78 6.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 111.181 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.17 -119.69 6.83 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.648 -0.787 . . . . 71.409999999999997 112.514 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 38' ' ' THR . 9.2 mpt_? -114.57 -38.96 3.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.530000000000001 110.946 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 174.51 -27.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 31.5 111.103 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.64 33.2 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.865 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.27 -7.55 8.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 111.12 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -60.72 129.77 43.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 73.200000000000003 110.878 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 153.71 51.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 65.150000000000006 110.907 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 32' ' ' LYS . 12.0 m -88.81 122.35 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 70.140000000000001 111.109 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -88.2 145.22 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 72.230000000000004 110.846 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.54 165.72 25.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.716 0.769 . . . . 71.129999999999995 110.798 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.59 0.87 4.9 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.722 2.281 . . . . 73.230000000000004 112.421 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.34 97.13 5.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.878 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.43 -31.7 71.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 43.299999999999997 112.513 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.43 -159.0 21.09 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.722 . . . . 74.329999999999998 112.548 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.74 -67.91 1.63 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.737 -0.744 . . . . 72.299999999999997 112.479 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 95.76 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.648 2.232 . . . . 51.43 112.319 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -84.22 -32.76 24.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 110.917 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.82 -26.56 68.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.322 -0.399 . . . . 75.230000000000004 110.8 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 -44.52 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 72.450000000000003 110.856 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -128.17 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 71.420000000000002 111.111 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.93 171.42 11.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 64.319999999999993 111.106 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 159.58 33.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 64.019999999999996 110.888 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 63' ' ' SER . 19.4 t -113.33 130.58 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 111.158 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD12 ' CB ' ' A' ' 63' ' ' SER . 77.4 mt -68.55 157.55 87.83 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.6 0.714 . . . . 64.329999999999998 110.889 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.8 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.632 2.221 . . . . 71.25 112.353 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -83.42 -0.15 48.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.812 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.4 9.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 15.42 112.461 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.64 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.1 m -111.65 179.6 3.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 72.310000000000002 110.898 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.34 128.08 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.482 . . . . 73.420000000000002 110.947 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CD1' HG22 ' A' ' 15' ' ' VAL . 9.5 t80 -126.68 132.83 51.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.629 HD22 HG12 ' A' ' 69' ' ' VAL . 7.6 mp -114.78 128.35 25.98 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.518 0.675 . . . . 71.400000000000006 110.985 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.29 19.12 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.651 2.234 . . . . 61.340000000000003 112.411 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.44 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -164.8 102.36 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 53.229999999999997 111.151 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 12' ' ' GLU . 28.9 m -72.09 118.97 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 42.119999999999997 111.167 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.37 158.64 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 63.32 112.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.787 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.74 -30.37 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 71.219999999999999 111.182 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.5 -23.11 56.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 74.219999999999999 110.92 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.38 -5.09 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 70.099999999999994 110.783 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.03 140.9 56.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 74.329999999999998 110.885 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.66 -139.57 6.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.82 -0.705 . . . . 24.300000000000001 112.476 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.322 HD13 ' C ' ' B' ' 2' ' ' GLU . 1.7 mp -131.78 135.34 58.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 73.319999999999993 111.11 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.83 ' CE2' HD13 ' A' ' 33' ' ' LEU . 9.2 m-85 -104.67 126.75 52.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 54.229999999999997 110.838 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.598 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 1.1 mmm180 -126.39 130.65 51.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 110.915 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.17 151.22 39.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 73.25 110.86 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -140.54 129.44 23.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.74 163.35 28.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 55.119999999999997 111.05 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.3 ttm -129.54 125.41 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 65.040000000000006 110.876 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.48 171.77 10.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -17.41 62.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.868 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.58 -25.13 61.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 71.109999999999999 110.894 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.94 -20.23 13.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.776 -0.726 . . . . 73.140000000000001 112.538 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.09 146.87 26.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.733 0.301 . . . . 72.530000000000001 110.868 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -105.04 145.39 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.834 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.77 131.89 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.520000000000003 111.212 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.723 ' HE2' ' O1 ' ' B' ' 4' ' ' MCL . 12.7 mtpt -105.05 142.66 34.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 72.209999999999994 110.917 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -145.93 126.95 14.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 72.239999999999995 110.913 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' CG ' ' HA ' ' B' ' 5' ' ' ALA . 0.8 OUTLIER -127.77 127.25 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 110.822 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -129.03 124.3 34.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 65.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.093 ' NH2' ' HG3' ' B' ' 2' ' ' GLU . 30.3 mmm-85 -82.61 135.53 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 72.530000000000001 110.933 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.456 HG21 ' CE1' ' A' ' 77' ' ' PHE . 53.5 t -123.98 132.5 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.010000000000005 111.232 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.0 128.4 40.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.340000000000003 110.908 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.3 m -93.71 -176.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 73.530000000000001 111.149 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -66.35 -81.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 64.310000000000002 110.874 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -63.93 145.87 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 70.150000000000006 110.945 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.53 159.48 50.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.509 0.671 . . . . 74.549999999999997 111.202 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.9 Cg_endo -69.74 -170.63 0.4 Allowed 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.759 2.306 . . . . 64.010000000000005 112.284 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 145.35 50.47 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 64.219999999999999 112.492 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -163.7 160.39 17.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.571 0.701 . . . . 71.450000000000003 110.893 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -172.35 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.635 2.224 . . . . 72.420000000000002 112.305 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.908 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.776 0.322 . . . . 63.299999999999997 110.882 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.322 ' C ' HD13 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -127.99 61.94 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.872 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.127 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 61.21 -166.73 0.2 Allowed 'General case' 0 C--O 1.182 -2.476 0 CA-C-O 118.088 -0.958 . . . . 55.140000000000001 110.889 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.723 ' O1 ' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 76' ' ' ILE . . . 42.99 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 72.040000000000006 111.087 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.11 28.96 8.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 110.83 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.82 ' HG3' HH22 ' A' ' 94' ' ' ARG . 53.5 mm-40 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 72.129999999999995 110.933 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.541 -0.224 . . . . 64.209999999999994 112.541 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t 63.7 108.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 73.040000000000006 110.938 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.54 62.93 2.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 44.240000000000002 111.118 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.0 132.9 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 110.9 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -86.98 120.97 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.86 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.64 122.74 63.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 111.076 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.08 142.17 28.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 111.075 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.66 28.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.450000000000003 111.11 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.45 148.23 44.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.299999999999997 110.84 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 99' ' ' GLN . 21.8 mt -57.77 122.16 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 64.430000000000007 111.141 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.708 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.13 4.22 78.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.673 -0.775 . . . . 51.539999999999999 112.519 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.778 ' O ' HG22 ' A' ' 69' ' ' VAL . 43.7 mm-40 -101.18 140.4 21.25 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.712 0.768 . . . . 71.349999999999994 110.879 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 141.49 45.46 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.669 2.246 . . . . 73.109999999999999 112.375 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 66' ' ' LEU . 19.8 tp -144.48 141.98 29.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 73.340000000000003 111.029 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.84 148.6 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 62.509999999999998 111.081 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.956 HD12 HD23 ' A' ' 64' ' ' LEU . 15.1 mt -130.56 147.94 52.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.896 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.95 31.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.868 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.4 100.79 8.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 72.400000000000006 110.875 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.64 122.05 7.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 53.439999999999998 110.916 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.55 -47.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.837 -0.697 . . . . 43.119999999999997 112.511 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . . . -95.96 102.2 10.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 61.210000000000001 111.065 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 20' ' ' GLY . 53.1 Cg_endo -69.75 -161.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.625 2.217 . . . . 31.239999999999998 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -11.15 5.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 64.439999999999998 110.916 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.466 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 2.7 mptt -46.53 168.65 0.11 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.662 0.744 . . . . 71.120000000000005 110.866 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 54.3 Cg_endo -69.72 172.17 13.09 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.762 2.308 . . . . 43.0 112.334 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 97.89 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.752 2.302 . . . . 71.5 112.338 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 -175.4 3.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.861 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -64.6 133.09 51.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 71.040000000000006 110.92 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 46' ' ' PRO . 2.3 pp -172.3 174.23 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 64.120000000000005 110.897 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.43 131.16 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.809 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -124.09 128.95 50.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 75.519999999999996 110.856 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -138.41 137.79 37.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 73.109999999999999 110.842 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 77' ' ' PHE . 2.4 tp -137.75 136.94 37.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 54.130000000000003 110.899 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.92 126.39 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.319999999999993 110.85 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.85 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 70.5 p -138.58 -179.35 5.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 62.119999999999997 111.083 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.26 -126.64 10.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.817 -0.706 . . . . 71.200000000000003 112.489 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 38' ' ' THR . 49.1 mmm-85 -112.61 -38.62 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.040000000000006 110.808 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 39' ' ' GLU . 5.0 t 178.93 -29.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 72.450000000000003 111.159 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HG3' HG23 ' A' ' 38' ' ' THR . 67.9 mt-10 -102.16 34.28 2.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.85 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.6 -7.01 8.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 55.219999999999999 111.14 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -63.07 131.23 47.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 75.140000000000001 110.927 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 154.27 47.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 61.240000000000002 110.904 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.29 117.01 33.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 72.409999999999997 111.073 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.29 149.71 22.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 64.400000000000006 110.927 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.659 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -124.96 162.14 45.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.751 0.786 . . . . 73.019999999999996 110.802 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.696 ' HB3' HD11 ' A' ' 29' ' ' LEU . 53.7 Cg_endo -69.75 -0.12 6.45 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.753 2.302 . . . . 73.129999999999995 112.316 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -120.11 72.26 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 73.439999999999998 110.877 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.5 23.74 32.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.762 . . . . 64.019999999999996 112.524 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.71 59.02 3.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.706 -0.759 . . . . 63.310000000000002 112.515 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.65 -127.32 2.75 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 74.150000000000006 112.432 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 91.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.313 . . . . 73.510000000000005 112.3 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 44.1 p-90 -83.43 -33.92 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 74.450000000000003 110.933 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -59.4 -25.9 64.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.315 -0.402 . . . . 72.120000000000005 110.881 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.52 -45.83 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 70.519999999999996 110.779 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -128.62 -98.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 63.0 111.143 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.578 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -166.19 175.21 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 74.219999999999999 111.111 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 161.42 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 73.140000000000001 110.876 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 46' ' ' PRO . 51.9 t -107.65 128.26 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 111.121 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 63' ' ' SER . 54.4 mt -70.31 158.68 87.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 60.219999999999999 110.926 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.4 Cg_endo -69.83 -22.42 31.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.649 2.233 . . . . 73.540000000000006 112.301 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -83.93 1.6 42.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.897 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 30.86 11.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 72.299999999999997 112.519 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.529 ' HB2' HD12 ' A' ' 59' ' ' LEU . 4.3 m -112.65 178.26 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 72.329999999999998 110.833 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.956 HD23 HD12 ' A' ' 16' ' ' LEU . 8.9 tp -131.62 130.62 42.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.127 -0.488 . . . . 64.310000000000002 110.89 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 6.8 t80 -124.57 128.2 48.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 110.913 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' A' ' 56' ' ' ALA . 1.8 mp -119.69 131.65 24.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.555 0.693 . . . . 64.430000000000007 110.918 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -32.7 18.39 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.729 2.286 . . . . 42.219999999999999 112.396 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -165.62 101.75 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.086 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.3 m -72.98 118.83 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 72.430000000000007 111.118 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.51 163.78 35.75 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.783 -0.722 . . . . 62.420000000000002 112.451 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -55.5 -29.97 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 54.030000000000001 111.049 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -74.41 -22.32 59.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 74.239999999999995 110.808 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -5.96 47.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.405 . . . . 74.519999999999996 110.912 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 8.8 pt-20 -60.0 141.99 54.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.841 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.66 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 158.24 -142.28 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.797 -0.716 . . . . 44.100000000000001 112.537 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.098 HD13 ' CB ' ' B' ' 2' ' ' GLU . 3.1 mp -130.94 135.48 59.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 111.195 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -101.6 127.39 48.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 110.766 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.717 ' HD3' ' H13' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -125.49 131.62 52.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 74.549999999999997 110.886 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 0.5 OUTLIER -122.63 150.09 43.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 75.200000000000003 110.866 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -148.9 125.65 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 54.109999999999999 110.851 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.57 27.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 72.510000000000005 111.103 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.22 125.23 27.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.310000000000002 110.872 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.59 170.79 11.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 70.430000000000007 110.854 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -72.69 -18.74 61.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 72.25 110.889 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -73.01 -20.03 61.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 64.319999999999993 110.883 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.54 -11.25 33.02 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.772 -0.728 . . . . 73.299999999999997 112.527 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -84.77 145.39 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 75.549999999999997 110.898 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -106.42 145.49 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 65.450000000000003 110.876 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.471 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -101.28 126.55 48.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 111.152 -179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.648 ' HB3' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -105.33 134.54 48.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 64.140000000000001 110.97 179.828 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . 73.9 m -144.68 120.08 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 53.200000000000003 110.788 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.771 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.3 OUTLIER -130.11 121.02 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 73.510000000000005 110.876 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -131.57 127.16 36.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.96 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.256 ' NH1' ' HB1' ' B' ' 5' ' ' ALA . 11.4 mmm-85 -83.88 136.8 33.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 63.140000000000001 110.934 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.17 130.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 74.150000000000006 111.091 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.84 128.82 39.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 71.230000000000004 110.871 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.3 m -93.5 -177.09 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 111.131 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -63.02 -69.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 73.540000000000006 110.884 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.588 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -76.98 138.92 39.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.963 179.941 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.29 159.54 49.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.716 0.769 . . . . 51.420000000000002 111.114 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.82 6.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 74.420000000000002 112.317 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.07 21.92 0.58 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 45.210000000000001 112.462 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? 57.76 70.12 1.38 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.58 0.705 . . . . 52.530000000000001 110.882 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 142.17 47.44 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.691 2.261 . . . . 43.119999999999997 112.379 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 110.838 -179.938 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 72.5 110.827 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.098 ' CB ' HD13 ' A' ' 76' ' ' ILE . 2.4 pm0 -135.76 -41.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 55.119999999999997 110.899 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.649 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -168.35 -168.9 0.99 Allowed 'General case' 0 C--O 1.181 -2.505 0 CA-C-O 118.181 -0.914 . . . . 74.450000000000003 110.875 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 0.771 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.256 ' HB1' ' NH1' ' A' ' 94' ' ' ARG . . . -43.65 154.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.85 -0.614 . . . . 62.549999999999997 111.105 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -148.49 17.77 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 65.409999999999997 110.895 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.796 ' H ' HH12 ' A' ' 94' ' ' ARG . 4.0 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 63.399999999999999 110.943 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.517 -0.233 . . . . 64.310000000000002 112.517 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -168.34 148.15 4.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.941 0.401 . . . . 51.340000000000003 110.806 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.57 100.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 71.219999999999999 111.147 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -92.64 134.64 34.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.92 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -83.21 120.79 26.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 71.510000000000005 110.914 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.478 ' CG2' HD11 ' A' ' 14' ' ' LEU . 47.8 mm -125.4 120.89 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.119999999999997 111.174 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -96.53 142.38 28.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 75.040000000000006 111.126 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.534 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -147.1 164.98 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 50.030000000000001 111.12 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.36 148.94 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.821 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mt -56.13 121.36 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 63.409999999999997 111.156 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.572 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 85.6 3.31 86.44 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.668 -0.777 . . . . 53.049999999999997 112.536 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.79 ' O ' HG22 ' A' ' 69' ' ' VAL . 49.7 mm-40 -101.17 140.89 21.66 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.564 0.697 . . . . 63.520000000000003 110.972 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 143.83 51.94 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.599 2.199 . . . . 72.019999999999996 112.411 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 8' ' ' ALA . 62.3 tp -144.35 142.88 30.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 74.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.53 146.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 62.030000000000001 111.178 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.415 HD13 ' CG ' ' A' ' 77' ' ' PHE . 75.0 mt -131.42 147.24 52.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 65.439999999999998 110.924 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -113.17 151.08 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.829 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.8 t -108.25 100.48 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 64.209999999999994 110.844 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.73 126.97 27.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 74.109999999999999 110.887 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.48 -38.84 2.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 65.25 112.518 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.41 31.1 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.536 0.684 . . . . 71.010000000000005 111.15 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -164.23 0.12 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 54.350000000000001 112.339 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.1 -50.96 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.88 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -111.18 152.55 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 54.450000000000003 110.909 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.5 Cg_endo -69.67 110.3 2.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.252 . . . . 44.229999999999997 112.375 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 52.7 Cg_endo -69.82 -84.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 55.240000000000002 112.318 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.404 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 36.8 mm-40 -100.6 -177.35 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.815 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -63.48 133.89 54.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 110.895 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -135.94 144.54 45.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 72.530000000000001 110.95 179.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -122.07 133.01 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.887 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.47 ' CE2' HD13 ' A' ' 29' ' ' LEU . 4.6 m0 -121.18 144.76 48.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.095 -0.502 . . . . 73.400000000000006 110.887 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.748 ' C ' HD13 ' A' ' 33' ' ' LEU . 5.7 mptt -136.49 138.26 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 110.885 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.122 HD21 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -134.57 141.44 46.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 110.886 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' HB3' ' HD2' ' B' ' 3' ' ' PHE . 8.5 t-20 -111.95 125.33 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 70.140000000000001 110.886 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.829 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 28.8 p -138.58 -179.24 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 111.124 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.54 -129.57 9.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 62.409999999999997 112.497 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -112.48 -37.23 5.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.747 0.308 . . . . 61.310000000000002 110.83 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t 176.81 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 111.192 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.52 33.64 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 74.019999999999996 110.945 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.829 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.54 -6.75 9.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 64.310000000000002 111.146 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -59.84 129.16 40.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.319999999999993 110.91 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.786 ' HE3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -137.4 161.11 37.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 54.149999999999999 110.85 179.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 32' ' ' LYS . 45.8 t -99.5 122.87 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 111.175 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.122 HD23 HD21 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -88.45 143.33 27.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.902 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.607 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.95 163.73 41.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 52.109999999999999 110.815 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.765 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.1 Cg_endo -69.74 1.08 4.74 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.753 2.302 . . . . 75.200000000000003 112.285 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -138.48 72.49 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.888 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.8 -47.01 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 53.210000000000001 112.537 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.02 -151.91 1.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 40.310000000000002 112.466 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.2 -159.91 1.9 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.839 -0.696 . . . . 35.420000000000002 112.433 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 122.64 9.33 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.645 2.23 . . . . 70.109999999999999 112.329 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -83.16 -34.65 25.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.947 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.88 -26.0 68.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 54.439999999999998 110.814 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -46.5 47.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 34.539999999999999 110.877 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.45 -98.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 71.299999999999997 111.098 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -166.17 172.54 11.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.409999999999997 111.132 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.93 159.52 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 74.209999999999994 110.879 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.765 HG11 ' HA ' ' A' ' 46' ' ' PRO . 7.9 t -108.95 130.34 62.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 111.181 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 63' ' ' SER . 66.5 mt -69.23 157.15 90.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.627 0.727 . . . . 71.430000000000007 110.933 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -22.04 32.77 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 74.319999999999993 112.273 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -82.88 0.39 44.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 63.229999999999997 110.9 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.54 28.2 13.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 70.530000000000001 112.418 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 59' ' ' LEU . 6.0 m -112.0 -179.18 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.908 0.385 . . . . 61.109999999999999 110.919 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD23 HD12 ' A' ' 16' ' ' LEU . 16.5 tp -128.53 127.4 42.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 62.100000000000001 110.9 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -126.9 132.06 50.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 110.819 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.786 HD22 HG12 ' A' ' 69' ' ' VAL . 3.5 mp -115.33 130.83 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 73.409999999999997 110.921 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.79 -32.83 17.68 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.679 2.253 . . . . 74.120000000000005 112.36 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.73 101.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 74.120000000000005 111.157 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 12' ' ' GLU . 17.2 m -76.58 118.54 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 53.109999999999999 111.229 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.99 165.39 34.6 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.764 -0.731 . . . . 41.420000000000002 112.414 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.731 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.87 -31.12 24.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 71.5 111.136 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.19 -22.59 57.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 62.140000000000001 110.914 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -5.35 44.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 110.88 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.7 142.21 50.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.876 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.758 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 156.16 -152.34 23.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.801 -0.714 . . . . 61.439999999999998 112.521 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 75' ' ' GLY . 6.9 mm -124.81 135.22 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.25 111.097 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.778 ' CD2' HD12 ' A' ' 33' ' ' LEU . 21.9 t80 -103.38 131.66 50.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 62.32 110.836 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HG3' ' CD1' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -124.83 138.4 54.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 110.837 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.29 149.86 42.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.019999999999996 110.857 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.36 125.34 19.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 110.848 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.38 163.91 27.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 33.509999999999998 111.091 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttm -129.69 125.66 36.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.464 . . . . 53.109999999999999 110.855 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.86 172.61 10.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 64.239999999999995 110.912 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -70.34 -18.04 63.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 54.530000000000001 110.914 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 55.43 110.881 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -18.78 32.93 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.762 -0.733 . . . . 73.030000000000001 112.481 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.12 147.84 26.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.313 . . . . 74.239999999999995 110.906 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -103.74 144.8 30.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 110.878 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -101.84 131.86 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 111.159 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.426 ' HE2' ' CX2' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -99.17 145.43 27.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 72.0 110.918 179.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.91 ' N ' ' CX2' ' B' ' 4' ' ' MCL . 1.8 t -143.79 127.96 17.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 42.539999999999999 110.826 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.555 ' ND2' ' HB3' ' B' ' 4' ' ' MCL . 28.7 t-20 -128.31 129.26 46.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 61.539999999999999 110.853 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.82 126.03 33.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.109999999999999 110.919 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.442 ' CZ ' ' HB1' ' B' ' 5' ' ' ALA . 0.6 OUTLIER -84.51 131.42 34.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 74.349999999999994 110.858 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.4 t -120.7 130.07 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 111.115 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 128.64 38.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.150000000000006 110.863 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.4 m -94.26 -177.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 111.076 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -62.12 -80.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 63.229999999999997 110.927 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.66 143.43 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 63.329999999999998 110.956 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.45 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.41 159.75 48.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 70.400000000000006 111.12 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD2' HG22 ' A' ' 100' ' ' ILE . 53.6 Cg_endo -69.78 161.6 45.3 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 72.150000000000006 112.319 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.92 -109.54 2.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 73.019999999999996 112.502 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -112.36 157.31 40.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 74.540000000000006 110.856 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 169.91 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.595 2.196 . . . . 71.230000000000004 112.376 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 64.420000000000002 110.959 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.791 0.329 . . . . 42.329999999999998 110.823 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.82 160.28 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 73.409999999999997 110.902 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.612 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -63.33 -164.65 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.472 0 CA-C-O 118.171 -0.919 . . . . 73.430000000000007 110.87 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.426 ' CX2' ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.442 ' HB1' ' CZ ' ' A' ' 94' ' ' ARG . . . 39.46 -150.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.857 -0.611 . . . . 61.049999999999997 111.072 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 1.293 ' H ' ' NH2' ' A' ' 94' ' ' ARG . 16.2 t0 71.75 38.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 74.219999999999999 110.893 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.468 . . . . 61.130000000000003 110.898 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.54 -0.224 . . . . 74.439999999999998 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 63.14 105.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 61.43 110.817 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.87 62.95 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 61.030000000000001 111.089 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -93.16 132.72 37.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 64.040000000000006 110.928 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 1.223 ' ND2' ' OE2' ' B' ' 7' ' ' GLU . 2.0 m-20 -89.36 122.78 32.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 74.319999999999993 110.849 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.3 mm -124.2 126.27 71.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.230000000000004 111.163 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -94.09 142.37 27.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 75.25 111.233 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -147.49 168.98 20.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 72.430000000000007 111.088 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -116.63 148.9 40.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 63.140000000000001 110.916 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 99' ' ' GLN . 28.8 mt -54.17 121.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 73.519999999999996 111.111 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.697 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.06 12.37 65.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 63.229999999999997 112.502 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.798 ' O ' HG22 ' A' ' 69' ' ' VAL . 5.3 mm-40 -102.7 138.31 19.58 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 73.209999999999994 110.908 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 143.14 50.55 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.697 2.265 . . . . 64.239999999999995 112.401 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.7 tp -145.68 143.05 29.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 75.430000000000007 110.891 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.1 144.69 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 111.106 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 64' ' ' LEU . 52.1 mt -131.39 147.55 52.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.854 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -113.77 153.33 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.855 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.9 t -104.28 100.88 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 62.140000000000001 110.832 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -56.01 123.52 14.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.852 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.582 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.73 -39.85 2.02 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.663 -0.78 . . . . 33.420000000000002 112.504 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.34 129.44 43.23 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.517 0.675 . . . . 72.099999999999994 111.152 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.7 Cg_endo -69.75 -163.91 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.787 2.325 . . . . 62.340000000000003 112.313 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -49.01 -48.2 43.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 53.329999999999998 110.909 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -105.98 156.1 37.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.586 0.708 . . . . 72.040000000000006 110.928 179.806 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.2 Cg_endo -69.84 109.77 2.41 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 65.150000000000006 112.318 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.486 ' HD3' ' HD2' ' A' ' 22' ' ' PRO . 53.1 Cg_endo -69.89 -87.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.659 2.239 . . . . 61.520000000000003 112.308 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -103.96 -178.06 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 71.450000000000003 110.836 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm-85 -64.72 135.03 55.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 74.530000000000001 110.878 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.641 HD11 ' HB3' ' A' ' 46' ' ' PRO . 4.0 pp -135.61 156.06 49.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 75.25 110.932 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -121.55 147.67 45.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 64.140000000000001 110.958 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -130.49 130.0 43.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 73.439999999999998 110.883 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' C ' HD23 ' A' ' 33' ' ' LEU . 11.3 mtmm -136.52 136.91 39.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.164 -0.471 . . . . 71.340000000000003 110.844 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.785 HD21 HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -138.35 138.54 38.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.926 179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -111.83 126.34 54.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 71.549999999999997 110.952 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 76.1 p -137.99 179.56 6.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 111.186 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.54 -129.93 14.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.791 -0.719 . . . . 71.219999999999999 112.449 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -112.65 -37.68 4.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 72.120000000000005 110.878 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 39' ' ' GLU . 6.5 t -179.12 -31.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.510000000000005 111.129 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.57 ' HG2' HG23 ' A' ' 38' ' ' THR . 5.0 mm-40 -102.57 33.94 2.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 74.340000000000003 110.945 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -122.93 -6.42 8.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 111.165 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -59.36 131.72 51.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 64.530000000000001 110.985 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.703 ' HE3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -128.52 153.53 47.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 64.099999999999994 110.866 -179.913 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.68 120.28 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 63.530000000000001 111.148 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.785 HD12 HD21 ' A' ' 33' ' ' LEU . 15.4 mt -95.83 146.75 24.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 75.019999999999996 110.899 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.5 ' O ' HG21 ' A' ' 58' ' ' VAL . 1.1 p -123.71 157.86 61.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.678 0.751 . . . . 74.230000000000004 110.847 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.683 ' HA ' HG11 ' A' ' 58' ' ' VAL . 54.3 Cg_endo -69.79 0.28 5.89 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.704 2.27 . . . . 43.329999999999998 112.301 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.88 82.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.945 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.71 95.55 0.94 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 70.230000000000004 112.493 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.414 ' HA3' HD22 ' A' ' 44' ' ' LEU . . . -81.71 4.28 74.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.754 . . . . 73.319999999999993 112.47 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.12 -158.77 15.42 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 55.520000000000003 112.597 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 114.67 3.79 Favored 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 122.677 2.252 . . . . 74.099999999999994 112.348 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -60.9 -34.24 74.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 72.239999999999995 110.915 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.05 -26.57 66.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 74.510000000000005 110.886 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -46.98 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.340000000000003 110.855 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.02 -98.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 75.430000000000007 111.053 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -165.41 176.31 8.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 71.519999999999996 111.052 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' HD12 ' A' ' 64' ' ' LEU . 49.4 mmm-85 -114.36 160.9 18.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 65.219999999999999 110.831 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.683 HG11 ' HA ' ' A' ' 46' ' ' PRO . 49.5 t -109.44 129.68 63.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 111.15 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 63' ' ' SER . 40.0 mt -69.47 157.87 88.34 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.582 0.706 . . . . 75.310000000000002 110.883 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -23.0 31.01 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.677 2.251 . . . . 62.0 112.284 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -82.96 1.14 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.899 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.24 29.84 11.86 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.772 -0.728 . . . . 72.310000000000002 112.484 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB2' HD12 ' A' ' 59' ' ' LEU . 14.7 m -112.62 -179.43 3.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.399 . . . . 71.129999999999995 110.846 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.617 HD23 HD12 ' A' ' 16' ' ' LEU . 22.1 tp -129.14 130.84 46.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 110.898 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.46 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 45.1 t80 -123.87 130.48 52.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 55.229999999999997 110.909 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.757 HD22 HG12 ' A' ' 69' ' ' VAL . 5.1 mp -116.86 124.15 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 73.349999999999994 110.929 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -32.8 18.05 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.676 2.251 . . . . 62.020000000000003 112.314 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.697 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -170.48 101.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.42 . . . . 62.539999999999999 111.151 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 12' ' ' GLU . 13.9 m -72.84 112.2 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 74.430000000000007 111.064 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.53 164.69 36.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.745 -0.74 . . . . 73.319999999999993 112.475 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.894 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -53.81 -33.46 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 72.400000000000006 111.086 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -77.6 -22.04 51.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 62.299999999999997 110.84 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -5.07 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 62.240000000000002 110.916 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.659 ' HG3' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.15 142.16 52.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 51.439999999999998 110.827 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 76' ' ' ILE . . . 161.48 -148.12 15.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 31.309999999999999 112.537 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.285 HG13 ' OE1' ' B' ' 2' ' ' GLU . 1.2 mm -129.71 135.59 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.358 . . . . 65.239999999999995 111.154 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 33' ' ' LEU . 52.8 m-85 -104.43 123.97 48.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.877 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HB2' ' CZ ' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -122.99 126.95 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 73.530000000000001 110.858 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.6 t -121.59 153.93 37.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -141.0 140.08 34.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 64.129999999999995 110.928 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.65 162.41 30.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 53.130000000000003 111.152 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 75.9 mmm -130.14 125.24 34.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 71.109999999999999 110.888 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -88.44 170.8 10.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 64.420000000000002 110.853 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -72.94 -22.48 60.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 64.040000000000006 110.888 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.54 -20.43 60.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.340000000000003 110.915 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.8 -2.86 31.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 75.109999999999999 112.515 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.56 146.46 27.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.677 0.275 . . . . 74.439999999999998 110.938 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -105.32 142.42 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 75.209999999999994 110.955 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.582 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -104.2 129.67 51.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.165 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.144 ' HB3' ' CX2' ' B' ' 4' ' ' MCL . 0.4 OUTLIER -101.82 141.46 34.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 74.049999999999997 110.922 179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 58.7 m -145.92 120.13 9.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 33.219999999999999 110.844 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 1.222 ' OD1' ' HB2' ' B' ' 4' ' ' MCL . 0.6 OUTLIER -131.72 121.92 25.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.907 -179.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 91' ' ' SER . 6.9 m-85 -131.96 120.61 22.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 75.349999999999994 110.906 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.539 ' CZ ' ' CB ' ' B' ' 5' ' ' ALA . 0.9 OUTLIER -85.14 132.6 34.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 71.439999999999998 110.881 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.6 t -120.66 136.03 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 72.109999999999999 111.199 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -130.75 151.22 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 63.240000000000002 110.89 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.894 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.5 m -112.06 -175.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 73.209999999999994 111.158 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -67.29 -76.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.896 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.605 ' HB2' HD11 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -64.02 137.31 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 62.140000000000001 110.909 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.01 159.87 47.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.665 0.745 . . . . 71.25 111.135 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 129.9 18.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 73.120000000000005 112.325 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.97 -82.81 1.0 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.688 -0.767 . . . . 71.400000000000006 112.488 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -134.79 68.42 71.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 61.020000000000003 110.915 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 115.1 3.95 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.709 2.272 . . . . 61.100000000000001 112.342 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.421 . . . . 44.130000000000003 110.929 179.975 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.838 0.351 . . . . 73.430000000000007 110.844 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.285 ' OE1' HG13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -117.72 -14.22 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.864 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.525 ' CD2' ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 175.94 -151.95 0.01 OUTLIER 'General case' 0 C--O 1.182 -2.452 0 CA-C-O 118.219 -0.896 . . . . 75.200000000000003 110.875 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.222 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.539 ' CB ' ' CZ ' ' A' ' 94' ' ' ARG . . . -52.98 157.38 1.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 23.219999999999999 111.086 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -159.98 89.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 75.430000000000007 110.876 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 1.223 ' OE2' ' ND2' ' A' ' 5' ' ' ASN . 1.4 mp0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 64.120000000000005 110.94 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.495 -0.242 . . . . 72.129999999999995 112.495 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -152.89 139.92 19.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 44.43 110.892 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.71 100.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 63.350000000000001 111.04 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.521 HE21 HD11 ' A' ' 6' ' ' ILE . 1.1 tt0 -93.65 135.18 35.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 61.520000000000003 110.98 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.616 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.6 p30 -90.42 122.91 33.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.109999999999999 110.875 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 5' ' ' ASN . 1.7 mp -125.39 124.56 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 64.239999999999995 111.164 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -89.61 144.17 26.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 61.509999999999998 111.147 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.645 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -140.54 165.68 26.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 71.340000000000003 111.038 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 110.887 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.432 HG12 ' HB3' ' A' ' 98' ' ' TYR . 18.5 mm -61.74 120.47 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 111.173 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.769 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 79.34 10.84 85.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 75.230000000000004 112.472 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.815 ' O ' HG22 ' A' ' 69' ' ' VAL . 42.6 mm-40 -101.44 140.69 21.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.609 0.718 . . . . 74.340000000000003 110.841 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 143.48 51.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.236 . . . . 71.340000000000003 112.37 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 tp -144.58 142.39 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 63.32 110.897 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.433 HG22 ' HD1' ' A' ' 65' ' ' PHE . 39.3 t -122.23 148.19 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.230000000000004 111.239 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.6 mt -131.54 148.05 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 61.509999999999998 110.824 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -113.33 152.53 29.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 71.430000000000007 110.877 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.0 t -107.09 102.24 11.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.109999999999999 110.868 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -58.19 123.25 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.915 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.668 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 124.57 -37.97 2.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 51.039999999999999 112.49 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.66 128.63 45.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.553 0.692 . . . . 73.540000000000006 111.109 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 26' ' ' PRO . 53.6 Cg_endo -69.81 -164.28 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.657 2.238 . . . . 72.310000000000002 112.345 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -49.31 -48.92 45.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 52.240000000000002 110.9 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -107.04 154.74 40.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 72.209999999999994 110.846 179.903 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 54.1 Cg_endo -69.79 109.17 2.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.678 2.252 . . . . 51.420000000000002 112.333 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.8 Cg_endo -69.72 -87.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.683 2.255 . . . . 65.200000000000003 112.371 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -104.13 -177.26 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 73.010000000000005 110.846 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -64.09 137.81 58.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 74.299999999999997 110.922 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.9 pp -135.94 157.93 45.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 74.409999999999997 110.899 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -123.08 147.17 47.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 74.409999999999997 110.841 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 44' ' ' LEU . 2.7 m95 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.040000000000006 110.988 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -151.84 137.13 17.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.311 -0.404 . . . . 73.129999999999995 110.835 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.769 HD22 ' CE2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -140.9 138.29 33.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 75.230000000000004 110.954 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.214 ' HB3' ' CD2' ' B' ' 3' ' ' PHE . 2.0 t-20 -113.83 127.35 55.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 65.239999999999995 110.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 42.9 p -140.52 -179.34 5.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 71.120000000000005 111.123 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.9 -120.45 5.31 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 72.150000000000006 112.528 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.67 ' O ' HG23 ' A' ' 38' ' ' THR . 29.6 mmm180 -114.68 -39.72 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 110.863 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER 173.66 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.329999999999998 111.139 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.37 33.46 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.875 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -121.42 -7.48 9.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 111.119 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -63.09 130.43 44.61 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.151 -0.477 . . . . 71.439999999999998 110.931 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.432 ' HE2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -135.67 158.91 43.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 71.019999999999996 110.885 179.911 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.84 121.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.44 . . . . 70.329999999999998 111.114 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.549 ' CD1' HD23 ' A' ' 33' ' ' LEU . 8.7 mp -89.7 145.27 25.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.871 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.536 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -126.13 164.23 34.91 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.658 0.742 . . . . 70.510000000000005 110.833 -179.918 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.734 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.74 0.41 5.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.721 2.28 . . . . 62.32 112.35 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.46 85.0 2.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 73.129999999999995 110.884 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.85 -39.09 60.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.673 -0.775 . . . . 73.519999999999996 112.495 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.42 -161.01 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.636 -0.792 . . . . 71.349999999999994 112.484 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.43 -160.64 1.31 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.703 -0.761 . . . . 63.240000000000002 112.478 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 127.07 14.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 74.25 112.289 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -83.18 -35.05 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 63.310000000000002 110.868 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.9 -25.09 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 72.120000000000005 110.809 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.24 -47.29 65.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 73.400000000000006 110.848 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.8 -97.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 52.509999999999998 111.168 179.88 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -163.4 170.63 17.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 64.239999999999995 111.071 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -127.14 159.84 33.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.842 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 46' ' ' PRO . 14.4 t -108.71 130.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.171 -0.468 . . . . 61.340000000000003 111.149 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 63' ' ' SER . 38.8 mt -68.41 157.93 86.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 71.209999999999994 110.936 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -23.04 30.99 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.754 2.303 . . . . 75.400000000000006 112.337 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -83.24 0.68 44.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.898 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.4 29.38 11.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 73.340000000000003 112.484 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.506 ' CB ' HD12 ' A' ' 59' ' ' LEU . 3.1 m -111.43 -178.95 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 54.420000000000002 110.881 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.0 tp -128.76 130.06 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.129999999999995 110.831 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HD1' HG22 ' A' ' 15' ' ' VAL . 12.9 t80 -124.05 130.72 53.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 70.409999999999997 110.861 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD22 HG12 ' A' ' 69' ' ' VAL . 7.1 mp -118.15 131.0 24.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.594 0.712 . . . . 72.150000000000006 110.9 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -38.29 8.12 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 73.099999999999994 112.377 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -164.19 103.8 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 42.329999999999998 111.084 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.7 m -73.97 115.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 51.439999999999998 111.135 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.58 165.76 29.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 75.120000000000005 112.479 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.803 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.02 -30.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.32 . . . . 75.150000000000006 111.131 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.09 -22.57 55.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 64.109999999999999 110.88 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.463 ' O ' HG21 ' A' ' 35' ' ' THR . 0.4 OUTLIER -80.65 -1.55 42.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 62.25 110.779 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.21 141.12 58.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 63.020000000000003 110.932 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.602 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 160.91 -145.17 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 74.329999999999998 112.456 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.266 ' CD1' ' HG3' ' B' ' 2' ' ' GLU . 3.7 mp -130.58 134.72 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 74.219999999999999 111.045 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.769 ' CE2' HD22 ' A' ' 33' ' ' LEU . 13.3 m-85 -103.44 135.29 45.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 75.230000000000004 110.832 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.466 ' HD3' ' O2 ' ' B' ' 4' ' ' MCL . 0.0 OUTLIER -128.01 130.71 48.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 64.120000000000005 110.874 -179.967 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 147.93 43.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 41.030000000000001 110.875 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -146.09 126.96 14.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 110.917 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.26 162.67 30.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 60.32 111.084 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 33.8 tpp -130.15 125.76 35.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.938 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.52 171.63 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.217 -0.447 . . . . 65.420000000000002 110.879 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -18.56 62.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 64.340000000000003 110.901 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -73.35 -19.78 60.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 51.509999999999998 110.865 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.16 37.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.58 -0.819 . . . . 72.400000000000006 112.369 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -84.78 145.73 27.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.689 0.281 . . . . 73.420000000000002 110.916 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -105.58 142.22 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 50.200000000000003 110.877 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.668 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -104.05 129.7 51.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 64.420000000000002 111.054 -179.894 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -105.72 144.13 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.983 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -145.65 120.63 10.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 54.310000000000002 110.877 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 1.011 ' HB2' ' CX2' ' B' ' 4' ' ' MCL . 25.1 t-20 -121.28 120.76 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 75.530000000000001 110.888 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -127.72 126.6 42.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 70.329999999999998 110.94 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.466 ' NE ' ' HB1' ' B' ' 5' ' ' ALA . 11.5 mmm-85 -91.11 135.65 33.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.892 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 77' ' ' PHE . 56.4 t -120.79 130.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 111.211 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.19 127.65 38.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 71.140000000000001 110.949 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.803 HG21 ' HA ' ' A' ' 71' ' ' ILE . 18.2 m -91.1 -176.32 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 72.310000000000002 111.148 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.432 ' HB3' HG12 ' A' ' 10' ' ' ILE . 40.5 t80 -75.84 -76.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -58.68 148.03 30.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 75.120000000000005 110.917 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.464 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -121.29 159.37 50.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.565 0.698 . . . . 70.019999999999996 111.093 -179.975 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 100' ' ' ILE . 52.8 Cg_endo -69.8 162.28 42.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.568 2.178 . . . . 65.540000000000006 112.343 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.01 56.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 74.019999999999996 112.458 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.78 73.12 0.78 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.683 0.754 . . . . 64.239999999999995 110.869 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -178.68 2.43 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.787 2.325 . . . . 71.540000000000006 112.355 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 73.120000000000005 110.917 179.943 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.725 0.298 . . . . 73.420000000000002 110.937 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 1.266 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -126.97 -38.05 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.200000000000003 110.883 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.214 ' CD2' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER 178.92 -161.02 0.03 OUTLIER 'General case' 0 C--O 1.183 -2.442 0 CA-C-O 118.216 -0.897 . . . . 75.430000000000007 110.906 -179.794 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.011 ' CX2' ' HB2' ' A' ' 92' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.466 ' HB1' ' NE ' ' A' ' 94' ' ' ARG . . . -41.57 120.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.819 -0.628 . . . . 31.030000000000001 111.132 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.48 80.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.450000000000003 110.861 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 1.029 ' HG2' HH12 ' A' ' 94' ' ' ARG . 55.2 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 64.200000000000003 110.862 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.555 -0.218 . . . . 71.209999999999994 112.555 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.91 158.08 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 52.439999999999998 110.885 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.666 ' HB1' HH11 ' A' ' 94' ' ' ARG . . . -59.63 96.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 65.239999999999995 111.048 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.61 133.25 37.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 53.219999999999999 110.917 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -84.65 120.76 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 110.91 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.584 HG21 HD11 ' A' ' 14' ' ' LEU . 46.2 mm -125.88 121.98 60.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 65.239999999999995 111.119 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -94.19 139.83 30.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 74.439999999999998 111.143 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.76 167.0 26.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 111.088 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.37 148.12 44.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 73.030000000000001 110.876 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 71' ' ' ILE . 32.1 mt -52.51 121.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 74.530000000000001 111.222 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.72 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 88.76 7.72 70.87 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 74.439999999999998 112.476 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.788 ' O ' HG22 ' A' ' 69' ' ' VAL . 10.7 mm-40 -101.76 139.43 20.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 62.310000000000002 110.822 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 143.05 49.4 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.682 2.255 . . . . 70.319999999999993 112.286 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.584 HD11 HG21 ' A' ' 6' ' ' ILE . 25.7 tp -145.58 141.84 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 75.099999999999994 110.95 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.6 t -123.16 146.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 111.13 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.536 HD12 HD23 ' A' ' 64' ' ' LEU . 58.4 mt -130.87 146.62 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.921 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.47 152.13 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 110.87 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.1 t -107.34 100.73 10.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 44.229999999999997 110.869 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -58.96 122.04 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 63.140000000000001 110.89 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.583 ' CA ' HG21 ' A' ' 89' ' ' THR . . . 125.53 -38.42 2.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.689 -0.767 . . . . 42.100000000000001 112.466 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.0 129.35 44.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.519 0.676 . . . . 53.219999999999999 111.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.64 0.16 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.752 2.301 . . . . 74.239999999999995 112.374 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -49.65 -49.89 45.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 72.329999999999998 110.913 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 153.6 41.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.568 0.699 . . . . 72.109999999999999 110.91 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.4 Cg_endo -69.8 109.85 2.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 73.340000000000003 112.346 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.3 Cg_endo -69.71 -85.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.757 2.304 . . . . 71.219999999999999 112.343 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -100.26 -176.55 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.549999999999997 110.917 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.02 137.22 58.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 51.020000000000003 110.877 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -136.19 155.27 50.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.929 179.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -120.87 148.52 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.030000000000001 110.952 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' CZ2' HD22 ' A' ' 29' ' ' LEU . 1.1 m95 -127.73 145.05 51.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.948 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -145.08 144.25 30.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 110.889 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' CE2' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -134.92 134.98 41.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 73.109999999999999 110.908 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -117.92 120.83 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 34.32 110.867 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.809 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 7.1 p -141.44 179.52 6.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 53.030000000000001 111.096 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.81 -133.26 20.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 73.400000000000006 112.568 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.7 mmm-85 -112.77 -36.78 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 72.200000000000003 110.914 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.535 HG23 ' HG3' ' A' ' 39' ' ' GLU . 2.3 t -179.16 -27.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 75.120000000000005 111.114 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 38' ' ' THR . 16.0 mt-10 -100.72 32.59 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 74.219999999999999 110.859 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -126.17 -6.68 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.299999999999997 111.089 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 t90 -73.92 128.14 34.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.921 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.71 ' HE3' HD22 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -137.63 159.07 43.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 75.239999999999995 110.958 179.939 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.2 t -87.2 121.54 38.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 111.094 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.45 146.76 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.917 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.574 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -123.69 162.01 43.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 61.340000000000003 110.875 -179.936 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.703 ' HA ' HG11 ' A' ' 58' ' ' VAL . 53.5 Cg_endo -69.61 -0.14 6.37 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.265 . . . . 73.439999999999998 112.35 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -140.35 86.53 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 55.009999999999998 110.862 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLY . . . -66.41 -45.84 82.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 75.409999999999997 112.544 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . 35.76 45.06 0.74 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.671 -0.776 . . . . 50.409999999999997 112.539 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -141.43 -165.17 10.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 65.140000000000001 112.565 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 55' ' ' VAL . 53.3 Cg_endo -69.87 105.48 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.667 2.244 . . . . 73.0 112.355 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -70.0 -34.73 73.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.319999999999993 110.954 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.61 -26.8 68.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 110.947 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -90.23 -42.64 10.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 72.25 110.832 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 51' ' ' PRO . 9.2 m -124.63 -125.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 75.140000000000001 111.141 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -148.38 172.66 14.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.107 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -122.79 159.74 27.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.815 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.703 HG11 ' HA ' ' A' ' 46' ' ' PRO . 52.9 t -107.92 129.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 72.230000000000004 111.114 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 63' ' ' SER . 45.4 mt -69.1 156.13 92.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.521 0.676 . . . . 53.43 110.951 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 53.3 Cg_endo -69.76 -22.2 32.39 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.672 2.248 . . . . 71.439999999999998 112.309 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -83.32 0.6 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 73.420000000000002 110.892 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.51 10.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.773 -0.727 . . . . 75.140000000000001 112.575 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.687 ' HB2' HD12 ' A' ' 59' ' ' LEU . 9.1 m -113.7 178.88 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 73.430000000000007 110.863 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD23 HD12 ' A' ' 16' ' ' LEU . 12.9 tp -128.81 127.52 42.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.905 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.442 ' N ' HD12 ' A' ' 64' ' ' LEU . 46.5 t80 -126.17 130.8 51.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 71.420000000000002 110.922 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.707 HD22 HG12 ' A' ' 69' ' ' VAL . 2.9 mp -117.83 128.18 26.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.532 0.682 . . . . 45.119999999999997 110.942 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.15 17.19 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.661 2.241 . . . . 74.010000000000005 112.33 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.72 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -167.73 101.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 51.310000000000002 111.118 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 12' ' ' GLU . 15.5 m -73.06 113.28 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 111.139 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.82 163.65 36.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.694 -0.765 . . . . 75.129999999999995 112.501 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.66 -30.02 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.777 0.323 . . . . 73.150000000000006 111.086 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.14 -23.77 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 73.230000000000004 110.918 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.61 -5.18 57.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.9 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.76 141.4 58.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 73.420000000000002 110.791 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.632 ' C ' HD12 ' A' ' 76' ' ' ILE . . . 157.66 -138.93 6.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.707 -0.759 . . . . 32.520000000000003 112.481 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.632 HD12 ' C ' ' A' ' 75' ' ' GLY . 3.0 mp -130.1 135.55 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 75.420000000000002 111.125 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.826 ' CE2' HD12 ' A' ' 33' ' ' LEU . 8.4 m-85 -102.61 134.8 45.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.019999999999996 110.906 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 1.304 ' NH2' ' NZ ' ' B' ' 4' ' ' MCL . 1.6 mmt180 -128.02 127.66 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.530000000000001 110.915 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.6 t -121.56 149.48 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 52.030000000000001 110.9 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.46 132.55 23.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 62.210000000000001 110.878 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 162.26 30.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 62.140000000000001 111.082 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.2 ttm -130.36 125.93 35.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 73.549999999999997 110.857 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -86.42 170.96 11.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 74.530000000000001 110.857 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -17.81 62.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.91 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -73.37 -25.59 60.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 71.219999999999999 110.841 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.01 19.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 24.039999999999999 112.496 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -84.59 146.78 27.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 74.030000000000001 110.94 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.24 142.34 35.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.041 0.448 . . . . 74.0 110.834 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.583 HG21 ' CA ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -102.54 131.84 49.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 70.209999999999994 111.145 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.196 ' CE ' ' H11' ' B' ' 4' ' ' MCL . 7.6 mtpp -104.97 140.86 37.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 73.030000000000001 110.984 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -146.57 127.23 14.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 61.32 110.876 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -124.74 129.4 50.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 54.450000000000003 110.856 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.439 ' CG ' HD22 ' A' ' 16' ' ' LEU . 8.4 m-85 -127.92 118.01 22.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 75.109999999999999 110.884 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 1.571 ' CZ ' ' CB ' ' B' ' 5' ' ' ALA . 11.5 mmm-85 -85.57 130.33 34.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 54.140000000000001 110.891 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 77' ' ' PHE . 77.4 t -122.54 132.25 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 70.109999999999999 111.105 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -131.17 128.26 39.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.976 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.4 m -93.86 -176.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 75.530000000000001 111.126 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -67.03 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 110.919 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.86 145.71 54.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 110.924 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -121.44 159.58 49.65 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.691 0.758 . . . . 75.409999999999997 111.105 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 100' ' ' ILE . 54.5 Cg_endo -69.67 -37.09 9.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.243 . . . . 70.340000000000003 112.358 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.62 34.93 56.32 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.716 -0.754 . . . . 41.32 112.581 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.2 tttt 53.04 73.9 0.86 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 71.140000000000001 110.937 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 163.22 39.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.737 2.291 . . . . 75.540000000000006 112.327 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 73.450000000000003 110.879 179.973 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.715 0.293 . . . . 72.239999999999995 110.859 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.632 ' HB2' HD13 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -123.17 -41.4 2.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 73.340000000000003 110.894 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.126 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -167.77 -166.59 0.76 Allowed 'General case' 0 C--O 1.183 -2.395 0 CA-C-O 118.081 -0.961 . . . . 74.209999999999994 110.915 -179.932 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' MCL . . . . . 1.304 ' NZ ' ' NH2' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 1.571 ' CB ' ' CZ ' ' A' ' 94' ' ' ARG . . . -38.78 116.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.789 -0.641 . . . . 43.520000000000003 111.082 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -141.72 65.86 1.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.853 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.168 -0.469 . . . . 71.299999999999997 110.899 -179.898 . . . . . . . . 0 0 . 1 stop_ save_